Citrus Sinensis ID: 001856
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1003 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.322 | 0.153 | 0.516 | 2e-99 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.330 | 0.184 | 0.455 | 5e-86 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.344 | 0.233 | 0.440 | 7e-86 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.330 | 0.190 | 0.449 | 8e-85 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.305 | 0.116 | 0.462 | 9e-85 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.330 | 0.126 | 0.449 | 2e-84 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.314 | 0.238 | 0.459 | 3e-83 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.315 | 0.201 | 0.461 | 9e-83 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.313 | 0.239 | 0.454 | 3e-82 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.314 | 0.200 | 0.459 | 5e-82 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 364 bits (935), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 189/366 (51%), Positives = 238/366 (65%), Gaps = 43/366 (11%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKK D IRKN V ++ ER+IL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
N FVV+ FY+F + LYLVMEYL GGD SLLR LGC +E +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS------------------------ 743
+VHRDLKPDN+LI GHIKLTDFGLSK+G+I+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 744 --TDDLS---GPAVSGTTLLGDEEPQLTASEHQQE-------RRKKRSAVGTPDYLAPEI 791
DD S P +G T L + + + Q++ ++ + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 792 LLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL--NRKIPWPRVPEEMSPE 849
LLGTGHG T DWW++GIIL+E + G PPFN + P+ IF +IL +R++ W PEE+S E
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISSE 1820
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKA--AFVPTSESALDTSY 907
A DLI + L DP++RLG+ GA EVK H FF ++NWDTL Q+ F+P E+ DT Y
Sbjct: 1821 AKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEMDNIFLPKPENNYDTDY 1880
Query: 908 FTSRYS 913
F R S
Sbjct: 1881 FWDRQS 1886
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 159/349 (45%), Positives = 217/349 (62%), Gaps = 18/349 (5%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD + S PSK S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 486 DTPETDDSIEGHGAS--LPSKKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKI 543
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 544 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKN 603
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 604 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 663
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + E + GTP+Y+APE++L G+G D
Sbjct: 664 LTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVD 707
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP E + P+A DL + L ++P
Sbjct: 708 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNP 767
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+G A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 768 LERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 162/368 (44%), Positives = 223/368 (60%), Gaps = 22/368 (5%)
Query: 544 LCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFG 603
L E+V D D S++ + D + P PS+ + DFE IK IS GA+G
Sbjct: 358 LEEIVQLDHYDTESSLQLDQEDYHDPYI------PSTPSRKKPCESDFETIKLISNGAYG 411
Query: 604 RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663
V+L + + T FA+K + K ++I +N + + ERDIL NPFVV F SF R +
Sbjct: 412 AVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENPFVVSMFCSFETRRH 471
Query: 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723
L +VMEY+ GGD +LL+N+G L D++R+Y AE VLALEYLH+ +VHRDLKPDNLLI
Sbjct: 472 LCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYGIVHRDLKPDNLLIT 531
Query: 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783
GHIKLTDFGLSKVGL+N T +L + E + GT
Sbjct: 532 SLGHIKLTDFGLSKVGLMNMTTNLYEGHI----------------EKDTREFLDKQVCGT 575
Query: 784 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP 843
P+Y+APE++L G+G DWW++GIIL+E +VG PF + P+++F +++ I WP
Sbjct: 576 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIIWPGGE 635
Query: 844 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESAL 903
E + ++ DLI R L ++ +RLG+GGA EVKQH FF ++W+ L RQKA FVP E+
Sbjct: 636 EALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLRQKAEFVPQLEADD 695
Query: 904 DTSYFTSR 911
DTSYF +R
Sbjct: 696 DTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 8e-85, Method: Compositional matrix adjust.
Identities = 157/349 (44%), Positives = 216/349 (61%), Gaps = 18/349 (5%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD V S PS+ S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 427 DTPETDDSVEGRGVS--QPSQKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKI 484
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 485 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN 544
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 545 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 604
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + E + GTP+Y+APE++L G+G D
Sbjct: 605 LTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVD 648
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP + + P+A DL + L ++P
Sbjct: 649 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNP 708
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+ A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 709 LERLGTSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 9e-85, Method: Compositional matrix adjust.
Identities = 149/322 (46%), Positives = 208/322 (64%), Gaps = 16/322 (4%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DFE IK IS GA+G V+ + + + FA+K + K ++I +N ++ ERDIL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
FVV + SF R +L +VMEY+ GGD +L++N+G L D+AR+Y AE VLALEYLH+
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+VHRDLKPDNLL+ GHIKLTDFGLSKVGL++ T +L + E
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNLYEGHI----------------E 735
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
+ GTP+Y+APE++L G+G DWW++GIIL+E +VG PF + P+++F
Sbjct: 736 KDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 795
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 889
+++ +I WP E P+A DLI L ++P +RLG+GGA EVKQH FF+ ++W++L
Sbjct: 796 GQVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLL 855
Query: 890 RQKAAFVPTSESALDTSYFTSR 911
RQKA F+P ES DTSYF +R
Sbjct: 856 RQKAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 157/349 (44%), Positives = 219/349 (62%), Gaps = 18/349 (5%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
+ P D+ V S TS K R S DFE IK IS GA+G V+ + + + FA+K +
Sbjct: 542 ETPEMDESVSSSNTSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKI 599
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV + SF R +L +VMEY+ GGD +L++N
Sbjct: 600 NKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKN 659
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHIKLTDFGLSKVGL++
Sbjct: 660 MGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMS 719
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + E + GTP+Y+APE++L G+G D
Sbjct: 720 MTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVD 763
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP E P+A +LI L ++P
Sbjct: 764 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNP 823
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+GGA EVKQH FF+ ++W++L RQKA F+P ES DTSYF +R
Sbjct: 824 LERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 152/331 (45%), Positives = 206/331 (62%), Gaps = 16/331 (4%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
PS+ + DFE IK IS GA+G V+L + R T FAIK + K ++I +N ++ + ER
Sbjct: 379 PSRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVER 438
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
DIL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L D+AR+Y AE VL
Sbjct: 439 DILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVL 498
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
ALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++ +L +
Sbjct: 499 ALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYEGHI-------- 550
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
E + GTP+Y+APE++ G+G DWW++G+IL+E +VG PF
Sbjct: 551 --------EKDAREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPF 602
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ P+++F +++ +I WP E + +A DLI R L + P RLG+GG EVKQH FF
Sbjct: 603 FGDTPEELFGQVVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFF 662
Query: 881 KDINWDTLARQKAAFVPTSESALDTSYFTSR 911
++W L R KA FVP E+ DTSYF +R
Sbjct: 663 LALDWAGLLRHKAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 9e-83, Method: Compositional matrix adjust.
Identities = 155/336 (46%), Positives = 211/336 (62%), Gaps = 20/336 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DF+ IK IS GA+G V+L + R T FA+K + K ++I +N ++ ERDIL N
Sbjct: 372 NDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAEN 431
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PFVV F SF R +L +VMEY+ GGD +LL+N+G L ++AR+Y AE VLALEYLH+
Sbjct: 432 PFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNY 491
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+VHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L +
Sbjct: 492 GIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHI---------------- 535
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
E + GTP+Y+APE++L G+G DWW++GIIL+E +VG PF + P+++
Sbjct: 536 EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 595
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888
F +++ I WP E + EA LI L +P RLG+GGA EVKQH FF+D++W L
Sbjct: 596 FGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGL 655
Query: 889 ARQKAAFVPTSESALDTSYFTSR----YSWNTTDEN 920
RQKA F+P ES DTSYF +R + N+ DE+
Sbjct: 656 LRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSYDED 691
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 150/330 (45%), Positives = 205/330 (62%), Gaps = 16/330 (4%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
S+ + DFE IK IS GA+G V+L + R T FAIK + K ++I +N ++ + ERD
Sbjct: 358 SRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERD 417
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
IL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L D+AR+Y AE VLA
Sbjct: 418 ILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLA 477
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
LEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++ +L +
Sbjct: 478 LEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYEGHI--------- 528
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
E + GTP+Y+APE++ G+G DWW++G++L+E +VG PF
Sbjct: 529 -------EKDAREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFF 581
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ P+++F +++ +I WP E + +A DLI R L + P RLG+GG EVKQH FF
Sbjct: 582 GDTPEELFGQVVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFL 641
Query: 882 DINWDTLARQKAAFVPTSESALDTSYFTSR 911
++W L R KA FVP E+ DTSYF +R
Sbjct: 642 ALDWAGLLRHKAEFVPQLEAEDDTSYFDTR 671
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 154/335 (45%), Positives = 210/335 (62%), Gaps = 20/335 (5%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DF+ IK IS GA+G V+L + R T FA+K + K ++I +N ++ ERDIL NP
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 434
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
FVV F SF R +L +VMEY+ GGD +LL+N+G L ++AR+Y AE VLALEYLH+
Sbjct: 435 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYG 494
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+VHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L + E
Sbjct: 495 IVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHI----------------E 538
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
+ GTP+Y+APE++L G+G DWW++GIIL+E +VG PF + P+++F
Sbjct: 539 KDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 598
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 889
+++ I WP E + +A LI L +P RLG+GGA EVKQH FF+D++W L
Sbjct: 599 GQVISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLL 658
Query: 890 RQKAAFVPTSESALDTSYFTSR----YSWNTTDEN 920
RQKA F+P ES DTSYF +R + N+ DE+
Sbjct: 659 RQKAEFIPHLESEDDTSYFDTRSDRYHHVNSYDED 693
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1003 | ||||||
| 255585466 | 1289 | kinase, putative [Ricinus communis] gi|2 | 0.979 | 0.761 | 0.866 | 0.0 | |
| 224121136 | 1322 | predicted protein [Populus trichocarpa] | 0.968 | 0.734 | 0.834 | 0.0 | |
| 359491046 | 1304 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.75 | 0.831 | 0.0 | |
| 224133272 | 1319 | predicted protein [Populus trichocarpa] | 0.972 | 0.739 | 0.832 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.701 | 0.817 | 0.0 | |
| 356520647 | 1296 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.754 | 0.811 | 0.0 | |
| 30684702 | 1296 | protein kinase family protein [Arabidops | 0.970 | 0.750 | 0.752 | 0.0 | |
| 6729348 | 1023 | IRE homolog 1 [Arabidopsis thaliana] | 0.970 | 0.951 | 0.752 | 0.0 | |
| 26449548 | 1296 | putative protein kinase [Arabidopsis tha | 0.970 | 0.750 | 0.751 | 0.0 | |
| 9294489 | 1398 | IRE homolog; protein kinase-like protein | 0.967 | 0.693 | 0.743 | 0.0 |
| >gi|255585466|ref|XP_002533426.1| kinase, putative [Ricinus communis] gi|223526726|gb|EEF28957.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1703 bits (4410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 855/987 (86%), Positives = 908/987 (91%), Gaps = 5/987 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLA+FA DLVG+LEKNAESHPEWQETIEDLLVLARSCAM+
Sbjct: 307 EEILVVIRAKFDKAKEEVNSDLAIFAADLVGVLEKNAESHPEWQETIEDLLVLARSCAMS 366
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SP EFWLQCE IVQELDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE++
Sbjct: 367 SPSEFWLQCESIVQELDDRRQELPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDENV 426
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
FQ RQSR+LHSA+KRIP +RDGK S+ AKASKAAS++KSYSQEQHGLDWKRD + G
Sbjct: 427 FQLRQSRLLHSAEKRIPPSIVRDGKSSSAAKASKAASAKKSYSQEQHGLDWKRDQVAQLG 486
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
+ L P DD +K+++S + RM+SWK+LPSP GK +KE SKE ND K+EPLK N R
Sbjct: 487 SSL-PTADDASKNMDSPGSGARMASWKRLPSPAGKSVKEVAPSKENNDCKIEPLKILNNR 545
Query: 258 RGLSEIDLTA-KPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEV 316
+G+S+ DLTA K SE P A ++ EHS KHQHK+SWGYWGDQQN+SDD+S IICRICEEEV
Sbjct: 546 KGVSDADLTATKLSELPVAKDSHEHSMKHQHKISWGYWGDQQNVSDDTS-IICRICEEEV 604
Query: 317 PTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAK 376
PT HVEDHS+ICAIADR DQKGLSVNERL RISETL+KM+ES QKD V GSPDVAK
Sbjct: 605 PTLHVEDHSRICAIADRSDQKGLSVNERLARISETLDKMIESIAQKDTQPAV-GSPDVAK 663
Query: 377 VSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKS 436
VSNSSVTEESDVLSPK SDWSRRGSEDMLD PEADNSVFMDDLKGLPSM+CKTRFGPKS
Sbjct: 664 VSNSSVTEESDVLSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPSMSCKTRFGPKS 723
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPL 496
DQGM TSSAGSMTPRSPLLTPRTS IDLLL GKGA SEHDD PQM ELADIARCV TTPL
Sbjct: 724 DQGMATSSAGSMTPRSPLLTPRTSPIDLLLTGKGAFSEHDDLPQMTELADIARCVVTTPL 783
Query: 497 DDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDIT 556
DDD SIPYLLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKYLQLCELV D++VDIT
Sbjct: 784 DDDRSIPYLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYLQLCELVEDERVDIT 843
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
ST+I+EDAPLEDDVVRSLRTSPIH SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL
Sbjct: 844 STIIDEDAPLEDDVVRSLRTSPIHSSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 903
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL
Sbjct: 904 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 963
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
YSLLRNLGCLDE+VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS
Sbjct: 964 YSLLRNLGCLDEEVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 1023
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
KVGLINSTDDLSGPAVSGT++L D+EPQL+ASEHQ+ERRKKRSAVGTPDYLAPEILLGTG
Sbjct: 1024 KVGLINSTDDLSGPAVSGTSMLEDDEPQLSASEHQRERRKKRSAVGTPDYLAPEILLGTG 1083
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 856
HGTTADWWSVG+ILFELIVGIPPFNAEHPQ IFDNILNRKIPWPRVPEEMSPEA DLIDR
Sbjct: 1084 HGTTADWWSVGVILFELIVGIPPFNAEHPQIIFDNILNRKIPWPRVPEEMSPEAQDLIDR 1143
Query: 857 FLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNT 916
LTEDP RLG+GGASEVKQHVFFKDINWDTLARQKAAFVP+SESALDTSYFTSRYSWNT
Sbjct: 1144 LLTEDPEVRLGAGGASEVKQHVFFKDINWDTLARQKAAFVPSSESALDTSYFTSRYSWNT 1203
Query: 917 TDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFK 976
+D+ +YP SDFEDSSDADSLSGSSSCLSNRQ+EVGDECGGLAEFESGSSVNYSFSNFSFK
Sbjct: 1204 SDQ-VYPTSDFEDSSDADSLSGSSSCLSNRQDEVGDECGGLAEFESGSSVNYSFSNFSFK 1262
Query: 977 NLSQLASINYDLLSKGWKDDPPRNPNA 1003
NLSQLASINYDLLSKGWKDDP NPN+
Sbjct: 1263 NLSQLASINYDLLSKGWKDDPSTNPNS 1289
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121136|ref|XP_002318507.1| predicted protein [Populus trichocarpa] gi|222859180|gb|EEE96727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1652 bits (4278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 834/999 (83%), Positives = 884/999 (88%), Gaps = 28/999 (2%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLA+FA DLVGILEKNA+SHPEWQETIEDLLVLARSCAMT
Sbjct: 330 EEILVVIRAKFDKAKEEVNSDLAIFAADLVGILEKNADSHPEWQETIEDLLVLARSCAMT 389
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SPGEFWLQCE IVQELDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKE L E+E++
Sbjct: 390 SPGEFWLQCEVIVQELDDRRQELPPGILKQLHTRMLFILTRCTRLLQFHKERVLDENENV 449
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQE-----------QHGL 186
F RQSR+LH DKRIP RDGK S+ AK KAAS RKSYSQE Q
Sbjct: 450 FGLRQSRLLHPVDKRIPSFVGRDGKVSSAAK--KAASGRKSYSQEHKAALVRKSYSQEQR 507
Query: 187 DWKRDHAVKQGNILSPPGD-----DNA-KSLESSAARDRMSSWKKLPSPVGKIMKESPTS 240
DW R+ + G + PG DNA KS ES RDR+SSWK LPSP GK KE
Sbjct: 508 DWSREQDILPGKL---PGKLLSLADNALKSDESPTGRDRISSWKPLPSPPGKSTKEVVPV 564
Query: 241 KEQNDGKVEPLKSSNIRRGLSEIDLTA-KPSEFPPAAETLEHSSKHQHKVSWGYWGDQQN 299
+EQND K+EPLK+SN RRG S++ L A K S+ P + E+S+KHQ K+SWG WGDQQN
Sbjct: 565 EEQNDSKIEPLKTSNDRRGASDVHLAAAKVSDLPMVKDVHENSTKHQPKISWGNWGDQQN 624
Query: 300 ISDDSSSIICRICEEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESS 359
I+D+SS IICRICEEEVPT HVEDH +ICAIADRCDQKGLSVNERL+RISETLEKM+
Sbjct: 625 IADESS-IICRICEEEVPTLHVEDHLRICAIADRCDQKGLSVNERLIRISETLEKMI--- 680
Query: 360 VQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDD 419
VQKDIH+ V GSPDVAK+SNSSVTEESDVLSPK SDWS RGSEDMLD PEADN+VFMDD
Sbjct: 681 VQKDIHHAV-GSPDVAKISNSSVTEESDVLSPKLSDWSHRGSEDMLDCFPEADNAVFMDD 739
Query: 420 LKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFP 479
LKGLPSM+CKTRFGPKSDQGM TSSAGSMTPRSPLLTP+TS IDLLLAGK A SEHDD P
Sbjct: 740 LKGLPSMSCKTRFGPKSDQGMATSSAGSMTPRSPLLTPKTSHIDLLLAGKSAFSEHDDLP 799
Query: 480 QMNELADIARCVATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIRE 539
Q+NELADIARCVATTPL+DD S PYLL+ L DLRVVI+RRKFDALTVETFG RIEKLIRE
Sbjct: 800 QLNELADIARCVATTPLEDDRSTPYLLTCLGDLRVVIERRKFDALTVETFGTRIEKLIRE 859
Query: 540 KYLQLCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISR 599
KYLQLCELV D+KVDI STVI ED PLEDDVVRSLRTSPIH SKDRTSIDDFEIIKPISR
Sbjct: 860 KYLQLCELVEDEKVDIASTVIHEDTPLEDDVVRSLRTSPIHSSKDRTSIDDFEIIKPISR 919
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
GAFGRVFLAKKR TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT
Sbjct: 920 GAFGRVFLAKKRATGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 979
Query: 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719
CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN
Sbjct: 980 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 1039
Query: 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 779
LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT++L D+EPQL+ SEHQ+ERRKKRS
Sbjct: 1040 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTSMLVDDEPQLSTSEHQRERRKKRS 1099
Query: 780 AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW 839
AVGTPDYLAPEILLGTGHGTTADWWSVG+ILFELIVGIPPFNAEHPQ IFDNILN KIPW
Sbjct: 1100 AVGTPDYLAPEILLGTGHGTTADWWSVGVILFELIVGIPPFNAEHPQTIFDNILNCKIPW 1159
Query: 840 PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTS 899
PRVPEEMSPEA DLIDR LTEDP+QRLG+GGASEVKQHVFFKDINWDTLARQKAAFVP+S
Sbjct: 1160 PRVPEEMSPEAQDLIDRLLTEDPYQRLGAGGASEVKQHVFFKDINWDTLARQKAAFVPSS 1219
Query: 900 ESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAE 959
ESALDTSYFTSRYSWNT+D+ IYPASDFEDSSDADSLSGSSSCLSNR +EVGDEC GLAE
Sbjct: 1220 ESALDTSYFTSRYSWNTSDDAIYPASDFEDSSDADSLSGSSSCLSNRHDEVGDECQGLAE 1279
Query: 960 FESGSSVNYSFSNFSFKNLSQLASINYDLLSKGWKDDPP 998
FESGS VNYSFSNFSFKNLSQLASINYD+LSKGWKDDPP
Sbjct: 1280 FESGSGVNYSFSNFSFKNLSQLASINYDILSKGWKDDPP 1318
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491046|ref|XP_003634211.1| PREDICTED: uncharacterized protein LOC100259538 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1631 bits (4224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 825/992 (83%), Positives = 881/992 (88%), Gaps = 14/992 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L VIR KFDKAKEEVNSDLA+FA DLVGILEKNAESHPEWQETIEDLLVLAR CA+T
Sbjct: 321 EEVLAVIRVKFDKAKEEVNSDLAIFAADLVGILEKNAESHPEWQETIEDLLVLARRCAVT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S G+FWLQCEGIVQELDDRRQELP G LKQL+TRMLFILTRCTRLLQFHKES LAEDEH+
Sbjct: 381 SSGQFWLQCEGIVQELDDRRQELPMGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEHV 440
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSR+LHSADKR+P G RDGK S+ A + A++RKSYSQEQHGLDWK DHA++ G
Sbjct: 441 LQLRQSRILHSADKRVPSGVGRDGK-SSSAAKASRAATRKSYSQEQHGLDWKSDHAIQPG 499
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N LSP + K+L+S RDRM+SWKKLPSP GK +KES KEQ D KVE K N
Sbjct: 500 NFLSPTSE-TTKTLDSPVGRDRMASWKKLPSPAGKTVKESVPMKEQTDIKVESSKMLN-N 557
Query: 258 RGLSEIDLT-AKPSEFPPAAETLEHSS---KHQHKVSWGYWGDQQNISDDSSSIICRICE 313
+ + ++DLT AKP + PPA + HSS KHQHK SWGYWGDQ NIS+DSS IICRICE
Sbjct: 558 QAIPDVDLTTAKPPDIPPAKDFHGHSSISSKHQHKASWGYWGDQPNISEDSS-IICRICE 616
Query: 314 EEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPD 373
EEVPTSHVEDHS+ICAIADRCDQKG+SVNERL+RI+ETLEKMMES QKD +V GSPD
Sbjct: 617 EEVPTSHVEDHSRICAIADRCDQKGISVNERLIRIAETLEKMMESLSQKDFQHV--GSPD 674
Query: 374 V-AKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRF 432
V AKVSNSSVTEESDVLSPK SD SRRGSEDMLD PEADN VF+DDLKG PSM+CKTRF
Sbjct: 675 VVAKVSNSSVTEESDVLSPKLSDCSRRGSEDMLDCFPEADNYVFVDDLKGFPSMSCKTRF 734
Query: 433 GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVA 492
GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGA SEHDD PQMNELADI+RC A
Sbjct: 735 GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGAYSEHDDLPQMNELADISRCAA 794
Query: 493 TTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDK 552
L DD S+ LL LEDLRVVIDRRK DALTVETFG RIEKLIREKYLQLCELV D+K
Sbjct: 795 NASLHDDHSMSILLGCLEDLRVVIDRRKLDALTVETFGTRIEKLIREKYLQLCELVDDEK 854
Query: 553 VDITSTVIEEDAPLEDDVVRSLRTSPIHP-SKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
VDITSTVI+EDAPLEDDVVRSLRTSPIH SKDRTSIDDFEIIKPISRGAFGRVFLAKKR
Sbjct: 855 VDITSTVIDEDAPLEDDVVRSLRTSPIHSTSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 914
Query: 612 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671
TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL
Sbjct: 915 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 974
Query: 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731
NGGDLYSLLR+LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT
Sbjct: 975 NGGDLYSLLRSLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 1034
Query: 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 791
DFGLSKVGLINSTDDLSGPAVSGT+LL +EPQL+ SE +ERRKKRSAVGTPDYLAPEI
Sbjct: 1035 DFGLSKVGLINSTDDLSGPAVSGTSLLEQDEPQLSTSEQHRERRKKRSAVGTPDYLAPEI 1094
Query: 792 LLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAH 851
LLGTGHGTTADWWSVG+ILFELIVGIPPFNAEHPQ IFDNILNR IPWPRVPEEMSPEA
Sbjct: 1095 LLGTGHGTTADWWSVGVILFELIVGIPPFNAEHPQMIFDNILNRNIPWPRVPEEMSPEAQ 1154
Query: 852 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
DLI R LTEDP+QRLG+GGASEVKQH FF+DINWDTLARQKAAFVP+SESALDTSYFTSR
Sbjct: 1155 DLIHRLLTEDPYQRLGAGGASEVKQHAFFRDINWDTLARQKAAFVPSSESALDTSYFTSR 1214
Query: 912 YSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFS 971
YSWN +D + + EDSSD S+SGSSSCLSNRQ+E+GDECGGLAEF+SGSSVNYSFS
Sbjct: 1215 YSWNPSDNQVLASE--EDSSDDGSMSGSSSCLSNRQDELGDECGGLAEFDSGSSVNYSFS 1272
Query: 972 NFSFKNLSQLASINYDLLSKGWKDDPPRNPNA 1003
NFSFKNLSQLASINYDLL+KGWK+DPP N NA
Sbjct: 1273 NFSFKNLSQLASINYDLLTKGWKEDPPTNHNA 1304
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133272|ref|XP_002321526.1| predicted protein [Populus trichocarpa] gi|222868522|gb|EEF05653.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1626 bits (4210), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 826/992 (83%), Positives = 881/992 (88%), Gaps = 17/992 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLAVFA DLVGILEKNA+SHPEWQETIEDLLVLARSCAMT
Sbjct: 328 EEILVVIRAKFDKAKEEVNSDLAVFAADLVGILEKNADSHPEWQETIEDLLVLARSCAMT 387
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SPGEFWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE++
Sbjct: 388 SPGEFWLQCEGIVQDLDDRRQELPPGILKQLHTRMLFILTRCTRLLQFHKESGLAEDENI 447
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGK-----------GSTIAKASKAASSRKSYSQEQHGL 186
FQ Q R+L SADK IP G RDGK + ++ KAAS RKSYSQEQ
Sbjct: 448 FQLHQLRLLQSADKHIPPGVGRDGKISSAPKKAASAKKSYSQEQKAASVRKSYSQEQCA- 506
Query: 187 DWKRDHAVKQGNILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDG 246
W R+ V G LSP D+ KS ES R+R+SSWK LPSP KI KE + QND
Sbjct: 507 -WGREQDVLPGKFLSP-ADNTPKSDESPTGRNRISSWKPLPSPPVKITKEVVPPRGQNDD 564
Query: 247 KVEPLKSSNIRRGLSEIDLTA-KPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSS 305
K EPLK+SN R+G S++ L A K SE P + EHS+KHQHK+SWG WGDQQNI+D+SS
Sbjct: 565 KNEPLKTSNDRKGASDVLLAAAKASELPLVKDLHEHSTKHQHKISWGNWGDQQNIADESS 624
Query: 306 SIICRICEEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIH 365
IICRICEEEVPT +VEDHS+ICAI DRCDQ LSVNERL+RISETLEKM+ES QKDI
Sbjct: 625 -IICRICEEEVPTLYVEDHSRICAITDRCDQMCLSVNERLIRISETLEKMIESFAQKDIQ 683
Query: 366 NVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPS 425
+ V GSPD+AKVSNSSVTEESDVLSPK SDWSRRGSEDMLD+ PEADNS+FMDD+KGLPS
Sbjct: 684 HAV-GSPDIAKVSNSSVTEESDVLSPKLSDWSRRGSEDMLDFFPEADNSIFMDDMKGLPS 742
Query: 426 MACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELA 485
M+CKTRFGPKSDQGM TSSAGSMTPRSPLLTPR SQIDLLLAGK A SEHDD PQ+NELA
Sbjct: 743 MSCKTRFGPKSDQGMATSSAGSMTPRSPLLTPRNSQIDLLLAGKSAFSEHDDLPQLNELA 802
Query: 486 DIARCVATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLC 545
DIARCVAT PL+DD +I YLL+ LEDLRVVIDRRKFDAL VETFG RIEKLIREKYLQLC
Sbjct: 803 DIARCVATMPLEDDRAISYLLTCLEDLRVVIDRRKFDALMVETFGTRIEKLIREKYLQLC 862
Query: 546 ELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRV 605
ELV D+KVDIT+TVI+EDAPLEDDVVRSLRTSP HPSKDRTSIDDF IIKPISRGAFGRV
Sbjct: 863 ELVGDEKVDITNTVIDEDAPLEDDVVRSLRTSPTHPSKDRTSIDDFVIIKPISRGAFGRV 922
Query: 606 FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665
FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY
Sbjct: 923 FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 982
Query: 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725
LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL VVHRDLKPDNLLIAHD
Sbjct: 983 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLHVVHRDLKPDNLLIAHD 1042
Query: 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPD 785
GHIKLTDFGLSKVGLINSTDDLSGPAVSGT++L D+EPQL+ SEHQ+ERRKKRSAVGTPD
Sbjct: 1043 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTSMLVDDEPQLSTSEHQRERRKKRSAVGTPD 1102
Query: 786 YLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEE 845
YLAPEILLGTGHGTTADWWSVG+ILFELI+GIPPFNAEHPQ IFDNILNR IPWPRVPEE
Sbjct: 1103 YLAPEILLGTGHGTTADWWSVGVILFELIIGIPPFNAEHPQTIFDNILNRNIPWPRVPEE 1162
Query: 846 MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDT 905
MSPEA DLIDR LTE P QRLG+GGASEVKQH+FFKDINWDTLARQKAAFVP+SESALDT
Sbjct: 1163 MSPEAQDLIDRLLTEVPDQRLGAGGASEVKQHIFFKDINWDTLARQKAAFVPSSESALDT 1222
Query: 906 SYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSS 965
SYFTSRYSWNT+D+ YPASDFEDSSD+DSLSGSSSCLS+R +EVGDECGGLAEFESGS
Sbjct: 1223 SYFTSRYSWNTSDDPNYPASDFEDSSDSDSLSGSSSCLSHRHDEVGDECGGLAEFESGSC 1282
Query: 966 VNYSFSNFSFKNLSQLASINYDLLSKGWKDDP 997
VNYSFSNFSFKNLSQLASINYDLLSKGWKDDP
Sbjct: 1283 VNYSFSNFSFKNLSQLASINYDLLSKGWKDDP 1314
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1611 bits (4171), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 806/986 (81%), Positives = 876/986 (88%), Gaps = 8/986 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKE+VNSDLA+FA DLVGILEKNA++HP+WQETIEDLLVLARSCAMT
Sbjct: 322 EEILVVIRAKFDKAKEDVNSDLAIFAADLVGILEKNADTHPDWQETIEDLLVLARSCAMT 381
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S GEFWLQCE IVQELDDRRQE PPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE +
Sbjct: 382 SSGEFWLQCESIVQELDDRRQEHPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEPV 441
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
F RQSRVLHSA K IP RD K S+ AKA K SS+K++SQEQ + WK+D ++
Sbjct: 442 FNLRQSRVLHSAGKFIPPSVGRDTKSSSAAKALKP-SSKKAFSQEQSMMGWKKD-VMQPE 499
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N+ P DDNAK +SS+ R+RM+SWKK PSP G+ KE+ K+QN G+VE K+SN +
Sbjct: 500 NLSIPADDDNAKLFDSSSGRNRMASWKKFPSPTGRSPKEAVQLKDQNYGRVESSKASNNK 559
Query: 258 RGLSEIDL-TAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEV 316
R S++DL TAKPSE P ++L+H+SKHQHKVSWGYWGDQQN + + +SIICRICEE+V
Sbjct: 560 RFTSDVDLSTAKPSELLPVKDSLDHASKHQHKVSWGYWGDQQNNNSEENSIICRICEEDV 619
Query: 317 PTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAK 376
PTSHVEDHS+ICA+ADRCDQKGLSVNERL+RIS+TLEKMMES QKD +V GSPDVAK
Sbjct: 620 PTSHVEDHSRICAVADRCDQKGLSVNERLVRISDTLEKMMESCTQKDTQQMV-GSPDVAK 678
Query: 377 VSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKS 436
VSNSS+TEESDV SPK SDWSRRGSEDMLD PEADNSVFMDDLKGLP M+CKTRFGPKS
Sbjct: 679 VSNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPLMSCKTRFGPKS 738
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPL 496
DQGMTTSSAGSMTPRSPL+TPRTSQIDLLLAGKGA SEHDD PQMNELADIARCVA PL
Sbjct: 739 DQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKGAYSEHDDLPQMNELADIARCVANAPL 798
Query: 497 DDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDIT 556
DDD + YLLS L+DLRVV+DRRKFDALTVETFG RIEKLIREKYLQL E+V +K+D
Sbjct: 799 DDDRTTSYLLSCLDDLRVVVDRRKFDALTVETFGTRIEKLIREKYLQLTEMVDVEKIDTE 858
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
STV +D LEDDVVRSLRTSPIH S+DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL
Sbjct: 859 STV--DDDILEDDVVRSLRTSPIHSSRDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 916
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
FAIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCRENLYLVMEYLNGGDL
Sbjct: 917 FAIKVLKKADMIRKNAVESILAERDILITVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 976
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
YSLLRNLGCLDE+VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS
Sbjct: 977 YSLLRNLGCLDEEVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 1036
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
KVGLINSTDDLSGPAV+GT+LL ++E + S Q+ERR+KRSAVGTPDYLAPEILLGTG
Sbjct: 1037 KVGLINSTDDLSGPAVNGTSLLEEDETDVFTSADQRERREKRSAVGTPDYLAPEILLGTG 1096
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 856
HG TADWWSVG+ILFEL+VGIPPFNAEHPQ IFDNILNRKIPWP VPEEMSPEA DLIDR
Sbjct: 1097 HGFTADWWSVGVILFELLVGIPPFNAEHPQIIFDNILNRKIPWPAVPEEMSPEALDLIDR 1156
Query: 857 FLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNT 916
LTEDP+QRLGS GASEVKQHVFFKDINWDTLARQKAAFVP SESALDTSYFTSRYSWNT
Sbjct: 1157 LLTEDPNQRLGSKGASEVKQHVFFKDINWDTLARQKAAFVPASESALDTSYFTSRYSWNT 1216
Query: 917 TDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFK 976
+D +YPASD EDSSDADSLSGSSSCLSNRQ+E GDECGGL EF+SG+SVNYSFSNFSFK
Sbjct: 1217 SDGFVYPASDVEDSSDADSLSGSSSCLSNRQDE-GDECGGLTEFDSGTSVNYSFSNFSFK 1275
Query: 977 NLSQLASINYDLLSKGWKDDPPRNPN 1002
NLSQLASINYD L+KGWKDDP N N
Sbjct: 1276 NLSQLASINYD-LTKGWKDDPATNSN 1300
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520647|ref|XP_003528972.1| PREDICTED: uncharacterized protein LOC100816852 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1565 bits (4051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 800/986 (81%), Positives = 871/986 (88%), Gaps = 8/986 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKE+VNSDLA+FA DLVGILEKNA++HPEWQETIEDLLVLARSCAMT
Sbjct: 319 EEILVVIRAKFDKAKEDVNSDLAIFAADLVGILEKNADTHPEWQETIEDLLVLARSCAMT 378
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S GEFWLQCE IVQELDDRRQE PPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE +
Sbjct: 379 SSGEFWLQCESIVQELDDRRQEHPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEPV 438
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
F RQSRVLHSA K IP RD K S+ K K SS+K++SQEQ + WK+D ++
Sbjct: 439 FNLRQSRVLHSAGKCIPPSVGRDTKSSSATKVLKP-SSKKAFSQEQSMMGWKKD-VMQPE 496
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N+ P DDNAK SS+ R+RM+SWKK PSP G+ KE+ K+QN G++E K+SN +
Sbjct: 497 NLSIPADDDNAKHFNSSSGRNRMASWKKFPSPTGRSPKEAVQLKDQNYGRIESSKASNNK 556
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
R S++D TAKPSE P ++L+H+SKHQHKVSWG+WGDQQN + + +SIICRICEE+VP
Sbjct: 557 RFSSDVD-TAKPSELHPVKDSLDHASKHQHKVSWGHWGDQQNNNSEENSIICRICEEDVP 615
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
TSHVEDHS+ICA+ADRCDQKGLSVNERL RI+ETLEKMMES QKD +V GSPDVAKV
Sbjct: 616 TSHVEDHSRICALADRCDQKGLSVNERLGRIAETLEKMMESCTQKDTQQMV-GSPDVAKV 674
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNSS+TEESDV SPK SDWSRRGSEDMLD PEADNSVFMDDLKGLP M+CKTRFGPKSD
Sbjct: 675 SNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPLMSCKTRFGPKSD 734
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSAGSMTPRSPL+TPRTSQIDLLLAGKGA SEHDD PQMNELADIARCVA PLD
Sbjct: 735 QGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKGAYSEHDDLPQMNELADIARCVANAPLD 794
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD + YLLS L+DLRVV+DRRKFDALTVETFG RIEKLIREKYLQL E+V +K+D S
Sbjct: 795 DDRTTSYLLSCLDDLRVVVDRRKFDALTVETFGTRIEKLIREKYLQLTEMVDVEKIDTES 854
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TV ++ EDDVVRSLRTSPIH S+DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 855 TVDDDLL--EDDVVRSLRTSPIHSSRDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 912
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY
Sbjct: 913 AIKVLKKADMIRKNAVESILAERDILITVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 972
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCLDE+VARVYIAEVVLALEYLHSL VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 973 SLLRNLGCLDEEVARVYIAEVVLALEYLHSLHVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1032
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDLSGPAV+GT+LL ++E + SE Q+ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1033 VGLINSTDDLSGPAVNGTSLLEEDETDVFTSEDQRERRKKRSAVGTPDYLAPEILLGTGH 1092
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVG+ILFEL+VGIPPFNAEHPQ IFDNILNRKIPWP VPEEMSP+A DLIDR
Sbjct: 1093 GFTADWWSVGVILFELLVGIPPFNAEHPQTIFDNILNRKIPWPAVPEEMSPQAQDLIDRL 1152
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDP+QRLGS GASEVKQHVFFKDINWDTLARQKAAFVP SESALDTSYFTSRYSWNT+
Sbjct: 1153 LTEDPNQRLGSKGASEVKQHVFFKDINWDTLARQKAAFVPASESALDTSYFTSRYSWNTS 1212
Query: 918 DENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFKN 977
D +YPASD EDSSDADSLSGSSSCLSNRQ+E GDEC GL EF+SG+SVNYSFSNFSFKN
Sbjct: 1213 DGLVYPASDDEDSSDADSLSGSSSCLSNRQDE-GDECWGLTEFDSGTSVNYSFSNFSFKN 1271
Query: 978 LSQLASINYDLLSKGWKDDPPRNPNA 1003
LSQLASINYD L+KGWKDDPP N +A
Sbjct: 1272 LSQLASINYD-LTKGWKDDPPTNSSA 1296
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30684702|ref|NP_188412.2| protein kinase family protein [Arabidopsis thaliana] gi|332642494|gb|AEE76015.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1496 bits (3873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 742/986 (75%), Positives = 833/986 (84%), Gaps = 13/986 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 321 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 381 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 439
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 440 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 493
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 494 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 553
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 554 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 610
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 611 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 669
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 670 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 729
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 730 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 789
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 790 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 849
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 850 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1208
Query: 918 DENIYPASDFEDSSDADSLSGSSSCLSN-RQEEVGDECGGLAEFESGSSVNYSFSNFSFK 976
DE +P+ + D SDADS++ SS C SN +E +EC G AEFESG V+YSFSNFSFK
Sbjct: 1209 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 1268
Query: 977 NLSQLASINYDLLSKGWKDDPPRNPN 1002
NLSQLASINYDLLSKGWKD+P + P+
Sbjct: 1269 NLSQLASINYDLLSKGWKDEPQQIPH 1294
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6729348|dbj|BAA89784.1| IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1494 bits (3869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 742/986 (75%), Positives = 833/986 (84%), Gaps = 13/986 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 48 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 107
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 108 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 166
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 167 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 220
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 221 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 280
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 281 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 337
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 338 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 396
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 397 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 456
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 457 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 516
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 517 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 576
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 577 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 635
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 636 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 695
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 696 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 755
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 756 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 815
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRF
Sbjct: 816 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 875
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+
Sbjct: 876 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 935
Query: 918 DENIYPASDFEDSSDADSLSGSSSCLSN-RQEEVGDECGGLAEFESGSSVNYSFSNFSFK 976
DE +P+ + D SDADS++ SS C SN +E +EC G AEFESG V+YSFSNFSFK
Sbjct: 936 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 995
Query: 977 NLSQLASINYDLLSKGWKDDPPRNPN 1002
NLSQLASINYDLLSKGWKD+P + P+
Sbjct: 996 NLSQLASINYDLLSKGWKDEPQQIPH 1021
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|26449548|dbj|BAC41900.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1492 bits (3863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/986 (75%), Positives = 832/986 (84%), Gaps = 13/986 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 321 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 381 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 439
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 440 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 493
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 494 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 553
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 554 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 610
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 611 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 669
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 670 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 729
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 730 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 789
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 790 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 849
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 850 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW VPEEMS EAHD+IDRF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWHHVPEEMSAEAHDIIDRF 1148
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1208
Query: 918 DENIYPASDFEDSSDADSLSGSSSCLSN-RQEEVGDECGGLAEFESGSSVNYSFSNFSFK 976
DE +P+ + D SDADS++ SS C SN +E +EC G AEFESG V+YSFSNFSFK
Sbjct: 1209 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 1268
Query: 977 NLSQLASINYDLLSKGWKDDPPRNPN 1002
NLSQLASINYDLLSKGWKD+P + P+
Sbjct: 1269 NLSQLASINYDLLSKGWKDEPQQIPH 1294
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9294489|dbj|BAB02708.1| IRE homolog; protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1478 bits (3827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 735/988 (74%), Positives = 823/988 (83%), Gaps = 18/988 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 424 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 483
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 484 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 542
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 543 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 596
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 597 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 656
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 657 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 713
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 714 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 772
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 773 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 832
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 833 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 892
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 893 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 952
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 953 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 1011
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 1012 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 1071
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 1072 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1131
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1132 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1191
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRF
Sbjct: 1192 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1251
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+
Sbjct: 1252 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1311
Query: 918 DENIYPASDFEDSSDADSLSGSSSCLSNRQEEV---GDECGGLAEFESGSSVNYSFSNFS 974
DE +P+ E SL +S V +EC G AEFESG V+YSFSNFS
Sbjct: 1312 DEQFFPS---ELVGKLLSLVFVGYAISLNWINVATQAEECEGHAEFESGIPVDYSFSNFS 1368
Query: 975 FKNLSQLASINYDLLSKGWKDDPPRNPN 1002
FKNLSQLASINYDLLSKGWKD+P + P+
Sbjct: 1369 FKNLSQLASINYDLLSKGWKDEPQQIPH 1396
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1003 | ||||||
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.970 | 0.750 | 0.710 | 0.0 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.961 | 0.780 | 0.650 | 0.0 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.657 | 0.564 | 0.606 | 2.3e-251 | |
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.576 | 0.541 | 0.552 | 7.6e-185 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.165 | 0.078 | 0.648 | 6.8e-85 | |
| UNIPROTKB|F1NAH4 | 1370 | MAST2 "Uncharacterized protein | 0.330 | 0.241 | 0.464 | 9.5e-83 | |
| UNIPROTKB|Q6P0Q8 | 1798 | MAST2 "Microtubule-associated | 0.330 | 0.184 | 0.464 | 1.4e-82 | |
| RGD|1304573 | 1795 | Mast2 "microtubule associated | 0.330 | 0.184 | 0.461 | 3.6e-82 | |
| UNIPROTKB|F1PRV4 | 1799 | MAST2 "Uncharacterized protein | 0.330 | 0.183 | 0.461 | 2e-81 | |
| UNIPROTKB|J9NXP5 | 1806 | MAST2 "Uncharacterized protein | 0.330 | 0.183 | 0.461 | 2.1e-81 |
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3567 (1260.7 bits), Expect = 0., P = 0.
Identities = 701/986 (71%), Positives = 780/986 (79%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 321 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 381 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 439
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGXXXXXXXXXXXXXXXXXXXQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R QEQHGLDWK D V+
Sbjct: 440 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 493
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 494 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 553
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNXXXXXXXXXXXXXEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q EEEVP
Sbjct: 554 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQP-LISEESSIMCRICEEEVP 610
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 611 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 669
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 670 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 729
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 730 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 789
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 790 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 849
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 850 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1208
Query: 918 DENIYPAXXXXXXXXXXXXXXXXXXXXNRQEE-VGDECGGLAEXXXXXXXXXXXXXXXXX 976
DE +P+ N EE +EC G AE
Sbjct: 1209 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 1268
Query: 977 XXXQLASINYDLLSKGWKDDPPRNPN 1002
QLASINYDLLSKGWKD+P + P+
Sbjct: 1269 NLSQLASINYDLLSKGWKDEPQQIPH 1294
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3153 (1115.0 bits), Expect = 0., P = 0.
Identities = 637/979 (65%), Positives = 729/979 (74%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
E+IL +IRTKFDKAKEEVNSDL F GDL+ I +KN ESHPE TIEDLLVLA++CA T
Sbjct: 264 EDILNLIRTKFDKAKEEVNSDLFAFGGDLLDIYDKNKESHPELLVTIEDLLVLAKTCAKT 323
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+ EFWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES ++E
Sbjct: 324 TSKEFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGQEEDA 382
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGXXXXXXXXXXXXXXXXXXXQEQHGLDWKRDHAVKQG 197
Q RQS VLHSADKR P G +RDG QEQ GL+W V+
Sbjct: 383 VQLRQSGVLHSADKRDPTGEVRDGKGSSTANALKVPSTKKAYSQEQRGLNWIEGFFVRPA 442
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
LS P ++ +K ES A D+MSSWK+LPSP K ++E+ SKEQND KVEP +
Sbjct: 443 P-LSSPYNETSKDSESPANIDKMSSWKRLPSPASKGVQEAAVSKEQNDRKVEPPQVVKKL 501
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNXXXXXXXXXXXXXEEEVP 317
+S+ AK E A + EH SK++H +SWGYWG Q+ EEE+P
Sbjct: 502 VAISDDMAVAKLPEVSSAKASQEHMSKNRHNISWGYWG-HQSCISEESSIICRICEEEIP 560
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS+ICA+AD+ DQKG+ V+ERL+ ++ TLEK+ ++ +QKD V SP+ K+
Sbjct: 561 TTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKD-SLAAVESPEGMKI 619
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SN+S+TEE DVLSPK SDWSRRGSEDMLD PE DNSVFMDD+ LPSM+C+TRFGPKSD
Sbjct: 620 SNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRFGPKSD 679
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGM TSSAGSMTPRSP+ TPR I+LLL GKG + DDFPQM+ELADIARC A
Sbjct: 680 QGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAANAIPV 739
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SI LLS LEDLRVVIDRRKFDAL VETFG RIEKLI+EKYLQLCEL+ D+K
Sbjct: 740 DDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK----G 795
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
T+I+EDAPLEDDVVRSLRTSP+H +DR SIDDFE++K ISRGAFG V LA+K TTGDLF
Sbjct: 796 TIIDEDAPLEDDVVRSLRTSPVH-LRDRISIDDFEVMKSISRGAFGHVILARKNTTGDLF 854
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVL+KADMIRKNAVESILAERDILI+ RNPFVVRFFYSFTC ENLYLVMEYLNGGD Y
Sbjct: 855 AIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEYLNGGDFY 914
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
S+LR +GCLDE ARVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGH+KLTDFGLSK
Sbjct: 915 SMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKLTDFGLSK 974
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLIN+TDDLSGP S T+LL +E+P+L +H KRSAVGTPDYLAPEILLGTGH
Sbjct: 975 VGLINNTDDLSGPVSSATSLLVEEKPKLPTLDH------KRSAVGTPDYLAPEILLGTGH 1028
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G TADWWSVGIIL+E +VGIPPFNA+HPQQIFDNILNR I WP VPE+MS EA DLIDR
Sbjct: 1029 GATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDLIDRL 1088
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTT 917
LTEDPHQRLG+ GA+EVKQH FFKDI+W+TLA+QKAAFVP SE+A DTSYF SRYSWN +
Sbjct: 1089 LTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQKAAFVPDSENAFDTSYFQSRYSWNYS 1148
Query: 918 DENIYPAXXXXXXXXXXXXXXXXXXXXNRQEEVGDECGGLAEXXXXXXXXXXXXXXXXXX 977
E +P N +E D G AE
Sbjct: 1149 GERCFPTNENEDSSEGDSLCGSSGRLSNHHDEGVDIPCGPAEFETSVSENYPFDNFSFKN 1208
Query: 978 XXQLASINYDLLSKGWKDD 996
QLA INY+L+SKG KD+
Sbjct: 1209 LSQLAYINYNLMSKGHKDE 1227
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2019 (715.8 bits), Expect = 2.3e-251, Sum P(2) = 2.3e-251
Identities = 417/687 (60%), Positives = 504/687 (73%)
Query: 313 EEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGS- 371
E E+P HVE+HS+IC IADRCD KG++VN RL R++E+LEK++ES K +V +
Sbjct: 492 EVEIPVVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKS--SVTPRAV 549
Query: 372 PDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTR 431
D A++SNSS E+ D +S + SD DMLD VP + N+ +D+L L M+
Sbjct: 550 ADSARLSNSSRQEDLDEISQRCSD-------DMLDCVPRSQNTFSLDELNILNEMSMTN- 601
Query: 432 FGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCV 491
G SSAGS+TP SP TPR SQ+DLLL+G+ +SE +++ Q+N+L DIAR V
Sbjct: 602 -------GTKDSSAGSLTPPSPA-TPRNSQVDLLLSGRKTISELENYQQINKLLDIARSV 653
Query: 492 ATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDD 551
A + SS+ +++ L++L+ VI RK DAL VETFG RIEKL++EKY++LC L+ D+
Sbjct: 654 ANVNVCGYSSLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDE 713
Query: 552 KVDITSTVIEEDAPLEDDVVRSLRTSPIHP-SKDRTSIDDFEIIKPISRGAFGRVFLAKK 610
KVD ++ + +E++ ++D VRSLR SP++P +KDRTSI+DFEIIKPISRGAFGRVFLAKK
Sbjct: 714 KVDSSNAMPDEESSADEDTVRSLRASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKK 773
Query: 611 RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670
R TGDLFAIKVLKKADMIRKNAVESILAER+ILISVRNPFVVRFFYSFTCRENLYLVMEY
Sbjct: 774 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 833
Query: 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730
LNGGDL+SLLRNLGCLDED+AR+YIAEVVLALEYLHS+ ++HRDLKPDNLLI DGHIKL
Sbjct: 834 LNGGDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKL 893
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
TDFGLSKVGLINSTDDLSG + G + E+ ++ RKK + VGTPDYLAPE
Sbjct: 894 TDFGLSKVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPE 953
Query: 791 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEA 850
ILLG GHG TADWWSVG+ILFE++VGIPPFNAE PQQIF+NI+NR IPWP VPEE+S EA
Sbjct: 954 ILLGMGHGKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEA 1013
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS 910
HDLI++ LTE+P QRLG+ GA EVKQH FFKDINWDTLARQKA FVP++E DTSYF S
Sbjct: 1014 HDLINKLLTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEPQ-DTSYFMS 1072
Query: 911 RYSWNTTDENIYPAXXXXXXXXXXXXXXXXXXXXNRQEEVGDECGGLAEXXXX--XXXXX 968
RY WN DEN++ N QEE GDECG LAE
Sbjct: 1073 RYIWNPEDENVHGGSDFDDLTDTCSSSSF-----NTQEEDGDECGSLAEFGNGPNLAVKY 1127
Query: 969 XXXXXXXXXXXQLASINYDLLSKGWKD 995
QLASINYDL+ K K+
Sbjct: 1128 SFSNFSFKNLSQLASINYDLVLKNAKE 1154
|
|
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1597 (567.2 bits), Expect = 7.6e-185, Sum P(2) = 7.6e-185
Identities = 335/606 (55%), Positives = 426/606 (70%)
Query: 313 EEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVV-VGS 371
EEEVP H+E HS ICA AD+C+ + V+ERLL++ E LE++++S + +++ G
Sbjct: 406 EEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDS---RSLNSFTQAGG 462
Query: 372 PDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTR 431
+ + + S V E SPK ++W +G E M + + E D + F+D+ P + K+
Sbjct: 463 LENSVLRKSGVASEG--CSPKINEWRNKGLEGMFEDLHEMDTA-FIDESYTYP-IHLKSH 518
Query: 432 FGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCV 491
G K T+SS GS+T S TPRTS D + E +D M +L+DIARC
Sbjct: 519 VGAKFCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHC-PEQEDLRLMMDLSDIARCG 577
Query: 492 ATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDD 551
A+T + S Y+++ ++D++ V+ + K AL ++TFG RIEKL+ EKYL EL T D
Sbjct: 578 ASTDFSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHAREL-TAD 636
Query: 552 KVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
K + + I+E +DV+ +P KDR SIDDFEIIKPISRGAFG+VFLA+KR
Sbjct: 637 KSSVGN--IKES----EDVLEHASATPQLLLKDRISIDDFEIIKPISRGAFGKVFLARKR 690
Query: 612 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671
TTGD FAIKVLKK DMIRKN +E IL ER+ILI+VR PF+VRFFYSFTCR+NLYLVMEYL
Sbjct: 691 TTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYL 750
Query: 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731
NGGDLYSLL+ +GCLDE++AR+YIAE+VLALEYLHSL++VHRDLKPDNLLIA++GHIKLT
Sbjct: 751 NGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLT 810
Query: 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH----QQERRKKRSAVGTPDYL 787
DFGLSK+GLIN+T DLSG D P+ T S H Q+E R + SAVGTPDYL
Sbjct: 811 DFGLSKIGLINNTIDLSGHE-------SDVSPR-TNSHHFQKNQEEERIRHSAVGTPDYL 862
Query: 788 APEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMS 847
APEILLGT HG ADWWS GI+LFEL+ GIPPF A P++IFDNILN K+PWP VP EMS
Sbjct: 863 APEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMS 922
Query: 848 PEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSY 907
EA DLI+R L +P +RLG+ GA+EVK H FF+ ++W+ LA QKAAFVP ES DTSY
Sbjct: 923 YEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSY 982
Query: 908 FTSRYS 913
F SR+S
Sbjct: 983 FVSRFS 988
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 6.8e-85, Sum P(5) = 6.8e-85
Identities = 109/168 (64%), Positives = 130/168 (77%)
Query: 577 SPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
S + S + TSI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKK D IRKN V
Sbjct: 1511 SSLTTSSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVN 1570
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVY 694
++ ER+IL V+N FVV+ FY+F + LYLVMEYL GGD SLLR LGC +E +A+ Y
Sbjct: 1571 HVIVERNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHY 1630
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
IAE VL LEYLH +VHRDLKPDN+LI GHIKLTDFGLSK+G+I+
Sbjct: 1631 IAETVLCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIID 1678
|
|
| UNIPROTKB|F1NAH4 MAST2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 9.5e-83, Sum P(2) = 9.5e-83
Identities = 162/349 (46%), Positives = 227/349 (65%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD V S R + + SK S ++FE IK IS GA+G V+L + +TT FA+K +
Sbjct: 321 DTPETDDSVES-RGATVQ-SKKTPSEEEFETIKLISNGAYGAVYLVRHKTTRQRFAMKKI 378
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 379 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN 438
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 439 IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 498
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + T +E K+ GTP+Y+APE++L G+G D
Sbjct: 499 LTTNLYEGHIEKDT---------------REFLDKQ-VCGTPEYIAPEVILRQGYGKPVD 542
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++G+IL+E +VG PF + P+++F +++ +I WP + + P+A DLI + L ++P
Sbjct: 543 WWAMGVILYEFLVGCVPFFGDTPEELFGQVISDEIAWPEGDDALPPDAQDLISKLLRQNP 602
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+R+G+G A EVKQH FFKD++W+ L RQKA F+P ES DTSYF +R
Sbjct: 603 LERMGTGSAFEVKQHRFFKDLDWNGLLRQKAEFIPQLESEDDTSYFDTR 651
|
|
| UNIPROTKB|Q6P0Q8 MAST2 "Microtubule-associated serine/threonine-protein kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 783 (280.7 bits), Expect = 1.4e-82, Sum P(3) = 1.4e-82
Identities = 162/349 (46%), Positives = 220/349 (63%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD + S PSK S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 486 DTPETDDSIEGHGASL--PSKKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKI 543
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 544 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKN 603
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 604 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM- 662
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
S TT L + + A E ++ GTP+Y+APE++L G+G D
Sbjct: 663 ----------SLTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIAPEVILRQGYGKPVD 707
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP E + P+A DL + L ++P
Sbjct: 708 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNP 767
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+G A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 768 LERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
|
| RGD|1304573 Mast2 "microtubule associated serine/threonine kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 3.6e-82, Sum P(3) = 3.6e-82
Identities = 161/349 (46%), Positives = 219/349 (62%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD V S PSK S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 494 DTPETDDSVEGRGAS--QPSKKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKI 551
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 552 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN 611
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 612 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM- 670
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
S TT L + + A E ++ GTP+Y+APE++L G+G D
Sbjct: 671 ----------SLTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIAPEVILRQGYGKPVD 715
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP + + P+A DL + L ++P
Sbjct: 716 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNP 775
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+ A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 776 LERLGTSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 824
|
|
| UNIPROTKB|F1PRV4 MAST2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 2.0e-81, Sum P(3) = 2.0e-81
Identities = 161/349 (46%), Positives = 222/349 (63%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD V R + + SK S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 490 DTPETDDSVEG-RGASV-TSKRTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKV 547
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 548 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN 607
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 608 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM- 666
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
S TT L + + A E ++ GTP+Y+APE++L G+G D
Sbjct: 667 ----------SLTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIAPEVILRQGYGKPVD 711
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP + + P+A DL + L ++P
Sbjct: 712 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNP 771
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+G A+EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 772 LERLGTGSATEVKQHSFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 820
|
|
| UNIPROTKB|J9NXP5 MAST2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 2.1e-81, Sum P(3) = 2.1e-81
Identities = 161/349 (46%), Positives = 222/349 (63%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD V R + + SK S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 497 DTPETDDSVEG-RGASV-TSKRTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKV 554
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 555 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN 614
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 615 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM- 673
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
S TT L + + A E ++ GTP+Y+APE++L G+G D
Sbjct: 674 ----------SLTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIAPEVILRQGYGKPVD 718
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WW++GIIL+E +VG PF + P+++F +++ +I WP + + P+A DL + L ++P
Sbjct: 719 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNP 778
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
+RLG+G A+EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 779 LERLGTGSATEVKQHSFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 827
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pm.C_LG_XII000141 | SubName- Full=Putative uncharacterized protein; (1322 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1003 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-150 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-122 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-118 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-117 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-116 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-115 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-112 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-95 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-95 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-94 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-94 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-94 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-86 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-86 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-85 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-83 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-81 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-80 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-80 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-80 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-79 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-78 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-78 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-78 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-77 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-76 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-76 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-75 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-73 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-73 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-72 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-72 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-72 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-71 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-70 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-69 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-69 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-67 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-67 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-67 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-67 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-67 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-66 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-64 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-64 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-63 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-63 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-63 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-62 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-62 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-62 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-62 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-61 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-61 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-59 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-59 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-58 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-56 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-53 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-52 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-52 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-52 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-51 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-50 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-49 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-48 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-47 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-47 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-47 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-47 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-47 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-46 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-44 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-43 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-43 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-43 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-42 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-41 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-40 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-40 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-39 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-39 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-39 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-39 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-39 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-38 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-38 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-38 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-37 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-37 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-37 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-37 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-36 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-35 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-33 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-33 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-32 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-32 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-32 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-31 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-31 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-31 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-30 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-30 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-30 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-29 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-28 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-28 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-27 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-25 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-24 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-19 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 7e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 9e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 447 bits (1151), Expect = e-150
Identities = 165/289 (57%), Positives = 209/289 (72%), Gaps = 24/289 (8%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
IS+GA+GRVFLAKK++TGD++AIKV+KKADMIRKN V+ +L ERDIL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
SF ++NLYLVMEYL GGDL SLL N+G LDEDVAR+YIAE+VLALEYLHS ++HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
PDN+LI +GH+KLTDFGLSKVGL+ +L+ +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK-----------------------E 157
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836
+ VGTPDY+APE++LG GH T DWWS+G IL+E +VGIPPF+ E P++IF NILN K
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
Query: 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885
I WP E+S EA DLI + L DP +RLG+ E+K H FFK I+W
Sbjct: 218 IEWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 377 bits (969), Expect = e-122
Identities = 155/321 (48%), Positives = 208/321 (64%), Gaps = 6/321 (1%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE+IK I RGAFG V+L + + TG ++A+KVL+K+DMI++N + + AERDIL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P++V+ +YSF E+LYLVMEY+ GGDL +LL E+ AR YIAE+VLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+HRD+KPDN+LI DGHIKL DFGL K +N D LL + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKK--MNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
+H+Q R + S VGTPDY+APE+L GT +G DWWS+G+IL+E++ G PPF ++ Q+
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 829 FDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT 887
++ I+N K P+ +SPEA DLI R L DP RLGS E+K H FFK I+W+
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWEN 295
Query: 888 LARQKAAFVPTSESALDTSYF 908
L K FVP S LDTS F
Sbjct: 296 LRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 360 bits (927), Expect = e-118
Identities = 132/284 (46%), Positives = 180/284 (63%), Gaps = 34/284 (11%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G+FG+V L +K+ TG L+A+KVLKK +I++ VE L ER+IL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
+F E LYLV+EY GG+L+S L G E+ AR Y AE+VLALEYLHSL +++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P+N+L+ DGHIKLTDFGL+K E T
Sbjct: 121 PENILLDADGHIKLTDFGLAKE--------------------LSSEGSRT---------- 150
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836
+ GTP+YLAPE+LLG G+G DWWS+G++L+E++ G PPF AE ++I++ IL
Sbjct: 151 -NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
Query: 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ R PE +SPEA DLI L +DP +RLGSGGA E+K H FF
Sbjct: 210 L---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 360 bits (926), Expect = e-117
Identities = 155/295 (52%), Positives = 195/295 (66%), Gaps = 37/295 (12%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVV 652
+KPIS+GAFG V+LAKKR+TGD FAIKVLKK+DMI KN V ++ AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
+ +YSF ++ LYLVMEYLNGGD SL++ LG L ED A+ YIAEVVL +E LH ++H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLEN------------------------------ 150
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 832
+ VGTPDYLAPE +LG G +DWWS+G ++FE + G PPF+AE P +FDNI
Sbjct: 151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205
Query: 833 LNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886
L+R+I WP V E SPEA DLI+R L DP +RLG+ G E+K H FFK INWD
Sbjct: 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 359 bits (922), Expect = e-116
Identities = 152/324 (46%), Positives = 209/324 (64%), Gaps = 24/324 (7%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DFE IK IS GA+G V+L + + T FA+K + K ++I +N ++ + ERDIL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PFVV F SF + +L +VMEY+ GGD +LL+N+G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+VHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------------Y 160
Query: 769 EHQQERRKK----RSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
E E+ + + GTP+Y+APE++L G+G DWW++GIIL+E +VG PF +
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
P+++F +++ I WP E + +A DLI R L ++P +RLG+GGA EVKQH FF ++
Sbjct: 221 PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280
Query: 885 WDTLARQKAAFVPTSESALDTSYF 908
W+ L RQKA F+P ES DTSYF
Sbjct: 281 WNGLLRQKAEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 356 bits (915), Expect = e-115
Identities = 140/324 (43%), Positives = 196/324 (60%), Gaps = 41/324 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE IK + G+FGRV L + + +G +A+K+L KA +++ VE +L E+ IL S+R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+V + SF NLYLVMEY+ GG+L+S LR G E VAR Y A+VVLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+V+RDLKP+NLL+ DG+IK+TDFG +K V G T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-------------VKGRTY----------- 156
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
+ GTP+YLAPEI+L G+G DWW++GI+++E++ G PPF ++P QI
Sbjct: 157 ----------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWD 886
++ IL K+ R P SP+A DLI L D +RLG+ G +++K H +F I+W
Sbjct: 207 YEKILEGKV---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263
Query: 887 TLARQK--AAFVPTSESALDTSYF 908
L ++K A F+P + DTS F
Sbjct: 264 ALLQRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 351 bits (903), Expect = e-112
Identities = 138/329 (41%), Positives = 199/329 (60%), Gaps = 11/329 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE IK I RGAFG V L +K+ TG ++A+K L+K++M+ K V + AERDIL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P+VV+ +YSF LYL+MEYL GGD+ +LL E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPAVSGTTLLGDEEPQL 765
+HRD+KPDNLL+ GHIKL+DFGL GL + + L +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 766 TASEHQQERRKKR-----SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
++ + ++ R S VGTPDY+APE+ L TG+ DWWS+G+I++E++VG PPF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 821 NAEHPQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
+++PQ+ + I+N K E +SPEA DLI R + +RLG+ G +E+K H F
Sbjct: 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298
Query: 880 FKDINWDTLARQKAAFVPTSESALDTSYF 908
FK ++W+ + + A +P +S DTS F
Sbjct: 299 FKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-101
Identities = 121/291 (41%), Positives = 170/291 (58%), Gaps = 38/291 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+EI++ + G+FG+V+LA+ + TG L AIKV+KK + + E IL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+VR + F + LYLVMEY GGDL+ LL+ G L ED AR Y+ +++ ALEYLHS +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRDLKP+N+L+ DGH+KL DFGL++
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------Q 146
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF-NAEHPQQIF 829
K + VGTP+Y+APE+LLG G+G D WS+G+IL+EL+ G PPF + ++F
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELF 206
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
I K P+P ++SPEA DLI + L +DP +RL A E QH FF
Sbjct: 207 KKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 306 bits (785), Expect = 3e-95
Identities = 149/375 (39%), Positives = 210/375 (56%), Gaps = 33/375 (8%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F IK I GAFG V L +K T L+A+K L+KAD++ +N + AERDIL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VV+ +YSF ++NLY VM+Y+ GGD+ SLL LG +ED+AR YIAE+ A+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKVGLINSTDDLSGPAVSGTTLLGDE 761
+HRD+KPDN+LI DGHIKLTDFGL SK D ++ + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK--YYQKGDHHRQDSMEPSEEWSEI 180
Query: 762 EP-QLTASE----HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ +L E Q +R S VGTP+Y+APE+LL TG+ DWWSVG+IL+E++VG
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 817 IPPFNAEHPQQIFDNILNRKIPWP---RVPE--EMSPEAHDLIDRFLTEDPHQRLGSGGA 871
PPF A+ P + ++N W +P ++S EA DLI R RLG GA
Sbjct: 241 QPPFLADTPAETQLKVIN----WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGA 295
Query: 872 SEVKQHVFFKDINWDTLAR-QKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDS 930
E+K H FFK I++ +L R QKA ++P DTS F + D + D +S
Sbjct: 296 DEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNF------DPVDPEKLRSDDSGES 349
Query: 931 SDADSLSGSSSCLSN 945
S ++ ++ +
Sbjct: 350 SPDRNVKPNNRKRTE 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = 6e-95
Identities = 110/294 (37%), Positives = 170/294 (57%), Gaps = 16/294 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
DDF+ K I G+F V LAK++ T +AIK+L K +I++ V+ + E+++L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+P +++ +Y+F ENLY V+EY G+L +R G LDE R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRDLKP+N+L+ D HIK+TDFG +KV L + + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV--------LDPNSSPESN---KGDATNID 169
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
S+ ++ RR+ S VGT +Y++PE+L G ++D W++G I+++++ G PPF +
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG-GASEVKQHVFF 880
F IL + +P P+A DLI++ L DP RLG G E+K H FF
Sbjct: 230 TFQKILKLEYSFPPN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 302 bits (775), Expect = 2e-94
Identities = 131/336 (38%), Positives = 193/336 (57%), Gaps = 47/336 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DF+I+ + +G +G+VFLAKK+ TG++ A+K +KK+ + + N V +L ERDIL + ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
++V+ Y+F E LYL MEY+ GGD +LL NLG L ED AR Y+AE+ A++ LH L
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+HRDLKP+N LI GHIKLTDFGLSK G++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVT--------------------------- 153
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
S VG+PDY+APE+L G G+ T D+WS+G +L+E + G PPF+ P + +
Sbjct: 154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207
Query: 830 DNILNRK--IPWPRVPE---EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
+N+ K + P + +S EA DLI + + + R GS ++K H FFK+++
Sbjct: 208 ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSR-RFGS--LEDIKNHPFFKEVD 264
Query: 885 WDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDEN 920
W+ L K FVP ES +DT YF + +E+
Sbjct: 265 WNELRELKPPFVPELESEIDTGYFD-----DFENED 295
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = 2e-94
Identities = 133/321 (41%), Positives = 195/321 (60%), Gaps = 10/321 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F+ IK + +G GRVFL + + TG LFA+KVL K +MI++N V+ +L E++IL ++ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALEYLH 706
PF+ + SF L LVM+Y GG+L+ LL + CL E+VAR Y AEV+LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS--GTTLLGDEEPQ 764
L +V+RDLKP+N+L+ GHI L+DF LSK + A+ + P
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK--QSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
T SE R S VGT +Y+APE++ G GHG+ DWW++GI+L+E++ G PF +
Sbjct: 179 ETFSEEPSFR--SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDI 883
+ F NIL +++ +P P +S A DLI + L +DP +RLGS GA+E+KQH FF+ +
Sbjct: 237 RDETFSNILKKEVTFPGSP-PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295
Query: 884 NWDTLARQKAAFVPTSESALD 904
NW + +P + +D
Sbjct: 296 NWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 303 bits (778), Expect = 3e-94
Identities = 149/387 (38%), Positives = 216/387 (55%), Gaps = 45/387 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DF +K I +GAFG V L +K+ TG ++A+K L K++M +K+ + + AERD+L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P+VV +YSF + LYL+ME+L GGDL ++L EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD----------DLSGPAVSGTTLL 758
+HRD+KPDN+LI GHIKL+DFGLS G D + + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 759 GDEEPQLTASEHQQ---ERRKKR----SAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
+ LT S Q ++ +R S VGTPDY+APEI L G+G DWWS+G I+F
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 812 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRV---PEE--MSPEAHDLIDRFLTEDPHQRL 866
E ++G PPF +E+ + + I+N W P++ +S EA DLI R +T + RL
Sbjct: 240 ECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294
Query: 867 GSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASD 926
G GGA E+K H FF+ ++WDT+ + +A F+P +S DTSYF P +
Sbjct: 295 GRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF--------------PTDE 340
Query: 927 FEDSSDADSLSGSSSCLSNRQEEVGDE 953
E +A +L +QEE +
Sbjct: 341 LEQVPEAPAL---KQAAPAQQEESVEL 364
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 280 bits (717), Expect = 2e-86
Identities = 112/319 (35%), Positives = 179/319 (56%), Gaps = 39/319 (12%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVR 653
K + +G+FG+V LA+ + T +L+A+KVLKK +++ + VE + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
F ++ L+ VMEY+NGGDL ++ G DE AR Y AE+VL L++LH +++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG------------------------------- 149
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+ GTPDY+APEIL +G DWW++G++L+E++ G PF + ++F +IL
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ 891
++ +PR +S EA ++ FLT++P +RLG G ++K H FF++I+WD L R+
Sbjct: 210 EDEVRYPR---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERK 266
Query: 892 --KAAFVPTSESALDTSYF 908
K F P + D S F
Sbjct: 267 EIKPPFKPKIKGRFDVSNF 285
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 278 bits (713), Expect = 3e-86
Identities = 121/324 (37%), Positives = 179/324 (55%), Gaps = 41/324 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DD E IK + G FGRV L + R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF++R F++ + LY++MEY+ GG+L+S LRN G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+V+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
GTP+YLAPE++ GH DWW++GI+++E++VG PPF ++P I
Sbjct: 159 ------------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWD 886
++ IL K+ +PR + A DLI + L D +RLG+ GA +VK H +FK ++WD
Sbjct: 207 YEKILAGKLEFPR---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263
Query: 887 T--LARQKAAFVPTSESALDTSYF 908
+ K VP DTS F
Sbjct: 264 DVPQRKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 273 bits (701), Expect = 9e-85
Identities = 108/296 (36%), Positives = 171/296 (57%), Gaps = 41/296 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G FGRV L K ++ FA+K +KK ++ E I +E++IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
+F ++ +Y++MEY GG+L+++LR+ G DE AR YIA VVLA EYLH+ +++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P+NLL+ +G++KL DFG +K L +K
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKK-------------------LKS-------------GQK 148
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA--EHPQQIFDNIL- 833
+ GTP+Y+APEI+L G+ + D+WS+GI+L+EL+ G PPF E P +I+++IL
Sbjct: 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208
Query: 834 -NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINWD 886
N K+ +P + A DLI + L +P +RLG GG ++K+H +F +W+
Sbjct: 209 GNGKLEFPNY---IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 1e-83
Identities = 105/295 (35%), Positives = 160/295 (54%), Gaps = 40/295 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+E+++ + G+FG V+ AK + TG + A+K+LKK + ++ E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+VR +F +++LYLVMEY GGDL+ L G L ED A+ +++ LEYLHS +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDLKP+N+L+ +G +K+ DFGL+K L +S+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 771 QQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEH---PQ 826
+ VGTP Y+APE+LL G G+G D WS+G+IL+EL+ G PPF+ E+
Sbjct: 154 -----SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL 208
Query: 827 QIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
Q+ IL + + S EA DLI + L +DP +R A E+ QH +F
Sbjct: 209 QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 265 bits (678), Expect = 4e-81
Identities = 124/321 (38%), Positives = 181/321 (56%), Gaps = 46/321 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-NAVESILAERDILIS 645
+FE+++ + GA+G+VFL +K G L+A+KVLKKA +++K E ER +L +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 646 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
VR PF+V Y+F L+L+++Y+NGG+L++ L E RVYIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH L +++RD+K +N+L+ +GH+ LTDFGLSK L +
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE------------------- 161
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822
+ S GT +Y+APE++ G GH DWWS+G++ FEL+ G PF
Sbjct: 162 -----------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 823 EHPQ----QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
+ Q +I IL K P P+ MS EA D I + L +DP +RLG+ GA E+K H
Sbjct: 211 DGEQNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267
Query: 879 FFKDINWDTLA--RQKAAFVP 897
FF+ I+WD LA R A F P
Sbjct: 268 FFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 2e-80
Identities = 140/328 (42%), Positives = 200/328 (60%), Gaps = 12/328 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE +K I RGAFG V L +K+ TG ++A+K+L+KADM+ K V I AERDIL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+VV+ FYSF + NLYL+ME+L GGD+ +LL L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDF----GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HRD+KPDNLL+ GH+KL+DF GL K +L+ S + +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ + R+ S VGTPDY+APE+ + TG+ DWWS+G+I++E+++G PPF +E
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 825 PQQIFDNILNRK----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
PQ+ + ++N K P P VP +S +A DLI RF T D R+GS G E+K H FF
Sbjct: 241 PQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF 296
Query: 881 KDINWDTLARQKAAFVPTSESALDTSYF 908
+ ++W + + AA +S DTS F
Sbjct: 297 EGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 7e-80
Identities = 149/366 (40%), Positives = 212/366 (57%), Gaps = 25/366 (6%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F IK + GAFG V LA+K T L+A+K L+K D++ +N V + AERDIL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VVR +YSF ++NLY VM+Y+ GGD+ SLL +G ED+AR YIAE+ A+E +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSK-------VGLINSTDDLSGPAVSGTTLLGDEE- 762
+HRD+KPDN+LI DGHIKLTDFGL S D + ++ + GD
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 763 --------PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
P + Q +R S VGTP+Y+APE+LL TG+ DWWSVG+IL+E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 815 VGIPPFNAEHPQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASE 873
VG PPF A+ P + ++N + P+ ++SPEA DLI + L P RLG GA E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 874 VKQHVFFKDINWDT-LARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSD 932
+K H FFK I++ + L +Q A ++P DTS F + D + + D ++ +
Sbjct: 302 IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNF------DPVDPDKLWSDDDKEGNV 355
Query: 933 ADSLSG 938
D+L+G
Sbjct: 356 NDTLNG 361
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 8e-80
Identities = 120/327 (36%), Positives = 186/327 (56%), Gaps = 42/327 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DFE+ + + G+FGRV +AK + TG+ +AIK LKK ++++ V+ + E+ IL+ + +P
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
F+V SF +Y ++E++ GG+L++ LR G DVA+ Y AE+VLA EYLHS
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAK-------------------------------- 166
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
+ + + GTP+YLAPE++ GHG DWW++G++L+E I G PPF + P +I+
Sbjct: 167 --KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDT 887
+ IL ++ +P + A DL+ L D +RLG+ GG ++VK H +F NWD
Sbjct: 225 EKILAGRLKFPNWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281
Query: 888 L-ARQKAAFVPTS-ESALDTSYFTSRY 912
L AR A +P +S DTS F +Y
Sbjct: 282 LYARYYPAPIPVRVKSPGDTSNF-EKY 307
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 261 bits (668), Expect = 3e-79
Identities = 136/357 (38%), Positives = 206/357 (57%), Gaps = 54/357 (15%)
Query: 594 IKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVES--ILAERDILISVRN 648
+K + +G +G+VF +K T TG +FA+KVLKKA ++R N ++ AER+IL +V++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+V Y+F LYL++EYL+GG+L+ L G ED A Y++E+ LALE+LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLKP+N+L+ GH+KLTDFGL K
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK------------------------------- 148
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
E E + GT +Y+APEIL+ +GHG DWWS+G ++++++ G PPF AE+ ++
Sbjct: 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINW- 885
D IL K+ +P ++PEA DL+ + L +P RLG+G A+EV+ H FF+ +NW
Sbjct: 209 IDKILKGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265
Query: 886 DTLARQ-KAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSS 941
D LAR+ + F P +S D S F S+++ T P DS D +LS S++
Sbjct: 266 DLLARKVEPPFKPLLQSEEDVSQFDSKFTRQT------PV----DSPDDSTLSESAN 312
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 3e-78
Identities = 123/349 (35%), Positives = 191/349 (54%), Gaps = 42/349 (12%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LAK + G +A+KVL+K +++K + I+AER++L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
YSF + LY V++Y+NGG+L+ L+ E AR Y AE+ AL YLHSL +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GH+ LTDFGL K G+ S TT
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGI----------EHSKTT----------------- 153
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+ GTP+YLAPE+L + T DWW +G +L+E++ G+PPF + +++DNIL
Sbjct: 154 ----STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA-SEVKQHVFFKDINWDTLARQK 892
N+ + R+ +S A L++ L +D +RLG+ E+K HVFF INWD L +K
Sbjct: 210 NKPL---RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKK 266
Query: 893 --AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDF----EDSSDADS 935
F P +D +F ++ ++ + D +AD
Sbjct: 267 ITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADD 315
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 3e-78
Identities = 117/319 (36%), Positives = 179/319 (56%), Gaps = 36/319 (11%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I +G+FG+V +KR T ++A+K ++KA ++ ++ V LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
SF E LYLV+ ++NGG+L+ L+ G D AR Y AE++ ALE LH V++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P+N+L+ + GHI L DFGL K+ + + K
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDD-------------------------------K 149
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836
+ GTP+YLAPE+LLG G+ DWW++G++L+E++ G+PPF E+ +++ IL
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209
Query: 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AA 894
+ R P+ +A DL+ L+ DP +RLG GA E+K H FF ++W L +
Sbjct: 210 L---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPP 266
Query: 895 FVPTSESALDTSYFTSRYS 913
F P SA+DTS F ++
Sbjct: 267 FKPAVSSAIDTSNFDEEFT 285
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 6e-78
Identities = 138/327 (42%), Positives = 202/327 (61%), Gaps = 10/327 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DFE +K I RGAFG V L +K+ TG ++A+K+L+KADM+ K V I AERDIL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+VV+ FYSF + NLYL+ME+L GGD+ +LL L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDF----GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HRD+KPDNLL+ GH+KL+DF GL K +L+ S T +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ + R+ S VGTPDY+APE+ + TG+ DWWS+G+I++E+++G PPF +E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 825 PQQIFDNILNRK---IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
PQ+ + ++N K I P VP +S +A DLI RF E H R+G+ G E+K + FF+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEH-RIGAPGVEEIKTNPFFE 297
Query: 882 DINWDTLARQKAAFVPTSESALDTSYF 908
++W+ + + AA +S DTS F
Sbjct: 298 GVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 8e-77
Identities = 123/330 (37%), Positives = 184/330 (55%), Gaps = 42/330 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI---SVR 647
F + + RG FG+V LA+ + TG+L+AIK LKK D+I ++ VES++ E+ I S R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+PF+V F F +++ VMEY GGDL + E A Y A VVL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++V+RDLK DNLL+ +G +K+ DFGL K G+ G +T
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM--------GFGDRTSTF---------- 161
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
GTP++LAPE+L T + DWW +G++++E++VG PF + ++
Sbjct: 162 -------------CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINW 885
+FD+I+N ++ +PR +S EA ++ R L +P +RLGSG A +VK+ FF+DINW
Sbjct: 209 VFDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265
Query: 886 DTL--ARQKAAFVPTSESALDTSYFTSRYS 913
D L + K FVPT + D S F ++
Sbjct: 266 DDLLARKIKPPFVPTIKGPEDVSNFDEEFT 295
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 4e-76
Identities = 124/332 (37%), Positives = 182/332 (54%), Gaps = 41/332 (12%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
R +DF++IK I RGAFG V L + +++ ++A+K+L K +MI+++ ERDI+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+ ++V+ Y+F + LY+VMEY+ GGDL +L+ N + E AR Y AEVVLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS+ +HRD+KPDN+L+ GH+KL DF GT + D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADF--------------------GTCMKMDANGM 197
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH----GTTADWWSVGIILFELIVGIPPF 820
+ +AVGTPDY++PE+L G G DWWSVG+ L+E++VG PF
Sbjct: 198 VRCD----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 821 NAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
A+ + I++ K + +P E+S +A DLI FLT+ RLG G E+K H
Sbjct: 248 YADSLVGTYSKIMDHKNSLTFPDDI-EISKQAKDLICAFLTDREV-RLGRNGVDEIKSHP 305
Query: 879 FFK--DINWDTLARQKAAFVPTSESALDTSYF 908
FFK +D + A VP S +DTS F
Sbjct: 306 FFKNDQWTFDNIRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 8e-76
Identities = 145/375 (38%), Positives = 204/375 (54%), Gaps = 36/375 (9%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F IK + GAFG V LA K T L+A+K L+K D++ +N V + AERDIL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VV+ +YSF ++NLY VM+Y+ GGD+ SLL + E +AR YIAE+ LA+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI---NSTDDLSGPAVSGTTL---------- 757
+HRD+KPDN+LI DGHIKLTDFGL G NS G + ++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLC-TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 758 ---LGDEEPQLTASEHQQERR-KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
GD L +Q +R S VGTP+Y+APE+LL G+ DWWSVG+ILFE+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWP---RVPEE--MSPEAHDLIDRFLTEDPHQRLGS 868
+VG PPF A P + ++N W +P + +SPEA DLI + RLG
Sbjct: 242 LVGQPPFLAPTPTETQLKVIN----WENTLHIPPQVKLSPEAVDLITKLCCSAEE-RLGR 296
Query: 869 GGASEVKQHVFFKDINWDT-LARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDF 927
GA ++K H FF ++++ + + Q A +VP +DTS F + +E
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNF------DPVEEESPWNDAS 350
Query: 928 EDSSDA-DSLSGSSS 941
DS+ D+L +
Sbjct: 351 GDSTRTWDTLCSPNG 365
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 1e-75
Identities = 130/328 (39%), Positives = 180/328 (54%), Gaps = 39/328 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFEI+K I RGAFG V + K + TG ++A+K+L K +M+++ ERD+L++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHS 707
++ Y+F NLYLVM+Y GGDL +LL L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
L VHRD+KPDN+L+ +GHI+L DFG S LL D Q
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG------------------SCLRLLADGTVQSNV 162
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL----GTGH-GTTADWWSVGIILFELIVGIPPFNA 822
AVGTPDY++PEIL G G G DWWS+G+ ++E++ G PF A
Sbjct: 163 ------------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 823 EHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
E + + I+N K +P ++S EA DLI R + P RLG G + K H FF
Sbjct: 211 ESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
Query: 881 KDINWDTLARQKAAFVPTSESALDTSYF 908
+ I+WD + A +VP S DTS F
Sbjct: 270 EGIDWDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 9e-73
Identities = 102/292 (34%), Positives = 156/292 (53%), Gaps = 37/292 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
FE+++ I +GAFG+V + +KR T +FA+K + K + K +V ++L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDL-YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+V +YSF EN+YLV++ L GGDL Y L + E+ + +I E+VLALEYLHS
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRD+KPDN+L+ GH+ +TDF ++ ++T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIAT--------------------------KVTPDT 154
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
GTP Y+APE+L G+ DWWS+G+ +E + G P+ H + I
Sbjct: 155 LTTST------SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG-HSRTIR 207
Query: 830 DNILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
D I ++ P S EA D I++ L DP +RLG ++K H +F
Sbjct: 208 DQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLG-DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 9e-73
Identities = 127/335 (37%), Positives = 195/335 (58%), Gaps = 41/335 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-NAVESILAERDILIS 645
+FE++K + GA+G+VFL +K T TG L+A+KVL+KA +++K VE ER++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 646 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
VR +PF+V Y+F L+L+++Y++GG++++ L ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH L +V+RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823
+E+ + S GT +Y+APEI+ G GHG DWWS+GI++FEL+ G PF E
Sbjct: 157 ------SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
Query: 824 HPQQIFDNILNRKIPW-PRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFF 880
+ + R + P P + PEA DL+ + L +DP +RLG+G GASE+K+H FF
Sbjct: 211 GERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
Query: 881 KDINWDTLARQK--AAFVPTSESALDTSYFTSRYS 913
K ++W+ LA +K F P+ + LD F ++
Sbjct: 271 KGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFT 305
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 1e-72
Identities = 117/317 (36%), Positives = 180/317 (56%), Gaps = 39/317 (12%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K + +G+FG+V LA+ + T + FAIK LKK ++ + VE + ER +L + +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
F +F +E+L+ VMEYLNGGDL +++ G DE AR Y AE++ L++LH +++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ DGHIK+ DFG+ K + G+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK-----------------ENMNGE------------- 150
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
K + GTPDY+APEIL G + + DWWS G++L+E+++G PF+ E ++FD+IL
Sbjct: 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK- 892
N P P +S EA D + + DP +RLG G +++QH FF+ I+W+ L +++
Sbjct: 210 N-DRPH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERLEKREI 264
Query: 893 -AAFVPTSESALDTSYF 908
F P +S D S F
Sbjct: 265 PPPFKPKVKSPSDASNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 1e-72
Identities = 126/340 (37%), Positives = 190/340 (55%), Gaps = 43/340 (12%)
Query: 594 IKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+K + +G+FG+VFL +K T G L+A+KVLKKA + ++ V + + ERDIL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+V+ Y+F LYL++++L GGDL++ L E+ + Y+AE+ LAL++LHSL +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
++RDLKP+N+L+ +GHIKLTDFGLSK E
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-------------------------------ES 148
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
+K S GT +Y+APE++ GH +ADWWS G+++FE++ G PF + ++
Sbjct: 149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTL 888
IL K+ +P+ +SPEA L+ +P RLG+G G E+K+H FF I+W+ L
Sbjct: 209 MILKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265
Query: 889 ARQ--KAAFVPTSESALDTSYFTSRYSWNT-TDENIYPAS 925
R+ K F P DT YF ++ T D P S
Sbjct: 266 YRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPS 305
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-72
Identities = 124/345 (35%), Positives = 194/345 (56%), Gaps = 38/345 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LAK+++ G +A+KVL+K +++K I+AER++L+ ++++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
YSF E LY V++Y+NGG+L+ L+ C E AR Y AEV A+ YLHSL +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GH+ LTDFGL K G+ EP+ T S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGV---------------------EPEETTS----- 154
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+ GTP+YLAPE+L + T DWW +G +L+E++ G+PPF + Q++DNIL
Sbjct: 155 -----TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQK 892
++ + ++P + A DL+ L +D +RLG+ E+K HVFF INWD L ++
Sbjct: 210 HKPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKR 266
Query: 893 AA--FVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADS 935
+ P D +F ++ ++ D SS + S
Sbjct: 267 ITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSAS 311
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 2e-71
Identities = 124/345 (35%), Positives = 182/345 (52%), Gaps = 40/345 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L +++ TG +A+K+LKK +I K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
YSF + L VMEY NGG+L+ L ED AR Y AE+V AL YLHS VV+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
LK +NL++ DGHIK+TDFGL K G+ +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDG------------------------------- 149
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834
++ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ IL
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 892
+I +PR +SPEA L+ L +DP QRLG G A E+ +H FF INW + ++K
Sbjct: 210 EEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266
Query: 893 --AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADS 935
F P S DT YF ++ + I P ++
Sbjct: 267 LEPPFKPQVTSETDTRYFDEEFTAQSIT--ITPPDRYDSLGLLQL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 7e-70
Identities = 129/359 (35%), Positives = 195/359 (54%), Gaps = 41/359 (11%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVR 653
I +G FG+V+ +K+ T ++A+KVL K +++ K V + ER+IL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+SF +LYLV +Y++GG+L+ L+ G ED A+ YIAE+VLALE+LH +V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GHI L DFGLSK L TD+ + GTT
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---TDNKTTNTFCGTT----------------- 160
Query: 774 RRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 832
+YLAPE+LL G+ D+WS+G+++FE+ G PF AE QQ++ NI
Sbjct: 161 -----------EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
Query: 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ 891
K+ +P+ +S E + L +P RLG+ A E+K+H FF DI+WD L+++
Sbjct: 210 AFGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKK 267
Query: 892 KAA--FVPTSESALDTSYFTSRYS-WNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQ 947
+ F P +S D S F ++ + + I P D A+S SSS N +
Sbjct: 268 QITPPFKPIVDSDEDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANSTPLSSSVQENFR 326
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 1e-69
Identities = 122/333 (36%), Positives = 180/333 (54%), Gaps = 52/333 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DF++ + RG FG V + +++ TGD++A+KV+KK+ ++ + V ERDIL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHS 707
P++ + Y+F ++NLYLVMEY GGDL SLL R DED+A+ Y+AE+VLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFG----LSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ VHRD+KP+N+LI GHIKL DFG L+ ++NS
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK------------------- 161
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELIVGI 817
VGTPDY+APE+L +G DWWS+G+I +E+I G
Sbjct: 162 ---------------LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
Query: 818 PPFNAEHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
PF+ + ++NI+N R + +P P ++S + DLI L +RLG G +
Sbjct: 207 SPFHEGTSAKTYNNIMNFQRFLKFPEDP-KVSSDFLDLIQSLLC-GQKERLGYEG---LC 261
Query: 876 QHVFFKDINWDTLARQKAAFVPTSESALDTSYF 908
H FF I+W+ + FVPT +S DTS F
Sbjct: 262 CHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 4e-69
Identities = 106/324 (32%), Positives = 179/324 (55%), Gaps = 39/324 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRN 648
DF + + +G+FG+V LA+++ T +L+AIK+LKK +I+ + VE + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK------------------------------- 149
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
E+ + R+ GTPDY+APEI+ +G + DWW+ G++L+E++ G PPF+ E ++
Sbjct: 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWD 886
F +I+ + +P+ +S EA + LT+ P +RLG G G ++++H FF+ I+W+
Sbjct: 210 FQSIMEHNVSYPK---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266
Query: 887 TLARQ--KAAFVPTSESALDTSYF 908
L R+ + F P + F
Sbjct: 267 KLERREIQPPFKPKVKGRRSAENF 290
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 1e-67
Identities = 94/294 (31%), Positives = 148/294 (50%), Gaps = 37/294 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
++ + + RG+FG V+LA + TG+L A+K ++ + + E++ E IL S+++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 650 FVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+VR++ S E L + +EY++GG L SLL+ G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+VHRD+K N+L+ DG +KL DFG +K + + G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKR--LGDIETGEG------------------ 159
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
S GTP ++APE++ G +G AD WS+G + E+ G PP++
Sbjct: 160 ---------TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM 210
Query: 828 IFDN-ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
I + P P +PE +S EA D + + L DP +R A E+ QH F
Sbjct: 211 AALYKIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKR---PTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 229 bits (584), Expect = 1e-67
Identities = 123/343 (35%), Positives = 187/343 (54%), Gaps = 41/343 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L +++ TG +A+K+L+K +I K+ V + E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEYLHS VV+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+K +NL++ DGHIK+TDFGL K G+ + G T+
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISD-----------GATM----------------- 152
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834
++ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ IL
Sbjct: 153 ---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209
Query: 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 892
+I R P +SPEA L+ L +DP QRLG G A EV +H FF INW + ++K
Sbjct: 210 EEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266
Query: 893 --AAFVPTSESALDTSYFTSRYSWNT---TDENIYPASDFEDS 930
F P S +DT YF ++ + T + Y + +
Sbjct: 267 LLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLEL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 2e-67
Identities = 121/323 (37%), Positives = 186/323 (57%), Gaps = 48/323 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-NAVESILAERDILIS 645
+FE++K + GA+G+VFL +K + +G L+A+KVLKKA +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 646 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+R +PF+V Y+F L+L+++Y+NGG+L++ L E ++Y E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH L +++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------- 153
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822
H+ E + S GT +Y+AP+I+ G GH DWWS+G++++EL+ G PF
Sbjct: 154 ---EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210
Query: 823 EHPQ----QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQ 876
+ + +I IL + P+P +EMS A D+I R L +DP +RLG G A E+K+
Sbjct: 211 DGEKNSQAEISRRILKSEPPYP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 877 HVFFKDINWDTLARQK--AAFVP 897
H FF+ INWD LA +K A F P
Sbjct: 268 HPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 2e-67
Identities = 116/326 (35%), Positives = 190/326 (58%), Gaps = 41/326 (12%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVR 653
K + +G+FG+V LA+ + T +++AIKVLKK +++ + V+ + E+ IL ++ ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
F ++ L+ VMEY+NGGDL ++ DE +R Y AEV LAL +LH V++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ +GH KL DFG+ K G++N V+ TT
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNG--------VTTTTF---------------- 156
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
GTPDY+APEIL +G + DWW++G++++E++ G PPF A++ +F++IL
Sbjct: 157 -------CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG----SGGASEVKQHVFFKDINWDTL- 888
+ + + P +S EA ++ F+T++P++RLG GG +KQH FFK+I+W L
Sbjct: 210 HDDVLY---PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLE 266
Query: 889 ARQ-KAAFVPTSESALDTSYFTSRYS 913
R+ K F P ++ D + F ++
Sbjct: 267 QRKIKPPFKPKIKTKRDVNNFDQDFT 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 7e-67
Identities = 120/344 (34%), Positives = 191/344 (55%), Gaps = 52/344 (15%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVR 653
K + +G+FG+VFLA+ + T FAIK LKK ++ + VE + E+ +L ++ +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+ +F +ENL+ VMEYLNGGDL +++ D A Y AE++ L++LHS +V+R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ DGHIK+ DFG+ K +LGD
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK-----------------ENMLGDA------------ 151
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
K + GTPDY+APEILLG + T+ DWWS G++L+E+++G PF+ +++F +I
Sbjct: 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI- 208
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK- 892
++ P P ++ EA D++ + +P +RLG G +++QH FF++I+W L ++
Sbjct: 209 --RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREI 264
Query: 893 -AAFVPTSESALDTSYF-------------TSRYSWNTTDENIY 922
F P +SA D S F T R N+ D+N++
Sbjct: 265 EPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMF 308
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 1e-66
Identities = 115/318 (36%), Positives = 183/318 (57%), Gaps = 40/318 (12%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFF 655
+ +G+FG+V LA+ + +G L+A+KVLKK +++ + VE + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F + L+ VME++NGGDL ++ DE AR Y AE+ AL +LH +++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ H+GH KL DFG+ K G+ N T+
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGK--------------------TTS-------- 154
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 835
+ GTPDY+APEIL +G + DWW++G++L+E++ G PF AE+ +F+ ILN
Sbjct: 155 ---TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
Query: 836 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQK 892
++ + P +S +A D++ F+T++P RLGS GG + +H FFK+++W+ L R++
Sbjct: 212 EVVY---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQ 268
Query: 893 --AAFVPTSESALDTSYF 908
F P +S D S F
Sbjct: 269 IEPPFRPRIKSREDVSNF 286
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 4e-64
Identities = 124/327 (37%), Positives = 180/327 (55%), Gaps = 39/327 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L K++ TG +A+K+LKK ++ K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHR 713
YSF + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS + VV+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK +NL++ DGHIK+TDFGL K G+ + G T+
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKD-----------GATM---------------- 153
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
++ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ IL
Sbjct: 154 ----KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG--ASEVKQHVFFKDINWDTLARQ 891
+I +PR +SPEA L+ L +DP QRLG G A E+ QH FF I W + +
Sbjct: 210 MEEIRFPRT---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266
Query: 892 KAA--FVPTSESALDTSYFTSRYSWNT 916
K F P S DT YF ++
Sbjct: 267 KLVPPFKPQVTSETDTRYFDEEFTAQM 293
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 8e-64
Identities = 117/336 (34%), Positives = 187/336 (55%), Gaps = 38/336 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LA+ + +A+KVL+K +++K + I++ER++L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+SF + LY V++Y+NGG+L+ L+ C E AR Y AE+ AL YLHSL +V+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GHI LTDFGL K + E T S
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENI---------------------EHNGTTS----- 154
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+ GTP+YLAPE+L + T DWW +G +L+E++ G+PPF + + +++DNIL
Sbjct: 155 -----TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA-SEVKQHVFFKDINWDTLARQK 892
N+ + ++ ++ A L++ L +D +RLG+ E+K H+FF INWD L +K
Sbjct: 210 NKPL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKK 266
Query: 893 AA--FVPTSESALDTSYFTSRYSWNTTDENIYPASD 926
F P D +F ++ +I + D
Sbjct: 267 ITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPD 302
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 4e-63
Identities = 118/339 (34%), Positives = 185/339 (54%), Gaps = 40/339 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L +++ +G +A+K+LKK +I K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
YSF ++ L VMEY+NGG+L+ L ED R Y AE+V AL+YLHS ++V+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
LK +NL++ DGHIK+TDFGL K G+ ++
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAA------------------------------ 150
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834
++ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ IL
Sbjct: 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 892
I +PR +S +A L+ L +DP++RLG G A E+ +H FF +NW + +K
Sbjct: 210 EDIKFPRT---LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKK 266
Query: 893 --AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFED 929
F P S DT YF ++ T I P +++
Sbjct: 267 LVPPFKPQVTSETDTRYFDEEFTAQTI--TITPPEKYDE 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 5e-63
Identities = 88/280 (31%), Positives = 150/280 (53%), Gaps = 38/280 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+EIIK I +G+FG+V+L ++++ G L+ +K + ++M K ++ L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYL 705
+++++ SF + L +VMEY +GGDL ++ E+ + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS +++HRD+KP N+ + +G +KL DFG+SKV ++ST DL T+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDL------AKTV-------- 163
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
VGTP YL+PE+ + +D WS+G +L+EL PF E+
Sbjct: 164 ---------------VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208
Query: 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
++ IL + P +P + S E +L+ L +DP +R
Sbjct: 209 LELALKILKGQY--PPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 5e-63
Identities = 130/336 (38%), Positives = 190/336 (56%), Gaps = 49/336 (14%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
R +D+E++K I RGAFG V L + ++T ++A+K+L K +MI+++ ERDI+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+P+VV+ FY+F LY+VMEY+ GGDL +L+ N + E AR Y AEVVLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFG----LSKVGLINSTDDLSGPAVSGTTLLGD 760
+HS+ +HRD+KPDN+L+ GH+KL DFG ++K G++
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD---------------- 201
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVG 816
+AVGTPDY++PE+L G +G DWWSVG+ L+E++VG
Sbjct: 202 ------------------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
Query: 817 IPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
PF A+ + I+N K + +P ++S EA +LI FLT D RLG G E+
Sbjct: 244 DTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEI 301
Query: 875 KQHVFFKDIN--WDTLARQKAAFVPTSESALDTSYF 908
K+H+FFK+ W+TL A VP S +DTS F
Sbjct: 302 KRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 7e-63
Identities = 126/328 (38%), Positives = 182/328 (55%), Gaps = 39/328 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DFEI+K I RGAFG V + K + +FA+K+L K +M+++ ERD+L++ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
++ Y+F NLYLVM+Y GGDL +LL L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
L VHRD+KPDN+L+ +GHI+L DFG S L+ D Q +
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG------------------SCLKLMEDGTVQSSV 162
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL----GTG-HGTTADWWSVGIILFELIVGIPPFNA 822
AVGTPDY++PEIL G G +G DWWS+G+ ++E++ G PF A
Sbjct: 163 ------------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 823 EHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
E + + I+N K +P ++S +A DLI R + H RLG G + KQH FF
Sbjct: 211 ESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREH-RLGQNGIEDFKQHPFF 269
Query: 881 KDINWDTLARQKAAFVPTSESALDTSYF 908
I+WD + +A ++P S DTS F
Sbjct: 270 TGIDWDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 116/337 (34%), Positives = 191/337 (56%), Gaps = 38/337 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LAK++ G +A+KVL+K ++ + + I+AER++L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
YSF E LY V++++NGG+L+ L+ E AR Y AE+ AL YLHS+ +V+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GH+ LTDFGL K G+ A S TT
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGI----------AQSDTT----------------- 153
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+ GTP+YLAPE++ + T DWW +G +L+E++ G+PPF +++DNIL
Sbjct: 154 ----TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQK 892
++ + + S A +++ L +D +RLG+ E+++H FF+ ++W L ++K
Sbjct: 210 HKPL---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKK 266
Query: 893 --AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDF 927
F P E D S F + ++ T ++ +SD+
Sbjct: 267 IPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDY 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 1e-62
Identities = 123/328 (37%), Positives = 180/328 (54%), Gaps = 39/328 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFEIIK I RGAFG V + K + T ++A+K+L K +M+++ ER++L++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
++ Y+F LYLVM+Y GGDL +LL L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
L VHRD+KPDN+L+ +GHI+L DFG + D GT
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG----SCLKMNQD-------GTV----------- 158
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL----GTG-HGTTADWWSVGIILFELIVGIPPFNA 822
+ AVGTPDY++PEIL G G +G DWWS+G+ ++E++ G PF A
Sbjct: 159 --------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 823 EHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
E + + I+N + +P ++S EA DLI R + +RLG G + K+H FF
Sbjct: 211 ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFF 269
Query: 881 KDINWDTLARQKAAFVPTSESALDTSYF 908
+ I+W+ + +A ++P S DTS F
Sbjct: 270 EGIDWENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 4e-62
Identities = 127/328 (38%), Positives = 186/328 (56%), Gaps = 41/328 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D++++K I RGAFG V L + +++ ++A+K+L K +MI+++ ERDI+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P+VV+ F +F + LY+VMEY+ GGDL +L+ N + E A+ Y AEVVLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+KPDN+L+ GH+KL DFG T + DE +
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFG--------------------TCMKMDETGMVRCD 201
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAEH 824
+AVGTPDY++PE+L G +G DWWSVG+ LFE++VG PF A+
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251
Query: 825 PQQIFDNILNRKIPWPRVPE--EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+ I++ K PE E+S A +LI FLT D RLG G E+KQH FFK+
Sbjct: 252 LVGTYSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309
Query: 883 --INWDTLARQKAAFVPTSESALDTSYF 908
NWD + A VP S +D+S F
Sbjct: 310 DQWNWDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (545), Expect = 5e-62
Identities = 116/332 (34%), Positives = 178/332 (53%), Gaps = 44/332 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAER 640
K++ +DF I+ + G+FGRV LA + D AIK +K+ +I++ V+ + +ER
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
IL + +PF V + SF LYLV+E++ GG+ ++ LR DV Y A++VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
EYL SL +V+RDLKP+NLL+ DG IK+TDFG +KV
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---------------------- 180
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ + GTP+Y+APEILL GHG ADWW++GI ++E++VG PPF
Sbjct: 181 ------------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHV 878
A P I+ IL I +P+ + L+ + L+ D +R G+ GA VK+H
Sbjct: 229 YANEPLLIYQKILEGIIYFPKF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285
Query: 879 FFKDINWDTLARQ--KAAFVPTSESALDTSYF 908
+F +I+W +L + + + P ++ D+S F
Sbjct: 286 WFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNF 317
|
Length = 340 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 8e-62
Identities = 95/168 (56%), Positives = 125/168 (74%), Gaps = 3/168 (1%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
SI++F I+KPISRGAFG+V+L +K+ L+A+KV+KKADMI KN V + AERD L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
++PF+V +YS N+YLVMEYL GGD+ SLL G DE++A YI+EV LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPA 751
++HRDLKPDN+LI+++GHIKLTDFGLSKV L +N D L+ P+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPS 169
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 6e-61
Identities = 94/291 (32%), Positives = 148/291 (50%), Gaps = 39/291 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
FEI++ I +G FG V+ A+ + TG AIKV+K +K E I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSL 708
+V+++ S+ ++ L++VME+ +GG L LL++ L E E++ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+K N+L+ DG +KL DFGLS QL+ +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--------------------------QLSDT 151
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
+ + VGTP ++APE++ G + AD WS+GI EL G PP++ P +
Sbjct: 152 KARNTM------VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
I P R PE+ S E D + + L ++P +R A ++ +H F
Sbjct: 206 LFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKR---PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 7e-61
Identities = 114/349 (32%), Positives = 190/349 (54%), Gaps = 40/349 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVR 653
K + +G+FG+V LA+ + G+ FA+K LKK ++ + VE + E+ +L ++ NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+ +F +E+L+ VME+LNGGDL +++ G D A Y AE+V L++LHS +++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+++ DGHIK+ DFG+ K + GD
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK-----------------ENVFGDN------------ 151
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+ + GTPDY+APEIL G + + DWWS G++L+E+++G PF+ + ++F++I
Sbjct: 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI- 208
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK- 892
++ P P ++ E+ D++++ DP +RLG G ++ H FFK INW L +++
Sbjct: 209 --RVDTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKREL 264
Query: 893 -AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSS 940
F P +S D S F + + Y + DS D + +G S
Sbjct: 265 DPPFKPKVKSPSDYSNFDREF-LSEKPRLSYSDKNLIDSMDQSAFAGFS 312
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 1e-59
Identities = 104/306 (33%), Positives = 175/306 (57%), Gaps = 37/306 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRN 648
DF + + +G+FG+V LA+++ T +L+AIK+LKK +I+ + VE + E+ +L +S +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLK DN+++ +GHIK+ DFG+ K + + G T
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-----------GVT------------ 157
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
++ GTPDY+APEI+ +G + DWW+ G++L+E++ G PF E ++
Sbjct: 158 --------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWD 886
F +I+ + +P+ MS EA + +T+ P +RLG G G ++K+H FF+ I+W+
Sbjct: 210 FQSIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266
Query: 887 TLARQK 892
L R++
Sbjct: 267 KLERKE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 3e-59
Identities = 102/306 (33%), Positives = 173/306 (56%), Gaps = 37/306 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRN 648
DF + + +G+FG+V LA+++ T +L+AIK+LKK +I+ + VE + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------------------- 149
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
EH + R+ GTPDY+APEI+ +G + DWW+ G++L+E++ G PPF+ E ++
Sbjct: 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWD 886
F +I+ + +P+ +S EA + +T+ P +RLG G G ++++H FF+ I+WD
Sbjct: 210 FQSIMEHNVSYPK---SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266
Query: 887 TLARQK 892
L ++
Sbjct: 267 KLENRE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 1e-58
Identities = 101/309 (32%), Positives = 160/309 (51%), Gaps = 41/309 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRD 714
+F +++L LVM +NGGDL + N+G E A Y A+++ LE+LH R+V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
LKP+N+L+ G+++++D GL AV +
Sbjct: 121 LKPENVLLDDHGNVRISDLGL---------------AV-----------------ELKGG 148
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834
+K + GTP Y+APE+L G + + DW+++G L+E+I G PF +++ L
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ-RKEKVEKEELK 207
Query: 835 RKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLAR 890
R+ V P++ SPEA DL + L +DP +RLG G A EV++H FKD+NW L
Sbjct: 208 RRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA 267
Query: 891 QK--AAFVP 897
F+P
Sbjct: 268 GMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 3e-57
Identities = 111/348 (31%), Positives = 185/348 (53%), Gaps = 53/348 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFF 655
I RG++ +V L + + T ++A+KV+KK + ++ + E+ + + N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F L+ V+E+++GGDL ++ L E+ AR Y AE+ LAL +LH +++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ +GHIKLTD+G+ K G+ P + +T
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGI--------RPGDTTSTF------------------ 156
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF----NAEHPQQ---- 827
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF +++P Q
Sbjct: 157 -----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211
Query: 828 -IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG---SGGASEVKQHVFFKDI 883
+F IL ++I R+P +S +A ++ FL +DP +RLG G ++K H FF++I
Sbjct: 212 YLFQVILEKQI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268
Query: 884 NWDTLARQKAA--FVPTSESALDTSYFTSRYSWNTTDENIYPASDFED 929
+WD L +++ + P ES D F ++ TDE + D D
Sbjct: 269 DWDLLEQKQVLPPYKPNIESDRDLDNFDPQF----TDEPVQLTPDDPD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 4e-56
Identities = 95/284 (33%), Positives = 137/284 (48%), Gaps = 73/284 (25%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G FG V+LA+ + TG AIK++KK D + +E +L E +IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 657 SFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F +LYLVMEY GG L LL N G L ED + +++ LEYLHS ++HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 716 KPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
KP+N+L+ D G +KL DFGLSK ++
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK-------------------------------LLTSDK 147
Query: 775 RKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
++ VGTP Y+APE+LLG G+ +D WS+G+IL+EL
Sbjct: 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------- 187
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
PE DLI + L +DP +R A E+ +H
Sbjct: 188 --------------PELKDLIRKMLQKDPEKRP---SAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-53
Identities = 104/309 (33%), Positives = 160/309 (51%), Gaps = 47/309 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
++ ++ I GA G V+ A R TG AIK ++ +RK E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDED-VARVYIAEVVLALEYLHSL 708
+V ++ S+ + L++VMEY++GG L ++ N ++E +A V EV+ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+HRD+K DN+L++ DG +KL DFG + QLT
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAA--------------------------QLT-- 167
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
+E+ K+ S VGTP ++APE++ +G D WS+GI+ E+ G PP+ E P +
Sbjct: 168 ---KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888
I + IP + PE+ SPE D +++ L +DP +R A E+ QH F K
Sbjct: 225 LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR---PSAEELLQHPFLK------K 275
Query: 889 ARQKAAFVP 897
A K F P
Sbjct: 276 ACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 7e-53
Identities = 112/344 (32%), Positives = 180/344 (52%), Gaps = 47/344 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFF 655
I RG++ +V L + + ++A+KV+KK + ++ + E+ + NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F L+LV+EY+NGGDL ++ L E+ AR Y AE+ +AL +LH +++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ DGHIKLTD+G+ K GL GP + +T
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGL--------GPGDTTSTF------------------ 156
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN--AEHP-----QQI 828
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+ ++P +
Sbjct: 157 -----CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG---SGGASEVKQHVFFKDINW 885
F IL + I R+P +S +A ++ FL +DP +RLG G S++K H FF+ I+W
Sbjct: 212 FQVILEKPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268
Query: 886 DTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFED 929
D L +++ P + + Y + T E + D ED
Sbjct: 269 DLLEKKQV--TPPFKPQITDDYGLENFDTQFTSEPVQLTPDDED 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 86/276 (31%), Positives = 141/276 (51%), Gaps = 34/276 (12%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
++++ I RGAFG V+ TGD AIK + I++ A++SI+ E D+L ++++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+V++ S ++LY+++EY G L +++ G E + VY+ +V+ L YLH
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
V+HRD+K N+L DG +KL DFG++ T L D
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-------------------TKLNDVSKDDA--- 157
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
S VGTP ++APE++ +G T +D WS+G + EL+ G PP+ +P
Sbjct: 158 ---------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
I+ P +PE +SPE D + + +DP+ R
Sbjct: 209 FRIVQD--DHPPLPEGISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-52
Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 47/300 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISV 646
D E +K + +G+ G V+ + + TG ++A+K + RK +L E L S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+P+VV+ + +F + +V+EY++GG L LL+ +G + E V +++ L+YLH
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 707 S-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+ ++HRD+KP NLLI G +K+ DFG+SKV + +T D
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD------------------- 155
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ + VGT Y++PE + G + AD WS+G+ L E +G PF
Sbjct: 156 ----------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ 205
Query: 826 QQIFD---NILNRKIP-WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
F+ I + P P EE SPE D I L +DP +R A+E+ QH F K
Sbjct: 206 PSFFELMQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 7e-52
Identities = 110/348 (31%), Positives = 184/348 (52%), Gaps = 53/348 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFF 655
I RG++ +V L + + T ++A+KV+KK + ++ + E+ + N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F L+ V+EY+NGGDL ++ L E+ AR Y AE+ LAL YLH +++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ +GHIKLTD+G+ K GL P T S
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGL---------------------RPGDTTSTF----- 156
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN----AEHPQQ---- 827
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+ +++P Q
Sbjct: 157 -----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211
Query: 828 -IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG---SGGASEVKQHVFFKDI 883
+F IL ++I R+P +S +A ++ FL +DP +RLG G ++++ H FF+++
Sbjct: 212 YLFQVILEKQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268
Query: 884 NWDTLARQKAA--FVPTSESALDTSYFTSRYSWNTTDENIYPASDFED 929
+WD + +++ F P F +++ T+E + D +D
Sbjct: 269 DWDLMEQKQVVPPFKPNISGEFGLDNFDAQF----TNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 100/287 (34%), Positives = 149/287 (51%), Gaps = 35/287 (12%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I G FG+V+ A TG+L A+K ++ D K ++ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
RE +Y+ MEY +GG L LL + LDE V RVY +++ L YLHS +VHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P N+ + H+G IKL DFG + + TT +G E Q
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK------------LKNNTTTMG---------EEVQ---- 161
Query: 777 KRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNI 832
S GTP Y+APE++ G GHG AD WS+G ++ E+ G P++ ++ QI ++
Sbjct: 162 --SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV 219
Query: 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
P ++SPE D +DR L DP +R ASE+ QH F
Sbjct: 220 GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 8e-51
Identities = 114/381 (29%), Positives = 169/381 (44%), Gaps = 50/381 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-N 648
+ I++ + G+FG V+LA+ R A+KVL K + VE L E IL S+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYL 705
P +V+ + F +LYLVMEY++GG L LL+ +G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 706 HSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
HS ++HRD+KP+N+L+ DG +KL DFGL+K LL D
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK-------------------LLPDP--- 155
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVGIPPFN 821
++VGTP Y+APE+LLG +++D WS+GI L+EL+ G+PPF
Sbjct: 156 ---GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
Query: 822 AEH----PQQIFDNILNRKIPW------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
E Q IL P P PE +S A DL+ + L +DP RL S
Sbjct: 213 GEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS--- 269
Query: 872 SEVKQHVFFKDINW-DTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDS 930
S H + ++ ++ L + I + D
Sbjct: 270 SSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDD 329
Query: 931 SDADSLSGSSSCLSNRQEEVG 951
S+ + S+
Sbjct: 330 SNFSKELAPNGVSSSPHNSSS 350
|
Length = 384 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 95/296 (32%), Positives = 148/296 (50%), Gaps = 44/296 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILAERDILISV 646
+ F +++ I +G+FG V+ A + T + AIKV L++A+ + +E I E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
R+P++ +++ SF L+++MEY GG LL+ G LDE + EV+L LEYLH
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLH 115
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HRD+K N+L++ +G +KL DFG VSG QLT
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFG-----------------VSG---------QLT 149
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
++ K+ + VGTP ++APE++ +G+ AD WS+GI EL G PP + HP
Sbjct: 150 ST-----MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204
Query: 827 QIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
++ I P + S D + L +DP +R A E+ +H F K
Sbjct: 205 RVLFLIPKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 88/293 (30%), Positives = 149/293 (50%), Gaps = 40/293 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ F+I++ + G++G V+ A + TG + AIKV+ + ++ I+ E IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHS 707
P++V+++ S+ +L++VMEY G + +++ L E+ + + + LEYLHS
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ +HRD+K N+L+ +G KL DFG VSG QLT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFG-----------------VSG---------QLT- 150
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
K+ + +GTP ++APE++ G+ AD WS+GI E+ G PP++ HP +
Sbjct: 151 ----DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
I N+ P PE+ SPE +D + + L +DP +R A ++ QH F
Sbjct: 207 AIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER---PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 97/303 (32%), Positives = 146/303 (48%), Gaps = 37/303 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + N+G DE+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+V+RDLKP+N+L+ GHI+++D GL AV
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGL---------------AV---------------- 150
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
E R VGT Y+APE++ + + DWW +G +++E+I G PF +
Sbjct: 151 -EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
Query: 829 FDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINW 885
+ + R E+ S A + + LT+DP RLG GA EVK H FF+ N+
Sbjct: 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
Query: 886 DTL 888
L
Sbjct: 270 KRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 86/286 (30%), Positives = 137/286 (47%), Gaps = 39/286 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISVRNPFVVRF 654
+ G+FG V+ GD FA+K + AD + AV+ + E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
+ +NLY+ +E + GG L LL+ G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+K N+L+ +G +KL DFG++K E
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK--------------------------------QVVEF 155
Query: 775 RKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833
+S G+P ++APE++ G +G AD WS+G + E+ G PP++ I
Sbjct: 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
K P +P+ +S EA D I + L DP R A+E+ +H F
Sbjct: 216 RSKE-LPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 104/305 (34%), Positives = 157/305 (51%), Gaps = 45/305 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVR 653
I RG FG V+ +K TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
Y+F + L +++ +NGGDL+ L G E R Y E++L LE++H+ VV+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP N+L+ GH++++D GL+ D S
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--------DFS------------------------- 148
Query: 774 RRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPF---NAEHPQQIF 829
++K ++VGT Y+APE+L GT + ++ADW+S+G +LF+L+ G PF + +I
Sbjct: 149 KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINWDT 887
L + +P+ SPE L++ L D +RLG GA EVK+HVFFK I+W
Sbjct: 209 RMTLTVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265
Query: 888 LARQK 892
+ QK
Sbjct: 266 VYLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 101/305 (33%), Positives = 156/305 (51%), Gaps = 45/305 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVR 653
I RG FG V+ +K TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
Y+F + L +++ +NGGDL+ L G E R Y AE++L LE++H+ VV+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP N+L+ GH++++D GL+ D S
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--------DFS------------------------- 148
Query: 774 RRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPF---NAEHPQQIF 829
++K ++VGT Y+APE+L G + ++ADW+S+G +LF+L+ G PF + +I
Sbjct: 149 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINWDT 887
L + P+ SPE L++ L D ++RLG GA EVK+H FF+ ++W
Sbjct: 209 RMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265
Query: 888 LARQK 892
+ QK
Sbjct: 266 VFLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-47
Identities = 90/302 (29%), Positives = 153/302 (50%), Gaps = 44/302 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 657 SFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
+F + +L LVM +NGGDL Y++ E A Y A+++ LE+LH R+++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDLKP+N+L+ +DG+++++D GL A E +
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGL-------------------------------AVELKD 149
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE----HPQQI 828
+ K + GTP ++APE+L G + + D++++G+ L+E+I PF A +++
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINWD 886
ILN + + P++ SP + + L +DP +RLG G ++ H F+D+NW
Sbjct: 210 KQRILNDSVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266
Query: 887 TL 888
L
Sbjct: 267 QL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 8e-47
Identities = 101/303 (33%), Positives = 149/303 (49%), Gaps = 55/303 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D+E+I+ I G +G V+ A+ TG+L AIKV+K + + E I E +L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGG---DLYSLLRNLGCLDEDVARVYIA----EVVLA 701
P +V +F S+ R+ L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L YLH +HRD+K N+L+ DG +KL DFG+S
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------------------------ 149
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIILFELIVGIP 818
QLTA+ K++S +GTP ++APE+ G+ D W++GI EL P
Sbjct: 150 --QLTAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
Query: 819 PFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
P HP + I P P++ E+ SP HD I + LT+DP +R A+++ Q
Sbjct: 203 PMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQ 259
Query: 877 HVF 879
H F
Sbjct: 260 HPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 51/290 (17%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
D+E+++ I +G+FG V ++++ G + K + +M K + +++E +IL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59
Query: 650 FVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALE 703
+VR++ R N LY+VMEY GGDL L++ ++E+ + +++LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 704 YLH-----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
H V+HRDLKP N+ + + ++KL DFGL+K ++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSF----------- 166
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
A + VGTP Y++PE L + +D WS+G +++EL P
Sbjct: 167 --------AKTY----------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
Query: 819 PFNAEHPQQIFDNILNRKI---PWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
PF A + Q L KI + R+P S E +++I L DP +R
Sbjct: 209 PFTARNQLQ-----LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 8e-45
Identities = 100/307 (32%), Positives = 154/307 (50%), Gaps = 43/307 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + ++G +E A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAV------------------------------- 150
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
H E + + VGT Y+APE++ + + DWW++G +L+E+I G PF + ++I
Sbjct: 151 -HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ-QRKKKI 208
Query: 829 FDNILNRKIPWPRVPEE----MSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKD 882
+ R + V EE SP+A L L +DP +RLG GGA EVK+H FK
Sbjct: 209 KREEVERLV--KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
Query: 883 INWDTLA 889
IN+ L
Sbjct: 267 INFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 5e-44
Identities = 96/324 (29%), Positives = 144/324 (44%), Gaps = 72/324 (22%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL---KKADMIRKNAVESILAERDILISV 646
++I+ I GA G VF AK R TG+ A+K + + I A+ I A L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQAC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYL 705
++P+VV+ F LVMEY+ DL +LR+ L E + Y+ ++ + Y+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H+ ++HRDLKP NLLI+ DG +K+ DFGL+++ +E
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARL------------------FSEEEPRLY 157
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEH 824
+ HQ V T Y APE+L G D W+VG I EL+ G P F E+
Sbjct: 158 S---HQ---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
Query: 825 P-QQ---IFDNIL------------------------NRKIPWPRVPEEMSPEAHDLIDR 856
+Q +F L ++ IP + + SPEA DL+
Sbjct: 206 DIEQLAIVFR-TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKG 264
Query: 857 FLTEDPHQRLGSGGASEVKQHVFF 880
L DP +RL A+E +H +F
Sbjct: 265 LLVYDPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 88/302 (29%), Positives = 141/302 (46%), Gaps = 45/302 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA-VESILAERDILISVR 647
DD+E+I+ I GA V+ A + AIK + D+ + V+ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVLALEY 704
+P VV+++ SF + L+LVM YL+GG L +++ G LDE + + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +HRD+K N+L+ DG +K+ DFG+S L + D
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-ASLADGGDR------------------ 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
R+ +++ VGTP ++APE++ G+ AD WS GI EL G P++
Sbjct: 159 --------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210
Query: 824 HPQQIFDNILNRKIPWPRVPEEMSPEAH-----DLIDRFLTEDPHQRLGSGGASEVKQHV 878
P ++ L P + + + +I L +DP +R A E+ +H
Sbjct: 211 PPMKVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHK 265
Query: 879 FF 880
FF
Sbjct: 266 FF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 99/314 (31%), Positives = 154/314 (49%), Gaps = 39/314 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + N+G +E+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+RDLKP+N+L+ GHI+++D GL+ + P
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA----------VKIP------------------ 153
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
E R VGT Y+APE+L + + D+W +G +++E+I G PF +
Sbjct: 154 ----EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209
Query: 829 FDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINW 885
+ + R + V + S EA + LT+DP QRLG GA EVK+H FF+++N+
Sbjct: 210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269
Query: 886 DTL--ARQKAAFVP 897
L FVP
Sbjct: 270 KRLEAGMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 95/304 (31%), Positives = 153/304 (50%), Gaps = 39/304 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + N+G DE A Y AE+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+V+RDLKP+N+L+ GHI+++D GL+ + P
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV-----------------------QIP----- 153
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
E R VGT Y+APE++ + + DWW +G +++E+I G PF + +++
Sbjct: 154 ----EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR-KRKERV 208
Query: 829 FDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLG--SGGASEVKQHVFFKDIN 884
++R++ E+ S +A + LT++P +RLG GA+ VKQH FK+IN
Sbjct: 209 KREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268
Query: 885 WDTL 888
+ L
Sbjct: 269 FKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 91/301 (30%), Positives = 153/301 (50%), Gaps = 41/301 (13%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
P R+ +D+F I G+ G V +A ++TG A+K K D+ ++ E + E
Sbjct: 14 PGDPRSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEV 67
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
I+ ++P +V + S+ + L++VME+L GG L ++ + +E +A V +A V+
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-VLK 126
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL +LH+ V+HRD+K D++L+ DG +KL+DFG
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA----------------------- 163
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
Q++ +E +++S VGTP ++APE++ +GT D WS+GI++ E++ G PP+
Sbjct: 164 ---QVS-----KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
E P Q I + P + ++SP +DR L DP QR A+E+ H F
Sbjct: 216 FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR---ATAAELLNHPFL 272
Query: 881 K 881
Sbjct: 273 A 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 3e-42
Identities = 67/131 (51%), Positives = 86/131 (65%), Gaps = 3/131 (2%)
Query: 781 VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP 840
+GTPDYLAPE+LLG HG DWW++G+ LFE + GIPPFN E PQQ+F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 841 RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 900
E++S A + I+ LT DP +R G E+KQH F ++W+ L Q F+P +
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 901 SALDTSYFTSR 911
DTSYF +R
Sbjct: 658 DETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-41
Identities = 86/288 (29%), Positives = 138/288 (47%), Gaps = 34/288 (11%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVRNPFVV 652
K + +GAFGRV+L TG A+K + K V ++ E +L ++++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
+++ E L + MEY+ GG + L+ G L E V R Y +++ +EYLHS +VH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RD+K N+L G++KL DFG SK L SGT +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK--------RLQTICSSGTGM--------------- 164
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 832
+S GTP +++PE++ G G+G AD WSVG + E++ PP+ I
Sbjct: 165 -----KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219
Query: 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ P++P +SP+A + + R E+ +R A E+ +H F
Sbjct: 220 ATQP-TNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 102/333 (30%), Positives = 161/333 (48%), Gaps = 52/333 (15%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LRT S P K T + I +GA G V+ A TG AIK +
Sbjct: 1 DEEILEKLRTIVSVGDPKKKYTRFEK------IGQGASGTVYTAIDVATGQEVAIKQMNL 54
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+K E I+ E ++ ++P +V + S+ + L++VMEYL GG L ++
Sbjct: 55 QQQPKK---ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 110
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 163
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 164 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 805 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 864
S+GI+ E++ G PP+ E+P + I P + PE++S D ++R L D +
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 259
Query: 865 RLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 897
R G A E+ QH F K +A+ ++ P
Sbjct: 260 R---GSAKELLQHPFLK------IAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 99/324 (30%), Positives = 148/324 (45%), Gaps = 71/324 (21%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI--SVRN 648
+E I I G +G+V+ A+ + TG+L A LKK M + I A R+I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 649 PFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYL 705
P +VR T + ++Y+V EY++ DL LL + E + Y+ +++ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS ++HRD+K N+LI +DG +KL DFGL++
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR------------------PYTKRNSADY 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN--- 821
T + V T Y PE+LLG T +G D WSVG IL EL +G P F
Sbjct: 159 T------------NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206
Query: 822 -AEHPQQIFD-------------------NILNRKIPWPRVPEE-----MSPEAHDLIDR 856
E ++IF+ L K P+ R E + P A DL+D+
Sbjct: 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266
Query: 857 FLTEDPHQRLGSGGASEVKQHVFF 880
LT DP +R+ A + QH +F
Sbjct: 267 LLTLDPKKRI---SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DF+++K + +G++G V+ K+ + +A+K + M +K +++ E IL SV +P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYL 705
++ + +F L +VMEY GDL + + E +++ L+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H +++HRDLK N+L+ + +K+ D G+SKV N
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--------------------- 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
++ +GTP Y+APE+ G + +D WS+G +L+E+ PPF A
Sbjct: 159 ------------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206
Query: 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 867
Q + + K +P +P S + + I L P R
Sbjct: 207 QDLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 95/305 (31%), Positives = 148/305 (48%), Gaps = 56/305 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISV 646
DD E + + G G V R TG + A+K ++ + I+K IL E DIL
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDV-ARVYIAEVVLALEY 704
+P++V F+ +F ++ + MEY++GG L +L+ + G + E + ++ +A V+ L Y
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTY 115
Query: 705 LHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
LH +++HRD+KP N+L+ G IKL DFG+S L+NS
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNS-------------------- 154
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPF 820
++ VGT Y+APE + G + +D WS+G+ L EL G PP
Sbjct: 155 ------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202
Query: 821 NAEHPQQIFD---NILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
N P IF+ I+N P PR+P SP+ D ++ L +DP +R E+ +
Sbjct: 203 NDP-PDGIFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRER---PSYKELLE 256
Query: 877 HVFFK 881
H F K
Sbjct: 257 HPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 86/302 (28%), Positives = 143/302 (47%), Gaps = 43/302 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
D +EII + GAFG+V+ A+ + TG A K+ + + +E + E DIL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKI---IQIESEEELEDFMVEIDILSECK 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLH 706
+P +V + ++ L++++E+ +GG L S++ L L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +V+HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFN 821
+K+ + +GTP ++APE++ + AD WS+GI L EL PP +
Sbjct: 155 -----STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+P ++ IL + P P + S +D + L +DP R A+E+ +H F
Sbjct: 210 ELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVS 266
Query: 882 DI 883
D
Sbjct: 267 DQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 91/325 (28%), Positives = 143/325 (44%), Gaps = 78/325 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDILISV 646
+E ++ + G +G V+ A+ + TG++ A+K ++ + + E I L E +L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR---LDNEE--EGIPSTALREISLLKEL 55
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYL 705
++P +V+ LYLV EY + DL L G L ++ + + +++ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK---VGLINSTDDLSGPAVSGTTLLGDEE 762
HS R++HRDLKP N+LI DG +KL DFGL++ + L T +
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---------------- 158
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF- 820
V T Y APEILLG+ H T D WSVG I E+I G P F
Sbjct: 159 ------------------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200
Query: 821 -NAEHPQ--QIFD-----------------NILNRKIPWPRVPEE-----MSPEAHDLID 855
++E Q +IF + +P E + PE DL+
Sbjct: 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLS 260
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFF 880
+ L +P +R+ A E +H +F
Sbjct: 261 KMLQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 3e-39
Identities = 91/298 (30%), Positives = 153/298 (51%), Gaps = 39/298 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V + + TG ++A K L K + +K+ + L E++IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
+F + +L LVM +NGGDL + N+G ++ RV Y A++ + +LHS+ +V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+KP+N+L+ G+ +L+D GL AV +L + +R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL---------------AV-----------ELKDGKTITQR 154
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834
GT Y+APEIL + DW+++G ++E++ G PF +H +++ L
Sbjct: 155 ------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELK 207
Query: 835 RKIPWPRVPEE---MSPEAHDLIDRFLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTL 888
R+ V E + E+ D+ FL + P RLGS + + ++H FFK IN+ L
Sbjct: 208 RRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 9e-39
Identities = 106/333 (31%), Positives = 165/333 (49%), Gaps = 52/333 (15%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LRT S P K T + I +GA G VF A TG AIK +
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEK------IGQGASGTVFTAIDVATGQEVAIK---Q 51
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
++ ++ E I+ E ++ ++NP +V F SF + L++VMEYL GG L ++
Sbjct: 52 INLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET- 110
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + ALE+LH+ +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA------- 163
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 164 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 805 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 864
S+GI+ E++ G PP+ E+P + I P + PE++SP D ++R L D +
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259
Query: 865 RLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 897
R G A E+ QH F K LA+ ++ P
Sbjct: 260 R---GSAKELLQHPFLK------LAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 81/281 (28%), Positives = 140/281 (49%), Gaps = 49/281 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVL-------KKADMIRKNAVESILAERDILISVRNP 649
I RGA+G V+ K TG + A+K++ +D+ R+ A+ S L + P
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP------P 62
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+ +++ S+ L+++MEY GG + +L++ G + E V I EV++AL+Y+H +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG 121
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
V+HRD+K N+L+ + G++KL DFG+ A+
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGV-------------------------------AAL 150
Query: 770 HQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
Q K+ + VGTP ++APE++ G + T AD WS+GI ++E+ G PP++ +
Sbjct: 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
Query: 829 FDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGS 868
I K P PR+ + S + + L E+P +RL +
Sbjct: 211 MMLIPKSK-P-PRLEDNGYSKLLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 93/322 (28%), Positives = 147/322 (45%), Gaps = 71/322 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVR 647
++ + I G +G V+ A+ + TG++ AIK +K ++ I K A L E +L +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA----LREIKLLKELN 56
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLH 706
+P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +++ L + H
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S ++HRDLKP+NLLI +G +KL DFGL++ P T
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARS--------FGSPVRPYT----------- 156
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF----- 820
H V T Y APE+LLG G+ T D WSVG I EL+ P F
Sbjct: 157 ---HY---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204
Query: 821 --------------NAEHPQQIFDNILNRK--------IPWPRVPEEMSPEAHDLIDRFL 858
+ E + N K +P P++ SP+A DL+ + L
Sbjct: 205 IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQML 264
Query: 859 TEDPHQRLGSGGASEVKQHVFF 880
DPH+R+ A + H +F
Sbjct: 265 HYDPHKRI---TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 81/279 (29%), Positives = 142/279 (50%), Gaps = 38/279 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DFEI+ I +G+FG VF ++ ++A+K + + M R+ E+I E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLH 706
+++R++ SF + L +VMEY GDL+ LL R ++ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +++HRD+K NL + ++K+ D G++K+ +S T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-------------LSDNTNFA------- 158
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ VGTP YL+PE+ + +D W++G++L+E G PF+A +
Sbjct: 159 -----------NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I+ +P V + S + LID+ LT+D QR
Sbjct: 208 ALILKIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-38
Identities = 89/329 (27%), Positives = 146/329 (44%), Gaps = 71/329 (21%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES--ILAERDILISVRN 648
+E++KPI GA+G V A + TG AIK K + + +++ IL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 649 PFVVR---FFY--SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
++ S ++Y+V E + DL+ ++++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YLHS V+HRDLKP N+L+ + +K+ DFGL++ G DE+
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR----------------GVDPDEDEKG 161
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNA 822
LT E+ V T Y APE+LL + T A D WSVG I EL+ P F
Sbjct: 162 FLT--EY----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209
Query: 823 EH---------------PQQIFDNILN-------------RKIPWPRVPEEMSPEAHDLI 854
++ I + K P ++ SPEA DL+
Sbjct: 210 RDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLL 269
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
++ L DP +R+ A E H + +
Sbjct: 270 EKMLVFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 88/308 (28%), Positives = 136/308 (44%), Gaps = 56/308 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK-KADMIRKNAVESILAERDILISVR 647
FE+++ I G +G+V+ A+ + TG L AIK++ D E I E +IL
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-----EEIKEEYNILRKYS 60
Query: 648 N-PFVVRFFYSF------TCRENLYLVMEYLNGG---DLYSLLRNLG-CLDEDVARVYIA 696
N P + F+ +F + L+LVME GG DL LR G L E+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
E + L YLH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA------------------- 161
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILF 811
QL ++ ++ + +GTP ++APE++ + +D WS+GI
Sbjct: 162 -------QLDSTLG-----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209
Query: 812 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
EL G PP HP + I P + PE S + +D I L ++ QR
Sbjct: 210 ELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM--- 266
Query: 872 SEVKQHVF 879
E+ +H F
Sbjct: 267 EELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 100/317 (31%), Positives = 155/317 (48%), Gaps = 46/317 (14%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LR+ S P K T + I +GA G V+ A TG AI+ +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK------IGQGASGTVYTAMDVATGQEVAIRQMNL 55
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 56 QQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 111
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 164
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 165 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 805 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 864
S+GI+ E+I G PP+ E+P + I P + PE++S D ++R L D +
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 865 RLGSGGASEVKQHVFFK 881
R G A E+ QH F K
Sbjct: 261 R---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 86/302 (28%), Positives = 155/302 (51%), Gaps = 41/302 (13%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ R+ ++++ IK I G+ G V +A+++ +G A+K++ D+ ++ E +
Sbjct: 14 VDQGDPRSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFN 67
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E I+ ++ VV + S+ E L+++ME+L GG L ++ +E +A V V
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV-CESV 126
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL YLHS V+HRD+K D++L+ DG +KL+DFG
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGF----------------------- 163
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
++ ++ K++S VGTP ++APE++ T +GT D WS+GI++ E++ G P
Sbjct: 164 --------CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
P+ ++ P Q + + P + ++SP D ++R LT +P +R A E+ H
Sbjct: 216 PYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHP 272
Query: 879 FF 880
F
Sbjct: 273 FL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 9e-37
Identities = 105/347 (30%), Positives = 166/347 (47%), Gaps = 52/347 (14%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LR+ S P K T + I +GA G V+ A TG AIK +
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEK------IGQGASGTVYTAIDIATGQEVAIKQMNL 54
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 55 QQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 110
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + AL++LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 163
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 164 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 805 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 864
S+GI+ E++ G PP+ E+P + I P + PE +S D ++R L D +
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDR 259
Query: 865 RLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
R G A E+ QH F K LA+ ++ P +A + +SR
Sbjct: 260 R---GSAKELLQHPFLK------LAKPLSSLTPLIIAAKEAIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 92/302 (30%), Positives = 155/302 (51%), Gaps = 41/302 (13%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ P RT +D+F IK I G+ G V +A +++G L A+K K D+ ++ E +
Sbjct: 13 VDPGDPRTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFN 66
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E I+ ++ VV + S+ + L++VME+L GG L ++ + +E +A V +A V
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-V 125
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL LH+ V+HRD+K D++L+ HDG +KL+DFG
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF----------------------- 162
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
++ +E +++S VGTP ++APE++ +G D WS+GI++ E++ G P
Sbjct: 163 --------CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
Query: 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
P+ E P + I + P + ++SP +DR L DP QR A+E+ +H
Sbjct: 215 PYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKHP 271
Query: 879 FF 880
F
Sbjct: 272 FL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 99/332 (29%), Positives = 147/332 (44%), Gaps = 87/332 (26%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK--------KADMIRKNAVESILAERDI 642
+E + I GA+G V+ A+ TG A+K ++ +R+ A+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQ--- 54
Query: 643 LISVRNPFVVRFFYSF----TCRE-NLYLVMEYLNGGDLYSLLRNLGC----LDEDVARV 693
L S +P +VR T RE L LV E+++ DL + L C L + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKD 111
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+ +++ +++LHS R+VHRDLKP N+L+ DG +K+ DFGL+++
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--------------- 156
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
E LT S V T Y APE+LL + + T D WSVG I EL
Sbjct: 157 -----YSFEMALT------------SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
Query: 814 IVGIPPF----NAEHPQQIFDNI-LNRKIPWPR--------------------VPEEMSP 848
P F A+ +IFD I L + WPR VP E+
Sbjct: 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVP-EICE 258
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
E DL+ + LT +PH+R+ A E QH +F
Sbjct: 259 EGLDLLKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 3e-35
Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 43/282 (15%)
Query: 592 EIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ K + GAFG V+ A+K LK+ +E L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYL 705
+P +V+ T E L +VMEY+ GGDL LR + ++ + + ++ +EYL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
S +HRDL N L+ + +K++DFGLS+ + + G
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG---------------- 163
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPFNAE 823
+ + ++APE L G T+ D WS G++L+E+ +G P+
Sbjct: 164 -----------GKLPI---RWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208
Query: 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
++ + + P PE + L+ + EDP R
Sbjct: 209 SNAEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 77/289 (26%), Positives = 120/289 (41%), Gaps = 58/289 (20%)
Query: 592 EIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ K + GAFG V+ K A+K LK+ + +E L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDE------DVARVYIAEV 698
+P VV+ T E LY+VMEY+ GGDL S LR L + +AR
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR------ 113
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+EYL S +HRDL N L+ + +K++DFGLS+ + G
Sbjct: 114 --GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG--------- 162
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VG 816
+ + ++APE L G T+ D WS G++L+E+ +G
Sbjct: 163 ------------------GKLPI---RWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLG 200
Query: 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
P+ +++ + + N P PE +DL+ + EDP R
Sbjct: 201 EQPYPGMSNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 88/321 (27%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
H +D + +EII + GAFG+V+ AK + TG L A KV++ + +E + E
Sbjct: 3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVE 59
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEV 698
+IL + +P++V+ +F L++++E+ GG + +++ L L E +V ++
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL+YLHS++++HRDLK N+L+ DG IKL DFG+S
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS---------------------- 157
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFEL 813
+++ + +++ S +GTP ++APE+++ T + AD WS+GI L E+
Sbjct: 158 ---------AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873
PP + +P ++ I + P P + S E D + L + P R A++
Sbjct: 209 AQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQ 265
Query: 874 VKQHVFFKDINWDTLARQKAA 894
+ +H F + + R+ A
Sbjct: 266 LLEHPFVSSVTSNRPLRELVA 286
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 39/281 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILISV 646
E+ K + GAFG V+ + G+ A+K LK+ E L E I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYL 705
+P +VR T E LY+V EY+ GGDL LR + L ++ +EYL
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYY------------------ 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEH 824
RK+ ++APE L + +D WS G++L+E+ +G P+
Sbjct: 159 ---------RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 209
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+++ + + + PR PE E ++L+ + DP R
Sbjct: 210 NEEVLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 80/277 (28%), Positives = 137/277 (49%), Gaps = 36/277 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ +K I G+FG+ L K + G + IK + + M K ES E +L ++++P
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCL-DEDVARVYIAEVVLALEYLHSL 708
+V++ SF NLY+VM+Y GGDLY + G L ED + ++ LAL+++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++HRD+K N+ + DG IKL DFG+++V +NST +L+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA-------------------- 158
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
R+ +GTP YL+PEI + +D W++G +L+E+ F A + + +
Sbjct: 159 ---------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
I+ +P V S + +L+ + +P R
Sbjct: 210 VLKIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-34
Identities = 82/294 (27%), Positives = 135/294 (45%), Gaps = 42/294 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLK---KADMIRKNAVESILAERDILISVRNPFVVR 653
+ GAF + A+ TG L A+K + ++ VE++ E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 654 FFYSFTCRENLY-LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
TC ++ + L +E++ GG + LL G E V Y +++ L YLH +++H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 713 RDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQ 771
RD+K NLLI G +++ DFG + +G A E Q
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA----ARLAAKGTG-----------------AGEFQ 165
Query: 772 QERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE----HPQQ 827
+ +GT ++APE+L G +G + D WSVG ++ E+ PP+NAE H
Sbjct: 166 GQ------LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL 219
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
IF I + P +PE +SP D+ R L P R + E+ +H F+
Sbjct: 220 IF-KIASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 81/286 (28%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ +F+I K I +G F V+ A G + A+K ++ +M+ A + L E D+L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALE 703
+P V+++ SF L +V+E + GDL ++++ + E Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++HS R++HRD+KP N+ I G +KL D GL G S+
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGL---GRFFSSK------------------ 159
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
T + H S VGTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 160 --TTAAH--------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 824 HPQ--QIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRL 866
+ I K +P +P + S E DL+ R + DP +R
Sbjct: 210 KMNLYSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 92/326 (28%), Positives = 138/326 (42%), Gaps = 79/326 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-----DMIRKNAVESILAERDILIS 645
+++IK + G FG V+LA+ + TG+L AIK +KK + + V+S+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN----- 55
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALE 703
+P +V+ F + LY V EY+ G +LY L+ R E V R I +++ L
Sbjct: 56 -EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++H HRDLKP+NLL++ +K+ DFGL++ I S P
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE--IRS------------------RP 153
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFN- 821
T V T Y APEILL + ++ D W++G I+ EL P F
Sbjct: 154 PYTDY------------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 822 ---AEHPQQIFD-----------------NILNRKIPWPRVPEEM-------SPEAHDLI 854
+ +I + L + P P + SPEA DLI
Sbjct: 202 SSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLI 260
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFF 880
L DP +R AS+ QH +F
Sbjct: 261 KDMLRWDPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 98/319 (30%), Positives = 155/319 (48%), Gaps = 47/319 (14%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ P R +D F IK I G+ G V +A ++ TG A+K K D+ ++ E +
Sbjct: 15 VSPGDPREYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFN 68
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E I+ + VV + S+ + L++VME+L GG L ++ + +E +A V ++ V
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-V 127
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL YLH+ V+HRD+K D++L+ DG IKL+DFG
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF----------------------- 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
++ +E K++S VGTP ++APE++ +GT D WS+GI++ E+I G P
Sbjct: 165 --------CAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
P+ E P Q I + P + ++S +D L +P QR A E+ QH
Sbjct: 217 PYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR---ATAQELLQHP 273
Query: 879 FFKDINWDTLARQKAAFVP 897
F K LA + VP
Sbjct: 274 FLK------LAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 87/293 (29%), Positives = 134/293 (45%), Gaps = 56/293 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL---KKADMIRKNAVESILAERDILIS 645
+D E I + G G V K TG + A KV+ K+ + ++ IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
R+P++V F+ +F N+ + ME+++ G L + + G + ++ VV L YL
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 706 HS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
++ R++HRD+KP N+L+ G IKL DFG+S LINS D
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------ 160
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA-- 822
+ VGT Y++PE + G + +D WS+GI + EL +G PF
Sbjct: 161 --------------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206
Query: 823 ------EHPQQIFD---NILNRKIPWPRVPEEMSPE-AHDLIDRFLTEDPHQR 865
+ P I D I+ P PR+P PE D +D L +DP +R
Sbjct: 207 IDDDGQDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 90/323 (27%), Positives = 142/323 (43%), Gaps = 70/323 (21%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD---MIRKNAVESILAERDILISVR 647
+E++ + GA+G V + + TG++ AIK K+++ ++K + L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKK----TALREVKVLRQLR 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ +V +F + LYLV EY+ L L + G L D R YI +++ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRD+KP+N+L++ G +KL DFG ++ L LT
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRARP----------ASPLT- 159
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH-- 824
V T Y APE+L+G T +G D W++G I+ EL+ G P F +
Sbjct: 160 -----------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208
Query: 825 --------------PQQ--IFD-NILNR--KIPWPRVPE--------EMSPEAHDLIDRF 857
P +F N P P PE ++S A D +
Sbjct: 209 DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKAC 268
Query: 858 LTEDPHQRLGSGGASEVKQHVFF 880
L DP +RL E+ QH +F
Sbjct: 269 LRMDPKERL---TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 46/284 (16%)
Query: 595 KPISRGAFGRVFLAK---KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + GAFG V+ K K A+K LK+ + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN---------LGCLDEDVARVYIAEVVLAL 702
VR T E LYLV+EY+ GGDL LR L + ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
EYL S + VHRDL N L+ D +K++DFGLS+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR------------------------- 153
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821
+ ++ +++ + + ++APE L + +D WS G++L+E+ G P+
Sbjct: 154 -DVYDDDYYRKKTGGKLPI---RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+++ + + P+ PE E ++L+ DP R
Sbjct: 210 GLSNEEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 82/292 (28%), Positives = 143/292 (48%), Gaps = 44/292 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIK--VLKKADMIR-KNAVESILAERDILISVRNPFVVR 653
+ +GA+G V+ G L A+K L ++++ + E + E D+L S+++ +V+
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 654 FFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVV 711
Y TC ++ + + ME++ GG + S+L G L E V Y +++ + YLH+ VV
Sbjct: 67 --YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 712 HRDLKPDNLLIAHDGHIKLTDFGLSK----VGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
HRD+K +N+++ +G IKL DFG ++ VGL + ++
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML------------------- 165
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
+S GTP ++APE++ +G+G +D WS+G +FE+ G PP +
Sbjct: 166 ----------KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
I + PR+P+ S A D + LT D H+R A ++ +H F
Sbjct: 216 AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 95/324 (29%), Positives = 148/324 (45%), Gaps = 72/324 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDILISV 646
+E K + G + V+ A+ + TG + AIK +K + RK A + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEY 704
++P ++ F + N+ LV E++ DL ++++ + A + Y+ + LEY
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEY 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS ++HRDLKP+NLLIA DG +KL DFGL++ G +
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARS-------------------FGSPNRK 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIP--PFN 821
+T HQ V T Y APE+L G H G D WSVG I EL++ +P P +
Sbjct: 159 MT---HQ---------VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206
Query: 822 AEHPQ--QIFDNILNRKIP--WPRVPEEMSP--------------------EAHDLIDRF 857
++ Q +IF L WP V +A DL+ R
Sbjct: 207 SDIDQLGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRL 265
Query: 858 LTEDPHQRLGSGGASEVKQHVFFK 881
LT +P++R+ A + +H +F
Sbjct: 266 LTLNPNKRI---TARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 88/289 (30%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I +G+FG VF T + AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V +++ S+ L+++MEYL GG LLR G DE + E++ L+YLHS +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG++ QLT ++
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------QLTDTQ- 155
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
K+ + VGTP ++APE++ + + + AD WS+GI EL G PP + HP ++
Sbjct: 156 ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
I K P + E S + ID L +DP R A E+ +H F
Sbjct: 212 LI--PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 89/305 (29%), Positives = 150/305 (49%), Gaps = 50/305 (16%)
Query: 591 FEIIKP--ISRGAFGRVFLAKKRTTGDLFAIK-------VLKKADMIRKNAVESILAERD 641
F+ +K I +G +GRV+LA TTG++ A+K + + D +K+ V+++ +E +
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L + + +V++ T E L + +EY+ GG + S LR G +E + R + +V+
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L YLHS ++HRDLK DNLL+ DG K++DFG+SK +DD+ ++
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYD-NDQNMSMQ--- 171
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA--DWWSVGIILFELIVGIPP 819
G+ ++APE++ G +A D WS+G ++ E+ G P
Sbjct: 172 --------------------GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
Query: 820 F-NAEHPQQIFDNILNRKIPWPRVPEE----MSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
+ + E +F L K P +P + +SP A D ++ T +P R A E+
Sbjct: 212 WSDEEAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR---PTAREL 266
Query: 875 KQHVF 879
QH F
Sbjct: 267 LQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 92/306 (30%), Positives = 148/306 (48%), Gaps = 53/306 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +EII+ I +G +G+VF + G A+K+L I E I AE +IL ++ +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 649 -PFVVRFFYSFTCRE-----NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA----EV 698
P VV+F+ + ++ L+LV+E NGG + L++ E + IA E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
++ L++LH + +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFEL 813
QLT++ ++ ++VGTP ++APE++ L + + D WS+GI EL
Sbjct: 173 -----QLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873
G PP HP + I P PE S E +D I + LT+D +R S+
Sbjct: 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR---PTVSD 279
Query: 874 VKQHVF 879
+ QHVF
Sbjct: 280 LLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 39/289 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I +G+FG V+ T ++ AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+ R++ S+ L+++MEYL GG LL+ G L+E + E++ L+YLHS R
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG++ QLT ++
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------QLTDTQ- 155
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
K+ + VGTP ++APE++ + + AD WS+GI EL G PP + HP ++
Sbjct: 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL- 210
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
L K P + + S + ++ L +DP R A E+ +H F
Sbjct: 211 -FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 84/301 (27%), Positives = 145/301 (48%), Gaps = 58/301 (19%)
Query: 590 DFEIIKPI--SRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE--RDILIS 645
+ EI+K + G FG+V + K + T LF K++K + NA+E ++ + +D
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIEPMVHQLMKD---- 67
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
NP ++ +YS T + L+M+Y+ GDL+ LL+ G L E + I ++V AL L
Sbjct: 68 --NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 706 HSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H ++H D+K +N+L I L D+GL K + GT D
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------------IIGTPSCYD---- 167
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
GT DY +PE + G + + DWW+VG++ +EL+ G PF +
Sbjct: 168 -----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 825 PQQI-FDNILNR---KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+++ +++L R K+P+ + +S A+D + L + + RL + +E+ +H F
Sbjct: 211 DEELDLESLLKRQQKKLPFIKN---VSKNANDFVQSMLKYNINYRLTNY--NEIIKHPFL 265
Query: 881 K 881
K
Sbjct: 266 K 266
|
Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 79/293 (26%), Positives = 147/293 (50%), Gaps = 44/293 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIK------VLKKADMIRKNAVESILAERDILISVRNPF 650
I G+FG V+L ++G+L A+K V + +++ ++++ E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+V++ S ++L + +EY+ GG + +LL N G +E + R ++ +++ L YLH+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L+ + G IK++DFG+SK NS +T P L S
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSL----------STKTNGARPSLQGSVF 177
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF-NAEHPQQIF 829
++APE++ T + AD WS+G ++ E++ G PF + Q IF
Sbjct: 178 ---------------WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222
Query: 830 ---DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
+N P +P +S EA D +++ D ++R A+E+ +H F
Sbjct: 223 KIGENAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 95/327 (29%), Positives = 144/327 (44%), Gaps = 81/327 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR----KNAVESILAERDI--LI 644
++ ++ I G +G V+ A+ + TG++ A LKK IR V S A R+I L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPST-AIREISLLK 53
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLAL 702
+ +P +VR LYLV E+L+ DL + + LD + + Y+ +++ +
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK-VGLINSTDDLSGPAVSGTTLLGDE 761
Y HS RV+HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV---------P----------- 152
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
+ H+ V T Y APEILLG+ +T D WS+G I E++ P F
Sbjct: 153 ---VRTYTHE---------VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
Query: 821 --NAEHPQ--QIFDNILN----------RKIP--------WPRVPE-----EMSPEAHDL 853
++E Q +IF L +P W R + + DL
Sbjct: 201 PGDSEIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDL 259
Query: 854 IDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ + L DP +R+ A QH +F
Sbjct: 260 LSKMLVYDPAKRI---SAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 93/308 (30%), Positives = 148/308 (48%), Gaps = 53/308 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +EII+ I +G +G+V+ + G L A+K+L D I + E I AE +IL S+ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPIS-DVDEEIEAEYNILQSLPN 77
Query: 649 -PFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNL-GC---LDEDVARVYIAEV 698
P VV+F+ F + L+LV+E NGG + L++ L C LDE + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L L++LH+ R++HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFEL 813
QLT++ R ++ ++VGTP ++APE++ + D WS+GI EL
Sbjct: 177 -----QLTST-----RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873
G PP HP + I P PE+ + I + L +D R +
Sbjct: 227 GDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEAR---PSVTH 283
Query: 874 VKQHVFFK 881
+ +H F K
Sbjct: 284 LLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 40/279 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA--ERDILISVRN 648
+ I+ + +GAFG L ++ L V K+ ++ R + E A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCL-DEDVARVYIAEVVLALEYLH 706
P ++ ++ F L + MEY NGG LY ++R G L +E++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
++HRD+K N+ + G IKL DFG+SK+ LG E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-------------------LGSEYSM-- 157
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ VGTP Y++PE+ G + +D W++G +L+EL+ F+A +P
Sbjct: 158 ----------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I+ + V S E L+ L +DP +R
Sbjct: 208 NLVVKIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 93/341 (27%), Positives = 144/341 (42%), Gaps = 97/341 (28%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
S+D++E + I G +G V+ A+ + TG++ A+K LK + S L E +IL+ +
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKL 61
Query: 647 RNPFVVRFFYSFTCRE--------NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
++P +V T +E +Y+VMEY+ DL SL+ + + +EV
Sbjct: 62 QHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM---KQPFL---QSEV 108
Query: 699 -------VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ + +LH ++HRDLK NLL+ + G +K+ DFGL
Sbjct: 109 KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL---------------- 152
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIIL 810
A E+ + V T Y APE+LLG +TA D WSVG I
Sbjct: 153 ---------------AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197
Query: 811 FELIVGIPPFNAEHP----QQIFDNIL---NRKIPWPRVPE------------------- 844
EL+ P F + +IF +L KI WP E
Sbjct: 198 AELLTKKPLFPGKSEIDQLNKIF-KLLGTPTEKI-WPGFSELPGAKKKTFTKYPYNQLRK 255
Query: 845 -----EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+S DL++R LT DP +R+ A + +H +F
Sbjct: 256 KFPALSLSDNGFDLLNRLLTYDPAKRI---SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 81/291 (27%), Positives = 140/291 (48%), Gaps = 51/291 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTG-DLFAIK-------VLKKADMIRKNAVESILAERDI 642
+ +++ + GAFG V+ +K+ G +L A+K K R ++ I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 643 LI-SVRNPFVVRFFYSFTCRENLYLVMEYLNG---GDLYSLLRNLG--CLDEDVARVYIA 696
+ +R+P +VR++ +F + LY+VM+ + G G+ ++ L+ +E + +++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 697 EVVLALEYLH-SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
++VLAL YLH R+VHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
+Q K S VGT Y PEI+ +G AD W+ G IL+++
Sbjct: 163 --------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQR 865
PPF + + + I+ + +PE M S + D+I LT D R
Sbjct: 209 LQPPFYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+EIIK I G+FG+++LAK ++ + IK + M K E+ E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCL-DEDVARVYIAEVVLALEYLHSL 708
+V FF SF L++VMEY +GGDL + R G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 709 RVVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+++HRD+K N+ ++ +G + KL DFG+++ +N + +L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
+ VGTP YL+PEI + D WS+G +L+EL PF + Q
Sbjct: 160 ----------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I P P S + LI + P R
Sbjct: 210 LVLKICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 38/278 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+E I+ + RGAFG V L +++ L IK + M + + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
++ ++ +F + L +VMEY GG L ++ LDED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 709 RVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRDLK N+L+ H +K+ DFG+SK+ LS
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LS------------------- 153
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
+ K + VGTP Y++PE+ G + +D W++G +L+EL F A +
Sbjct: 154 -----SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I++ + + + SP+ LI L DP +R
Sbjct: 209 LVLKIMSGT--FAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-30
Identities = 85/297 (28%), Positives = 144/297 (48%), Gaps = 43/297 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +EII + GAFG+V+ A+ + TG L A KV+ D + +E + E DIL S +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHS 707
P +V+ +F NL++++E+ GG + +++ L L E RV + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+++HRDLK N+L DG IKL DFG+S
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVS------------------------------- 150
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822
+++ + +++ S +GTP ++APE+++ + AD WS+GI L E+ PP +
Sbjct: 151 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
+P ++ I + P P S E D + + L ++ R +++ QH F
Sbjct: 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 87/300 (29%), Positives = 139/300 (46%), Gaps = 42/300 (14%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
R +DFE+I+ I G +G V+ A+ TG+L AIKV+K + + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
++ +V +F S+ R+ L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +HRD+K N+L+ +GH+KL DFG+S Q
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSA--------------------------Q 155
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFN 821
+TA+ K++S +GTP ++APE+ G+ D W+VGI EL PP
Sbjct: 156 ITAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEM--SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
HP + + P++ ++M S H + LT++P +R A ++ QH F
Sbjct: 211 DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR---PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 39/289 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I +G+FG VF T + AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V +++ S+ L+++MEYL GG LL G LDE + E++ L+YLHS +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG++ QLT ++
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--------------------------QLTDTQ- 155
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
K+ + VGTP ++APE++ + + + AD WS+GI EL G PP + HP ++
Sbjct: 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL- 210
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
L K P + S + ++ L ++P R A E+ +H F
Sbjct: 211 -FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-29
Identities = 96/330 (29%), Positives = 156/330 (47%), Gaps = 76/330 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISVRN 648
+EI++ + +GA+G V+ A R T ++ A+K K D R NA ++ R+I L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFR-NATDAQRTFREIMFLQELGD 65
Query: 649 -PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEY 704
P +V+ + +YLV EY+ DL++++R L EDV + YI +++ AL+Y
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NIL-EDVHKRYIMYQLLKALKY 122
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS V+HRDLKP N+L+ D +KL DFGL++ ++ ++ E P
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEE------------NPENPV 168
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--- 820
LT V T Y APEILLG+ T D WSVG IL E+++G P F
Sbjct: 169 LT------------DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216
Query: 821 ------------------------NAEHPQQIFDNILNRKIPWPRVPEEM----SPEAHD 852
+ + D++ +R + +E+ S +A D
Sbjct: 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRP---RKPLDELLPKASDDALD 273
Query: 853 LIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
L+ + L +P++RL A E +H +
Sbjct: 274 LLKKLLVFNPNKRL---TAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 89/314 (28%), Positives = 146/314 (46%), Gaps = 63/314 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL--KKADMIRKNAVESILAERDILISV 646
+ + + GA G V + + TG +FA+K + ++K IL E +I S
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSC 56
Query: 647 RNPFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVL 700
++P++V+++ +F ++ + MEY GG L S+ + + G + E V IAE VL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115
Query: 701 -ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L YLHS +++HRD+KP N+L+ G +KL DFG+S L+NS ++GT
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVNS--------LAGTF--- 163
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
GT Y+APE + G + T+D WS+G+ L E+ P
Sbjct: 164 ---------------------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
Query: 820 FNAEHPQ-----QIFDNILNRKIPWPRVPEEM------SPEAHDLIDRFLTEDPHQRLGS 868
F E ++ I+N +P P + +E S E D I + L +DP +R
Sbjct: 203 FPPEGEPPLGPIELLSYIVN--MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTP 260
Query: 869 GGASEVKQHVFFKD 882
++ +H + K
Sbjct: 261 ---WDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 92/332 (27%), Positives = 148/332 (44%), Gaps = 80/332 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE + + G G V R +G + A K++ I+ I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNS 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLHS 707
P++V F+ +F + + ME+++GG L +L+ G + E++ ++ IA V+ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 708 -LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNAE 823
S VGT Y++PE L GT + +D WS+G+ L E+ +G IPP +A+
Sbjct: 157 ------------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204
Query: 824 H------------------------------PQQIF---DNILNRKIPWPRVPEE-MSPE 849
P IF D I+N P P++P S E
Sbjct: 205 ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDE 262
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
D +D+ L ++P +R E+ +H F K
Sbjct: 263 FQDFVDKCLKKNPKERADLK---ELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ +++ + G+FGR L + + +A+K ++ +AVE E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHP 58
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHS 707
+V F SF +LY+VMEY +GGDL ++ ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
RV+HRD+K N+ + +G +KL DFG +++ L+ P T
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSPGAYACTY---------- 160
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
VGTP Y+ PEI + +D WS+G IL+EL PF A +
Sbjct: 161 -------------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ + + + +P S E LI + +P R
Sbjct: 208 LILKVC--QGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 81/297 (27%), Positives = 136/297 (45%), Gaps = 48/297 (16%)
Query: 574 LRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV 633
LR +P H D+E+I+ + G +G V+ A+ TG+L A+K++K + +
Sbjct: 3 LRRNPQH---------DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDF 50
Query: 634 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 693
I E ++ ++ +V +F S+ RE L++ MEY GG L + G L E
Sbjct: 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
E + L YLHS +HRD+K N+L+ +G +KL DFG++
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA---------------- 154
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIIL 810
++TA+ K++S +GTP ++APE+ G+ D W+VGI
Sbjct: 155 ----------KITAT-----IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199
Query: 811 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEM--SPEAHDLIDRFLTEDPHQR 865
EL PP HP + + P++ ++ S H+ + LT++P +R
Sbjct: 200 IELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 83/285 (29%), Positives = 126/285 (44%), Gaps = 55/285 (19%)
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
G +V L T F +K L+K+ + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719
++++LV+++ GG L+S + + E+ + + AE+V+AL+ LH +V RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 720 LLIAHDGHIKLTDFG-LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 778
+L+ GHI+LT F S+V D G AV
Sbjct: 116 ILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENM----------------------- 147
Query: 779 SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI-LNRKI 837
Y APE+ + DWWS+G ILFEL+ G HP I + LN
Sbjct: 148 -------YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC-HPSGINTHTTLN--- 196
Query: 838 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA--SEVKQHVFF 880
+PE +S EA L+ + L +P +RLG+G A ++K H FF
Sbjct: 197 ----IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 77/292 (26%), Positives = 134/292 (45%), Gaps = 54/292 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D+ E++ + +G +G V+ R TG A+K ++ + ++ I+ E DIL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGD---LYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
P++V F+ +F +Y+ MEY++ G LY+ + EDV R VV L++L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 706 -HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
++HRD+KP N+L+ +G +KL DFG VSG
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG-----------------VSG---------N 152
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGT---TADWWSVGIILFELIVGIP 818
L AS ++ +G Y+APE + + T +D WS+G+ + E+ +G
Sbjct: 153 LVAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205
Query: 819 PFNAEHPQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
P+ P + + NI + P +P S +A D + + L + P++R
Sbjct: 206 PY----PPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 9e-28
Identities = 84/289 (29%), Positives = 137/289 (47%), Gaps = 37/289 (12%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVRNPFVV 652
K + +GAFGRV+L TG A K ++ V ++ E +L ++++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 653 RFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ R + L + MEY+ GG + L+ G L E V R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+K N+L G++KL DFG SK L +SGT +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK--------RLQTICMSGTGI------------- 166
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
RS GTP +++PE++ G G+G AD WS+G + E++ PP+ AE+
Sbjct: 167 -------RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW-AEYEAMAAI 218
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
+ + P++P +S A D + E H+ A E+ +H F
Sbjct: 219 FKIATQPTNPQLPSHISEHARDFLGCIFVEARHRP----SAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 88/336 (26%), Positives = 149/336 (44%), Gaps = 85/336 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK--------------VLKKADMIRKNAVE 634
++ I+ I GA+G V A +G AIK L++ ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVY 694
+I+A RDIL F +++Y+VM+ L DL+ ++ + L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ +++ L+Y+HS V+HRDLKP NLL+ D +++ DFG+++ GL +S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSP---------- 161
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
E + +E+ V T Y APE+LL TTA D WSVG I E+
Sbjct: 162 ------TEHKYFMTEY----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 814 I---------------------VGIPPFN------AEHPQQIFDNILNRK-IPWPRVPEE 845
+ +G P ++ ++ N+ ++ +PW ++ +
Sbjct: 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPK 265
Query: 846 MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
SPEA DL+ + L DP +R+ + QH F
Sbjct: 266 ASPEALDLLSQMLQFDPEERI---TVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 95/336 (28%), Positives = 146/336 (43%), Gaps = 85/336 (25%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVE-SILAERDILI 644
S+ +FE + I G +G V+ A+ T+G++ A LKK M ++ + S L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 645 SVRNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLA 701
++R+P +V + ++++LVMEY DL SLL N+ E + + +++
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L+YLH ++HRDLK NLL+ G +K+ DFGL++ PA T
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART--------YGLPAKPMT------ 166
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
P+ V T Y APE+LLG TTA D W+VG IL EL+ P
Sbjct: 167 -PK----------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
Query: 821 NA------------------EH----------------PQQIFDNILNRKIPWPRVPEEM 846
E P+Q ++N L K PW +
Sbjct: 210 PGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNN-LKHKFPW------L 262
Query: 847 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
S L++ L DP +R A E + +FK+
Sbjct: 263 SEAGLRLLNFLLMYDPKKR---ATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 80/284 (28%), Positives = 134/284 (47%), Gaps = 42/284 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+F I K I RG F V+ A G A+K ++ D++ A + E D+L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYL 705
V++++ SF L +V+E + GDL ++++ + E Y ++ ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS RV+HRD+KP N+ I G +KL D GL + +S
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSK--------------------- 159
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
T + H S VGTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 160 TTAAH--------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK- 210
Query: 826 QQIFDNILNRKIP---WPRVP-EEMSPEAHDLIDRFLTEDPHQR 865
++ L +KI +P +P + S E L++ + DP +R
Sbjct: 211 MNLYS--LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 81/286 (28%), Positives = 134/286 (46%), Gaps = 42/286 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ +F+I K I RG F V+ A A+K ++ +M+ A + + E D+L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALE 703
+P V+++ SF L +V+E + GDL +++ + E Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++HS RV+HRD+KP N+ I G +KL D GL G S+
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL---GRFFSSK------------------ 159
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
T + H S VGTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 160 --TTAAH--------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 824 HPQQIFDNILNRKIP---WPRVP-EEMSPEAHDLIDRFLTEDPHQR 865
+F L +KI +P +P E S + +L+ + DP QR
Sbjct: 210 K-MNLFS--LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 89/326 (27%), Positives = 141/326 (43%), Gaps = 93/326 (28%)
Query: 591 FEI------IKPISRGAFGRVFLAKKRTTGDLFAIK--------------VLKKADMIRK 630
FE+ IKPI RGA+G V AK T + AIK L++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 631 NAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 689
E+++A +DI+ R F ++Y+V E L DL+ ++R+ L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ ++ +++ L+Y+HS V+HRDLKP NLL+ + +K+ DFGL++ + D
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDF-- 164
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGI 808
+E+ V T Y APE+LL + + T D WSVG
Sbjct: 165 -----------------MTEY----------VVTRWYRAPELLLNCSEYTTAIDVWSVGC 197
Query: 809 ILFELIVGIPPF-NAEHPQQI--------------FDNILN-------RKIP-WPRVP-- 843
I EL+ P F ++ Q+ I N R +P PR
Sbjct: 198 IFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA 257
Query: 844 ---EEMSPEAHDLIDRFLTEDPHQRL 866
+P A DL+++ L DP +R+
Sbjct: 258 RLFPHANPLAIDLLEKMLVFDPSKRI 283
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 87/320 (27%), Positives = 141/320 (44%), Gaps = 82/320 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-------------VLKKADMIRKNAVES 635
++ + I GA+G V A + TG AIK L++ ++R+ E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
I+ DI+ F SF ++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIRP-------PSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+++ L+Y+HS V+HRDLKP NLL+ + +K+ DFGL+++
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI----------------A 156
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
D LT E+ V T Y APEI+L + T A D WSVG IL E++
Sbjct: 157 DPEHDHTGFLT--EY----------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
Query: 815 VGIPPFNAEH--------------PQQI-FDNILNRK-------------IPWPRVPEEM 846
P F + P Q + I++ + +PW ++
Sbjct: 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA 264
Query: 847 SPEAHDLIDRFLTEDPHQRL 866
P+A DL+D+ LT +PH+R+
Sbjct: 265 DPKALDLLDKMLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 41/277 (14%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVL--KKADMIRKNAVESILAERDILISVRNPFV 651
++ + +G++G V L + RT G + IK L + A + A E E +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNI 61
Query: 652 VRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
V + S+ + LY+VM + GGDLY L+ L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRDLK N+ + IK+ D G+++V L N D S
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAS-------------------- 160
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
+ +GTP Y++PE+ + +D W++G ++E+ FNA+ +
Sbjct: 161 ----------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
I+ K+ P +P++ SPE +LI L++ P +R
Sbjct: 211 VYRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 39/290 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVRNPFVV 652
K + +GAFGRV+L TG A+K ++ V ++ E +L ++ + +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 653 RFFYSF--TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ L + ME++ GG + L++ G L E+V R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+K N+L G++KL DFG SK L +SGT +
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASK--------RLQTICLSGTGM------------- 166
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIF 829
+S GTP +++PE++ G G+G AD WSVG + E++ PP+ E IF
Sbjct: 167 -------KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
+ + P +P +S D + R E + A E+ +H F
Sbjct: 220 K--IATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRP----SADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 91/326 (27%), Positives = 142/326 (43%), Gaps = 74/326 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD---MIRKNAVESILAERDILIS 645
+ +E + I G++G VF + R TG + AIK +++ +I+K A L E +L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----LREIRMLKQ 56
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+++P +V F + L+LV EY + L L +N + E + + I + + A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H +HRD+KP+N+LI G IKL DFG +++ L+GP T
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDDYT---------- 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP--PFNA 822
V T Y APE+L+G T +G D W++G + EL+ G P P +
Sbjct: 159 -------------DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205
Query: 823 EHPQ----------------QIFDNILNR-----KIPWP--RVPEEM-----SPEAHDLI 854
+ Q QIF N+ IP P R P E S A +
Sbjct: 206 DVDQLYLIRKTLGDLIPRHQQIFST--NQFFKGLSIPEPETREPLESKFPNISSPALSFL 263
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFF 880
L DP +RL E+ +H +F
Sbjct: 264 KGCLQMDPTERLSC---EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 82/261 (31%), Positives = 128/261 (49%), Gaps = 39/261 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ FE++ + GA+G V + + T ++ AIK K ++ + E+ L E +L +++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQ 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLH 706
+V +F R LYLV EY+ ++ LL + G E V R YI +++ A+ + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCH 117
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+VHRD+KP+NLLI+H+ +KL DFG ++ +LS E
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS------------EGSNAN 157
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP- 825
+E+ V T Y +PE+LLG +G D WSVG IL EL G P F E
Sbjct: 158 YTEY----------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207
Query: 826 QQIFDNILNRKIPWPRVPEEM 846
Q+F +K+ P E+M
Sbjct: 208 DQLFT---IQKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 89/320 (27%), Positives = 148/320 (46%), Gaps = 67/320 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F+ ++ I G +G V+ A+ + TG++ A+K ++ D + + + E +L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDL--YSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V+ LYLV E+L+ DL + L + + + Y+ +++ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV-GLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
RV+HRDLKP NLLI +G IKL DFGL++ G+ P + T
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---------PVRTYT------------ 158
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV--GIPPFNAEH 824
H+ V T Y APEILLG + +TA D WS+G I E++ + P ++E
Sbjct: 159 --HE---------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
Query: 825 PQ--QIFDNI-LNRKIPWPRV--------------PEEMS-------PEAHDLIDRFLTE 860
Q +IF + ++ WP V ++ S + DL+ + L
Sbjct: 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHY 267
Query: 861 DPHQRLGSGGASEVKQHVFF 880
DP++R+ + A H FF
Sbjct: 268 DPNKRISAKAA---LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 80/306 (26%), Positives = 134/306 (43%), Gaps = 58/306 (18%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
D + + + G G V+ A T + A+KV+ I + I++E +IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLH 706
+++ F+ +F + + E+++GG D+Y + E V R+ +A VV L YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVA-VVKGLTYLW 112
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
SL+++HRD+KP N+L+ G +KL DFG+S L+NS
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSI---------------------- 149
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNAE 823
++ VGT Y+APE + G +G +D WS+GI EL +G P
Sbjct: 150 ----------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199
Query: 824 H----PQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
P Q+ I++ P +P + S + I + + + P +R + H
Sbjct: 200 QGSLMPLQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERP---APENLMDHP 254
Query: 879 FFKDIN 884
F N
Sbjct: 255 FIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 86/324 (26%), Positives = 139/324 (42%), Gaps = 74/324 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL---KKADMIRKNAVESILAERDILISVR 647
+E + + G++G V K + TG + AIK + M++K A+ I +L +R
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI----RMLKQLR 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ +V F ++ LYLV E+++ L L + LDE R Y+ +++ +E+ HS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRD+KP+N+L++ G +KL DFG ++ L+ P T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEVYT------------ 158
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA---- 822
V T Y APE+L+G T +G D W+VG ++ E++ G P F
Sbjct: 159 -----------DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207
Query: 823 --------------EHPQQIFDNILNRKIPWPRVPE------------EMSPEAHDLIDR 856
Q+IF N R+PE ++S DL +
Sbjct: 208 DQLYHIIKCLGNLIPRHQEIFQK--NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ 265
Query: 857 FLTEDPHQRLGSGGASEVKQHVFF 880
L DP R S S++ H FF
Sbjct: 266 CLRIDPDDRPSS---SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 90/332 (27%), Positives = 142/332 (42%), Gaps = 78/332 (23%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISV 646
D +E ++ I G +G+V+ A+ + TG L A LKK +M + + L E +L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQML 57
Query: 647 -RNPFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNLG-----CLDEDVARVYI 695
+ ++VR E LYLV EYL+ DL + + G L + ++
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+++ + + H V+HRDLKP NLL+ G +K+ D GL + S P S
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA--------FSIPVKSY 168
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
T H+ + T Y APE+LLG+ H +T D WSVG I E+
Sbjct: 169 T--------------HE---------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205
Query: 814 IVGIPPF--NAEHPQ-------------QIFDNILNRK----IP-WP-----RVPEEMSP 848
P F ++E Q Q++ + + P W R ++SP
Sbjct: 206 SRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSP 265
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
E DL+ + L DP +R+ + A H +F
Sbjct: 266 EGLDLLQKMLRYDPAKRISAKAAL---THPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 54/306 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVR 647
DD E+I+ + RGA+G V + TG + A+K ++ + + +L + DI + SV
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVD 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALE 703
P+ V F+ + ++++ ME ++ L + + + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 704 YLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YLHS L V+HRD+KP N+LI +G +KL DFG+S D ++
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG----YLVDSVA-------------- 159
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIP 818
K G Y+APE + G+ +D WS+GI + EL G
Sbjct: 160 --------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205
Query: 819 PFNAEHP--QQIFDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
P+++ QQ+ + + P P++P E SPE D +++ L ++ +R E+
Sbjct: 206 PYDSWKTPFQQLKQVV---EEPSPQLPAEKFSPEFQDFVNKCLKKNYKER---PNYPELL 259
Query: 876 QHVFFK 881
QH FF+
Sbjct: 260 QHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 33/271 (12%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA--VESILAERDILISVRNPFVV 652
K + RGAFG V+L TG A+K + ++ + V ++ E +L ++R+ +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 653 RFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ E L + +EY+ GG + L+ G L E+V R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+K N+L G++KL DFG SK + +SGT +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK--------RIQTICMSGTGI------------- 166
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
+S GTP +++PE++ G G+G AD WSV + E++ PP+
Sbjct: 167 -------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTED 861
I + P +P+ +S D + + E+
Sbjct: 220 KIATQPTK-PMLPDGVSDACRDFLKQIFVEE 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 84/325 (25%), Positives = 135/325 (41%), Gaps = 78/325 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--- 647
++I+ I G F V A+ R TG +AIK +KK ++E + R+I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 648 NPFVVRF----FYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLAL 702
+P ++R F T R L LV E ++ +LY L++ L E + Y+ +++ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+++H + HRD+KP+N+LI D +KL DFG + I S
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRG--IYSK------------------ 152
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN 821
P T + T Y APE LL G +G D W+VG + FE++ P F
Sbjct: 153 PPYTEY------------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 822 AEHP----QQIFD-------NILNRKIPW--------PRVPEE-------MSPEAHDLID 855
+ +I D +L + + S E DL+
Sbjct: 201 GTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLK 260
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFF 880
+ L DP +R+ A + +H +F
Sbjct: 261 KLLAYDPDERI---TAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 88/336 (26%), Positives = 144/336 (42%), Gaps = 70/336 (20%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES--ILAERDIL 643
+ + D+EI+ + G FG V+ A++ TG + A LKK ++ N + I A R+I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKK--ILMHNEKDGFPITALREIK 59
Query: 644 I--SVRNPFVVRF---FYSFTCREN-----LYLVMEYLNGGDLYSLLRNLGC-LDEDVAR 692
I +++P VV + +Y+V Y++ DL LL N L E +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK 118
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
Y+ +++ + YLH ++HRD+K N+LI + G +K+ DFGL++ + G
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 811
RK + V T Y PE+LLG TTA D W +G +
Sbjct: 179 G--------------------TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218
Query: 812 ELIVGIPPF----NAEHPQQIFD-------------------NILNRKIPWPRVPEE--- 845
E+ P + + IF ++ +PR EE
Sbjct: 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG 278
Query: 846 -MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ PE DL+ + L+ DP++RL AS+ +H +F
Sbjct: 279 KLGPEGLDLLSKLLSLDPYKRL---TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 87/335 (25%), Positives = 130/335 (38%), Gaps = 77/335 (22%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI--S 645
+ +E + I +G FG VF A+ + T + A LKK M + I A R+I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 646 VRNPFVVRFF---------YSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYI 695
+++ VV Y+ + + YLV E+ DL LL N + +
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVM 125
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
++ L Y+H +++HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK--------- 176
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELI 814
+ + V T Y PE+LLG G D W G I+ E+
Sbjct: 177 ------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 815 VGIPPF--NAEHPQQIFDNILNRKIP---WP-------------------RVPEEMSP-- 848
P N E Q + L I WP +V E + P
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV 278
Query: 849 ---EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
A DLID+ L DP +R+ + A H FF
Sbjct: 279 KDPHALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 56/288 (19%)
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
GA G V AK+ + G+ FA+KV+ M + + AE L++ FF
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA-QAEVCCLLNCD------FFSIVK 95
Query: 660 CRENLY--------------LVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLA 701
C E+ LV++Y N GDL +++ E A + +V+LA
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ ++HS ++HRD+K N+L+ +G +KL DFG SK+ +DD+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG------------- 202
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
R+ GTP Y+APEI + AD +S+G++L+EL+ PF+
Sbjct: 203 ----------------RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 869
E+ +++ L + + +P +SPE +++ L+ DP +R S
Sbjct: 247 GENMEEVMHKTLAGR--YDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 46/278 (16%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G +G V+ A+ +T AIK + + D V+ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRN-LGCL--DEDVARVYIAEVVLALEYLHSLRVVHR 713
S + + ME + GG L +LLR+ G L +E Y +++ L+YLH ++VHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 714 DLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSG--PAVSGTTLLGDEEPQLTASEH 770
D+K DN+L+ + G +K++DFG SK L+G P T
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK--------RLAGINPCTETFT-------------- 170
Query: 771 QQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF-NAEHPQQ 827
GT Y+APE++ G+G AD WS+G + E+ G PPF PQ
Sbjct: 171 -----------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ KI P +PE +S EA + I R DP +R
Sbjct: 220 AMFKVGMFKIH-PEIPESLSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 80/266 (30%), Positives = 127/266 (47%), Gaps = 47/266 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE I + G G VF + +G + A K++ I+ I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLHS 707
P++V F+ +F + + ME+++GG L +L+ G + E + +V IA V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 708 L-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMAN-------------------- 160
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNAE 823
S VGT Y++PE L GT + +D WS+G+ L E+ +G IPP +A+
Sbjct: 161 ------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208
Query: 824 HPQQIF------DNILNRKIPWPRVP 843
+ +F D + P PR P
Sbjct: 209 ELELMFGCPVEGDPAESETSPRPRPP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 79/320 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+E+IK + +GA+G V A+ T + + + K ++ K ILA+R ++R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK----KILAKR----ALRELK 53
Query: 651 VVRFFY---SFTCR-----------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
++R F + TC LYL E L DL+ ++R+ L + + +I
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIY 112
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ L+Y+HS V+HRDLKP NLL+ D +K+ DFGL++ N
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP------------- 159
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 815
G+ +T V T Y APEI+L T A D WSVG IL EL+
Sbjct: 160 --GENAGFMT------------EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 816 GIPPFNA----EHPQQIF-------DNILNR-----------------KIPWPRVPEEMS 847
P F + QI + L+R K P+ + +
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNAN 265
Query: 848 PEAHDLIDRFLTEDPHQRLG 867
P A DL+++ L DP +R+
Sbjct: 266 PLALDLLEKLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 75/279 (26%), Positives = 132/279 (47%), Gaps = 40/279 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA--ERDILISVRNPFVVRF 654
+ +G+FG V+L K + +KVLK+ + N E++ A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE----VVLALEYLHSLRV 710
SF R+ ++ EY G DL L L + ++ + E ++L + Y+H R+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDLK N+ + ++ +K+ DFG+S++ L+ S D TT
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRL-LMGSCD-------LATTF------------- 165
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
GTP Y++PE L G+ + +D WS+G IL+E+ F ++ +
Sbjct: 166 ----------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215
Query: 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 869
I+ P P +PE S + + ++ L +DP R +
Sbjct: 216 RIVEG--PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 86/331 (25%), Positives = 140/331 (42%), Gaps = 96/331 (29%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--------------DMIRKNAVESILAE 639
++P+ GAFG V A+ + TG AIK + K +++ E+I++
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
DI IS P E++Y V E L G DL+ LL + L++ + ++ +++
Sbjct: 75 SDIFIS---P-----------LEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQIL 118
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L+Y+HS VVHRDLKP N+LI + +K+ DFGL+++
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--------------------- 157
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818
++PQ+T V T Y APEI+L + D WS G I E++ G P
Sbjct: 158 -QDPQMTGY------------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
Query: 819 PFNAEHPQQIF-----------DNILNR-----------------KIPWPRVPEEMSPEA 850
F + F D+++N +P+ + P A
Sbjct: 205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSA 264
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
DL+++ L DP +R+ A+E H +
Sbjct: 265 IDLLEKMLVFDPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 80/322 (24%), Positives = 134/322 (41%), Gaps = 71/322 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK---KADMIRKNAVESILAERDILISVR 647
+E ++ I G +G VF AK R T ++ A+K ++ + + +A+ I +L ++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELK 57
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLH 706
+ +VR + + L LV EY + DL + G +D ++ + ++ +++ L + H
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S V+HRDLKP NLLI +G +KL DFGL++ I P
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PV--------------- 153
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFEL------------ 813
R + V T Y P++L G + T+ D WS G I EL
Sbjct: 154 --------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205
Query: 814 ----------IVGIP-----PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 858
++G P P ++ P + V +++ DL+ L
Sbjct: 206 VDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLL 265
Query: 859 TEDPHQRLGSGGASEVKQHVFF 880
+P QR+ A E QH +F
Sbjct: 266 VCNPVQRI---SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 92/322 (28%), Positives = 136/322 (42%), Gaps = 75/322 (23%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ +D F+II I G +G+V+ A+ + TG+L A LKK + + I A R+I I
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVA---LKKVRLDNEKEGFPITAIREIKI 59
Query: 645 --SVRNPFVVRFFYSFTC----------RENLYLVMEYLNGGDLYSLLRN-LGCLDEDVA 691
+ + +V T + YLV EY++ DL LL + L ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ ++ +++ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIIL 810
+ +E R + V T Y PE+LLG +G D WS G IL
Sbjct: 166 -----------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 811 FELIVGIPPFNA--EHPQ-QIFDNILNRKIP--WP-------------------RVPEEM 846
EL P F A E Q ++ + P WP R+ EE
Sbjct: 209 GELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF 268
Query: 847 S---PEAHDLIDRFLTEDPHQR 865
S A DL+D LT DP +R
Sbjct: 269 SFIPTPALDLLDHMLTLDPSKR 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 91/335 (27%), Positives = 147/335 (43%), Gaps = 89/335 (26%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES-ILAERD-----I 642
D ++ + P+ GA+G+V A TG AIK L + +S I A+R +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-------FQSAIHAKRTYRELRL 67
Query: 643 LISVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
L + + V+ FT +L YLV L G DL ++++ L +D + +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVK-CQKLSDDHIQFLVY 125
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ L+Y+HS ++HRDLKP N+ + D +K+ DFGL++ TDD
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDD---------- 170
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIV 815
++T V T Y APEI+L H T D WSVG I+ EL+
Sbjct: 171 -------EMTGY------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 816 GIPPF-NAEHPQQIFDNILN----------RKIP----------WPRVPEE--------M 846
G F ++H Q+ I+N +KI P++P++
Sbjct: 212 GKTLFPGSDHIDQL-KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA 270
Query: 847 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+P A DL+++ L DP +R+ A+E H +
Sbjct: 271 NPLAIDLLEKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 89/325 (27%), Positives = 143/325 (44%), Gaps = 77/325 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE----SILAERDILISV 646
F+ ++ + G + V+ + RTTG++ A+K I +A E + + E ++ +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKEL 55
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVLALE 703
++ +VR L LV EY++ DL + G LD + + + +++ +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ H RV+HRDLKP NLLI G +KL DFGL++ I P
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI---------------------P 153
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF-- 820
T S + V T Y AP++LLG+ + T+ D WSVG I+ E+I G P F
Sbjct: 154 VNTFS----------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203
Query: 821 --NAEHPQQIFDNILN--RKIPWPRV---PE--------------EMSPEAH----DLID 855
N + +IF I+ + WP + PE ++ P A DL+
Sbjct: 204 TNNEDQLLKIF-RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLH 262
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFF 880
R L +P R+ A + QH +F
Sbjct: 263 RLLQLNPELRI---SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 85/292 (29%), Positives = 135/292 (46%), Gaps = 51/292 (17%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES--ILAERDI- 642
++D E + I G G+V+ + + TG + A+K +++ N E+ IL + D+
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMDLDVV 67
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLA 701
L S P++V+ + F ++++ ME L L LL+ + G + ED+ +V A
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 702 LEYL---HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
L YL H V+HRD+KP N+L+ G++KL DFG+S L++S
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR-LVDS--------------- 168
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGT---TADWWSVGIILFELI 814
+ K RSA G Y+APE I + AD WS+GI L EL
Sbjct: 169 ---------------KAKTRSA-GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212
Query: 815 VGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G P+ N + ++ IL + P E SP+ +D LT+D +R
Sbjct: 213 TGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 85/314 (27%), Positives = 131/314 (41%), Gaps = 72/314 (22%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL--KKADMIRKNAVESILAERDI 642
S+ + E + I GA G V+ R TG L+A+KV+ D +R+ I E +I
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEI 125
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
L V +P VV+ F + +++E+++GG L DVAR +++ +
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGI 181
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YLH +VHRD+KP NLLI ++K+ DFG+S++ + T D P
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMD---PC----------- 225
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFELIVGI 817
S+VGT Y++PE + G G D WS+G+ + E +G
Sbjct: 226 ---------------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
Query: 818 PPFNAEHPQQIFDNILNRKIPW------------PRVPEEMSPEAHDLIDRFLTEDPHQR 865
PF + R+ W P P S E I L +P +R
Sbjct: 271 FPFG-----------VGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKR 319
Query: 866 LGSGGASEVKQHVF 879
A ++ QH F
Sbjct: 320 W---SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 78/260 (30%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIK--------------VLKKADMIRKNAVES 635
D E +PI GAFG V+ G A+K V ++ M+ ++
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
+L+ DIL P + F E +Y+V E + DL+ ++ + L D +V++
Sbjct: 61 VLSALDIL----QPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFL 109
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+++ L+YLHS ++HRD+KP NLL+ + +K+ DFGL++V
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV----------------- 152
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
EEP E + V T Y APEIL+G+ H T+A D WSVG I EL+
Sbjct: 153 -----EEP--------DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
Query: 815 VGIPPFNAEHPQQIFDNILN 834
F A+ P Q D I +
Sbjct: 200 GRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 86/324 (26%), Positives = 141/324 (43%), Gaps = 72/324 (22%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK---KADMIRKNAVESILAERDILISV 646
D+ I+ I G +G V+ + + TG + A+K ++ + + + A+ I +L +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALE 703
++P +V LYL+ E+L+ DL L +L +D ++ + Y+ +++ +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ HS RV+HRDLKP NLLI + G IKL DFGL++ G V T
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA---------FGIPVRVYT------- 159
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822
H+ V T Y APE+LLG + T D WS+G I E+ P F+
Sbjct: 160 ------HE---------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204
Query: 823 EHP-QQIFDNILNRKIP----WPRV---PE------------------EMSPEAHDLIDR 856
+ Q+F P WP V P+ + + DL+++
Sbjct: 205 DSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEK 264
Query: 857 FLTEDPHQRLGSGGASEVKQHVFF 880
L DP +R+ A + H +F
Sbjct: 265 MLIYDPAKRI---SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-21
Identities = 75/246 (30%), Positives = 121/246 (49%), Gaps = 41/246 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE I + G G V + + +G + A K++ I+ I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLHS 707
P++V F+ +F + + ME+++GG L +L+ + E++ +V IA V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 708 L-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMAN-------------------- 160
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNAE 823
S VGT Y++PE L GT + +D WS+G+ L EL +G IPP +A+
Sbjct: 161 ------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208
Query: 824 HPQQIF 829
+ IF
Sbjct: 209 ELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 94/328 (28%), Positives = 152/328 (46%), Gaps = 70/328 (21%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LIS 645
+D +E ++ I G +G V+ A+ R T + A LKK + +++ A R+I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED--VARVYIAEVVLALE 703
+++ +VR + LYLV EYL+ DL + + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y HS RV+HRDLKP NLLI + +KL DFGL++ I P + T
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--------PVRTFT------- 161
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIP--P 819
H+ V T Y APEILLG+ H T D WSVG I E++ P P
Sbjct: 162 -------HE---------VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205
Query: 820 FNAEHPQ--QIF--------------DNILNRKIPWPRVPEE--------MSPEAHDLID 855
++E + +IF ++ + K +P+ P + + P DL+
Sbjct: 206 GDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLS 265
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFFKDI 883
+ L DP +R+ + A E H +FKD+
Sbjct: 266 KMLRLDPSKRITARAALE---HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 79/313 (25%), Positives = 141/313 (45%), Gaps = 62/313 (19%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
RSL + +D I FE+++ + G +G+V+ + TG L AIKV+ + ++
Sbjct: 1 RSLDDIDLSALRDPAGI--FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTED 54
Query: 632 AVESILAERDILISV---RNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRN 682
E I E ++L RN + ++ +F + + L+LVME+ G + L++N
Sbjct: 55 EEEEIKLEINMLKKYSHHRN--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN 112
Query: 683 L--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740
L ED E++ L +LH+ +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 113 TKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--- 169
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR--KKRSAVGTPDYLAPEILL----- 793
Q +R ++ + +GTP ++APE++
Sbjct: 170 ------------------------------QLDRTVGRRNTFIGTPYWMAPEVIACDENP 199
Query: 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV-PEEMSPEAHD 852
+ +D WS+GI E+ G PP HP + L + P P++ ++ S + D
Sbjct: 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--FLIPRNPPPKLKSKKWSKKFID 257
Query: 853 LIDRFLTEDPHQR 865
I+ L ++ R
Sbjct: 258 FIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 52/290 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
FE+++ + G +G+V+ + TG L AIKV+ + + E I E ++L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 651 VVRFFYSFTCREN-------LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLA 701
+ +Y ++N L+LVME+ G + L++N L E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L +LH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS------------------------- 158
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVG 816
++ + ++ + +GTP ++APE++ + +D WS+GI E+ G
Sbjct: 159 ------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
Query: 817 IPPFNAEHPQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQR 865
PP HP + L + P PR+ ++ S + I+ L ++ QR
Sbjct: 213 APPLCDMHPMRAL--FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 83/318 (26%), Positives = 123/318 (38%), Gaps = 59/318 (18%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES---ILAERDILISVR 647
F ++ I G+FG V+ A+ T ++ AIK K K + E I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNG--GDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+P + + + +LVMEY G D+ + + L E + L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS +HRD+K N+L+ G +KL DFG + L PA
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFG---------SASLVSPA-------------- 168
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
S VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 169 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
++ N + S + +D L + P R S E+ +H F
Sbjct: 217 MNAMSALYHIAQND--SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSS---EELLKHRFVL 271
Query: 882 -----DINWDTLARQKAA 894
+ D + R K A
Sbjct: 272 RERPPTVIIDLIQRTKDA 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 83/330 (25%), Positives = 138/330 (41%), Gaps = 79/330 (23%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE----SILAERDIL 643
++ ++ + + G++ V+ + + TG L A+K IR E + + E +L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLAL 702
+++ +V ++ L LV EYL+ DL + + G L R+++ +++ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y H RV+HRDLKP NLLI+ G +KL DFGL++ +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--------------------- 155
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821
P T S + V T Y P++LLG T + T+ D W VG I +E+ G P F
Sbjct: 156 PSKTYS----------NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205
Query: 822 A-----EHPQQIFDNILNRKIP--WPRVPE------------------------EMSPEA 850
+ +IF +L WP V + P
Sbjct: 206 GSTDVEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHG 264
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+L +FL +P +R+ A+E +H +F
Sbjct: 265 EELALKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 9e-20
Identities = 86/333 (25%), Positives = 146/333 (43%), Gaps = 81/333 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILIS 645
D + +K + GA+G V A R TG AIK L + +++ K A E +L
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 646 VRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+++ V+ FT +L YLVM ++ G DL L+++ L ED + + +++
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L+Y+H+ ++HRDLKP NL + D +K+ DFGL++ + +++G V
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV------- 177
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVGIP 818
T Y APE++L H T T D WSVG I+ E++ G P
Sbjct: 178 -----------------------TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 819 PFNA-EH-------------PQQIF------DNILNRKIPWPRVPEE--------MSPEA 850
F +H P + F ++ N PR ++ +P A
Sbjct: 215 LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLA 274
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
+++++ L D R+ A+E H +F++
Sbjct: 275 VNVLEKMLVLDAESRI---TAAEALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 96/356 (26%), Positives = 150/356 (42%), Gaps = 79/356 (22%)
Query: 591 FEIIKPISRGAFGRVFLA--KKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISV 646
+EI I RG +GRV+ A K G +AIK K D + + S A R+I L +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGI-SQSACREIALLREL 59
Query: 647 RNPFVV---RFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEV 698
++ VV F + +YL+ +Y DL+ +++ + + + + ++
Sbjct: 60 KHENVVSLVEVFLEHADKS-VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGH----IKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ + YLHS V+HRDLKP N+L+ +G +K+ D GL++ L N+ P
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNA------PLKP- 168
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
L D +P V T Y APE+LLG H T A D W++G I EL
Sbjct: 169 ---LADLDP----------------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
Query: 814 IVGIP-------------PFNAEHPQQIFDNILNRKIP--WPRVPEEMSPEAHDLIDRFL 858
+ P PF + ++IF +L WP + ++M PE L+ F
Sbjct: 210 LTLEPIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKDWPDI-KKM-PEYDTLMKDFK 266
Query: 859 TED-PHQRLGS-----GGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 908
T+ P L + K + +D R T+E AL+ YF
Sbjct: 267 TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR------ITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 83/332 (25%), Positives = 139/332 (41%), Gaps = 79/332 (23%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIK------------VLKKADMIRKNAVESILAERD 641
++P+ G+ G VF A A+K L++ +IR+ ++I+ +
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 642 ILIS--VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+L V ++Y+V EY+ DL ++L G L E+ AR+++ +++
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLL 124
Query: 700 LALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
L+Y+HS V+HRDLKP N+ I D +K+ DFGL+++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------- 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
+P + + E + T Y +P +LL + T A D W+ G I E++ G
Sbjct: 165 --VDPHYSHKGYLSE------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 818 PPFNAEHP----QQIFDNI----------LNRKIPW--------PRVP-----EEMSPEA 850
P F H Q I +++ L IP PR P ++PEA
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEA 276
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
D +++ LT +P RL A E H +
Sbjct: 277 LDFLEQILTFNPMDRL---TAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-19
Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+V+ F F + L L+MEY +GGDL L+ E + ++VLAL+ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +++HRDLK N+ + G IKL DFG SK +D +S S
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVAS------------- 229
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
S GTP YLAPE+ + AD WS+G+IL+EL+ PF +
Sbjct: 230 ------------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+I +L K + P +S L+D L+++P R
Sbjct: 278 EIMQQVLYGK--YDPFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-19
Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 34/233 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +E ++ + G++ V+ K + G L A+KV++ + + + + E +L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V +E L LV EY++ + ++ G L + ++++ +++ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRDLKP NLLI+ G +KL DFGL++ + P T S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------------PSHTYS 161
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P++LLG T + T D W VG I E+I G+ F
Sbjct: 162 ----------NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 79/322 (24%), Positives = 130/322 (40%), Gaps = 75/322 (23%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDILISVRNP 649
++ + G++ V+ R G L A+KV I E + + E +L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+V +E L V EY++ ++++ G L R+++ +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRDLKP NLLI++ G +KL DFGL++ I P T S
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------------PSQTYS- 161
Query: 770 HQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF--NAEHPQ 826
S V T Y P++LLG T + + D W G I E++ G P F ++ +
Sbjct: 162 ---------SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212
Query: 827 QIFDNILNRKIP----WPRV-------PE-----------------EMSPEAHDLIDRFL 858
Q+ +P WP V PE P+A DL + L
Sbjct: 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQML 272
Query: 859 TEDPHQRLGSGGASEVKQHVFF 880
P R+ A + H +F
Sbjct: 273 MMFPKDRI---SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 82/323 (25%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES------------ILAERDILI 644
+ G +G+V A TG + AIK +K + I + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIE-ISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+++ ++ + + + LVM+ + DL ++ L E + + +++ L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH +HRDL P N+ I G K+ DFGL++ P S T
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR--------RYGYPPYSDT--------- 177
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823
L+ E Q R + S V T Y APE+L+G + D WSVG I EL+ G P F E
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 824 HPQQIFDNILN-RKIP----WPRVPE-----EMSP---------------EAHDLIDRFL 858
+ I P WP+ + E +P +A DL+ L
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 859 TEDPHQRLGSGGASEVKQHVFFK 881
+P +R+ A E +H +FK
Sbjct: 298 KLNPLERI---SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 5e-19
Identities = 79/297 (26%), Positives = 144/297 (48%), Gaps = 37/297 (12%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
+ ++++E+IK I G FG VFL K + T + F K + + + + ++ E +++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRE 68
Query: 646 VRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVV 699
+++ +VR+ F + N LY++ME+ + GDL ++ G ++E +++
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 700 LALEYLHSL-------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS-TDDLSGPA 751
AL Y H+L RV+HRDLKP N+ ++ G+ +G I + ++L+G
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLST---------GIRHIGKITAQANNLNGRP 179
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGII 809
++ +GD S++ S VGTP Y +PE+LL + +D W++G I
Sbjct: 180 IAK---IGD----FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 810 LFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQR 865
++EL G PF H F +++ P +P + S E + LI L +R
Sbjct: 233 IYELCSGKTPF---HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286
|
Length = 1021 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 97/326 (29%), Positives = 143/326 (43%), Gaps = 75/326 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK---VLKKADMIRKNAV-ESILAERDILISV 646
+E + I GA+G V+ A+ +G A+K V D + + V E L +R L +
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR--LEAF 59
Query: 647 RNPFVVRFF----YSFTCRE-NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVV 699
+P +VR S T RE + LV E+++ DL + L + L + + + + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L++LH+ +VHRDLKP+N+L+ G +KL DFGL++ I S P V TL
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVV--VTLW- 172
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
Y APE+LL + + T D WSVG I E+ P
Sbjct: 173 --------------------------YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 820 F--NAEHPQ--QIFDNI-LNRKIPWPR--------------------VPEEMSPEAHDLI 854
F N+E Q +IFD I L + WPR VP E+ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFF 880
LT +PH+R+ A QH FF
Sbjct: 266 LEMLTFNPHKRI---SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-18
Identities = 79/307 (25%), Positives = 139/307 (45%), Gaps = 60/307 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--- 647
++II+ I +G G V+LA A LKK IR++ E+ L ++ L +
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 648 ---NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL---GCLDEDVA---------R 692
+P +V + + + +Y M Y+ G L SLL+++ L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
++ ++ +EY+HS V+HRDLKPDN+L+ G + + D+G + ++
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--FKKLEEE------ 168
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
L D + + VGTPDY+APE LLG + D +++G+IL++
Sbjct: 169 ----DLLDIDVDERNICY-SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQ 223
Query: 813 LIVGIPPFNAEHPQQIFDNILNRKIPWPRV---PEEMSPEAHDLIDRFLTE--------D 861
++ P+ + RKI + V P E++P + I FL++ D
Sbjct: 224 MLTLSFPYRRKK---------GRKISYRDVILSPIEVAP--YREIPPFLSQIAMKALAVD 272
Query: 862 PHQRLGS 868
P +R S
Sbjct: 273 PAERYSS 279
|
Length = 932 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 65/295 (22%), Positives = 118/295 (40%), Gaps = 51/295 (17%)
Query: 589 DDFEIIKPISRGAFGRVF--LAKKRTTGDLF---AIKVLKKADMIRKNAVESILAERDIL 643
+ +I+ + +G+FG V+ LAK G+ AIK + + +R+ L E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVM 63
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI-------- 695
VVR + + +VME + GDL S LR+ + +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRP-EAENNPGLGPPTLQKFI 122
Query: 696 ---AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
AE+ + YL + + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETD------- 173
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
RK + ++APE L T +D WS G++L+E
Sbjct: 174 --------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213
Query: 813 LI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866
+ + P+ +++ +++ +PE + +L+ +P R
Sbjct: 214 MATLAEQPYQGLSNEEVLKFVIDGGH--LDLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 85/317 (26%), Positives = 143/317 (45%), Gaps = 67/317 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES----ILAERDILI 644
+D + + I RGAFG V + +G + A+K IR E +L + D+++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 645 SVRN-PFVVRFFYSFTCRE-NLYLVMEYLNGG--DLYSLLRNL--GCLDEDV-ARVYIAE 697
+ P++V+F Y RE + ++ ME ++ Y + + + E++ ++ +A
Sbjct: 58 RSSDCPYIVKF-YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA- 115
Query: 698 VVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG-LINSTDDLSGPAVSGT 755
V AL YL L+++HRD+KP N+L+ +G+IKL DFG+S G L++S
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI----------- 162
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFE 812
K R A G Y+APE + G+ +D WS+GI L+E
Sbjct: 163 -------------------AKTRDA-GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYE 202
Query: 813 LIVGIPPFNAEHPQQIFDNILN-RKIPWPRVP----EEMSPEAHDLIDRFLTEDPHQRLG 867
+ G P+ + +FD + K P + E SP + I+ L +D +R
Sbjct: 203 VATGKFPYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK 260
Query: 868 SGGASEVKQHVFFKDIN 884
E+ +H F KD
Sbjct: 261 YK---ELLEHPFIKDYE 274
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 47/277 (16%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I RG FG VF + R A+K + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV-------LALEYLHSLR 709
T ++ +Y+VME + GGD + LR G R+ + E++ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+HRDL N L+ +K++DFG+S+ +EE + AS
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR----------------------EEEDGVYAST 152
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQI 828
++ + + APE L + + +D WS GI+L+E +G P+ QQ
Sbjct: 153 GGMKQIPVK-------WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT 205
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I + + P PE + L++R DP QR
Sbjct: 206 REAI-EQGVRLP-CPELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 83/268 (30%), Positives = 124/268 (46%), Gaps = 52/268 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFA----IKVLKKADMIRKNAVESILAERDILISV 646
+E + I GA+G+VF A+ G F ++V + + + + + R L +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 647 RNPFVVRFF----YSFTCREN-LYLVMEYLNGGDLYSLLRNL---GCLDEDVARVYIAEV 698
+P VVR F S T RE L LV E+++ DL + L + G E + + + ++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++ S L
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------YSFQMAL 166
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
S V T Y APE+LL + + T D WSVG I E+ P
Sbjct: 167 T-------------------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
Query: 819 PF--NAEHPQ--QIFDNI-LNRKIPWPR 841
F +++ Q +I D I L + WPR
Sbjct: 208 LFRGSSDVDQLGKILDVIGLPGEEDWPR 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 63/303 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKR---TTGD--LFAIKVLKKADMIRKNAVESILAERDIL 643
D + + + GAFG+VFL + D L A+K LK + +A + E ++L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELL 62
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------LGCLDEDVAR---- 692
+ ++ +V+F+ T + +V EY+ GDL LR+ L D +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 693 --VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ IA ++ + YL S VHRDL N L+ +D +K+ DFG+S+ + +TD
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD--VYTTDYYR- 179
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGI 808
V G T+L P ++ PE ++ T +D WS G+
Sbjct: 180 --VGGHTML-------------------------PIRWMPPESIMYRKFTTESDVWSFGV 212
Query: 809 ILFELIV-GIPPF----NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPH 863
+L+E+ G P+ N E + I L ++ P E +D++ DP
Sbjct: 213 VLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQ 266
Query: 864 QRL 866
QR+
Sbjct: 267 QRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 57/291 (19%)
Query: 597 ISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
+ GAFG+VFLA+ L A+K LK+A ++A + E ++L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLD--EDVA--------RVYIA- 696
VRF+ T L +V EY+ GDL LR+ G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
++ + YL SL VHRDL N L+ +K+ DFG+S+ I STD V G T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYSTDYYR---VGGRT 184
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815
+L ++ PE +L T +D WS G++L+E+
Sbjct: 185 MLPIR------------------------WMPPESILYRKFTTESDIWSFGVVLWEIFTY 220
Query: 816 GIPPFNAEHPQQIFDNILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G P+ + + I R++ PR PE + ++ +P QR
Sbjct: 221 GKQPWYQLSNTEAIECITQGRELERPRT---CPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-17
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 68/290 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ +IK ++ G+ GRVF+A K D +K+ +K + L E +L +V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPS 118
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLR 709
V+R + +V+ + + DLY+ L + L D A + +++ L YLH+ R
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRD+K +N+ I + + D G ++ + + L G A
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFP-VVAPAFL-GLA------------------ 217
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
GT + APE+L + + AD WS GI+LFE++ +P IF
Sbjct: 218 ------------GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--------YPSTIF 257
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLT----------EDPHQRLGSG 869
++ P PEE H + + ++ DP RL G
Sbjct: 258 EDP-------PSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRG 300
|
Length = 357 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 76/304 (25%), Positives = 134/304 (44%), Gaps = 69/304 (22%)
Query: 595 KPISRGAFGRV-----FLAKKRTTGDLFAIKVLKKADMIRKNAVE--SILAERDILISVR 647
K + G FG+V F K R A+K+LK+ ++ E +L+E ++L V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVN 61
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR----------------NLGCLDEDVA 691
+P V++ + + + L L++EY G L S LR N LD
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 692 RVYIAEVVLA--------LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743
R +++ ++YL +++VHRDL N+L+A +K++DFGLS+
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR------ 175
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTAD 802
++++ KRS P ++A E L + T +D
Sbjct: 176 ------------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 803 WWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 861
WS G++L+E++ +G P+ P+++F N+L R PE S E ++L+ ++
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAPERLF-NLLKTGYRMER-PENCSEEMYNLMLTCWKQE 269
Query: 862 PHQR 865
P +R
Sbjct: 270 PDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 84/325 (25%), Positives = 140/325 (43%), Gaps = 82/325 (25%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVRNPF 650
+K + GA+G V A + TG+ AIK L + +++ K A + +L +++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT----LLKHMQHEN 75
Query: 651 VVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
V+ FT ++ YLVM Y+ DL ++ + L ED + + +++ L+Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKY 132
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS ++HRDLKP NL + D +K+ DFGL++ ++ +++G V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV------------ 176
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVGIPPFNAE 823
T Y APE++L H T D WSVG I+ E++ G F +
Sbjct: 177 ------------------TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218
Query: 824 --------------HPQQIFDNILNRKI------PWPRVPEE--------MSPEAHDLID 855
P F L K P+ P + SP+A DL++
Sbjct: 219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLE 278
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFF 880
+ L D +RL A+E +H +F
Sbjct: 279 KMLELDVDKRL---TATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G + VF + + T +L A+K ++ + A + + E +L ++++ +V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDL 715
L LV EYL+ DL L N G L ++++ +++ L Y H +++HRDL
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
KP NLLI G +KL DFGL++ + P T S
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSV---------------------PTKTYS------- 161
Query: 776 KKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P++LLG T + T D W VG IL+E+ G P F
Sbjct: 162 ---NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 68/260 (26%), Positives = 106/260 (40%), Gaps = 62/260 (23%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+ + ++ I +G FG V L R G A+K LK A ++ LAE ++ ++
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEY 704
R+P +V+ LY+V EY+ G L LR+ G + + +V +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--------------------------- 150
Query: 765 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ Q+ K P + APE L T +D WS GI+L+E I F
Sbjct: 151 --EASQGQDSGK------LPVKWTAPEALREKKFSTKSDVWSFGILLWE----IYSFG-- 196
Query: 824 HPQQIFDNILNRKIPWPRVP 843
++P+PR+P
Sbjct: 197 ------------RVPYPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 50/292 (17%)
Query: 594 IKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
IK + G FG+V L + TG+ A+K L + E +IL ++ +
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH--SGEEQHRSDFEREIEILRTLDHE 66
Query: 650 FVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLH 706
+V++ +L L+MEYL G L L+ + ++ ++ +++ ++YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S R +HRDL N+L+ + +K++DFGL+KV D
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVL---PEDK-------------------- 163
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF------ 820
++ + S + + APE L + + +D WS G+ L+EL P
Sbjct: 164 --DYYYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218
Query: 821 -----NAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQR 865
Q I +L R+ P E +DL+ +P R
Sbjct: 219 FLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 74/292 (25%), Positives = 118/292 (40%), Gaps = 42/292 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I G+FG V+ A+ T ++ AIK + + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+ + + +LVMEY G L + L E + L YLHS +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L+ G +KL DFG + ++ PA
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG---------SASIASPA------------------- 178
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPPFNAEHPQQ 827
S VGTP ++APE++L G D WS+GI EL PP +
Sbjct: 179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
+I + P + E S + +D L + P R S E+ +H+F
Sbjct: 232 ALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQDRPTS---EELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 55/291 (18%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
R S+ ++ + + G FG V++ T + A+K LK M + E+ L E I+
Sbjct: 4 PRESL---KLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIM 55
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------LGCLDEDVARVYIA 696
+R+ +V+ + + E +Y+V EY++ G L L++ L L D+A A
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMA----A 110
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINSTDDLSGPAVSGT 755
++ + YL S +HRDL N+L+ + + K+ DFGL++
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR------------------ 151
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
L+ D+E TA E + K + APE +D WS GI+L E++
Sbjct: 152 -LIEDDE--YTAREGAKFPIK---------WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
Query: 816 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G P+ +++ + + R PR P E +DL+ + +DP +R
Sbjct: 200 YGRVPYPGMTNREVLEQV-ERGYRMPR-PPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 44/230 (19%)
Query: 594 IKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I+ + +G FG V L + + TG++ A+K L+ + + E +IL S+++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 650 FVVRFFYSFTC----RENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+V+ Y C R NL LVMEYL G L L ++ LD +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R VHRDL N+L+ + +K+ DFGL+KV PQ
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------------LPQ 160
Query: 765 LTASEHQQERRKKRSAVGTPDY-LAPEILLGTGHGTTADWWSVGIILFEL 813
+E K R +P + APE L + +D WS G++L+EL
Sbjct: 161 ------DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 87/334 (26%), Positives = 139/334 (41%), Gaps = 80/334 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK-----ADMIRKNAVESILAERDILIS 645
++I + I +G++G V A TG+ AIK + +D R IL E +L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR------ILREIKLLRL 55
Query: 646 VRNPFVV---RFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+R+P +V + RE ++Y+V E L DL+ +++ L + + ++ +++
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL+Y+H+ V HRDLKP N+L D +K+ DFGL++V + + A+ T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-----TPTAIFWT----- 164
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG--TTA-DWWSVGIILFELIVGI 817
V T Y APE L G+ T A D WS+G I E++ G
Sbjct: 165 ------------------DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
Query: 818 PPF---NAEH------------PQQIFDNILNRK-------------IPWPRVPEEMSPE 849
P F N H + + N K +P+ + P
Sbjct: 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPL 265
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
A L++R L DP R A E +FK +
Sbjct: 266 ALRLLERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 73/328 (22%), Positives = 123/328 (37%), Gaps = 77/328 (23%)
Query: 597 ISRGAFGR--VFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVV 652
I + V LAK + T L A+K K ++ + + L +++I+ S +++P ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRV 710
+ SF LY+V + G LL+ L E + +V+ AL+Y+HS
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HR +K ++L++ DG + L+ V +I +H
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLR-YSVSMI---------------------------KH 154
Query: 771 QQERRK----KRSAVGTPDYLAPEILLGTGHGTTA--DWWSVGIILFELIVGIPPFNAEH 824
+ +R +S+V +L+PE+L G D +SVGI EL G PF
Sbjct: 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
Query: 825 PQQIFDNILNRKIPWP----RVPEEM---------------------------SPEAHDL 853
Q+ + +P P S H
Sbjct: 215 ATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF 274
Query: 854 IDRFLTEDPHQRLGSGGASEVKQHVFFK 881
++ L DP R AS++ H FFK
Sbjct: 275 VELCLQRDPESR---PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G + V+ + + T +L A+K ++ + A + + E +L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
++L LV EYL+ DL L + G ++ ++++ +++ L Y H +V+HRDL
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
KP NLLI G +KL DFGL++ I P T S
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSI---------------------PTKTYS------- 162
Query: 776 KKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P+ILLG T + T D W VG I +E+ G P F
Sbjct: 163 ---NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 85/329 (25%), Positives = 143/329 (43%), Gaps = 79/329 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ + P+ GA+G V A TG A+K L + +A + E +L +++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKH 75
Query: 649 PFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVL 700
V+ FT +L YLV +L G DL ++++ C L +D + I +++
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVK---CQKLTDDHVQFLIYQILR 131
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
L+Y+HS ++HRDLKP NL + D +K+ DFGL++ ++ D+++G
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTG----------- 176
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPP 819
V T Y APEI+L H T D WSVG I+ EL+ G
Sbjct: 177 -------------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217
Query: 820 F-NAEHPQQIF---------DNILNRKIP----------WPRVPEE--------MSPEAH 851
F +H Q+ L +KI ++P+ +P A
Sbjct: 218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 277
Query: 852 DLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
DL+++ L D +R+ A++ H +F
Sbjct: 278 DLLEKMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 51/235 (21%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I G+FG V+ A T ++ A+K + + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 657 SFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDVARVYIAEV----VLALEYLHSLRV 710
+ +LVMEY G DL + + + + V IA + + L YLHS +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L+ G +KL DFG + S PA
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK---------SSPA------------------- 174
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
S VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 175 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 71/281 (25%), Positives = 129/281 (45%), Gaps = 43/281 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +++K + G FG V++ + AIK LK+ M + E+ LAE +++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLH 706
P +VR Y+ +E +Y++ EY+ G L L+ + + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HRDL+ N+L++ K+ DFGL++ LI E+ + T
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR--LI-------------------EDNEYT 158
Query: 767 ASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824
A E + K + APE I GT +D WS GI+L E++ G P+
Sbjct: 159 AREGAKFPIK---------WTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMT 208
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
++ N L R PR P+ E ++L+ E P +R
Sbjct: 209 NPEVIQN-LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 46/289 (15%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
I PS + +K + G FG V L K R D+ AIK++++ M + +E
Sbjct: 1 IDPS-------ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE---- 48
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAE 697
E +++ + +P +V+ + T + +++V EY+ G L + LR G L + ++
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V A+EYL S +HRDL N L+ D +K++DFGL++ L DD
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----DD----------- 153
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816
Q T+S+ + K + PE+ + + +D WS G++++E+ G
Sbjct: 154 ------QYTSSQGTKFPVK---------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG 198
Query: 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
P+ ++ +++ R P+ E + ++ E P R
Sbjct: 199 KMPYERFSNSEVVESVS-AGYRLYR-PKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 60/248 (24%), Positives = 113/248 (45%), Gaps = 43/248 (17%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
D +K + G FG V K R D+ AIK++K+ M +E E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHSL 708
+V+ + T + +Y+V EY++ G L + LR G + + + +V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+ +HRDL N L+ G +K++DFGLS+ +L DE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRY------------------VLDDE------- 154
Query: 769 EHQQERRKKRSAVGTP---DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEH 824
S+VG+ + PE+LL + + +D W+ G++++E+ +G P+ +
Sbjct: 155 --------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206
Query: 825 PQQIFDNI 832
+ + +
Sbjct: 207 NSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 76/319 (23%), Positives = 135/319 (42%), Gaps = 66/319 (20%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653
++ + G + VF + + T +L A+K ++ + A + + E +L +++ +V
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVH 712
++L LV EYL+ DL + + G + ++++ +++ L Y H +V+H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDLKP NLLI G +KL DFGL++ + P T S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSV---------------------PTKTYS---- 162
Query: 773 ERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF---NAEHPQQI 828
+ V T Y P++LLG+ + T D W VG I FE+ G P F E +
Sbjct: 163 ------NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
Query: 829 FDNILN--RKIPWPRV---------------PE-------EMSPEAHDLIDRFLTEDPHQ 864
+L + WP + P+ + E +L+ +FL + +
Sbjct: 217 IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKK 276
Query: 865 RLGSGGASEVKQHVFFKDI 883
R+ A E +H +F+ +
Sbjct: 277 RI---SAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 49/284 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++IK + G FG V++ + A+K LK M + ES L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-----RNLGCLD-EDVARVYIAEVVLAL 702
+V+ Y+ E +Y+V EY++ G L L R L + D+A A+V +
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGM 115
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y+ + +HRDL+ N+L+ K+ DFGL++ LI E+
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LI-------------------ED 154
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821
+ TA ++ A + APE L +D WS GI+L EL+ G P+
Sbjct: 155 NEYTA---------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ +++ + + R P P++ H+L+ + +DP +R
Sbjct: 206 GMNNREVLEQV-ERGYRMP-CPQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 65/267 (24%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
++ + ++++ I +G FG V L R G+ A+K +K ++ LAE ++ +
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 56
Query: 647 RNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLAL 702
R+ +V+ E LY+V EY+ G L LR+ G L D + +V A+
Sbjct: 57 RHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
EYL + VHRDL N+L++ D K++DFGL+K +ST D V T
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWT------- 166
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
APE L T +D WS GI+L+E I F
Sbjct: 167 -------------------------APEALREKKFSTKSDVWSFGILLWE----IYSFG- 196
Query: 823 EHPQQIFDNILNRKIPWPRVP-EEMSP 848
++P+PR+P +++ P
Sbjct: 197 -------------RVPYPRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 58/237 (24%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD--ILISVRNPFV 651
+KPI GA G V A TG AIK L + +N + A R+ ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---FQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 652 VRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGC------LDEDVARVYIAEVV 699
+ FT +++L YLVME ++ NL C LD + + +++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDA--------NL-CQVIQMDLDHERMSYLLYQML 128
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+++LHS ++HRDLKP N+++ D +K+ DFGL++ T + P V
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVV------ 179
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 180 -----------------------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 39/235 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I G+FG V+ A+ ++ AIK + + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ + +LVMEY G L + L E + L YLHS +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG + + PA
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPA------------------- 168
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 44/219 (20%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I G FG V + TG A+K +K D+ ++ L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDV----TAQAFLEETAVMTKLHHKNLVRLL- 65
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
LY+VME ++ G+L + LR G V ++ + +V +EYL S ++VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
L N+L++ DG K++DFGL++V G + L
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV----------GSMGVDNSKL---------------- 159
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ APE L + +D WS G++L+E+
Sbjct: 160 --------PVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 52/289 (17%)
Query: 594 IKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISVRN 648
I + RG FG VFLAK + + L +K L+K +N E D+ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 649 PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDV--------ARVYIA-E 697
VVR CRE Y+++EY + GDL LR DE + +V + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ L +++L + R VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816
+ E K R+A+ +LAPE + T +D WS G++++E+ G
Sbjct: 166 ----------DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
PF +++ + + K+ P VPE + L+ R +P R
Sbjct: 216 ELPFYGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 58/282 (20%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI- 644
T + ++ +KPI GA G V A G A+K L + +N + A R++++
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLL 74
Query: 645 -SVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ FT + +++YLVME ++ + L D + + +
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMEL---DHERMSYLLYQ 131
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++ T+ + P V
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVV---- 184
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
T Y APE++LG G+ D WSVG I+ EL+ G
Sbjct: 185 -------------------------TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGS 219
Query: 818 PPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 858
F +H Q W +V E++ + + ++R
Sbjct: 220 VIFQGTDHIDQ-----------WNKVIEQLGTPSAEFMNRLQ 250
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 87/327 (26%), Positives = 140/327 (42%), Gaps = 88/327 (26%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDI 642
+R+ +++ I G+FG V+ A T + AIK VL+ D KN R++
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKN--------REL 110
Query: 643 LI-----SVRNPFVVRFFYSFTCREN-----LYLVMEYLNGG-----DLYSLLRNLGCLD 687
LI + F+ ++Y+ ++N L +VME++ Y+ RN L
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALP 168
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDD 746
+ ++Y ++ AL Y+HS + HRDLKP NLLI + H +KL DFG
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG------------ 216
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWS 805
S LL + + S + + Y APE++LG T + T D WS
Sbjct: 217 ------SAKNLLAGQ--------------RSVSYICSRFYRAPELMLGATNYTTHIDLWS 256
Query: 806 VGIILFELIVGIPPFNAEH--------------PQQIFDNILN---RKIPWPRV------ 842
+G I+ E+I+G P F+ + P + +N I +P V
Sbjct: 257 LGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLK 316
Query: 843 ---PEEMSPEAHDLIDRFLTEDPHQRL 866
P+ +A + I +FL +P +RL
Sbjct: 317 KVFPKGTPDDAINFISQFLKYEPLKRL 343
|
Length = 440 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 49/281 (17%)
Query: 595 KPISRGAFGRVFLAKKRTTGDL---FAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + G FG V A+K LK+ + + L E ++ + +P +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCI 58
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVV 711
VR E L LVME G L L+ + + +V + + YL S V
Sbjct: 59 VRLI-GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 712 HRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQ 771
HRDL N+L+ + K++DFG+S+ LG S++
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRA-------------------LG------AGSDYY 152
Query: 772 QERRKKRSAVGTPDYLAPE-ILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIF 829
+ R + + APE I G + +D WS G+ L+E G P+ ++
Sbjct: 153 RATTAGRWPL---KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208
Query: 830 DNI-----LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ L R PEE E + ++ P R
Sbjct: 209 AMLESGERLPR-------PEECPQEIYSIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 43/244 (17%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV--ESILAERDILISVRNPFV 651
+K + G FG V L K R IKV KA I + A+ E + E +++ + +P +
Sbjct: 9 MKELGSGQFGVVHLGKWRAQ-----IKVAIKA--INEGAMSEEDFIEEAKVMMKLSHPKL 61
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V+ + T ++ LY+V E++ G L + LR G L +D+ +V +EYL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDL N L++ G +K++DFG+++ L DD + T+S
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVL----DD-----------------EYTSS-- 158
Query: 771 QQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 828
S P + PE+ + + + +D WS G++++E+ G PF + ++
Sbjct: 159 --------SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210
Query: 829 FDNI 832
+ I
Sbjct: 211 VEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 62/279 (22%), Positives = 117/279 (41%), Gaps = 40/279 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+F + + + G FG V+ + + AIK+LK D++++ + E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLHS 707
++ F + E +Y++ E + G L + LR+ VA + +A +V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+HRDL N+L+ D K+ DFGL+++ +E +
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL---------------------IKEDVYLS 161
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826
S+ + + + APE T +D WS GI+L+E+ G P+ +
Sbjct: 162 SDKKIPYK----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+++D I P P + E + ++ +P R
Sbjct: 212 EVYDQI-TAGYRMPC-PAKCPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 48/277 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVRNPFVVR 653
I +G FG V+ + ++ A+K + D+ RK L E +IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
++ +Y+VME + GG L + LR L + +EYL S +H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDL N L+ + +K++DFG+S+ +E T S+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---------------------EEEGGIYTVSDGLK 155
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFD 830
+ K + APE L G T+ D WS GI+L+E +G P+ QQ +
Sbjct: 156 QIPIK--------WTAPEA-LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206
Query: 831 NI-LNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQR 865
I ++P P+ PEE+ + L+ + DP R
Sbjct: 207 RIESGYRMPAPQLCPEEI----YRLMLQCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 69/279 (24%), Positives = 125/279 (44%), Gaps = 47/279 (16%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI- 644
T + ++ +KPI GA G V A AIK L + +N + A R++++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLM 77
Query: 645 -SVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ FT + +++Y+VME ++ +L +++ LD + + +
Sbjct: 78 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQ 134
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++ +GT+
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 180
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
+ V T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 181 MMTPY------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
Query: 818 PPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 855
F +H Q I P P +++ P ++
Sbjct: 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 53/303 (17%)
Query: 595 KPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ + GAFG+VFLA+ L A+K LK A NA + E ++L ++++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHE 67
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------------VYIAE 697
+V+F+ + L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 698 VVLA-LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ A + YL S VHRDL N L+ + +K+ DFG+S+ + STD V G T
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD--VYSTDYYR---VGGHT 182
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815
+L ++ PE ++ T +D WS+G++L+E+
Sbjct: 183 MLPIR------------------------WMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
G P+ ++ + I ++ + P E +DL+ +PH RL +
Sbjct: 219 GKQPWYQLSNNEVIECITQGRV--LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276
Query: 876 QHV 878
Q++
Sbjct: 277 QNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 51/235 (21%)
Query: 594 IKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I+ + G FG+V L + TG+ A+K LK N + + E +IL ++ +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 650 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+V+ Y C E+ + L+ME+L G L L RN ++ Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV-----GLINSTDDLSGPAVSGTTLLG 759
L S + VHRDL N+L+ + +K+ DFGL+K DDL P
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF------- 177
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ APE L+ + +D WS G+ L+EL+
Sbjct: 178 --------------------------WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 42/201 (20%)
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYLNGGDL 676
AIKVLK + K+ + ++ E +I+ + NP++VR C E L LVME +GG L
Sbjct: 26 AIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIG--VCEAEALMLVMEMASGGPL 81
Query: 677 YSLLRNLGCLDEDVARVYIAE----VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732
L +++ + E V + ++YL VHRDL N+L+ + + K++D
Sbjct: 82 NKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISD 138
Query: 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEI 791
FGLSK LG ++ A RSA P + APE
Sbjct: 139 FGLSKA-------------------LGADDSYYKA----------RSAGKWPLKWYAPEC 169
Query: 792 LLGTGHGTTADWWSVGIILFE 812
+ + +D WS GI ++E
Sbjct: 170 INFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 60/301 (19%)
Query: 590 DFEIIKPISRGAFGRVFLAK---KRTTGD--LFAIKVLKKADMIRKNAVESILAERDILI 644
D + + + GAFG+VFLA+ T D L A+K LK + A + E ++L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLT 62
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVAR-------- 692
++++ +V+F+ + L +V EY+ GDL LR G L + R
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 693 ---VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748
++IA ++ + YL S VHRDL N L+ + +K+ DFG+S+ + STD
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VYSTDYYR 180
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
V G T+L ++ PE ++ T +D WS G+
Sbjct: 181 ---VGGHTMLPIR------------------------WMPPESIMYRKFTTESDVWSFGV 213
Query: 809 ILFELIV-GIPPFNAEHPQQIFDNILN-RKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQR 865
IL+E+ G P+ ++ + I R + PRV P+E+ +D++ +P QR
Sbjct: 214 ILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEV----YDIMLGCWQREPQQR 269
Query: 866 L 866
L
Sbjct: 270 L 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/285 (22%), Positives = 125/285 (43%), Gaps = 50/285 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +++K + G FG V++ + + A+K LK M +V++ L E +++ ++++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV-------YIAEVVLA 701
+VR + T E +Y++ EY+ G L L++ ++ +V + A++
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEG 115
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ Y+ +HRDL+ N+L++ K+ DFGL++V E
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV---------------------IE 154
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820
+ + TA E + K + APE + +D WS GI+L+E++ G P+
Sbjct: 155 DNEYTAREGAKFPIK---------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ + L R PR E E +D++ E +R
Sbjct: 206 PGMSNSDVM-SALQRGYRMPR-MENCPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 81/332 (24%), Positives = 139/332 (41%), Gaps = 89/332 (26%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
++ + P+ GA+G V A A+K L + +A + E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT-YRELRLLKHMKHEN 75
Query: 651 VVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
V+ FT ++ YLV L G DL ++++ DE V + I +++ L+Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQKLSDEHV-QFLIYQLLRGLKY 133
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS ++HRDLKP N+ + D +++ DFGL++ + D+++G
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTG--------------- 174
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFEL---------- 813
V T Y APEI+L H T D WSVG I+ EL
Sbjct: 175 ---------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
Query: 814 -----------IVGIP------PFNAEHPQQIFDNILNRKIPWPRVPEE--------MSP 848
+VG P ++EH ++ ++ P +P++ +P
Sbjct: 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL-------PHMPQQDLKKIFRGANP 272
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
A DL+++ L D +R+ ASE H +F
Sbjct: 273 LAIDLLEKMLVLDSDKRI---SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 45/281 (16%)
Query: 595 KPISRGAFGRVF--LAKKRTTGDLFAIKVLKKADMIRKNAV-ESILAERDILISVRNPFV 651
+ G FG V + K + + A+K+LK + A+ + +L E +++ + NP++
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYI 58
Query: 652 VRFFYSFTCR-ENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLR 709
VR C E+ LVME G L L +N ++++ + + +V + ++YL
Sbjct: 59 VRMIG--ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL-VHQVSMGMKYLEETN 115
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
VHRDL N+L+ + K++DFGLSK LG +E A
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKA-------------------LGADENYYKAKT 156
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQI 828
H + K + APE + + +D WS G++++E G P+ ++
Sbjct: 157 HGKWPVK---------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
Query: 829 FDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLG 867
I + + R+ P+ PE +DL+ T +R G
Sbjct: 208 TQMIESGE----RMECPQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-13
Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 46/237 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI- 644
T + ++ +KPI GA G V A AIK L + +N + A R++++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLM 70
Query: 645 -SVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ FT +++L YLVME ++ +L +++ LD + + +
Sbjct: 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQ 127
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++ +GT+
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ V T Y APE++LG G+ D WSVG I+ E++
Sbjct: 174 M------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
G +G V+ + A+K LK+ M VE L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDED-VARVYIA-EVVLALEYLHSLRVVHRDLKP 717
Y++ E++ G+L LR + + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 718 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKK 777
N L+ + +K+ DFGLS+ + + D + A G + P
Sbjct: 133 RNCLVGENHLVKVADFGLSR---LMTGDTYTAHA-------GAKFP-------------- 168
Query: 778 RSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 836
+ APE L +D W+ G++L+E+ G+ P+ Q+++ +L +
Sbjct: 169 ------IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKG 221
Query: 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
R PE P+ ++L+ +P R
Sbjct: 222 YRMER-PEGCPPKVYELMRACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-13
Identities = 65/267 (24%), Positives = 104/267 (38%), Gaps = 43/267 (16%)
Query: 613 TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-LYLVMEYL 671
TG AIK+L+ ++ E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HI 728
G L +L G L + +V+ AL H+ +VHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788
K+ DFG+ + G D + + +GTP Y A
Sbjct: 122 KVLDFGIGTLL-------------PGV---RDADVATLTRTTE--------VLGTPTYCA 157
Query: 789 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMS- 847
PE L G +D ++ G+I E + G +I L+ P ++S
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLS--------PVDVSL 209
Query: 848 P---EAH---DLIDRFLTEDPHQRLGS 868
P H ++ + L +DP QR S
Sbjct: 210 PPWIAGHPLGQVLRKALNKDPRQRAAS 236
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 43/232 (18%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISV 646
E IK + GAFG V+ G+ AIKVL++ + K E IL E ++ SV
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKE-ILDEAYVMASV 66
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLAL 702
+P VVR + L+ + + G L +RN +G V IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YL R+VHRDL N+L+ H+K+TDFGL+K LL +E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLDVDE 163
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ A + + ++A E +L + +D WS G+ ++EL+
Sbjct: 164 KEYHAEGGKVPIK----------WMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 68/277 (24%), Positives = 106/277 (38%), Gaps = 38/277 (13%)
Query: 595 KPISRGAFGRVFLAK-KRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + G+FG V + + G + A+K LK + + ++ L E I+ S+ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLR 709
+R Y L +V E G L LR LG Y ++ + YL S R
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+HRDL N+L+A D +K+ DFGL + L E E
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRA-------------------LPQNEDHYVMEE 158
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 828
H K A + APE L +D W G+ L+E+ G P+ QI
Sbjct: 159 H----LKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI 209
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
I R PE + ++++ + +P R
Sbjct: 210 LKKIDKEGERLER-PEACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 55/294 (18%)
Query: 594 IKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
++ + AFG+++ G L AIK LK D+ E ++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL------RNLGCLDEDVARV---------- 693
+V T + + ++ EYLN GDL+ L ++GC ++ V
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 694 YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+ I S D V
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE--IYSADYYR---V 182
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
+LL ++ PE ++ + +D WS G++L+E
Sbjct: 183 QPKSLLPIR------------------------WMPPEAIMYGKFSSDSDIWSFGVVLWE 218
Query: 813 LI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ G+ P+ Q++ + + R++ P E+ P + L+ E P +R
Sbjct: 219 IFSFGLQPYYGFSNQEVIEMVRKRQL-LP-CSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 65/291 (22%), Positives = 125/291 (42%), Gaps = 56/291 (19%)
Query: 597 ISRGAFGRVFLAKKRT-----TGDL-FAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ GAFG V+ +G + A+K L+K ++ L E ++ + +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV-LALE------ 703
+V+ E Y++ME + GGDL S LR+ + + E++ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
YL + +HRDL N L++ G+ +K+ DFGL++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------------------- 159
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE-LIVGI 817
+ S++ ++ + V ++APE LL T +D WS G++++E L +G
Sbjct: 160 -----DIYKSDYYRKEGEGLLPV---RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211
Query: 818 PPFNAEHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866
P+ A + Q++ ++ R P+++ + L+ +DP +R
Sbjct: 212 QPYPALNNQEVLQHVTAGGRLQKPENCPDKI----YQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 73/319 (22%), Positives = 124/319 (38%), Gaps = 89/319 (27%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTG-------DLFAIKVLK-------KADMIRKNAVE 634
++ E ++ I +GAFGRVF A R G + A+K+LK +AD R+ A
Sbjct: 5 NNIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-- 60
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDED 689
++AE D +P +V+ + + L+ EY+ GDL LR L
Sbjct: 61 -LMAEFD------HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113
Query: 690 VARVYI-----------------AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732
+ +V + YL + VHRDL N L+ + +K+ D
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792
FGLS+ I S D E + ++ PE +
Sbjct: 174 FGLSRN--IYSADYYK----------ASENDAIPIR-----------------WMPPESI 204
Query: 793 LGTGHGTTADWWSVGIILFELI-VGIPP-FNAEHPQQIF----DNILNRKIPWPRVPEEM 846
+ T +D W+ G++L+E+ G+ P + H + I+ N+L+ P+
Sbjct: 205 FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS-------CPDNC 257
Query: 847 SPEAHDLIDRFLTEDPHQR 865
E ++L+ ++ P R
Sbjct: 258 PLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 59/293 (20%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
DRTSI ++++ + G FG V+ T + A+K LK M + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDE--DVARVYIAE 697
+R+P +++ + T E +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V + YL + +HRDL N+L+ + K+ DFGL++V
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV------------------- 152
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816
+ ++ A E + K + APE L +D WS GI+L E++ G
Sbjct: 153 IKEDI--YEAREGAKFPIK---------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201
Query: 817 IPPF----NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
P+ NAE QQ+ ++P P E +D++ EDP R
Sbjct: 202 RMPYPGMTNAEVLQQVDQGY---RMP---CPPGCPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 41/272 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V++ T + AIK LK M + E+ L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
+ E +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
L+ N+L+ + K+ DFGL++ LI E+ + TA
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LI-------------------EDNEYTA------- 159
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 833
++ A + APE L +D WS GI+L EL G P+ +++ D +
Sbjct: 160 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV- 216
Query: 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
R P P E HDL+ + ++P +R
Sbjct: 217 ERGYRMP-CPPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 49/263 (18%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILIS 645
+F+ IK + GAFG V+ G+ AIK L++A + N + IL E ++ S
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI----AEVVLA 701
V NP V R + L+ + + G L +R +++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ YL R+VHRDL N+L+ H+K+TDFGL+K LLG +
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLGAD 162
Query: 762 EPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819
E E+ E K P ++A E +L + +D WS G+ ++EL+ G P
Sbjct: 163 E-----KEYHAEGGK------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
Query: 820 FNAEHPQQIFDNILNR--KIPWP 840
++ +I +IL + ++P P
Sbjct: 212 YDGIPASEI-SSILEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 66/284 (23%), Positives = 108/284 (38%), Gaps = 64/284 (22%)
Query: 553 VDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDD----------------FEIIKP 596
++ + +D L +D + I +D + D F I++
Sbjct: 40 SEMNPGIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILET 99
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ GA G F T + IK ++ E IL ++ +P +++
Sbjct: 100 FTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKG 150
Query: 657 SFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVL-ALEYLHSLRVVH 712
+FT + L++ DLY L RN+ D + I VL A++YLH R++H
Sbjct: 151 TFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICD----ILAIERSVLRAIQYLHENRIIH 205
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RD+K +N+ I H G + L DFG + + + + G A
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA--------------------- 244
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
GT APE+L +G D WS GI+LFE+
Sbjct: 245 ---------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 594 IKPISRGAFGRVFL----AKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I+ + G FG+V L TG++ A+K LK + ++N E +IL ++ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNT-SGWKKEINILKTLYHE 66
Query: 650 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+V+ Y C E L L+MEY+ G L L ++ L + + ++ ++ + Y
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--LFAQQICEGMAY 122
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +HRDL N+L+ +D +K+ DFGL+K AV
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-------------AVP----------- 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
E+ + R S V + A E L +D WS G+ L+EL+
Sbjct: 159 -EGHEYYRVREDGDSPVF---WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 67/274 (24%), Positives = 121/274 (44%), Gaps = 45/274 (16%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V++ T + AIK LK M E+ L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
+ E +Y+V E++ G L L+ + ++ A++ + Y+ + +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
L+ N+L+ + K+ DFGL++ LI E+ + TA
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LI-------------------EDNEYTA------- 159
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI- 832
++ A + APE L +D WS GI+L EL+ G P+ +++ + +
Sbjct: 160 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
Query: 833 LNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQR 865
++P P+ PE + H+L+ +DP +R
Sbjct: 218 RGYRMPCPQGCPESL----HELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 61/252 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDL-----FAIKVLKKADMIRKNAVESILAERDIL 643
D + KP+ GAFG+V A+ + A+K+LK D K+ + +++E +++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKD-LSDLVSEMEMM 69
Query: 644 ISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-------------------NL 683
+ ++ ++ T LY+V+EY G+L LR L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 684 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743
D V+ Y +V +E+L S + +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDL-VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------ 180
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTAD 802
D+ H + +K + P ++APE L + +D
Sbjct: 181 --DI----------------------HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216
Query: 803 WWSVGIILFELI 814
WS G++L+E+
Sbjct: 217 VWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 48/286 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLA---KKRTTGDLFAIKVLKK-ADMIRKNAVESILAERDILI 644
+D + + I G FG V+ A+K K + E L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR---EKFLQEAYIMR 62
Query: 645 SVRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLAL 702
+P +V+ EN +++VME G+L S L N LD +Y ++ AL
Sbjct: 63 QFDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YL S R VHRD+ N+L++ +KL DFGLS+ L DE
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-------------------YLEDES 161
Query: 763 PQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFE-LIVGIPPF 820
K S P ++APE + + +D W G+ ++E L++G+ PF
Sbjct: 162 ------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
Query: 821 NAEHPQQIFDNILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I N ++P +P P + L+ + DP +R
Sbjct: 210 QGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 41/236 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG VF K T D + V + + + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVF---KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL----ALEYLHSLRVVH 712
T R+ +Y+VME + GGD S LR +++ + + L + YL S +H
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDL N L+ + +K++DFG+S+ E+ + +S +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----------------------QEDDGIYSSSGLK 154
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQ 827
+ K + APE L + + +D WS GI+L+E +G+ P+ QQ
Sbjct: 155 QIPIK--------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
IHP + +++ I G FG V+L AIK +++ M ++ +E
Sbjct: 1 IHP-------SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE---- 48
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAE 697
E +++ + +P +V+ + T R + LV E++ G L LR G ++ +
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V + YL S V+HRDL N L+ + +K++DFG+++ L DD
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL----DD----------- 153
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
Q T+S + K + +PE+ + + + +D WS G++++E+
Sbjct: 154 ------QYTSSTGTKFPVK---------WSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675
L A+K+L+ D KNA L E I+ +++P ++R + L ++ EY+ GD
Sbjct: 48 LVAVKMLR-EDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 676 LYSLLRNL----GCLDEDVARV------YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAH 724
L L DV + ++A ++ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 725 DGHIKLTDFGLSK 737
+ IK+ DFG+S+
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 58/296 (19%)
Query: 594 IKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSL 708
+V R + LV + + G L +R N + + ++ + YL +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------------------------ 164
Query: 769 EHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826
E+ + K P ++A E +L +D WS G+ ++EL+ G P++ +
Sbjct: 165 EYHADGGK------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218
Query: 827 QIFDNI-LNRKIPWP---------------RVPEEMSPEAHDLIDRF--LTEDPHQ 864
+I D + ++P P + E P +L+D F + DP +
Sbjct: 219 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 53/275 (19%)
Query: 585 RTSIDDFEIIKPISRGAFGRV-----FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
+ ++ + GAFG+V +R + AIK LK+ + + E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQE 58
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRN-------LGCLDEDVA 691
+++ +++P +V T + ++ EYL GDL+ L+RN DE V
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 692 R-------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743
++IA ++ +EYL S VHRDL N L+ +K++DFGLS+ I S
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--DIYS 176
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
D R + ++ ++ PE +L T +D
Sbjct: 177 AD---------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDI 209
Query: 804 WSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKI 837
WS G++L+E+ G+ P+ Q++ + I +R++
Sbjct: 210 WSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 52/237 (21%)
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675
L A+K+L+ D KNA L E IL +++P ++R + L ++ EY+ GD
Sbjct: 48 LVAVKILR-PDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 676 LYSLLRNLGCLDEDV------------------ARVYIA-EVVLALEYLHSLRVVHRDLK 716
L L + D++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
N L+ + IK+ DFG+S+ L A ++ R
Sbjct: 166 TRNCLVGENLTIKIADFGMSR--------------------------NLYAGDYY---RI 196
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV--GIPPFNAEHPQQIFDN 831
+ AV ++A E +L T +D W+ G+ L+E+++ P+ +Q+ +N
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 66/293 (22%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 589 DDFEIIKPISRGAFGRVF--LAKKRTTGDL---FAIKVLKKADMIRKNAVESILAERDIL 643
+ +++ + +G+FG V+ A+ G+ A+K + ++ +R+ L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-------VARVYI- 695
VVR + + +VME + GDL S LR+L E+ + I
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 696 --AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
AE+ + YL++ + VHRDL N ++AHD +K+ DFG+++ I TD
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETD-------- 173
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
RK + ++APE L T++D WS G++L+E+
Sbjct: 174 -------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
Query: 814 -IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ P+ +Q+ +++ + P+ DL+ +P R
Sbjct: 215 TSLAEQPYQGLSNEQVLKFVMDGG--YLDQPDNCPERVTDLMRMCWQFNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 60/299 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
+D + I G FG+V A+ + G + + + K+ E ++L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV-------------- 693
+P ++ + R LYL +EY G+L LR L+ D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 694 --YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ A+V ++YL + +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------------- 172
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIIL 810
QE K++ P ++A E L + + T +D WS G++L
Sbjct: 173 -------------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 811 FELI-VGIPPFNAEHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQR 865
+E++ +G P+ ++++ K+P P E +DL+ + E P++R
Sbjct: 214 WEIVSLGGTPYCGMTCAELYE-----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 267
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 31/174 (17%)
Query: 592 EIIKPISRGAFGRVFLAK---------------KRTTG-DLFAIKVLKK-ADMIRKNAVE 634
++ + G FG V L + L A+KVL+ A NA E
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNARE 64
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-- 692
L E IL + +P + R T L ++MEY+ GDL L+ +A
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 693 --------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+Y+A ++ + YL SL VHRDL N L+ + IK+ DFG+S+
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 66/246 (26%), Positives = 114/246 (46%), Gaps = 58/246 (23%)
Query: 597 ISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVV 652
+ RG +G V+ AK++ D +A+K ++ + S+ A R+I L +++P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVI 61
Query: 653 ---RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---------LDEDVARVYIAEVVL 700
+ F S R+ ++L+ +Y DL+ +++ L + + + +++
Sbjct: 62 SLQKVFLSHADRK-VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L NS
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSP----------LK 167
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 815
L D +P V T Y APE+LLG H T A D W++G I EL+
Sbjct: 168 PLADLDP----------------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 816 GIPPFN 821
P F+
Sbjct: 212 SEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 62/261 (23%), Positives = 116/261 (44%), Gaps = 58/261 (22%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-DMIRKNAVES----ILAERDILISV-RN 648
KP+ G FG+V +A+ +V K A M++ +A E +++E +++ + ++
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----------NLGCLDED-------V 690
++ + T LY+++EY + G+L LR N + E+ V
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ Y +V +EYL S + +HRDL N+L+ D +K+ DFGL++ D+
Sbjct: 144 SCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DI--- 190
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGII 809
H + KK + P ++APE L + +D WS G++
Sbjct: 191 -------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231
Query: 810 LFELI-VGIPPFNAEHPQQIF 829
L+E+ +G P+ +++F
Sbjct: 232 LWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 45/288 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLK-KADMIRKNAVESILAERDI 642
++ K + GAFG+V A K A+K+LK A + A+ S L
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVL 700
L + N +V + T + ++ EY GDL + LR L + + +V
Sbjct: 95 LGNHEN--IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ +L S +HRDL N+L+ H G I K+ DFGL++ ++N S V G L
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR-DIMND----SNYVVKGNARL- 205
Query: 760 DEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGI 817
P ++APE + + +D WS GI+L+E+ +G
Sbjct: 206 ------------------------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 818 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
P+ F ++ + PE E +D++ DP +R
Sbjct: 242 NPYPGMPVDSKFYKLIKEGYRMAQ-PEHAPAEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 63/276 (22%), Positives = 124/276 (44%), Gaps = 45/276 (16%)
Query: 595 KPISRGAFGRVFLA--KKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652
K + G FG V++A K T A+K +K M +VE+ LAE +++ ++++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRV 710
+ ++ +E +Y++ E++ G L L++ + + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDL+ N+L++ K+ DFGL++V E+ + TA E
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARV---------------------IEDNEYTAREG 162
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 829
+ K + APE + +D WS GI+L E++ G P+ ++
Sbjct: 163 AKFPIK---------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
Query: 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
L R PR E E ++++ R P +R
Sbjct: 214 RA-LERGYRMPRP-ENCPEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 66/246 (26%), Positives = 115/246 (46%), Gaps = 58/246 (23%)
Query: 597 ISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVV 652
+ RG +G V+ AK++ D +A+K ++ + S+ A R+I L +++P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVI 61
Query: 653 ---RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---------LDEDVARVYIAEVVL 700
+ F S + R+ ++L+ +Y DL+ +++ L + + + +++
Sbjct: 62 ALQKVFLSHSDRK-VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L NS
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSP----------LK 167
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 815
L D +P V T Y APE+LLG H T A D W++G I EL+
Sbjct: 168 PLADLDP----------------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 816 GIPPFN 821
P F+
Sbjct: 212 SEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 47/231 (20%)
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675
L A+K+L+ AD + K A L E I+ ++NP ++R + L ++ EY+ GD
Sbjct: 46 LVAVKMLR-AD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 676 LYSLL------------RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723
L L N+ + ++ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783
+ IK+ DFG+S+ L + ++ R + AV
Sbjct: 164 NHYTIKIADFGMSR--------------------------NLYSGDYY---RIQGRAVLP 194
Query: 784 PDYLAPE-ILLGTGHGTTADWWSVGIILFELIVGIP--PFNAEHPQQIFDN 831
++A E ILLG T +D W+ G+ L+E+ P++ +Q+ +N
Sbjct: 195 IRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 58/237 (24%), Positives = 87/237 (36%), Gaps = 43/237 (18%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDI 642
I K I G FG V + + G AIK LK L E I
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGSSDKQRLDFLTEASI 58
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE----V 698
+ +P ++R T + ++ EY+ G L LR D + +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGI 115
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
++YL + VHRDL N+L+ + K++DFGLS+ L
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-------------------L 156
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
D E T + K T APE + T+A D WS GI+++E++
Sbjct: 157 EDSEATYTT------KGGKIPIRWT----APEA-IAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 38/226 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ I+ ++ G+ G VF+ K GD KV+ KA K I DIL ++ +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVKAVTGGKTPGREI----DILKTISHRA 147
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL-ALEYLHSLR 709
++ +++ + + +VM DL++ + G L + A + I +L AL YLH
Sbjct: 148 IINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRG 205
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRD+K +N+ + + L DFG + +L A
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAA--------------------------CKLDAHP 239
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
+ GT + +PE+L + D WS G++LFE+ V
Sbjct: 240 DTP---QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
|
Length = 392 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 67/293 (22%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 591 FEIIKPISRGAFGRV---FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
F + + + +G FG V L + + A+K+LK AD+ + +E L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 648 NPFVVRFF-YSFTCRENLYL-----VMEYLNGGDLYS--LLRNLG----CLDEDVARVYI 695
+P V++ S R L ++ ++ GDL++ L+ +G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
++ +EYL S +HRDL N ++ + + + DFGLSK I S
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK--IYS------------ 165
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
GD Q AS+ + +LA E L + T +D W+ G+ ++E++
Sbjct: 166 ---GDYYRQGCASKLPVK------------WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
Query: 816 -GIPPFNAEHPQQIFDNIL--NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G P+ +I++ ++ NR P E++ ++L+ + + +P R
Sbjct: 211 RGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDV----YELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 60/269 (22%), Positives = 115/269 (42%), Gaps = 58/269 (21%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAK-------KRTTGDLFAIKVLKKADMIRKNAVESILAE 639
S D + KP+ G FG+V +A+ K A+K+LK D + + +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 640 RDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE----DVARV- 693
+++ + ++ ++ + T LY+++EY + G+L LR D+ARV
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 694 -----------YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+V +EYL S + +HRDL N+L+ + +K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 185
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA 801
+ + KK + P ++APE L + +
Sbjct: 186 -------------------------DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220
Query: 802 DWWSVGIILFELI-VGIPPFNAEHPQQIF 829
D WS G++++E+ +G P+ +++F
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 61/250 (24%), Positives = 99/250 (39%), Gaps = 69/250 (27%)
Query: 595 KPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---- 646
KP+ G FG+V A+ ++ D +K M++ NA + LA+ LIS
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK---MLKDNATDKDLAD---LISEMELM 71
Query: 647 ----RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR------------------NLG 684
++ ++ T LY+++EY G+L LR
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
+ V+ Y +V +EYL S R +HRDL N+L+ D +K+ DFGL++
Sbjct: 132 SFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR------- 182
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADW 803
H + KK S P ++APE L + +D
Sbjct: 183 -----------------------GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 804 WSVGIILFEL 813
WS GI+++E+
Sbjct: 220 WSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 61/261 (23%), Positives = 104/261 (39%), Gaps = 53/261 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKR-TTGDLFAIKVLKKA--DMIRKNAVESILAERDILIS 645
D +++ + GAFG V+ R GD ++V K + + L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 646 VRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRN----------LGCLDEDVARVY 694
+ +VR SF R ++++E + GGDL S LR L D ++
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD----LLF 120
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGP 750
A +V +YL +HRD+ N L+ G K+ DFG+++ D+
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--------DIYR- 171
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810
AS + RK A+ ++ PE L + D WS G++L
Sbjct: 172 ----------------ASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 811 FELI-VGIPPFNAEHPQQIFD 830
+E+ +G P+ Q++ +
Sbjct: 212 WEIFSLGYMPYPGRTNQEVME 232
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 25/160 (15%)
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
D +V + + +V+ L LH + +VHRD+KP+NLL+ DG +K+ DFG + D
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGA-------AVDM 359
Query: 747 LSGPAVSGTTLLGDEEPQLTASEH----QQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
+G ++ L G +P+ + E Q R A+ L+P L G D
Sbjct: 360 CTG--INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAA--LLSPFAWL-YGRPDLFD 414
Query: 803 WWSVGIILFELIV-------GIPPFNAEHPQQIFDNILNR 835
++ G++L ++ V I FN E Q +DN LNR
Sbjct: 415 SYTAGVLLMQMCVPELRPVANIRLFNTELRQ--YDNDLNR 452
|
Length = 507 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 61/264 (23%), Positives = 112/264 (42%), Gaps = 64/264 (24%)
Query: 595 KPISRGAFGRVFLA------KKRTTGDL-FAIKVLKKADMIRKNAVESILAERDILISV- 646
KP+ G FG+V +A K + + A+K+LK D + +++E +++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-------------------NLGCLD 687
++ ++ + T LY+++EY + G+L LR L D
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
V+ Y +V +EYL S + +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 L-VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---------- 182
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSV 806
H + KK + P ++APE L + +D WS
Sbjct: 183 --------------------DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 807 GIILFELI-VGIPPFNAEHPQQIF 829
G++L+E+ +G P+ +++F
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 46/232 (19%)
Query: 593 IIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I K I G FG V + + G AIK LK ++ L+E I+ +P
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV-------LAL 702
++ T + + +V EY+ G L + LR + + + ++V +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR------KHDGQFTVIQLVGMLRGIASGM 119
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+YL + VHRDL N+L+ + K++DFGLS+V DD P + TT G
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV----LEDD---PEAAYTTRGGKIP 172
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ TA E R+ + +D WS GI+++E++
Sbjct: 173 IRWTAPEAIAYRK---------------------FTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-08
Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 76/297 (25%)
Query: 549 TDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDD-----FEIIKPISRGAFG 603
+ D + +E P P+ ++ + DD F +I + GAFG
Sbjct: 111 GAEDSDASHLDFDEAPPDAA--------GPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFG 162
Query: 604 RVFL-AKKRTTGDLFAIKVLKK------------ADMIRKNAVESILAERDILISVR--N 648
++F+ A + +T + A + + A ++ + +I E +IL R +
Sbjct: 163 KIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV----------ARVYIAEV 698
+++ N Y++ + + DLYS + DE R + ++
Sbjct: 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFM-----YDEAFDWKDRPLLKQTRAIMKQL 276
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ A+EY+H +++HRD+K +N+ + DG I L DFG
Sbjct: 277 LCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG------------------------ 312
Query: 759 GDEEPQLTASEHQQERRKKRSA-VGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
TA ++ER VGT +PEIL G G+ D WS G+IL +++
Sbjct: 313 -------TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 62/300 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISV 646
+D + I G FG+V A + G AIK+LK + +N E ++L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 647 -RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV------------ 693
+P ++ + R LY+ +EY G+L LR L+ D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 694 ----YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ ++V ++YL + +HRDL N+L+ + K+ DFGLS+ G
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----------G 168
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
V +G R R ++A E L + + T +D WS G++
Sbjct: 169 EEVYVKKTMG--------------RLPVR-------WMAIESLNYSVYTTKSDVWSFGVL 207
Query: 810 LFELI-VGIPPFNAEHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQR 865
L+E++ +G P+ ++++ K+P P E ++L+ + + P++R
Sbjct: 208 LWEIVSLGGTPYCGMTCAELYE-----KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYER 262
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 62/252 (24%), Positives = 102/252 (40%), Gaps = 51/252 (20%)
Query: 595 KPISRGAFGRVF--LAK---KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ + +G+FG V+ +AK K AIK + +A +R+ L E ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFNCH 69
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI----------AEVV 699
VVR + + ++ME + GDL S LR+L E+ E+
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ YL++ + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETD-------------- 173
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
RK + +++PE L T +D WS G++L+E+
Sbjct: 174 -------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---- 216
Query: 820 FNAEHPQQIFDN 831
AE P Q N
Sbjct: 217 -LAEQPYQGMSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 52/289 (17%)
Query: 595 KPISRGAFGRVF---LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + G FG V L++ + A+K +K D+ + +E L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 652 VRFF-YSFTCRENLYL-----VMEYLNGGDLYSLL--RNLGCLDEDVAR----VYIAEVV 699
++ F + ++ ++ GDL+S L LG L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L +EYL + +HRDL N ++ D + + DFGLSK I S D
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK--IYSGD-------------- 167
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818
R+ R A ++A E L + + +D W+ G+ ++E+ G
Sbjct: 168 -------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214
Query: 819 PFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQR 865
P+ +I+D + + R+ PE+ E +DL+ DP R
Sbjct: 215 PYPGVENHEIYDYLRHGN----RLKQPEDCLDELYDLMYSCWRADPKDR 259
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 58/290 (20%)
Query: 597 ISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISV-RNPFVVR 653
I G FG+V A+ + G AIK +K + K+ E ++L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV----------------YIAE 697
+ R LYL +EY G+L LR L+ D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V ++YL + +HRDL N+L+ + K+ DFGLS+ G V
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----------GQEVYVKKT 169
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VG 816
+G R R ++A E L + + T +D WS G++L+E++ +G
Sbjct: 170 MG--------------RLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208
Query: 817 IPPFNAEHPQQIFDNI-LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
P+ ++++ + ++ P ++ E +DL+ + E P++R
Sbjct: 209 GTPYCGMTCAELYEKLPQGYRLEKPLNCDD---EVYDLMRQCWREKPYER 255
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 595 KPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K I G FG VF + G AIK LK K + L+E I+ + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQD-FLSEASIMGQFSHHNI 68
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE----VVLALEYLHS 707
+R T + ++ EY+ G L LR+ D + + + + ++YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ VHRDL N+L+ + K++DFGLS+V L D E T
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRV------------------LEDDPEGTYTT 167
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
S + R + APE + + +D WS GI+++E++
Sbjct: 168 SGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 39/186 (20%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+ +V +E+L S VHRDL N+L+A +K+ DFGL++ +++ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVS----K 296
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
G+T L ++APE + + T +D WS GI+L+E+
Sbjct: 297 GSTFL------------------------PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 814 --IVGIPPFNAEHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQRLGS 868
+ G P +P I D+ KI P+ + E +D++ + +P +R
Sbjct: 333 FSLGGTP-----YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF 387
Query: 869 GGASEV 874
S++
Sbjct: 388 LHLSDI 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 56/297 (18%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISVRNPFV 651
+K + G FG V GD I V K D + + I + S+ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VR +L LV + G L +R + LD + ++ + YL R+
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHR+L N+L+ D +++ DFG++ LL ++ + SEH
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVAD-------------------LLYPDDKKYFYSEH 171
Query: 771 QQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 828
+ TP ++A E +L + +D WS G+ ++E++ G P+ P ++
Sbjct: 172 K-----------TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220
Query: 829 FDNILNR--KIPWPR---------------VPEEMSPEAHDLIDRF--LTEDPHQRL 866
D +L + ++ P+ + E + P +L + F + DP + L
Sbjct: 221 PD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 55/255 (21%)
Query: 594 IKPISRGAFGRVF----LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+K + GAFG V+ + + T AIK+L + + N + E I+ S+ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHP 69
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYL 705
+VR + LV + + G L + N+G + + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIG---SQLLLNWCVQIAKGMMYL 125
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
R+VHRDL N+L+ H+K+TDFGL+++ L GDE+
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL------------------LEGDEK--- 164
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV--GIPPFNAE 823
E+ + K ++A E + +D WS G+ ++EL+ G P
Sbjct: 165 ---EYNADGGKM-----PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP----- 211
Query: 824 HPQQIFDNILNRKIP 838
+D I R+IP
Sbjct: 212 -----YDGIPTREIP 221
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 597 ISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653
I G FG V + + G AIK LK ++ L+E I+ +P ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIH 69
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
T + ++ E++ G L S LR N G + + ++YL + VH
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDL N+L+ + K++DFGLS+ DD S P T+ LG + P
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRF----LEDDTSDPTY--TSSLGGKIPI-------- 175
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ APE + + +D WS GI+++E++
Sbjct: 176 ------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 32/159 (20%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKV-----LKKADMIRKNAVESILAERDI----LI 644
+K I RGA ++L GD IK + K + E I ER ++
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELD-ERIRRERTRREARIM 53
Query: 645 S------VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
S V P V EN +VMEY+ G L L+ + G + +++R E+
Sbjct: 54 SRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR----EI 104
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+ LHS ++H DL N+++ G I L DFGL++
Sbjct: 105 GRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-06
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 37/251 (14%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA-VESILAERDILIS 645
S F+I+ + G FG+V A R + A+K+++ ++A +E E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 646 VRNPF----VVRFFYSFTCRENLYLVM-EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ F + R+F + T ++ +VM +Y G L + G I + +
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 701 ALEYLHS-LRVVHRDLKPDNLLI-AHDGHIK-LTDFGLSKVGLINSTDDLSGPAVSGTTL 757
AL+Y H+ L ++H DLKP+N+L+ D + +T+ L DL G
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC------ 296
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
ER + + V T Y +PE++LG G + D WS+G I++EL G
Sbjct: 297 --------------DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
Query: 818 PPF----NAEH 824
+ N EH
Sbjct: 343 LLYDTHDNLEH 353
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 41/178 (23%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 228
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ +K SA ++APE + + T +D WS G++L+E+
Sbjct: 229 -------------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
Query: 814 I-VGIPPF-----NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+G P+ N E Q++ D R PE +PE + ++ DP +R
Sbjct: 270 FSLGASPYPGVQINEEFCQRLKDGTRM------RAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 44/170 (25%)
Query: 670 YLNGGDLYSLLRNLGCLDEDVAR-------VYIA-EVVLALEYLHSLRVVHRDLKPDNLL 721
Y+N G+L L+ + + + V++A ++ + YLH V+H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 781
I + +K+TD LS+ DL P LGD E R K
Sbjct: 150 IDEELQVKITDNALSR--------DLF-P--MDYHCLGDNE----------NRPVK---- 184
Query: 782 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-------VGIPPFNAEH 824
++A E L+ + + +D WS G++L+EL+ V I PF
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 31/173 (17%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 233
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ +K A ++APE + + +D WS G++L+E+
Sbjct: 234 -------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
Query: 814 I-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+G P+ + F L R P+ +PE + + +P QR
Sbjct: 275 FSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 54/251 (21%), Positives = 104/251 (41%), Gaps = 45/251 (17%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652
K + G FG V + + A+K +K A + ++ +E L+E + +P V+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 653 RFF---YSFTCRENL---YLVMEYLNGGDLYSLL--RNLG----CLDEDVARVYIAEVVL 700
R E +++ ++ GDL+S L LG L + ++ ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK----------------------- 160
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819
++ ++ ++ R + V ++A E L + T +D WS G+ ++E+ G P
Sbjct: 161 ---KIYNGDYYRQGRIAKMPV---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
Query: 820 FNAEHPQQIFD 830
+ +I+D
Sbjct: 215 YPGVENSEIYD 225
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 39/175 (22%), Positives = 62/175 (35%), Gaps = 49/175 (28%)
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ L+ L +LR +HR K N+L+ DG +KL G V P S
Sbjct: 22 VCLQCLGALRELHRQAKSGNILLTWDGLLKL--DGS--VAF-------KTPEQSR----- 65
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 820 FNAEHP-QQIFDNILNRKIPWPRVPE--------EMSPEAHDLIDRFLTEDPHQR 865
+N E I + +LN P + D + + P +R
Sbjct: 104 YNEERELSAILEILLNG--MPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRR 156
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 42/146 (28%), Positives = 63/146 (43%), Gaps = 38/146 (26%)
Query: 675 DLYSLL----RNLGCLD-EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729
DLY+ L R LG VAR +++ A++Y+H ++HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 789
L DFG + + S P G GT D AP
Sbjct: 301 LGDFGAACF----ARGSWSTPFHYGIA-------------------------GTVDTNAP 331
Query: 790 EILLGTGHGTTADWWSVGIILFELIV 815
E+L G + + D WS G+++FE V
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFEAAV 357
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 605 VFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTC 660
V+LA+ TG L +++ L+ A++ ++++S R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQ-----NEVVLSHFFRHPNIMTSWTVFTT 70
Query: 661 RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718
L+++ ++ G SLL+ + E + + + L YLH +HR++K
Sbjct: 71 GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS 130
Query: 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 778
++LI+ DG + L+ GLS + + + + PQ + S
Sbjct: 131 HILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY--------DFPQFSTS---------- 170
Query: 779 SAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829
+L+PE+L G+ +D +SVGI EL G PF Q+
Sbjct: 171 ----VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 82/351 (23%), Positives = 131/351 (37%), Gaps = 97/351 (27%)
Query: 592 EIIKPISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
E++ I RG V LA+ + TG+ ++ + + V + E + +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD-----EDVARVYIAEVVL-ALE 703
+V + +F L++V ++ Y ++L C ++A YI + VL AL+
Sbjct: 60 NIVPYRATFIADNELWVVTSFM----AYGSAKDLICTHFMDGMSELAIAYILQGVLKALD 115
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL-SKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y+H + VHR +K ++LI+ DG + L+ GL S + +IN
Sbjct: 116 YIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN-------------------- 153
Query: 763 PQLTASEHQQERR-----KKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIV 815
H Q R K S P +L+PE+L G+ +D +SVGI EL
Sbjct: 154 -------HGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205
Query: 816 GIPPFNAEHPQQIFDNILNRKIPW----PRVPEE-------------------------- 845
G PF Q+ LN +P +P E
Sbjct: 206 GHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRP 265
Query: 846 -------------MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
SP H +++ L +P R AS + H FFK I
Sbjct: 266 SNGESSSHPYNRTFSPHFHHFVEQCLQRNPDAR---PSASTLLNHSFFKQI 313
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 31/161 (19%)
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V +E+L S VHRDL N+LI +K+ DFGL++ ++ ++ +S G+T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYIS----KGST 301
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-V 815
L ++APE + + T +D WS GI+L+E+ +
Sbjct: 302 FL------------------------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 856
G P+ + F N + R + P S E ++++ +
Sbjct: 338 GGTPYPELPMNEQFYNAIKRGYRMAK-PAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 60/259 (23%), Positives = 100/259 (38%), Gaps = 52/259 (20%)
Query: 597 ISRGAFGRVF------LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
I +G FG V+ ++ A+K L + + + VE L E I+ +P
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIH---CAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPN 57
Query: 651 VVRFFYSFTCRENLYLV-MEYLNGGDLYSLLRNLGCLDEDVARV-----YIAEVVLALEY 704
V+ E LV + Y+ GDL + +R+ + V + +V +EY
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEY 113
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S + VHRDL N ++ +K+ DFGL++
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLAR--------------------------D 147
Query: 765 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822
+ E+ P ++A E L T +D WS G++L+EL+ G PP+
Sbjct: 148 IYDKEYYSVHNHT--GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
Query: 823 EHPQQIFDNILN-RKIPWP 840
I +L R++ P
Sbjct: 206 VDSFDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 24/81 (29%)
Query: 666 LVMEYLNGGDL--------YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 717
+VMEY+ G L LLR +G V + LH +VH DL
Sbjct: 74 IVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK------------LHKAGIVHGDLTT 118
Query: 718 DNLLIAHDGHIKLTDFGLSKV 738
N+++ D + L DFGL K
Sbjct: 119 SNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 49/241 (20%)
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIK LK D E E + +++P +V T + L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 678 SLL------RNLGCLDEDVARV----------YIAEVVLALEYLHSLRVVHRDLKPDNLL 721
L ++G D+D + ++ +E+L S VVH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 781
+ ++K++D GL + + + D + G +LL
Sbjct: 157 VFDKLNVKISDLGLFRE--VYAADYYK---LMGNSLLPIR-------------------- 191
Query: 782 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKI-PW 839
+++PE ++ +D WS G++L+E+ G+ P+ Q + + I NR++ P
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247
Query: 840 P 840
P
Sbjct: 248 P 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 33/159 (20%)
Query: 593 IIKPISRGAFGRVFLAK--------KRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
IK + G RV+L K ++ +++ +LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQ------LLARKGLPV 55
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL-ALE 703
P V+ S YL+ME++ G L + + + IAE + L
Sbjct: 56 ----PKVL---ASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLA 100
Query: 704 YLHSLR---VVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
LH L + H DL P N+L+ + + D+ + G
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 48/288 (16%)
Query: 595 KPISRGAFGRVFL--AKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652
I G FG+V L A + + +K L+ + + L E + +P V+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVL 58
Query: 653 RFFYSFTCREN--LYLVMEYLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYL 705
+ C E+ LV+E+ GDL + LR+ +DV + EV L +L
Sbjct: 59 QCLGQ--CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS----KVGLINSTDDLSGPAVSGTTLLGDE 761
H +H DL N + D +K+ D+GL+ + D + P L
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP-------LRWL 169
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPF 820
P+L Q K ++ + WS+G+ ++EL P+
Sbjct: 170 APELVEIRGQDLLPKDQTKKS-------------------NIWSLGVTMWELFTAADQPY 210
Query: 821 NAEHPQQIFDNIL---NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+Q+ ++ + K+P P++ + S ++++ +F DP R
Sbjct: 211 PDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM-QFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 2e-04
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 14/93 (15%)
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
V P + Y E +VMEY+ G DL +L L V +A+ L
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVGE-IVAK-------L 444
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
H +VH DL N ++ D + L DFGL K
Sbjct: 445 HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 17/131 (12%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
ISRG G + K G F +K + + I S +A+ + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIAD---MGKLQHPNIVKLIG 750
Query: 657 SFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH---SLRVV 711
CR YL+ EY+ G +L +LRNL + IA+ AL +LH S VV
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 712 HRDLKPDNLLI 722
+L P+ ++I
Sbjct: 806 VGNLSPEKIII 816
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 62/220 (28%)
Query: 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-------EVVLALEYLHSLRVVHRD 714
EN+ +V E++ G L LR ++ RV +A ++ AL YL +VH +
Sbjct: 90 ENI-MVEEFVEHGPLDVCLR------KEKGRVPVAWKITVAQQLASALSYLEDKNLVHGN 142
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTD---DLSGPAVSGTTLLGDEEPQLTASEHQ 771
+ N+L+A ++GL T LS P VS T L
Sbjct: 143 VCAKNILLA-------------RLGLAEGTSPFIKLSDPGVSFTAL-------------S 176
Query: 772 QERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF- 829
+E R +R ++APE + G T AD WS G L E+ F+ E P +
Sbjct: 177 REERVERIP-----WIAPECVPGGNSLSTAADKWSFGTTLLEIC-----FDGEVPLKERT 226
Query: 830 ----DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ +K R+PE E LI + LT +P QR
Sbjct: 227 PSEKERFYEKKH---RLPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 9/73 (12%)
Query: 666 LVMEYLNGGDLYS-LLRNLGCLDEDVARVY---IAEVVLALEYLHSLRVVHRDLKPDNLL 721
LVME++ G + + L+++ L ED +Y + + +VH DL N+L
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147
Query: 722 IAHDGHIKLTDFG 734
+ DG + + D
Sbjct: 148 V-DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 36/167 (21%), Positives = 59/167 (35%), Gaps = 49/167 (29%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA------------DMIRK--NAVESILAE 639
+ I +GA ++L D + + K + +R+ E+ +
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILA 54
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL--------YSLLRNLGCLDEDVA 691
+ V P +V N +VMEY+ G L LLR +G V
Sbjct: 55 KAREAGVPVP-IVYDVDPD----NGLIVMEYIEGELLKDALEEARPDLLREVG---RLVG 106
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ LH +VH DL N++++ G I DFGL +
Sbjct: 107 K------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 31/173 (17%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 227
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ +K A ++APE + + T +D WS G++L+E+
Sbjct: 228 -------------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
Query: 814 I-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+G P+ + F L R PE +PE + ++ +P R
Sbjct: 269 FSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 18/90 (20%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
R +Y F E L + + + + C ++ + + + +++ LEY+H + H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 42/155 (27%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K I G FG+V L + + +V+ K +R +A S+ + L + P+
Sbjct: 1 KEIGNGWFGKVILGEVNS--GYTPAQVVVKE--LRVSA--SVQEQMKFLEEAQ-PYRSLQ 53
Query: 655 FYSF-----TCRENL--YLVMEYLNGGDLYSLLR------NLGCLDEDVARVYIAEVVLA 701
+ C E LVME+ GDL LR + D + E+ L
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALG 112
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
L +LH +H DL N L+ D +K+ D+GLS
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 41.3 bits (98), Expect = 9e-04
Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER--DILISVRNPFVVR 653
IS G V+ A+ G+ A+K+ K + + K+ + I + S NP +
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNP--RK 60
Query: 654 FFYSFTCRE--NLY-------------------LVMEYL-NGGDLYSLLRNLGCLDEDVA 691
+++ +E NL LVME++ + G L+++ +E+
Sbjct: 61 LVFAWAEKEFRNLKRLYEAGVPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAE 120
Query: 692 RVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
+Y +VV + L +VH DL N+L HDG + D
Sbjct: 121 ELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 59/291 (20%), Positives = 100/291 (34%), Gaps = 65/291 (22%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFA----------IKVLKKADMIRKNAVESILAERDILISV 646
+ +G F ++ R DL +KVL E+ ++ +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETA----SLMSQL 58
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYL 705
+ +V+ + EN+ +V EY+ G L L ++ +A ++ AL YL
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 706 HSLRVVHRDLKPDNLLIAHDGH-------IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
++VH ++ N+L+A G IKL+D G+ T+L
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI------------------PITVL 159
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT--ADWWSVGIILFELIVG 816
EE ++APE + T AD WS G L E+
Sbjct: 160 SREERVERIP-----------------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
Query: 817 IP-PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866
P + + R+P E +LI++ T DP +R
Sbjct: 203 GEEPLSTLSSSE----KERFYQDQHRLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1003 | |||
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.32 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.17 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.08 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.81 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.38 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.98 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.91 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.07 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.01 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.95 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.88 | |
| PLN02236 | 344 | choline kinase | 95.8 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.1 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.33 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.27 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.07 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.05 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.46 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.1 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.04 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.42 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.99 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 90.51 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.16 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.79 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 88.54 |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-70 Score=653.12 Aligned_cols=924 Identities=39% Similarity=0.502 Sum_probs=713.0
Q ss_pred hhhhhhhhhhhhhhhhhccc-----hhhhhhhHHHHhhhccccCchhhHHHHHHHHHHhhhcccCCcceeeeehhhHhhh
Q 001856 19 EILVVIRTKFDKAKEEVNSD-----LAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMTSPGEFWLQCEGIVQEL 93 (1003)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (1003)
+.+|.|+++|...++=+..| +++|++|.|-..|+.-+.-+|-|+.|++||+.+..|..+.+|+||+-|++|+|-|
T Consensus 242 wamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 242 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred HHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 88999999999999999999 9999999999999999999999999999999999999999999999999999999
Q ss_pred hhh---cccCCcchHHHHHHHHHHHHHhhHHHhhhhcccccccccccccccccccccccccCCCCcc---ccCCCcchHh
Q 001856 94 DDR---RQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHMFQFRQSRVLHSADKRIPQGT---LRDGKGSTIA 167 (1003)
Q Consensus 94 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 167 (1003)
|.- ||+++-+.+++.+.+|+||+|||+|.-||.+|.- ...|+...|||-- +.--|+++.. .+=-.-++.+
T Consensus 322 Dw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~-~~ees~~~~~qFs---scs~r~~kv~ss~~~l~~~~t~~ 397 (1205)
T KOG0606|consen 322 DWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDT-GDEESSLEFRQFS---SCSPRFSKVYSSWESLAQLETAT 397 (1205)
T ss_pred ccchhhhhhccccccccccccchhhcccchheeeccccCC-ccccccccccccc---cccccccccccchhhhhcccccc
Confidence 999 9999999999999999999999999999999983 3344545677632 1112222111 1100011222
Q ss_pred hhhhhhcccccc---hhhhhcc--CccccccccCCcccCCCCCCCcccccchhhhhcccccccCCCCcccccccCCCccc
Q 001856 168 KASKAASSRKSY---SQEQHGL--DWKRDHAVKQGNILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKE 242 (1003)
Q Consensus 168 ~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (1003)
.+.+ +.-++| ++--.+. +|++.- +.+..+-.+. +.+.-++. ++++.|+.++++--+.-+...+.+-
T Consensus 398 ~~~~--~~~~~~~~~~~~~~g~k~~~~~~s----p~~~kl~~st-~~ss~s~~--~~~s~~~~~~~~~s~~~~~~~~s~~ 468 (1205)
T KOG0606|consen 398 PREK--SSQSSQGEVSPSSAGQKDSWKSNS----PESSKLELST-ALSSVSPN--HPGSPSKSLTSAASTLRTALRTSSP 468 (1205)
T ss_pred cccc--ccccccccccCCccccccccccCC----hhhhhccccc-hhhhcccc--cCCCccccccchhhhhccccccCCC
Confidence 2222 222222 2211111 355432 2222222222 22222222 7999999999999999999999999
Q ss_pred cCCCccccccccccccCCcccccccCCCCCCchhhhhhccc---cccCcccccccCCCCccCCCCcceeeecccccCCCc
Q 001856 243 QNDGKVEPLKSSNIRRGLSEIDLTAKPSEFPPAAETLEHSS---KHQHKVSWGYWGDQQNISDDSSSIICRICEEEVPTS 319 (1003)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (1003)
++|+++.|+..---+ --.++-..+-|+.+...+-++ .--+.--|+.|++-+-+.-. .+.||||||.++|+.
T Consensus 469 ~~ds~~~~~~~~p~~-----~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~-d~~i~~~~e~~~p~~ 542 (1205)
T KOG0606|consen 469 SEDSKIFPLRAPPPP-----SSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTS-DSGICRICEAEGPRL 542 (1205)
T ss_pred CCCccccccCCCCCc-----cccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccC-Ccccccccccccccc
Confidence 999999998633222 122233333333333221111 11223449999888877665 788999999999999
Q ss_pred ccccccchhhhhccccccCCccchhHHHHHHHHHHHHHHhhhcc-ccccccCCcccccccCCcccccccCCCCccccccc
Q 001856 320 HVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKD-IHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSR 398 (1003)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (1003)
|.|.|++||.++++|+-++++++.|+.+|.+-+++...|..-+- ... -|+|.-.-.|+.+ .-|+..| +-+.|+|
T Consensus 543 ~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~--~~~~l~s~lS~~~--~sS~p~S-rdsspsr 617 (1205)
T KOG0606|consen 543 HSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP--TGGPLCSPLSPRS--LSSNPSS-RDSSPSR 617 (1205)
T ss_pred cccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC--cccccccccCCCC--CCCCccc-Ccccccc
Confidence 99999999999999999999999999999999999988865433 222 2455555555433 3455556 9999999
Q ss_pred cCccccccccccCCCcccccccCCCCCcccccccCCCCCCCCccCCCCCCCCCCCCCCCcchhHHHHHhccCCCCCCCCc
Q 001856 399 RGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDF 478 (1003)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (1003)
++|+.|+++.|.-+..-.-+.+. +-.|+-+.-.|-++ .-..-++.++.++-||+-+|+.+|-|++.-+++-..+--+.
T Consensus 618 d~s~~~~~~~ppI~i~~~~~~yG-ft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v~gl~H 695 (1205)
T KOG0606|consen 618 DSSAAMLSLRPPITIHFSGKKYG-FTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPVHGLVH 695 (1205)
T ss_pred ccchhhcCcCCceeeeccccccC-ceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCcccchhhH
Confidence 99999999999777665555544 66777777778887 55556889999999999999999999999999999999999
Q ss_pred cchhhHHH--Hhhh-cCCCCCCCCCCcchhhhhhccceEEEecCCcccchhHhHH-HHHHHHHHHHHHHhhhhccCCCCc
Q 001856 479 PQMNELAD--IARC-VATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFG-ARIEKLIREKYLQLCELVTDDKVD 554 (1003)
Q Consensus 479 ~~~~~~~~--~~~~-~~~~p~~~~~~~~~~l~~~~~~r~~~d~rk~~sit~e~~~-~ri~~l~R~ky~~Lce~v~~d~l~ 554 (1003)
+||++|+. ++++ +.++|+.. .++-+.-.-..+.+-++.+|+-.++..+.++ .++.+++|..|.+.|++..++...
T Consensus 696 ~ev~~Lll~~gn~v~~~ttplen-TSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~~~s~ 774 (1205)
T KOG0606|consen 696 TEVMELLLKSGNKVTLRTTPLEN-TSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHTSRSF 774 (1205)
T ss_pred HHHHHHHHhcCCeeEEEeecccc-chhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcccccc
Confidence 99999887 7754 45667643 3444444444466667778999999999999 889999999999999988765543
Q ss_pred ccceeecCCCCCchhhhcccCCCCCCCCCCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHH
Q 001856 555 ITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634 (1003)
Q Consensus 555 ~~s~~Iee~~plEee~l~sl~tsp~~Psk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie 634 (1003)
.. ....+..+..+.+...+..|.+.+...+++.+++.+-.|+||.++.+.-..+|...+.|+..+.........+
T Consensus 775 ~s-----s~eS~pgdp~~sls~sP~sp~~yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~ 849 (1205)
T KOG0606|consen 775 LS-----SSESLPGDPTRSLSASPRSPTKYRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYE 849 (1205)
T ss_pred cc-----ccccCCCCcccccccCCCCcccccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccccc
Confidence 11 1122223345566666666766778889999999999999999999999889989999998887777777777
Q ss_pred HHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecc
Q 001856 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714 (1003)
Q Consensus 635 ~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRD 714 (1003)
.+..+..++....+|.++..+..|......+|+|+|+.|++|...+++.++.+++-++.++..+..+++|||...++|||
T Consensus 850 s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~ 929 (1205)
T KOG0606|consen 850 SIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRD 929 (1205)
T ss_pred ccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhccc
Confidence 78888888877888999999888888899999999999999999999999999999999999999999999999999999
Q ss_pred CCCcceeecCCCcEEEeecC-CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc
Q 001856 715 LKPDNLLIAHDGHIKLTDFG-LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (1003)
Q Consensus 715 IKPeNILLd~dG~VKLiDFG-LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~ 793 (1003)
++|.|+|+..+|+.+++||| +.+.+......+.+++.-.++...-........... ..........||+.|.+||.+.
T Consensus 930 ~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 930 LKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSA-DEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred ccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccccccc-chhhccccccCCCcccCCcccc
Confidence 99999999999999999999 666666666666654443333222111111111111 1224456789999999999999
Q ss_pred cCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 794 g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
+..++..+|||++|++++|.++|.+||....++.++++|.+...+||..+...+.++++++.++|..+|.+|.+...+.+
T Consensus 1009 g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1009 GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred cccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998777789
Q ss_pred HHcCCCCCCCChhHHhhhcCCccCCCCCCCCCCCccccccCCCCCCCCCCCCCCCCCcccccCCCCCCCCccchhhhhcc
Q 001856 874 VKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDE 953 (1003)
Q Consensus 874 LLqHPFFk~Idw~~L~~~k~pfiP~~~s~lDts~F~s~~s~~~td~n~~~~s~~~~~~~~~~~sgs~s~~s~~q~e~~~~ 953 (1003)
+..|+||+.++|+.+..++..|+|.+.+..|+++|.+++.|...+++..-.+.+.. -.++..+..|..+ +.-...
T Consensus 1089 ~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~---~~s~~~~~~~~~p--e~~~~~ 1163 (1205)
T KOG0606|consen 1089 VKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSEESQDETVSGSSSGSK---LDSPDESPECTTP--ELKPAM 1163 (1205)
T ss_pred cccCCccCCCCccccccccCccCCCCCCCCccchhhcccccccccccccCCCcccC---ccCccccccccCc--cccCCc
Confidence 99999999999999999999999999999999999999998876655433332211 1111112222221 111223
Q ss_pred cCCCccccCCCccceeeecccccCcccccchhhhcccC
Q 001856 954 CGGLAEFESGSSVNYSFSNFSFKNLSQLASINYDLLSK 991 (1003)
Q Consensus 954 ~~~~~~~~~~~~~~~~f~~F~~~~~~~~~~~~~~~~~~ 991 (1003)
|+ +..|.||+|.+.++++|+||+.+-+
T Consensus 1164 ~~-----------~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1164 CG-----------NLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred Cc-----------cccccccCccChhhccccChHhhcC
Confidence 33 3459999999999999999998866
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-68 Score=599.38 Aligned_cols=378 Identities=45% Similarity=0.759 Sum_probs=303.7
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+..+++|++++.||+|+||.||+|+.+.||..||||+++|+.+...+++++++.|.++|...++|+||+||++|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||||||++||++.++|.+.+.|+++.+++|+++++.||+.||+.|+|||||||+|+|||..||+||+|||||+-......
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999963222111
Q ss_pred CCC------CCCCccCcccCCCC----Cccch--hhh-----hhhhhhccccccCCCCCCCchhhccCCCCccceeechh
Q 001856 745 DDL------SGPAVSGTTLLGDE----EPQLT--ASE-----HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807 (1003)
Q Consensus 745 ddl------s~p~~sgttl~gd~----~p~lt--~~~-----~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLG 807 (1003)
.+. ........ ...+. .+..+ ... .........+.+|||.|||||++.+.+|+..|||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEA-KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccC-CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 110 00011000 00000 00111 111 11223344678999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHhhhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 808 IILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 808 VILYELLTGk~PF~~~~~~ei~qkIl~~~--~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
|||||||.|.+||.+.++.+++++|++.. ..+|. ...++++++|||.+||+ ||.+|+|.++++||++||||++|+|
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 99999999999999999999999999877 44443 24688999999999999 9999999899999999999999999
Q ss_pred hHHhhhcCCccCCCCCCCCCCCccccccCCCCCCCCCCCCCCCCCcccccCCCCCCCCccchhhhhcccCCCccccCCCc
Q 001856 886 DTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSS 965 (1003)
Q Consensus 886 ~~L~~~k~pfiP~~~s~lDts~F~s~~s~~~td~n~~~~s~~~~~~~~~~~sgs~s~~s~~q~e~~~~~~~~~~~~~~~~ 965 (1003)
+.+....+||+|.+.+.+|++||+.. ++++.... ....+..+..+.........-.+..+
T Consensus 454 ~~l~~~~apfvP~v~~~~DT~yFddF-----~e~~~~~~---------------~~~~~~~~~k~~~~~~~~~~~~~~~F 513 (550)
T KOG0605|consen 454 DHLREMPAPFVPQVNSELDTQYFDDF-----PEEDSMTP---------------TADKSGPSRKMLSMVDTNNSSKDINF 513 (550)
T ss_pred chhhcCCCCCCCCCCCcccccccccC-----cccccCcc---------------cccccccchhhhhcccccCCcccccc
Confidence 99999999999999999999999731 11111000 00111111111111111122344568
Q ss_pred cceeeecccccCcccccchh
Q 001856 966 VNYSFSNFSFKNLSQLASIN 985 (1003)
Q Consensus 966 ~~~~f~~F~~~~~~~~~~~~ 985 (1003)
+||+|++|++.+..+...++
T Consensus 514 vgfTyk~~~~~~~~~~~~~~ 533 (550)
T KOG0605|consen 514 VGFTYKNFDGLNKANSLLIN 533 (550)
T ss_pred cceeeecccccccccccccc
Confidence 99999999999888776544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-64 Score=555.03 Aligned_cols=301 Identities=49% Similarity=0.894 Sum_probs=278.9
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
....++|+++++||+|+||+||+++.+.|++.||||+++|..+...+..+++.+|+.||..++||+||++++.|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34578999999999999999999999999999999999999999888999999999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|||+||+.||+|+.+|++.+.++|..+++|+++|+.||.|||++|||||||||+||||+.+|||+|+|||||+....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--- 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--- 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999995211
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
....+.++|||+.|||||++.+.+|+.++||||||+++||||+|.+||.+.+
T Consensus 178 ----------------------------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 178 ----------------------------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred ----------------------------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 1123457999999999999999999999999999999999999999999999
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 901 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s 901 (1003)
...++++|...+.. ..+..++.++++||+++|++||.+|+|. +++.+|.+||||++++|+.+... .|||.|....
T Consensus 230 ~~~~~~~I~~~k~~--~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 230 VKKMYDKILKGKLP--LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred HHHHHHHHhcCcCC--CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence 99999999988743 3456699999999999999999999974 68999999999999999999876 4899999999
Q ss_pred CCCCCCccccccCCCCC
Q 001856 902 ALDTSYFTSRYSWNTTD 918 (1003)
Q Consensus 902 ~lDts~F~s~~s~~~td 918 (1003)
..++++|+.+++..+.+
T Consensus 308 ~~~~~~Fd~eft~~~~~ 324 (357)
T KOG0598|consen 308 LEDTSNFDNEFTSYTVD 324 (357)
T ss_pred ccccccccHHHHhcccc
Confidence 99999999987665544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-61 Score=517.20 Aligned_cols=288 Identities=41% Similarity=0.841 Sum_probs=271.5
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
..+++|++++.||.|+||+|.+++++.+|.+||+|++.+..+.+..++++..+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|||||++||.|+.++++.+++++..+++|++||+.||+|||+++|++|||||+|||||.+|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999841
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
...+.+.||||.|+|||++..++|+.++|||||||++|||+.|.+||...++
T Consensus 195 ----------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 195 ----------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 1235678999999999999999999999999999999999999999999999
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccC-CCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVP-TSE 900 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP-~~~ 900 (1003)
..+|++|+.+++.|| ..++++++|||+++|+.|-.+|.|. ++..+|+.||||++++|..+..+ ++|++| ...
T Consensus 247 ~~iY~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~ 323 (355)
T KOG0616|consen 247 IQIYEKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIH 323 (355)
T ss_pred HHHHHHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCcccc
Confidence 999999999998765 6799999999999999999999986 58899999999999999999876 478887 666
Q ss_pred CCCCCCCccc
Q 001856 901 SALDTSYFTS 910 (1003)
Q Consensus 901 s~lDts~F~s 910 (1003)
...|+++|+.
T Consensus 324 ~~gdtsnfd~ 333 (355)
T KOG0616|consen 324 GPGDTSNFDD 333 (355)
T ss_pred CCcccccccc
Confidence 6788888865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-60 Score=548.31 Aligned_cols=295 Identities=40% Similarity=0.801 Sum_probs=272.8
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE 662 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~ 662 (1003)
....+++|+++++||+|+||+|++|..+.++++||||+++|..+...+.++..+.|..|+...+ ||+++.||.+|++++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3677899999999999999999999999999999999999999999999999999999998875 999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
++|+||||+.||++..+ ...+.+++..+++|+++|+.||+|||++||||||||.+|||||.+||+||+|||+++.++..
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999999994443 44478999999999999999999999999999999999999999999999999999953211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
...+.++||||.|||||++.+..|+.++|||||||+|||||.|.+||.+
T Consensus 522 -------------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 522 -------------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred -------------------------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1245689999999999999999999999999999999999999999999
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCC
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPT 898 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~ 898 (1003)
.+.++++..|++..+.+ |..+|.++.++++++|+++|++|+|+ .++++|++||||++|+|+.+..+ +|||+|.
T Consensus 571 ddEee~FdsI~~d~~~y---P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 571 DDEEEVFDSIVNDEVRY---PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred CCHHHHHHHHhcCCCCC---CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcc
Confidence 99999999999987654 57899999999999999999999997 57999999999999999999876 5999999
Q ss_pred CCCCCCCCCcccccc
Q 001856 899 SESALDTSYFTSRYS 913 (1003)
Q Consensus 899 ~~s~lDts~F~s~~s 913 (1003)
..+..|.++|+..|+
T Consensus 648 i~~~~D~snFd~eFt 662 (694)
T KOG0694|consen 648 IKGPEDVSNFDEEFT 662 (694)
T ss_pred cCChhhhcccchhhh
Confidence 999999999988664
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-57 Score=501.19 Aligned_cols=317 Identities=38% Similarity=0.684 Sum_probs=270.3
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
...++.|++++.||.|.-|+||+|+.+.++..+||||+.|..+..++...++..|.+||..++||+++.||..|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 45567899999999999999999999999999999999999998888899999999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
|++||||+||+|..+++++ +.++++.+++|+++++.||+|||-+|||+|||||+||||.++|||.|+||.|+......
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999876 57999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCC--------CCCccC--------cccCCCCC---------ccchhhhhhhhhhccccccCCCCCCCchhhccCCC
Q 001856 743 STDDLS--------GPAVSG--------TTLLGDEE---------PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797 (1003)
Q Consensus 743 s~ddls--------~p~~sg--------ttl~gd~~---------p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y 797 (1003)
.+-..+ .+...+ ........ ..++.....-...+.++++||-+|+|||++.|.++
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 110000 000000 00000000 00000001112345678999999999999999999
Q ss_pred CccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHc
Q 001856 798 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQ 876 (1003)
Q Consensus 798 s~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLq 876 (1003)
+.++|||+||+++||||.|..||.+.+..+++.+|+.....||..+ .++..++|||+++|.+||.+|+|+ .+|.||++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999999999999998765 789999999999999999999987 58999999
Q ss_pred CCCCCCCChhHHhhhcCCccCCCCCC
Q 001856 877 HVFFKDINWDTLARQKAAFVPTSESA 902 (1003)
Q Consensus 877 HPFFk~Idw~~L~~~k~pfiP~~~s~ 902 (1003)
||||++++|..+....||++|.....
T Consensus 392 HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 392 HPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred CccccCCChhheeccCCCcCCCcccc
Confidence 99999999998778899999987543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-57 Score=511.19 Aligned_cols=286 Identities=37% Similarity=0.729 Sum_probs=258.2
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccce
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~ 663 (1003)
.....||.+.+.||.|+|++|++|+.+.+++.|||||+.|..+.+++.+..+..|..+|..| .||.|++||..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45678999999999999999999999999999999999999999898899999999999999 89999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|+|+||+++|+|.++|++.|.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||.|+......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999632111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.. ..++.. .........+++||..|.+||+|.....++.+|||+||||||+|+.|.+||.+.
T Consensus 229 ~~-~~~~~~-----------------~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 229 KS-QENPVD-----------------PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred cc-ccCccC-----------------cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 10 000000 000111246799999999999999999999999999999999999999999999
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCC
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAA 894 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~p 894 (1003)
+.--++++|+...+.|| +++++.++|||+++|..||.+|+ |+++|++||||.+|+|+.+..+.||
T Consensus 291 NeyliFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 291 NEYLIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred cHHHHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCChhhhhhcCCC
Confidence 99999999999998765 68999999999999999999999 8999999999999999999888654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-57 Score=503.95 Aligned_cols=360 Identities=34% Similarity=0.593 Sum_probs=306.3
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
..+.|+..++||+||||.||.|+.+.||+.||+|.+.|.++..+......++|..||..++.++||.+-++|++++.+||
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34669999999999999999999999999999999999888888888899999999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||..|+||+|..+|.+.+ .+++..+++|+++|+.||++||+.+||+|||||+|||+|+.|||+|+|+|||....
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~---- 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP---- 338 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC----
Confidence 999999999999998876 79999999999999999999999999999999999999999999999999997311
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.....+..+||.+|||||++.+..|++..|||||||+||||+.|+.||....
T Consensus 339 ----------------------------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 339 ----------------------------EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred ----------------------------CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 0122345699999999999999999999999999999999999999997543
Q ss_pred ----hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCcc
Q 001856 825 ----PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFV 896 (1003)
Q Consensus 825 ----~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfi 896 (1003)
.+++-++++.... .+++.+|+++++|++.+|++||.+|+|+ ++++++.+||||+++||..+... .|||+
T Consensus 391 eKvk~eEvdrr~~~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfi 467 (591)
T KOG0986|consen 391 EKVKREEVDRRTLEDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFI 467 (591)
T ss_pred hhhhHHHHHHHHhcchh---hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCC
Confidence 3455556655544 3457899999999999999999999998 68999999999999999999886 59999
Q ss_pred CCCCC-----CCCCCCccc--cccCCCCCCCCCCCCCCCCCcccccCCCCCCCCc-cchhhhhc-ccCC-CccccCCCcc
Q 001856 897 PTSES-----ALDTSYFTS--RYSWNTTDENIYPASDFEDSSDADSLSGSSSCLS-NRQEEVGD-ECGG-LAEFESGSSV 966 (1003)
Q Consensus 897 P~~~s-----~lDts~F~s--~~s~~~td~n~~~~s~~~~~~~~~~~sgs~s~~s-~~q~e~~~-~~~~-~~~~~~~~~~ 966 (1003)
|++.. .+|..+|++ .+.++++|+++|..+ +++|+| +||+||++ +|+. ++.|.+.++.
T Consensus 468 Pdp~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F-------------~tg~vsipWQnE~~ET~~f~elnv~~~~~~~ 534 (591)
T KOG0986|consen 468 PDPGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNF-------------ATGSVSIPWQNEMIETECFEELNVFGDDGAK 534 (591)
T ss_pred CCccccchhhhhhhhhcccccceecccccHHHHHhc-------------cCCcccchHHHHHHHhhhHHHhhcccccccc
Confidence 98754 588999986 567888998888888 455667 89999998 6888 8899888755
Q ss_pred ceeeecccccCcccccchhhhcccCCCCC
Q 001856 967 NYSFSNFSFKNLSQLASINYDLLSKGWKD 995 (1003)
Q Consensus 967 ~~~f~~F~~~~~~~~~~~~~~~~~~~~~~ 995 (1003)
+=.-. .-|.|..-...-.-+|++.+.+.
T Consensus 535 ~~d~~-~~~p~~~~~~~~~~~l~~~~~~~ 562 (591)
T KOG0986|consen 535 NPDLR-YLFPNRLEKRGEGPRLFTMKNIS 562 (591)
T ss_pred Ccchh-cccCCccccCCCCcccccccccc
Confidence 43322 33444444444444455554443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-57 Score=537.01 Aligned_cols=294 Identities=41% Similarity=0.758 Sum_probs=269.0
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+...+||+++++||+|+||.|.+++++.|++.||||++.|-.+..+.....|..|.++|...+.++|++++++|++..++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 44568999999999999999999999999999999999998888777788999999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|||||||+||+|..++.+.+.+++..++||+++|+.||.-||+.|+|||||||+|||||..|||||+|||.|.....
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~--- 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA--- 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHHHHHHhCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
...-.....+|||.|++||++.. ..|+..||||||||++||||.|..|
T Consensus 228 ---------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 228 ---------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred ---------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 00123456899999999999963 4589999999999999999999999
Q ss_pred CCCCChhhHHHhhhhc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccC
Q 001856 820 FNAEHPQQIFDNILNR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 897 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~--~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP 897 (1003)
|+..+..++|.+|++. ...||.. ..+|+++++||.++|+ +|..|+|.++++++..||||.+++|+.++...|||+|
T Consensus 281 FYadslveTY~KIm~hk~~l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 281 FYADSLVETYGKIMNHKESLSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred chHHHHHHHHHHHhchhhhcCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 9999999999999987 4556632 4599999999999999 7999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccc
Q 001856 898 TSESALDTSYFTS 910 (1003)
Q Consensus 898 ~~~s~lDts~F~s 910 (1003)
...++.||++|+.
T Consensus 359 evssd~DTsnFd~ 371 (1317)
T KOG0612|consen 359 EVSSDDDTSNFDV 371 (1317)
T ss_pred cCCCCCccccccc
Confidence 9999999999943
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=482.24 Aligned_cols=303 Identities=40% Similarity=0.773 Sum_probs=282.0
Q ss_pred CCCCCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001856 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659 (1003)
Q Consensus 580 ~Psk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~ 659 (1003)
.+.+....+++|..+++||+|.||+|.+|+.+.+++.||||+++|.-+..++.+.+.+.|-++|+..+||++..|.+.|+
T Consensus 159 ~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 159 AKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred ccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34456678899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccc
Q 001856 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 660 d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~ 739 (1003)
..+++|+||||.+||.|+.++.+...+++..+++|-++|+.||.|||+++||+||||.+|+|+|.+|||||+|||+++..
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
.. -.....++||||.|+|||++....|+.++|||.+||+||||++|+.|
T Consensus 319 I~-------------------------------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLP 367 (516)
T KOG0690|consen 319 IK-------------------------------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLP 367 (516)
T ss_pred cc-------------------------------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCc
Confidence 21 12345689999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhhc--CCc
Q 001856 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAF 895 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~k--~pf 895 (1003)
|+..+...+++-|+.....|| ..++++++.|+..+|.+||.+|+|. ..|.||.+|+||..++|....+++ |||
T Consensus 368 Fyn~dh~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 368 FYNKDHEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred ccccchhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 999999999999999887665 6899999999999999999999997 479999999999999999988764 899
Q ss_pred cCCCCCCCCCCCccccccCCC
Q 001856 896 VPTSESALDTSYFTSRYSWNT 916 (1003)
Q Consensus 896 iP~~~s~lDts~F~s~~s~~~ 916 (1003)
.|...+..|++||+..|+..+
T Consensus 445 KPqVtSetDTryFD~EFT~q~ 465 (516)
T KOG0690|consen 445 KPQVTSETDTRYFDEEFTSQP 465 (516)
T ss_pred CCCcccccchhhhhhhhhcce
Confidence 999999999999998776443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-54 Score=476.35 Aligned_cols=263 Identities=35% Similarity=0.603 Sum_probs=234.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH----HHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK----NAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~----~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+...... .....+.+|++||++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3558899999999999999999999999999999988655432 233456799999999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC---CcEEEeecCCccccc
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGL 740 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d---G~VKLiDFGLAk~~~ 740 (1003)
.||||||+.||+|++.+-.++.+.+..-+.|++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|++..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999876 689999999999510
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC---CccceeechhHHHHHHHhCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y---s~kSDIWSLGVILYELLTGk 817 (1003)
.....++.||||.|.|||++.+.++ ..++|||||||+||-+|+|.
T Consensus 331 --------------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 331 --------------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred --------------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 1123568999999999999998764 45789999999999999999
Q ss_pred CCCCCCChhh-HHHhhhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 818 PPFNAEHPQQ-IFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 818 ~PF~~~~~~e-i~qkIl~~~~~~P-~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
+||....... +.++|..+.+.+- ..+..+|+++.+||.+||..||+.|| +++|+|+||||+..+-
T Consensus 379 pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 379 PPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALNHPWFKDAPC 445 (475)
T ss_pred CCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhcChhhhcccc
Confidence 9999877666 8899999888764 45678999999999999999999999 9999999999997753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=489.00 Aligned_cols=256 Identities=34% Similarity=0.639 Sum_probs=243.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|+..+.||+|||++||.+++..+|..||+|++.+..+......+.+.+|++|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999998888889999999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|+|..++|..++++.+.++|.+++.|++||+.||.|||+++|||||||..|+||+.+.+|||+|||||....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-------- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-------- 169 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
....+..+.||||.|+|||++...+|+..+||||+||+||.||+|+|||...+..++
T Consensus 170 -----------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket 226 (592)
T KOG0575|consen 170 -----------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET 226 (592)
T ss_pred -----------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH
Confidence 112456789999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
+.+|....+.+| ..+|.+++|||.+||++||.+|| ++++||.|+||+
T Consensus 227 y~~Ik~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 227 YNKIKLNEYSMP---SHLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFK 273 (592)
T ss_pred HHHHHhcCcccc---cccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhh
Confidence 999999988765 58999999999999999999999 999999999994
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=482.64 Aligned_cols=318 Identities=45% Similarity=0.769 Sum_probs=270.7
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
.-|..++.||-|+||+|.+++..+|...||+|.+.|.+...++++.++..|.+||..-++++||+||+.|++++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 44999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC-
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL- 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl- 747 (1003)
+|++||++..+|-+.+.|+|+.+++|++++.+|+++.|+.|+|||||||+|||||.+|||||+|||||+ ++. .+++.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT-GfR-WTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT-GFR-WTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc-cce-eccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999997 222 12111
Q ss_pred ---CCCCccCccc-----CCCCCccchhhhh----hhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 748 ---SGPAVSGTTL-----LGDEEPQLTASEH----QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 748 ---s~p~~sgttl-----~gd~~p~lt~~~~----~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
.+.+.....+ .++...-+...+. ...+-...+.+||+.|+|||++...+|+..|||||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1111111111 1111111111111 111223346799999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKA 893 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~l--p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~ 893 (1003)
|++||-...+.++..++.+... +..+ ..++|.++.+||.++++ ++..|+|..++++|+.||||++|||..++.+.+
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~-~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~A 944 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRN-FLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRA 944 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhh-ccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhccC
Confidence 9999999988888878776542 2222 35799999999999887 789999999999999999999999999999999
Q ss_pred CccCCCCCCCCCCCccc
Q 001856 894 AFVPTSESALDTSYFTS 910 (1003)
Q Consensus 894 pfiP~~~s~lDts~F~s 910 (1003)
+|+|...-..|+++|+.
T Consensus 945 pYIP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 945 PYIPRITHPTDTSNFDP 961 (1034)
T ss_pred CcCccccCCCccccCCc
Confidence 99999999999999976
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-53 Score=464.52 Aligned_cols=302 Identities=37% Similarity=0.778 Sum_probs=276.0
Q ss_pred CCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR 661 (1003)
Q Consensus 583 k~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~ 661 (1003)
.......+|.++.+||+|+||+|.+|..+.+.+.||||+++|..+.+.+.++-.+.|.++|... +-|++++++.+|++-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 4456678999999999999999999999999999999999999999988889999999999876 468999999999999
Q ss_pred ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
+.+|+||||+.||+|..+|+..+.+.|..+.+|+++|+-||-|||++|||+||||.+|||++.+|||||+|||+++....
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999984211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
....++++||||.|+|||++..++|+.++||||+||+|||||.|++||.
T Consensus 503 -------------------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 503 -------------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred -------------------------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 1234578999999999999999999999999999999999999999999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhh--cCCccC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVP 897 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~--SAeELLqHPFFk~Idw~~L~~~--k~pfiP 897 (1003)
+.+.+++++.|+.....+| ..+|.++.++++.+|.+.|.+|+|++ +-.+|..||||+.|+|+.+.+. .|||.|
T Consensus 552 GeDE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 552 GEDEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred CCCHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 9999999999999887654 68999999999999999999999984 5679999999999999999876 589999
Q ss_pred CCCCCCCCCCccccccCCCCC
Q 001856 898 TSESALDTSYFTSRYSWNTTD 918 (1003)
Q Consensus 898 ~~~s~lDts~F~s~~s~~~td 918 (1003)
...---+.++|+..|+-..++
T Consensus 629 k~k~~r~~eNFD~~Ft~~~~~ 649 (683)
T KOG0696|consen 629 KIKCGRDAENFDKFFTREPTD 649 (683)
T ss_pred ccccCCchhhhhHHHhcCCCC
Confidence 998888888998766544433
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=443.71 Aligned_cols=318 Identities=42% Similarity=0.766 Sum_probs=256.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||+++++.|.+..++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555566678889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998742111000000
Q ss_pred CC----------CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCC
Q 001856 749 GP----------AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 749 ~p----------~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
.. ........... ..............+.+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKR---KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccc---cccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00 00000000000 000000000112235689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccC
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 897 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP 897 (1003)
||.+.+..+.+..++.....++. ....+++++++||.+||. +|.+|++..++.++++||||++++|+.+....++++|
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~ 316 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIP 316 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 99998888888887765433221 123579999999999997 9999995556999999999999999998888888898
Q ss_pred CCCCCCCCCCccc
Q 001856 898 TSESALDTSYFTS 910 (1003)
Q Consensus 898 ~~~s~lDts~F~s 910 (1003)
...+..|.++|..
T Consensus 317 ~~~~~~~~~~~~~ 329 (364)
T cd05599 317 ELKSITDTSNFDD 329 (364)
T ss_pred CCCCchhhhhccc
Confidence 8888777777753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=451.29 Aligned_cols=259 Identities=32% Similarity=0.611 Sum_probs=235.4
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce-
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN- 663 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~- 663 (1003)
+...++.+.++.||+|+.|+||+|+|+.|++.||+|++... .+....+++.+|+++++.++|||||++|++|.....
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 35567899999999999999999999999999999999432 345566889999999999999999999999999995
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
++|+||||+||+|.+++.+.++++|..+..++.+++.||.|||. ++||||||||+|||++..|.|||||||.++...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999999999999999999999999999995 999999999999999999999999999988410
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
+....+++||..|||||.+.+..|+.++||||||++++||.+|+.||..
T Consensus 231 -------------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 231 -------------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred -------------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 1134679999999999999999999999999999999999999999977
Q ss_pred C-----ChhhHHHhhhhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 823 E-----HPQQIFDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 823 ~-----~~~ei~qkIl~~~~~~P~lp~~-iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
. +..+++..|+.+.. |.+|.. +|+++++||..||++||.+|+ ++.|+++|||++..
T Consensus 280 ~~~~~~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 280 PNPPYLDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERP---SAKQLLQHPFIKKF 341 (364)
T ss_pred cCCCCCCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCC---CHHHHhcCHHHhhc
Confidence 4 67788888888654 567776 999999999999999999999 99999999999854
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=444.50 Aligned_cols=319 Identities=41% Similarity=0.736 Sum_probs=249.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.++..++||||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566678889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998742110000000
Q ss_pred ----CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 749 ----GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 749 ----~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
................................+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 0000000000000000000000000112245689999999999999999999999999999999999999999999
Q ss_pred hhhHHHhhhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCCCC
Q 001856 825 PQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESA 902 (1003)
Q Consensus 825 ~~ei~qkIl~~~--~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~s~ 902 (1003)
..+.+.++.... ..+|. ...+++++++||.+|+. +|.+|++..+++||++||||++++|+.+....++..+...+.
T Consensus 241 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 318 (363)
T cd05628 241 PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSI 318 (363)
T ss_pred HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCCc
Confidence 888888887643 22332 12478999999999886 677776555999999999999999999876654443444444
Q ss_pred CCCCCcc
Q 001856 903 LDTSYFT 909 (1003)
Q Consensus 903 lDts~F~ 909 (1003)
.+++.|+
T Consensus 319 ~~~~~~~ 325 (363)
T cd05628 319 DDTSNFD 325 (363)
T ss_pred chhhccC
Confidence 4555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=447.65 Aligned_cols=320 Identities=43% Similarity=0.790 Sum_probs=255.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.++..++||||++++++|.+..++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555566778899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC--
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD-- 746 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd-- 746 (1003)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999996311100000
Q ss_pred --CCCCCccCcccCCC-----CCccchhhh-------hhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHH
Q 001856 747 --LSGPAVSGTTLLGD-----EEPQLTASE-------HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 747 --ls~p~~sgttl~gd-----~~p~lt~~~-------~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYE 812 (1003)
............+. ......... ...........+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 00000000000000 000000000 0000011224689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhh
Q 001856 813 LIVGIPPFNAEHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR 890 (1003)
Q Consensus 813 LLTGk~PF~~~~~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~ 890 (1003)
|++|.+||.+.+..+.+..+..... .+|. ...++.++++||.+||+ +|.+|++..++.++++||||++++|+.+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 9999999999888888888775332 2222 12578999999999998 888988777999999999999999999988
Q ss_pred hcCCccCCCCCCCCCCCccc
Q 001856 891 QKAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 891 ~k~pfiP~~~s~lDts~F~s 910 (1003)
..++++|......+..+|..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~ 338 (377)
T cd05629 319 IRAPFIPQLKSITDTSYFPT 338 (377)
T ss_pred CCCCcccCCCCccccccCCc
Confidence 88899998888777776644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=445.90 Aligned_cols=320 Identities=43% Similarity=0.726 Sum_probs=253.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|+++++||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 59999999999999999999999999999999987665556677889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999986311000000000
Q ss_pred CC------ccCcc---------cCCCCCccchh-hhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHH
Q 001856 750 PA------VSGTT---------LLGDEEPQLTA-SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 750 p~------~sgtt---------l~gd~~p~lt~-~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYEL 813 (1003)
.. ..... ..++....... ...........+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00 00000 00000000000 0000011122456899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhhHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh-hh
Q 001856 814 IVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA-RQ 891 (1003)
Q Consensus 814 LTGk~PF~~~~~~ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~-~~ 891 (1003)
++|++||.+.+..+....+.......+. ....+++++.+||.+|+ .+|.+|++..+++++++||||++++|.... ..
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~ 320 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQ 320 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHHHHhcC
Confidence 9999999998887777777654332221 12468999999999986 599999966679999999999999998754 44
Q ss_pred cCCccCCCCCCCCCCCccc
Q 001856 892 KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 892 k~pfiP~~~s~lDts~F~s 910 (1003)
.+++.|......|+++|+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~ 339 (382)
T cd05625 321 SAPYIPKITHPTDTSNFDP 339 (382)
T ss_pred CCCccCcCCCcchhhhcCC
Confidence 6789999888888888854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=437.56 Aligned_cols=284 Identities=42% Similarity=0.790 Sum_probs=249.6
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
+.||+|+||.||+|+++.+|+.||||++++...........+.+|+.++..++||||+++++.|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765555556677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 001856 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (1003)
Q Consensus 675 SL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sg 754 (1003)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------------ 148 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------------ 148 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------------
Confidence 99999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhh
Q 001856 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834 (1003)
Q Consensus 755 ttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~ 834 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||...+...++..+..
T Consensus 149 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05571 149 -------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (323)
T ss_pred -------------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 0112346899999999999999999999999999999999999999999888888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 835 ~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
.... ++..+++++.+||.+||++||.+||+. .++.++++||||.+++|..+... .+++.|......++.+|+.
T Consensus 210 ~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (323)
T cd05571 210 EEIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDE 286 (323)
T ss_pred CCCC---CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 6554 456789999999999999999999964 37999999999999999988764 3677787777777777765
Q ss_pred cc
Q 001856 911 RY 912 (1003)
Q Consensus 911 ~~ 912 (1003)
.+
T Consensus 287 ~~ 288 (323)
T cd05571 287 EF 288 (323)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-50 Score=432.40 Aligned_cols=283 Identities=41% Similarity=0.825 Sum_probs=249.5
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555556667888999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 001856 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (1003)
Q Consensus 677 ~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgtt 756 (1003)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------------- 146 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-------------- 146 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--------------
Confidence 999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcC
Q 001856 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836 (1003)
Q Consensus 757 l~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~ 836 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.++.+....
T Consensus 147 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 147 -----------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209 (312)
T ss_pred -----------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 011234679999999999999999999999999999999999999999988888888888765
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCcccccc
Q 001856 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSRYS 913 (1003)
Q Consensus 837 ~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s~~s 913 (1003)
.. ++..+++++.+||.+||+.||.+||+..++.++++||||...+|..+... .+++.|...+..++++|+..++
T Consensus 210 ~~---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (312)
T cd05585 210 LR---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFT 285 (312)
T ss_pred CC---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCcccc
Confidence 54 45678999999999999999999998778999999999999999877554 4677777777777777765443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=436.43 Aligned_cols=288 Identities=40% Similarity=0.801 Sum_probs=251.9
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
...+++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++..++||||+++++.+.+.+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 44578999999999999999999999999999999999876555555667889999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~---- 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---- 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 170 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 170 ------------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ------------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 01123579999999999999999999999999999999999999999988
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhhc--CCccCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSE 900 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~k--~pfiP~~~ 900 (1003)
..++++.+......+ +..++..+++||.+||+.||.+|+++ .+++++++||||++.+|+.+.... +++.+...
T Consensus 220 ~~~~~~~i~~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~ 296 (329)
T PTZ00263 220 PFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVK 296 (329)
T ss_pred HHHHHHHHhcCCcCC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCC
Confidence 888888888776543 45689999999999999999999964 468999999999999999887543 34444444
Q ss_pred CCCCCCCcc
Q 001856 901 SALDTSYFT 909 (1003)
Q Consensus 901 s~lDts~F~ 909 (1003)
...++.+|.
T Consensus 297 ~~~~~~~~~ 305 (329)
T PTZ00263 297 SPGDTSNFE 305 (329)
T ss_pred Ccccchhcc
Confidence 444555553
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=431.31 Aligned_cols=285 Identities=41% Similarity=0.811 Sum_probs=252.4
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987310
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++
T Consensus 153 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~ 206 (291)
T cd05612 153 --------------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206 (291)
T ss_pred --------------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011235799999999999999999999999999999999999999999998888
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALD 904 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lD 904 (1003)
++.+......+ +..+++.+++||++||+.||.+|++. .+++++++||||+.++|..+... .+++.|......+
T Consensus 207 ~~~i~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 283 (291)
T cd05612 207 YEKILAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGD 283 (291)
T ss_pred HHHHHhCCcCC---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccc
Confidence 99888776544 45679999999999999999999954 36999999999999999987654 4677777777777
Q ss_pred CCCccc
Q 001856 905 TSYFTS 910 (1003)
Q Consensus 905 ts~F~s 910 (1003)
+.+|++
T Consensus 284 ~~~~~~ 289 (291)
T cd05612 284 TSNFDD 289 (291)
T ss_pred cccccC
Confidence 776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=440.01 Aligned_cols=317 Identities=43% Similarity=0.726 Sum_probs=248.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.++..++||||+++++.+.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 59999999999999999999999999999999987766666677889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC-C
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL-S 748 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl-s 748 (1003)
||+||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+++.......... .
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999863110000000 0
Q ss_pred -CCCc-----cCccc--------CCCCCccchhh-hhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHH
Q 001856 749 -GPAV-----SGTTL--------LGDEEPQLTAS-EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 749 -~p~~-----sgttl--------~gd~~p~lt~~-~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYEL 813 (1003)
+... ....+ .+.....+... ..........+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0000 00000 00000000000 000001112457899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhhHHHhhhhcC--CCCCCCCCCCCHHHHHHHHhhccCC--cCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 001856 814 IVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTED--PHQRLGSGGASEVKQHVFFKDINWDTLA 889 (1003)
Q Consensus 814 LTGk~PF~~~~~~ei~qkIl~~~--~~~P~lp~~iS~elkDLIrrcL~kD--P~kRpg~~SAeELLqHPFFk~Idw~~L~ 889 (1003)
++|.+||...+..+....+.... ..+|. ...+++++.+||.+||..+ |..|+ ++.++++||||++++|....
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~---~~~~~l~hp~f~~~~~~~~~ 317 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRN---GADDIKAHPFFSEVDFSSDI 317 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCC---CHHHHhcCcccCCCChhHHh
Confidence 99999999888777766665432 22221 2358999999999976554 44488 99999999999999998754
Q ss_pred h-hcCCccCCCCCCCCCCCccc
Q 001856 890 R-QKAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 890 ~-~k~pfiP~~~s~lDts~F~s 910 (1003)
. ..+|++|......++++|+.
T Consensus 318 ~~~~~~~~p~~~~~~~~~~~~~ 339 (381)
T cd05626 318 RTQPAPYVPKISHPMDTSNFDP 339 (381)
T ss_pred hcCCCCccCcCCCcchhhhcCC
Confidence 4 45788888877778777754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=436.58 Aligned_cols=321 Identities=43% Similarity=0.726 Sum_probs=252.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|..++||||+++++.|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544555678889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC-
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL- 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl- 747 (1003)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999852110000000
Q ss_pred CC------CCccCcccCCC----CCccchh-hhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhC
Q 001856 748 SG------PAVSGTTLLGD----EEPQLTA-SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 748 s~------p~~sgttl~gd----~~p~lt~-~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTG 816 (1003)
.. ........... ....+.. .............+||+.|||||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 00000000000 0000000 0000011122356899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHhhhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh-hhcCC
Q 001856 817 IPPFNAEHPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA-RQKAA 894 (1003)
Q Consensus 817 k~PF~~~~~~ei~qkIl~~~~~~P-~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~-~~k~p 894 (1003)
++||.+.+..+....+......+. .....+++++.+||.+|+ .+|.+|++..++.++++||||++++|..+. ...++
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~~ 319 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCCC
Confidence 999999888777776665432221 112468999999999987 599999987789999999999999999885 44678
Q ss_pred ccCCCCCCCCCCCccc
Q 001856 895 FVPTSESALDTSYFTS 910 (1003)
Q Consensus 895 fiP~~~s~lDts~F~s 910 (1003)
++|......++++|..
T Consensus 320 ~~~~~~~~~~~~~~~~ 335 (376)
T cd05598 320 YIPKITHPTDTSNFDP 335 (376)
T ss_pred CCCcCCCcchhhhcCC
Confidence 8888877777777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=436.67 Aligned_cols=319 Identities=42% Similarity=0.758 Sum_probs=251.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.++..++||||+++++.|.+.+++||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555566778889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998742111000000
Q ss_pred ----CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 749 ----GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 749 ----~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........+.......................+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0000000000000000000000001112235689999999999999999999999999999999999999999999
Q ss_pred hhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCCCC
Q 001856 825 PQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESA 902 (1003)
Q Consensus 825 ~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~s~ 902 (1003)
....+..++.... .+|. ...+++++++||.+|+. ||.+|++..++.++++||||++++|..+....++..+...+.
T Consensus 241 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 318 (360)
T cd05627 241 PQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSI 318 (360)
T ss_pred HHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCCc
Confidence 8888888876432 2222 12478999999999875 999999877899999999999999999977654444444555
Q ss_pred CCCCCcc
Q 001856 903 LDTSYFT 909 (1003)
Q Consensus 903 lDts~F~ 909 (1003)
.|.++|+
T Consensus 319 ~~~~~~~ 325 (360)
T cd05627 319 DDTSNFD 325 (360)
T ss_pred chhhhcC
Confidence 6666664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=430.04 Aligned_cols=315 Identities=48% Similarity=0.848 Sum_probs=254.9
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.++..++||||+++++.+.+.+++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555556678899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR-EY 159 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc-cc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998742111100 00
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
............. ...................||+.|+|||++.+..++.++|||||||++|||++|+.||...+....
T Consensus 160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 160 YLNDSHNLLFRDN-VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccc-ccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0000000000000 000000000111223456899999999999999999999999999999999999999999888888
Q ss_pred HHhhhh--cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC-HHHHHcCCCCCCCChhHHhhhcCCccCCCCCCCCC
Q 001856 829 FDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG-ASEVKQHVFFKDINWDTLARQKAAFVPTSESALDT 905 (1003)
Q Consensus 829 ~qkIl~--~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~S-AeELLqHPFFk~Idw~~L~~~k~pfiP~~~s~lDt 905 (1003)
+.++.. ....+|.. ..+++++.+||.+||. ||.+|+ + ++++++||||++++|+......++++|......++
T Consensus 239 ~~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~---~s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (350)
T cd05573 239 YNKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRL---GSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDT 313 (350)
T ss_pred HHHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcC---CCHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhh
Confidence 888876 33333332 2379999999999998 999999 6 99999999999999999887788899888777776
Q ss_pred CCccc
Q 001856 906 SYFTS 910 (1003)
Q Consensus 906 s~F~s 910 (1003)
..|+.
T Consensus 314 ~~~~~ 318 (350)
T cd05573 314 SNFDD 318 (350)
T ss_pred hhcCC
Confidence 66644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=430.18 Aligned_cols=285 Identities=39% Similarity=0.780 Sum_probs=249.6
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998765555556678889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 001856 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (1003)
Q Consensus 675 SL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sg 754 (1003)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------------ 148 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------------ 148 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhh
Q 001856 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834 (1003)
Q Consensus 755 ttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~ 834 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..
T Consensus 149 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~ 209 (328)
T cd05593 149 -------------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (328)
T ss_pred -------------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc
Confidence 0112346799999999999999999999999999999999999999998888888877776
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 835 ~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
.... ++..+++++.+||.+||++||.+|++. .++.++++||||.+++|..+... .+++.|...+..++.+|..
T Consensus 210 ~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (328)
T cd05593 210 EDIK---FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDE 286 (328)
T ss_pred CCcc---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCc
Confidence 5544 456789999999999999999999864 38999999999999999987655 4677888777777777776
Q ss_pred ccc
Q 001856 911 RYS 913 (1003)
Q Consensus 911 ~~s 913 (1003)
.++
T Consensus 287 ~~~ 289 (328)
T cd05593 287 EFT 289 (328)
T ss_pred ccc
Confidence 554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=427.17 Aligned_cols=287 Identities=36% Similarity=0.772 Sum_probs=247.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC-cEEEEEeeeeccceEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HP-nIVkL~~~f~d~~~lyLVm 668 (1003)
+|++++.||+|+||.||+|++..+++.||||++.+.........+.+..|..++..++|+ +|++++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876554555667788999999998765 6889999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------ 154 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998631000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 155 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~ 209 (324)
T cd05587 155 -------------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209 (324)
T ss_pred -------------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112346799999999999999999999999999999999999999999998888
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALD 904 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lD 904 (1003)
+..+...... ++..+++++.+||.+||.+||.+|++. ....++++||||+.++|..+... .+++.|......+
T Consensus 210 ~~~i~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (324)
T cd05587 210 FQSIMEHNVS---YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRS 286 (324)
T ss_pred HHHHHcCCCC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcch
Confidence 8888876554 346789999999999999999999965 24589999999999999988654 3566666655555
Q ss_pred CCCccc
Q 001856 905 TSYFTS 910 (1003)
Q Consensus 905 ts~F~s 910 (1003)
.++|+.
T Consensus 287 ~~~~~~ 292 (324)
T cd05587 287 AENFDK 292 (324)
T ss_pred hhhcCc
Confidence 555543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=435.08 Aligned_cols=289 Identities=39% Similarity=0.788 Sum_probs=254.2
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCCC-CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~tg-k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
....+++|++++.||+|+||.||+|++..++ ..||+|++.+.........+.+.+|+.++..++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4556789999999999999999999976654 689999998765555556678889999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~-- 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
......+||+.|||||++.+..++.++|||||||++|||++|.+||.+
T Consensus 183 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 183 --------------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred --------------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 011245799999999999999999999999999999999999999999
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCC
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPT 898 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~ 898 (1003)
.+...+++.+......+ +..+++.+.+||++||+.||.+|++. .+++++++||||.+++|..+... .+|++|.
T Consensus 231 ~~~~~~~~~i~~~~~~~---p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~ 307 (340)
T PTZ00426 231 NEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307 (340)
T ss_pred CCHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 98888888888766543 46789999999999999999999754 38999999999999999987755 4688888
Q ss_pred CCCCCCCCCcc
Q 001856 899 SESALDTSYFT 909 (1003)
Q Consensus 899 ~~s~lDts~F~ 909 (1003)
.....+.++|.
T Consensus 308 ~~~~~~~~~~~ 318 (340)
T PTZ00426 308 YKNVFDSSNFE 318 (340)
T ss_pred CCCCcchhhcC
Confidence 77766665553
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=425.41 Aligned_cols=284 Identities=36% Similarity=0.768 Sum_probs=245.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+|++++.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+ +|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544455556677888888776 5899999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~------ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------ 154 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+
T Consensus 155 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 209 (323)
T cd05616 155 -------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209 (323)
T ss_pred -------------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH
Confidence 0112346899999999999999999999999999999999999999999999899
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALD 904 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lD 904 (1003)
++.+......+ |..++.++.+||.+||++||.+|++. ....++++||||+.++|..+... .+|+.|.... .|
T Consensus 210 ~~~i~~~~~~~---p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 285 (323)
T cd05616 210 FQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RD 285 (323)
T ss_pred HHHHHhCCCCC---CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-ch
Confidence 98888766544 46789999999999999999999975 35799999999999999998765 3677765432 44
Q ss_pred CCCc
Q 001856 905 TSYF 908 (1003)
Q Consensus 905 ts~F 908 (1003)
..+|
T Consensus 286 ~~~~ 289 (323)
T cd05616 286 AENF 289 (323)
T ss_pred hhhc
Confidence 4444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=426.49 Aligned_cols=285 Identities=44% Similarity=0.813 Sum_probs=251.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||.||+|++..+++.||||++++...........+.+|+.++..++||||+++++.+...+++||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765544556678889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987310
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+.
T Consensus 153 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 153 --------------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred --------------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 012346799999999999999999999999999999999999999999888888
Q ss_pred HHhhhhcCC--CCCCCC---CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCCCCC
Q 001856 829 FDNILNRKI--PWPRVP---EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESAL 903 (1003)
Q Consensus 829 ~qkIl~~~~--~~P~lp---~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~s~l 903 (1003)
+..+..... ..|... ..++.++.+||.+||..+|.+|+ ++.++++||||++++|..+....++++|......
T Consensus 207 ~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (333)
T cd05600 207 WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDWNELRELKPPFVPELESEI 283 (333)
T ss_pred HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcc
Confidence 777765332 112111 25689999999999999999999 9999999999999999999877889999887777
Q ss_pred CCCCccc
Q 001856 904 DTSYFTS 910 (1003)
Q Consensus 904 Dts~F~s 910 (1003)
+..+|..
T Consensus 284 ~~~~~~~ 290 (333)
T cd05600 284 DTGYFDD 290 (333)
T ss_pred hhhhccC
Confidence 6666643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=427.23 Aligned_cols=282 Identities=40% Similarity=0.795 Sum_probs=245.7
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876544455567778898888876 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~----------- 149 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN----------- 149 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++++.+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 150 --------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred --------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 011234679999999999999999999999999999999999999999999989998888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYF 908 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~---~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F 908 (1003)
..... .+..++.++.+||++||++||.+|+++ ++.+++++||||++++|..+... .++|.|...+..+.++|
T Consensus 210 ~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (320)
T cd05590 210 NDEVV---YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNF 286 (320)
T ss_pred cCCCC---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhc
Confidence 76654 345689999999999999999999954 23499999999999999988654 47888888777777777
Q ss_pred cc
Q 001856 909 TS 910 (1003)
Q Consensus 909 ~s 910 (1003)
+.
T Consensus 287 ~~ 288 (320)
T cd05590 287 DP 288 (320)
T ss_pred Cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=424.07 Aligned_cols=282 Identities=39% Similarity=0.781 Sum_probs=244.1
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||.||+|++..+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876555555667788899998865 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~----------- 149 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN----------- 149 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.++.+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~ 209 (321)
T cd05591 150 --------------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209 (321)
T ss_pred --------------------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999999999999988
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC----CHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCC
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG----GASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSY 907 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~----SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~ 907 (1003)
.....+ +..++.++.+||.+||++||.+|+++. +++++++||||..++|..+... .+++.|......+..+
T Consensus 210 ~~~~~~---p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (321)
T cd05591 210 HDDVLY---PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNN 286 (321)
T ss_pred cCCCCC---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhh
Confidence 766543 456899999999999999999999762 7999999999999999988654 3567776655555555
Q ss_pred ccc
Q 001856 908 FTS 910 (1003)
Q Consensus 908 F~s 910 (1003)
|++
T Consensus 287 ~~~ 289 (321)
T cd05591 287 FDQ 289 (321)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=457.90 Aligned_cols=292 Identities=36% Similarity=0.726 Sum_probs=273.0
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
..+.+++++..||-||||.|=+++.......+|+|+++|..+....+.+++..|.+||..+++|+||+||-.|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 45678999999999999999999987666679999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|+||-|-||+|+..++..+.|++..+++|++.++.|++|||++|||+|||||+|.|++.+|.+||.|||+|+..
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki------ 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI------ 570 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999841
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
....++.++||||.|.|||++.+++++.++|+||||+++||||+|.+||.+.++
T Consensus 571 --------------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 571 --------------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred --------------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 123567889999999999999999999999999999999999999999999999
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 901 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s 901 (1003)
..+|..|+++-- .-.+|..++..+.+||++++..+|.+|+|+ +++.+|.+|-||.+.||+.+..+ .||++|...+
T Consensus 625 mktYn~ILkGid-~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 625 MKTYNLILKGID-KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred HHHHHHHHhhhh-hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 999999998643 335678899999999999999999999995 89999999999999999999876 5899999999
Q ss_pred CCCCCCccc
Q 001856 902 ALDTSYFTS 910 (1003)
Q Consensus 902 ~lDts~F~s 910 (1003)
+.|++||+.
T Consensus 704 ptD~s~Fd~ 712 (732)
T KOG0614|consen 704 PTDVSNFDN 712 (732)
T ss_pred cccchhccC
Confidence 999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=435.94 Aligned_cols=261 Identities=33% Similarity=0.626 Sum_probs=238.6
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
..+.+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ..+..+.+..|+.+|+.++|||||.+++++.+.+++|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 356789999999999999999999999999999999988765 4556688899999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC------CcEEEeecCCcccc
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD------GHIKLTDFGLSKVG 739 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d------G~VKLiDFGLAk~~ 739 (1003)
||||||+||+|.++|++.+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999874 35899999999952
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
. ......+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++|
T Consensus 166 ~--------------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 166 Q--------------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred C--------------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence 1 11234578999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
|...+..+++..+..+....|.++..++....+|+..+|+.+|.+|. +..+-+.|+|...
T Consensus 214 f~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 214 FDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLAA 273 (429)
T ss_pred ccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccC---chHHhhhhhhccc
Confidence 99999999999988887777777888999999999999999999999 8888888988764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=414.66 Aligned_cols=278 Identities=34% Similarity=0.598 Sum_probs=235.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.++..++|+||+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987654444445677899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999999888643 3689999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......+||+.|||||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 155 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 208 (285)
T cd05631 155 --------------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208 (285)
T ss_pred --------------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence 001123579999999999999999999999999999999999999998765433
Q ss_pred HHHhhhhcC-CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCC
Q 001856 828 IFDNILNRK-IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTS 899 (1003)
Q Consensus 828 i~qkIl~~~-~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~ 899 (1003)
....+.... .....++..+++++.+||++||+.||.+||+. .+++++++||||++++|+.+... ++||+|.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 209 KREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred hHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 222222111 11123456789999999999999999999964 36999999999999999999876 68998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=440.87 Aligned_cols=260 Identities=39% Similarity=0.707 Sum_probs=234.7
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH--HHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK--NAVESILAERDILISVR-NPFVVRFFYSFTCRE 662 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~--~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~ 662 (1003)
...+.|++.+.||+|+||+|++|++..++..||+|++.+...... ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 445789999999999999999999999999999998877533211 34566778999999999 999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-CcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-G~VKLiDFGLAk~~~~ 741 (1003)
++|+|||||.||+|++++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998410
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC-C-CccceeechhHHHHHHHhCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-H-GTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-y-s~kSDIWSLGVILYELLTGk~P 819 (1003)
.......+.||||.|+|||++.+.. | +.++||||+||+||.|++|..|
T Consensus 173 ------------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 173 ------------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred ------------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 0112345789999999999999988 8 5899999999999999999999
Q ss_pred CCCCChhhHHHhhhhcCCCCCCCCCCC-CHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 820 FNAEHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~~~~P~lp~~i-S~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
|...+...++..|..+.+.+| ..+ |+++++||++||..||.+|+ ++.+|+.||||+.
T Consensus 223 F~d~~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 223 FDDSNVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPWFQK 280 (370)
T ss_pred CCCccHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChhhcc
Confidence 999999999999998887665 456 99999999999999999999 9999999999985
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=420.37 Aligned_cols=286 Identities=42% Similarity=0.781 Sum_probs=246.2
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHH---HhcCCCcEEEEEeeeeccceEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL---ISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL---~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
|++++.||+|+||.||+|++..+++.||||++++.........+.+.+|+.++ ..++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544455566777777765 456799999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||++||+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~----- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF----- 154 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence 999999999988865 57999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 155 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~ 208 (324)
T cd05589 155 --------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208 (324)
T ss_pred --------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 011235689999999999999999999999999999999999999999998888
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESAL 903 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~l 903 (1003)
.+..+...... ++..+++.+.+||.+||++||.+||+. .++.++++||||++++|..+... .++++|......
T Consensus 209 ~~~~i~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (324)
T cd05589 209 VFDSIVNDEVR---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPE 285 (324)
T ss_pred HHHHHHhCCCC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcc
Confidence 88888776544 446789999999999999999999975 37999999999999999887544 467788776666
Q ss_pred CCCCcccc
Q 001856 904 DTSYFTSR 911 (1003)
Q Consensus 904 Dts~F~s~ 911 (1003)
|.++|...
T Consensus 286 d~~~~~~~ 293 (324)
T cd05589 286 DVSNFDEE 293 (324)
T ss_pred hhhhcCcc
Confidence 66666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=420.29 Aligned_cols=283 Identities=41% Similarity=0.810 Sum_probs=242.2
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~-IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444444456666665 45779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------- 149 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------- 149 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+++..+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 150 --------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred --------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 011234579999999999999999999999999999999999999999998888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
..... ++..+++.+.+||.+||++||.+||+. ....++++||||..++|..+... .+++.|......+..+|+.
T Consensus 210 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (323)
T cd05575 210 NKPLR---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDP 286 (323)
T ss_pred cCCCC---CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCc
Confidence 76543 345689999999999999999999964 35589999999999999988754 3677777766666666654
Q ss_pred c
Q 001856 911 R 911 (1003)
Q Consensus 911 ~ 911 (1003)
.
T Consensus 287 ~ 287 (323)
T cd05575 287 E 287 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=428.52 Aligned_cols=298 Identities=35% Similarity=0.726 Sum_probs=267.5
Q ss_pred CCCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeec
Q 001856 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTC 660 (1003)
Q Consensus 582 sk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d 660 (1003)
+.+...+.+|+++++||+|+|++|.+++++.|.+.||+|+++|.-....+.+.-+..|..+... .+||++|-++.+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 4567788999999999999999999999999999999999999877777778888888888766 479999999999999
Q ss_pred cceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
...+++|.||++||+|..++++...++++.+++|..+|+.||.|||++|||+||||.+|||++..||+||+|+|+++.+.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998532
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
. ....+.++||||.|+|||++++..|++.+|||+|||+|+||+.|+.||
T Consensus 403 ~-------------------------------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 403 G-------------------------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred C-------------------------------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 1 112356799999999999999999999999999999999999999999
Q ss_pred CC--------CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHh
Q 001856 821 NA--------EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLA 889 (1003)
Q Consensus 821 ~~--------~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~---~SAeELLqHPFFk~Idw~~L~ 889 (1003)
.- ...+.+++-|+...+. +|..+|-.+..+++..|.+||.+|+|+ -+..++..|+||+.++|+.+.
T Consensus 452 divgm~n~d~ntedylfqvilekqir---iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 452 DIVGMDNPDMNTEDYLFQVILEKQIR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred ceecCCCcccchhHHHHHHHhhhccc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 51 2344567778777764 456789999999999999999999997 378999999999999999998
Q ss_pred hh--cCCccCCCCCCCCCCCcccccc
Q 001856 890 RQ--KAAFVPTSESALDTSYFTSRYS 913 (1003)
Q Consensus 890 ~~--k~pfiP~~~s~lDts~F~s~~s 913 (1003)
++ .|||.|...+..+..+|+..|+
T Consensus 529 qk~v~ppf~p~i~~d~~l~~fd~qft 554 (593)
T KOG0695|consen 529 QKQVLPPFQPQITDDYGLDNFDTQFT 554 (593)
T ss_pred hcccCCCCCCccccccCccccccccc
Confidence 76 4899999999888888887664
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=423.97 Aligned_cols=282 Identities=41% Similarity=0.795 Sum_probs=241.3
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L---~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
||+|+||+||+|+++.+++.||+|++.+..............|..++..+ +||||++++..|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876554445555667777777665 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------- 149 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------- 149 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 832 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkI 832 (1003)
.......+||+.|||||++.+. .++.++|||||||++|+|++|+.||.+.+..+++..+
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 150 --------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred --------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 0112346899999999999764 4899999999999999999999999999888888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCcc
Q 001856 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 909 (1003)
Q Consensus 833 l~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~ 909 (1003)
......++. ..+++++.+||++||++||.+||+. .++.++++||||++++|+.+... .+++.|......+.++|.
T Consensus 210 ~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (330)
T cd05586 210 AFGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFD 287 (330)
T ss_pred HcCCCCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcC
Confidence 776655442 3578999999999999999999965 47999999999999999987654 357777776666666665
Q ss_pred cc
Q 001856 910 SR 911 (1003)
Q Consensus 910 s~ 911 (1003)
..
T Consensus 288 ~~ 289 (330)
T cd05586 288 PE 289 (330)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=418.69 Aligned_cols=282 Identities=40% Similarity=0.798 Sum_probs=242.1
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+++.||+|++++.........+.+..|..++.. .+||||+++++.+.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999987654444455566677777765 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~----------- 149 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----------- 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 209 (316)
T cd05592 150 --------------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209 (316)
T ss_pred --------------------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999998888888876
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCcccc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 911 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s~ 911 (1003)
.... .++..++.++.+||.+||..||.+|++ .+.++++||||+.++|..+... .+++.|......+.++|+..
T Consensus 210 ~~~~---~~~~~~~~~~~~ll~~~l~~~P~~R~~--~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd05592 210 NDRP---HFPRWISKEAKDCLSKLFERDPTKRLG--VDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDRE 284 (316)
T ss_pred cCCC---CCCCCCCHHHHHHHHHHccCCHHHcCC--ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 6543 445678999999999999999999993 2468999999999999988654 36778877777777777654
Q ss_pred c
Q 001856 912 Y 912 (1003)
Q Consensus 912 ~ 912 (1003)
+
T Consensus 285 ~ 285 (316)
T cd05592 285 F 285 (316)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=421.43 Aligned_cols=283 Identities=41% Similarity=0.788 Sum_probs=248.2
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++.|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765545556677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 001856 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (1003)
Q Consensus 675 SL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sg 754 (1003)
+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------------ 148 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------------ 148 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhh
Q 001856 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 834 (1003)
Q Consensus 755 ttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~ 834 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....+..+..
T Consensus 149 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05595 149 -------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209 (323)
T ss_pred -------------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 0012246799999999999999999999999999999999999999999888888888776
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhhc--CCccCCCCCCCCCCCccc
Q 001856 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 835 ~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~k--~pfiP~~~s~lDts~F~s 910 (1003)
.... ++..+++++.+||.+||++||.+|++. .++.++++||||.+++|..+.... +++.|......++.+|+.
T Consensus 210 ~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (323)
T cd05595 210 EEIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 286 (323)
T ss_pred CCCC---CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCc
Confidence 6554 346789999999999999999999964 489999999999999999887653 677887777777777765
Q ss_pred c
Q 001856 911 R 911 (1003)
Q Consensus 911 ~ 911 (1003)
.
T Consensus 287 ~ 287 (323)
T cd05595 287 E 287 (323)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=418.53 Aligned_cols=283 Identities=37% Similarity=0.733 Sum_probs=239.5
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+++.||+|++++...........+.+|..++..+ +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788999999887 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------- 149 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP----------- 149 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC-------Chh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-------HPQ 826 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~-------~~~ 826 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ...
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~ 209 (327)
T cd05617 150 --------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209 (327)
T ss_pred --------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH
Confidence 01123468999999999999999999999999999999999999999532 223
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 901 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~---~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s 901 (1003)
.+++.+..... .+|..++..+.++|.+||.+||.+|++. .+.+++++||||+.++|+.+... .++|.|....
T Consensus 210 ~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 286 (327)
T cd05617 210 YLFQVILEKPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITD 286 (327)
T ss_pred HHHHHHHhCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCC
Confidence 34455544433 3456789999999999999999999964 35789999999999999988755 3577787766
Q ss_pred CCCCCCcccc
Q 001856 902 ALDTSYFTSR 911 (1003)
Q Consensus 902 ~lDts~F~s~ 911 (1003)
..+.++|.+.
T Consensus 287 ~~~~~~~~~~ 296 (327)
T cd05617 287 DYGLENFDTQ 296 (327)
T ss_pred CcchhhcCCc
Confidence 6666666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=417.90 Aligned_cols=276 Identities=37% Similarity=0.781 Sum_probs=241.7
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444555677888999998875 578889999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~------ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD------ 154 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...+
T Consensus 155 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~ 209 (323)
T cd05615 155 -------------------------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209 (323)
T ss_pred -------------------------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112346799999999999999999999999999999999999999999998888
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTS 899 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~ 899 (1003)
++.+...... ++..++.++.+||.+||+++|.+|++. ...+++++||||..++|..+... .+++.|..
T Consensus 210 ~~~i~~~~~~---~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05615 210 FQSIMEHNVS---YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKV 281 (323)
T ss_pred HHHHHhCCCC---CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCcc
Confidence 8888876654 346789999999999999999999975 25789999999999999988765 36777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=418.04 Aligned_cols=281 Identities=39% Similarity=0.810 Sum_probs=244.6
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+++.||||++++...........+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555667778899999887 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----------- 149 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG----------- 149 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-----------
Confidence 999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+.
T Consensus 150 --------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~ 209 (318)
T cd05570 150 --------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209 (318)
T ss_pred --------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 011234579999999999999999999999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH-----HHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCC
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA-----SEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTS 906 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SA-----eELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts 906 (1003)
..... ++..++.++.+||++||++||.+|| ++ .++++||||+.++|...... .+++.|......+.+
T Consensus 210 ~~~~~---~~~~~~~~~~~li~~~l~~dP~~R~---s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (318)
T cd05570 210 EDEVR---YPRWLSKEAKSILKSFLTKNPEKRL---GCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVS 283 (318)
T ss_pred cCCCC---CCCcCCHHHHHHHHHHccCCHHHcC---CCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhh
Confidence 76543 3467899999999999999999999 66 99999999999999877654 467777777767766
Q ss_pred Cccccc
Q 001856 907 YFTSRY 912 (1003)
Q Consensus 907 ~F~s~~ 912 (1003)
+|+..+
T Consensus 284 ~~~~~~ 289 (318)
T cd05570 284 NFDDEF 289 (318)
T ss_pred hcCchh
Confidence 665533
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=419.26 Aligned_cols=282 Identities=36% Similarity=0.730 Sum_probs=237.3
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||.||+|++..+++.||+|++++...........+.+|..++..+ +||||++++++|.+...+|||||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788999999888 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----------- 149 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----------- 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC---------C
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE---------H 824 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~---------~ 824 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05588 150 --------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209 (329)
T ss_pred --------------------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc
Confidence 01123468999999999999999999999999999999999999999632 1
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhh--cCCccCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTS 899 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~---~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~ 899 (1003)
....++.+..... .+|..++.++.+||++||++||.+|+++ .+++++++||||.+++|..+... .+++.|..
T Consensus 210 ~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T cd05588 210 EDYLFQVILEKQI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNI 286 (329)
T ss_pred hHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccC
Confidence 2234455555443 3456789999999999999999999964 25899999999999999988654 35666666
Q ss_pred CCCCCCCCccc
Q 001856 900 ESALDTSYFTS 910 (1003)
Q Consensus 900 ~s~lDts~F~s 910 (1003)
....+..+|..
T Consensus 287 ~~~~~~~~~~~ 297 (329)
T cd05588 287 ESDRDLDNFDP 297 (329)
T ss_pred CCcchhhhcCC
Confidence 55555555544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=417.35 Aligned_cols=279 Identities=38% Similarity=0.765 Sum_probs=239.1
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||.||+|+++.+|+.||+|++++..............|..++.. ++||||+++++.|.+.+++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999987544333445667778888875 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999873100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
+ .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++++.+.
T Consensus 149 -----~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~ 209 (316)
T cd05620 149 -----G--------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209 (316)
T ss_pred -----C--------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0 011234679999999999999999999999999999999999999999988888888776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH-HHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA-SEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SA-eELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
.... .++..++.++++||.+||+.||.+|+ ++ +++++||||+.++|..+... .+++.|......+.++|..
T Consensus 210 ~~~~---~~~~~~~~~~~~li~~~l~~dP~~R~---~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (316)
T cd05620 210 VDTP---HYPRWITKESKDILEKLFERDPTRRL---GVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283 (316)
T ss_pred hCCC---CCCCCCCHHHHHHHHHHccCCHHHcC---CChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 5543 44567899999999999999999999 65 68999999999999987654 3677777766666666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=417.79 Aligned_cols=281 Identities=39% Similarity=0.769 Sum_probs=242.6
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+++.||||++++..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987543333445666778888876 5899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----------- 149 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----------- 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998731000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++++.+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~ 209 (316)
T cd05619 150 --------------------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209 (316)
T ss_pred --------------------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999988888888776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH-HHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAe-ELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
.... .++..++.++++||.+||++||.+|+ ++. ++++||||+.++|..+... .+++.|...+..+.++|+.
T Consensus 210 ~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (316)
T cd05619 210 MDNP---CYPRWLTREAKDILVKLFVREPERRL---GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283 (316)
T ss_pred hCCC---CCCccCCHHHHHHHHHHhccCHhhcC---CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcCh
Confidence 5543 34567899999999999999999999 675 9999999999999988654 5788888888888888765
Q ss_pred cc
Q 001856 911 RY 912 (1003)
Q Consensus 911 ~~ 912 (1003)
.+
T Consensus 284 ~~ 285 (316)
T cd05619 284 EF 285 (316)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=416.76 Aligned_cols=283 Identities=38% Similarity=0.761 Sum_probs=242.3
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~I-L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.++||||+++++.+...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987644444444566666654 6779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----------- 149 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----------- 149 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|||||++.+..++.++|||||||++|+|++|.+||...+..++++.++
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 150 --------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred --------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999998888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
..... ++...+..+.++|++||+++|.+||+. .++.++++||||+.++|..+... .+++.|......+.++|+.
T Consensus 210 ~~~~~---~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (325)
T cd05604 210 HKPLV---LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDA 286 (325)
T ss_pred cCCcc---CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCC
Confidence 76543 335689999999999999999999975 46789999999999999988765 3577777766666766655
Q ss_pred c
Q 001856 911 R 911 (1003)
Q Consensus 911 ~ 911 (1003)
.
T Consensus 287 ~ 287 (325)
T cd05604 287 V 287 (325)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=413.72 Aligned_cols=281 Identities=41% Similarity=0.806 Sum_probs=238.3
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~-IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++.|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999998765444444455666655 57889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----------- 149 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----------- 149 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998731000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++..+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 150 --------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred --------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 011234679999999999999999999999999999999999999999998888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCcc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 909 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~ 909 (1003)
..... ++...+..+.++|.+||++||.+|++. .++.++++|+||..++|..+... .+++.|......+...|+
T Consensus 210 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (321)
T cd05603 210 HKPLQ---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFD 285 (321)
T ss_pred cCCCC---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcC
Confidence 76543 446789999999999999999999965 36789999999999999987654 356666555555554444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=418.79 Aligned_cols=283 Identities=42% Similarity=0.783 Sum_probs=246.3
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|..++..++||||+++++.|...+.+||||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765545555677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 675 SL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
+|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~----------- 149 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----------- 149 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-----------
Confidence 999999888889999999999999999999997 89999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~ 209 (325)
T cd05594 150 --------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209 (325)
T ss_pred --------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh
Confidence 001224579999999999999999999999999999999999999999988888888877
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhhc--CCccCCCCCCCCCCCcc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFT 909 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~k--~pfiP~~~s~lDts~F~ 909 (1003)
..... ++..+++++.+||.+||++||.+|++. .++.++++||||.++.|....... +++.|......++.+|+
T Consensus 210 ~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (325)
T cd05594 210 MEEIR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFD 286 (325)
T ss_pred cCCCC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcC
Confidence 66554 346789999999999999999999854 389999999999999999876543 67777776777777776
Q ss_pred cc
Q 001856 910 SR 911 (1003)
Q Consensus 910 s~ 911 (1003)
..
T Consensus 287 ~~ 288 (325)
T cd05594 287 EE 288 (325)
T ss_pred ch
Confidence 54
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=412.05 Aligned_cols=289 Identities=41% Similarity=0.769 Sum_probs=246.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755444555567888999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----- 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
........+||+.|||||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 -------------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred -------------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 001122357999999999986 34578999999999999999999999999
Q ss_pred CChhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCC
Q 001856 823 EHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 900 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~ 900 (1003)
.+..+.+..+..... .+|.....+++++++||++||+.++ +|++..+++++++||||.+++|+.+....++++|...
T Consensus 211 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~-~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 289 (332)
T cd05623 211 ESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVS 289 (332)
T ss_pred CCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChh-hhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCC
Confidence 988888888876543 3444445789999999999998644 5554559999999999999999999888888888776
Q ss_pred CCCCCCCc
Q 001856 901 SALDTSYF 908 (1003)
Q Consensus 901 s~lDts~F 908 (1003)
+..+++++
T Consensus 290 ~~~~~~~~ 297 (332)
T cd05623 290 SPTDTSNF 297 (332)
T ss_pred CCcccccC
Confidence 66655544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=413.21 Aligned_cols=290 Identities=41% Similarity=0.757 Sum_probs=247.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++..++|+||+++++.+.+.+++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755444555567888999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---- 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC----
Confidence 99999999999987 4679999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 157 --------------------------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred --------------------------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 001123579999999999976 4578899999999999999999999999
Q ss_pred CChhhHHHhhhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCC
Q 001856 823 EHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 900 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~--~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~ 900 (1003)
.+..+.+..+.... .++|.....++.++++||.+||+.++ +|++..+++++++||||++++|..+....++++|...
T Consensus 211 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~ 289 (331)
T cd05624 211 ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVS 289 (331)
T ss_pred CCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCC
Confidence 88888888887644 33444445679999999999999654 6665568999999999999999999887888888876
Q ss_pred CCCCCCCcc
Q 001856 901 SALDTSYFT 909 (1003)
Q Consensus 901 s~lDts~F~ 909 (1003)
...+.++|+
T Consensus 290 ~~~~~~~~~ 298 (331)
T cd05624 290 SPSDTSNFD 298 (331)
T ss_pred CcchhhhcC
Confidence 666555553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=423.83 Aligned_cols=289 Identities=42% Similarity=0.765 Sum_probs=241.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++.|.+...+|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46799999999999999999999999999999999875554455556788999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~--~--- 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE--T--- 195 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc--C---
Confidence 9999999999999764 689999999999999999999999999999999999999999999999999873100 0
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC----CCccceeechhHHHHHHHhCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........+||+.|||||++.+.. ++.++|||||||++|+|++|.+||.+.
T Consensus 196 -------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 196 -------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred -------------------------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 001123568999999999997643 788999999999999999999999999
Q ss_pred ChhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh--HHhhhcCCccCCC
Q 001856 824 HPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD--TLARQKAAFVPTS 899 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~--~L~~~k~pfiP~~ 899 (1003)
+....+.+++.... .+|. ...++..++++|.+||+. +.+|++..++.++++||||++..|+ .+....+++.|..
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~-~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~ 328 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTD-REVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPEL 328 (370)
T ss_pred CHHHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccC-chhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCC
Confidence 88888888876443 2222 235799999999999984 4444433499999999999986664 3434457888887
Q ss_pred CCCCCCCCcc
Q 001856 900 ESALDTSYFT 909 (1003)
Q Consensus 900 ~s~lDts~F~ 909 (1003)
....|.++|.
T Consensus 329 ~~~~~~~~~~ 338 (370)
T cd05621 329 SSDIDSSNFD 338 (370)
T ss_pred CCcchhhhcC
Confidence 7777766664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=413.74 Aligned_cols=287 Identities=40% Similarity=0.739 Sum_probs=247.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998765545556677889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----- 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-----
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc------cCCCCccceeechhHHHHHHHhCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~------g~~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
........+||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 156 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 156 -------------------------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred -------------------------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 000122357999999999997 4567899999999999999999999999
Q ss_pred CCChhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCC
Q 001856 822 AEHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTS 899 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~ 899 (1003)
..+....+.+++.... .+|. ...+++++.+||.+||+ +|.+|| +++++++||||+.++|..+....+++.|..
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~---t~~~l~~h~~~~~~~~~~~~~~~~~~~~~~ 285 (330)
T cd05601 211 EGTSAKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERL---GYEGLCCHPFFSKIDWNNIRNSLPPFVPTL 285 (330)
T ss_pred CCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCC---CHHHHhCCCCcCCCCHHHHhhCCCCccCcC
Confidence 8888888888776432 2222 23579999999999998 999999 999999999999999999988778888887
Q ss_pred CCCCCCCCccc
Q 001856 900 ESALDTSYFTS 910 (1003)
Q Consensus 900 ~s~lDts~F~s 910 (1003)
....+.++|..
T Consensus 286 ~~~~~~~~~~~ 296 (330)
T cd05601 286 KSDDDTSNFDE 296 (330)
T ss_pred CCcchhhhcCC
Confidence 77666666643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=416.55 Aligned_cols=281 Identities=36% Similarity=0.735 Sum_probs=235.1
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+++.||+|++++...........+.+|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554555667788899988776 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----------- 149 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----------- 149 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC---------C
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE---------H 824 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~---------~ 824 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05618 150 --------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209 (329)
T ss_pred --------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc
Confidence 01123468999999999999999999999999999999999999999521 1
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhh--cCCccCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTS 899 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~---~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~ 899 (1003)
...+++.+..... .+|..++..+.+||.+||++||.+|+++ .++.++++||||++++|+.+... .+++.|..
T Consensus 210 ~~~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T cd05618 210 EDYLFQVILEKQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNI 286 (329)
T ss_pred HHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCC
Confidence 2234445554443 3456789999999999999999999954 24789999999999999988654 35667766
Q ss_pred CCCCCCCCcc
Q 001856 900 ESALDTSYFT 909 (1003)
Q Consensus 900 ~s~lDts~F~ 909 (1003)
....+..+|.
T Consensus 287 ~~~~~~~~~~ 296 (329)
T cd05618 287 SGEFGLDNFD 296 (329)
T ss_pred CCcccchhcC
Confidence 5554444444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=412.16 Aligned_cols=290 Identities=43% Similarity=0.794 Sum_probs=246.7
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.......+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 157 --------------------------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred --------------------------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 001123579999999999973 4478899999999999999999999999
Q ss_pred CChhhHHHhhhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCC
Q 001856 823 EHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 900 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~--~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~ 900 (1003)
.+..+.+..+.... ..++.....++..+++||++||+. |.+|++..++.++++||||.+++|..+....++++|...
T Consensus 211 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
T cd05597 211 ESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVS 289 (331)
T ss_pred CCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCC
Confidence 88888888876543 233333446899999999999986 555555459999999999999999999887888888877
Q ss_pred CCCCCCCcc
Q 001856 901 SALDTSYFT 909 (1003)
Q Consensus 901 s~lDts~F~ 909 (1003)
+..+++.|+
T Consensus 290 ~~~~~~~~~ 298 (331)
T cd05597 290 SPTDTSNFD 298 (331)
T ss_pred CcchhhhcC
Confidence 777766664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=422.17 Aligned_cols=292 Identities=44% Similarity=0.782 Sum_probs=245.5
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
....++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+..++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34557899999999999999999999999999999999875554455556788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-- 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-- 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC--
Confidence 999999999999999876 45899999999999999999999999999999999999999999999999998741000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC----CCccceeechhHHHHHHHhCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
........+||+.|||||++.+.. ++.++|||||||++|||++|.+||
T Consensus 196 ----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 196 ----------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred ----------------------------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 001123568999999999997643 789999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh--hHHhhhcCCcc
Q 001856 821 NAEHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW--DTLARQKAAFV 896 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw--~~L~~~k~pfi 896 (1003)
.+.+....+.+++.... .+|. ...++..+++||.+||. +|..|++..+++++++||||++..| ..+....++++
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~ 325 (371)
T cd05622 248 YADSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVV 325 (371)
T ss_pred CCCCHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCC
Confidence 99998888888886543 2332 24689999999999998 6777666669999999999998655 44545567888
Q ss_pred CCCCCCCCCCCcc
Q 001856 897 PTSESALDTSYFT 909 (1003)
Q Consensus 897 P~~~s~lDts~F~ 909 (1003)
|......+.++|.
T Consensus 326 ~~~~~~~~~~~~~ 338 (371)
T cd05622 326 PDLSSDIDTSNFD 338 (371)
T ss_pred CCCCCcchhhhcC
Confidence 8776666665553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=413.60 Aligned_cols=284 Identities=43% Similarity=0.840 Sum_probs=241.6
Q ss_pred EEEeeccCceEEEEEEEC---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 594 IKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk---~tgk~VALKVIkKs~~~-~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
++.||+|+||.||+|++. .+++.||+|++++.... .......+.+|+.+|+.++||||+++++.|...+.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 57889999999875432 22334567889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------- 153 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE------- 153 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-------
Confidence 9999999999998888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~ 829 (1003)
.......+||+.|+|||++.+..++.++|||||||++|||++|++||...+....+
T Consensus 154 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~ 209 (323)
T cd05584 154 ------------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209 (323)
T ss_pred ------------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH
Confidence 01123467999999999999999999999999999999999999999998888888
Q ss_pred HhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCC
Q 001856 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDT 905 (1003)
Q Consensus 830 qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDt 905 (1003)
..+...... ++..+++.+.+||.+||++||.+||+. .+++++++||||...+|..+... .+++.+......+.
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (323)
T cd05584 210 DKILKGKLN---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDV 286 (323)
T ss_pred HHHHcCCCC---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchh
Confidence 888776543 456789999999999999999999964 47999999999999999888654 35566665555555
Q ss_pred CCcccc
Q 001856 906 SYFTSR 911 (1003)
Q Consensus 906 s~F~s~ 911 (1003)
+.|...
T Consensus 287 ~~~~~~ 292 (323)
T cd05584 287 SQFDSK 292 (323)
T ss_pred hhcCch
Confidence 555543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=413.66 Aligned_cols=282 Identities=39% Similarity=0.793 Sum_probs=238.1
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~-IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++.+...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999998754433333445555554 46779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----------- 149 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----------- 149 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-----------
Confidence 999999998888999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 150 --------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred --------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 011234689999999999999999999999999999999999999999998888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCCccc
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 910 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~F~s 910 (1003)
..... ++..++..+.++|.+||++||.+|++. ....++++|+||..++|+.+... .+++.|......+...|..
T Consensus 210 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (325)
T cd05602 210 NKPLQ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDP 286 (325)
T ss_pred hCCcC---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCC
Confidence 65543 345789999999999999999999965 35679999999999999988754 3566666655555555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=420.40 Aligned_cols=290 Identities=41% Similarity=0.720 Sum_probs=245.5
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
...++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999999999999999998765544555567889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
+||||++||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~--- 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN--- 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC---
Confidence 99999999999999876 46899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC----CCCccceeechhHHHHHHHhCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----GHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~----~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
........+||+.|||||++.+. .++.++|||||||++|||++|++||.
T Consensus 196 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 196 ---------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred ---------------------------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 00112346799999999999764 37899999999999999999999999
Q ss_pred CCChhhHHHhhhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCC--cCCCCCHHHHHcCCCCCCCChhHHh--hhcCCc
Q 001856 822 AEHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQ--RLGSGGASEVKQHVFFKDINWDTLA--RQKAAF 895 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~--~~P~lp~~iS~elkDLIrrcL~kDP~k--Rpg~~SAeELLqHPFFk~Idw~~L~--~~k~pf 895 (1003)
+.+....+..+..... .+|. ...+|.++++||.+||+.+|.+ |+ +++++++||||++.+|.... ...+++
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~---s~~ell~h~~~~~~~~~~~~~~~~~~~~ 324 (370)
T cd05596 249 ADSLVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRN---GVDEIKSHPFFKNDQWTFDNIRETVAPV 324 (370)
T ss_pred CCCHHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCC---CHHHHhcCcccCCCChhhHHhcCCCcCc
Confidence 9988888888876543 2222 1257999999999999998877 87 99999999999998886543 345788
Q ss_pred cCCCCCCCCCCCccc
Q 001856 896 VPTSESALDTSYFTS 910 (1003)
Q Consensus 896 iP~~~s~lDts~F~s 910 (1003)
+|......++++|+.
T Consensus 325 ~p~~~~~~~~~~~~~ 339 (370)
T cd05596 325 VPELSSDIDTSNFDD 339 (370)
T ss_pred cCcCCCcchhhhcCC
Confidence 888777777666643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=445.27 Aligned_cols=261 Identities=33% Similarity=0.606 Sum_probs=241.0
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.++-|++.+.||.|+.|.|.+|++..||+..|||++.+...........+.+|+-||+.+.||||+++|++++++.++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45669999999999999999999999999999999988755555566788899999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|+||++||.|++++.+.|++++.+++++++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|.+..
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~------ 163 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV------ 163 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999997511
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC-CccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-s~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
......+.||+|.|.|||++.|.+| +.++||||.|||||.||||+.||.+.+.
T Consensus 164 --------------------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi 217 (786)
T KOG0588|consen 164 --------------------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI 217 (786)
T ss_pred --------------------------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence 1123457899999999999999998 7999999999999999999999999999
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
..++.++..+.+.+| ..+|.++++||++||..||.+|+ |.+||++|||+.+..-
T Consensus 218 r~LLlKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 218 RVLLLKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHcCcccCC---CcCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 999999999988655 78999999999999999999999 9999999999986543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=409.36 Aligned_cols=288 Identities=43% Similarity=0.827 Sum_probs=239.6
Q ss_pred CeEEEEEeeccCceEEEEEEEC---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk---~tgk~VALKVIkKs~~~-~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~l 664 (1003)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.++..+ +||||++++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 57899999999865432 233456788899999999 599999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-- 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-- 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........+||+.|||||++.+. .++.++|||||||++|||++|..||...
T Consensus 159 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 159 ----------------------------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ----------------------------CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 00112346899999999999875 4789999999999999999999999643
Q ss_pred C----hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhh--cCCc
Q 001856 824 H----PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAF 895 (1003)
Q Consensus 824 ~----~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~--SAeELLqHPFFk~Idw~~L~~~--k~pf 895 (1003)
. ...+...+..... .++..+++.+.+||.+||+.||.+||+.+ +++++++||||++++|..+... .+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~ 287 (332)
T cd05614 211 GERNTQSEVSRRILKCDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPF 287 (332)
T ss_pred CCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCc
Confidence 2 3334444444333 34567899999999999999999999876 8999999999999999887654 3667
Q ss_pred cCCCCCCCCCCCccc
Q 001856 896 VPTSESALDTSYFTS 910 (1003)
Q Consensus 896 iP~~~s~lDts~F~s 910 (1003)
.|......+...|..
T Consensus 288 ~~~~~~~~~~~~~~~ 302 (332)
T cd05614 288 RPSIRNELDVGNFAE 302 (332)
T ss_pred CCCCCCcchhhhcCc
Confidence 777766666665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=411.18 Aligned_cols=281 Identities=42% Similarity=0.800 Sum_probs=238.3
Q ss_pred EEeeccCceEEEEEEE---CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEec
Q 001856 595 KPISRGAFGRVFLAKK---RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 595 k~LG~G~FGtVyLArd---k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
+.||+|+||.||++++ ..+|+.||+|++.+.... ......+.+|+.+|..++||||+++++.+.+...+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999987 357899999999875432 223356778999999999999999999999999999999999
Q ss_pred cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 001856 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (1003)
Q Consensus 672 ~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~ 751 (1003)
+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---------- 150 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID---------- 150 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC----------
Confidence 9999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHh
Q 001856 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 831 (1003)
Q Consensus 752 ~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qk 831 (1003)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..
T Consensus 151 ---------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 209 (318)
T cd05582 151 ---------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209 (318)
T ss_pred ---------------------CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH
Confidence 00112346799999999999999999999999999999999999999999888888888
Q ss_pred hhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC--HHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCC
Q 001856 832 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG--ASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSY 907 (1003)
Q Consensus 832 Il~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~S--AeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~ 907 (1003)
+...... ++..+++.+.+||++||++||.+||++.. +.++++||||..++|..+... .+++.|......+..+
T Consensus 210 i~~~~~~---~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (318)
T cd05582 210 ILKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFY 286 (318)
T ss_pred HHcCCCC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhh
Confidence 8776554 44678999999999999999999995432 889999999999999987654 3566665544444444
Q ss_pred ccc
Q 001856 908 FTS 910 (1003)
Q Consensus 908 F~s 910 (1003)
+.+
T Consensus 287 ~~~ 289 (318)
T cd05582 287 FDP 289 (318)
T ss_pred cCc
Confidence 444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=435.85 Aligned_cols=256 Identities=35% Similarity=0.616 Sum_probs=236.1
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+++|.+++.||+|+||.||+|+.+.+.+.||||.+.|... .++.+..+.+|++|++.++|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3679999999999999999999999999999999988653 345678899999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
+|||.| +|+.++...+.++|+.++.++.+++.||.|||+.+|+|||+||.|||++..|++|+||||+|+....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~------ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST------ 152 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc------
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999994100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
......+..|||.|||||++.+.+|+..+|+||||||+|||++|+|||......+
T Consensus 153 -------------------------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~ 207 (808)
T KOG0597|consen 153 -------------------------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ 207 (808)
T ss_pred -------------------------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence 1123456789999999999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
+.+.|+.....+| ...|..+..||..+|.+||.+|+ +..+++.|||.++
T Consensus 208 Lv~~I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 208 LVKSILKDPVKPP---STASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKG 256 (808)
T ss_pred HHHHHhcCCCCCc---ccccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhh
Confidence 9999998877665 48999999999999999999999 9999999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=395.07 Aligned_cols=277 Identities=34% Similarity=0.601 Sum_probs=233.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|+++++||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554444445667889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999988654 4699999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 155 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 155 --------------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred --------------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 001123579999999999999889999999999999999999999998766544
Q ss_pred HHHhhhhcCC-CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhh--cCCccCC
Q 001856 828 IFDNILNRKI-PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPT 898 (1003)
Q Consensus 828 i~qkIl~~~~-~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~--SAeELLqHPFFk~Idw~~L~~~--k~pfiP~ 898 (1003)
....+..... ..+.++..++..+.+||.+||..||.+||++. +++++++||||...+|+.+... .+||.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 209 KREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred HHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 3333222111 11234566899999999999999999999875 8999999999999999988765 3677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=392.35 Aligned_cols=304 Identities=49% Similarity=0.913 Sum_probs=257.7
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||.|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+....++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999988765444455678889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+++..........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~- 159 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL- 159 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc-
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874221111000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.... .. ............|++.|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+.
T Consensus 160 ---------~~~~---~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~ 224 (305)
T cd05609 160 ---------YEGH---IE---KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224 (305)
T ss_pred ---------cccc---cc---cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0000 00 00001112235789999999999988899999999999999999999999999888888
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCCCCCCCCCc
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 908 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~s~lDts~F 908 (1003)
+..+......+|.....++.++.+||.+||++||.+||++.++.++++||||...+|....+....++|......+.+||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (305)
T cd05609 225 FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYF 304 (305)
T ss_pred HHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccC
Confidence 88887776666655557899999999999999999999877799999999999999999988888888888777777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=411.99 Aligned_cols=250 Identities=31% Similarity=0.560 Sum_probs=222.7
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEe-eeeccc
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY-SFTCRE 662 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~-~f~d~~ 662 (1003)
....+.+|+++++||+|+||+||+|++..+|+.+|.|.+.-. .......+.+..|+.+|++|+|||||++|+ .|..+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 345678999999999999999999999999999999999844 455666788999999999999999999998 666655
Q ss_pred e-EEEEEEeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhh--cC--ceeccCCCcceeecCCCcEEEeec
Q 001856 663 N-LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHS--LR--VVHRDLKPDNLLIAHDGHIKLTDF 733 (1003)
Q Consensus 663 ~-lyLVmEy~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs--~G--IIHRDIKPeNILLd~dG~VKLiDF 733 (1003)
. ++||||||.+|+|.+.|+.. +.++|..++.|+.|++.||..+|. .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 99999999999999999643 569999999999999999999998 45 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHH
Q 001856 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 734 GLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYEL 813 (1003)
||+++... ......+.+|||.||+||++.+.+|+.++|||||||++|||
T Consensus 173 GL~r~l~s-------------------------------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM 221 (375)
T KOG0591|consen 173 GLGRFLSS-------------------------------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM 221 (375)
T ss_pred hhHhHhcc-------------------------------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 99995211 11234578999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhhHHHhhhhcCCCCCCCC-CCCCHHHHHHHHhhccCCcCCcCC
Q 001856 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQRLG 867 (1003)
Q Consensus 814 LTGk~PF~~~~~~ei~qkIl~~~~~~P~lp-~~iS~elkDLIrrcL~kDP~kRpg 867 (1003)
..-++||.+.+..++.++|.++.+ |.+| ..+|.++..||..|+..||.+||+
T Consensus 222 caL~~PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 222 CALQSPFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred HhcCCCcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 999999999999999999988854 5566 678999999999999999999994
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.34 Aligned_cols=267 Identities=34% Similarity=0.660 Sum_probs=224.8
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||+|+||+||+|.++.+++.||+|++.+.........+.+..|+.+++.++||||++++++|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876554444556788899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 001856 677 YSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (1003)
Q Consensus 677 ~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~ 752 (1003)
..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 988743 356999999999999999999999999999999999999999999999999998631000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh----hhH
Q 001856 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQI 828 (1003)
Q Consensus 753 sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~----~ei 828 (1003)
........||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... ...
T Consensus 151 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 209 (280)
T cd05608 151 ---------------------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209 (280)
T ss_pred ---------------------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 0012245799999999999999999999999999999999999999976543 223
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhhc--CCccC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVP 897 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~k--~pfiP 897 (1003)
...+..... .++..+++.+.+|+.+||+.||.+||+. .+++++++||||++++|..+.... +||.|
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 210 KQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred HHhhcccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 333333222 3456789999999999999999999976 388999999999999999886643 45544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=421.44 Aligned_cols=274 Identities=35% Similarity=0.655 Sum_probs=231.7
Q ss_pred CCCCCCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH-----------HHHHHHHHHHHHHHhcC
Q 001856 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-----------NAVESILAERDILISVR 647 (1003)
Q Consensus 579 ~~Psk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~-----------~~ie~~lrEi~IL~~L~ 647 (1003)
+.+......++.|++++.||+|.||+|.+|++..+++.||||++.|...... ..++.+.+|+.||++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 3444566778999999999999999999999999999999999987543321 22468999999999999
Q ss_pred CCcEEEEEeeeecc--ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC
Q 001856 648 NPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (1003)
Q Consensus 648 HPnIVkL~~~f~d~--~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d 725 (1003)
|||||+|+++..+. +++|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+|||||||||+|+||+.+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 99999999998874 5799999999988875433332239999999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC---C-Cccc
Q 001856 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---H-GTTA 801 (1003)
Q Consensus 726 G~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---y-s~kS 801 (1003)
|+|||+|||.+...... +.+. ........+|||.|||||...+.. + +.+.
T Consensus 247 g~VKIsDFGVs~~~~~~-----------------~~~~---------~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~ 300 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQG-----------------SDEG---------SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFAL 300 (576)
T ss_pred CcEEeeccceeeecccC-----------------Cccc---------cHHHHhhcCCCccccchHhhcCCCCccccchhh
Confidence 99999999998741100 0000 001122379999999999998732 2 6789
Q ss_pred eeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 802 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 802 DIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
|||||||+||.|+.|+.||.+....+++.+|.+....+|..+ .+.+.++|||.+||++||.+|+ +..+|+.|||..
T Consensus 301 DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri---~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 301 DIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRI---TLPDIKLHPWVT 376 (576)
T ss_pred hhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhhee---ehhhheecceec
Confidence 999999999999999999999999999999999999888754 6889999999999999999999 999999999986
Q ss_pred C
Q 001856 882 D 882 (1003)
Q Consensus 882 ~ 882 (1003)
.
T Consensus 377 ~ 377 (576)
T KOG0585|consen 377 R 377 (576)
T ss_pred c
Confidence 4
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=411.91 Aligned_cols=260 Identities=34% Similarity=0.607 Sum_probs=220.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--eEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLY 665 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~--~ly 665 (1003)
..+|...+.||+|+||.||++.+..+|..+|+|.+..... ...+.+.+|+.+|..++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 3568899999999999999999999999999999876521 12677899999999999999999999755555 699
Q ss_pred EEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~s 743 (1003)
++|||++||+|.+++.+.+ .+++..++.|.+||+.||+|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999987 7999999999999999999999999999999999999999 7999999999988411000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
..........|||.|||||++.+ ...++++|||||||++.||+||++||..
T Consensus 173 ----------------------------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 ----------------------------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----------------------------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 00112345789999999999995 2334599999999999999999999987
Q ss_pred -CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 823 -EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 823 -~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.......-.+.... ..|.+|..+|.++++||.+||.+||.+|| ||.++|+|||.+.
T Consensus 225 ~~~~~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 225 FFEEAEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLKQ 281 (313)
T ss_pred hcchHHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhhc
Confidence 34444444444333 45688899999999999999999999999 9999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=386.92 Aligned_cols=284 Identities=48% Similarity=0.881 Sum_probs=250.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999999999998766555566778899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~------- 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------- 153 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999873100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+....
T Consensus 154 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 206 (290)
T cd05580 154 ---------------------------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206 (290)
T ss_pred ---------------------------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01235789999999999988889999999999999999999999998887777
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALD 904 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lD 904 (1003)
.+.+...... ++..++..++++|.+||+.||.+|++. .+++++++||||+.++|..+... .+++.|......+
T Consensus 207 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (290)
T cd05580 207 YEKILEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGD 283 (290)
T ss_pred HHHHhcCCcc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccc
Confidence 7777765543 456679999999999999999999976 38999999999999999988764 4677777766666
Q ss_pred CCCcc
Q 001856 905 TSYFT 909 (1003)
Q Consensus 905 ts~F~ 909 (1003)
.+.|+
T Consensus 284 ~~~~~ 288 (290)
T cd05580 284 TSNFD 288 (290)
T ss_pred ccccc
Confidence 66654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=404.89 Aligned_cols=259 Identities=25% Similarity=0.477 Sum_probs=220.0
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
++.|+.+.++|+|+||.||+|+++.||+.||||.+.-+. .+....+..++|+.+|++++|||+|.|+++|..+..++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367999999999999999999999999999999986543 2344556788999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
+|||+. ++.+-+.+. ..++++.++.|++|++.|+.|+|+++||||||||+||||+.+|.+||||||+|+...
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------ 152 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------ 152 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc------
Confidence 999987 565666554 569999999999999999999999999999999999999999999999999998411
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
. .....+.++.|.+|+|||.+.| ..|+.++||||+||++.||++|.+.|.+.+.
T Consensus 153 --~-----------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 153 --A-----------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred --C-----------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 0 0122345789999999999998 7899999999999999999999999998877
Q ss_pred hhHHHhhhhcC-------------------CCCCCC---------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 826 QQIFDNILNRK-------------------IPWPRV---------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~ei~qkIl~~~-------------------~~~P~l---------p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
-+.+..|.... ..+|.. ...++.-+.||+++||..||.+|+ +.++++.|
T Consensus 208 iDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~---sc~qll~H 284 (396)
T KOG0593|consen 208 IDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL---SCEQLLHH 284 (396)
T ss_pred HHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc---cHHHHhcC
Confidence 66555554311 112221 134678899999999999999999 99999999
Q ss_pred CCCCC
Q 001856 878 VFFKD 882 (1003)
Q Consensus 878 PFFk~ 882 (1003)
+||.+
T Consensus 285 ~yFd~ 289 (396)
T KOG0593|consen 285 PYFDG 289 (396)
T ss_pred hHHHH
Confidence 99954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=413.38 Aligned_cols=260 Identities=38% Similarity=0.645 Sum_probs=237.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyL 666 (1003)
.+.|++.+.||.|.||.||+|+.+.+|+.||+|++.+.........+.+.+|+.+|+.+. |||||.++++|++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 346999999999999999999999999999999999887766556688999999999998 9999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC----CcEEEeecCCccccccC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d----G~VKLiDFGLAk~~~~~ 742 (1003)
|||+|.||+|++.+.+. .+++..+..+++||+.|+.|||+.||+||||||+|+|+... +.+|++|||+|+....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999999876 49999999999999999999999999999999999999653 5799999999985210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.......||||.|+|||++...+|+..+||||+||++|.|++|.+||.+
T Consensus 192 -------------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 192 -------------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred -------------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 1234578999999999999999999999999999999999999999999
Q ss_pred CChhhHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 823 EHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.+....+.+|..+.+.++. ....+|..+++||++||..||.+|+ ++.++|+|||+++.
T Consensus 241 ~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 241 ETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKSI 299 (382)
T ss_pred CChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccCC
Confidence 9999999999998887663 3467899999999999999999999 99999999998864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=394.18 Aligned_cols=261 Identities=35% Similarity=0.686 Sum_probs=243.0
Q ss_pred CCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 583 k~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
.....+++|++.+.||+|-||.||+|+.+.++-.||+||+.|+.+........+.+|++|-..|+||||+++|++|.+..
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 34567899999999999999999999999999999999999998877777788999999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLR--NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~--~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.+||++||.++|+|+..+. ....+++..+..|++|++.||.|+|.++||||||||+|+|++..|.+||+|||.+...
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 9999999999999999998 5678999999999999999999999999999999999999999999999999998631
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
...+..+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||
T Consensus 175 --------------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppF 222 (281)
T KOG0580|consen 175 --------------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPF 222 (281)
T ss_pred --------------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCch
Confidence 012356789999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
...+..++|++|......+| ..++.++.|||.+||.++|.+|+ ...|++.|||...
T Consensus 223 es~~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 223 ESQSHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred hhhhhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 99999999999999887655 78999999999999999999999 9999999999863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=385.50 Aligned_cols=258 Identities=31% Similarity=0.468 Sum_probs=214.9
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 469999999999999999999999999999999976532 2234567788999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++++.|..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 154 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS----- 154 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-----
Confidence 999998776665555679999999999999999999999999999999999999999999999999987410000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
........||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 155 -------------------------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred -------------------------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0011235789999999999998899999999999999999999999987665444
Q ss_pred HHhhhhcCC-------------------CCCC----------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 829 FDNILNRKI-------------------PWPR----------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 829 ~qkIl~~~~-------------------~~P~----------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
...+..... .++. ....+|.++.+||++||++||.+|| +++++++|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~---s~~~~l~hp~ 286 (287)
T cd07848 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY---LTEQCLNHPA 286 (287)
T ss_pred HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC---CHHHHhcCCC
Confidence 333322111 0111 0123688999999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 287 f 287 (287)
T cd07848 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=399.77 Aligned_cols=259 Identities=32% Similarity=0.553 Sum_probs=235.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+.|++-+.||+|.|+.|+++.+..+|+.+|+|++........ ..+.+.+|+.|-+.|+||||++|++.+......|||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 459999999999999999999999999999999976655444 5688999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC---CCcEEEeecCCccccccCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~---dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|+|.|++|..-|-..-.++|..+..|++||+.||.|+|.+||||||+||+|+|+.. ..-+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~----- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN----- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-----
Confidence 99999999887766677899999999999999999999999999999999999964 3469999999998310
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
.......++|||.|||||++...+|+..+|||+.|||||-||.|.+||.+.+.
T Consensus 165 ---------------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 165 ---------------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred ---------------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 01223457999999999999999999999999999999999999999999999
Q ss_pred hhHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 826 QQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
..+|++|+.+.+.++. ....+++++++||++||..||.+|+ |+.|.|+|||+.+-
T Consensus 218 ~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 218 HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcch
Confidence 9999999999998875 6788999999999999999999999 99999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=422.43 Aligned_cols=258 Identities=32% Similarity=0.491 Sum_probs=222.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc-eE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE-NL 664 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~-~l 664 (1003)
..++|.++++||.|+||.||+|+.+.+|..||||.+++....-+ .-.-++|+..|++++ ||||++|++++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 45789999999999999999999999999999999987543322 234468999999999 999999999999988 99
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+|||||+. +|+++++.. ..|++..++.|+.||++||+|+|++|++||||||||||+..+..|||+|||+|+....
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--
Confidence 999999976 999999765 5699999999999999999999999999999999999999999999999999994211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
....+.++.|.+|+|||++.. .-|+.++|+||+|||++|+.+-++.|.|
T Consensus 163 ------------------------------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 163 ------------------------------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred ------------------------------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 112345789999999999875 4589999999999999999999999999
Q ss_pred CChhhHHHhhhh-------------------cCCCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 823 EHPQQIFDNILN-------------------RKIPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 823 ~~~~ei~qkIl~-------------------~~~~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
.+..+.+-+|.. -.+.||. +-..++.++.+||.+||.+||.+|| ||.++|
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp---TA~~al 289 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP---TASQAL 289 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc---cHHHHh
Confidence 888777766654 1122332 2235889999999999999999999 999999
Q ss_pred cCCCCCC
Q 001856 876 QHVFFKD 882 (1003)
Q Consensus 876 qHPFFk~ 882 (1003)
+||||+.
T Consensus 290 ~~pffq~ 296 (538)
T KOG0661|consen 290 QHPFFQV 296 (538)
T ss_pred cCccccc
Confidence 9999974
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=385.10 Aligned_cols=275 Identities=35% Similarity=0.646 Sum_probs=230.1
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999877654444455677889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 99999999998654 3589999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh-
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ- 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~- 826 (1003)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||......
T Consensus 155 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~ 208 (285)
T cd05630 155 --------------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208 (285)
T ss_pred --------------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence 00112347999999999999999999999999999999999999999865432
Q ss_pred --hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhh--hcCCccCC
Q 001856 827 --QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLAR--QKAAFVPT 898 (1003)
Q Consensus 827 --ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~--~k~pfiP~ 898 (1003)
.....+..... ...+..+++++.+||.+||+.||.+||++ ++++|+++||||+.++|..+.. .+++|+|.
T Consensus 209 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 209 KREEVERLVKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred hHHHHHhhhhhhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 22222222111 12456789999999999999999999943 2499999999999999998865 34677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=387.55 Aligned_cols=257 Identities=27% Similarity=0.508 Sum_probs=214.9
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+++|++++.||.|+||+||+|++..++..||+|+++.... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 35789999999999999999999999999999999875432 1223467789999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
||||++| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 9999986 9999987654 5799999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 157 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 157 ----------------------------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred ----------------------------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 001123578999999999876 568999999999999999999999998877
Q ss_pred hhhHHHhhhhcCC-------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 825 PQQIFDNILNRKI-------------------PWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 825 ~~ei~qkIl~~~~-------------------~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..+....+..... .++. ....+++++++||++||++||.+|| |++|+++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~---t~~~~l~h 285 (288)
T cd07871 209 VKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI---SAEAALRH 285 (288)
T ss_pred HHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC---CHHHHhcC
Confidence 7665555433110 0110 1134688999999999999999999 99999999
Q ss_pred CCC
Q 001856 878 VFF 880 (1003)
Q Consensus 878 PFF 880 (1003)
|||
T Consensus 286 p~f 288 (288)
T cd07871 286 SYF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.87 Aligned_cols=267 Identities=32% Similarity=0.603 Sum_probs=220.6
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||+|+||.||+++.+.+|+.||+|++.+...........+..|+++++.++||||+++++.|....++|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544333445567799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 001856 677 YSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (1003)
Q Consensus 677 ~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sg 754 (1003)
.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 99886543 588999999999999999999999999999999999999999999999999873100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh----hhHHH
Q 001856 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFD 830 (1003)
Q Consensus 755 ttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~----~ei~q 830 (1003)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .++..
T Consensus 148 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 148 -------------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred -------------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 0011234689999999999998899999999999999999999999976432 33344
Q ss_pred hhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC-CHHHHHcCCCCCCCChhHHhhh--cCCccC
Q 001856 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG-GASEVKQHVFFKDINWDTLARQ--KAAFVP 897 (1003)
Q Consensus 831 kIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~-SAeELLqHPFFk~Idw~~L~~~--k~pfiP 897 (1003)
.+......+ ....+++++++||.+||++||.+||++. -.++++.||||+.++|..+... .+||+|
T Consensus 209 ~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 209 RTLEDEVKF--EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred Hhhcccccc--ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 443333322 2246899999999999999999999321 1278999999999999998865 356654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=420.65 Aligned_cols=258 Identities=34% Similarity=0.583 Sum_probs=232.8
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
.....|....+||+|+.|.||.|+...+++.||+|.+....... .+-+++|+.+|+..+|+|||++++.|--.+.++
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 34466899999999999999999999999999999998765332 367889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
+|||||+||+|.+.+... .++|.++..+.++++.||+|||.+||||||||.+|||++.+|.+||+|||+|.....
T Consensus 347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~---- 421 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE---- 421 (550)
T ss_pred EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc----
Confidence 999999999999998764 599999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
...+..+.+|||+|||||++..+.|++++||||||++++||+.|.+||-..++
T Consensus 422 ---------------------------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 422 ---------------------------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred ---------------------------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 11245678999999999999999999999999999999999999999998888
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
...+..|.....+-...++.+|+.++|||.+||+.|+.+|+ +|.|||+||||+
T Consensus 475 lrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~ 527 (550)
T KOG0578|consen 475 LRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLK 527 (550)
T ss_pred HHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhh
Confidence 88888887776655566889999999999999999999999 999999999995
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=383.25 Aligned_cols=305 Identities=41% Similarity=0.790 Sum_probs=245.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.++..++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46999999999999999999999999999999998766555556678899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 669 EYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||+.|++|.+++.+. ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP- 159 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc-
Confidence 999999999999764 56999999999999999999999999999999999999999999999999998742111000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.................. ................||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIP-SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred cccccccccccccccccc-hhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 000000000000000000 0000001112234568999999999999988999999999999999999999999988888
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC----HHHHHcCCCCCCCChhHHhhhcCCccCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG----ASEVKQHVFFKDINWDTLARQKAAFVPTS 899 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~S----AeELLqHPFFk~Idw~~L~~~k~pfiP~~ 899 (1003)
..+..+......++.. ..++..+.+||.+||+.||.+|| + ++++++||||++.+|..+....+|.+|.+
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~---s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 311 (316)
T cd05574 239 ETFSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRL---GSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311 (316)
T ss_pred HHHHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCC---CchhhHHHHHcCchhhcCChhhcccCCCCCCCCc
Confidence 8888877666555432 23789999999999999999999 7 99999999999999999988777777664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=388.73 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=212.7
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----ceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-----~~l 664 (1003)
+|++.++||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 59999999999999999999999999999999875322 223345688999999999999999999887543 358
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+|||||. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 69999998888899999999999999999999999999999999999999999999999999873110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc--CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 159 ----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 159 ----------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ----------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 0011234679999999999876 6789999999999999999999999987
Q ss_pred CChhhHHHhhhh--------------------------cCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 823 EHPQQIFDNILN--------------------------RKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 823 ~~~~ei~qkIl~--------------------------~~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
.+.......+.. ... ++......+++.+.+||.+||+.||.+|| +++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~e~ 287 (338)
T cd07859 211 KNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP---TAEEA 287 (338)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC---CHHHH
Confidence 654332221111 000 01111134678899999999999999999 99999
Q ss_pred HcCCCCCCCCh
Q 001856 875 KQHVFFKDINW 885 (1003)
Q Consensus 875 LqHPFFk~Idw 885 (1003)
++||||+++..
T Consensus 288 l~hp~f~~~~~ 298 (338)
T cd07859 288 LADPYFKGLAK 298 (338)
T ss_pred hcCchhhhcCc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=386.49 Aligned_cols=262 Identities=29% Similarity=0.543 Sum_probs=212.1
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||.|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999875432 12234567899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 156 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP---- 156 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC----
Confidence 99996 5888887654 57899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 157 ---------------------------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred ---------------------------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 001123578999999999876 4578999999999999999999999986432
Q ss_pred -hhHHHhhhhcC-C----CCC------CC---------C---------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 826 -QQIFDNILNRK-I----PWP------RV---------P---------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 826 -~ei~qkIl~~~-~----~~P------~l---------p---------~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
.+....+.... . .++ .+ + ...++.+.+||.+||++||.+|| |+.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~---s~~~~l 286 (303)
T cd07869 210 IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL---SAQAAL 286 (303)
T ss_pred HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc---CHHHHh
Confidence 22232222100 0 000 00 0 12457899999999999999999 999999
Q ss_pred cCCCCCCCChh
Q 001856 876 QHVFFKDINWD 886 (1003)
Q Consensus 876 qHPFFk~Idw~ 886 (1003)
+||||+++.+.
T Consensus 287 ~h~~f~~~~~~ 297 (303)
T cd07869 287 SHEYFSDLPPR 297 (303)
T ss_pred cCcccccCChh
Confidence 99999988653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=379.00 Aligned_cols=277 Identities=34% Similarity=0.603 Sum_probs=232.4
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|+..+.||.|+||+||+|.+..+++.||+|++.+...........+.+|+.+|+.++|+||+.+++.+...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999987654444445667889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 99999999888654 3699999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.....
T Consensus 155 --------------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 155 --------------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred --------------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 001123579999999999999899999999999999999999999998776544
Q ss_pred HHHhhhhcCCC-CCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCC
Q 001856 828 IFDNILNRKIP-WPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPT 898 (1003)
Q Consensus 828 i~qkIl~~~~~-~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~ 898 (1003)
....+...... ...++..++.++.+||.+||+.||.+||++ ..+.++++|+||+.++|+.+... .++|+|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 209 KREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 43333221111 123456788999999999999999999943 13899999999999999987654 4678775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=410.66 Aligned_cols=260 Identities=33% Similarity=0.574 Sum_probs=225.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 665 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~ly 665 (1003)
.+.|+.+++||+|+||.||+|++..+|+.||||.+..... +......+.+|+.||++|+||||++|.+...+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4569999999999999999999999999999999987543 344556778999999999999999999998877 6899
Q ss_pred EEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||+|||+. +|.-++...+ .|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||++.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~- 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG- 272 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-
Confidence 99999987 9999988754 69999999999999999999999999999999999999999999999999999632111
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
....++.+-|.+|+|||+++| ..|+.++|+||+||||.||++|++.|.+.
T Consensus 273 -----------------------------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 273 -----------------------------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred -----------------------------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 012346789999999999998 46999999999999999999999999999
Q ss_pred ChhhHHHhhhhcCCC-----CC--CCC-------------------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 824 HPQQIFDNILNRKIP-----WP--RVP-------------------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~-----~P--~lp-------------------~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+..+.+..|.+.... |+ .+| ..++..+.+|+..||+.||.+|. ||.++|+|
T Consensus 324 tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~---tA~~aL~s 400 (560)
T KOG0600|consen 324 TEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG---TASSALQS 400 (560)
T ss_pred cHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc---cHHHHhcC
Confidence 999988888762111 21 111 34789999999999999999999 99999999
Q ss_pred CCCCC
Q 001856 878 VFFKD 882 (1003)
Q Consensus 878 PFFk~ 882 (1003)
+||..
T Consensus 401 eyF~t 405 (560)
T KOG0600|consen 401 EYFTT 405 (560)
T ss_pred ccccc
Confidence 99953
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=385.58 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=218.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||.||+|++..++..||+|++.... .......+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999987542 234456789999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~-GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||++||+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 156 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-----
Confidence 99999999999999888899999999999999999999986 699999999999999999999999999873100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 157 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ----------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0112457999999999999999999999999999999999999999766554
Q ss_pred hHHHhhhhc--------------------------------------------CCCCCCC-CCCCCHHHHHHHHhhccCC
Q 001856 827 QIFDNILNR--------------------------------------------KIPWPRV-PEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 827 ei~qkIl~~--------------------------------------------~~~~P~l-p~~iS~elkDLIrrcL~kD 861 (1003)
++...+... ....+.. ...+++++++||.+||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 432211100 0000111 1246889999999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCCC
Q 001856 862 PHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~I 883 (1003)
|++|| ++.+|++||||+..
T Consensus 289 P~~Rp---t~~ell~h~~~~~~ 307 (331)
T cd06649 289 PAERA---DLKMLMNHTFIKRS 307 (331)
T ss_pred cccCC---CHHHHhcChHHhhc
Confidence 99999 99999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=399.47 Aligned_cols=254 Identities=31% Similarity=0.611 Sum_probs=236.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
.+|++.+.||+|.||+|-+|+....|+.||||.|+|..+..+..+-++.+|++||..|+||||+.+|++|+.++.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46999999999999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||..+|+|++++.+.+.|++.+++.+++||+.|+.|+|+++++|||||.+|||+|.++++||+||||+...
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly--------- 203 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY--------- 203 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999998631
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC-CccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-s~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......++||+|.|.+||++.|.+| ++.+|-||||++||.|+.|..||.+.+...
T Consensus 204 -----------------------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~ 260 (668)
T KOG0611|consen 204 -----------------------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR 260 (668)
T ss_pred -----------------------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence 11223457999999999999999998 799999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
+..+|-.+.+.-|. -+.++.-||+.||-.||.+|. |+++|..|=|.+
T Consensus 261 lvrQIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWvN 307 (668)
T KOG0611|consen 261 LVRQISRGAYREPE----TPSDASGLIRWMLMVNPERRA---TIEDIASHWWVN 307 (668)
T ss_pred HHHHhhcccccCCC----CCchHHHHHHHHHhcCcccch---hHHHHhhhheee
Confidence 99999988876554 456789999999999999999 999999998873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=393.42 Aligned_cols=268 Identities=32% Similarity=0.527 Sum_probs=231.8
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
....++|++..+||.|.-++||+|+.+.++..||||++...+... .++.+.+|+..|..++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 345678999999999999999999999999999999998765533 378899999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
|+||.||.+|++.++++.. ..++|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+-....
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~- 178 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD- 178 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc-
Confidence 9999999999999999865 4599999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc--CCCCccceeechhHHHHHHHhCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
+|.+ . .....+++|||.|||||++.. .+|+.|+||||||++..||.+|..||
T Consensus 179 ----------~G~R---------------~-~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 179 ----------SGDR---------------Q-VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ----------cCce---------------e-eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 0000 0 111267899999999999653 67999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCCCCCCC-------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 821 NAEHPQQIFDNILNRKIPWPRV-------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~l-------p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
....+.+++-.-+++.++.+.. ...++..++.+|..||++||.+|| +|.++|+|+||+...
T Consensus 233 ~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---tAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---TASKLLKHAFFKKAK 300 (516)
T ss_pred ccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---CHHHHhccHHHhhcc
Confidence 9988888877777766653321 124678899999999999999999 999999999998653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=372.28 Aligned_cols=255 Identities=32% Similarity=0.520 Sum_probs=208.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECC-CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeec----
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTC---- 660 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~-tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L---~HPnIVkL~~~f~d---- 660 (1003)
++|++++.||+|+||+||+|++.. +++.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 57889999987543222 2223455677776655 69999999998752
Q ss_pred -cceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 661 -RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 661 -~~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 456999999997 5999999764 458999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCC
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk 817 (1003)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 159 ~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 206 (290)
T cd07862 159 IYSF--------------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206 (290)
T ss_pred eccC--------------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCC
Confidence 3100 01123457999999999999989999999999999999999999
Q ss_pred CCCCCCChhhHHHhhhhcCC-----CCC-------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 818 PPFNAEHPQQIFDNILNRKI-----PWP-------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 818 ~PF~~~~~~ei~qkIl~~~~-----~~P-------------------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
+||.+.+..+.+..+..... .++ .+...+++.+++||.+||+.||.+|| ++.+
T Consensus 207 ~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~~ 283 (290)
T cd07862 207 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYS 283 (290)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC---CHHH
Confidence 99998887777776654211 010 11135788899999999999999999 9999
Q ss_pred HHcCCCC
Q 001856 874 VKQHVFF 880 (1003)
Q Consensus 874 LLqHPFF 880 (1003)
+++||||
T Consensus 284 ~l~hp~f 290 (290)
T cd07862 284 ALSHPYF 290 (290)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=364.07 Aligned_cols=257 Identities=60% Similarity=1.066 Sum_probs=223.6
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHH-HhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL-~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++.+...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999999999999999999876544344444555665554 445899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999988889999999999999999999999999999999999999999999999999987310
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+...++..+.
T Consensus 149 ----------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 149 ----------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred ----------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 0123568899999999998889999999999999999999999999888888888777
Q ss_pred hcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 001856 834 NRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 834 ~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~ 886 (1003)
.....++. ....+++.+.++|.+||+.+|.+||++.+++|++.||||++++|+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 66554442 334689999999999999999999988888999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=416.43 Aligned_cols=152 Identities=59% Similarity=1.006 Sum_probs=143.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+++|+++++||+|+||+||+|++..+++.||||++++...........+..|+.++..++||||+++++.+....++||
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36789999999999999999999999999999999987766666667888999999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
||||+.|++|.+++...+.+++..++.|+.||+.||+|||.+|||||||||+||||+.++++||+|||+++.
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=384.33 Aligned_cols=260 Identities=30% Similarity=0.526 Sum_probs=232.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeecccc-----ccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-----IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~-----~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~ 662 (1003)
+.|+..+.||.|..++|.+|.++.+|+.+|+|++..... ......+....|+.||+++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 568888899999999999999999999999999864221 1234456777899999987 6999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+++|+|.|+.|.|++++...-.++|...+.+++||+.|++|||.++||||||||+|||++++.+|||+|||+|...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l--- 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL--- 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc---
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999731
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc------CCCCccceeechhHHHHHHHhC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g------~~ys~kSDIWSLGVILYELLTG 816 (1003)
....+.+..||||+|+|||.+.. .+|+..+|+||+|||||.||.|
T Consensus 174 -----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 174 -----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred -----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 12234567899999999999863 5689999999999999999999
Q ss_pred CCCCCCCChhhHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 817 IPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 817 k~PF~~~~~~ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.+||......-++..|+.+++.|.. -+.++|...+|||++||+.||.+|+ |++|+|+||||..+
T Consensus 225 cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri---take~LaHpff~q~ 289 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI---TAKEALAHPFFIQI 289 (411)
T ss_pred CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc---cHHHHhcChHHHHH
Confidence 9999999999999999999988753 3567999999999999999999999 99999999999644
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=368.09 Aligned_cols=254 Identities=30% Similarity=0.496 Sum_probs=207.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeec-----c
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTC-----R 661 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L---~HPnIVkL~~~f~d-----~ 661 (1003)
+|++++.||+|+||+||+|+++.+++.||+|+++..... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 489999999999999999999999999999998754321 11123445666666554 79999999998865 3
Q ss_pred ceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccc
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~ 739 (1003)
..+|++|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999985 899988764 34899999999999999999999999999999999999999999999999998741
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 159 ~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 206 (288)
T cd07863 159 SC--------------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206 (288)
T ss_pred cC--------------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcC
Confidence 00 0011235789999999999998999999999999999999999999
Q ss_pred CCCCChhhHHHhhhhcC-----CCCC-------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 820 FNAEHPQQIFDNILNRK-----IPWP-------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~-----~~~P-------------------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
|.+....+.+.++.... ..++ .....++..+.+||.+||++||.+|| ++.+++
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~~~l 283 (288)
T cd07863 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI---SAFRAL 283 (288)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC---CHHHHh
Confidence 98877666655554311 0000 11235788899999999999999999 999999
Q ss_pred cCCCC
Q 001856 876 QHVFF 880 (1003)
Q Consensus 876 qHPFF 880 (1003)
.||||
T Consensus 284 ~hp~f 288 (288)
T cd07863 284 QHPFF 288 (288)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=359.47 Aligned_cols=260 Identities=32% Similarity=0.543 Sum_probs=223.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~--~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
++|++.+.||.|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++.+.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5699999999999999999999999999999998754322 22345678899999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
..........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 159 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 213 (263)
T cd06625 159 -------------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213 (263)
T ss_pred -------------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence 0000112456889999999999988999999999999999999999999877666
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.....+..... .+.++..++..+.+||.+||.++|.+|| ++.++++||||
T Consensus 214 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 214 AAIFKIATQPT-NPQLPSHVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred HHHHHHhccCC-CCCCCccCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 55555544333 2346678899999999999999999999 99999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=366.06 Aligned_cols=266 Identities=36% Similarity=0.697 Sum_probs=224.0
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++.|...+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544444556778899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 001856 677 YSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (1003)
Q Consensus 677 ~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sg 754 (1003)
.+++.+.+ .+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99997765 799999999999999999999999999999999999999999999999999863100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh----hhHHH
Q 001856 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFD 830 (1003)
Q Consensus 755 ttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~----~ei~q 830 (1003)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+..
T Consensus 148 -------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 148 -------------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred -------------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 0011234678899999999988899999999999999999999999976544 22333
Q ss_pred hhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-C-CHHHHHcCCCCCCCChhHHhhh--cCCccC
Q 001856 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-G-GASEVKQHVFFKDINWDTLARQ--KAAFVP 897 (1003)
Q Consensus 831 kIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~-~-SAeELLqHPFFk~Idw~~L~~~--k~pfiP 897 (1003)
.+.... ...+..+++.+.++|.+||+.||.+||+. . ++.++++||||+.++|..+... .++|.|
T Consensus 209 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 209 RTLEMA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cccccc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 332222 23456789999999999999999999976 3 7899999999999999988654 245544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=393.83 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=209.9
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+....+|++++.||+|+||.||+|++..+++.||+|+... ..+.+|+.+|+.++||||++++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3445679999999999999999999999999999997432 3467899999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+|||++. ++|..++.....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-- 235 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-- 235 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence 99999995 699999988888999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 236 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~ 287 (391)
T PHA03212 236 ----------------------------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287 (391)
T ss_pred ----------------------------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcc
Confidence 0011234689999999999999999999999999999999999998875321
Q ss_pred -------hhhHHHhhhhcCCC--------------------------CCC-C-----CCCCCHHHHHHHHhhccCCcCCc
Q 001856 825 -------PQQIFDNILNRKIP--------------------------WPR-V-----PEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 825 -------~~ei~qkIl~~~~~--------------------------~P~-l-----p~~iS~elkDLIrrcL~kDP~kR 865 (1003)
....+..+...... .+. . ...++.++.+||.+||++||.+|
T Consensus 288 ~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~R 367 (391)
T PHA03212 288 GLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367 (391)
T ss_pred cccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhC
Confidence 11111112111000 000 0 01346789999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 001856 866 LGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 866 pg~~SAeELLqHPFFk~I 883 (1003)
| ||.|+|+||||+.+
T Consensus 368 p---ta~elL~hp~f~~~ 382 (391)
T PHA03212 368 P---SAEALLDFAAFQDI 382 (391)
T ss_pred C---CHHHHhcChhhccC
Confidence 9 99999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=399.60 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=208.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------ 661 (1003)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 357999999999999999999999999999999886432 2234699999999999999998876432
Q ss_pred --ceEEEEEEeccCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-cEEEeecC
Q 001856 662 --ENLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFG 734 (1003)
Q Consensus 662 --~~lyLVmEy~~GGSL~d~L~----~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-~VKLiDFG 734 (1003)
..+|+||||+++ +|.+++. ....+++..++.|+.||+.||+|||++|||||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 257899999975 7777764 346799999999999999999999999999999999999999765 69999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYEL 813 (1003)
+|+.... .......+||+.|||||++.+. .|+.++|||||||++|||
T Consensus 217 la~~~~~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 217 SAKNLLA--------------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred cchhccC--------------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 9973110 0112246789999999998764 689999999999999999
Q ss_pred HhCCCCCCCCChhhHHHhhhhcC-----------------CCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCC
Q 001856 814 IVGIPPFNAEHPQQIFDNILNRK-----------------IPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLG 867 (1003)
Q Consensus 814 LTGk~PF~~~~~~ei~qkIl~~~-----------------~~~P~---------lp~~iS~elkDLIrrcL~kDP~kRpg 867 (1003)
++|.+||.+.+..+.+.++.... ..+|. +|...++++.+||.+||++||.+||
T Consensus 265 ltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~- 343 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL- 343 (440)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc-
Confidence 99999999887666555554311 11111 2345788999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCh
Q 001856 868 SGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 868 ~~SAeELLqHPFFk~Idw 885 (1003)
++.|+++||||.++..
T Consensus 344 --ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 344 --NPIEALADPFFDDLRD 359 (440)
T ss_pred --CHHHHhCChhHHhhhc
Confidence 9999999999987543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=384.55 Aligned_cols=261 Identities=29% Similarity=0.455 Sum_probs=217.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----eE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~-----~l 664 (1003)
+|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22334567889999999999999999999998876 79
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999996 5899999888889999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........||+.|+|||++.+. .++.++|||||||++|||++|++||.+.
T Consensus 158 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 158 -----------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred -----------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 0011234689999999999874 4799999999999999999999999887
Q ss_pred ChhhHHHhhhhc-----------------------CCCCC------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 824 HPQQIFDNILNR-----------------------KIPWP------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 824 ~~~ei~qkIl~~-----------------------~~~~P------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
+..+.+..+... ....+ .+....++++.+||.+||+.||.+|| ++.++
T Consensus 209 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~---t~~e~ 285 (372)
T cd07853 209 SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI---SAADA 285 (372)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc---CHHHH
Confidence 766655554321 11111 12345688999999999999999999 99999
Q ss_pred HcCCCCCCCCh
Q 001856 875 KQHVFFKDINW 885 (1003)
Q Consensus 875 LqHPFFk~Idw 885 (1003)
++||||++..+
T Consensus 286 l~hp~~~~~~~ 296 (372)
T cd07853 286 LAHPYLDEGRL 296 (372)
T ss_pred hcCHhhCCCcc
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=373.01 Aligned_cols=259 Identities=32% Similarity=0.559 Sum_probs=222.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
.+|..+++||+|.||.||+|++..||+.||||.++..+.. .......++|+..|+.++|+||+.++++|.....+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4688999999999999999999999999999999876432 223356789999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||+. +|...|+.. -.++...++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~---- 155 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN---- 155 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC----
Confidence 99986 999999765 469999999999999999999999999999999999999999999999999999532110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
......+-|.+|+|||.+.| ..|+..+|+||.|||+.||+-|.|-|.+.+.-
T Consensus 156 ---------------------------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 156 ---------------------------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred ---------------------------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 11122378999999999998 45999999999999999999999999999888
Q ss_pred hHHHhhhhcCC-----CCCC--------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 827 QIFDNILNRKI-----PWPR--------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 827 ei~qkIl~~~~-----~~P~--------------------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
+.+..|..... .||+ +....+.++.||+.+||.+||.+|+ ++.|+|+|+||+
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri---ta~qaL~~~yf~ 285 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI---TASQALKHPYFK 285 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc---cHHHHhcchhhh
Confidence 87777765211 1221 1134678899999999999999999 999999999998
Q ss_pred CC
Q 001856 882 DI 883 (1003)
Q Consensus 882 ~I 883 (1003)
..
T Consensus 286 ~~ 287 (318)
T KOG0659|consen 286 SL 287 (318)
T ss_pred cC
Confidence 53
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=373.61 Aligned_cols=260 Identities=27% Similarity=0.522 Sum_probs=215.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+++|++++.||+|+||+||+|+++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875432 2223456789999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 9999975 888888665 45899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 158 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 158 ----------------------------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred ----------------------------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 001123468999999999875 458999999999999999999999998877
Q ss_pred hhhHHHhhhhcC-------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 825 PQQIFDNILNRK-------------------IPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 825 ~~ei~qkIl~~~-------------------~~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..+....+.... ..++. ....+++++++||.+||+.||.+|| |+.|+++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h 286 (309)
T cd07872 210 VEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI---SAEEAMKH 286 (309)
T ss_pred hHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC---CHHHHhcC
Confidence 655544443210 01111 1134788999999999999999999 99999999
Q ss_pred CCCCCC
Q 001856 878 VFFKDI 883 (1003)
Q Consensus 878 PFFk~I 883 (1003)
|||+.+
T Consensus 287 ~~~~~~ 292 (309)
T cd07872 287 AYFRSL 292 (309)
T ss_pred hhhhhc
Confidence 999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=384.33 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=211.7
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
...+++|+++++||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999986542 234456788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||+.+|+|... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~--~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ--T 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc--c
Confidence 999999999998643 3457888889999999999999999999999999999999999999999999874110 0
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHHHHHHhCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
.......+||+.|+|||++.. ...+.++|||||||++|||++|+.|
T Consensus 222 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p 272 (353)
T PLN00034 222 -----------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272 (353)
T ss_pred -----------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence 001224579999999999853 2345789999999999999999999
Q ss_pred CCCCChhhH---HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 820 FNAEHPQQI---FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 820 F~~~~~~ei---~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
|......+. ...+... ..+..+..++.++++||.+||+.||.+|| ++.|+++||||..-
T Consensus 273 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp~~~~~ 334 (353)
T PLN00034 273 FGVGRQGDWASLMCAICMS--QPPEAPATASREFRHFISCCLQREPAKRW---SAMQLLQHPFILRA 334 (353)
T ss_pred CCCCCCccHHHHHHHHhcc--CCCCCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccccC
Confidence 974333222 2222211 12344567899999999999999999999 99999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=366.70 Aligned_cols=261 Identities=39% Similarity=0.685 Sum_probs=212.9
Q ss_pred EeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHH---HhcCCCcEEEEEeeeeccceEEEEEEecc
Q 001856 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL---ISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL---~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
.||+|+||.||+|.+..+++.||+|++.+.............+|..++ ...+||||+.+++.+...+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999999765443333233344454443 34479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 001856 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (1003)
Q Consensus 673 GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~ 752 (1003)
||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----------- 149 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----------- 149 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999862100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-cCCCCccceeechhHHHHHHHhCCCCCCCCCh---hhH
Q 001856 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHP---QQI 828 (1003)
Q Consensus 753 sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~---~ei 828 (1003)
.......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ..+
T Consensus 150 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 207 (279)
T cd05633 150 ----------------------KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (279)
T ss_pred ----------------------cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH
Confidence 0012346899999999986 46689999999999999999999999975432 222
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhhc
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK 892 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~k 892 (1003)
........ +.++..++.++.+||.+||..||.+|+++ .++.++++||||++++|.....++
T Consensus 208 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~ 270 (279)
T cd05633 208 DRMTLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQK 270 (279)
T ss_pred HHHhhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCC
Confidence 11111111 23566789999999999999999999954 369999999999999999886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=398.81 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=204.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC------CCcEEEEEeeeecc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR------NPFVVRFFYSFTCR 661 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~------HPnIVkL~~~f~d~ 661 (1003)
.++|+++++||+|+||+||+|.+..+++.||||+++... ........|+.++..++ |++|++++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 467999999999999999999999999999999986532 12234455666666654 45689999888765
Q ss_pred -ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCC-------------
Q 001856 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDG------------- 726 (1003)
Q Consensus 662 -~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG------------- 726 (1003)
.++|+|||++ |++|.+++.+.+.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 77999999888899999999999999999999997 5999999999999998765
Q ss_pred ---cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCcccee
Q 001856 727 ---HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (1003)
Q Consensus 727 ---~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDI 803 (1003)
.+||+|||++... .......+||+.|||||++.+..|+.++||
T Consensus 283 ~~~~vkl~DfG~~~~~----------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~Di 328 (467)
T PTZ00284 283 DPCRVRICDLGGCCDE----------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDM 328 (467)
T ss_pred CCceEEECCCCccccC----------------------------------ccccccccCCccccCcHHhhcCCCCcHHHH
Confidence 4999999987520 011234689999999999999999999999
Q ss_pred echhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCC------------------------C-C--------------C
Q 001856 804 WSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR------------------------V-P--------------E 844 (1003)
Q Consensus 804 WSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~------------------------l-p--------------~ 844 (1003)
|||||++|||++|++||.+.+..+....+......+|. . + .
T Consensus 329 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (467)
T PTZ00284 329 WSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV 408 (467)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh
Confidence 99999999999999999887765544433321111110 0 0 0
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 845 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 845 ~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
..++.+.|||.+||++||.+|| +++|+|+||||..
T Consensus 409 ~~~~~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 409 IRDDLLCDLIYGLLHYDRQKRL---NARQMTTHPYVLK 443 (467)
T ss_pred hchHHHHHHHHHhCCcChhhCC---CHHHHhcCccccc
Confidence 1245678999999999999999 9999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=389.31 Aligned_cols=252 Identities=32% Similarity=0.544 Sum_probs=217.0
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCE-EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-eE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDL-FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NL 664 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~-VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~-~l 664 (1003)
..++..+.+.||.|+||+||++.++ |.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.... .+
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 3455677777999999999999985 444 999999876654444 789999999999999999999999999887 79
Q ss_pred EEEEEeccCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC-ceeccCCCcceeecCCC-cEEEeecCCccccc
Q 001856 665 YLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGL 740 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~--~g~LsEe~ar~Ia~QIL~ALeYLHs~G-IIHRDIKPeNILLd~dG-~VKLiDFGLAk~~~ 740 (1003)
+|||||+++|+|..++.+ .+.++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999999987 578999999999999999999999999 99999999999999998 99999999998511
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc--cCCCCccceeechhHHHHHHHhCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~--g~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
.. ........||+.|||||++. ...|+.++||||||++||||+||+.
T Consensus 196 ~~-------------------------------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 196 IS-------------------------------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred cc-------------------------------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 00 01122368999999999999 5689999999999999999999999
Q ss_pred CCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
||.+....++...+..... .|.+|..+++.+..||.+||..||.+|| +..+|+.
T Consensus 245 Pf~~~~~~~~~~~v~~~~~-Rp~~p~~~~~~l~~l~~~CW~~dp~~RP---~f~ei~~ 298 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGL-RPPIPKECPPHLSSLMERCWLVDPSRRP---SFLEIVS 298 (362)
T ss_pred CCCCCCHHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHhCCCCCCcCC---CHHHHHH
Confidence 9999888777666654443 3667778999999999999999999999 6666553
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=378.05 Aligned_cols=256 Identities=30% Similarity=0.523 Sum_probs=216.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++.++||.|+||.||+|++..++..+|+|++.... .......+.+|+.+++.++||||++++++|.+.+++|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 468999999999999999999999999999999987542 233456788999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~-GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||++||+|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----- 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 156 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-----
Confidence 99999999999999888899999999999999999999975 799999999999999999999999999863100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ----------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 0112357999999999999988999999999999999999999999765443
Q ss_pred hHHHh--------------------------------------------hhhcCCCCCCCC-CCCCHHHHHHHHhhccCC
Q 001856 827 QIFDN--------------------------------------------ILNRKIPWPRVP-EEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 827 ei~qk--------------------------------------------Il~~~~~~P~lp-~~iS~elkDLIrrcL~kD 861 (1003)
++... +.+.. .+..+ ..++.++++||.+||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~ 286 (333)
T cd06650 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKN 286 (333)
T ss_pred HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCC
Confidence 32211 11111 01111 236789999999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCCC
Q 001856 862 PHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~I 883 (1003)
|.+|| ++.|+++||||+..
T Consensus 287 P~~Rp---t~~ell~h~~~~~~ 305 (333)
T cd06650 287 PAERA---DLKQLMVHAFIKRS 305 (333)
T ss_pred cccCc---CHHHHhhCHHHhcC
Confidence 99999 99999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=380.53 Aligned_cols=257 Identities=27% Similarity=0.468 Sum_probs=210.4
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~---- 662 (1003)
.+++|++++.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45789999999999999999999999999999999876432 2334567789999999999999999999986543
Q ss_pred --eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 663 --~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 6777664 358899999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 175 ~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 222 (359)
T cd07876 175 T--------------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222 (359)
T ss_pred c--------------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 0 00122357899999999999999999999999999999999999999
Q ss_pred CCCChhhHHHhhhhc----------------------CCCCCC-----------------CCCCCCHHHHHHHHhhccCC
Q 001856 821 NAEHPQQIFDNILNR----------------------KIPWPR-----------------VPEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~----------------------~~~~P~-----------------lp~~iS~elkDLIrrcL~kD 861 (1003)
.+.+....+..+... ...++. .....++.+++||.+||+.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 302 (359)
T cd07876 223 QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302 (359)
T ss_pred CCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccC
Confidence 877654433322211 111100 11124678999999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCC
Q 001856 862 PHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~ 882 (1003)
|.+|| ++.|+++||||..
T Consensus 303 P~~R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 303 PDKRI---SVDEALRHPYITV 320 (359)
T ss_pred cccCC---CHHHHhcCchhhh
Confidence 99999 9999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=381.94 Aligned_cols=262 Identities=31% Similarity=0.527 Sum_probs=222.8
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ce
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--EN 663 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~ 663 (1003)
.++++|+.+..|++|+||.||+|+++.|++.||+|.++... .....--..++|+.+|.+++|||||.+-++.... +.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35678999999999999999999999999999999997654 1222233567999999999999999999887654 57
Q ss_pred EEEEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
+|||||||+. +|..++.+.+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+....
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs- 229 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS- 229 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC-
Confidence 9999999987 9999998875 899999999999999999999999999999999999999999999999999994110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
........+-|.+|+|||.+.+. .|+.++|+||+|||+.||+++++.|.
T Consensus 230 ------------------------------p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 230 ------------------------------PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred ------------------------------CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 01223456889999999999984 59999999999999999999999999
Q ss_pred CCChhhHHHhhhhcC-------------------CCCCCCC---------C-CCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 822 AEHPQQIFDNILNRK-------------------IPWPRVP---------E-EMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~-------------------~~~P~lp---------~-~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
+....+.+.+|+... ..++..| . .+++...+|+..+|.+||.+|. ||+
T Consensus 280 G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~---tA~ 356 (419)
T KOG0663|consen 280 GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI---TAE 356 (419)
T ss_pred CCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc---cHH
Confidence 999888888887611 1112111 1 1568999999999999999999 999
Q ss_pred HHHcCCCCCCC
Q 001856 873 EVKQHVFFKDI 883 (1003)
Q Consensus 873 ELLqHPFFk~I 883 (1003)
+.|+|.||.+.
T Consensus 357 ~~L~h~~F~e~ 367 (419)
T KOG0663|consen 357 DGLKHEYFRET 367 (419)
T ss_pred HhhcccccccC
Confidence 99999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=358.18 Aligned_cols=257 Identities=40% Similarity=0.804 Sum_probs=223.7
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+...+|++|||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876655555667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 001856 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (1003)
Q Consensus 677 ~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgtt 756 (1003)
.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~--------------- 145 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--------------- 145 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc---------------
Confidence 99999888899999999999999999999999999999999999999999999999999873100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC--hhhHHHhhhh
Q 001856 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH--PQQIFDNILN 834 (1003)
Q Consensus 757 l~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~--~~ei~qkIl~ 834 (1003)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ..+.+..+..
T Consensus 146 -----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 208 (262)
T cd05572 146 -----------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208 (262)
T ss_pred -----------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc
Confidence 001123578999999999988889999999999999999999999998766 6666777664
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChh
Q 001856 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 835 ~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~ 886 (1003)
... .+..+...++++.+||.+||+.+|.+|++. .++.|+++||||++.+|+
T Consensus 209 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 209 GNG-KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred cCC-CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 222 234455678999999999999999999932 239999999999999986
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=384.78 Aligned_cols=261 Identities=32% Similarity=0.494 Sum_probs=220.4
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-----cce
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-----REN 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d-----~~~ 663 (1003)
..|..++.||.|+||.|+.|.++.+|+.||||.+.... ...-..++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34666899999999999999999999999999886432 334456889999999999999999999999876 346
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|+|+|+| +-+|...|+..+.+++..++.+++||+.||+|+|+.||+||||||.|+|++.+..+||+|||+|+.....
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 4599999999888999999999999999999999999999999999999999999999999999952111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
......+.++-|.+|.|||++.. ..|+.++||||+|||+.|||+|++.|.|
T Consensus 179 ----------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 179 ----------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred ----------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 00112345789999999999865 6799999999999999999999999998
Q ss_pred CChhhHHHhhhhc-----------------------CC-----CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 823 EHPQQIFDNILNR-----------------------KI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 823 ~~~~ei~qkIl~~-----------------------~~-----~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
.+....++.|+.. .. +|..+..+.++.+.||+.+||..||.+|+ |++|+
T Consensus 231 ~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi---ta~eA 307 (359)
T KOG0660|consen 231 KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI---TAEEA 307 (359)
T ss_pred CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC---CHHHH
Confidence 8766655555441 11 11122357899999999999999999999 99999
Q ss_pred HcCCCCCCC
Q 001856 875 KQHVFFKDI 883 (1003)
Q Consensus 875 LqHPFFk~I 883 (1003)
|+||||...
T Consensus 308 L~hPYl~~~ 316 (359)
T KOG0660|consen 308 LAHPYLAPY 316 (359)
T ss_pred hcChhhhhh
Confidence 999999853
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=365.24 Aligned_cols=266 Identities=32% Similarity=0.571 Sum_probs=227.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+.|+++++||.|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 5699999999999999999999999999999998754 2345677889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||++|++|..++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~----- 163 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT----- 163 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-----
Confidence 99999999988765 456899999999999999999999999999999999999999999999999987631000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
........|++.|+|||++. ...++.++|||||||++|+|++|.+||..
T Consensus 164 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 164 --------------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred --------------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 01112356889999999985 34468899999999999999999999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhh
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 891 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~ 891 (1003)
.+....+.++.....+....+..++.++.+||.+||..||.+|| +++++++||||..++|....+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 218 LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred ccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccccccchhHHH
Confidence 77766666665444333334567889999999999999999999 9999999999999999875443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=355.11 Aligned_cols=265 Identities=62% Similarity=1.116 Sum_probs=227.7
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||.|+||.||+|++..+|+.||+|++.+.........+.+.+|++++..++||||+++++.+.....+|++|||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999876555556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 001856 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (1003)
Q Consensus 677 ~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgtt 756 (1003)
.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99999888899999999999999999999999999999999999999999999999999874211100000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcC
Q 001856 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836 (1003)
Q Consensus 757 l~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~ 836 (1003)
...........+++.|+|||++.+..++.++|+||||+++|+|++|..||......+.+..+....
T Consensus 152 --------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (265)
T cd05579 152 --------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217 (265)
T ss_pred --------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 000012234578899999999998889999999999999999999999999888888888887766
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 837 ~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
..++.. ..++..+.+||.+||+.+|.+||++.++.++++||||++++|
T Consensus 218 ~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 218 IEWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cCCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 554432 225899999999999999999995555599999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=395.14 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=223.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCC-CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTT-GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~t-gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++||||+++++.|...+++||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976543 23444667889999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 667 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999999741100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 223 -~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 223 -V----------------------------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred -c----------------------------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 0 00112356899999999999999999999999999999999999999999
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.+..+++..++.+... ..+..++.++.+||.+||++||.+|| ++.+++.|+|++.
T Consensus 274 ~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~ 328 (478)
T PTZ00267 274 PSQREIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHH
Confidence 8888888888766542 34567899999999999999999999 9999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=400.34 Aligned_cols=258 Identities=32% Similarity=0.583 Sum_probs=232.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|..+..||+|+||.||+|.+..+++.||+|++.... .+..++.+..|+.+|..++++||.++|+.|.....++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 34888899999999999999999999999999998653 3456788999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|||.||++.+.++..+.+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+-..
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql--------- 161 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQL--------- 161 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeee---------
Confidence 99999999999998877899999999999999999999999999999999999999999999999998631
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.....++.+++|||.|||||++...+|+.++||||||++.|||++|.+||....+...
T Consensus 162 ----------------------~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 162 ----------------------TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred ----------------------echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 0112334789999999999999999999999999999999999999999999888766
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
+-.|-+..+ |.+...+|+.+++||..||.+||+.|| +|.++|+|+|++...
T Consensus 220 lflIpk~~P--P~L~~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 220 LFLIPKSAP--PRLDGDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRAK 270 (467)
T ss_pred EEeccCCCC--CccccccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhcC
Confidence 666655443 556678999999999999999999999 999999999998743
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=392.20 Aligned_cols=262 Identities=34% Similarity=0.591 Sum_probs=236.0
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+..-.=|.+-+.||+|-|+.|-+|++.-||..||||++.|..+..- ...++..|+..|+.++|||||+||++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 3334559999999999999999999999999999999999876433 346788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~ 742 (1003)
|||+|+-.||+|++||.++ ..+.|+.++.|++||+.|+.|+|+..+|||||||+||.+.. -|-|||+|||++...
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf--- 169 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF--- 169 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC---
Confidence 9999999999999999776 56999999999999999999999999999999999997754 699999999998531
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCC-ccceeechhHHHHHHHhCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-TTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys-~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
+...+..+.||+..|.|||++.|..|+ +++||||||||||-|++|++||.
T Consensus 170 -----------------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 170 -----------------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred -----------------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 112445679999999999999999985 78899999999999999999999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
..+..+++.+|+..++.. |..+|.+++|||..||..||.+|. +.++|..|+|++.++-
T Consensus 221 eANDSETLTmImDCKYtv---PshvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 221 EANDSETLTMIMDCKYTV---PSHVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDR 278 (864)
T ss_pred cccchhhhhhhhcccccC---chhhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCC
Confidence 999999999999999864 578999999999999999999999 9999999999998753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=378.21 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=212.3
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~----- 661 (1003)
.+++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45789999999999999999999999999999999876432 233446778899999999999999999887653
Q ss_pred -ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 662 -~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
..+|+||||+++ +|...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 358999999975 78777754 48899999999999999999999999999999999999999999999999997310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 178 ~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 178 T--------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred C--------------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 0 00112457899999999999999999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCCC----------------------C---------C--------CCCCCCCHHHHHHHHhhccCC
Q 001856 821 NAEHPQQIFDNILNRKIP----------------------W---------P--------RVPEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~----------------------~---------P--------~lp~~iS~elkDLIrrcL~kD 861 (1003)
.+.+..+.+..++..... + + ......+..+++||.+||+.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 305 (364)
T cd07875 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305 (364)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcC
Confidence 887776665555431110 0 0 001123567899999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCC
Q 001856 862 PHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~ 882 (1003)
|.+|| |+.++|+||||..
T Consensus 306 P~~R~---t~~e~L~hp~~~~ 323 (364)
T cd07875 306 ASKRI---SVDEALQHPYINV 323 (364)
T ss_pred cccCC---CHHHHhcCccccc
Confidence 99999 9999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.39 Aligned_cols=255 Identities=37% Similarity=0.649 Sum_probs=215.3
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|++++.||+|+||+||+|++..+++.||+|++......... .....+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876543332 23445699999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 001856 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p 750 (1003)
+.+++|.+++.+.+.+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---------- 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 9999999999988899999999999999999999999999999999999999999999999999987310
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-cCCCCccceeechhHHHHHHHhCCCCCCCCC---hh
Q 001856 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEH---PQ 826 (1003)
Q Consensus 751 ~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~ys~kSDIWSLGVILYELLTGk~PF~~~~---~~ 826 (1003)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||.... ..
T Consensus 150 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~ 208 (260)
T PF00069_consen 150 ---------------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL 208 (260)
T ss_dssp ---------------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH
T ss_pred ---------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 0012234568899999999998 7889999999999999999999999998873 33
Q ss_pred hHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....+.......... .....+.++.++|.+||+.||.+|| ++.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 209 EIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred hhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 333333332211110 1112348999999999999999999 99999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=373.52 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=207.6
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF 658 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f 658 (1003)
....++|++.+.||.|+||.||+|.+. .++..||+|+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 344578999999999999999999852 445789999987532 233456788999999999 899999999988
Q ss_pred ecc-ceEEEEEEeccCCChHHHHHhc------------------------------------------------------
Q 001856 659 TCR-ENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------ 683 (1003)
Q Consensus 659 ~d~-~~lyLVmEy~~GGSL~d~L~~~------------------------------------------------------ 683 (1003)
... ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4689999999999999999752
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 001856 684 --------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755 (1003)
Q Consensus 684 --------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgt 755 (1003)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------ 228 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 228 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc------------
Confidence 237778889999999999999999999999999999999999999999999987311000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhh
Q 001856 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILN 834 (1003)
Q Consensus 756 tl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~ 834 (1003)
.........+|+.|||||++.+..++.++|||||||++|||++ |..||.+....+.+...+.
T Consensus 229 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 291 (338)
T cd05102 229 -----------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291 (338)
T ss_pred -----------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh
Confidence 0011123456789999999999999999999999999999997 9999987654443333333
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 835 ~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
... .+..+..+++++.+||.+||+.||.+|| ++.++++
T Consensus 292 ~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 292 DGT-RMRAPENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 222 2334667899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.97 Aligned_cols=254 Identities=27% Similarity=0.536 Sum_probs=219.4
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-cceEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVM 668 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d-~~~lyLVm 668 (1003)
+|++++.||+|+||.||++.++.+++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 49999999999999999999999999999999875432 23345678889999999999999999988875 44689999
Q ss_pred EeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 669 EYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... .
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~-- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--Q-- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--c--
Confidence 999999999999763 4589999999999999999999999999999999999999999999999999874110 0
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 156 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 208 (257)
T cd08223 156 ---------------------------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208 (257)
T ss_pred ---------------------------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 01122457899999999999998999999999999999999999999988777
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.....+..... +..+..+++++.+||.+||+.||.+|| ++.++++||||
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 209 SLVYRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred HHHHHHHhcCC--CCCccccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 76666655543 345667899999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=376.54 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=210.4
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~----- 661 (1003)
.+++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45789999999999999999999999999999999876432 233456778899999999999999999988654
Q ss_pred -ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 662 -~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 67777654 48899999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 171 ~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 171 T--------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred C--------------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 0 00112457899999999999999999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcC----------------------CC-----CC------------CCCCCCCHHHHHHHHhhccCC
Q 001856 821 NAEHPQQIFDNILNRK----------------------IP-----WP------------RVPEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~----------------------~~-----~P------------~lp~~iS~elkDLIrrcL~kD 861 (1003)
.+.+..+.+..++... .. ++ ..+...+.++++||.+||+.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 298 (355)
T cd07874 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298 (355)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCC
Confidence 8876544433332210 00 00 011224568899999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCC
Q 001856 862 PHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~ 882 (1003)
|.+|| |+.|+++||||..
T Consensus 299 P~~Rp---s~~ell~hp~~~~ 316 (355)
T cd07874 299 PAKRI---SVDEALQHPYINV 316 (355)
T ss_pred chhcC---CHHHHhcCcchhc
Confidence 99999 9999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.30 Aligned_cols=254 Identities=30% Similarity=0.536 Sum_probs=222.7
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|.+.+.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 589999999999999999999999999999998765433 3445678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|++|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 99999999999764 56899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 155 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 155 --------------------------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred --------------------------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 001123578999999999999989999999999999999999999999888777
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....+..... +.++..++..+.++|.+||+.+|.+|| ++.++++|||+
T Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 209 LILKIIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred HHHHHHcCCC--CCCccccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 7777665443 445557889999999999999999999 99999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=393.96 Aligned_cols=258 Identities=31% Similarity=0.549 Sum_probs=234.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce-EEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-LYL 666 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~-lyL 666 (1003)
+++|..++.+|+|+||.+++++++..++.|++|.+.......+.. ....+|..+++++.|||||.+++.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 578999999999999999999999999999999998776655543 478899999999999999999999999988 999
Q ss_pred EEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||+||+||+|.+.|.+.+ .++++.+..|+.||+.||+|||+++|+|||||+.||+++.++.|||.|||+|+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--- 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--- 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC---
Confidence 999999999999997653 699999999999999999999999999999999999999999999999999995110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
......+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|.+.+
T Consensus 159 ----------------------------~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 159 ----------------------------EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred ----------------------------chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 0113457899999999999999999999999999999999999999999999
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
...+..+|..... ..+|..++.+++.+|+.||.++|..|| +|.++|.+|....
T Consensus 211 m~~Li~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 211 MSELILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLR 263 (426)
T ss_pred hHHHHHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhh
Confidence 9999999998773 456789999999999999999999999 9999999998763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=396.51 Aligned_cols=260 Identities=29% Similarity=0.488 Sum_probs=224.9
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~----- 662 (1003)
.++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.++..++|+||++++..+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4689999999999999999999999999999999976543 3344567889999999999999999988775432
Q ss_pred ---eEEEEEEeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 663 ---NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 663 ---~lyLVmEy~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 378999999999999998643 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
++...... ........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 190 s~~~~~~~-----------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt 240 (496)
T PTZ00283 190 SKMYAATV-----------------------------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240 (496)
T ss_pred Ceeccccc-----------------------------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 87411000 0011235689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
|+.||.+.+..+++..+..... +.++..+++++.+||.+||+.||.+|| ++.++++|||++.
T Consensus 241 G~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~RP---s~~ell~~p~~~~ 302 (496)
T PTZ00283 241 LKRPFDGENMEEVMHKTLAGRY--DPLPPSISPEMQEIVTALLSSDPKRRP---SSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcccChhhCc---CHHHHHhCHHHHH
Confidence 9999999888888888776544 345678999999999999999999999 9999999999875
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.33 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=211.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------ 661 (1003)
.++|++++.||.|+||+||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3679999999999999999999999999999999876432 223345677899999999999999999888643
Q ss_pred ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..+|++||++ |++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~- 169 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD- 169 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC-
Confidence 3579999988 7799887754 579999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 170 ---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 170 ---------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred ---------------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 01123578999999999987 56899999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCC--------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 821 NAEHPQQIFDNILNRKI--------------------PWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~--------------------~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
.+.+..+.+..+..... .++. .....++.+.+||.+||+.||.+|| ++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~---s~~ 293 (343)
T cd07878 217 PGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI---SAS 293 (343)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC---CHH
Confidence 87765554444432110 0011 1124567899999999999999999 999
Q ss_pred HHHcCCCCCCC
Q 001856 873 EVKQHVFFKDI 883 (1003)
Q Consensus 873 ELLqHPFFk~I 883 (1003)
|+++||||...
T Consensus 294 ell~hp~~~~~ 304 (343)
T cd07878 294 EALAHPYFSQY 304 (343)
T ss_pred HHhcCcchhcc
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=360.39 Aligned_cols=260 Identities=33% Similarity=0.572 Sum_probs=224.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||.|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5799999999999999999999889999999998653 3345577889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+++++|..++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~------ 155 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS------ 155 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc------
Confidence 999999999999764 5699999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.........||+.|+|||++. +..++.++|+|||||++|+|++|++||..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 156 -------------------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred -------------------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 001123457899999999985 34467899999999999999999999998
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
.+.......+.....+....+..++.++.+||.+||+.+|.+|| ++.++++||||.+...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~~ 270 (280)
T cd06611 211 LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSDQSD 270 (280)
T ss_pred CCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcccch
Confidence 88777777776554433334567899999999999999999999 9999999999987644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.96 Aligned_cols=262 Identities=29% Similarity=0.506 Sum_probs=221.7
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeecccc---ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~---~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
+|++.+.||.|+||+||+|.. .+++.+|+|.+..... ........+.+|+.+++.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 488899999999999999987 5788999999875321 223445678899999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
+|||++|++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 158 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH- 158 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998731100000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
. ..........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 159 ------------~------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 159 ------------G------------THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred ------------c------------cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 0 0001123457999999999999988999999999999999999999999876655
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.....+.......+.++..++.++.+||++||..+|.+|| ++.++++||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 215 AAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred HHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 5544444443445667778999999999999999999999 99999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=359.62 Aligned_cols=261 Identities=37% Similarity=0.655 Sum_probs=215.4
Q ss_pred EeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHH---HHHhcCCCcEEEEEeeeeccceEEEEEEecc
Q 001856 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD---ILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~---IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
.||+|+||.||+|++..+++.||+|++.+...........+..|.. ++...+||+|+++++.|...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987654332222223334433 4445689999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 001856 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (1003)
Q Consensus 673 GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~ 752 (1003)
||+|..++.+.+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----------- 149 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----------- 149 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCC---ChhhH
Q 001856 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE---HPQQI 828 (1003)
Q Consensus 753 sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~---~~~ei 828 (1003)
......+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||... .....
T Consensus 150 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~ 207 (278)
T cd05606 150 ----------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (278)
T ss_pred ----------------------cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 01123479999999999975 46899999999999999999999999765 33333
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhhc
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 892 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~--SAeELLqHPFFk~Idw~~L~~~k 892 (1003)
...+.... +.++..++.++.++|.+||..+|.+|+... ++.++++||||+.++|..+...+
T Consensus 208 ~~~~~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~ 270 (278)
T cd05606 208 DRMTLTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQK 270 (278)
T ss_pred HHHhhccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcc
Confidence 33332222 234556799999999999999999999765 89999999999999999886654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.88 Aligned_cols=261 Identities=28% Similarity=0.524 Sum_probs=221.3
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc------cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI------RKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~------~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
+|.+...||.|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.++..++||||+++++.+.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 377888999999999999999889999999988754322 12344678899999999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
.|++|||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.. ...........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 161 ~~-------------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 161 LS-------------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cc-------------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 00 00001123456899999999999888999999999999999999999999877
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+.......+... ..+.++..++..+.++|++||+.||.+|| ++.++++||||
T Consensus 216 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 216 TQLQAIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred cHHHHHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 665555554442 23456677899999999999999999999 99999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.27 Aligned_cols=260 Identities=26% Similarity=0.510 Sum_probs=214.9
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+++|++++.||.|+||.||+|++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.....+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999875432 2223456789999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--- 157 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 157 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC---
Confidence 999997 4999888764 56899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||...+
T Consensus 158 ----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 158 ----------------------------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred ----------------------------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0011234678999999998764 47889999999999999999999998877
Q ss_pred hhhHHHhhhhcC-------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 825 PQQIFDNILNRK-------------------IPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 825 ~~ei~qkIl~~~-------------------~~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..+....+.... ..++. ....+++.+++||.+||+.||.+|| |++|+++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~---t~~eil~h 286 (301)
T cd07873 210 VEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI---SAEEAMKH 286 (301)
T ss_pred HHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc---CHHHHhcC
Confidence 655544433210 01111 1135788999999999999999999 99999999
Q ss_pred CCCCCC
Q 001856 878 VFFKDI 883 (1003)
Q Consensus 878 PFFk~I 883 (1003)
|||+.+
T Consensus 287 ~~f~~~ 292 (301)
T cd07873 287 PYFHCL 292 (301)
T ss_pred cccccc
Confidence 999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.40 Aligned_cols=256 Identities=32% Similarity=0.552 Sum_probs=219.4
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|++++.||.|+||.||+|++..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986532 34456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
+++++|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------- 156 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------- 156 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-------
Confidence 999999988865 467999999999999999999999999999999999999999999999999998631000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........||+.|+|||++. +..++.++|||||||++|+|++|.+||...+
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 157 ------------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ------------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 01122457899999999984 3457789999999999999999999998887
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
..+....+.....+....+..++.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 213 PMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 776666665544333334567889999999999999999999 99999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.93 Aligned_cols=255 Identities=32% Similarity=0.527 Sum_probs=214.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++.+.||.|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999987542 22345677899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT----- 159 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-----
Confidence 999999999999988889999999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc---cCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....
T Consensus 160 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 160 --------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred --------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 01122457999999999985 4558899999999999999999999997655
Q ss_pred hhhHHHhhhhcCCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 825 PQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~l--p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
+......+.......+.. ...++..+.+||.+||+.+|.+|| +++++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 214 PMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred chhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 444333333332222222 125788999999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=348.74 Aligned_cols=260 Identities=33% Similarity=0.557 Sum_probs=220.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987644322 5578899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 669 EYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~---g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|+++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.........+|++.|+|||++... .++.++|+|||||++|+|++|+.||...+
T Consensus 158 --------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 --------------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred --------------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 000112345789999999999876 78999999999999999999999998877
Q ss_pred hhhHHHhhhhcCCCC-CCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 825 PQQIFDNILNRKIPW-PRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~-P~l--p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....+.++.....+. +.. ...+++.+.+||.+||++||.+|| ++.+|++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 212 PMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred hhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 766666665543221 111 136789999999999999999999 99999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.69 Aligned_cols=253 Identities=28% Similarity=0.492 Sum_probs=212.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|+++++||.|+||.||+|++..+++.||+|++.+.. .......+.+|+.++..++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46899999999999999999999999999999987542 2334467889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||+++++|..+ ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~------- 147 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------- 147 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-------
Confidence 99999998654 3578999999999999999999999999999999999999999999999999873100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh---
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP--- 825 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~--- 825 (1003)
......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 148 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 201 (279)
T cd06619 148 --------------------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201 (279)
T ss_pred --------------------------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc
Confidence 012245799999999999999999999999999999999999999965321
Q ss_pred ----hhHHHhhhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 826 ----QQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 826 ----~ei~qkIl~~~~~~P~l-p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
....+.+..... +.. ....++++.+||.+||+.+|.+|| +++++++||||...+-
T Consensus 202 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~~~~ 261 (279)
T cd06619 202 SLMPLQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQYND 261 (279)
T ss_pred ccchHHHHHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCcccccccC
Confidence 122233222221 111 235788999999999999999999 9999999999986643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=362.87 Aligned_cols=256 Identities=30% Similarity=0.526 Sum_probs=215.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||+|+||.||+|++..++..||+|.+.... .......+.+|++++..++||||+++++.|.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986532 2344567889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||++|++|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999988889999999999999999999997 699999999999999999999999999886310
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+...
T Consensus 152 --------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 152 --------------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred --------------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 001224578999999999988889999999999999999999999997655433
Q ss_pred HHHhhhhcCC----------------------------------CCCCCC-CCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 828 IFDNILNRKI----------------------------------PWPRVP-EEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 828 i~qkIl~~~~----------------------------------~~P~lp-~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
....+..... ..|..+ ..++.++++||.+||..+|.+|| ++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~ 282 (308)
T cd06615 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA---DLK 282 (308)
T ss_pred HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc---CHH
Confidence 3221111000 001111 23678999999999999999999 999
Q ss_pred HHHcCCCCCC
Q 001856 873 EVKQHVFFKD 882 (1003)
Q Consensus 873 ELLqHPFFk~ 882 (1003)
++++||||.+
T Consensus 283 ~ll~~~~~~~ 292 (308)
T cd06615 283 ELTKHPFIKR 292 (308)
T ss_pred HHhcChhhhh
Confidence 9999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.48 Aligned_cols=253 Identities=39% Similarity=0.727 Sum_probs=221.1
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999999999999999987665555567889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|+.|++|..++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~------- 153 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD------- 153 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-------
Confidence 9999999999988778999999999999999999999999999999999999999999999999998731100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh---h
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP---Q 826 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~---~ 826 (1003)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. .
T Consensus 154 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (258)
T cd05578 154 -------------------------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208 (258)
T ss_pred -------------------------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH
Confidence 011235688899999999988899999999999999999999999987763 3
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH--HHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA--SEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SA--eELLqHPFF 880 (1003)
.+.+.... ..+..+..++..+.++|.+||..||.+|| ++ .|+++||||
T Consensus 209 ~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~~~l~~~~~~ 258 (258)
T cd05578 209 QIRAKQET---ADVLYPATWSTEAIDAINKLLERDPQKRL---GDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHhcc---ccccCcccCcHHHHHHHHHHccCChhHcC---CccHHHHhcCCCC
Confidence 33333222 22345677899999999999999999999 66 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=375.37 Aligned_cols=260 Identities=30% Similarity=0.548 Sum_probs=220.6
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeeccc----
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRE---- 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn-IVkL~~~f~d~~---- 662 (1003)
+..|+.+++||+|+||+||+|+.+.+|+.||+|.+.-.... +.......+|+.+|+.++|+| |++|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688899999999999999999999999999998765321 223456689999999999999 999999999887
Q ss_pred --eEEEEEEeccCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 663 --NLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 663 --~lyLVmEy~~GGSL~d~L~~~g----~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
.+|||+||+.. +|..++...+ .++...++.+++||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 9999998765 5888999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHh
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLT 815 (1003)
+..... .....+.++|.+|+|||++.+. .|+..+||||+|||++||++
T Consensus 168 ra~~ip-------------------------------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 168 RAFSIP-------------------------------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred HHhcCC-------------------------------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence 831100 0113456899999999999986 68999999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcC-----CCCCC-------------CC---------CCCCHHHHHHHHhhccCCcCCcCCC
Q 001856 816 GIPPFNAEHPQQIFDNILNRK-----IPWPR-------------VP---------EEMSPEAHDLIDRFLTEDPHQRLGS 868 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~-----~~~P~-------------lp---------~~iS~elkDLIrrcL~kDP~kRpg~ 868 (1003)
+++.|.+.+..+....|.... ..||. .. ...++...+++.+||+++|.+|.
T Consensus 217 ~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~-- 294 (323)
T KOG0594|consen 217 RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI-- 294 (323)
T ss_pred CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc--
Confidence 999999998877777776511 11221 11 12346899999999999999999
Q ss_pred CCHHHHHcCCCCCCC
Q 001856 869 GGASEVKQHVFFKDI 883 (1003)
Q Consensus 869 ~SAeELLqHPFFk~I 883 (1003)
+|+.++.||||..+
T Consensus 295 -Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 295 -SAKGALTHPYFSEL 308 (323)
T ss_pred -CHHHHhcChhhccc
Confidence 99999999999876
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=379.58 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=212.9
Q ss_pred CCeEEEEEeeccCceEEEEEEEC--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk--~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+|++++.||+|+||.||+|... .+++.||+|.+.... ...+|+.+|+.++||||+++++.|.....+|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 46999999999999999999864 356789999876532 34579999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||++. ++|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||+++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~--- 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP--- 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc---
Confidence 999996 5999999777889999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....
T Consensus 240 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 240 --------------------------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred --------------------------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 001123467999999999999999999999999999999999999999765421
Q ss_pred ---hHHHhhhhc----CC-------------------------CCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 827 ---QIFDNILNR----KI-------------------------PWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 827 ---ei~qkIl~~----~~-------------------------~~P~l--p~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
..+..+... .. ..+.. ...++.++.+||.+||+.||.+|| ++.
T Consensus 294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp---sa~ 370 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP---SAQ 370 (392)
T ss_pred CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC---CHH
Confidence 112222110 00 00000 123567899999999999999999 999
Q ss_pred HHHcCCCCCCCChhHHh
Q 001856 873 EVKQHVFFKDINWDTLA 889 (1003)
Q Consensus 873 ELLqHPFFk~Idw~~L~ 889 (1003)
|+|+||||+...|+.+.
T Consensus 371 e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 371 DILSLPLFTKEPINLLN 387 (392)
T ss_pred HHhhCchhhccchhhhc
Confidence 99999999998888764
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=353.99 Aligned_cols=255 Identities=30% Similarity=0.528 Sum_probs=209.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|+||.||+|++..++..||+|++..... .......+.+|+.++..++||||+++++.+.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999875432 22234567889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 670 YLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 670 y~~GGSL~d~L~~~---g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 997 5898888653 46899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........|++.|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus 155 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 155 ---------------------------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred ---------------------------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 0011234678999999998764 478999999999999999999999987654
Q ss_pred hhHHHhhhhcCC------------------CC--------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 826 QQIFDNILNRKI------------------PW--------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 826 ~ei~qkIl~~~~------------------~~--------P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
......+..... .+ ......+++++.+||++||+.||.+|| ++.++++|||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~~ll~~~~ 284 (285)
T cd07861 208 IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI---SAKKALNHPY 284 (285)
T ss_pred HHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC---CHHHHhcCCC
Confidence 333222211000 00 011235789999999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 285 ~ 285 (285)
T cd07861 285 F 285 (285)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=377.75 Aligned_cols=251 Identities=33% Similarity=0.559 Sum_probs=212.9
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----ceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-----~~l 664 (1003)
.|+-.+++|.|+||.||.|....+++.||||.+-.... --.+|+.+|+.++|||||+|..+|... -++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 48999999999999999999999999999998765431 223699999999999999999888643 256
Q ss_pred EEEEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-CcEEEeecCCcccc
Q 001856 665 YLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVG 739 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-G~VKLiDFGLAk~~ 739 (1003)
.+|||||+. +|.++++. ...++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 799999986 99999974 4679999999999999999999999999999999999999986 99999999999952
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
.. +....++..|..|+|||.+.| ..|+.+.||||.||++.||+-|++
T Consensus 177 ~~--------------------------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p 224 (364)
T KOG0658|consen 177 VK--------------------------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP 224 (364)
T ss_pred cc--------------------------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence 11 112346788999999999997 569999999999999999999999
Q ss_pred CCCCCChhhHHHhhhhc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 819 PFNAEHPQQIFDNILNR-----------------KIPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~~-----------------~~~~P~---------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
.|.|.+..+.+..|.+- ...+|. +....++++.+|+.++|+++|.+|. ++.
T Consensus 225 lFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~---~~~ 301 (364)
T KOG0658|consen 225 LFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL---SAL 301 (364)
T ss_pred ccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC---CHH
Confidence 99998887777666551 111221 2245789999999999999999999 999
Q ss_pred HHHcCCCCCCC
Q 001856 873 EVKQHVFFKDI 883 (1003)
Q Consensus 873 ELLqHPFFk~I 883 (1003)
|+++||||.++
T Consensus 302 ~~l~h~fFdel 312 (364)
T KOG0658|consen 302 EALAHPFFDEL 312 (364)
T ss_pred HHhcchhhHHh
Confidence 99999999865
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=352.20 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=214.1
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++..++||||+++++.+...+.+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999987542 22335678899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||+++++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT----- 159 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc-----
Confidence 999999999999988888999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc---cCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........|++.|+|||++. ...++.++|+|||||++|||++|..||....
T Consensus 160 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 160 --------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred --------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 00112357899999999985 3447889999999999999999999997655
Q ss_pred hhhHHHhhhhcCCCCCC--CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 825 PQQIFDNILNRKIPWPR--VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~--lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
+......+.......+. ....++..+.+||++||+.+|.+|| +++++++|+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 214 PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred hhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 54433333333222222 1235789999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.93 Aligned_cols=254 Identities=37% Similarity=0.596 Sum_probs=218.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999997643 224577889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~------ 153 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA------ 153 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh------
Confidence 999999999999776 7899999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC---CCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.........|+..|+|||++.+. .++.++|+|||||++|+|++|++||...+
T Consensus 154 -------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 154 -------------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -------------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 00112345789999999999876 78899999999999999999999998877
Q ss_pred hhhHHHhhhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 825 PQQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P--~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
.......+.......+ ..+..++.++.+||.+||..+|.+|| ++.+++.|+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 209 PMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 6655555544422222 12345678899999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=350.12 Aligned_cols=262 Identities=28% Similarity=0.517 Sum_probs=218.4
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc---cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI---RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~---~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
+|+..+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998754321 22345788999999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-cEEEeecCCccccccCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-~VKLiDFGLAk~~~~~s~d 745 (1003)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~- 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT- 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc-
Confidence 999999999999998888899999999999999999999999999999999999998776 599999999874110000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
..........||..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 160 --------------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 160 --------------------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred --------------------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 000112235789999999999988899999999999999999999999975543
Q ss_pred hhHHHhhhh--cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 826 QQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 826 ~ei~qkIl~--~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
......+.. .....+.++..+++++.++|.+||..+|.+|| ++.++++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred cchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 332222221 11122455667899999999999999999999 999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.11 Aligned_cols=260 Identities=29% Similarity=0.510 Sum_probs=218.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccc--cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~--~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~l 664 (1003)
.+|++.+.||+|+||.||+|++..+++.||||++.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 12234567888999999999999999999988764 468
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|++|||++|++|.+++.+.+.+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~-- 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI-- 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.. .........||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 160 ------~~--------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 160 ------CL--------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred ------cc--------------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 00 0001223568999999999998889999999999999999999999998766
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
.......+.... ..+..+..++..+.++|++||. +|.+|| +++++++|||+.
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 214 AMAAIFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRP---SADELLRHTFVH 265 (265)
T ss_pred hHHHHHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCC---CHHHHhcCcccC
Confidence 555554444322 2344567788999999999995 899999 999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=396.47 Aligned_cols=262 Identities=32% Similarity=0.571 Sum_probs=237.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+-|+|+..||.|+||+||+|.++.++...|.|+|.. .....++.++-|++||..++||+||+|+++|...+.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 348999999999999999999999999999998864 34677889999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||.||-+..++... ..|++.+++.+.+|++.||.|||+++|||||||..|||++.+|.|+|+|||.+-.
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK--------- 179 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK--------- 179 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc---------
Confidence 999999999988766 4699999999999999999999999999999999999999999999999998752
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
......+..+++|||+|||||++. ..+|++++||||||++|.||..+.||-..
T Consensus 180 ----------------------n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 180 ----------------------NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ----------------------chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 012234566899999999999875 47899999999999999999999999999
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhH
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT 887 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~ 887 (1003)
.++..++-+|.+..++-.-.|..++..+.||+.+||.+||..|| ++.+|++||||.+++-..
T Consensus 238 lnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 238 LNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred cchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCcccccCCcch
Confidence 99999999998887765556889999999999999999999999 999999999999887654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.52 Aligned_cols=259 Identities=34% Similarity=0.572 Sum_probs=220.2
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
....+|++++.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.|....+.|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 344689999999999999999999999999999999876432 23466889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--- 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc---
Confidence 99999999999999865 46899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus 170 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 170 ----------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred ----------------------------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0011235789999999999988899999999999999999999999987776
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
......+.....+....+..++..+.+||.+||.++|.+|| ++.++++||||..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~ 275 (296)
T cd06654 222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (296)
T ss_pred HHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhc
Confidence 54443333332222234567889999999999999999999 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.88 Aligned_cols=260 Identities=30% Similarity=0.501 Sum_probs=217.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cceE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENL 664 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~--~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~~l 664 (1003)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.+++.++||||+++++.+.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 369999999999999999999999999999999875432 223445678899999999999999999998876 3578
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|++|||+++++|.+++.+.+.+++.....++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999873110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.........|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 162 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 162 ----------------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ----------------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 0001123568899999999999889999999999999999999999998766
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
.......+.... ..+.++..+++.+++|| +||..+|.+|| +++|+++||||+
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 214 AMAAIFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred hHHHHHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCc---CHHHHhcCcccc
Confidence 555444443322 23455667889999999 57778999999 999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=362.75 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=193.5
Q ss_pred EEEeeccCceEEEEEEEC--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cceEEEEEE
Q 001856 594 IKPISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVME 669 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk--~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~~lyLVmE 669 (1003)
.++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|+.++||||+++++.|.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999975 4678999999875432 2346789999999999999999999854 457899999
Q ss_pred eccCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceee----cCCCcEEEeecCCc
Q 001856 670 YLNGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLS 736 (1003)
Q Consensus 670 y~~GGSL~d~L~~~---------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILL----d~dG~VKLiDFGLA 736 (1003)
|+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 898887532 258999999999999999999999999999999999999 45679999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHh
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLT 815 (1003)
+...... .........+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 160 ~~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 211 (317)
T cd07868 160 RLFNSPL----------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (317)
T ss_pred eccCCCC----------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh
Confidence 7411000 000112346799999999999874 58999999999999999999
Q ss_pred CCCCCCCCChh---------hHHHhhhhcCC-----------CCC------------------------CCCCCCCHHHH
Q 001856 816 GIPPFNAEHPQ---------QIFDNILNRKI-----------PWP------------------------RVPEEMSPEAH 851 (1003)
Q Consensus 816 Gk~PF~~~~~~---------ei~qkIl~~~~-----------~~P------------------------~lp~~iS~elk 851 (1003)
|++||...... ..+..+..... ..+ ......+.++.
T Consensus 212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (317)
T cd07868 212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291 (317)
T ss_pred CCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHH
Confidence 99999653321 11222211000 000 00012356789
Q ss_pred HHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 852 DLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 852 DLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+||.+||++||.+|| |++|+|+||||
T Consensus 292 dli~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 292 HLLQKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred HHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=351.36 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=213.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||+|+||.||+|+++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4699999999999999999999999999999998754321 223356788999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------ 153 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP------ 153 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC------
Confidence 99999988888877778999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 154 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 154 -------------------------GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred -------------------------cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 001123468889999999876 457899999999999999999999998766544
Q ss_pred HHHhhhhcCC-------------------CCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 828 IFDNILNRKI-------------------PWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 828 i~qkIl~~~~-------------------~~P~---------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
....+..... ..+. ....++..+.+||.+||+.+|.+|| ++.+++.|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~eil~~~~ 285 (286)
T cd07847 209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL---SCEELLEHPY 285 (286)
T ss_pred HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC---CHHHHhcCCC
Confidence 4333321100 0010 0134688899999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 286 f 286 (286)
T cd07847 286 F 286 (286)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.18 Aligned_cols=254 Identities=29% Similarity=0.544 Sum_probs=222.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|+||.||++++..+|+.||+|.+...... ......+.+|+.+++.++||||+++++.+...++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998765432 3344678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~------ 153 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS------ 153 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc------
Confidence 99999999999764 3589999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 154 -------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 154 -------------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred -------------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 0011123568999999999998889999999999999999999999999888888
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....+..+.. +..+..++.++.++|.+||+.+|.+|| ++.++++||||
T Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 209 LVLKIIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred HHHHHhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 8777766543 345677899999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=346.35 Aligned_cols=253 Identities=33% Similarity=0.610 Sum_probs=218.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+.+|+.+++.++||||+++++.+.+...+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 67999999999999999999999889999999987542 1578889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+++++|.+++.. ...+++..++.++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~----- 152 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT----- 152 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC-----
Confidence 99999999999975 457899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|+..|+|||++.+..++.++|||||||++|+|++|++||.......
T Consensus 153 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 153 --------------------------MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred --------------------------ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 001123458899999999999999999999999999999999999998776655
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....+..........+..++..+.+||.+||+.||.+|| ++.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 207 AIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred hhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 444443333222233456788999999999999999999 99999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=351.89 Aligned_cols=257 Identities=34% Similarity=0.606 Sum_probs=222.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|++..++..||+|++.... .......+.+|+.+++.++||||+++++.+.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46899999999999999999999999999999987543 2334466789999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||+++++|.+++... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~------ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST------ 151 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc------
Confidence 999999999999865 8999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
........|++.|+|||++.+..++.++|||||||++|+|++|.+||...+....
T Consensus 152 -------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~ 206 (274)
T cd06609 152 -------------------------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206 (274)
T ss_pred -------------------------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH
Confidence 0112245789999999999998899999999999999999999999988777666
Q ss_pred HHhhhhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~-iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
...+..... +.++.. ++.++.++|.+||..+|.+|| +++++++||||.+..
T Consensus 207 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 207 LFLIPKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred HHHhhhcCC--CCCcccccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 665555432 333344 889999999999999999999 999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=389.96 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=216.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-C-----CcEEEEEeeeeccce
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-N-----PFVVRFFYSFTCREN 663 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-H-----PnIVkL~~~f~d~~~ 663 (1003)
+|++++.||+|+||.|.+|.+..|++.||||+++.. .....+...|+.+|..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 699999999999999999999999999999999864 455677788999999997 4 389999999999999
Q ss_pred EEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC--CcEEEeecCCcccc
Q 001856 664 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVG 739 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d--G~VKLiDFGLAk~~ 739 (1003)
+|||+|++.. +|+++|+.+ ..++...++.++.||+.||.+||+.||||+|||||||||.+- ..|||+|||.|...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999954 999999876 469999999999999999999999999999999999999764 47999999998741
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
.....+++-+..|+|||+|.|.+|+.+.||||||||++||++|.+.
T Consensus 342 ----------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 342 ----------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred ----------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 0112367888999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHhhhhcCCC---------------------CCC----------------------------CC-------
Q 001856 820 FNAEHPQQIFDNILNRKIP---------------------WPR----------------------------VP------- 843 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~~~---------------------~P~----------------------------lp------- 843 (1003)
|.+.+..+.+..|+.-... ++. .|
T Consensus 388 fpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~ 467 (586)
T KOG0667|consen 388 FPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLE 467 (586)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccc
Confidence 9999988887777651100 000 01
Q ss_pred ----CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 844 ----EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 844 ----~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
..-...+.|||.+||.+||.+|+ |+.++|+||||...
T Consensus 468 ~~~~~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 468 SGLPKADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGT 508 (586)
T ss_pred hhcccccHHHHHHHHHHHhccCchhcC---CHHHHhcCcccccc
Confidence 01235689999999999999999 99999999999854
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.54 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=219.2
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d 660 (1003)
...++|++.+.||+|+||.||+|..+. .+..||+|++.... .......+.+|..+++.++||||+++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345789999999999999999997642 35589999876543 22233567889999999999999999999999
Q ss_pred cceEEEEEEeccCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEE
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLG----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~~g----------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKL 730 (1003)
....|+||||+++|+|.+++.+.+ .++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999997532 3456788899999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHH
Q 001856 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (1003)
Q Consensus 731 iDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVIL 810 (1003)
+|||+++....... ........++..|+|||.+.+..++.++|+|||||++
T Consensus 161 ~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 161 GDFGMTRDIYETDY-----------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred CcCCcccccccccc-----------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 99999873110000 0011123467789999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc------CCCCCCC
Q 001856 811 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ------HVFFKDI 883 (1003)
Q Consensus 811 YELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq------HPFFk~I 883 (1003)
|||++ |.+||.+....+.+..+..... +..+..+++.+.++|.+||+.||.+|| ++.++++ ||||.++
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRP---TFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHHHHHhhcCCCCCCC
Confidence 99998 8999998888777777665432 344567789999999999999999999 8888876 9999999
Q ss_pred Ch
Q 001856 884 NW 885 (1003)
Q Consensus 884 dw 885 (1003)
+|
T Consensus 287 ~~ 288 (288)
T cd05061 287 SF 288 (288)
T ss_pred CC
Confidence 98
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=355.13 Aligned_cols=257 Identities=28% Similarity=0.527 Sum_probs=216.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||.|+||.||+|++..++..||+|.++... .......+.+|+.++..++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46999999999999999999999999999999886531 2334567889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 669 EYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~---g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999998763 379999999999999999999996 6999999999999999999999999999863100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC------CCCccceeechhHHHHHHHhCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT------GHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~------~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
.......|++.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 156 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 156 ------------------------------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred ------------------------------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence 011234688899999998653 35789999999999999999999
Q ss_pred CCCCCChhhHHHhhhh-cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 819 PFNAEHPQQIFDNILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~-~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
||........+..+.. .....+.++..++.++.+||.+||+.+|.+|| ++.++++||||...
T Consensus 206 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~~~~~~~ 268 (286)
T cd06622 206 PYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRP---TYAQLLEHPWLVKY 268 (286)
T ss_pred CCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCC---CHHHHhcChhhhhc
Confidence 9976655444433221 11223455667999999999999999999999 99999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.55 Aligned_cols=242 Identities=18% Similarity=0.223 Sum_probs=211.5
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----cceEEEEEEe
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEY 670 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d----~~~lyLVmEy 670 (1003)
..||+|++|.||+|.. +|+.||+|++++.........+.+.+|+.+|.+++||||+++++++.+ ...+|+||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999987 689999999987655455556788899999999999999999999877 4578999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
++||+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~--------- 174 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS--------- 174 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc---------
Confidence 9999999999988889999999999999999999998 599999999999999999999999999987310
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc--CCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+
T Consensus 175 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 175 -------------------------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred -------------------------cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 00113468899999999976 678999999999999999999999999988888
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
++..+......+ .++..+++++++||.+||+.||.+|| ++.++++
T Consensus 230 ~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 230 IYDLIINKNNSL-KLPLDCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred HHHHHHhcCCCC-CCCCcCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 888876655443 34557899999999999999999999 8888875
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=364.31 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=209.9
Q ss_pred EEEEeecc--CceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 593 IIKPISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 593 Ilk~LG~G--~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
++++||+| +|++||+++++.+|+.||+|++..... .......+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999876432 233456778899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 671 LNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 671 ~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~-~~---- 155 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN-HG---- 155 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccc-cc----
Confidence 9999999999653 4589999999999999999999999999999999999999999999999987542100 00
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc--CCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.. .. ..........++..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 156 -~~---~~---------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 216 (327)
T cd08227 156 -QR---LR---------------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 216 (327)
T ss_pred -cc---cc---------------ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 00 00 00001123467888999999976 46899999999999999999999999865544
Q ss_pred hHHHhhhhcCCCC-------------------------------------------CCCCCCCCHHHHHHHHhhccCCcC
Q 001856 827 QIFDNILNRKIPW-------------------------------------------PRVPEEMSPEAHDLIDRFLTEDPH 863 (1003)
Q Consensus 827 ei~qkIl~~~~~~-------------------------------------------P~lp~~iS~elkDLIrrcL~kDP~ 863 (1003)
...........+. ......+++.+.+||.+||+.||.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 296 (327)
T cd08227 217 QMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD 296 (327)
T ss_pred HHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence 4333322211100 001123578899999999999999
Q ss_pred CcCCCCCHHHHHcCCCCCCCC
Q 001856 864 QRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 864 kRpg~~SAeELLqHPFFk~Id 884 (1003)
+|| |++++++||||+++.
T Consensus 297 ~Rp---t~~ell~~p~f~~~~ 314 (327)
T cd08227 297 ARP---SASTLLNHSFFKQIK 314 (327)
T ss_pred hcC---CHHHHhcChhhhhcc
Confidence 999 999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.08 Aligned_cols=259 Identities=33% Similarity=0.540 Sum_probs=214.3
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc--
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR-- 661 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~-- 661 (1003)
+...++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ +||||+++++.+...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 344678999999999999999999999999999999986542 1235567889999988 899999999988753
Q ss_pred ---ceEEEEEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 662 ---ENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 662 ---~~lyLVmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
..+|+||||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 368999999999999998863 3568999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-----CCCccceeechhHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGII 809 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-----~ys~kSDIWSLGVI 809 (1003)
++...... ........|++.|+|||++... .++.++|||||||+
T Consensus 174 ~~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi 222 (291)
T cd06639 174 VSAQLTST-------------------------------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222 (291)
T ss_pred cchhcccc-------------------------------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence 98731100 0011235689999999998643 26789999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 810 LFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 810 LYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
+|+|++|++||...........+.....+....+..++..+.+||.+||+++|.+|| ++.++++||||+
T Consensus 223 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~ 291 (291)
T cd06639 223 AIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP---SVTHLLEHPFIK 291 (291)
T ss_pred HHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCc---CHHHHhcCcccC
Confidence 999999999998877655555554443222223456788999999999999999999 999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.09 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=223.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|+||.||.++...+++.+++|.+...... ......+.+|+.+++.++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 489999999999999999999999999999998765433 3345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 99999999999765 468999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 156 ---------------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 156 ---------------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred ---------------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 01224578999999999998889999999999999999999999999888888
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....+..... +..+..++.++.++|.+||.++|.+|| ++.++++|||+
T Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 209 LVVKIVQGNY--TPVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred HHHHHHcCCC--CCCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 8877766543 334467899999999999999999999 99999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.36 Aligned_cols=255 Identities=31% Similarity=0.532 Sum_probs=213.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc----
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE---- 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~---- 662 (1003)
.++|++.+.||.|+||.||+|.++.+++.|++|++..... ..+.+.+|+.+++.+ +||||+++++.+....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999998999999999876432 336788999999998 7999999999997644
Q ss_pred --eEEEEEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 663 --NLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 663 --~lyLVmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
.+|+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999999865 357999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHHH
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILF 811 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVILY 811 (1003)
..... .........|++.|+|||++.. ..++.++|||||||++|
T Consensus 161 ~~~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 209 (275)
T cd06608 161 AQLDS-------------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209 (275)
T ss_pred eeccc-------------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHH
Confidence 63100 0011234578999999999864 34678899999999999
Q ss_pred HHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 812 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 812 ELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+|++|++||...........+.....+....+..++..+++||.+||..||.+|| ++.++++|||+
T Consensus 210 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~ll~~~~~ 275 (275)
T cd06608 210 ELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPFI 275 (275)
T ss_pred HHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc---CHHHHhcCCCC
Confidence 9999999998766655555555443322222345788999999999999999999 99999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.80 Aligned_cols=254 Identities=31% Similarity=0.586 Sum_probs=220.1
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cceEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLV 667 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~~lyLV 667 (1003)
+|++++.||.|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876543 33445778899999999999999999987754 4568999
Q ss_pred EEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----hcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLH-----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLH-----s~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 357899999999999999999999 89999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCC
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 739 ~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
.... ........|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 160 ~~~~-------------------------------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 160 LGHD-------------------------------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred ccCC-------------------------------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 1100 001223578999999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
||...+...+.+.+.... ++.++..++..+.+++.+||..+|.+|| ++.+|++|||+
T Consensus 209 p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~~ 265 (265)
T cd08217 209 PFTARNQLQLASKIKEGK--FRRIPYRYSSELNEVIKSMLNVDPDKRP---STEELLQLPLI 265 (265)
T ss_pred cccCcCHHHHHHHHhcCC--CCCCccccCHHHHHHHHHHccCCcccCC---CHHHHhhCCCC
Confidence 999888777777765543 3456678899999999999999999999 99999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=352.89 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=217.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCC-----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tg-----k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~ 661 (1003)
.+++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4578999999999999999999986554 689999986542 234456788999999999999999999999999
Q ss_pred ceEEEEEEeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d 725 (1003)
...|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457888999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeec
Q 001856 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (1003)
Q Consensus 726 G~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWS 805 (1003)
+.++|+|||+++..... + .........+|+.|+|||++.+..++.++||||
T Consensus 161 ~~~~L~dfg~~~~~~~~--~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s 211 (283)
T cd05048 161 LTVKISDFGLSRDIYSA--D---------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211 (283)
T ss_pred CcEEECCCcceeecccc--c---------------------------cccccCCCcccccccCHHHhccCcCchhhhHHH
Confidence 99999999998731100 0 001122346788999999999888999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 806 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 806 LGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|||++|||++ |..||.+.+..++...+..... +..+..+++++.+|+.+||+.||.+|| ++.+|+++
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp---~~~~i~~~ 279 (283)
T cd05048 212 FGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRP---RFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999998 9999999888888877765543 345678999999999999999999999 89998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.30 Aligned_cols=259 Identities=34% Similarity=0.567 Sum_probs=219.8
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
...+|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.|....++|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 34779999999999999999999999999999999875432 233667889999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~---- 168 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC----
Confidence 9999999999999865 56899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus 169 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~ 221 (297)
T cd06656 169 ---------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (297)
T ss_pred ---------------------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 00112356899999999999988999999999999999999999999876654
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.....+.....+....+..++..+.+||.+||..+|.+|| ++.++++||||+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 275 (297)
T cd06656 222 RALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKLA 275 (297)
T ss_pred hheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhccc
Confidence 4433333332222234567889999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.16 Aligned_cols=253 Identities=28% Similarity=0.503 Sum_probs=210.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc------
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR------ 661 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~------ 661 (1003)
+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ +||||+++++.|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56899999999999999999999999999999987542 1235677899999988 799999999998753
Q ss_pred ceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccc
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~ 739 (1003)
..+|++|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999999999864 46899999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHH
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELL 814 (1003)
... ........|++.|+|||++. +..++.++|||||||++|||+
T Consensus 162 ~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~ 210 (272)
T cd06637 162 DRT-------------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210 (272)
T ss_pred ccc-------------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH
Confidence 000 01123467999999999986 345788999999999999999
Q ss_pred hCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 815 VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 815 TGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+|..||...........+...... ...+..++.++.+||.+||..+|.+|| ++.++++||||
T Consensus 211 ~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~~ 272 (272)
T cd06637 211 EGAPPLCDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQLMKHPFI 272 (272)
T ss_pred hCCCCccccCHHHHHHHHhcCCCC-CCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHHhhCCCC
Confidence 999999876655444443332211 122346789999999999999999999 99999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=349.23 Aligned_cols=257 Identities=33% Similarity=0.558 Sum_probs=210.6
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee-----
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFT----- 659 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~----- 659 (1003)
...++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|..++..+ +||||+++++.+.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34578999999999999999999999999999999876532 1234577899999998 6999999999874
Q ss_pred ccceEEEEEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 660 CRENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 660 d~~~lyLVmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
....+|+||||++|++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 44679999999999999998753 25689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHH
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIIL 810 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVIL 810 (1003)
++..... ........||+.|+|||++.. ..++.++|||||||++
T Consensus 171 ~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~ 219 (286)
T cd06638 171 SAQLTST-------------------------------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219 (286)
T ss_pred eeecccC-------------------------------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence 8731000 001223569999999999853 4478899999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 811 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 811 YELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
|+|++|+.||...........+.....+....+..++..+.+||.+||+.||.+|| ++.|+++|+||
T Consensus 220 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~~~~ 286 (286)
T cd06638 220 IELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP---TVSDLLQHVFI 286 (286)
T ss_pred HHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCC---CHHHHhhcccC
Confidence 99999999998766544443333322211123445788999999999999999999 99999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=354.40 Aligned_cols=255 Identities=32% Similarity=0.533 Sum_probs=208.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++.+.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48999999999999999999999999999999875432 22233567789999999999999999999999999999999
Q ss_pred eccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 670 YLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 670 y~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~------ 152 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP------ 152 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC------
Confidence 9975 88888765 467999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCC-CCCChh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF-NAEHPQ 826 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF-~~~~~~ 826 (1003)
........+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..
T Consensus 153 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 153 -------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred -------------------------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 0011234678999999998774 4789999999999999999988875 444444
Q ss_pred hHHHhhhhcC-----------------CCCC---------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRK-----------------IPWP---------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~-----------------~~~P---------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+.++.+.... ..++ .....+++++.+||.+||+.||.+|| |++++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~~il~h~~f 284 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI---SAEEALQHPYF 284 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC---CHHHHhcCCCC
Confidence 4444332210 0011 11235789999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=355.34 Aligned_cols=257 Identities=36% Similarity=0.591 Sum_probs=221.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
..+|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 3579999999999999999999999999999999865432 2346678999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||++|++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~----- 168 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE----- 168 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-----
Confidence 999999999998875 46899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 169 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~ 222 (296)
T cd06655 169 --------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (296)
T ss_pred --------------------------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 001123568999999999998889999999999999999999999998877765
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
....+.....+....+..+++.+.+||.+||..||.+|| ++.++++||||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~ 274 (296)
T cd06655 223 ALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhh
Confidence 555554433333334567899999999999999999999 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=371.49 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=202.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
..+|++++.||+|+||.||+|++..++..||+|+..+. ....|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 35699999999999999999999999999999985543 234689999999999999999999999999999
Q ss_pred EEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+. ++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV----- 209 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-----
Confidence 99996 588888865 46799999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCC-CCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI-PPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk-~PF~~~~~ 825 (1003)
........||+.|+|||++.+..++.++|||||||++|||+++. ++|.....
T Consensus 210 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~ 262 (357)
T PHA03209 210 ---------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262 (357)
T ss_pred ---------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCC
Confidence 00112457999999999999999999999999999999999854 44443211
Q ss_pred h---------hHHHhhhhc-C---CCCC-----------------------C----CCCCCCHHHHHHHHhhccCCcCCc
Q 001856 826 Q---------QIFDNILNR-K---IPWP-----------------------R----VPEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 826 ~---------ei~qkIl~~-~---~~~P-----------------------~----lp~~iS~elkDLIrrcL~kDP~kR 865 (1003)
. ..+..++.. . ..++ . ....++.++.+||.+||+.||.+|
T Consensus 263 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 342 (357)
T PHA03209 263 TPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMR 342 (357)
T ss_pred cHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccC
Confidence 0 111111110 0 0011 0 002457788899999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 001856 866 LGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 866 pg~~SAeELLqHPFFk~I 883 (1003)
| |+.|+|+||||+++
T Consensus 343 p---ta~e~l~hp~f~~~ 357 (357)
T PHA03209 343 P---SAEEILNYPMFAQL 357 (357)
T ss_pred c---CHHHHhcCchhccC
Confidence 9 99999999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.54 Aligned_cols=253 Identities=29% Similarity=0.516 Sum_probs=220.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|+||.||+|.+..+++.+|+|++...... ......+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999999765433 3345788899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-CcEEEeecCCccccccCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-G~VKLiDFGLAk~~~~~s~dd 746 (1003)
|++|++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 358999999999999999999999999999999999999865 4689999999874100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 155 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 207 (256)
T cd08220 155 ---------------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207 (256)
T ss_pred ---------------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence 00112356899999999999888899999999999999999999999988877
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.....+..... ..++..++..+.++|.+||..+|.+|| ++.++++||||
T Consensus 208 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 208 ALVLKIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 77777665433 345567899999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.06 Aligned_cols=254 Identities=33% Similarity=0.600 Sum_probs=218.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|.++.+++.+|+|++..... ......+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999876532 244567889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||++|++|.+++... ..+++..+..++.||+.||+|||+ .||+|+||||+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~------ 152 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV------ 152 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH------
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999886310
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC---
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE--- 823 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~--- 823 (1003)
........|+..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 153 ---------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 205 (265)
T cd06605 153 ---------------------------NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205 (265)
T ss_pred ---------------------------HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Confidence 00011267899999999999999999999999999999999999999654
Q ss_pred --ChhhHHHhhhhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 824 --HPQQIFDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 824 --~~~ei~qkIl~~~~~~P~lp~~-iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
...+..+.+.... .+.++.. ++.++.+||.+||..||.+|| ++.+++.||||+.
T Consensus 206 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~ 262 (265)
T cd06605 206 PDGIFELLQYIVNEP--PPRLPSGKFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKK 262 (265)
T ss_pred cccHHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhc
Confidence 2333444444332 2334444 899999999999999999999 9999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.14 Aligned_cols=275 Identities=40% Similarity=0.746 Sum_probs=229.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLV 667 (1003)
++|++.+.||.|+||.||+|....+++.||+|++.+...........+.+|..++..++ ||||+++++.+...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555555678889999999998 99999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||||+||+++.+|.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~- 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE- 159 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987421111000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
....... .................|+..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 160 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 160 SNKGDAT----------NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cCCCCCc----------cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 0000000 000000011123345678999999999998889999999999999999999999999888777
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH----HHHHcCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA----SEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SA----eELLqHPFF 880 (1003)
.++.+...... ++..+++.+.+||.+||+.+|.+|| ++ +++++||||
T Consensus 230 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILKLEYS---FPPNFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhcCCC---CCCccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 77777655443 3457799999999999999999999 88 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=348.02 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=211.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec-----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC----- 660 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d----- 660 (1003)
..+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++..+ +||||+++++.|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3467999999999999999999999999999999986542 2335677899999888 79999999999853
Q ss_pred -cceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 661 -RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 661 -~~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
...+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 45789999999999999999753 458899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHH
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYE 812 (1003)
.... .........|++.|+|||++. +..++.++|||||||++|+
T Consensus 170 ~~~~-------------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 170 QLDR-------------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred hhhc-------------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 3100 001123467999999999986 3457889999999999999
Q ss_pred HHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 813 LIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 813 LLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
|++|.+||....+......+..... .......++.++.+||++||..||.+|| ++.||++||||
T Consensus 219 l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~ell~~~~~ 282 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRP---STEQLLKHPFI 282 (282)
T ss_pred HHhCCCCccccCHHhhhhhHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCc---CHHHHhcCCCC
Confidence 9999999987665444444333221 1122346889999999999999999999 99999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.33 Aligned_cols=258 Identities=33% Similarity=0.590 Sum_probs=223.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|++..+++.||+|++...... .....+.+|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4699999999999999999999999999999998765422 44577889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+++++|.+++.....+++..+..++.||+.||+|||+ .|++||||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~----- 153 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT----- 153 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC-----
Confidence 999999999999888889999999999999999999999 99999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC---C
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE---H 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~---~ 824 (1003)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||... .
T Consensus 154 --------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 207 (264)
T cd06623 154 --------------------------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207 (264)
T ss_pred --------------------------CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence 00112356889999999999988999999999999999999999999776 4
Q ss_pred hhhHHHhhhhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~-iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
..+....+..... +..+.. ++..+.++|.+||..+|.+|| ++.++++||||+.++
T Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 208 FFELMQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 4455555553322 334455 899999999999999999999 999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=350.64 Aligned_cols=269 Identities=44% Similarity=0.838 Sum_probs=224.1
Q ss_pred CeEEEEEeeccCceEEEEEEEC---CCCCEEEEEEeecccccc-HHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIR-KNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk---~tgk~VALKVIkKs~~~~-~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~l 664 (1003)
+|++.+.||.|+||.||+|++. .+++.||+|++++..... ......+.+|+.++..+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467899999998654322 23446788999999999 699999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||++||+|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC--CCccceeechhHHHHHHHhCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.........|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 159 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 159 ----------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ----------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 000112356899999999987654 78899999999999999999999964
Q ss_pred CC----hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhh
Q 001856 823 EH----PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 891 (1003)
Q Consensus 823 ~~----~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~ 891 (1003)
.. ..++.+.+.... +..+..++..+.++|.+||+.||.+||+..++.++++||||++++|+.+...
T Consensus 211 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~ 280 (288)
T cd05583 211 DGEQNSQSEISRRILKSK---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280 (288)
T ss_pred CcccchHHHHHHHHHccC---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence 32 223333443333 2345668899999999999999999997777899999999999999888654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.85 Aligned_cols=268 Identities=42% Similarity=0.805 Sum_probs=223.0
Q ss_pred CeEEEEEeeccCceEEEEEEEC---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk---~tgk~VALKVIkKs~~~-~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~l 664 (1003)
+|++.+.||.|+||.||+|++. .+|..||+|++...... .....+.+.+|+.++..+ +|+||+++++.|.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999974 47899999998764332 223346778899999999 599999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC--CCCccceeechhHHHHHHHhCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.........|+..|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus 159 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 159 ----------------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ----------------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 00011235789999999998753 467899999999999999999999974
Q ss_pred CC----hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhh
Q 001856 823 EH----PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLAR 890 (1003)
Q Consensus 823 ~~----~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~ 890 (1003)
.. ...+...+..... ..+..+++.+.+||.+||+.||.+|+++ .++++++.||||..++|+.+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 281 (290)
T cd05613 211 DGEKNSQAEISRRILKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA 281 (290)
T ss_pred CCccccHHHHHHHhhccCC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhh
Confidence 33 2334444443333 3456789999999999999999999865 3899999999999999988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=339.52 Aligned_cols=255 Identities=33% Similarity=0.574 Sum_probs=219.7
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~--~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+|+..+.||+|+||+||+|....++..|++|++..... ......+.+.+|+.+++.++||||+++++.+.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988999999999875432 2234557888999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||++|++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~----- 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF----- 155 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc-----
Confidence 999999999999988888999999999999999999999999999999999999999999999999998741000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC-CCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......
T Consensus 156 ---------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~ 208 (258)
T cd06632 156 ---------------------------SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV 208 (258)
T ss_pred ---------------------------ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH
Confidence 0122456899999999998776 899999999999999999999999876654
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.....+... ...+.++..+++.+.+||.+||+.+|.+|| ++.+++.|||+
T Consensus 209 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 209 AAVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred HHHHHHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 444444331 234556677899999999999999999999 99999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.65 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=213.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++++.||.|+||.||+|.+..+++.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46999999999999999999999899999999987644322 34466788999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++++.|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------ 153 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC------
Confidence 99999999888877667999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|+..|+|||++.+ ..++.++|||||||++|+|++|++||......+
T Consensus 154 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~ 208 (286)
T cd07846 154 -------------------------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208 (286)
T ss_pred -------------------------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 011123568899999999876 447889999999999999999999998766544
Q ss_pred HHHhhhhcCC-------------------CCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 828 IFDNILNRKI-------------------PWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 828 i~qkIl~~~~-------------------~~P~---------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
....+..... ..+. ....++..+.+||.+||..+|.+|| ++.++++|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~~~ 285 (286)
T cd07846 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP---SSSQLLHHEF 285 (286)
T ss_pred HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch---hHHHHhcCCC
Confidence 3333322100 0111 1235788999999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 286 ~ 286 (286)
T cd07846 286 F 286 (286)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=340.74 Aligned_cols=250 Identities=28% Similarity=0.523 Sum_probs=217.4
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||++++..+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+.+...+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986543 23345678889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~------ 152 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS------ 152 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc------
Confidence 99999999998653 4589999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+...
T Consensus 153 -------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 207 (255)
T cd08219 153 -------------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207 (255)
T ss_pred -------------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH
Confidence 0011124578999999999999889999999999999999999999999888777
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
....+..... +.++..++..+.+||.+||+.||.+|| ++.+++.-
T Consensus 208 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~ 252 (255)
T cd08219 208 LILKVCQGSY--KPLPSHYSYELRSLIKQMFKRNPRSRP---SATTILSR 252 (255)
T ss_pred HHHHHhcCCC--CCCCcccCHHHHHHHHHHHhCCcccCC---CHHHHhhc
Confidence 7777665543 335567899999999999999999999 99999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=345.81 Aligned_cols=257 Identities=34% Similarity=0.556 Sum_probs=214.6
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999998765432 2345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 670 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 670 y~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|+ |++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE----- 153 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-----
Confidence 99 99999998653 569999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.....
T Consensus 154 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~ 208 (286)
T cd07832 154 -------------------------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE 208 (286)
T ss_pred -------------------------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH
Confidence 0012235789999999998764 46899999999999999999999998776655
Q ss_pred HHHhhhhcCC-------------------CCC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 828 IFDNILNRKI-------------------PWP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~-------------------~~P--------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.+..++.... .++ ......+.++.+||.+||.++|.+|| +++++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~~l~h~~~ 285 (286)
T cd07832 209 QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL---SAAEALRHPYF 285 (286)
T ss_pred HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC---CHHHHhhCcCc
Confidence 5554443110 011 11134678999999999999999999 99999999999
Q ss_pred C
Q 001856 881 K 881 (1003)
Q Consensus 881 k 881 (1003)
.
T Consensus 286 ~ 286 (286)
T cd07832 286 T 286 (286)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.34 Aligned_cols=255 Identities=30% Similarity=0.527 Sum_probs=217.6
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.++..++||||+++++.+.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467999999999999999999999999999999986542 233457788999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+++++|..++.+.+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~------ 155 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI------ 155 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh------
Confidence 9999999999999888889999999999999999999997 699999999999999999999999999876310
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.......+||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 ---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 156 ---------------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred ---------------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 00112357999999999998888999999999999999999999999865432
Q ss_pred -----------hHHHhhhhcCCCCCCCCC-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 827 -----------QIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 827 -----------ei~qkIl~~~~~~P~lp~-~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
+....+..... +.++. .++.++.+||.+||.+||.+|| ++.|+++|+||..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~~~~~~~~ 271 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERP---TPQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 23333333221 22222 3788999999999999999999 9999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=345.88 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=212.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEEC---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk---~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
.++|++.+.||+|+||.||+|.++ ..+..||+|+++... .......+.+|+.++..++||||+++++.+...+.+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357999999999999999999875 346689999987642 233456788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~-- 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS-- 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc--
Confidence 9999999999999999764 5789999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
. .........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 160 -~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 160 -E---------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred -c---------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 0 0001112345678999999999999999999999999999775 9999998
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+..+..+.+..... . ..+..++..+.+++.+||+.+|.+|| ++++|++
T Consensus 212 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 212 MSGQDVIKAVEDGFR-L-PAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred CCHHHHHHHHHCCCC-C-CCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 888777777654432 2 34677899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=351.63 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=206.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC----------------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT----------------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~----------------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnI 651 (1003)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3679999999999999999998632 34479999987542 23445678899999999999999
Q ss_pred EEEEeeeeccceEEEEEEeccCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCcee
Q 001856 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-------------------CLDEDVARVYIAEVVLALEYLHSLRVVH 712 (1003)
Q Consensus 652 VkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g-------------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIH 712 (1003)
+++++++.+.+.+|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986532 3577788999999999999999999999
Q ss_pred ccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhh
Q 001856 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (1003)
Q Consensus 713 RDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL 792 (1003)
|||||+|||++.++.+||+|||+++...... .........+++.|||||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-----------------------------YYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-----------------------------eeEecCcCCCCccccCHHHH
Confidence 9999999999999999999999987310000 00011234568899999999
Q ss_pred ccCCCCccceeechhHHHHHHHh--CCCCCCCCChhhHHHhhhhc-----CCCCCCCCCCCCHHHHHHHHhhccCCcCCc
Q 001856 793 LGTGHGTTADWWSVGIILFELIV--GIPPFNAEHPQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 793 ~g~~ys~kSDIWSLGVILYELLT--Gk~PF~~~~~~ei~qkIl~~-----~~~~P~lp~~iS~elkDLIrrcL~kDP~kR 865 (1003)
.+..++.++|||||||++|||++ +..||...+..+....+... ...++..+..++..+.+||.+||+.||.+|
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 98889999999999999999986 67889877666655444221 111222345688999999999999999999
Q ss_pred CCCCCHHHHHc
Q 001856 866 LGSGGASEVKQ 876 (1003)
Q Consensus 866 pg~~SAeELLq 876 (1003)
| ++.+|.+
T Consensus 293 P---s~~~i~~ 300 (304)
T cd05096 293 P---SFSDIHA 300 (304)
T ss_pred c---CHHHHHH
Confidence 9 8888843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.77 Aligned_cols=266 Identities=28% Similarity=0.516 Sum_probs=227.2
Q ss_pred eEEE-EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEE
Q 001856 591 FEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 591 YeIl-k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
|++. +.||+|+|+.|--|....+|+.||||++.|.. .....++.+|++++..+ .|+||++|+++|+++..+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 5543 57999999999999999999999999998863 33457889999999988 5999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC---cEEEeecCCccccccCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG---~VKLiDFGLAk~~~~~s~d 745 (1003)
|-|.||.|..+|.+...++|.++..++++|+.||.|||.+||.||||||+|||...-. -||||||.|..- . .-+.
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg-~-k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG-I-KLNN 233 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc-c-ccCC
Confidence 9999999999999999999999999999999999999999999999999999997654 489999998752 1 1111
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHHHHhCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
+.+ |.. .....+.+|+..|||||+.. ...|+.++|.||||||+|-||.|.+||
T Consensus 234 ~~s-pas---------------------tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 234 DCS-PAS---------------------TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCC-CCC---------------------CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 111 110 12235789999999999874 245899999999999999999999999
Q ss_pred CCC---------------ChhhHHHhhhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 821 NAE---------------HPQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 821 ~~~---------------~~~ei~qkIl~~~~~~P~l-p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
.+. -...+++.|..+++.||+- +..+|.+++|||+.+|.+|+.+|+ ++.++++|||+..+.
T Consensus 292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl---sa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL---SAAQVLNHPWVQRCA 368 (463)
T ss_pred cCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh---hhhhccCCccccccc
Confidence 653 1467899999999999853 567999999999999999999999 999999999998764
Q ss_pred hh
Q 001856 885 WD 886 (1003)
Q Consensus 885 w~ 886 (1003)
-+
T Consensus 369 ~e 370 (463)
T KOG0607|consen 369 PE 370 (463)
T ss_pred hh
Confidence 43
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.36 Aligned_cols=259 Identities=32% Similarity=0.516 Sum_probs=215.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~--~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999865433 122345677899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~---- 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP---- 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC----
Confidence 9999 889999998766 7999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.
T Consensus 156 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 156 ---------------------------NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred ---------------------------CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 001123457889999999865 4578999999999999999999999987776
Q ss_pred hhHHHhhhhcCCC-------------------------CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 826 QQIFDNILNRKIP-------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 826 ~ei~qkIl~~~~~-------------------------~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.+.+.++...... ........+..+.+||.+||.+||.+|| ++.++++|+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~e~l~~~~~ 285 (298)
T cd07841 209 IDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI---TARQALEHPYF 285 (298)
T ss_pred HHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc---CHHHHhhCccc
Confidence 5555554321100 0001234578899999999999999999 99999999999
Q ss_pred CCC
Q 001856 881 KDI 883 (1003)
Q Consensus 881 k~I 883 (1003)
++.
T Consensus 286 ~~~ 288 (298)
T cd07841 286 SND 288 (298)
T ss_pred cCC
Confidence 863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=343.11 Aligned_cols=259 Identities=32% Similarity=0.543 Sum_probs=214.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc-------cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-------RKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~-------~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... .....+.+.+|+.++..++||||+++++.+...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 488899999999999999999989999999988642211 1223467888999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~- 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD- 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc-
Confidence 9999999999999999999888899999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC--CCccceeechhHHHHHHHhCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
.. .........|+..|+|||++.+.. ++.++|+||||+++|+|++|..||
T Consensus 161 ---~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 161 ---IY-------------------------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred ---cc-------------------------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 00 001123456899999999998754 789999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCC--CCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 821 NAEHPQQIFDNILNRKI--PWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~--~~P-~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
...........+..... .++ .....++.++.+||.+||.++|.+|| +++++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~ 272 (272)
T cd06629 213 SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPFI 272 (272)
T ss_pred cCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCCC
Confidence 76555444333332221 111 12235689999999999999999999 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.74 Aligned_cols=255 Identities=29% Similarity=0.474 Sum_probs=214.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+++|++.+.||.|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++.+.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765555566667889999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~-- 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc--
Confidence 999999999988853 24589999999999999999999999999999999999999999999999999874100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 159 -----------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 -----------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred -----------------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 001112356899999999999888999999999999999999999999654
Q ss_pred C--hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 824 H--PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 824 ~--~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
. .......+..... .+..+..++..+.+||.+||..+|.+|| ++.++++.
T Consensus 210 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~~ 261 (267)
T cd08228 210 KMNLFSLCQKIEQCDY-PPLPTEHYSEKLRELVSMCIYPDPDQRP---DIGYVHQI 261 (267)
T ss_pred cccHHHHHHHHhcCCC-CCCChhhcCHHHHHHHHHHCCCCcccCc---CHHHHHHH
Confidence 3 2344444433222 1222346788999999999999999999 89998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.38 Aligned_cols=258 Identities=32% Similarity=0.545 Sum_probs=208.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCcEEEEEeeeeccceEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~I-L~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
++|++++.||+|+||.||+|++..+|+.||+|++++... ... ...+..|..+ ++.++||||+++++.+.....+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876432 222 2344556554 6667999999999999999999999
Q ss_pred EEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~-GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
|||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 588877754 24689999999999999999999997 999999999999999999999999999873100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc----CCCCccceeechhHHHHHHHhCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g----~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
........|+..|+|||++.+ ..++.++|+|||||++|+|++|+.
T Consensus 157 -------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (283)
T cd06617 157 -------------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205 (283)
T ss_pred -------------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCC
Confidence 001122468899999999865 456889999999999999999999
Q ss_pred CCCCC-ChhhHHHhhhhcCCCCCCCC-CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 001856 819 PFNAE-HPQQIFDNILNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 819 PF~~~-~~~ei~qkIl~~~~~~P~lp-~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~ 886 (1003)
||... ...+.+..+..... +.++ ..+|.++.+||.+||..+|.+|| ++.++++||||....+.
T Consensus 206 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 206 PYDSWKTPFQQLKQVVEEPS--PQLPAEKFSPEFQDFVNKCLKKNYKERP---NYPELLQHPFFELHLSK 270 (283)
T ss_pred CCCccccCHHHHHHHHhcCC--CCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhhhcccc
Confidence 99643 22233333333221 2222 35789999999999999999999 99999999999976554
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.08 Aligned_cols=254 Identities=32% Similarity=0.549 Sum_probs=219.6
Q ss_pred ccCCeEEE-EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeec----
Q 001856 587 SIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTC---- 660 (1003)
Q Consensus 587 ~lddYeIl-k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d---- 660 (1003)
..++|.+- ++||-|-.|+|..|.++.||+.+|+|++... ....+|+++... -.|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 45678775 6799999999999999999999999998643 345678877554 469999999988865
Q ss_pred cceEEEEEEeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC---CCcEEEeecCC
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGL 735 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~~g~--LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~---dG~VKLiDFGL 735 (1003)
...+.+|||.|+||+|+..|+..+. ++|.++..|++||+.|+.|||+.+|.||||||+|+|+.. +..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 4578999999999999999987754 999999999999999999999999999999999999975 45799999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
|+... ......+.|-||.|.|||++....|+..+|+|||||+||-||+
T Consensus 211 AK~t~--------------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC 258 (400)
T KOG0604|consen 211 AKETQ--------------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_pred ccccC--------------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc
Confidence 99411 0122346799999999999999999999999999999999999
Q ss_pred CCCCCCCCC----hhhHHHhhhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 816 GIPPFNAEH----PQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 816 Gk~PF~~~~----~~ei~qkIl~~~~~~P~l-p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
|.+||+... ...+..+|..+.+.||.- +..+|++++|+|+.+|..+|.+|+ |++++++|||+...
T Consensus 259 GyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 259 GYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEEVMDHPWINQY 328 (400)
T ss_pred CCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHHhhcCchhccc
Confidence 999998653 345788999999988852 457899999999999999999999 99999999999753
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.90 Aligned_cols=249 Identities=31% Similarity=0.542 Sum_probs=203.4
Q ss_pred CCeEEEEEe--eccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeeccceEE
Q 001856 589 DDFEIIKPI--SRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 589 ddYeIlk~L--G~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d~~~ly 665 (1003)
++|++.+.+ |.|+||.||+++++.++..||+|++.+...... |..+... .+||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456676666 999999999999999999999999876432111 2222221 27999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-cEEEeecCCccccccCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-~VKLiDFGLAk~~~~~s~ 744 (1003)
+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++...
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~---- 161 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---- 161 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC----
Confidence 9999999999999998878899999999999999999999999999999999999999988 99999999987310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 162 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 162 -------------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred -------------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 0112468899999999999899999999999999999999999998654
Q ss_pred hhhHH-HhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 825 PQQIF-DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 825 ~~ei~-qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
...+. ..+..........+..+++.+.+||.+||+.+|.+|+. +++++|+||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 211 DEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred cchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 33321 11111111122344578999999999999999999992 3599999999974
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.58 Aligned_cols=257 Identities=29% Similarity=0.562 Sum_probs=207.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999998999999999875432 1122346789999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
||||+.+ +|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 156 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--- 156 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC---
Confidence 9999985 999988764 46899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........+++.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus 157 ----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 ----------------------------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ----------------------------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 000112357889999999876 458899999999999999999999997654
Q ss_pred -hhhHHHhhhhcC-------------------CCCC--------CCCCCCC--HHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 825 -PQQIFDNILNRK-------------------IPWP--------RVPEEMS--PEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 825 -~~ei~qkIl~~~-------------------~~~P--------~lp~~iS--~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
..+....+.... ..++ .....++ .++.++|.+||+.+|.+|| ++.++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp---s~~e~ 285 (291)
T cd07844 209 DVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI---SAAEA 285 (291)
T ss_pred cHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc---CHHHH
Confidence 222222221100 0000 0011234 8899999999999999999 99999
Q ss_pred HcCCCC
Q 001856 875 KQHVFF 880 (1003)
Q Consensus 875 LqHPFF 880 (1003)
++||||
T Consensus 286 l~~~~f 291 (291)
T cd07844 286 MKHPYF 291 (291)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.31 Aligned_cols=258 Identities=37% Similarity=0.632 Sum_probs=216.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||+|+||.||+|.+..+++.||+|+++..... ......+.+|+.+++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 489999999999999999999889999999999866433 4567889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~---- 155 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT---- 155 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc----
Confidence 9999999999988778999999999999999999999999999999999999999999999999998742110000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC---CCccceeechhHHHHHHHhCCCCCCCCCh-
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---HGTTADWWSVGIILFELIVGIPPFNAEHP- 825 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---ys~kSDIWSLGVILYELLTGk~PF~~~~~- 825 (1003)
.........|++.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 156 -----------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~ 212 (264)
T cd06626 156 -----------------------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212 (264)
T ss_pred -----------------------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence 000012356889999999998766 88999999999999999999999976532
Q ss_pred hhHHHhhhhcCCCCCCCCC--CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPE--EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~--~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
......+... ..+.++. .+++.+.+||.+||+.+|.+|| ++.+++.|||+
T Consensus 213 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 213 FQIMFHVGAG--HKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred HHHHHHHhcC--CCCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 2222222222 1223333 3489999999999999999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=347.10 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=222.4
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 458889999999999999999998999999999875432 344578889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++||+|.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------ 154 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC------
Confidence 99999999999875 57899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
........|+..|+|||++.+..++.++|+|||||++|||++|.+||........
T Consensus 155 -------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06640 155 -------------------------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV 209 (277)
T ss_pred -------------------------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH
Confidence 0011235688899999999988899999999999999999999999988777666
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
...+.... .+.++..++..+.+||.+||..+|.+|| ++.++++|+||.....
T Consensus 210 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06640 210 LFLIPKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNAK 261 (277)
T ss_pred hhhhhcCC--CCCCchhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcch
Confidence 55543332 2445567889999999999999999999 9999999999986654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.78 Aligned_cols=258 Identities=32% Similarity=0.550 Sum_probs=214.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 369999999999999999999999999999999875432 2334467889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||++++.|..++.+...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~----- 154 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP----- 154 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-----
Confidence 999987777777666779999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........|+..|+|||++.+. .++.++|+||||+++|+|++|.+||.+....+
T Consensus 155 -------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 209 (288)
T cd07833 155 -------------------------ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209 (288)
T ss_pred -------------------------cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0012245788999999999887 78999999999999999999999998765544
Q ss_pred HHHhhhhcCC-------------------CCC----------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 001856 828 IFDNILNRKI-------------------PWP----------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878 (1003)
Q Consensus 828 i~qkIl~~~~-------------------~~P----------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHP 878 (1003)
....+..... .++ ..+..++.++.+||++||..+|.+|| ++.++++||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~ 286 (288)
T cd07833 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL---TCDELLQHP 286 (288)
T ss_pred HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc---cHHHHhcCC
Confidence 3322221000 000 11234588999999999999999999 999999999
Q ss_pred CC
Q 001856 879 FF 880 (1003)
Q Consensus 879 FF 880 (1003)
||
T Consensus 287 ~f 288 (288)
T cd07833 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.04 Aligned_cols=253 Identities=31% Similarity=0.486 Sum_probs=208.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34444568999999999999999999999999887543 234567889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCL--DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~L--sEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||++|++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 162 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-- 162 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--
Confidence 999999999999764 455 88889999999999999999999999999999999976 679999999998631000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC--CCccceeechhHHHHHHHhCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
........|++.|+|||++.+.. ++.++|+||||+++|+|++|.+||..
T Consensus 163 -----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 163 -----------------------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred -----------------------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 00112345889999999987643 78999999999999999999999975
Q ss_pred CChhh--HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 823 EHPQQ--IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 823 ~~~~e--i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
..... .+...... ..+.++..+++++.+||.+||+.+|.+|| ++.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 214 LGEPQAAMFKVGMFK--IHPEIPESLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred ccChhhhHhhhhhhc--cCCCCCcccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 43221 11111111 22445677899999999999999999999 99999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=352.93 Aligned_cols=249 Identities=25% Similarity=0.465 Sum_probs=191.7
Q ss_pred EEeeccCceEEEEEEECC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cceEEEEEEe
Q 001856 595 KPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEY 670 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~--tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy 670 (1003)
.+||+|+||+||+|+++. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 568999999875432 2356789999999999999999998854 5678999999
Q ss_pred ccCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceee----cCCCcEEEeecCCcc
Q 001856 671 LNGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSK 737 (1003)
Q Consensus 671 ~~GGSL~d~L~~~---------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILL----d~dG~VKLiDFGLAk 737 (1003)
+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 865 888887522 248899999999999999999999999999999999999 456799999999997
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhC
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTG 816 (1003)
..... . ..........||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 161 ~~~~~-~---------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg 212 (317)
T cd07867 161 LFNSP-L---------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred ccCCC-c---------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence 41100 0 000112345789999999999874 579999999999999999999
Q ss_pred CCCCCCCChh---------hHHHhhhhc--------------CCCC---------------------CCCCCCCCHHHHH
Q 001856 817 IPPFNAEHPQ---------QIFDNILNR--------------KIPW---------------------PRVPEEMSPEAHD 852 (1003)
Q Consensus 817 k~PF~~~~~~---------ei~qkIl~~--------------~~~~---------------------P~lp~~iS~elkD 852 (1003)
++||...... .....+... ...+ .......+..+.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (317)
T cd07867 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292 (317)
T ss_pred CCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHH
Confidence 9999754321 001111100 0000 0011124567899
Q ss_pred HHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 853 LIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 853 LIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
||.+||+.||.+|| |+.|+|+||||
T Consensus 293 ll~~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 293 LLQKLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred HHHHHhccCccccc---CHHHHhcCCCC
Confidence 99999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.97 Aligned_cols=254 Identities=33% Similarity=0.651 Sum_probs=223.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+++++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999998999999999876543 23445678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 670 YLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 670 y~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|++|++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--- 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--- 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC---
Confidence 99999999999764 67999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 157 ----------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 208 (258)
T cd08215 157 ----------------------------VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208 (258)
T ss_pred ----------------------------cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence 0012235789999999999988899999999999999999999999988887
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
..+...+.... .+.++..++..+.++|.+||..+|.+|| ++.++++||||
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 209 LELALKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred HHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 77777766544 3455668899999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=359.88 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=210.5
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~----- 661 (1003)
..++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34779999999999999999999999999999999875432 233445677899999999999999999988654
Q ss_pred -ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 662 -~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.++|+||||+.+ +|.+.+... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 898888654 8999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 170 ~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 170 T--------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred C--------------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 0 00112356889999999999999999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCCC------------------------------------CCC----CCCCCCHHHHHHHHhhccC
Q 001856 821 NAEHPQQIFDNILNRKIP------------------------------------WPR----VPEEMSPEAHDLIDRFLTE 860 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~------------------------------------~P~----lp~~iS~elkDLIrrcL~k 860 (1003)
...+....+..+...... ++. .+...+..+.+||.+||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 297 (353)
T cd07850 218 PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297 (353)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC
Confidence 877655544444321100 000 0113466789999999999
Q ss_pred CcCCcCCCCCHHHHHcCCCCC
Q 001856 861 DPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 861 DP~kRpg~~SAeELLqHPFFk 881 (1003)
||.+|| ++.|+|+||||+
T Consensus 298 dP~~R~---t~~eiL~~~~~~ 315 (353)
T cd07850 298 DPEKRI---SVDDALQHPYIN 315 (353)
T ss_pred ChhhCc---CHHHHhcChhHh
Confidence 999999 999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.16 Aligned_cols=256 Identities=31% Similarity=0.561 Sum_probs=219.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|...+.||.|++|.||++.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+...++.|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3566689999999999999998899999999886432 2334568899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|++|++|.+++.. +.+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~------- 168 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------- 168 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-------
Confidence 9999999999987 67999999999999999999999999999999999999999999999999987631000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~ 829 (1003)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.....
T Consensus 169 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 169 ------------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred ------------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 00112356899999999999888999999999999999999999999888877777
Q ss_pred HhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 830 qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
..+.....+....+..++..+.+||.+||+.+|.+|| ++.++++||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~ 275 (285)
T cd06648 225 KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAKA 275 (285)
T ss_pred HHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCcccccC
Confidence 7766554333223344789999999999999999999 99999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.21 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=211.8
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCE--EEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR 661 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~--VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~ 661 (1003)
...+++|++.+.||+|+||.||+|.++.++.. +|+|.++. .........+.+|+.++..+ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 34568999999999999999999999877765 46666543 22344556788999999999 899999999999999
Q ss_pred ceEEEEEEeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d 725 (1003)
+.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 47899999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeec
Q 001856 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (1003)
Q Consensus 726 G~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWS 805 (1003)
+.+||+|||+++.... ........++..|+|||++.+..++.++||||
T Consensus 161 ~~~kl~dfg~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 208 (303)
T cd05088 161 YVAKIADFGLSRGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 208 (303)
T ss_pred CcEEeCccccCcccch--------------------------------hhhcccCCCcccccCHHHHhccCCcccccchh
Confidence 9999999999862000 00011223467899999998888999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 806 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 806 LGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|||++|||++ |.+||...+..+.+..+.... .+..+..+++++.+||.+||+.+|.+|| ++.+++++
T Consensus 209 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~ 276 (303)
T cd05088 209 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 276 (303)
T ss_pred hhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999998 999998887777776654332 1234456889999999999999999999 89999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=345.17 Aligned_cols=255 Identities=31% Similarity=0.539 Sum_probs=209.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|+||.||+|++..+++.||||.+..... .......+.+|+++++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875432 22233578889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|+. ++|..++... +.+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 996 5899988653 56899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC-CCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+..
T Consensus 154 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 207 (284)
T cd07860 154 --------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207 (284)
T ss_pred --------------------------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 00112345788999999987644 588999999999999999999999877655
Q ss_pred hHHHhhhhcCC------------------CCC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKI------------------PWP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~------------------~~P--------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
....++..... .++ .....+++++++||.+||+.||.+|| ++.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~l~~~~f 284 (284)
T cd07860 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI---SAKAALAHPFF 284 (284)
T ss_pred HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC---CHHHHhcCCCC
Confidence 44433332110 011 01234788999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.49 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=214.6
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
.++|.+.+.||+|+||.||+|.+.. +++.||+|+++... .......+.+|+.+|..++||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 46789999987543 2334578899999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcE
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG--------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g--------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~V 728 (1003)
..|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997643 37888999999999999999999999999999999999999999
Q ss_pred EEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhH
Q 001856 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808 (1003)
Q Consensus 729 KLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGV 808 (1003)
||+|||+++..... .. ........+++.|+|||++.+..++.++|||||||
T Consensus 162 kl~d~g~~~~~~~~--~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05049 162 KIGDFGMSRDVYTT--DY---------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212 (280)
T ss_pred EECCcccceecccC--cc---------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence 99999998731100 00 00112345678999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 809 ILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 809 ILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
++|||++ |..||...+..+....+..+.. +..+..++..+.+||.+||+.||.+|| ++.|+++
T Consensus 213 il~e~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~eil~ 276 (280)
T cd05049 213 VLWEIFTYGKQPWYGLSNEEVIECITQGRL--LQRPRTCPSEVYDIMLGCWKRDPQQRI---NIKDIHE 276 (280)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 9999998 9999988888887777765443 334567899999999999999999999 8988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=328.88 Aligned_cols=257 Identities=36% Similarity=0.595 Sum_probs=220.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLV 667 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~lyLV 667 (1003)
+|++.+.||.|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+|++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 488999999999999999999989999999998765432 45567889999999999999999999999988 899999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC-hh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH-PQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~-~~ 826 (1003)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..
T Consensus 157 --------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 210 (260)
T cd06606 157 --------------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM 210 (260)
T ss_pred --------------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 001234578899999999998889999999999999999999999998765 22
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.....+.. ....+.++..++..+.+||.+||+.||.+|| ++.++++||||
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 211 AALYKIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred HHHHhccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 22223222 1234556778899999999999999999999 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.97 Aligned_cols=255 Identities=23% Similarity=0.421 Sum_probs=213.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEEC----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKR----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
.+++|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++.+....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 456789999987532 2344567889999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d 725 (1003)
..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247888899999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeec
Q 001856 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (1003)
Q Consensus 726 G~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWS 805 (1003)
+.+||+|||+++...... .........++..|+|||++.+..++.++||||
T Consensus 161 ~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05090 161 LHVKISDLGLSREIYSAD-----------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211 (283)
T ss_pred CcEEeccccccccccCCc-----------------------------ceecccCCCccceecChHHhccCCCCchhhhHH
Confidence 999999999987411000 001122345678899999999888999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 806 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 806 LGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|||++|||++ |.+||.+.....+.+.+..... +..+..+++.+.++|.+||+.||.+|| ++.+|+++
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~i~~~ 279 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRP---RFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCc---CHHHHHHH
Confidence 9999999998 9999988877777666654432 335677899999999999999999999 88888775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=366.81 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=210.5
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~t-----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~ 657 (1003)
+....++|++.+.||+|+||.||+|++..+ +..||+|+++... .......+.+|+.+++.+ +||||++++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 345567899999999999999999986543 3579999997643 233456788999999999 89999999999
Q ss_pred eeccceEEEEEEeccCCChHHHHHhc------------------------------------------------------
Q 001856 658 FTCRENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------ 683 (1003)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~d~L~~~------------------------------------------------------ 683 (1003)
+.....+|+|||||++|+|.+++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999999999998642
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 684 ----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 684 ----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
.++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--- 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--- 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc---
Confidence 1367888999999999999999999999999999999999999999999999873110000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ 826 (1003)
........+++.|||||++.+..++.++|||||||++|||++ |+.||......
T Consensus 268 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 268 --------------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred --------------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 001122345678999999999899999999999999999997 99999876655
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+..+...... +..+..+++++.++|.+||+.||.+|| ++.++++
T Consensus 322 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 322 SKFYKMVKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred HHHHHHHHcccC-ccCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 444444444332 224456789999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.74 Aligned_cols=261 Identities=31% Similarity=0.499 Sum_probs=214.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~l 664 (1003)
.+++|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++|+||+++++.+... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 467899999999999999999999999999999998754322 12223456799999999999999999998765 568
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 999999975 898888753 67899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 162 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 162 ------------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred ------------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 000112346788999999876 5579999999999999999999999998
Q ss_pred CChhhHHHhhhhcCC-------------------CCCCC--------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 823 EHPQQIFDNILNRKI-------------------PWPRV--------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~-------------------~~P~l--------p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
.+..+.+..+..... ..+.. ....++.+.+||.+||+.||.+|| ++.+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~---t~~~il 288 (309)
T cd07845 212 KSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA---TAEEAL 288 (309)
T ss_pred CCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc---CHHHHh
Confidence 888777766654211 00000 123588999999999999999999 999999
Q ss_pred cCCCCCCC
Q 001856 876 QHVFFKDI 883 (1003)
Q Consensus 876 qHPFFk~I 883 (1003)
+||||+..
T Consensus 289 ~h~~f~~~ 296 (309)
T cd07845 289 ESSYFKEK 296 (309)
T ss_pred cChhhccC
Confidence 99999843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.92 Aligned_cols=257 Identities=31% Similarity=0.512 Sum_probs=208.4
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccce----
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCREN---- 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~---- 663 (1003)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+. ||||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999986542 22223356788999999995 6999999999887665
Q ss_pred -EEEEEEeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCc
Q 001856 664 -LYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLS 736 (1003)
Q Consensus 664 -lyLVmEy~~GGSL~d~L~~~-----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLA 736 (1003)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 898888643 35799999999999999999999999999999999999998 899999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHh
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLT 815 (1003)
+..... ........+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 159 ~~~~~~-------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 159 RAFSIP-------------------------------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred eecCCC-------------------------------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 731100 001122357889999999875 457899999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCC-----C------------CC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKI-----P------------WP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 870 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~-----~------------~P--------~lp~~iS~elkDLIrrcL~kDP~kRpg~~S 870 (1003)
|.+||.+.+....+..+..... . ++ .....+++++.+||.+||.+||.+|| +
T Consensus 208 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~---~ 284 (295)
T cd07837 208 KQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI---S 284 (295)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC---C
Confidence 9999988766555444432100 0 00 01135789999999999999999999 9
Q ss_pred HHHHHcCCCCC
Q 001856 871 ASEVKQHVFFK 881 (1003)
Q Consensus 871 AeELLqHPFFk 881 (1003)
+.+++.||||+
T Consensus 285 ~~eil~~~~~~ 295 (295)
T cd07837 285 AKAALTHPYFD 295 (295)
T ss_pred HHHHhcCCCcC
Confidence 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=376.69 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=204.9
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|+.++||||+++++++......|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3469999999999999999999999999999996432 2356899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||++. ++|..++... +.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-- 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-- 315 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc--
Confidence 99995 6899888654 5699999999999999999999999999999999999999999999999999874110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC---
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE--- 823 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~--- 823 (1003)
.......+||+.|||||++.+..++.++|||||||+||||++|..|+...
T Consensus 316 ---------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~ 368 (461)
T PHA03211 316 ---------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368 (461)
T ss_pred ---------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcc
Confidence 00112467999999999999999999999999999999999987654321
Q ss_pred -----ChhhHHHhhhhcCCC---CCCC----------------------------CCCCCHHHHHHHHhhccCCcCCcCC
Q 001856 824 -----HPQQIFDNILNRKIP---WPRV----------------------------PEEMSPEAHDLIDRFLTEDPHQRLG 867 (1003)
Q Consensus 824 -----~~~ei~qkIl~~~~~---~P~l----------------------------p~~iS~elkDLIrrcL~kDP~kRpg 867 (1003)
...++.+.+...... ++.. ...++.++.+||.+||+.||.+||
T Consensus 369 ~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP- 447 (461)
T PHA03211 369 DERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP- 447 (461)
T ss_pred cccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc-
Confidence 122233322221111 1100 013466899999999999999999
Q ss_pred CCCHHHHHcCCCCCC
Q 001856 868 SGGASEVKQHVFFKD 882 (1003)
Q Consensus 868 ~~SAeELLqHPFFk~ 882 (1003)
++.|+|+||||+.
T Consensus 448 --sa~elL~hp~f~~ 460 (461)
T PHA03211 448 --SAAELLRLPLFQS 460 (461)
T ss_pred --CHHHHhhCcccCC
Confidence 9999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=379.04 Aligned_cols=260 Identities=34% Similarity=0.583 Sum_probs=237.3
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
.......|.++++||+|.|++|.+|++..++..||||++.+........ ..+.+|+++|+.++|||||++|.+......
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3455678999999999999999999999999999999999987654443 458899999999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|+||||+.||++++++.+.++..+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++.+...
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999985211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC-CccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-s~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.....++||++.|.|||++.+..| ++.+|+||||+++|-|+.|..||.+
T Consensus 208 ------------------------------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 208 ------------------------------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ------------------------------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 123457899999999999999887 7899999999999999999999999
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.+..++..+.+.+++.. |..++.+++++|+++|..+|.+|+ +.+++.+|.|...
T Consensus 258 ~~lk~Lr~rvl~gk~rI---p~~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 258 QNLKELRPRVLRGKYRI---PFYMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRND 311 (596)
T ss_pred cccccccchheeeeecc---cceeechhHHHHHHhhccCccccC---CHHHhhhhcccch
Confidence 99999988888887754 457899999999999999999999 9999999999864
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.42 Aligned_cols=259 Identities=29% Similarity=0.506 Sum_probs=218.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccc--cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~--~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~l 664 (1003)
.+|++.+.||+|+||.||+|++..+++.||+|++.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875432 12234557888999999999999999999998764 468
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+++|||++|++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.. .........|+..|+|||++.+..++.++|+|||||++|+|++|++||....
T Consensus 160 ------~~--------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 160 ------CM--------------------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred ------cc--------------------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 00 0001123568999999999999889999999999999999999999998776
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
......++.... ..+.+|..+++.+.++|.+||. +|..|| ++.+++.|||.
T Consensus 214 ~~~~~~~~~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 214 AMAAIFKIATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCc---cHHHHhcCCCC
Confidence 655555544332 2245678899999999999999 579999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.96 Aligned_cols=254 Identities=30% Similarity=0.542 Sum_probs=211.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++++.||.|++|.||+|++..+|..||+|+++.... ......+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876532 2223566789999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 670 YLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 670 y~~GGSL~d~L~~~---g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9985 899888654 35899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........+|+.|++||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 154 ---------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 154 ---------------------------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred ---------------------------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 0011234678999999998764 568899999999999999999999998777
Q ss_pred hhHHHhhhhcCC------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 826 QQIFDNILNRKI------------------PWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 826 ~ei~qkIl~~~~------------------~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
.+.+..+..... .++. +...+++.+.++|.+||+.||.+|| ++.++++|||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~ 283 (284)
T cd07836 207 EDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI---SAHDALQHPW 283 (284)
T ss_pred HHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC---CHHHHhcCCC
Confidence 666555443110 0010 1124678899999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 284 f 284 (284)
T cd07836 284 F 284 (284)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=330.71 Aligned_cols=254 Identities=33% Similarity=0.630 Sum_probs=222.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+|++..+++.||+|.+...... ......+.+|++++..++|||++++++.+.+...+|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876432 3456789999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------- 152 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------- 152 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC-------
Confidence 9999999999988888999999999999999999999999999999999999999999999999998741100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~ 829 (1003)
........|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.....
T Consensus 153 ------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~ 208 (254)
T cd06627 153 ------------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208 (254)
T ss_pred ------------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 00012356889999999998888899999999999999999999999876655544
Q ss_pred HhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 830 qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
..+... ..+.++..++..+.++|.+||..+|.+|| ++.+++.||||
T Consensus 209 ~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 209 FRIVQD--DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred HHHhcc--CCCCCCCCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 444332 33456678899999999999999999999 99999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.43 Aligned_cols=254 Identities=29% Similarity=0.530 Sum_probs=218.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+|.++.+|..||+|.+...... ....+.+.+|+.+++.++|+||+++++.+.....+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999998765332 2234677899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-cEEEeecCCccccccCCCCC
Q 001856 670 YLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-~VKLiDFGLAk~~~~~s~dd 746 (1003)
|+++++|.+++.+.. .+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .+||+|||.+..... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~-- 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--S-- 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--C--
Confidence 999999999997643 479999999999999999999999999999999999999886 469999998863100 0
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 156 ---------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 208 (257)
T cd08225 156 ---------------------------MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208 (257)
T ss_pred ---------------------------cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 00112346899999999998888999999999999999999999999888777
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+....+..... +..+..++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 209 QLVLKICQGYF--APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred HHHHHHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 77666655432 344567889999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.31 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=212.3
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 665 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~ly 665 (1003)
+++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++..++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999765432 22334567899999999999999999998877 8899
Q ss_pred EEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 666 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999975 999998764 45999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC-CCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........+++.|+|||++.+.. ++.++|||||||++|+|++|.+||...
T Consensus 160 -----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 160 -----------------------------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred -----------------------------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00112346788999999987644 689999999999999999999999887
Q ss_pred ChhhHHHhhhhcCC-------------------CC---------CCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 824 HPQQIFDNILNRKI-------------------PW---------PRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~-------------------~~---------P~lp~~-iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
.....+.++..... .+ ..++.. +++.+.+||++||+.+|.+|| ++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---t~~el 287 (293)
T cd07843 211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI---SAEDA 287 (293)
T ss_pred ChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC---CHHHH
Confidence 76665555432110 00 011222 588999999999999999999 99999
Q ss_pred HcCCCC
Q 001856 875 KQHVFF 880 (1003)
Q Consensus 875 LqHPFF 880 (1003)
++||||
T Consensus 288 l~~~~f 293 (293)
T cd07843 288 LKHPYF 293 (293)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.58 Aligned_cols=257 Identities=31% Similarity=0.563 Sum_probs=219.6
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.|+.++.||.|+||.||+|.+..++..||+|++..... ....+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 47788899999999999999998999999999875432 3345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|++|++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~------- 154 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------- 154 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-------
Confidence 9999999998865 57899999999999999999999999999999999999999999999999998731000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~ 829 (1003)
........|+..|+|||++.+..++.++|+|||||++|||++|..||.........
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06642 155 ------------------------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 210 (277)
T ss_pred ------------------------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH
Confidence 00112356889999999999988999999999999999999999999876666555
Q ss_pred HhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 830 qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
..+.... .+.+...++.++.++|.+||..+|.+|| ++.++++||||....+
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06642 211 FLIPKNS--PPTLEGQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTK 261 (277)
T ss_pred hhhhcCC--CCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhh
Confidence 5443332 2344556889999999999999999999 9999999999986544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.55 Aligned_cols=260 Identities=32% Similarity=0.533 Sum_probs=211.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+++|++.+.||.|+||+||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+..+.|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999865432 223345678899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccCCC
Q 001856 668 MEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~--LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|||++ ++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 99996 488888865443 578889999999999999999999999999999999985 567999999998731000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........|++.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 157 -----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 -----------------------------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred -----------------------------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0011234678999999998764 5789999999999999999999999877
Q ss_pred ChhhHHHhhhhcCC-C-----------------CCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 824 HPQQIFDNILNRKI-P-----------------WPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~-~-----------------~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
...+.+.++..... + .+. ....+++++.++|.+||+.+|.+|| ++.++++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~~l~~ 284 (294)
T PLN00009 208 SEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI---TARAALEH 284 (294)
T ss_pred CHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc---CHHHHhcC
Confidence 66555444332100 0 000 1235788999999999999999999 99999999
Q ss_pred CCCCCC
Q 001856 878 VFFKDI 883 (1003)
Q Consensus 878 PFFk~I 883 (1003)
|||.++
T Consensus 285 ~~~~~~ 290 (294)
T PLN00009 285 EYFKDL 290 (294)
T ss_pred chHhHH
Confidence 999865
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.42 Aligned_cols=254 Identities=31% Similarity=0.580 Sum_probs=219.9
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++..++||||+++++.+......|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 8889999999999999999988999999999865432 23456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 001856 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p 750 (1003)
+++++|..++.+ +.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-------- 154 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-------- 154 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--------
Confidence 999999999875 56899999999999999999999999999999999999999999999999998631000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHH
Q 001856 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830 (1003)
Q Consensus 751 ~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~q 830 (1003)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||..........
T Consensus 155 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 211 (277)
T cd06641 155 -----------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211 (277)
T ss_pred -----------------------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence 001123568899999999988888999999999999999999999998877766666
Q ss_pred hhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 831 kIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.+.... .+.++..++.++.++|.+||..+|.+|| ++.++++||||.+.
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~~ 259 (277)
T cd06641 212 LIPKNN--PPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVRF 259 (277)
T ss_pred HHhcCC--CCCCCcccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhhh
Confidence 654433 2445567899999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=326.03 Aligned_cols=250 Identities=35% Similarity=0.611 Sum_probs=215.7
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++.+......|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58999999999999999999988999999999876542 345778899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 670 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 670 y~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|++|++|.+++... ..+++..+..++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------ 151 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT------ 151 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc------
Confidence 99999999999876 67999999999999999999999999999999999999999999999999998731000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....
T Consensus 152 --------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 205 (253)
T cd05122 152 --------------------------KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205 (253)
T ss_pred --------------------------ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 002245788999999999988899999999999999999999999987755554
Q ss_pred HHhhhhcCCCCCCCCC--CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 829 FDNILNRKIPWPRVPE--EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~--~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
...+.... .+..+. .++..+.++|.+||+.||.+|| ++.++++|||
T Consensus 206 ~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 206 LFKIATNG--PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred HHHHHhcC--CCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 44443322 222332 3489999999999999999999 9999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=338.56 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=214.9
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
....+|++.+.||.|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.++||||+++++.+.....+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 34567999999999999999999999999999999987542 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
++|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~- 157 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 157 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc-
Confidence 999999999999999754 35899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
. ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 158 -------~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 158 -------T----------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred -------e----------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 0 000112334678999999999999999999999999999998 9999998
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+..+.+..+..... +..+..++.++.++|.+||+.||.+|| ++.++++
T Consensus 209 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~l~~ 257 (263)
T cd05052 209 IDLSQVYELLEKGYR--MERPEGCPPKVYELMRACWQWNPSDRP---SFAEIHQ 257 (263)
T ss_pred CCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 888877777655322 345677899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=352.02 Aligned_cols=256 Identities=32% Similarity=0.563 Sum_probs=218.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|+....||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++..++||||+++++.|...+..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 345556689999999999999998999999999865432 23456788999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~------ 170 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------ 170 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc------
Confidence 99999999998765 56899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.......+|++.|+|||++.+..++.++|+|||||++|||++|+.||......+.
T Consensus 171 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 225 (297)
T cd06659 171 -------------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225 (297)
T ss_pred -------------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112346789999999999988899999999999999999999999988777666
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
...+..........+..++..+.++|.+||+.+|.+|| ++.++++||||..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~ 276 (297)
T cd06659 226 MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQ 276 (297)
T ss_pred HHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhcc
Confidence 66655443333334456889999999999999999999 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.79 Aligned_cols=259 Identities=34% Similarity=0.569 Sum_probs=217.9
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
..++|++++.||.|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3478999999999999999999998899999999986432 2234678899999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|+||+++++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~---- 168 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc----
Confidence 9999999999999876 45889999999999999999999999999999999999999999999999987631000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 169 ---------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 169 ---------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred ---------------------------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 00112356899999999999888999999999999999999999999876654
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.....+.....+....+..++..+++||.+||..+|.+|| ++.+++.|+||+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 222 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred hheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 4433333222211123445788999999999999999999 99999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=352.23 Aligned_cols=257 Identities=32% Similarity=0.539 Sum_probs=217.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...++.|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44666788999999999999999999999999986532 234467889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------ 171 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------ 171 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc------
Confidence 99999999998854 56899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
........||+.|+|||++.+..++.++|+|||||++|||++|+.||...+....
T Consensus 172 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 172 -------------------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred -------------------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0111235789999999999988899999999999999999999999988777666
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
+..+.............++..+.+||.+||..||.+|| +++++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred HHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 55554332222222345788999999999999999999 99999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.88 Aligned_cols=261 Identities=35% Similarity=0.593 Sum_probs=224.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.+.|++...||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+......|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4569999999999999999999988899999999876432 456788999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
+||++|++|.+++...+ .++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~----- 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK----- 168 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc-----
Confidence 99999999999998876 899999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 169 --------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 169 --------------------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred --------------------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 000112346889999999999888999999999999999999999999887776
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~ 886 (1003)
.....+.....+....+..++..+.+||.+||+.+|.+|| ++.++++|+||+...|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 223 RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 6655555443322222334889999999999999999999 99999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.64 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=211.9
Q ss_pred ccCCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~ 661 (1003)
..++|++.+.||+|+||.||+|.++ .++..||+|++.... .......+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3467999999999999999999864 245689999986532 223345688999999999999999999999999
Q ss_pred ceEEEEEEeccCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEe
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNLG----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~g----------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLi 731 (1003)
...|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999997532 25677888999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHH
Q 001856 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811 (1003)
Q Consensus 732 DFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILY 811 (1003)
|||+++....... ........+++.|||||++.+..++.++|||||||++|
T Consensus 162 dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 162 DFGMTRDIYETDY-----------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212 (277)
T ss_pred CCCCccccCCcce-----------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHH
Confidence 9999873110000 00011235678899999999988999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 812 ELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 812 ELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
||++ |..||.+.+..+....+..... +..+..++..+.+||.+||+.||.+|| ++.|++++
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 274 (277)
T cd05062 213 EIATLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 274 (277)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9998 7999998888777776665443 345667899999999999999999999 89998865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.81 Aligned_cols=264 Identities=29% Similarity=0.461 Sum_probs=208.2
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-- 662 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~-- 662 (1003)
...+++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3456789999999999999999999999999999999865432 1222345668999999999999999999876643
Q ss_pred ------eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 663 ------NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 663 ------~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
..|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999965 888888664 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHH
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELL 814 (1003)
+......... .........++..|+|||++.+. .++.++||||||+++|+|+
T Consensus 166 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~ 218 (310)
T cd07865 166 ARAFSLSKNS---------------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218 (310)
T ss_pred cccccCCccc---------------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence 8742110000 00011235688999999998764 4688999999999999999
Q ss_pred hCCCCCCCCChhhHHHhhhhcCCC-------------------CCCC----------CCCCCHHHHHHHHhhccCCcCCc
Q 001856 815 VGIPPFNAEHPQQIFDNILNRKIP-------------------WPRV----------PEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 815 TGk~PF~~~~~~ei~qkIl~~~~~-------------------~P~l----------p~~iS~elkDLIrrcL~kDP~kR 865 (1003)
+|.+||.+.+.......+...... ++.. +...+..+.+||.+||..||.+|
T Consensus 219 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R 298 (310)
T cd07865 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKR 298 (310)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhc
Confidence 999999887665443333221100 0000 01235678899999999999999
Q ss_pred CCCCCHHHHHcCCCC
Q 001856 866 LGSGGASEVKQHVFF 880 (1003)
Q Consensus 866 pg~~SAeELLqHPFF 880 (1003)
| +++++++||||
T Consensus 299 ~---t~~e~l~h~~f 310 (310)
T cd07865 299 I---DADTALNHDFF 310 (310)
T ss_pred c---CHHHHhcCCCC
Confidence 9 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.04 Aligned_cols=256 Identities=32% Similarity=0.588 Sum_probs=216.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCcEEEEEeeeeccceEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~---HPnIVkL~~~f~d~~~lyL 666 (1003)
.|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++ ||||+++++.+......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999987542 2334567888999999986 9999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
||||++|++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN---- 154 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC----
Confidence 9999999999999866 57999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.....
T Consensus 155 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 155 ---------------------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred ---------------------------ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 011223578999999999875 4578999999999999999999999987766
Q ss_pred hhHHHhhhhcCCCCCCCCC-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~-~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
......+.... .+.++. .++.++.+||.+||..||.+|| ++.++++|+||++..
T Consensus 208 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 208 FRAMMLIPKSK--PPRLEDNGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred hhhhhccccCC--CCCCCcccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 55544433322 233333 3789999999999999999999 999999999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=341.18 Aligned_cols=259 Identities=31% Similarity=0.506 Sum_probs=213.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYL 666 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~lyL 666 (1003)
++|+..+.||.|++|.||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++.|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 469999999999999999999999999999999876432 24456788999999999999999999988654 47899
Q ss_pred EEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 667 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34589999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 158 --------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 158 --------------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred --------------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 001134578899999999998999999999999999999999999976
Q ss_pred C-----ChhhHHHhhhhcCCC-CCCCC---CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 823 E-----HPQQIFDNILNRKIP-WPRVP---EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 823 ~-----~~~ei~qkIl~~~~~-~P~lp---~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
. ...+....+.....+ ++..+ ..+++.+.+||.+||.++|.+|| ++.|+++||||++..-
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~eil~~~~~~~~~~ 274 (287)
T cd06621 206 EGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDMLEHPWIKAQMK 274 (287)
T ss_pred ccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHHHhCcccccccc
Confidence 5 223444444332211 11111 23567899999999999999999 9999999999986543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.77 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=214.2
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~t-----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d 660 (1003)
...++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.++..++||||+++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3457899999999999999999998643 4789999986543 22334678899999999999999999999999
Q ss_pred cceEEEEEEeccCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEE
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~~----------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKL 730 (1003)
....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999999653 23678889999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHH
Q 001856 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (1003)
Q Consensus 731 iDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVIL 810 (1003)
+|||+++..... + .........+|..|+|||++.+..++.++|||||||++
T Consensus 161 ~dfg~~~~~~~~--~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 161 GDFGMTRDIYET--D---------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred CCcccchhhccC--c---------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 999998731100 0 00011234578899999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 811 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 811 YELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|||++ |.+||.+.+..+....+.... .+..+..++.++.+||.+||+.+|.+|| ++.++++
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 273 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRP---TFLEIVS 273 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 99998 999999888887777766432 2445677899999999999999999999 8988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.94 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=209.6
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEE-----CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArd-----k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~ 657 (1003)
+....++|++.++||+|+||.||+|++ ..++..||+|+++.... ....+.+.+|+.+|..+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 344456899999999999999999974 34677899999875432 23446788999999999 89999999999
Q ss_pred eeccceEEEEEEeccCCChHHHHHhcC-----------------------------------------------------
Q 001856 658 FTCRENLYLVMEYLNGGDLYSLLRNLG----------------------------------------------------- 684 (1003)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~d~L~~~g----------------------------------------------------- 684 (1003)
+......|+|||||+||+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986431
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 685 ----------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 685 ----------------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 3678888999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
. .........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 268 ~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 268 S-----------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred c-----------------------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 0 0001122346678999999999999999999999999999998 899998
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.......+.+++..... +..+...+.++.+||.+||+.||.+|| ++.+|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~ 370 (375)
T cd05104 319 GMPVDSKFYKMIKEGYR-MLSPECAPSEMYDIMKSCWDADPLKRP---TFKQIVQL 370 (375)
T ss_pred CCCchHHHHHHHHhCcc-CCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 76544433344433322 223456788999999999999999999 89988764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.00 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=211.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||.||+|+++ .+..+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 367999999999999999999885 456899998865432 235678899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~--~- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--E- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC--c-
Confidence 9999999999999753 56899999999999999999999999999999999999999999999999998731000 0
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~ 825 (1003)
........++..|+|||++.+..++.++|+||||+++|+|++ |++||...+.
T Consensus 155 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 155 ---------------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred ---------------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 000112345678999999998889999999999999999999 9999999888
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+....+..... +..+...+..+.+||.+||+.+|.+|| ++.++++
T Consensus 208 ~~~~~~i~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 208 YEVVEMISRGFR--LYRPKLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred HHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 888888766543 233556788999999999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=397.53 Aligned_cols=262 Identities=30% Similarity=0.525 Sum_probs=216.1
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cce
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--REN 663 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~~ 663 (1003)
..+++|++++.||+|+||+||+|++..++..||+|++..... .......+..|+.+|..++|||||+++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345789999999999999999999999999999999876543 33445778899999999999999999998865 457
Q ss_pred EEEEEEeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhc-------CceeccCCCcceeecC--------
Q 001856 664 LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL-------RVVHRDLKPDNLLIAH-------- 724 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~-------GIIHRDIKPeNILLd~-------- 724 (1003)
+||||||+++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999999652 5799999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-
Q 001856 725 ---------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG- 794 (1003)
Q Consensus 725 ---------dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g- 794 (1003)
.+.+||+|||+++.... .......+||+.|+|||++.+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~--------------------------------~s~~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI--------------------------------ESMAHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc--------------------------------cccccccCCCccccCHHHHhcc
Confidence 23589999999873100 001124579999999999965
Q ss_pred -CCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 795 -TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 795 -~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
..++.++||||||||||+|++|..||...+....+...+.....++ ....+.++.+||.+||..+|.+|| ++.+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRP---Sa~Q 291 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERP---SALQ 291 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCc---CHHH
Confidence 4588999999999999999999999976554443333333332222 245789999999999999999999 9999
Q ss_pred HHcCCCCCCCCh
Q 001856 874 VKQHVFFKDINW 885 (1003)
Q Consensus 874 LLqHPFFk~Idw 885 (1003)
+|.|+||+.+..
T Consensus 292 lL~h~~ik~i~~ 303 (1021)
T PTZ00266 292 CLGYQIIKNVGP 303 (1021)
T ss_pred HhccHHHhhcCC
Confidence 999999987643
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=345.88 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=215.7
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999899999999987654444555677889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+.| +|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 99975 77777654 4579999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc---cCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
......|++.|+|||++. ...++.++||||||+++|||++|++||...+
T Consensus 167 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 167 ----------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred ----------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 012346888999999985 3557889999999999999999999998877
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.......+.....+ ...+..++..+.+||.+||+.+|.+|| ++.+++.||||..
T Consensus 219 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 272 (307)
T cd06607 219 AMSALYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcc
Confidence 66554444433221 112345788999999999999999999 9999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=333.03 Aligned_cols=252 Identities=31% Similarity=0.538 Sum_probs=213.4
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
++|++.+.||.|+||.||+|.+..+|+.||+|.++..........+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999999899999999998655555555678899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 669 EYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||++||+|..++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 999999999998642 45899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 160 -----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 160 -----------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred -----------------------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 001123568899999999999889999999999999999999999996543
Q ss_pred --hhhHHHhhhhcCCCCCCCCC-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 --PQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 --~~ei~qkIl~~~~~~P~lp~-~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+....+.... ++..+. .++..+.++|.+||..+|.+|| ++.+|++
T Consensus 211 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il~ 260 (267)
T cd08224 211 MNLYSLCKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRP---DISYVLQ 260 (267)
T ss_pred ccHHHHHhhhhcCC--CCCCChhhcCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 333444443332 233333 6888999999999999999999 8887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=339.37 Aligned_cols=251 Identities=29% Similarity=0.485 Sum_probs=204.9
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecc--ceEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCR--ENLYLV 667 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~--~~lyLV 667 (1003)
|++++.||+|+||.||+|.+..+++.||+|++++... .... ....+|+.++.++. ||||+++++.+.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999876432 1222 23457888888885 99999999999987 889999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+++ +|.+++... +.+++..++.++.||+.||+|||+.||+||||||+||+++. +.+||+|||+++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---- 152 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---- 152 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC----
Confidence 999975 888888753 57899999999999999999999999999999999999999 99999999998731000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
.......+|+.|+|||++.. ..++.++|||||||++|||++|.+||.+.+.
T Consensus 153 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 153 ----------------------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred ----------------------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 00112467899999998754 4568999999999999999999999988776
Q ss_pred hhHHHhhhhcC------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 826 QQIFDNILNRK------------------IPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 826 ~ei~qkIl~~~------------------~~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
.+.+..+.... ..++. ....++.++.+||.+||.++|.+|| ++.++++|||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~~~ 281 (282)
T cd07831 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI---TAKQALRHPY 281 (282)
T ss_pred HHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc---CHHHHhhCCC
Confidence 65544443211 01111 1135689999999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 282 ~ 282 (282)
T cd07831 282 F 282 (282)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=343.52 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=204.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++|+||+++++++......|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999865432 12223567899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP---- 156 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC----
Confidence 99996 577777654 356888999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
........+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 157 ---------------------------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred ---------------------------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 0011234678999999998764 578899999999999999999999976543
Q ss_pred -hhHHHhhhhcC-CC----------CCC----------------CC--CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 826 -QQIFDNILNRK-IP----------WPR----------------VP--EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 826 -~ei~qkIl~~~-~~----------~P~----------------lp--~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
.+.+..+.... .+ .+. .. ...+..+.+||.+||+.||.+|| |+.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~---t~~~~l 286 (291)
T cd07870 210 VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI---SAQDAL 286 (291)
T ss_pred HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc---CHHHHh
Confidence 12222211100 00 000 00 11357899999999999999999 999999
Q ss_pred cCCCC
Q 001856 876 QHVFF 880 (1003)
Q Consensus 876 qHPFF 880 (1003)
.||||
T Consensus 287 ~h~~~ 291 (291)
T cd07870 287 LHPYF 291 (291)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.29 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=213.3
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+++|++.+.||.|+||.||+|++..+++.||||.+.+...........+.+|+.+++.++||||+++++.|...+.+|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36799999999999999999999999999999998776555555667889999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999999864 346899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.
T Consensus 160 ------------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 ------------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ------------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 00112356899999999999988999999999999999999999999765
Q ss_pred Ch--hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 824 HP--QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 824 ~~--~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.. ......+.....+ +..+..++..+.+||.+||..||.+|| ++.+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~~ 260 (267)
T cd08229 210 KMNLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRP---DITYVYD 260 (267)
T ss_pred cchHHHHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCC---CHHHHHH
Confidence 43 3334444332221 122346889999999999999999999 8887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=331.57 Aligned_cols=252 Identities=28% Similarity=0.506 Sum_probs=221.1
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+|++.+.||.|+||.||+++++.+++.||+|++.+.... ......+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999998865543 3345677889999999999999999999999999999999
Q ss_pred eccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 670 YLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 670 y~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|+++++|..++.+ ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~---- 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---- 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc----
Confidence 9999999999866 35689999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 156 -----------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 156 -----------------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred -----------------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 011234688899999999999899999999999999999999999998887
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
......+.... ++.++..++.++.++|.+||+.+|.+|| ++.++++||++
T Consensus 207 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 207 QDLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred HHHHHHHhcCC--CCCCchhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 77766665543 3455667899999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.39 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=213.9
Q ss_pred EEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEec
Q 001856 595 KPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.++..++|+||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999865 8899999997654322 4678889999999999999999999999999999999999
Q ss_pred cCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 672 NGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 672 ~GGSL~d~L~~~---------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
.. ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 159 ~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 159 DY-----------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cc-----------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 00 011234567889999999998889999999999999999999 699999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.....++.+.+.... ....+..++.++.++|.+||+.+|.+|| ++.++++|
T Consensus 210 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 210 GLSNEEVLEYLRKGY--RLPKPEYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred CCCHHHHHHHHHcCC--CCCCCccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 988888887776532 2345677899999999999999999999 99999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.87 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=212.8
Q ss_pred CCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
++|.+.+.||+|+||+||++... .++..||+|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57999999999999999999853 345679999886542 3445678899999999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEE
Q 001856 664 LYLVMEYLNGGDLYSLLRNLG-------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g-------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKL 730 (1003)
+|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999997543 3899999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHH
Q 001856 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (1003)
Q Consensus 731 iDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVIL 810 (1003)
+|||+++...... .........+++.|+|||++.+..++.++|||||||++
T Consensus 162 ~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 162 GDFGMSRDVYSTD-----------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred ccCCccccccCCc-----------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 9999987311000 00011224567889999999999899999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 811 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 811 YELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|+|++ |.+||......+....+..... +..+..++.++.+||.+||+.||.+|| ++.++++
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~v~~ 274 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQGRV--LQRPRTCPKEVYDLMLGCWQREPHMRL---NIKEIHS 274 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99998 9999998888888878776543 234567889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=365.09 Aligned_cols=257 Identities=32% Similarity=0.590 Sum_probs=227.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+-|.++.+||+|+||.||+|.++.+|..+|||.+... ..++.+..|+.||.++++|+||++|+.|-....+++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 3489999999999999999999999999999987653 34678899999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||..|++.++++. ..+++++++..+++.-+.||+|||...-||||||..|||++.+|+.||+|||.|-.
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ--------- 178 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ--------- 178 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccch---------
Confidence 99999999999974 47899999999999999999999999999999999999999999999999998852
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
++ ..-.+.++.+|||.|||||++..-+|+.++||||||++..||..|++||....+..
T Consensus 179 -----------------LT-----DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 179 -----------------LT-----DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred -----------------hh-----hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 11 11234568999999999999999999999999999999999999999999888866
Q ss_pred HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 828 i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
.+-.|-....+--.-|+.+|.++.|||++||.+.|++|- ||.++++|||.++-.
T Consensus 237 AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 237 AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAP 290 (502)
T ss_pred eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCC
Confidence 555554444332234678999999999999999999999 999999999998643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=332.05 Aligned_cols=247 Identities=51% Similarity=0.962 Sum_probs=219.2
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999887665556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 001856 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (1003)
Q Consensus 677 ~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgtt 756 (1003)
.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-------------- 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-------------- 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--------------
Confidence 999998888999999999999999999999999999999999999999999999999998741100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcC
Q 001856 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836 (1003)
Q Consensus 757 l~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~ 836 (1003)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 147 -----------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (250)
T cd05123 147 -----------------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209 (250)
T ss_pred -----------------CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 011234578899999999998888999999999999999999999998887777777776644
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH---HHHHcCCCC
Q 001856 837 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA---SEVKQHVFF 880 (1003)
Q Consensus 837 ~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SA---eELLqHPFF 880 (1003)
. .++..++..+.+||++||..||.+|| ++ +++++||||
T Consensus 210 ~---~~~~~~~~~l~~~i~~~l~~~p~~R~---~~~~~~~l~~~~~f 250 (250)
T cd05123 210 L---RFPEFLSPEARDLISGLLQKDPTKRL---GSGGAEEIKAHPFF 250 (250)
T ss_pred C---CCCCCCCHHHHHHHHHHhcCCHhhCC---CcccHHHHHhCCCC
Confidence 3 34566799999999999999999999 66 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.97 Aligned_cols=263 Identities=27% Similarity=0.470 Sum_probs=211.1
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyL 666 (1003)
.++|+..+.||+|+||.||++.+..+++.||+|.+.+.... .....+.+|+.++.++. ||||+++++.+......|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35678889999999999999999999999999998764322 34567889999999986 9999999999999999999
Q ss_pred EEEeccCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 667 VMEYLNGGDLYSLL---R--NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 667 VmEy~~GGSL~d~L---~--~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
+|||+.+ +|.++. . ..+.+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 554433 2 23679999999999999999999997 599999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC---CCCccceeechhHHHHHHHhCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~ys~kSDIWSLGVILYELLTGk 817 (1003)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 160 ~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 207 (288)
T cd06616 160 D--------------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207 (288)
T ss_pred c--------------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCC
Confidence 0 0011234688999999999876 6899999999999999999999
Q ss_pred CCCCCCCh-hhHHHhhhhcCCC-CC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 001856 818 PPFNAEHP-QQIFDNILNRKIP-WP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888 (1003)
Q Consensus 818 ~PF~~~~~-~ei~qkIl~~~~~-~P-~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L 888 (1003)
+||..... .+...++.....+ .+ ..+..++.++.+||.+||++||.+|| ++++|++||||+...|.+.
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 208 FPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELLEHPFIKDYEERNV 278 (288)
T ss_pred CCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcChhhhchhhcch
Confidence 99976542 1222222222211 11 12235789999999999999999999 9999999999998766554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.34 Aligned_cols=255 Identities=21% Similarity=0.347 Sum_probs=215.0
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~t-----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~ 661 (1003)
.+.+|++++.||+|+||.||+|.+..+ ++.||+|+++... .....+.+.+|..++..++||||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 346789999999999999999987543 5789999987542 233446788999999999999999999999999
Q ss_pred ceEEEEEEeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d 725 (1003)
..+++++||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 347888899999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeec
Q 001856 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (1003)
Q Consensus 726 G~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWS 805 (1003)
+.+||+|||+++..... ..........+++.|+|||++.+..++.++||||
T Consensus 161 ~~~kl~Dfg~~~~~~~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05091 161 LNVKISDLGLFREVYAA-----------------------------DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211 (283)
T ss_pred CceEecccccccccccc-----------------------------hheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence 99999999998731100 0001122345678999999999888999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 806 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 806 LGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|||++|||++ |..||.+....+++..+..... +..+..++.++.+|+.+||+.+|.+|| ++.+|++.
T Consensus 212 lG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RP---~~~~i~~~ 279 (283)
T cd05091 212 YGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV--LPCPDDCPAWVYTLMLECWNEFPSRRP---RFKDIHSR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHhCCCcccCC---CHHHHHHH
Confidence 9999999998 8999998888888888776553 335678999999999999999999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.85 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=209.5
Q ss_pred eEEEEEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce----
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN---- 663 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~---- 663 (1003)
|++.+.||+|+||.||+|....+ +..||+|+++.... .......+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999997653 47899999875432 34456778999999999999999999988765443
Q ss_pred --EEEEEEeccCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 664 --LYLVMEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 664 --lyLVmEy~~GGSL~d~L~~~------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
.+++|||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999998542 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 160 SKKIYSGDY-----------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred eeecccccc-----------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence 874211000 000112335678999999998889999999999999999999
Q ss_pred -CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 816 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 816 -Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|.+||.+....++++.+..... +..+..++..+.++|.+||+.||.+|| ++.+++++
T Consensus 211 ~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~~~ 268 (273)
T cd05035 211 RGQTPYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRP---TFTKLREV 268 (273)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999998888888777765432 345678899999999999999999999 89888765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.08 Aligned_cols=251 Identities=23% Similarity=0.408 Sum_probs=210.9
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
...++|+++++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34578999999999999999999974 567899998765322 3467889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
++|||+++++|.+++... ..++...+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN- 156 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC-
Confidence 999999999999999753 46888999999999999999999999999999999999999999999999998741000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
. ........++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 157 ----~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 157 ----E-------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred ----c-------------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 0 000112346778999999998889999999999999999998 9999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.........+.... .++ ....++.++.+||.+||..+|.+|| +++++.+
T Consensus 208 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 256 (261)
T cd05072 208 MSNSDVMSALQRGY-RMP-RMENCPDELYDIMKTCWKEKAEERP---TFDYLQS 256 (261)
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 87777777765442 233 3356889999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.12 Aligned_cols=259 Identities=28% Similarity=0.487 Sum_probs=206.4
Q ss_pred CeEEEEEeeccCceEEEEEEECC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 665 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~--tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~ly 665 (1003)
.|++.+.||+|+||.||+|.+.. ++..||+|++.............+.+|+.++..++||||+++++.+.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999999874433333446678899999999999999999999988 8899
Q ss_pred EEEEeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC----CCcEEEeecCCc
Q 001856 666 LVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLS 736 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~-----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~----dG~VKLiDFGLA 736 (1003)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777776432 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHh
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLT 815 (1003)
+....... ........+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 160 RLFNAPLK----------------------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred cccCCCcc----------------------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 74211000 00112345789999999998764 57899999999999999999
Q ss_pred CCCCCCCCChhh---------HHHhhhh--------------------------cCCCCCC--------CCCCCCHHHHH
Q 001856 816 GIPPFNAEHPQQ---------IFDNILN--------------------------RKIPWPR--------VPEEMSPEAHD 852 (1003)
Q Consensus 816 Gk~PF~~~~~~e---------i~qkIl~--------------------------~~~~~P~--------lp~~iS~elkD 852 (1003)
|.+||.+..... .+..++. ....++. .....+..+.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd07842 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291 (316)
T ss_pred cCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHH
Confidence 999997654322 1111100 0000110 00156788999
Q ss_pred HHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 853 LIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 853 LIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+|.+||+.||.+|| ++.|+++||||
T Consensus 292 ~i~~~l~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 292 LLRKLLEYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred HHHHHhcCCcccCc---CHHHHhcCCCC
Confidence 99999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=339.49 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=214.5
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF 658 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~t-----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f 658 (1003)
....++|++.+.||+|+||.||++.+... ...+|+|++.... .......+.+|+.++..+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44557899999999999999999998643 3689999987542 233446788999999999 899999999999
Q ss_pred eccceEEEEEEeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceee
Q 001856 659 TCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722 (1003)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~d~L~~~----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILL 722 (1003)
.....+|++|||+++|+|..++... +.+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999642 458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccce
Q 001856 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802 (1003)
Q Consensus 723 d~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSD 802 (1003)
+.++.+||+|||+++.... .. .........++..|+|||++.+..++.++|
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~--~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 216 (293)
T cd05053 166 TEDHVMKIADFGLARDIHH--ID---------------------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216 (293)
T ss_pred cCCCeEEeCcccccccccc--cc---------------------------ceeccCCCCCCccccCHHHhccCCcCcccc
Confidence 9999999999999874110 00 000011223567899999999989999999
Q ss_pred eechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 803 WWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 803 IWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
||||||++|||++ |..||.+....+.+..+..... +..+..++..+.+|+.+||..||.+|| ++.+++++
T Consensus 217 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~eil~~ 287 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRP---TFKQLVED 287 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCc---CHHHHHHH
Confidence 9999999999997 9999998888777776655432 334567889999999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.22 Aligned_cols=260 Identities=30% Similarity=0.523 Sum_probs=208.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----ce
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----EN 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-----~~ 663 (1003)
++|++.+.||+|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 67999999999999999999999999999999986432 233456678899999999999999999876543 35
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|+||||+.+ +|..++.. +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 8999999965 88888754 579999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 161 ~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 161 D----------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred c----------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 0 0001123578999999998765 5689999999999999999999999977
Q ss_pred CChhhHHHhhhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 823 EHPQQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~----------------------------~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
.+.......+.... .++.......++++.+||.+||+.+|.+|| ++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~e~ 289 (336)
T cd07849 213 KDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI---TVEEA 289 (336)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc---CHHHH
Confidence 65433322221100 000011134678899999999999999999 99999
Q ss_pred HcCCCCCCC
Q 001856 875 KQHVFFKDI 883 (1003)
Q Consensus 875 LqHPFFk~I 883 (1003)
++||||+.+
T Consensus 290 l~hp~~~~~ 298 (336)
T cd07849 290 LAHPYLEQY 298 (336)
T ss_pred hcCcccccc
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=339.23 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=212.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3679999999999999999999977 77899999876432 2333467889999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC---cEEEee
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTD 732 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g-------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG---~VKLiD 732 (1003)
..|+||||++|++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997653 488999999999999999999999999999999999998765 599999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHH
Q 001856 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 733 FGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYE 812 (1003)
||+++.... .. . ........+++.|+|||++.+..++.++|||||||++||
T Consensus 163 fg~~~~~~~--~~-----------~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (277)
T cd05036 163 FGMARDIYR--AS-----------Y----------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE 213 (277)
T ss_pred CccccccCC--cc-----------c----------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHH
Confidence 999874100 00 0 000112234567999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 813 LIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 813 LLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|++ |..||...+..++...+..... +..+..++..+.+||.+||+.+|.+|| ++.++++|
T Consensus 214 l~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp---s~~~vl~~ 274 (277)
T cd05036 214 IFSLGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRP---NFATILER 274 (277)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 997 9999998887777666554322 234567899999999999999999999 99999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.40 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=212.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCC----------------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTG----------------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tg----------------k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnI 651 (1003)
.++|++++.||+|+||.||+|.+..++ ..||+|++..... ....+.+.+|+.++..++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 467999999999999999999876544 5689999876432 3456788899999999999999
Q ss_pred EEEEeeeeccceEEEEEEeccCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcce
Q 001856 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (1003)
Q Consensus 652 VkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g-----------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNI 720 (1003)
+++++++.....+|++|||+++++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999998765 689999999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCcc
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 800 (1003)
+++.++.++|+|||+++..... + .........+|+.|+|||++.+..++.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~--~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSS--D---------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred eecCCCceEEccccceeecccC--c---------------------------ceeecCcCCCCceecCHHHhhcCCCCcc
Confidence 9999999999999998731100 0 0011224567889999999998889999
Q ss_pred ceeechhHHHHHHHh--CCCCCCCCChhhHHHhhhhc-----CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 801 ADWWSVGIILFELIV--GIPPFNAEHPQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 801 SDIWSLGVILYELLT--Gk~PF~~~~~~ei~qkIl~~-----~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
+|||||||++|||++ |..||...+..+++..+... .......+..++.++.+||.+||+.||.+|| ++.+
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---t~~e 289 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP---TFRE 289 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC---CHHH
Confidence 999999999999998 78899877776666655432 1111223456789999999999999999999 8999
Q ss_pred HHc
Q 001856 874 VKQ 876 (1003)
Q Consensus 874 LLq 876 (1003)
|++
T Consensus 290 l~~ 292 (296)
T cd05051 290 IHL 292 (296)
T ss_pred HHH
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.38 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=213.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----cceE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENL 664 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d----~~~l 664 (1003)
++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+|+.++||||+++++.|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 579999999999999999999999999999999876432 22345677789999999999999999988763 3578
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 59999998778899999999999999999999999999999999999999999999999999874111000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
. ........+|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 163 ~---------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 163 E---------------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred C---------------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 0 0011123578999999999876 45899999999999999999999999876
Q ss_pred ChhhHHHhhhhc-----------------------C-----CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 824 HPQQIFDNILNR-----------------------K-----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 824 ~~~ei~qkIl~~-----------------------~-----~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
+.......+... . .++..+....+.++.+||.+||+.+|.+|| ++.+++
T Consensus 216 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~l 292 (334)
T cd07855 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI---TVEQAL 292 (334)
T ss_pred ChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc---CHHHHH
Confidence 554333222210 0 000111245789999999999999999999 999999
Q ss_pred cCCCCCCC
Q 001856 876 QHVFFKDI 883 (1003)
Q Consensus 876 qHPFFk~I 883 (1003)
+||||+..
T Consensus 293 ~~~~~~~~ 300 (334)
T cd07855 293 QHPFLAQY 300 (334)
T ss_pred hChhhhhc
Confidence 99999843
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=332.29 Aligned_cols=246 Identities=28% Similarity=0.413 Sum_probs=205.1
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
+.||+|+||.||+|+++.+++.||+|.+... ........+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3689999999999999999999999987643 23444567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 675 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 675 SL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... . ...
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~----~~~ 150 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED----G----VYA 150 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc----c----ccc
Confidence 999999765 4689999999999999999999999999999999999999999999999999873100 0 000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 832 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkI 832 (1003)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||...........+
T Consensus 151 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~ 209 (252)
T cd05084 151 ---------------------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209 (252)
T ss_pred ---------------------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 00001123467999999998889999999999999999997 99999877776665555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 833 l~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..... +..+..++..+.+||.+||+.+|.+|| ++.++++
T Consensus 210 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 248 (252)
T cd05084 210 EQGVR--LPCPELCPDAVYRLMERCWEYDPGQRP---SFSTVHQ 248 (252)
T ss_pred HcCCC--CCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 44322 234567899999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=351.99 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=212.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~----- 662 (1003)
.++|++++.||+|+||.||+|.+..++..||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 367999999999999999999999999999999986532 22334456789999999999999999999987654
Q ss_pred -eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 -NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 -~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~- 169 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD- 169 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc-
Confidence 469999999 7799888864 579999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||
T Consensus 170 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 170 ---------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred ---------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 00123467899999999876 45789999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCCCC----------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 821 NAEHPQQIFDNILNRKIPW----------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~----------------------------P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
.+.+....+..++...... ......+++.+.++|.+||+.||.+|| ++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~---t~~ 293 (343)
T cd07880 217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI---TAA 293 (343)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC---CHH
Confidence 8776655554443321110 112246788999999999999999999 999
Q ss_pred HHHcCCCCCCC
Q 001856 873 EVKQHVFFKDI 883 (1003)
Q Consensus 873 ELLqHPFFk~I 883 (1003)
+++.||||+..
T Consensus 294 ~~l~~~~~~~~ 304 (343)
T cd07880 294 EALAHPYFEEF 304 (343)
T ss_pred HHhcCccHhhh
Confidence 99999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=339.24 Aligned_cols=254 Identities=31% Similarity=0.539 Sum_probs=210.1
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|++++.||.|++|.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++.+.+....|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999876432 223335678899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 671 LNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
++ ++|.+++.... .+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 95 59999997765 6899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||...+...
T Consensus 153 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 207 (283)
T cd07835 153 -------------------------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207 (283)
T ss_pred -------------------------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0011233578899999988764 46889999999999999999999998776544
Q ss_pred HHHhhhhcCC--------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 828 IFDNILNRKI--------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 828 i~qkIl~~~~--------------------------~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
...++..... ........++..+.++|.+||+.||.+|| ++.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~ 283 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI---SAKAALQHPYF 283 (283)
T ss_pred HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc---CHHHHhcCCCC
Confidence 4333322100 00112345778999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=346.16 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=209.0
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~----VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
...+|++++.||+|+||+||+|++..++.. ||+|+++... .....+.+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998766654 8999986432 234456788999999999999999999988764
Q ss_pred eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..++++||+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999999875 4688999999999999999999999999999999999999999999999999984110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF 820 (1003)
... ........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 162 ~~~-----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 162 DEK-----------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred CCc-----------------------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 000 001112345678999999999999999999999999999997 99999
Q ss_pred CCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.+....++... ......++ .+..++.++.++|.+||..+|.+|| ++.+++.+
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 213 DGIPASEISSI-LEKGERLP-QPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred CCCCHHHHHHH-HhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 88776665443 33333333 3456789999999999999999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=374.82 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=200.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCC-CCEEEEE--------------EeeccccccHHHHHHHHHHHHHHHhcCCCcE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTT-GDLFAIK--------------VLKKADMIRKNAVESILAERDILISVRNPFV 651 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~t-gk~VALK--------------VIkKs~~~~~~~ie~~lrEi~IL~~L~HPnI 651 (1003)
.+++|++++.||+|+||+||+|..+.. +..++.| ++.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 346899999999999999999976432 2222222 1111111122344567899999999999999
Q ss_pred EEEEeeeeccceEEEEEEeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC
Q 001856 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (1003)
Q Consensus 652 VkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~-----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG 726 (1003)
+++++++...+..|+|||++. ++|..++... .......++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 5888877542 2244667888999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeech
Q 001856 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (1003)
Q Consensus 727 ~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSL 806 (1003)
.+||+|||+++..... ........+||+.|+|||++.+..|+.++|||||
T Consensus 305 ~vkL~DFGla~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 305 KIVLGDFGTAMPFEKE------------------------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred CEEEEeCCCceecCcc------------------------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 9999999999741100 0011234689999999999999999999999999
Q ss_pred hHHHHHHHhCCCC-CCCC--ChhhHHHhhhhc-C---CCCCC----------------C---------CCCCCHHHHHHH
Q 001856 807 GIILFELIVGIPP-FNAE--HPQQIFDNILNR-K---IPWPR----------------V---------PEEMSPEAHDLI 854 (1003)
Q Consensus 807 GVILYELLTGk~P-F~~~--~~~ei~qkIl~~-~---~~~P~----------------l---------p~~iS~elkDLI 854 (1003)
||++|||++|..+ |... +....+.+++.. . ..+|. . ...++.++.++|
T Consensus 355 Gvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li 434 (501)
T PHA03210 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPL 434 (501)
T ss_pred HHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHH
Confidence 9999999998754 4322 222222222110 0 00110 0 013567788999
Q ss_pred HhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 001856 855 DRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888 (1003)
Q Consensus 855 rrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L 888 (1003)
.+||++||.+|| ++.|+|+||||.....+.+
T Consensus 435 ~kmL~~DP~~Rp---sa~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 435 VKMLTFDWHLRP---GAAELLALPLFSAEEEEEI 465 (501)
T ss_pred HHHhccCcccCc---CHHHHhhChhhhcCCchHH
Confidence 999999999999 9999999999998766554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.78 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=213.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
.++|++.+.||+|+||+||+|++..+ ...||+|++.... .......+.+|+.+++.++||||+++++.+...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36799999999999999999998644 4589999987543 233456788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|++|||+++++|.+++... +.+++..+..++.|++.||+|||++||+|+||||+|||++.++.++|+|||+++.... .
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~-~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED-S 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc-c
Confidence 9999999999999999764 5789999999999999999999999999999999999999999999999999984210 0
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
.. ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 160 ~~----------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 160 EA----------------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cc----------------------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 00 001112345678999999998889999999999999999998 9999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
....+....+..... . ..+..++..+.+|+.+||+.+|.+|| ++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 212 MSNQDVIKAVEDGYR-L-PPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred CCHHHHHHHHHcCCC-C-CCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 777777776654422 1 23467899999999999999999999 89988875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.40 Aligned_cols=253 Identities=33% Similarity=0.540 Sum_probs=208.6
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeeccce----
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCREN---- 663 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L---~HPnIVkL~~~f~d~~~---- 663 (1003)
|++.+.||.|+||.||+|+++.+++.||+|+++.... .......+.+|+.++..+ +||||+++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975432 222234566787777665 69999999999998776
Q ss_pred -EEEEEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 664 -LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 664 -lyLVmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
+|++|||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 159 ~~--------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 159 FE--------------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred CC--------------------------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 00 0112235788999999999988999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCC-----CCC-------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 821 NAEHPQQIFDNILNRKI-----PWP-------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~-----~~P-------------------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+.+..+.+.++..... .++ .....+++.+.+||.+||+.||.+|| ++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~il~ 283 (287)
T cd07838 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI---SAFEALQ 283 (287)
T ss_pred cCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC---CHHHHhc
Confidence 98887776666643110 000 01123567889999999999999999 9999999
Q ss_pred CCCC
Q 001856 877 HVFF 880 (1003)
Q Consensus 877 HPFF 880 (1003)
||||
T Consensus 284 ~~~~ 287 (287)
T cd07838 284 HPYF 287 (287)
T ss_pred CcCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.60 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=212.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----ce
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----EN 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-----~~ 663 (1003)
.+|++++.||+|+||+||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 469999999999999999999999999999999875432 223345677899999999999999999887654 35
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~-- 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-- 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC--
Confidence 899999996 69999998888899999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
. ........||..|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 161 ~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 161 K-----------------------------GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred C-----------------------------cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 0 001123568899999999875 4689999999999999999999999987
Q ss_pred CChhhHHHhhhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 823 EHPQQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~----------------------------~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
.+....+..+.... ..+......+++++.+||++||+.+|.+|| ++.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---s~~el 288 (337)
T cd07858 212 KDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI---TVEEA 288 (337)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc---CHHHH
Confidence 65433332222100 000112246789999999999999999999 99999
Q ss_pred HcCCCCCCC
Q 001856 875 KQHVFFKDI 883 (1003)
Q Consensus 875 LqHPFFk~I 883 (1003)
++||||..+
T Consensus 289 l~h~~~~~~ 297 (337)
T cd07858 289 LAHPYLASL 297 (337)
T ss_pred HcCcchhhh
Confidence 999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=375.58 Aligned_cols=250 Identities=33% Similarity=0.554 Sum_probs=214.5
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
-+||+|.||+||.|++..|....|||-+.... ....+.+..|+.+.+.++|.|||++++.+..++++-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 36999999999999999999999999886432 345678889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCC
Q 001856 675 DLYSLLRN-LGCL--DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGP 750 (1003)
Q Consensus 675 SL~d~L~~-~g~L--sEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~s~ddls~p 750 (1003)
+|.++++. +|++ .|..+.+|.+||++||.|||.+.|||||||-+|||++. .|.+||+|||.++.. .
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL--------A-- 727 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL--------A-- 727 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh--------c--
Confidence 99999975 5888 88999999999999999999999999999999999975 799999999999841 0
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc--CCCCccceeechhHHHHHHHhCCCCCCCCC-h-h
Q 001856 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEH-P-Q 826 (1003)
Q Consensus 751 ~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ys~kSDIWSLGVILYELLTGk~PF~~~~-~-~ 826 (1003)
| -+..+.++.||..|||||++.. .+|+.++|||||||++.||.||+|||.... + .
T Consensus 728 --------g-------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 728 --------G-------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred --------c-------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 0 1123457899999999999975 469999999999999999999999996432 2 2
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.+++-=+- ..-|.+|..+|.+++.||.+|+..||.+|| +|.++|+.||++.-
T Consensus 787 AMFkVGmy--KvHP~iPeelsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 787 AMFKVGMY--KVHPPIPEELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhhhcce--ecCCCCcHHHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 23322111 123678899999999999999999999999 99999999999854
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.60 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=209.9
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk--~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~ly 665 (1003)
++|++.+.||+|+||.||+|+...++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++.+.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 679999999999999999999877765 4688877632 2334456788999999998 7999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEE
Q 001856 666 LVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VK 729 (1003)
++|||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997542 478899999999999999999999999999999999999999999
Q ss_pred EeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHH
Q 001856 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809 (1003)
Q Consensus 730 LiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVI 809 (1003)
|+|||++..... ........++..|+|||++.+..++.++|||||||+
T Consensus 160 l~dfg~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~i 207 (297)
T cd05089 160 IADFGLSRGEEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVL 207 (297)
T ss_pred ECCcCCCccccc--------------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHH
Confidence 999999862100 000111223457999999999889999999999999
Q ss_pred HHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 810 LFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 810 LYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+|||++ |..||......+.+..+..... +..+..++..+.+||.+||..+|.+|| +++++++.
T Consensus 208 l~el~t~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~~ 271 (297)
T cd05089 208 LWEIVSLGGTPYCGMTCAELYEKLPQGYR--MEKPRNCDDEVYELMRQCWRDRPYERP---PFAQISVQ 271 (297)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999997 9999998888887777655422 234567899999999999999999999 89998765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=348.95 Aligned_cols=261 Identities=30% Similarity=0.463 Sum_probs=219.0
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----eE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~-----~l 664 (1003)
+|++.+.||.|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 58999999999999999999998999999999876431 2334567889999999999999999999988775 79
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|++|||+++ +|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 8999998878899999999999999999999999999999999999999999999999999874110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.........||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.
T Consensus 159 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 159 ----------------------------EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ----------------------------ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 00112235689999999999887 7899999999999999999999999988
Q ss_pred ChhhHHHhhhhcCCCC----------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 824 HPQQIFDNILNRKIPW----------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~----------------------------P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
+..+.+..++...... ......++.++.+||.+||+++|.+|| ++.+++
T Consensus 211 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ll 287 (330)
T cd07834 211 DYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI---TADEAL 287 (330)
T ss_pred CHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 8776666655422110 111234688999999999999999999 999999
Q ss_pred cCCCCCCC
Q 001856 876 QHVFFKDI 883 (1003)
Q Consensus 876 qHPFFk~I 883 (1003)
+||||+++
T Consensus 288 ~~~~~~~~ 295 (330)
T cd07834 288 AHPYLAQL 295 (330)
T ss_pred hCccHHhh
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.18 Aligned_cols=245 Identities=27% Similarity=0.481 Sum_probs=207.6
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeee-eccceE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF-TCRENL 664 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f-~d~~~l 664 (1003)
....+|++.+.||+|+||.||++... |..||+|.++... ..+.+.+|+.+++.++|+||+++++.+ .....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999864 7889999986432 245688999999999999999999875 455679
Q ss_pred EEEEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
|++|||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997653 488999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||.
T Consensus 155 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 155 ---------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ---------------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 0112334567999999999889999999999999999997 999998
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+..++...+..... +..+..+++.+.++|.+||+.+|.+|| ++.++++
T Consensus 202 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 202 RIPLKDVVPRVEKGYK--MDAPDGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred CCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 8887777766654422 344567899999999999999999999 8888865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.61 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=205.1
Q ss_pred EeeccCceEEEEEEE--CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 596 PISRGAFGRVFLAKK--RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 596 ~LG~G~FGtVyLArd--k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
.||+|+||.||+|.+ ..++..+|+|+++... ......+.+.+|+.+++.++||||+++++.+. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4578899999987543 23445678899999999999999999998875 4567999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 674 GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~--------- 150 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN--------- 150 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC---------
Confidence 99999998878899999999999999999999999999999999999999999999999999873110000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 832 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkI 832 (1003)
.........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++.+.+
T Consensus 151 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 151 -------------------YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred -------------------eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0000112345688999999988889999999999999999998 99999988887777777
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 833 l~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+.. +..+..+++++.+||.+||+.||.+|| ++.+|..
T Consensus 212 ~~~~~--~~~~~~~~~~l~~li~~~~~~~p~~Rp---~~~~i~~ 250 (257)
T cd05116 212 ESGER--MECPQRCPPEMYDLMKLCWTYGVDERP---GFAVVEL 250 (257)
T ss_pred HCCCC--CCCCCCCCHHHHHHHHHHhccCchhCc---CHHHHHH
Confidence 65432 445678999999999999999999999 6666543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.42 Aligned_cols=268 Identities=29% Similarity=0.467 Sum_probs=209.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------ 661 (1003)
+++|++.++||.|+||.||+|+++.+++.||+|++....... .....+.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 688999999999999999999999999999999987543221 1224567899999999999999999877543
Q ss_pred --ceEEEEEEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 662 --ENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 662 --~~lyLVmEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
..+|+||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||+++.
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 77777754 35799999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCC
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 739 ~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk 817 (1003)
.......... .............||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 165 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~ 224 (311)
T cd07866 165 YDGPPPNPKG--------------------GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224 (311)
T ss_pred ccCCCccccc--------------------CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCC
Confidence 2110000000 000011123456789999999998754 5789999999999999999999
Q ss_pred CCCCCCChhhHHHhhhhcCCC--------------------CCCC-------CCCCCHHHHHHHHhhccCCcCCcCCCCC
Q 001856 818 PPFNAEHPQQIFDNILNRKIP--------------------WPRV-------PEEMSPEAHDLIDRFLTEDPHQRLGSGG 870 (1003)
Q Consensus 818 ~PF~~~~~~ei~qkIl~~~~~--------------------~P~l-------p~~iS~elkDLIrrcL~kDP~kRpg~~S 870 (1003)
+||.+.+.....+.+...... .... ...+++.+.+||.+||+.||.+|| +
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t 301 (311)
T cd07866 225 PILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL---T 301 (311)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc---C
Confidence 999887776655554431110 0000 123557889999999999999999 9
Q ss_pred HHHHHcCCCC
Q 001856 871 ASEVKQHVFF 880 (1003)
Q Consensus 871 AeELLqHPFF 880 (1003)
+.+++.||||
T Consensus 302 ~~ell~~~~f 311 (311)
T cd07866 302 ASDALEHPYF 311 (311)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.82 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=208.8
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
..++|++++.||.|+||+||+|++..++. .||+|+++... .......+.+|..++..++||||+++++.+.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 34679999999999999999999877766 48999986542 23345678899999999999999999998875 4
Q ss_pred eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..+++|||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999999764 5699999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF 820 (1003)
... ........+++.|+|||++.+..++.++|||||||++|||++ |.+||
T Consensus 162 ~~~-----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 162 DET-----------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred ccc-----------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 000 000112245678999999999899999999999999999998 99999
Q ss_pred CCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.......+...+..... +..+..++..+.++|.+||..||.+|| ++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 213 DGIPAREIPDLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred CCCCHHHHHHHHHCCCc--CCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 87776666555444322 233567899999999999999999999 8999885
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=352.23 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=209.7
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~ 657 (1003)
|...-++|++.+.||.|+||.||+|++. .+++.||+|++.... .......+..|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 3444568999999999999999999754 345789999987532 233456778899999999 89999999998
Q ss_pred eec-cceEEEEEEeccCCChHHHHHhc-----------------------------------------------------
Q 001856 658 FTC-RENLYLVMEYLNGGDLYSLLRNL----------------------------------------------------- 683 (1003)
Q Consensus 658 f~d-~~~lyLVmEy~~GGSL~d~L~~~----------------------------------------------------- 683 (1003)
+.. ...+|++|||+++++|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 765 45789999999999999998542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 001856 684 --------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755 (1003)
Q Consensus 684 --------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgt 755 (1003)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------ 227 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 227 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc------------
Confidence 257889999999999999999999999999999999999999999999999997421000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhh
Q 001856 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILN 834 (1003)
Q Consensus 756 tl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~ 834 (1003)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+.
T Consensus 228 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~ 290 (337)
T cd05054 228 -----------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290 (337)
T ss_pred -----------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh
Confidence 0011223456788999999999999999999999999999998 9999987655444444443
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 835 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 835 ~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
... .+..+...++++.+++.+||+.+|.+|| ++.++++|
T Consensus 291 ~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 291 EGT-RMRAPEYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred ccC-CCCCCccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 322 2334567889999999999999999999 99999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.71 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=206.8
Q ss_pred eEEEEEeeccCceEEEEEEECCCCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------c
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------E 662 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk--~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------~ 662 (1003)
|.+.+.||+|+||.||+|++..++. .+|+|.++... ......+.+.+|..+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467889999999999999877765 69999987643 2344567888999999999999999999876432 2
Q ss_pred eEEEEEEeccCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
..+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999987421 34889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT- 815 (1003)
+....... ........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 160 KKIYNGDY-----------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred cccCcccc-----------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 74110000 000122356778999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|..||.+....+++..+..... +..+..++..+.++|.+||+.||.+|| ++.+|+++
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 267 (272)
T cd05075 211 GQTPYPGVENSEIYDYLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRP---SFETLRCE 267 (272)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 8999988887777777765443 234567889999999999999999999 89988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.06 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=211.3
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF 658 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~-------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f 658 (1003)
..++|.+.+.||+|+||.||+|++.. +...+|+|++.... .......+.+|+.++..+ +||||+++++.+
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34789999999999999999998743 23579999987542 233456788899999999 799999999999
Q ss_pred eccceEEEEEEeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceee
Q 001856 659 TCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722 (1003)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILL 722 (1003)
.....+|+||||+++|+|.+++...+ .++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 99999999999999999999997642 47888999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccce
Q 001856 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802 (1003)
Q Consensus 723 d~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSD 802 (1003)
+.++.+||+|||+++.... .. .........+++.|+|||++.+..++.++|
T Consensus 174 ~~~~~~kL~dfg~a~~~~~--~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 174 TEDNVMKIADFGLARDIHH--ID---------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred cCCCcEEECCCcccccccc--cc---------------------------hhhccccCCCccceeChHHhccCCCCcHHH
Confidence 9999999999999873110 00 000011223557899999999988999999
Q ss_pred eechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 803 WWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 803 IWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
||||||++|+|++ |..||.+....+++..+..... +..+..++.++.+||.+||..+|.+|| ++.+++++
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~~ 295 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRP---TFKQLVED 295 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCc---CHHHHHHH
Confidence 9999999999998 8999988887777766654332 345567899999999999999999999 89888775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=350.17 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=205.3
Q ss_pred Eeecc--CceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 596 PISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 596 ~LG~G--~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
.||.| +||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|...+.+|+||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45666 9999999999999999999998765432 34457888999999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 001856 674 GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (1003)
Q Consensus 674 GSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~ 751 (1003)
++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------- 156 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------- 156 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc-------
Confidence 9999999765 3589999999999999999999999999999999999999999999999986542100000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC--CCCccceeechhHHHHHHHhCCCCCCCCChhhHH
Q 001856 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 829 (1003)
Q Consensus 752 ~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~ 829 (1003)
..... ........++..|||||++.+. .++.++|||||||++|+|++|.+||.........
T Consensus 157 -~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 157 -KAKVV----------------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred -ccccc----------------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 00000 0001123456789999999763 4789999999999999999999999876554444
Q ss_pred HhhhhcCCCCC--------------------------------------------CCCCCCCHHHHHHHHhhccCCcCCc
Q 001856 830 DNILNRKIPWP--------------------------------------------RVPEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 830 qkIl~~~~~~P--------------------------------------------~lp~~iS~elkDLIrrcL~kDP~kR 865 (1003)
..++......+ ..+..+++.+.+||++||+.||.+|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 299 (328)
T cd08226 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKR 299 (328)
T ss_pred HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccC
Confidence 33332211000 0122367789999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 001856 866 LGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 866 pg~~SAeELLqHPFFk~I 883 (1003)
| |+.++++||||+++
T Consensus 300 p---ta~e~l~~~~~~~~ 314 (328)
T cd08226 300 P---SASSLLSHAFFKQV 314 (328)
T ss_pred C---CHHHHhhCHHHHHH
Confidence 9 99999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=350.83 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=209.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc------
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------ 662 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~------ 662 (1003)
++|.+.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 579999999999999999999999999999999876432 2233456789999999999999999999887543
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+|+||||+.+ +|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~-- 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-- 168 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC--
Confidence 46999999964 7776652 468999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 169 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 169 --------------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred --------------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 00123467889999999876 458899999999999999999999999
Q ss_pred CCChhhHHHhhhhcCC----------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 822 AEHPQQIFDNILNRKI----------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~----------------------------~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
+.+....+..++.... .+.......++.+.+||.+||+.||.+|| ++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~---~~~e 293 (342)
T cd07879 217 GKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL---TATE 293 (342)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc---CHHH
Confidence 8776555444433110 00011134678899999999999999999 9999
Q ss_pred HHcCCCCCCCCh
Q 001856 874 VKQHVFFKDINW 885 (1003)
Q Consensus 874 LLqHPFFk~Idw 885 (1003)
++.||||+.+..
T Consensus 294 ~l~h~~f~~~~~ 305 (342)
T cd07879 294 ALEHPYFDSFRD 305 (342)
T ss_pred HhcCcchhhccc
Confidence 999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.71 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=211.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++++.||+|+||+||+|++.. +..+|+|.+..... ..+.+.+|+.++..++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998753 45699998875432 235678899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++..... .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~-~-- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-E-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC-c--
Confidence 9999999999999764 46899999999999999999999999999999999999999999999999998731100 0
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~ 825 (1003)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 155 ---------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 155 ---------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred ---------------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 000112345678999999998889999999999999999998 9999988887
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.+....+...... ..+...+..+.+++.+||..+|.+|| ++.+|+++
T Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 208 SETVEKVSQGLRL--YRPHLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred HHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 7777777665432 23456789999999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.89 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=210.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
..++|++.+.||.|+||.||+|.+. +++.||+|.++.... ..+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999975 457899999876432 23567889999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+|||++|++|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-- 156 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC--
Confidence 999999999999997654 6899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~ 823 (1003)
. ........++..|+|||++.+..++.++|+|||||++|||++ |+.||.+.
T Consensus 157 ------~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 157 ------I----------------------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred ------c----------------------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 0 000011223467999999999889999999999999999999 99999988
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
....++..+.... .. ..+..++..+.+++.+||+.+|.+|| ++.++++
T Consensus 209 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~l~~ 256 (261)
T cd05068 209 TNAEVLQQVDQGY-RM-PCPPGCPKELYDIMLDCWKEDPDDRP---TFETLQW 256 (261)
T ss_pred CHHHHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHhhcCcccCC---CHHHHHH
Confidence 8877777765442 22 23457889999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.58 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=209.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
..+|++.+.||+|+||.||+|+++ ++..+|+|++.+.... ...+.+|+.+++.++||||+++++.+......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 356999999999999999999985 5678999998754321 24577899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~---- 153 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD---- 153 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc----
Confidence 9999999999999764 56899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~ 825 (1003)
. ........++..|+|||++.+..++.++|||||||++|+|++ |.+||...+.
T Consensus 154 ----~----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 154 ----Q----------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred ----c----------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 0 000111234567999999999899999999999999999998 8999988777
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.+....+..... +..+..++.++.+++.+||..+|.+|| ++.++++.
T Consensus 208 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~~ 254 (256)
T cd05059 208 SEVVESVSAGYR--LYRPKLAPTEVYTIMYSCWHEKPEDRP---AFKKLLSQ 254 (256)
T ss_pred HHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 777766654321 233456899999999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.16 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=213.3
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
-.+|++++.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999977 8999999987653 22345678899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|||+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~---- 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE---- 156 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC----
Confidence 9999999999999763 4689999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~ 824 (1003)
. ........++..|+|||++.+..++.++|||||||++|+|++ |+.||...+
T Consensus 157 ~---------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 157 D---------------------------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred c---------------------------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 0 000112346778999999998889999999999999999998 899999888
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+++..+..... +..+..+++.+.++|.+||+.||.+|| ++.+|++
T Consensus 210 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~l~~ 256 (261)
T cd05148 210 NHEVYDQITAGYR--MPCPAKCPQEIYKIMLECWAAEPEDRP---SFKALRE 256 (261)
T ss_pred HHHHHHHHHhCCc--CCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 8888877765422 234567899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.80 Aligned_cols=245 Identities=28% Similarity=0.464 Sum_probs=211.4
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
..++|++.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++.+.+....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4578999999999999999999874 78999999876432 45778899999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~--- 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ--- 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc---
Confidence 999999999999998765 699999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~ 823 (1003)
......++..|+|||++.+..++.++|+|||||++|+|++ |..||...
T Consensus 155 -------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 155 -------------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred -------------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 0012234567999999988889999999999999999997 99999888
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
...++...+..... +..+..+++.+.++|.+||..+|.+|| ++.++++
T Consensus 204 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 204 PLKDVVPHVEKGYR--MEAPEGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred CHHHHHHHHhcCCC--CCCccCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 77777666554322 234567899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.89 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=211.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
..+|.+.+.||+|+||.||+|++. .++..+++|.+.... ......+.+|+.+++.++||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999864 345678999876533 233456889999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG 726 (1003)
..++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997543 378999999999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeech
Q 001856 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (1003)
Q Consensus 727 ~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSL 806 (1003)
.++|+|||+++...... .........|++.|+|||++.+..++.++|||||
T Consensus 161 ~~~l~dfg~a~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 161 LVKIGDFGMSRDVYSTD-----------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred cEEECCCCcccccCCCc-----------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 99999999987311000 0001123457889999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 807 GIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 807 GVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
||++|||++ |.+||...+..+..+.+..... +..+..++..+.+||.+||+.+|.+|| ++.++++
T Consensus 212 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~v~~ 277 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRV--LERPRVCPKEVYDIMLGCWQREPQQRL---NIKEIYK 277 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC--CCCCccCCHHHHHHHHHHcccChhhCc---CHHHHHH
Confidence 999999998 9999988887777776655433 334566889999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.80 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=215.6
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|...+.||+|+||+||+|++..++..||+|++.............+.+|+.+++.++|||++++++.+.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 77788899999999999999999999999999765544455567788999999999999999999999999999999999
Q ss_pred ccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
+.| +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---------- 171 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---------- 171 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc----------
Confidence 964 78877765 457899999999999999999999999999999999999999999999999987620
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc---cCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.......|+..|+|||++. +..++.++|||||||++|+|++|.+||...+..
T Consensus 172 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 172 -------------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred -------------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 0012356889999999985 355788999999999999999999999887765
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
.....+.....+. .....++..+++||.+||+++|.+|| ++.+++.||||...+
T Consensus 227 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 227 SALYHIAQNDSPT-LQSNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 5555554433221 12345778899999999999999999 999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=330.80 Aligned_cols=255 Identities=35% Similarity=0.604 Sum_probs=211.4
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceEEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVM 668 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~lyLVm 668 (1003)
|++++.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|||++++++.+... ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998754 2233446678899999999999999999999988 8999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+++ +|..++... ..+++..+..++.||+.||+|||+.|++|+||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99975 899988765 579999999999999999999999999999999999999999999999999987411100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 155 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~ 208 (287)
T cd07840 155 --------------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208 (287)
T ss_pred --------------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 001122457889999998875 45789999999999999999999999887776
Q ss_pred hHHHhhhhcCCC-----CCC----------------------CCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 001856 827 QIFDNILNRKIP-----WPR----------------------VPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878 (1003)
Q Consensus 827 ei~qkIl~~~~~-----~P~----------------------lp~~-iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHP 878 (1003)
.....+...... ++. .... ++..+.++|++||..+|.+|| ++.++++||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~~l~~~ 285 (287)
T cd07840 209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI---SADQALQHE 285 (287)
T ss_pred HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc---CHHHHhhCc
Confidence 665555432110 000 0012 388999999999999999999 999999999
Q ss_pred CC
Q 001856 879 FF 880 (1003)
Q Consensus 879 FF 880 (1003)
||
T Consensus 286 ~~ 287 (287)
T cd07840 286 YF 287 (287)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.73 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=211.3
Q ss_pred cCCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
..+|++.++||+|+||.||+|+.. .++..+|+|.+.... ......+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 357999999999999999999753 356789999876542 344567899999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG---------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH 727 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g---------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~ 727 (1003)
..|++|||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997653 4788999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechh
Q 001856 728 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807 (1003)
Q Consensus 728 VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLG 807 (1003)
+||+|||+++...... .........+++.|+|||++.+..++.++||||||
T Consensus 161 ~kL~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 211 (280)
T cd05092 161 VKIGDFGMSRDIYSTD-----------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211 (280)
T ss_pred EEECCCCceeEcCCCc-----------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence 9999999987311000 00011234467889999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 808 IILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 808 VILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|++|||++ |.+||......+....+..... +..+..+++.+.+||.+||+.||.+|| ++.+|++
T Consensus 212 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp---~~~~l~~ 276 (280)
T cd05092 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRM---VIKDIHS 276 (280)
T ss_pred HHHHHHHcCCCCCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99999998 9999988777777766655432 234567899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.37 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=215.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
++|++++.||.|+||+||+|+.+. +.+.||+|++.... .....+.+.+|+.+++.++||||+++++.+.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 34679999876532 23355778999999999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLG---------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g---------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998665 68999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELL 814 (1003)
+++..... .........+++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 163 ~~~~~~~~------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 163 LSKDVYNS------------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred cccccCcc------------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 98631100 001122345678899999998888899999999999999999
Q ss_pred h-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 815 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 815 T-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+ |..||...........+......++ .+..++..+.++|.+||+.+|.+|| ++.+++++
T Consensus 213 ~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~~l~~ 272 (275)
T cd05046 213 TQGELPFYGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRP---SFSELVSA 272 (275)
T ss_pred hCCCCCccccchHHHHHHHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHH
Confidence 8 8899988777777777765555443 3457889999999999999999999 99998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=327.77 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=204.7
Q ss_pred EEeeccCceEEEEEEECCCC---CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEec
Q 001856 595 KPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tg---k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 78999998765433 34567889999999999999999999776 45689999999
Q ss_pred cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 001856 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (1003)
Q Consensus 672 ~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~ 751 (1003)
++|+|.+++.+.+.+++..+..++.||+.||+|||..||+|+||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------- 150 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------- 150 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999873110000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHH
Q 001856 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 830 (1003)
Q Consensus 752 ~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~q 830 (1003)
.........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+...
T Consensus 151 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05060 151 ---------------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209 (257)
T ss_pred ---------------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 0000112235578999999998889999999999999999998 999998888777766
Q ss_pred hhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 831 kIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+..... ...+..++..+.++|.+||..+|.+|| ++.++++
T Consensus 210 ~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~~ 250 (257)
T cd05060 210 MLESGER--LPRPEECPQEIYSIMLSCWKYRPEDRP---TFSELES 250 (257)
T ss_pred HHHcCCc--CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 6654432 234567899999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.16 Aligned_cols=261 Identities=35% Similarity=0.619 Sum_probs=227.1
Q ss_pred eEEE--EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 591 FEII--KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 591 YeIl--k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
|++. ++||.|.||+||-|+++.+|+.||||+|.|.+...+ +...+.+|+.||..++||.||.+-..|++.+.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 6654 789999999999999999999999999998776444 4488999999999999999999999999999999999
Q ss_pred EeccCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC---CcEEEeecCCccccccCC
Q 001856 669 EYLNGGDLYSLLR--NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 669 Ey~~GGSL~d~L~--~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d---G~VKLiDFGLAk~~~~~s 743 (1003)
|-+.| ++...|. ..+++++...++++.||+.||.|||-+||+|+||||+|||+... -++||||||+|++..
T Consensus 643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--- 718 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--- 718 (888)
T ss_pred hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---
Confidence 99966 7777663 45899999999999999999999999999999999999999764 479999999999521
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.....++.+|||.|+|||++++++|+..-|+||+|||+|--|.|..||...
T Consensus 719 -----------------------------EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 719 -----------------------------EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred -----------------------------hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 112356799999999999999999999999999999999999999999643
Q ss_pred ChhhHHHhhhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC-hhHHhh
Q 001856 824 HPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN-WDTLAR 890 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~-lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id-w~~L~~ 890 (1003)
+++-.+|.+...-+|. .+.++++++.|||..+|+..-.+|. +++..|.|||+++.. |-.++.
T Consensus 770 --EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 770 --EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred --cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHHHHH
Confidence 3456667766655553 3468999999999999999999999 999999999999763 666654
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.00 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=217.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|+..+.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.++|||++++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34889999999999999999999999999999987654444555678889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 99975 78777754 4668999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc---cCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
......|++.|+|||++. +..++.++|||||||++|+|++|.+||...+
T Consensus 177 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 177 ----------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ----------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 011346889999999984 3557899999999999999999999998877
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.......+.....+. .....+++.+.+||.+||+.+|.+|| ++.++++|+|+..
T Consensus 229 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 229 AMSALYHIAQNESPT-LQSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHHhccCCC-CCCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 766666665544322 22346788999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=338.92 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=211.4
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~-------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~ 657 (1003)
...++|.+.+.||+|+||.||+|++.. ....+|+|+++... .......+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 344679999999999999999998642 34579999987532 234456788999999999 69999999999
Q ss_pred eeccceEEEEEEeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCccee
Q 001856 658 FTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721 (1003)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~d~L~~~----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNIL 721 (1003)
+.....+|++|||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999653 24788899999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccc
Q 001856 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 801 (1003)
Q Consensus 722 Ld~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kS 801 (1003)
++.++.+||+|||+++....... ........+++.|||||++.+..++.++
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY-----------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQS 217 (314)
T ss_pred EcCCCcEEEcccccccccccccc-----------------------------ccccccCCCCccccCHHHHccCCcCccc
Confidence 99999999999999973110000 0001122345679999999998899999
Q ss_pred eeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 802 DWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 802 DIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|||||||++|+|++ |..||.+....+++..+..... +..+..++.++.+||.+||..+|.+|| ++.++++
T Consensus 218 DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~ll~ 288 (314)
T cd05099 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRP---TFKQLVE 288 (314)
T ss_pred hhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 99999999999999 8999998888888777765432 234567889999999999999999999 8888886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.90 Aligned_cols=274 Identities=28% Similarity=0.424 Sum_probs=215.4
Q ss_pred CCeEE-EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHH-----------HHHHHHHHHHHHHhcCCCcEEEEEe
Q 001856 589 DDFEI-IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN-----------AVESILAERDILISVRNPFVVRFFY 656 (1003)
Q Consensus 589 ddYeI-lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~-----------~ie~~lrEi~IL~~L~HPnIVkL~~ 656 (1003)
++|.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45765 46799999999999999999999999998764332211 1124678999999999999999999
Q ss_pred eeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 657 ~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
++...+.+|+||||+. |+|.+++.....+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 599999988888999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHh
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLT 815 (1003)
............ . ... ............+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 167 ~~~~~~~~~~~~----~-----~~~--------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 167 RRYGYPPYSDTL----S-----KDE--------TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred eecccccccccc----c-----ccc--------cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 742110000000 0 000 00001112335678999999999764 46899999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCC-----CC--------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIP-----WP--------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 870 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~-----~P--------------------~lp~~iS~elkDLIrrcL~kDP~kRpg~~S 870 (1003)
|.+||.+.+..+.+..+...... |+ ......+..+.+||.+||..+|.+|| +
T Consensus 230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s 306 (335)
T PTZ00024 230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI---S 306 (335)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc---C
Confidence 99999988776666555431100 10 01134578899999999999999999 9
Q ss_pred HHHHHcCCCCCCC
Q 001856 871 ASEVKQHVFFKDI 883 (1003)
Q Consensus 871 AeELLqHPFFk~I 883 (1003)
+++++.||||+..
T Consensus 307 ~~~~l~~~~~~~~ 319 (335)
T PTZ00024 307 AKEALKHEYFKSD 319 (335)
T ss_pred HHHHhcCcccCCC
Confidence 9999999999853
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=356.67 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=209.6
Q ss_pred CCCcccCCeEEEEEeeccCceEEEEEEECCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEe
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFY 656 (1003)
Q Consensus 583 k~~~~lddYeIlk~LG~G~FGtVyLArdk~t-----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~ 656 (1003)
++....++|++.+.||+|+||.||+|.+... +..||||+++... .....+.+.+|+.+|..++ ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445567899999999999999999987433 3479999987542 2344567899999999996 999999999
Q ss_pred eeeccceEEEEEEeccCCChHHHHHhc-----------------------------------------------------
Q 001856 657 SFTCRENLYLVMEYLNGGDLYSLLRNL----------------------------------------------------- 683 (1003)
Q Consensus 657 ~f~d~~~lyLVmEy~~GGSL~d~L~~~----------------------------------------------------- 683 (1003)
++.....+|||||||++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988642
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcce
Q 001856 684 -------------------------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (1003)
Q Consensus 684 -------------------------------------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNI 720 (1003)
..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367788889999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCcc
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 800 (1003)
|++.++.+||+|||+++....... ........|++.|+|||++.+..++.+
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 319 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN-----------------------------YVSKGSTFLPVKWMAPESIFDNLYTTL 319 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc-----------------------------ccccCCcCCCcceEChhhhcCCCCCch
Confidence 999999999999999874110000 011223467889999999999999999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 801 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 801 SDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+|||||||++|||++ |..||........+...+.....+ ..+..++.++.++|.+||+.||.+|| ++.+|.+
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 392 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRP---SFLHLSD 392 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCc---CHHHHHH
Confidence 999999999999997 999998765444433333333332 34567899999999999999999999 7766654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=328.41 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=207.8
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
...++|++++.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34568999999999999999999875 5677999998764432 246889999999999999999998875 45689
Q ss_pred EEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
++|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999763 458999999999999999999999999999999999999999999999999987310000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+
T Consensus 157 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 157 ------------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ------------------------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 000112345678999999988889999999999999999999 9999998
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+..+....+.... . +..+...+..+.+||.+||.++|.+|| ++.++.+
T Consensus 207 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 255 (260)
T cd05070 207 MNNREVLEQVERGY-R-MPCPQDCPISLHELMLQCWKKDPEERP---TFEYLQS 255 (260)
T ss_pred CCHHHHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcccCcccCc---CHHHHHH
Confidence 88777777765432 2 234567899999999999999999999 7877763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=346.03 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=209.0
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------ 661 (1003)
.++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3679999999999999999999999999999999876432 223346678899999999999999999988643
Q ss_pred ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..+|++++++ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~- 171 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 171 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc-
Confidence 3478888887 7799888765 469999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 172 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 172 ---------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred ---------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 01123568899999999876 56889999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCC----------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 821 NAEHPQQIFDNILNRKI----------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~----------------------------~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
...+....+..+..... .+.......++.+.+||.+||++||.+|+ ++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~ 295 (345)
T cd07877 219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAA 295 (345)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC---CHH
Confidence 87665544443322110 00111124688899999999999999999 999
Q ss_pred HHHcCCCCCC
Q 001856 873 EVKQHVFFKD 882 (1003)
Q Consensus 873 ELLqHPFFk~ 882 (1003)
+++.||||+.
T Consensus 296 e~l~h~~f~~ 305 (345)
T cd07877 296 QALAHAYFAQ 305 (345)
T ss_pred HHhcChhhhh
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.93 Aligned_cols=255 Identities=30% Similarity=0.482 Sum_probs=213.3
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce----
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN---- 663 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~---- 663 (1003)
.++|++.+.||.|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3679999999999999999999999999999999875432 23344667889999999999999999988876554
Q ss_pred --EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 664 --LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 664 --lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
+|+|+||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~- 169 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD- 169 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc-
Confidence 89999999 6699999876 579999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 170 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 170 ---------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred ---------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 00123568889999999875 46789999999999999999999999
Q ss_pred CCCChhhHHHhhhhcCCC----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 821 NAEHPQQIFDNILNRKIP----------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~----------------------------~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
.+.+....+..+...... +......+++.+.+||.+||+.||.+|| ++.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp---t~~ 293 (343)
T cd07851 217 PGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI---TAA 293 (343)
T ss_pred CCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC---CHH
Confidence 887776666555442110 0011234689999999999999999999 999
Q ss_pred HHHcCCCCCC
Q 001856 873 EVKQHVFFKD 882 (1003)
Q Consensus 873 ELLqHPFFk~ 882 (1003)
+|++||||..
T Consensus 294 ell~h~~~~~ 303 (343)
T cd07851 294 EALAHPYLAE 303 (343)
T ss_pred HHhcCCCccc
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=328.01 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=211.6
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk---~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
..+|++.+.||+|+||.||+|+++.+++ .||+|++.+.. .......+..|+.+++.++||||+++++.+.....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999877665 69999987542 344557889999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||+++++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD- 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC-
Confidence 9999999999999999764 56899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
.. . +. ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 160 ~~---~-------------~~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 160 TS---D-------------PT---------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cc---c-------------cc---------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 00 0 00 000011123467999999998889999999999999999886 9999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+.......+... ...+ .+..++..+.+++.+||+.+|.+|| ++.++++
T Consensus 215 ~~~~~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 215 MSNQDVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 8877777766433 2222 3457889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=364.82 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=211.0
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
....+.+++++.||+|-||.||+|.++. ...||+|.++...+ ..+.+.+|+++|++|+|++||++++++...+.+
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3344568889999999999999999953 34799999986543 235677999999999999999999999998899
Q ss_pred EEEEEeccCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~--~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
|||||||+.|+|.++|+. .+.+...+...++.|||.|++||+++++|||||...|||++.+..+||+|||||+...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-- 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-- 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC--
Confidence 999999999999999987 4679999999999999999999999999999999999999999999999999999310
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
++... .....--...|.|||.+....++.++|||||||+||||+| |+.||.
T Consensus 355 -----------------d~~Y~-----------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 355 -----------------DDEYT-----------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred -----------------CCcee-----------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 00000 0111223457999999999999999999999999999998 999999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 867 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg 867 (1003)
+.+..++.+.+..+. .+| .|..+|+++-+++..||..+|++||+
T Consensus 407 ~msn~ev~~~le~Gy-Rlp-~P~~CP~~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 407 GMSNEEVLELLERGY-RLP-RPEGCPDEVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred CCCHHHHHHHHhccC-cCC-CCCCCCHHHHHHHHHHhhCCcccCCC
Confidence 999999998887654 444 47889999999999999999999993
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.69 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=213.8
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEEC-------CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEe
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKR-------TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk-------~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~ 656 (1003)
....++|++.+.||+|+||.||+|++. ..+..||+|++.... .......+.+|+.++..+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 445678999999999999999999853 234579999986532 234457788999999999 8999999999
Q ss_pred eeeccceEEEEEEeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcce
Q 001856 657 SFTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (1003)
Q Consensus 657 ~f~d~~~lyLVmEy~~GGSL~d~L~~~----------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNI 720 (1003)
.+.....+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999764 2367788899999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCcc
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 800 (1003)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 219 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQ 219 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-----------------------------cccccCCCCCceeeCchhhccCCCCch
Confidence 999999999999999874110000 001122356778999999999889999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 801 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 801 SDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+|||||||++|+|++ |..||.+.+..+++..+..... ...+..++..+.+||.+||..+|.+|| ++.++++.
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~e~l~~ 292 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRP---TFKQLVED 292 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCC---CHHHHHHH
Confidence 999999999999998 8999998888888777755432 234567899999999999999999999 89998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=334.29 Aligned_cols=259 Identities=32% Similarity=0.502 Sum_probs=209.8
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~---- 662 (1003)
..++|++.+.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45789999999999999999999999999999999875432 2223356678999999999999999999887655
Q ss_pred ------eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 663 ------NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 663 ------~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
.+|+||||+++ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 79999999986 777777654 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHH
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELL 814 (1003)
+........ .......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 163 ~~~~~~~~~------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~ 212 (302)
T cd07864 163 ARLYNSEES------------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212 (302)
T ss_pred cccccCCcc------------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH
Confidence 874110000 00112356788999999875 45789999999999999999
Q ss_pred hCCCCCCCCChhhHHHhhhhcCC-----CCCC----------------------CCCCCCHHHHHHHHhhccCCcCCcCC
Q 001856 815 VGIPPFNAEHPQQIFDNILNRKI-----PWPR----------------------VPEEMSPEAHDLIDRFLTEDPHQRLG 867 (1003)
Q Consensus 815 TGk~PF~~~~~~ei~qkIl~~~~-----~~P~----------------------lp~~iS~elkDLIrrcL~kDP~kRpg 867 (1003)
+|++||...+..+.+..+..... .++. ....++..+.+||.+||..||.+||
T Consensus 213 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp- 291 (302)
T cd07864 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC- 291 (302)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC-
Confidence 99999987766555544433110 0000 1124688999999999999999999
Q ss_pred CCCHHHHHcCCCC
Q 001856 868 SGGASEVKQHVFF 880 (1003)
Q Consensus 868 ~~SAeELLqHPFF 880 (1003)
++.+++.||||
T Consensus 292 --~~~~il~~~~~ 302 (302)
T cd07864 292 --TAEEALNSPWL 302 (302)
T ss_pred --CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=329.13 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=210.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk---~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
..+|++.+.||+|+||.||+|+++.++. .+|+|.++... .......+.+|+.++..++||||+++++.+...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3579999999999999999999865443 79999986542 233456788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||++|++|.+++... +.++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD- 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc-
Confidence 9999999999999999765 56899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
.. . ........++..|+|||++.+..++.++|+|||||++|++++ |..||..
T Consensus 160 ~~-----~----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 160 PE-----A----------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cc-----e----------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 00 0 000112234678999999998889999999999999999886 9999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
....+....+.... .. ..+..+++.+.+++.+||+++|.+|| ++.++++
T Consensus 213 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 261 (267)
T cd05066 213 MSNQDVIKAIEEGY-RL-PAPMDCPAALHQLMLDCWQKDRNERP---KFEQIVS 261 (267)
T ss_pred CCHHHHHHHHhCCC-cC-CCCCCCCHHHHHHHHHHcccCchhCC---CHHHHHH
Confidence 77777777665542 22 23456889999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.50 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=207.6
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.-++|+++++||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++++.+. .+.+|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 3467999999999999999999864 578899999876442 2356788999999999999999998764 567899
Q ss_pred EEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+|||+.+++|.+++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 99999999999998754 368999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~ 823 (1003)
........++..|+|||++.+..++.++|||||||++|+|++ |++||.+.
T Consensus 157 -----------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 157 -----------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred -----------------------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 000112346778999999998889999999999999999998 99999988
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+..+....+.... . +..+...+.++.++|.+||..+|.+|| +++++++
T Consensus 208 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 208 TNPEVIQNLERGY-R-MPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred ChHHHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 7777766654432 2 234567889999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=338.21 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=213.0
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEE-----CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArd-----k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~ 657 (1003)
+....++|++.+.||+|+||.||+|.+ ..++..||+|++++.. .....+.+.+|+.+++++ +||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344557899999999999999999985 3355689999987542 233456788999999999 79999999999
Q ss_pred eeccceEEEEEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 658 FTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
+...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 389999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
++....... ........+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 188 ~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 188 ARDIMNDSN-----------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred cccccCCCc-----------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 873110000 001123456788999999999889999999999999999998
Q ss_pred -CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 816 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 816 -Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|.+||........+.......... ..+...++++.+||.+||.++|.+|| ++.++++
T Consensus 239 ~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell~ 296 (302)
T cd05055 239 LGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIVQ 296 (302)
T ss_pred CCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 999998777665555554443322 23456789999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.34 Aligned_cols=254 Identities=28% Similarity=0.499 Sum_probs=214.3
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~--~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+|.+.+.||+|+||.||+|++..++..+++|+++..... .......+..|..+++.++||||+++++.+.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 489999999999999999999888888888887653321 122334567789999999999999999999999999999
Q ss_pred EEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++||+|+||||+||+++. +.++|+|||+++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999998864 356899999999999999999999999999999999999975 67999999998741100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 159 ------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 159 ------------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred ------------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 00122356889999999998888999999999999999999999999877
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
........+.... .+..+..++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 209 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 209 NFLSVVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 7766666665433 3445677899999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.32 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=200.3
Q ss_pred EeeccCceEEEEEEEC--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 596 PISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk--~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++.++||||+++++.+.. ...|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999775 445679999986542 24445678899999999999999999998764 578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 001856 674 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (1003)
Q Consensus 674 GSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~ 752 (1003)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 150 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-------- 150 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc--------
Confidence 999999975 45799999999999999999999999999999999999999999999999999873110000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHh
Q 001856 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 831 (1003)
Q Consensus 753 sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qk 831 (1003)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 151 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 210 (257)
T cd05115 151 --------------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210 (257)
T ss_pred --------------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 0000112234678999999998889999999999999999996 9999998887777666
Q ss_pred hhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 832 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 832 Il~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+..+.. +..+..+++++.++|.+||..+|.+|| ++.+|++
T Consensus 211 ~~~~~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp---~~~~i~~ 250 (257)
T cd05115 211 IEQGKR--LDCPAECPPEMYALMKDCWIYKWEDRP---NFAKVEE 250 (257)
T ss_pred HHCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 655432 345677899999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.26 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=211.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk---~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
.++|+..+.||+|+||.||+|....++. .+|+|.+.... .....+.+.+|+.++..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3579999999999999999999876655 79999886542 233456788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||+++++|.+++... +.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999999764 578999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
. ..........++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 162 ~----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 162 E----------------------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred c----------------------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 0 0000111233567999999998889999999999999999997 9999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+..++...+.... ..| .+..++.++.+|+.+||+.+|.+|| ++.++++
T Consensus 214 ~~~~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 214 MSNHEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred CCHHHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 88777777776542 222 3456889999999999999999999 8888775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=344.96 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=208.2
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-------
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------- 661 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------- 661 (1003)
.+|++.+.||.|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 579999999999999999999999999999999866432 3456788899999999999999999776654
Q ss_pred -------ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeec
Q 001856 662 -------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDF 733 (1003)
Q Consensus 662 -------~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDF 733 (1003)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35899999997 489888864 56899999999999999999999999999999999999975 567899999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHH
Q 001856 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 734 GLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYE 812 (1003)
|+++.... ... .........||..|+|||++.+ ..++.++|||||||++|+
T Consensus 160 g~~~~~~~--~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (342)
T cd07854 160 GLARIVDP--HYS--------------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211 (342)
T ss_pred ccceecCC--ccc--------------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHH
Confidence 99873100 000 0001122468889999998764 567899999999999999
Q ss_pred HHhCCCCCCCCChhhHHHhhhhcCC---------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCc
Q 001856 813 LIVGIPPFNAEHPQQIFDNILNRKI---------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 813 LLTGk~PF~~~~~~ei~qkIl~~~~---------------------------~~P~lp~~iS~elkDLIrrcL~kDP~kR 865 (1003)
|++|..||...+..+....+..... ++......++.++.+||.+||+.||.+|
T Consensus 212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 291 (342)
T cd07854 212 MLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDR 291 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhc
Confidence 9999999987765554444332110 0001123578899999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 001856 866 LGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 866 pg~~SAeELLqHPFFk~I 883 (1003)
| ++.++++||||+.+
T Consensus 292 ~---t~~ell~h~~~~~~ 306 (342)
T cd07854 292 L---TAEEALMHPYMSCY 306 (342)
T ss_pred c---CHHHHhCCCccccc
Confidence 9 99999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=381.06 Aligned_cols=273 Identities=26% Similarity=0.411 Sum_probs=210.0
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
+++|+++++||+|+||.||+|++..+|+.||+|++...........+++.+|+.+++.++||||+++++.+.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 46899999999999999999999999999999999765433444557789999999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 668 MEYLNGGDLYSLLRNL-----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-----------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23455677889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhC
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTG 816 (1003)
+...... +.......... +. ...........+||+.|||||++.+..++.++|||||||++|||++|
T Consensus 161 k~i~~~~-~~~~~l~~~~~---~s---------~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 161 IFKKLEE-EDLLDIDVDER---NI---------CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred eeccccc-ccccccccccc---cc---------cccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence 8521100 00000000000 00 00001122346899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHhh-hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 817 IPPFNAEHPQQIFDNI-LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 817 k~PF~~~~~~ei~qkI-l~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..||.......+.... ........ ....+++.+.+++.+||+.||.+|++ +++++++
T Consensus 228 ~~PF~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~s--s~eeLl~ 285 (932)
T PRK13184 228 SFPYRRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYS--SVQELKQ 285 (932)
T ss_pred CCCCCCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcC--HHHHHHH
Confidence 9999876554332221 11111111 12467899999999999999999994 4444443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=335.41 Aligned_cols=260 Identities=30% Similarity=0.519 Sum_probs=210.1
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccce
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~ 663 (1003)
....++|++.+.||.|+||.||+|.+..+++.||||++++... ......+..|..++... .||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4456889999999999999999999998899999999976532 22334566677766666 49999999999999999
Q ss_pred EEEEEEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 664 LYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
+|++|||+.+ +|..++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999854 77777765 3578999999999999999999997 6999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC----CCccceeechhHHHHHHHhCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----ys~kSDIWSLGVILYELLTGk 817 (1003)
. .......|++.|+|||++.+.. ++.++||||||+++|+|++|+
T Consensus 168 --~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 215 (296)
T cd06618 168 --S------------------------------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215 (296)
T ss_pred --C------------------------------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCC
Confidence 0 0011235788999999997654 788999999999999999999
Q ss_pred CCCCCCC-hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 818 PPFNAEH-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 818 ~PF~~~~-~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.||.... ..+.+..++....+.......++.++.+||.+||..||.+|| +++++++||||..
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 278 (296)
T cd06618 216 FPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQHPFIRR 278 (296)
T ss_pred CCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhc
Confidence 9997633 234455555443222112234789999999999999999999 9999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=332.68 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=211.2
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
.++|++++.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999999743 67899999987542 2334467889999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcce
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG----------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g----------------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNI 720 (1003)
.+|++|||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997432 367888899999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCcc
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 800 (1003)
|++.++.++|+|||++........ ........+++.|+|||++.+..++.+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADY-----------------------------YKASENDAIPIRWMPPESIFYNRYTTE 212 (288)
T ss_pred EecCCCceEECccccceecccCcc-----------------------------ccccCCCccChhhcCHHHHhcCCCCch
Confidence 999999999999999863110000 000112344667999999998899999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 801 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 801 SDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+|||||||++|||++ |..||.+.+..+....+..... +..+..++.++.+||.+||+.+|.+|| ++.|+++
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~el~~ 284 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV--LSCPDNCPLELYNLMRLCWSKLPSDRP---SFASINR 284 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 999999999999997 8899988888887777765543 234567889999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.89 Aligned_cols=254 Identities=33% Similarity=0.578 Sum_probs=211.8
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999989999999998765432 23446788899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
+++ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------ 152 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence 976 888888764 679999999999999999999999999999999999999999999999999987411000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|++||...+..+.
T Consensus 153 -------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 207 (283)
T cd05118 153 -------------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207 (283)
T ss_pred -------------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011234678899999999876 789999999999999999999999988776555
Q ss_pred HHhhhhcCCC-------------------C--------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 829 FDNILNRKIP-------------------W--------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 829 ~qkIl~~~~~-------------------~--------P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+..+...... + ......++.++.+||.+||.+||.+|| ++.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~ll~~~~~ 283 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI---TAEQALAHPYF 283 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc---CHHHHhhCCCC
Confidence 4444321100 0 011234688999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.69 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=205.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++.++||+|+||.||+|++..+ ..||+|++.+... ..+.+.+|+.+++.++||||+++++.+. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 36799999999999999999998655 4699999876432 1246788999999999999999998875 4568999
Q ss_pred EEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++.... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~--~~ 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NE 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc--cc
Confidence 9999999999999763 3588999999999999999999999999999999999999999999999999873110 00
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~ 824 (1003)
........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+..
T Consensus 157 ----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 157 ----------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ----------------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 000112346778999999998889999999999999999999 899998887
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..++...+.... .. ..+..++..+.+||.+||++||.+|| ++.++++
T Consensus 209 ~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~~~~ 255 (262)
T cd05071 209 NREVLDQVERGY-RM-PCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 255 (262)
T ss_pred hHHHHHHHhcCC-CC-CCccccCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 777777665432 22 23456889999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.88 Aligned_cols=261 Identities=30% Similarity=0.447 Sum_probs=209.3
Q ss_pred CeEEEEEeeccCceEEEEEEECCC--CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec----cc
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTT--GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC----RE 662 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~t--gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d----~~ 662 (1003)
+|++.+.||+|+||.||+|++..+ +..||+|++.... ........+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 489999999999999999999888 8999999986532 2223346678899999998 59999999986432 24
Q ss_pred eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+|++|||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999986 599999988888999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 159 ~~---------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 159 PG---------------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred cc---------------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 00 00011234679999999998876 568999999999999999999999998
Q ss_pred CCChhhHHHhhhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 822 AEHPQQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~----------------------------~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
..+....+..++... ..++......+..+.+||.+||+.||.+|| ++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~~ 288 (332)
T cd07857 212 GKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI---SVEE 288 (332)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC---CHHH
Confidence 766544443332210 111122234688999999999999999999 9999
Q ss_pred HHcCCCCCC
Q 001856 874 VKQHVFFKD 882 (1003)
Q Consensus 874 LLqHPFFk~ 882 (1003)
++.||||..
T Consensus 289 ll~~~~~~~ 297 (332)
T cd07857 289 ALEHPYLAI 297 (332)
T ss_pred HhcChhhhh
Confidence 999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=335.10 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=206.7
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCC--------------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTG--------------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tg--------------k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL 654 (1003)
.+|++.+.||+|+||.||+|++..++ ..||+|++.... .......+.+|++++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 57999999999999999999875432 358999987532 23445678899999999999999999
Q ss_pred EeeeeccceEEEEEEeccCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceee
Q 001856 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLG------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722 (1003)
Q Consensus 655 ~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILL 722 (1003)
++.+.....+|+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999986532 36788899999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccce
Q 001856 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802 (1003)
Q Consensus 723 d~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSD 802 (1003)
+.++.+||+|||++....... .........+++.|+|||++.+..++.++|
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGD-----------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred cCCCcEEecccccccccccCc-----------------------------ceeccCcCcCceeecChhhhccCCcCchhh
Confidence 999999999999987311000 000112345678899999999888999999
Q ss_pred eechhHHHHHHHh--CCCCCCCCChhhHHHhhhh-----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 803 WWSVGIILFELIV--GIPPFNAEHPQQIFDNILN-----RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 803 IWSLGVILYELLT--Gk~PF~~~~~~ei~qkIl~-----~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
||||||++|+|++ |..||...+..+....+.. ....+...+..+++.+.+||.+||+.||.+|| ++++|+
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP---s~~~i~ 290 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP---TFNKIH 290 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHH
Confidence 9999999999988 6789988776666554432 11112233456789999999999999999999 888876
Q ss_pred c
Q 001856 876 Q 876 (1003)
Q Consensus 876 q 876 (1003)
+
T Consensus 291 ~ 291 (295)
T cd05097 291 H 291 (295)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.79 Aligned_cols=254 Identities=31% Similarity=0.557 Sum_probs=213.9
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|+...+||+|+||.||++....+++.||+|.+.... ......+.+|+.+++.++||||+++++.|...++.|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 444567999999999999999999999999875422 23446788999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 001856 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p 750 (1003)
+++++|.+++.. +.+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-------- 169 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------- 169 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--------
Confidence 999999998754 56899999999999999999999999999999999999999999999999987631000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHH
Q 001856 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830 (1003)
Q Consensus 751 ~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~q 830 (1003)
........||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+........
T Consensus 170 -----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~ 226 (292)
T cd06657 170 -----------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 226 (292)
T ss_pred -----------------------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 001123568999999999988888999999999999999999999998877666555
Q ss_pred hhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 831 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 831 kIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.+.............++..+.++|.+||+.+|.+|| ++.++++||||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~ 275 (292)
T cd06657 227 MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAK 275 (292)
T ss_pred HHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhc
Confidence 544332221122345789999999999999999999 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.04 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=207.9
Q ss_pred CeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+|++.+.||+|+||.||+|.+.. ....+|+|++.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 48899999999999999998753 23578999886543 223456788999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcce
Q 001856 665 YLVMEYLNGGDLYSLLRNL------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~------------------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNI 720 (1003)
|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2477889999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCcc
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 800 (1003)
|++.++.+||+|||+++....... ........++..|+|||++.+..++.+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~ 209 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-----------------------------YVKRSKGRIPVKWMAIESLFDHIYTTQ 209 (290)
T ss_pred EEcCCCcEEeccccccccccCccc-----------------------------hhcccCCCCCccccCHHHHccCCcchH
Confidence 999999999999999873110000 001122346778999999998889999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 801 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 801 SDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+|||||||++|||++ |..||.+..+..+++.+... .. +..+..++.++.+||.+||+.+|.+|| ++.++++
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp---~~~~i~~ 281 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YR-MERPENCSEEMYNLMLTCWKQEPDKRP---TFADISK 281 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CC-CCCCCCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 999999999999998 99999988887776655433 22 234567899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.88 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=211.2
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
...++|++.+.||.|+||.||+|.+. .++.||+|.+..... ..+.+.+|+.+++.++||||+++++.+.....+|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34578999999999999999999975 557899999876432 2356788999999999999999999999989999
Q ss_pred EEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+||||+++++|.+++... ..++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 999999999999999765 36899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+
T Consensus 157 -----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 157 -----------------------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred -----------------------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 0001112335678999999998889999999999999999998 9999998
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+.......+.... . ...+...+.++.+++.+||+.+|.+|| +++++++
T Consensus 208 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 256 (261)
T cd05034 208 MTNREVLEQVERGY-R-MPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQS 256 (261)
T ss_pred CCHHHHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 88777777775542 2 223456789999999999999999999 8887764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.75 Aligned_cols=242 Identities=26% Similarity=0.408 Sum_probs=201.9
Q ss_pred EeeccCceEEEEEEECCCCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEecc
Q 001856 596 PISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tgk--~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
.||+|+||.||+|++..++. .+|+|.++.. ........+.+|+.++..+ +||||+++++.+.....+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999988776 4688877642 2334456788999999999 89999999999999999999999999
Q ss_pred CCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 673 GGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 673 GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
+|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997543 4788999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT- 815 (1003)
..... ........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~--------------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 160 RGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred cccch--------------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 62000 000111234667999999998889999999999999999997
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|..||.+.+..+.++.+..... ...+..++.++.+|+.+||..||.+|| ++.++++
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (270)
T cd05047 208 GGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILV 263 (270)
T ss_pred CCCCccccCHHHHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcccChhhCC---CHHHHHH
Confidence 9999988877777776654321 234556889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.16 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=212.8
Q ss_pred eEEEEEeeccCceEEEEEEECCCC----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tg----k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
+++.+.||.|+||.||+|++...+ ..||+|++..... ......+..|+.++..++|+||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 8999999865432 2255788899999999999999999999999999999
Q ss_pred EEEeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~--LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+|||+++++|.+++..... +++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD- 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc-
Confidence 9999999999999976544 9999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~ 823 (1003)
........+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||...
T Consensus 158 -----------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 158 -----------------------------YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred -----------------------------ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 000001237889999999988889999999999999999998 89999988
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+...+++.+..... +..+..++.++.+++.+||..||.+|| ++.++++
T Consensus 209 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 209 SNEEVLEYLKKGYR--LPKPENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred CHHHHHHHHhcCCC--CCCCCcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 88888877766543 334566899999999999999999999 9999876
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.86 Aligned_cols=253 Identities=20% Similarity=0.313 Sum_probs=206.1
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~----VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
..++|++++.||+|+||+||+|.+..++.. +++|++... ........+..|+.++..++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 346899999999999999999999877774 666665432 12334466778888999999999999999875 45
Q ss_pred eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..++++||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 678999999999999999764 5789999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF 820 (1003)
.. .........|+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 162 ~~-----------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 162 DD-----------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred CC-----------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 00 0001123457788999999998889999999999999999998 99999
Q ss_pred CCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+.....+.+.+.++.. +..+..++.++.+++.+||..||.+|| ++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 213 AGMRPHEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred CCCCHHHHHHHHHCCCc--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 88777665544433322 233456788999999999999999999 8988876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.27 Aligned_cols=255 Identities=31% Similarity=0.517 Sum_probs=208.6
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-cceEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYL 666 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d-~~~lyL 666 (1003)
.++|++++.||.|+||.||+|.+..+++.||+|++.+... .......+.+|+.++..++||||++++++|.. ...+|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4679999999999999999999999999999998865432 22344677889999999999999999999876 567999
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
+|||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~------ 159 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD------ 159 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC------
Confidence 99998 5689888764 568899999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.....
T Consensus 160 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 160 ----------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred ----------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 00123467889999999866 5689999999999999999999999987654
Q ss_pred hhHHHhhhhc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 826 QQIFDNILNR----------------------------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~ei~qkIl~~----------------------------~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
...+..+.+. ..+.......++..+.++|++||+.+|.+|| ++++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~ell~~ 288 (328)
T cd07856 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI---SAAEALAH 288 (328)
T ss_pred HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC---CHHHHhcC
Confidence 3322221110 0011111235788999999999999999999 99999999
Q ss_pred CCCCC
Q 001856 878 VFFKD 882 (1003)
Q Consensus 878 PFFk~ 882 (1003)
|||..
T Consensus 289 ~~~~~ 293 (328)
T cd07856 289 PYLAP 293 (328)
T ss_pred Ccccc
Confidence 99973
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=360.30 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=206.3
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLV 667 (1003)
..|+++++||.||.++||++..... ..||+|.+... ..+...+..+.+|+.+|.+|+ |.+||+||++-..++++|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3599999999999999999997544 45666554332 235566789999999999995 89999999999999999999
Q ss_pred EEeccCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~-LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||=+ .+|..+|++... ++.-.+++|..||+.|+.++|.+||||.||||.|+|+- .|.+||+|||+|.....+.+
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT-- 514 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT-- 514 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc--
Confidence 99754 499999987654 44468999999999999999999999999999999985 48999999999985322211
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC-----------CCccceeechhHHHHHHHh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------ys~kSDIWSLGVILYELLT 815 (1003)
.-...+.+||+.||+||.+.... .+.++||||||||||+|+.
T Consensus 515 ---------------------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 515 ---------------------------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred ---------------------------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 11234679999999999996433 3578999999999999999
Q ss_pred CCCCCCCCC-hhhHHHhhhhc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 816 GIPPFNAEH-PQQIFDNILNR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 816 Gk~PF~~~~-~~ei~qkIl~~--~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
|++||.... ...-+..|..- .++||.++... ++.++++.||++||.+|| ++.++|+|||+..
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~---si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRW---SIPELLQHPFLQI 632 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCC---CcHHHhcCccccc
Confidence 999997543 33344555543 33666655433 399999999999999999 9999999999985
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.43 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=211.8
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCC-------CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTT-------GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~t-------gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~ 657 (1003)
....+|++.+.||+|+||.||+|++... +..||+|+++.. ........+.+|+.++..+ +||||+++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3345799999999999999999986432 236899988743 2334457888999999999 79999999999
Q ss_pred eeccceEEEEEEeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCccee
Q 001856 658 FTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721 (1003)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNIL 721 (1003)
+.....+|++|||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999997532 3677888899999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccc
Q 001856 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 801 (1003)
Q Consensus 722 Ld~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kS 801 (1003)
++.++.+||+|||+++..... . .........++..|+|||++.+..++.++
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~-~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNI-D----------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQS 217 (334)
T ss_pred EcCCCcEEECCcccceecccc-c----------------------------ccccccCCCcCceEcCHHHhccCCcCchh
Confidence 999999999999998731100 0 00011123445789999999999999999
Q ss_pred eeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 802 DWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 802 DIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|||||||++|||++ |..||.+.+..+.+..+..... +..+..++.++.+||.+||+.+|.+|| ++.+++++
T Consensus 218 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~ell~~ 289 (334)
T cd05100 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRP---TFKQLVED 289 (334)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCc---CHHHHHHH
Confidence 99999999999998 8999998888887777655432 234567889999999999999999999 99999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.22 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=207.6
Q ss_pred EEeeccCceEEEEEEECC-CCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEec
Q 001856 595 KPISRGAFGRVFLAKKRT-TGD--LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~-tgk--~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
+.||+|+||.||+|.+.. .++ .||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999875433 556788999999999999999999999988 8899999999
Q ss_pred cCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 672 NGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 672 ~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
++++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 152 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----- 152 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc-----
Confidence 9999999997754 689999999999999999999999999999999999999999999999999874210000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 828 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei 828 (1003)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.
T Consensus 153 -----------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 209 (257)
T cd05040 153 -----------------------HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI 209 (257)
T ss_pred -----------------------ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 0001113467888999999999899999999999999999998 9999988887777
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
...+......+ ..+..++..+.+++.+||+.+|.+|| ++.++++
T Consensus 210 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 210 LKKIDKEGERL-ERPEACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred HHHHHhcCCcC-CCCccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 77766533322 34567889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=328.86 Aligned_cols=254 Identities=34% Similarity=0.588 Sum_probs=211.7
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+..|+.+++.++||||+++++.+.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998654 2233346677899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
+++ +|.+++.+. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||+++.....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~------- 151 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP------- 151 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC-------
Confidence 984 999999876 57999999999999999999999999999999999999999999999999998731100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhhH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei 828 (1003)
........++..|+|||++.+. .++.++|+|||||++|||++|.+||...+....
T Consensus 152 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 152 ------------------------LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred ------------------------ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 0011234567889999999876 789999999999999999999999988776555
Q ss_pred HHhhhhc------------------CCCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 829 FDNILNR------------------KIPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 829 ~qkIl~~------------------~~~~P~--------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
+.++... ...++. ....++..+.++|.+||..||.+|| ++.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~~l~~p~~ 282 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---SAKEALKHPYF 282 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC---CHHHHhhCcCC
Confidence 4444321 001111 1123578899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=373.89 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=211.9
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeee-cc-----
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFT-CR----- 661 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~-d~----- 661 (1003)
.+++|.+.|.+|||+.||+|++...|..||||.+-.. ++...+.+.+|+++|+.|+ |+|||.+++... ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3588999999999999999999888899999987543 5677889999999999997 999999999432 21
Q ss_pred -ceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCcceeecCCCcEEEeecCCc
Q 001856 662 -ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 662 -~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~G--IIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
-.++|+||||.||.|-++|... ..|++.++..|+.++++|+.+||.+. |||||||-|||||+.+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 2478999999999999999743 56999999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc---cCCCCccceeechhHHHHHH
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~---g~~ys~kSDIWSLGVILYEL 813 (1003)
..... .+. ....+ ...+.. -...-|+.|+|||++. +.+.+.|+|||||||+||-|
T Consensus 194 tt~~~-------~~~---------~~~e~---~~ve~e---I~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 194 TTKIL-------SPT---------SAQEV---NYVEEE---IEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccccC-------CCc---------cHHHH---HHHHHH---HHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 73111 110 00000 111111 1235699999999984 77889999999999999999
Q ss_pred HhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 814 LTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+....||..... -.|+++.+.+|.. ..++..+++||+.||+.||.+|| ++.+++.+
T Consensus 252 Cy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RP---nI~Qv~~~ 307 (738)
T KOG1989|consen 252 CYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERP---NIYQVLEE 307 (738)
T ss_pred HHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCC---CHHHHHHH
Confidence 999999987533 3788999998876 46899999999999999999999 88877765
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.41 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=214.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|...+.||.|+||.||+|+++.++..+|+|.+.............+.+|+.+++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44888899999999999999999999999999987543334445567889999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9997 588877754 4568999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+
T Consensus 167 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 167 ----------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred ----------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 0123468899999999853 457889999999999999999999998766
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.......+.....+. .....++..+.+||.+||..+|.+|| ++.++++||||...
T Consensus 219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~~ 273 (308)
T cd06634 219 AMSALYHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhcCCCC-cCcccccHHHHHHHHHHhhCCcccCC---CHHHHhhCcccccc
Confidence 555544444433221 12346889999999999999999999 99999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.78 Aligned_cols=248 Identities=24% Similarity=0.413 Sum_probs=205.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.++|++.+.||.|+||.||+|.+..+ ..+|+|++..... ..+.+.+|+.+++.++||||+++++.+. ....|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 36799999999999999999998654 4699998765432 2356788999999999999999998875 4568999
Q ss_pred EEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++..... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~--~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN--E 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC--c
Confidence 9999999999999764 34789999999999999999999999999999999999999999999999998741000 0
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~ 824 (1003)
........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+..
T Consensus 157 ----------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 157 ----------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred ----------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 000112346778999999998889999999999999999999 999999888
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+....+.... . +..+..++..+.+||.+||.+||.+|| +++++++
T Consensus 209 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 255 (260)
T cd05069 209 NREVLEQVERGY-R-MPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQS 255 (260)
T ss_pred HHHHHHHHHcCC-C-CCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 777777665432 2 234567889999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.80 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=210.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
..+|++.+.||.|+||.||+|.+. .+..+|+|++...... ...+.+|+.+++.++||||+++++.+......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999885 4678999998754321 24577899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+++++|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++..... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-Q-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC-c--
Confidence 9999999999999764 56899999999999999999999999999999999999999999999999998731000 0
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~ 825 (1003)
........++..|+|||++.+..++.++|||||||++|||++ |.+||.....
T Consensus 155 ---------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05112 155 ---------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207 (256)
T ss_pred ---------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 000112345678999999998889999999999999999998 9999998887
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..+.+.+...... ..+...+..+.+|+.+||+.+|.+|| ++.+++++
T Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~~ 254 (256)
T cd05112 208 SEVVETINAGFRL--YKPRLASQSVYELMQHCWKERPEDRP---SFSLLLHQ 254 (256)
T ss_pred HHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHcccChhhCC---CHHHHHHh
Confidence 7777776544322 22455789999999999999999999 99998874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=343.77 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=205.9
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEE-----CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF 658 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArd-----k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f 658 (1003)
....++|++.+.||.|+||.||+|++ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34557899999999999999999985 3467899999987542 233456788999999999 689999999887
Q ss_pred ecc-ceEEEEEEeccCCChHHHHHhc------------------------------------------------------
Q 001856 659 TCR-ENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------ 683 (1003)
Q Consensus 659 ~d~-~~lyLVmEy~~GGSL~d~L~~~------------------------------------------------------ 683 (1003)
... ..+|+|||||++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 5689999999999999998642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 001856 684 -------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (1003)
Q Consensus 684 -------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p 750 (1003)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------- 233 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------- 233 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc-------
Confidence 136777888999999999999999999999999999999999999999999987411000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHH
Q 001856 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 829 (1003)
Q Consensus 751 ~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~ 829 (1003)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||........+
T Consensus 234 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 291 (343)
T cd05103 234 ----------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291 (343)
T ss_pred ----------------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH
Confidence 0001122346778999999999899999999999999999997 99999765443333
Q ss_pred HhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 830 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 830 qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
...+..... +..+...++++.+++.+||+.||.+|| ++.+|++|
T Consensus 292 ~~~~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 292 CRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred HHHHhccCC-CCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 333322221 234556788999999999999999999 99999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.15 Aligned_cols=254 Identities=23% Similarity=0.388 Sum_probs=204.6
Q ss_pred CCeEEEEEeeccCceEEEEEEECC----------------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRT----------------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~----------------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIV 652 (1003)
++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999996532 34579999987542 234456788999999999999999
Q ss_pred EEEeeeeccceEEEEEEeccCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCccee
Q 001856 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721 (1003)
Q Consensus 653 kL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g-----------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNIL 721 (1003)
++++++...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999997642 3667789999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccc
Q 001856 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 801 (1003)
Q Consensus 722 Ld~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kS 801 (1003)
++.++.++|+|||+++....... ........+++.|+|||+..+..++.++
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 213 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-----------------------------YRIQGRAVLPIRWMSWESILLGKFTTAS 213 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-----------------------------eeccCcCcCccccCCHHHHhcCCccchh
Confidence 99999999999999873110000 0011223456789999999888899999
Q ss_pred eeechhHHHHHHHh--CCCCCCCCChhhHHHhhhh-----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 802 DWWSVGIILFELIV--GIPPFNAEHPQQIFDNILN-----RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 802 DIWSLGVILYELLT--Gk~PF~~~~~~ei~qkIl~-----~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
|||||||++|||++ |..||...+..+....... ........+..+++.+.+||.+||+.||.+|| ++.+|
T Consensus 214 DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~i 290 (296)
T cd05095 214 DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP---SFQEI 290 (296)
T ss_pred hhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHH
Confidence 99999999999998 7899987766655443321 11111123456789999999999999999999 88877
Q ss_pred Hc
Q 001856 875 KQ 876 (1003)
Q Consensus 875 Lq 876 (1003)
++
T Consensus 291 ~~ 292 (296)
T cd05095 291 HA 292 (296)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=337.00 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=201.2
Q ss_pred CceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHH
Q 001856 601 AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 680 (1003)
Q Consensus 601 ~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L 680 (1003)
++|.||+++...+++.||+|++..... .......+.+|+.+++.++||||++++++|...+.+|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 556777777777999999999976532 3345678999999999999999999999999999999999999999999999
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 001856 681 RNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758 (1003)
Q Consensus 681 ~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~ 758 (1003)
.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||.+...... ....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~--~~~~---------- 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH--GKRQ---------- 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccc--cccc----------
Confidence 764 45899999999999999999999999999999999999999999999999988632110 0000
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCCchhhcc--CCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcC
Q 001856 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836 (1003)
Q Consensus 759 gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g--~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~ 836 (1003)
...........++..|+|||++.+ ..++.++|+|||||++|||++|..||..............+.
T Consensus 159 ------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~ 226 (314)
T cd08216 159 ------------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226 (314)
T ss_pred ------------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 000011234567889999999976 458899999999999999999999998655433322111111
Q ss_pred CC-------CC------------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 837 IP-------WP------------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 837 ~~-------~P------------------------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.+ ++ .....++.++.+||.+||++||.+|| ++.++++||||+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ll~~p~~~~~ 301 (314)
T cd08216 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP---SASQLLNHSFFKQC 301 (314)
T ss_pred CccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc---CHHHHhcCchHhhh
Confidence 00 00 01123457899999999999999999 99999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=342.82 Aligned_cols=265 Identities=31% Similarity=0.513 Sum_probs=212.5
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc--ce
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR--EN 663 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~--~~ 663 (1003)
..++|++.+.||.|+||.||+|.+..+++.+|+|.+.+... .......+.+|+.++..+ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34679999999999999999999998999999998865322 223345677899999999 999999999988654 36
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|+||||+++ +|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 8999999975 999998775 78999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 162 ~~--------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 162 EN--------------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred cc--------------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 00 00011234578999999998865 4578999999999999999999999987
Q ss_pred CChhhHHHhhhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 823 EHPQQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~----------------------------~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
....+....+.... .+.......++.++.+||.+||+.||.+|| ++.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---s~~~i 292 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL---TAEEA 292 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc---CHHHH
Confidence 66554443332211 011112234789999999999999999999 99999
Q ss_pred HcCCCCCCC
Q 001856 875 KQHVFFKDI 883 (1003)
Q Consensus 875 LqHPFFk~I 883 (1003)
++||||+.+
T Consensus 293 l~~~~~~~~ 301 (337)
T cd07852 293 LEHPYVAQF 301 (337)
T ss_pred hhChhhhhh
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=325.18 Aligned_cols=232 Identities=31% Similarity=0.514 Sum_probs=193.8
Q ss_pred cCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHH
Q 001856 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679 (1003)
Q Consensus 600 G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~ 679 (1003)
|.||+||+|+++.+++.||+|.+.+.. ...+|...+....||||+++++.+...+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987643 122344455566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCC
Q 001856 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759 (1003)
Q Consensus 680 L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~g 759 (1003)
+.+...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9888889999999999999999999999999999999999999999999999999875210
Q ss_pred CCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCC
Q 001856 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW 839 (1003)
Q Consensus 760 d~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~ 839 (1003)
.......++..|+|||++.+..++.++|+|||||++|||++|..||...... . .....
T Consensus 137 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~- 194 (237)
T cd05576 137 ---------------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTT- 194 (237)
T ss_pred ---------------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccc-
Confidence 0011235677899999998888999999999999999999999988643221 1 00111
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCC
Q 001856 840 PRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFF 880 (1003)
Q Consensus 840 P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFF 880 (1003)
..++..+++.+++||.+||+.||.+|++. .+++++++||||
T Consensus 195 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 195 LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 12456789999999999999999999954 346999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.77 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=210.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
..+|++++.||+|+||.||+|.++.+|. .+|+|++.+... ......+.+|+.++..++||||+++++.+.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4679999999999999999999876665 589998876532 3445678899999999999999999999887 78
Q ss_pred EEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999999764 56999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
.. ........++..|+|||.+.+..++.++|+|||||++|||++ |..||.
T Consensus 163 ~~-----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 163 EK-----------------------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred cc-----------------------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 00 000111234678999999988889999999999999999998 999999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+....++.+.+..... ...+..++..+.+++.+||..||.+|| ++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp---~~~~l~~ 263 (279)
T cd05057 214 GIPAVEIPDLLEKGER--LPQPPICTIDVYMVLVKCWMIDAESRP---TFKELIN 263 (279)
T ss_pred CCCHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9888887777765432 223456889999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.72 Aligned_cols=252 Identities=35% Similarity=0.522 Sum_probs=206.8
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
|++.+.||.|+||+||+|+...+++.||||.+...... .......+|+..+..++ ||||+++++.+...+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999989999999998754321 12234457889999999 9999999999999999999999
Q ss_pred eccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 670 YLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 779999997764 7899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.......|+..|+|||++.+ ..++.++|+||||+++|+|++|++||......
T Consensus 153 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~ 205 (283)
T cd07830 153 ---------------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI 205 (283)
T ss_pred ---------------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH
Confidence 01123468889999998854 45789999999999999999999999877665
Q ss_pred hHHHhhhhcCCC-------------------CC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 827 QIFDNILNRKIP-------------------WP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 827 ei~qkIl~~~~~-------------------~P--------~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
+.+..+...... ++ ......+..+.+||++||+.+|.+|| ++.|++.|||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~~~~ 282 (283)
T cd07830 206 DQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP---TASQALQHPY 282 (283)
T ss_pred HHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC---CHHHHhhCCC
Confidence 554443321000 00 01123368899999999999999999 9999999999
Q ss_pred C
Q 001856 880 F 880 (1003)
Q Consensus 880 F 880 (1003)
|
T Consensus 283 ~ 283 (283)
T cd07830 283 F 283 (283)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=361.57 Aligned_cols=247 Identities=24% Similarity=0.425 Sum_probs=212.7
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
|.+.++...-++-||.|+-|.||+|+.. ++.||||.++.- -..++..|++|+||||+.+.+++.....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 3445566666788999999999999874 688999976421 1246777999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
+|||||||..|.|+.+|+....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~---- 262 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL---- 262 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998831
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.....+.+++||..|||||+|++.+-+.++|||||||+|||||||..||.+.
T Consensus 263 ----------------------------~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 263 ----------------------------SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred ----------------------------hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 1112345799999999999999999999999999999999999999999887
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHP 878 (1003)
+...++--+=..-..+| +|..+++.++=||++||.-.|..|| ++.+||.|-
T Consensus 315 dssAIIwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~Hl 365 (904)
T KOG4721|consen 315 DSSAIIWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLHL 365 (904)
T ss_pred chheeEEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHHH
Confidence 76555433333333333 5788999999999999999999999 899999993
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.66 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=198.3
Q ss_pred eEEEEEeeccCceEEEEEEE----CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceE
Q 001856 591 FEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArd----k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~l 664 (1003)
|++++.||+|+||+||++.. ..++..||+|+++... .......+.+|+.+|+.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 49999999999999988753 3578899999987542 123346778899999999999999999987653 468
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|++|||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... .
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-~ 161 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-H 161 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc-c
Confidence 999999999999999976 45999999999999999999999999999999999999999999999999998741100 0
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
..........++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 162 ---------------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 162 ---------------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred ---------------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 00000112345677999999998889999999999999999999999986432
Q ss_pred hh--hH------------HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 PQ--QI------------FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 ~~--ei------------~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.. +. ......... .+..+..++.++.+|+.+||+.+|.+|| +++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~i~~ 276 (283)
T cd05080 215 KKFEEMIGPKQGQMTVVRLIELLERGM-RLPCPKNCPQEVYILMKNCWETEAKFRP---TFRSLIP 276 (283)
T ss_pred chhhhhhcccccccchhhhhhhhhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 11 00 111111111 1223567889999999999999999999 8888775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.58 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=204.5
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
++||.|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999864 68899999986542 2333456889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 675 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 675 SL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~--------- 147 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-I--------- 147 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-c---------
Confidence 999998754 46899999999999999999999999999999999999999999999999998631000 0
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 832 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkI 832 (1003)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 148 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 148 --------------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred --------------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 000112244678999999998889999999999999999998 99999888777776666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 833 l~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..... ...+..++..+.+|+.+||..+|.+|| ++.++++.
T Consensus 208 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~ 247 (250)
T cd05085 208 EKGYR--MSCPQKCPDDVYKVMQRCWDYKPENRP---KFSELQKE 247 (250)
T ss_pred HcCCC--CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHHH
Confidence 54322 234567899999999999999999999 88888753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=320.42 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=206.9
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ly 665 (1003)
...++|++.+.||+|+||.||+|.+. .+..+|+|++.... ...+.+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34578999999999999999999864 45679999887532 234678889999999999999999999887 7789
Q ss_pred EEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
++|||+++++|.+++.+. ..++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~- 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN- 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC-
Confidence 999999999999999764 35788889999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
. ........++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+
T Consensus 156 ~-----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 156 E-----------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred C-----------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 0 000112345678999999998889999999999999999998 9999998
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+.......+.... .. ..+...+.++.+++.+||+.+|.+|| ++.++++
T Consensus 207 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05073 207 MSNPEVIRALERGY-RM-PRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 255 (260)
T ss_pred CCHHHHHHHHhCCC-CC-CCcccCCHHHHHHHHHHcccCcccCc---CHHHHHH
Confidence 87776666654432 22 23467889999999999999999999 7776653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.23 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=205.8
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.++||||+++++.+......|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 368999999999999977 999999998765332 34567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 001856 675 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (1003)
Q Consensus 675 SL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~s 753 (1003)
+|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--------- 148 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--------- 148 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---------
Confidence 999999764 5689999999999999999999999999999999999999999999999999873110000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhHHHhh
Q 001856 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 832 (1003)
Q Consensus 754 gttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkI 832 (1003)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 149 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~ 208 (251)
T cd05041 149 --------------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208 (251)
T ss_pred --------------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence 000012234667999999998889999999999999999998 89999887776666665
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 833 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 833 l~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.... . +..+..++.++.+||.+||+.+|.+|| ++.|+++
T Consensus 209 ~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 209 ESGY-R-MPAPQLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred hcCC-C-CCCCccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 4432 1 224567889999999999999999999 9999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=394.02 Aligned_cols=259 Identities=35% Similarity=0.599 Sum_probs=222.2
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+++-...||.|.||.||-|.+..+|...|+|-++..... ......+.+|..++..++|||+|++|++-...+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 466677899999999999999999999999998765544 5566788899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
||.||+|.+.+...+..+|...+.|..|++.||.|||++|||||||||+||+|+.+|.+|++|||.|+.... +..+
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~-~~~~--- 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN-NAQT--- 1390 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC-chhc---
Confidence 999999999999888889999999999999999999999999999999999999999999999999984211 1100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHHHHhCCCCCCCCC-h
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEH-P 825 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYELLTGk~PF~~~~-~ 825 (1003)
+ ........|||.|||||++.+ ++++-+.|||||||++.||+||+.||...+ .
T Consensus 1391 ---------------~--------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1391 ---------------M--------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred ---------------C--------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 0 012346799999999999975 568899999999999999999999997543 3
Q ss_pred hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 826 ~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
-.+.-.+-.+.. |.+|..+|++.+|||.+||+.||++|+ ++.||++|.|=+
T Consensus 1448 ~aIMy~V~~gh~--Pq~P~~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1448 WAIMYHVAAGHK--PQIPERLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred hHHHhHHhccCC--CCCchhhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 334334333333 667888999999999999999999999 999999998765
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.14 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=221.4
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|.-++.||.|+||.||.|++..+...||||.+..+.......-..++.|+.+|..++|||++.+.++|-.....||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 77788999999999999999999999999999876655556668999999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|-| +-.+++.-. +++.+..+..|..+.+.||.|||+++.||||||..|||+++.|.|||+|||.|...
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------- 176 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------- 176 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----------
Confidence 965 777777543 57999999999999999999999999999999999999999999999999998741
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
...++++|||.|||||+|.. +.|+-++||||||++..||...+||+...+..
T Consensus 177 -------------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM 231 (948)
T KOG0577|consen 177 -------------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 231 (948)
T ss_pred -------------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence 12357999999999999974 55899999999999999999999998888877
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
..+.-|.....|... ...+|..++.|+..||++-|.+|| |.+++|.|+|...
T Consensus 232 SALYHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 232 SALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 766666555443221 357999999999999999999999 9999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.29 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=208.6
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
.++|.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++.+.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35699999999999999999987544 3468999876532 23445688899999999999999999998875 457
Q ss_pred EEEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999997654 58999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~ 822 (1003)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 162 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 162 ------------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ------------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 000112235578999999988889999999999999999996 9999988
Q ss_pred CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 823 ~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.+..+....+.+... +..+..++..+.+||.+||..+|.+|| ++.+++..
T Consensus 212 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~~ 261 (270)
T cd05056 212 VKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRP---RFTELKAQ 261 (270)
T ss_pred CCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 877776666654432 234567899999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.30 Aligned_cols=249 Identities=31% Similarity=0.517 Sum_probs=205.5
Q ss_pred EEEEEeeccCceEEEEEEEC----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 592 EIIKPISRGAFGRVFLAKKR----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 592 eIlk~LG~G~FGtVyLArdk----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.+.+.||.|+||.||+|.+. ..+..|+||+++.. ......+.+.+|++++..++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999987 34668999999542 2344568899999999999999999999999988889999
Q ss_pred EEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
||||++|+|.+++... ..++......++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~-- 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS-- 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 9999999999999886 679999999999999999999999999999999999999999999999999987410000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~ 824 (1003)
.........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 ---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 158 ---------------------------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp ---------------------------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ---------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0011223456778999999999889999999999999999999 789999888
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..++...+..... +..+..++..+.++|.+||..||.+|| ++.+|++
T Consensus 211 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 211 NEEIIEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp HHHHHHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred ccccccccccccc--ceeccchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 8888888755443 335677899999999999999999999 8988875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=320.11 Aligned_cols=243 Identities=26% Similarity=0.450 Sum_probs=204.9
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+++|++.+.||+|+||.||++.. +++.||+|++.... ....+.+|+.++..++||||+++++.+... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457799999999999999999864 68889999986532 235688999999999999999999988764 5799
Q ss_pred EEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+|||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997653 588999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~ 823 (1003)
.......+..|+|||++.+..++.++|+|||||++|+|++ |.+||...
T Consensus 153 -------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 153 -------------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred -------------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 0011233567999999998889999999999999999997 99999988
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+..+....+..... +..+..++..+.+||.+||+.+|.+|| ++.+++.
T Consensus 202 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 249 (254)
T cd05083 202 SLKEVKECVEKGYR--MEPPEGCPADVYVLMTSCWETEPKKRP---SFHKLRE 249 (254)
T ss_pred CHHHHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 87777666654322 233567889999999999999999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.55 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=202.2
Q ss_pred eEEEEEeeccCceEEEEEEE----CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--ceE
Q 001856 591 FEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArd----k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~--~~l 664 (1003)
|++++.||+|+||.||+|+. ..++..||+|.++... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 89999999999999999984 4578899999986542 234456788999999999999999999988875 568
Q ss_pred EEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s 743 (1003)
|+||||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
. .........|+..|+|||++.+..++.++|||||||++|+|+++..|+...
T Consensus 164 ~----------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~ 215 (284)
T cd05079 164 E----------------------------YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP 215 (284)
T ss_pred c----------------------------ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence 0 000112356778899999999888999999999999999999987765321
Q ss_pred Ch--------------hhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 824 HP--------------QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 824 ~~--------------~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.. ............. ...+..++..+.+||.+||+.+|.+|| ++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~ 279 (284)
T cd05079 216 MTLFLKMIGPTHGQMTVTRLVRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRT---TFQNLIEG 279 (284)
T ss_pred cchhhhhcccccccccHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 10 0111111122222 223567899999999999999999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=349.20 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=212.3
Q ss_pred CCCcccCCeEEEEEeeccCceEEEEEEEC-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEe
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFY 656 (1003)
Q Consensus 583 k~~~~lddYeIlk~LG~G~FGtVyLArdk-----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~ 656 (1003)
.+....++|.+.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.+|..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 45566678999999999999999999964 355689999997642 2333457889999999997 999999999
Q ss_pred eeeccceEEEEEEeccCCChHHHHHhcC----------------------------------------------------
Q 001856 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG---------------------------------------------------- 684 (1003)
Q Consensus 657 ~f~d~~~lyLVmEy~~GGSL~d~L~~~g---------------------------------------------------- 684 (1003)
++.....+|+|||||++|+|.+++.+.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996532
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCc
Q 001856 685 ----------------------------------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718 (1003)
Q Consensus 685 ----------------------------------------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPe 718 (1003)
.++...+..|+.||+.||+|||+.||+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566778889999999999999999999999999
Q ss_pred ceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCC
Q 001856 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 798 (1003)
Q Consensus 719 NILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys 798 (1003)
|||++.++.+||+|||+++....... ........|++.|||||++.+..++
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 319 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSN-----------------------------YISKGSTFLPLKWMAPESIFNNLYT 319 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccc-----------------------------cccCCCcCCCCceeChHHhcCCCCC
Confidence 99999999999999999874110000 0011234678899999999988899
Q ss_pred ccceeechhHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 799 TTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 799 ~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.++|||||||++|||++ |..||......+.....+..... +..+..++.++.+||.+||..+|.+|| ++.+|++.
T Consensus 320 ~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RP---s~~ell~~ 395 (401)
T cd05107 320 TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR-MAKPAHASDEIYEIMQKCWEEKFEIRP---DFSQLVHL 395 (401)
T ss_pred cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 99999999999999998 89999876555544444433322 234567899999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=322.51 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=209.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-cc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d-~~ 662 (1003)
.++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|..+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4679999999999999999999875 3678999987643 234556788899999999999999999997665 56
Q ss_pred eEEEEEEeccCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL--------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~--------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
..++++||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999999653 358899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELL 814 (1003)
+++....... . .......++..|+|||++.+..++.++|||||||++||++
T Consensus 163 ~~~~~~~~~~-----------~------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~ 213 (280)
T cd05043 163 LSRDLFPMDY-----------H------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213 (280)
T ss_pred CcccccCCce-----------E------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence 9873110000 0 0001234567899999999988999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 815 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 815 T-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+ |++||...+..++...+.... .+ ..+..+++++.+++.+||..||.+|| ++.++++
T Consensus 214 ~~g~~p~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 271 (280)
T cd05043 214 TLGQTPYVEIDPFEMAAYLKDGY-RL-AQPINCPDELFAVMACCWALDPEERP---SFSQLVQ 271 (280)
T ss_pred cCCCCCcCcCCHHHHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 8 999999888777666555432 22 23456789999999999999999999 8888775
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.35 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=194.4
Q ss_pred EEeeccCceEEEEEEECC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEecc
Q 001856 595 KPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~--tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997532 34568888765432 23344678889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 673 GGDLYSLLRNLG-----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 673 GGSL~d~L~~~g-----~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
+|+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---- 154 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED---- 154 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch----
Confidence 999999997643 24678889999999999999999999999999999999999999999999986311000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-------CCCCccceeechhHHHHHHHh-CCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIILFELIV-GIPP 819 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~ys~kSDIWSLGVILYELLT-Gk~P 819 (1003)
.........+++.|+|||++.. ..++.++|||||||++|||++ |.+|
T Consensus 155 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 155 -------------------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred -------------------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 0000123456788999999753 346789999999999999998 8899
Q ss_pred CCCCChhhHHHhhhhcC-CC--CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 820 FNAEHPQQIFDNILNRK-IP--WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~-~~--~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|......+....+.... .. .+..+..++..+.+++..|+ .||.+|| ++++|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rp---t~~~v~~ 265 (269)
T cd05042 210 YPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRP---TAEEVHE 265 (269)
T ss_pred CCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCccccc---CHHHHHH
Confidence 98777666555544332 22 23345578899999999998 5999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=355.89 Aligned_cols=264 Identities=30% Similarity=0.464 Sum_probs=227.4
Q ss_pred CCCCCCCCcccCCeEEEEEeeccCceEEEEEEECCCCC---E-EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEE
Q 001856 578 PIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD---L-FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653 (1003)
Q Consensus 578 p~~Psk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk---~-VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVk 653 (1003)
|+....|....++-.+.++||+|+||.||+|+.+..+. . ||+|..+......+.++..+++|.++|+.++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 44555678888888889999999999999999865422 3 8999988655566778899999999999999999999
Q ss_pred EEeeeeccceEEEEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEee
Q 001856 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732 (1003)
Q Consensus 654 L~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiD 732 (1003)
+|++......+|||||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999999887 499999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHH
Q 001856 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 733 FGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYE 812 (1003)
||+++.+..... ......-...|+|||.+...-|++++||||+||++||
T Consensus 306 FGLs~~~~~~~~-------------------------------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 306 FGLSRAGSQYVM-------------------------------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred cccccCCcceee-------------------------------ccccccCcceecChhhhccCccccccchhheeeeEEe
Confidence 999985210000 0001123568999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 813 LIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 813 LLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+++ |..||.+....++...|....++.+ .+...+.++..++.+|+..+|++|+ ++.++.+
T Consensus 355 if~~g~~Py~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~---tm~~i~~ 415 (474)
T KOG0194|consen 355 IFENGAEPYPGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRP---TMSTIKK 415 (474)
T ss_pred eeccCCCCCCCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhcc---CHHHHHH
Confidence 998 8899999999999999977666544 4567889999999999999999999 6666654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.70 Aligned_cols=245 Identities=26% Similarity=0.445 Sum_probs=202.2
Q ss_pred EeeccCceEEEEEEECCCC------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 596 PISRGAFGRVFLAKKRTTG------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tg------k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
.||.|+||.||+|++.... +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++......|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999999999986544 689999886532 12334678889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-----cEEEeecCCcc
Q 001856 670 YLNGGDLYSLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-----HIKLTDFGLSK 737 (1003)
Q Consensus 670 y~~GGSL~d~L~~~-------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-----~VKLiDFGLAk 737 (1003)
|++|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++ .++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999642 3478899999999999999999999999999999999999887 89999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-C
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-G 816 (1003)
..... . .........++..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 160 ~~~~~--~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g 210 (269)
T cd05044 160 DIYKS--D---------------------------YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG 210 (269)
T ss_pred ccccc--c---------------------------ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcC
Confidence 31100 0 0001122356788999999999889999999999999999998 9
Q ss_pred CCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 817 k~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..||...+..+....+..... +..+..++..+.+||.+||+.+|.+|| ++.++++
T Consensus 211 ~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 211 QQPYPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred CCCCcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 999988777776666544322 234567889999999999999999999 8888765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=363.62 Aligned_cols=244 Identities=33% Similarity=0.542 Sum_probs=210.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeeccceEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d~~~ly 665 (1003)
..++|++...+|.|+||.|..+.+..+++.+++|++.+.. ....+|..++.. -+||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3567999999999999999999999999999999998752 223345655444 47999999999999999999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceee-cCCCcEEEeecCCccccccCCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILL-d~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
+|||++.|+.|.+.+...+.+. ..+..|++||+.|+.|||++|||||||||+|||+ +..|+++|+|||.++...
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~---- 467 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE---- 467 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc----
Confidence 9999999999999998876666 8888999999999999999999999999999999 689999999999987310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
....+.|-|..|.|||++...+|+.+|||||||++||+||+|+.||....
T Consensus 468 ------------------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 468 ------------------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred ------------------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 01234577889999999999999999999999999999999999997654
Q ss_pred hh-hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 825 PQ-QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 825 ~~-ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.. ++..+|... .+...+|.+++|||++||+.||.+|| ++.+++.||||
T Consensus 518 ~~~ei~~~i~~~-----~~s~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 518 AGIEIHTRIQMP-----KFSECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred chHHHHHhhcCC-----ccccccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 44 666555433 33478999999999999999999999 99999999999
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.54 Aligned_cols=237 Identities=23% Similarity=0.389 Sum_probs=194.7
Q ss_pred EeeccCceEEEEEEECCCCC-------EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 596 PISRGAFGRVFLAKKRTTGD-------LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tgk-------~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
.||.|+||.||+|.+..++. .+|+|++.... ....+.+.+|..+++.++||||+++++.+......|+||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 68999999999999865544 48888875432 344567888999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCc--------EEEeecCCcccc
Q 001856 669 EYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKVG 739 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~--------VKLiDFGLAk~~ 739 (1003)
||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997654 5899999999999999999999999999999999999987764 689999987621
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhC-C
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG-I 817 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTG-k 817 (1003)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++| .
T Consensus 159 ~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 159 L-----------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred C-----------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 0 0112468889999999986 4579999999999999999998 5
Q ss_pred CCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 818 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 818 ~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+||.......... +..... .++...+.++.+||.+||+.||.+|| ++++|++.
T Consensus 204 ~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~ 256 (258)
T cd05078 204 KPLSALDSQKKLQ-FYEDRH---QLPAPKWTELANLINQCMDYEPDFRP---SFRAIIRD 256 (258)
T ss_pred CChhhccHHHHHH-HHHccc---cCCCCCcHHHHHHHHHHhccChhhCC---CHHHHHHh
Confidence 7776665544332 223222 34456778999999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=318.48 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=199.9
Q ss_pred EEeeccCceEEEEEEECC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee-ccceEEEEEEe
Q 001856 595 KPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT-CRENLYLVMEY 670 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~---tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~-d~~~lyLVmEy 670 (1003)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|..+++.++||||+++++.+. .+...|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998753 3457999987542 22344577889999999999999999999765 45568999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
+.+|+|.+++.+. ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~---~- 154 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---Y- 154 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc---e-
Confidence 9999999999764 4567788888999999999999999999999999999999999999999999873110000 0
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCChhhH
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 828 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~~~ei 828 (1003)
.........+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..++
T Consensus 155 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~ 211 (262)
T cd05058 155 -----------------------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211 (262)
T ss_pred -----------------------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 0001123456778999999998889999999999999999999 5778887777776
Q ss_pred HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 829 ~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
...+..... +..+..+++.+.+++.+||..+|.+|| ++.++++.
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~~ 255 (262)
T cd05058 212 TVYLLQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRP---TFSELVSR 255 (262)
T ss_pred HHHHhcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 666654432 233456789999999999999999999 88888763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.21 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=200.4
Q ss_pred CCeEEEEEeeccCceEEEEEEE----CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cc
Q 001856 589 DDFEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RE 662 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArd----k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~ 662 (1003)
.+|++++.||+|+||.||+|.. ..++..||+|.+.... ....+.+.+|+.++..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4699999999999999999984 4578899999986542 3445678899999999999999999987644 35
Q ss_pred eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
.+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
. .. . ........++..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 161 ~-~~---------~------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 161 D-KE---------Y------------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred C-Cc---------c------------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 0 00 0 000111234556999999998889999999999999999999877764
Q ss_pred CCChhh---------------HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 822 AEHPQQ---------------IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 822 ~~~~~e---------------i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
...... ....++.....+ ..+..++.++.+||.+||..+|.+|| |+.+|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05081 213 SPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRP---SFSELAL 278 (284)
T ss_pred CcchhhhhhcccccccccchHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 322110 011122222222 23467889999999999999999999 9999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=361.71 Aligned_cols=254 Identities=25% Similarity=0.504 Sum_probs=219.6
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeecccc-ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce--EEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--LYLV 667 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~-~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~--lyLV 667 (1003)
.+.-.+||+|+|-+||+|.+..+|..||---++..++ ......+++..|+.+|+.|+||||+++|+++.+..+ +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3445679999999999999999999998554443333 234567899999999999999999999999988665 8899
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCcceeecCC-CcEEEeecCCccccccCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~G--IIHRDIKPeNILLd~d-G~VKLiDFGLAk~~~~~s~ 744 (1003)
+|++..|+|+.|+++.+.++...++.|++||+.||.|||++. |||||||-+||+|+.+ |.|||+|+|||+..
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~----- 196 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL----- 196 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh-----
Confidence 999999999999999999999999999999999999999985 9999999999999864 99999999999851
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCC-CC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN-AE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~-~~ 823 (1003)
......+.+|||.|||||++. ..|+..+||||||++|.||.|+..||. ..
T Consensus 197 ----------------------------r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 197 ----------------------------RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred ----------------------------hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 112234589999999999998 779999999999999999999999996 57
Q ss_pred ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 824 ~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
++.++|+++..+..|- .+..--.+++++||.+||.. ...|+ ++.|+|+||||..-
T Consensus 248 n~AQIYKKV~SGiKP~-sl~kV~dPevr~fIekCl~~-~~~R~---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 248 NPAQIYKKVTSGIKPA-ALSKVKDPEVREFIEKCLAT-KSERL---SAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHcCCCHH-HhhccCCHHHHHHHHHHhcC-chhcc---CHHHHhhChhhccc
Confidence 8899999998876532 12223468999999999999 89999 99999999999863
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.26 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=194.6
Q ss_pred EEeeccCceEEEEEEEC--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEecc
Q 001856 595 KPISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk--~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 3456799998865432 2333578889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 673 GGDLYSLLRNLG-----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 673 GGSL~d~L~~~g-----~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
+|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++++||+|||+++.... ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~--~~-- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK--ED-- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccC--cc--
Confidence 999999997532 356778888999999999999999999999999999999999999999999863100 00
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-------CCCccceeechhHHHHHHHh-CCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-------GHGTTADWWSVGIILFELIV-GIPP 819 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-------~ys~kSDIWSLGVILYELLT-Gk~P 819 (1003)
.........|++.|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus 155 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p 209 (269)
T cd05087 155 -------------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209 (269)
T ss_pred -------------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence 00011235678899999998643 35789999999999999996 9999
Q ss_pred CCCCChhhHHHhhhhc-CC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 820 FNAEHPQQIFDNILNR-KI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~-~~--~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
|......+........ .. +.|.+....++.+.+++.+|+ .+|.+|| ++++|+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp---t~~~l~~ 265 (269)
T cd05087 210 YRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRP---SAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCC---CHHHHHH
Confidence 9876665554333322 12 222333457889999999999 5899999 8888874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.69 Aligned_cols=252 Identities=30% Similarity=0.532 Sum_probs=210.2
Q ss_pred CeEEEEEeeccCceEEEEEEECC-CCCEEEEEEeecccc-------ccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeec
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADM-------IRKNAVESILAERDILIS-VRNPFVVRFFYSFTC 660 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~-tgk~VALKVIkKs~~-------~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d 660 (1003)
+|++.+.||+|+||.||+|++.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 688999998864321 223445667788888865 799999999999999
Q ss_pred cceEEEEEEeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCC
Q 001856 661 RENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~----~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
.+..|++|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
+..... ........|+..|+|||++.+..++.++|+||||+++|+|++
T Consensus 161 ~~~~~~--------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~ 208 (269)
T cd08528 161 AKQKQP--------------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208 (269)
T ss_pred eeeccc--------------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence 873100 001224568999999999998889999999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|++||...+.......+...... +.....+++.+.+||.+||+.||.+|| ++.|+.++
T Consensus 209 g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~~ 266 (269)
T cd08528 209 LQPPFYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSAM 266 (269)
T ss_pred CCCcccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCC---CHHHHHHH
Confidence 99999887777666666554432 222236789999999999999999999 88887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.78 Aligned_cols=235 Identities=21% Similarity=0.308 Sum_probs=193.0
Q ss_pred EEeeccCceEEEEEEECCCC----------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 595 KPISRGAFGRVFLAKKRTTG----------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tg----------k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 3577887654321 15778899999999999999999999888 778
Q ss_pred EEEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-------cEEEeecCCc
Q 001856 665 YLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-------HIKLTDFGLS 736 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-------~VKLiDFGLA 736 (1003)
|+||||+++|+|.+++...+ .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999887 8999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC--CCCccceeechhHHHHHHH
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~--~ys~kSDIWSLGVILYELL 814 (1003)
..... .....++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 156 ~~~~~-----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 156 ITVLS-----------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred ccccc-----------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 73100 1124567789999999876 7899999999999999999
Q ss_pred h-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 815 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 815 T-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+ |..||...+......... .... .+......+.+||.+||..+|.+|| ++.++++
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~ 256 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQ-DQHR---LPMPDCAELANLINQCWTYDPTKRP---SFRAILR 256 (259)
T ss_pred hCCCCCcccCCchhHHHHHh-cCCC---CCCCCchHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9 688887765444333322 1111 1222348899999999999999999 8988875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.33 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=206.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
..++|+.++.||+|+||.||+|++..+|. .+|+|++.... .......+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34679999999999999999999887776 46888876532 233345688999999999999999999988754
Q ss_pred eEEEEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..++++||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 5689999999999999997653 689999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF 820 (1003)
.. .........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 162 ~~-----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 162 DE-----------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred cc-----------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 00 0001122356778999999999999999999999999999997 99999
Q ss_pred CCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.+.........+.. ...++ .+..++..+.+++.+||..+|.+|| ++.++++.
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 213 DGIPTREIPDLLEK-GERLP-QPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred CCCCHHHHHHHHHC-CCCCC-CCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 88766555444433 22222 3456788999999999999999999 88888774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.72 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=204.8
Q ss_pred CCeEEEEEeeccCceEEEEEEEC----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cc
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKR----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RE 662 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk----~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d--~~ 662 (1003)
.+|++++.||+|+||.||+|+.. .+++.||+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56899999999999999999864 34789999999765432 355788999999999999999999998877 56
Q ss_pred eEEEEEEeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g-~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
..|++|||+++++|.+++.... .++...+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7999999999999999997754 689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~ 821 (1003)
... .........++..|+|||.+.+..++.++|||||||++|||++|..||.
T Consensus 162 ~~~----------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 162 DKD----------------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCc----------------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 000 0000112345567999999998889999999999999999999999986
Q ss_pred CCChhh--------------HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 822 AEHPQQ--------------IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 822 ~~~~~e--------------i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
...... .....+.....++ .+..++.++.+|+.+||..+|.+|| ++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05038 214 SPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRP---SFADLIL 278 (284)
T ss_pred cccchhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 542211 1122222222222 2456788999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.46 Aligned_cols=238 Identities=20% Similarity=0.291 Sum_probs=192.6
Q ss_pred EEeeccCceEEEEEEECC------------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 595 KPISRGAFGRVFLAKKRT------------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~------------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
+.||+|+||.||+|+... ....+|+|++.... ......+.+|..++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 22358888876532 334457788999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCc-------EEEeecC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-------IKLTDFG 734 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~-------VKLiDFG 734 (1003)
..|+||||+++|+|..++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999988754 56999999999999999999999999999999999999987664 8999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-cCCCCccceeechhHHHHHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-g~~ys~kSDIWSLGVILYEL 813 (1003)
++.... ......|+..|+|||++. +..++.++|||||||++|||
T Consensus 158 ~~~~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el 202 (262)
T cd05077 158 IPITVL-----------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202 (262)
T ss_pred CCcccc-----------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence 886310 011246788999999987 46689999999999999999
Q ss_pred H-hCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 814 I-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 814 L-TGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
+ +|..||......+.. .+...... .....+.++.+||.+||+.||.+|| ++.+|+++
T Consensus 203 ~~~~~~p~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rp---~~~~il~~ 260 (262)
T cd05077 203 CYNGEIPLKDKTLAEKE-RFYEGQCM---LVTPSCKELADLMTHCMNYDPNQRP---FFRAIMRD 260 (262)
T ss_pred HhCCCCCCCCcchhHHH-HHHhcCcc---CCCCChHHHHHHHHHHcCCChhhCc---CHHHHHHh
Confidence 8 589999876554432 22222221 2233567899999999999999999 89999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.51 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=205.5
Q ss_pred eEEEEEeeccCceEEEEEEEC---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001856 591 FEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk---~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~----- 662 (1003)
|++.+.||+|+||.||+|... .+++.||||++.... ......+.+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678889999999999999864 357899999986543 33445677889999999999999999999886532
Q ss_pred -eEEEEEEeccCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 663 -NLYLVMEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 663 -~lyLVmEy~~GGSL~d~L~~~------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
..++++||+.+|+|..++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 257899999999999887432 2478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT 815 (1003)
++...... .........+++.|++||.+.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 160 SKKIYSGD-----------------------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred cccccCCc-----------------------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 87311000 0001112345678999999998889999999999999999999
Q ss_pred -CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 816 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 816 -Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|.+||.+.+..+.+..+..... ...+..++..+.+++.+||+.+|.+|| ++.+++++
T Consensus 211 ~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~~~ 268 (273)
T cd05074 211 RGQTPYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRP---SFQHLRDQ 268 (273)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999998887777776655432 223456789999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.73 Aligned_cols=237 Identities=24% Similarity=0.341 Sum_probs=192.4
Q ss_pred EeeccCceEEEEEEECCC------------------------CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE
Q 001856 596 PISRGAFGRVFLAKKRTT------------------------GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~t------------------------gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnI 651 (1003)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999975321 2358888876532 2334567889999999999999
Q ss_pred EEEEeeeeccceEEEEEEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC----
Q 001856 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---- 726 (1003)
Q Consensus 652 VkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG---- 726 (1003)
+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999975 46789999999999999999999999999999999999997643
Q ss_pred ---cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccce
Q 001856 727 ---HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTAD 802 (1003)
Q Consensus 727 ---~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSD 802 (1003)
.+||+|||++.... ......+++.|+|||++.+ ..++.++|
T Consensus 159 ~~~~~kl~d~g~~~~~~-----------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~D 203 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-----------------------------------SREERVERIPWIAPECVPGGNSLSTAAD 203 (274)
T ss_pred ccceeeecCCccccccc-----------------------------------cccccccCCcccCchhhcCCCCCCcHHH
Confidence 48999999876210 0112357788999999875 56899999
Q ss_pred eechhHHHHHHH-hCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 803 WWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 803 IWSLGVILYELL-TGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
||||||++|||+ +|..||......+.... ...... .+...++.+.++|.+||+.+|.+|| ++.+++++
T Consensus 204 v~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~il~~ 272 (274)
T cd05076 204 KWSFGTTLLEICFDGEVPLKERTPSEKERF-YEKKHR---LPEPSCKELATLISQCLTYEPTQRP---SFRTILRD 272 (274)
T ss_pred HHHHHHHHHHHHhCCCCCccccChHHHHHH-HHhccC---CCCCCChHHHHHHHHHcccChhhCc---CHHHHHHh
Confidence 999999999985 79999987766554332 222222 2344667899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.17 Aligned_cols=246 Identities=20% Similarity=0.311 Sum_probs=195.0
Q ss_pred EeeccCceEEEEEEECCCC--CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccC
Q 001856 596 PISRGAFGRVFLAKKRTTG--DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tg--k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 673 (1003)
.||+|+||+||+|+....+ ..+++|.+.... .....+.+.+|..+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999999999764332 345666655432 233457889999999999999999999999999999999999999
Q ss_pred CChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 674 GDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 674 GSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------- 152 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------- 152 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-------
Confidence 9999999764 34677788899999999999999999999999999999999999999999997631000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-------CCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-------~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||.
T Consensus 153 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 153 ----------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred ----------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 00011224578899999999853 235789999999999999997 678998
Q ss_pred CCChhhHHHhhhhcCC---CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 822 AEHPQQIFDNILNRKI---PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~---~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..+..+.+..+..... ..|.++..+++.+.+++..|| .+|.+|| ++.+|++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp---~~~~i~~ 264 (268)
T cd05086 211 HLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRA---TAEEVHR 264 (268)
T ss_pred CCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCC---CHHHHHH
Confidence 7777777666654432 123444568899999999999 5799999 8888865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.31 Aligned_cols=262 Identities=27% Similarity=0.395 Sum_probs=215.5
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~---- 662 (1003)
.-++|++.+.||+|||+.||+++...++..||+|.+.... .+..+..++|++..++++||||++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3467999999999999999999999999999999987654 456688999999999999999999987765443
Q ss_pred -eEEEEEEeccCCChHHHHHhc---C-CCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCcceeecCCCcEEEeecCC
Q 001856 663 -NLYLVMEYLNGGDLYSLLRNL---G-CLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 663 -~lyLVmEy~~GGSL~d~L~~~---g-~LsEe~ar~Ia~QIL~ALeYLHs~G--IIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
..||+++|...|+|.+.+.+. + .++|.++..|+.+|+.||++||+.. ++||||||.|||+...+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 499999999999999999653 3 6999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHH
Q 001856 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 736 Ak~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYE 812 (1003)
+...... ..................|..|+|||.+.- ...+.++|||||||+||+
T Consensus 176 ~~~a~i~----------------------i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 176 ATQAPIQ----------------------IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred ccccceE----------------------eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHH
Confidence 8742110 000111122233445668999999999864 445889999999999999
Q ss_pred HHhCCCCCCCC--ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 813 LIVGIPPFNAE--HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 813 LLTGk~PF~~~--~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
|+.|..||... ....+.-.+.+.++.+|.-.. +|+.+.+||+.||+.||.+|| ++.+++.+
T Consensus 234 ~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP---~i~~ll~~ 296 (302)
T KOG2345|consen 234 MMFGESPFERIYQQGGSLALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRP---TIPELLSK 296 (302)
T ss_pred HHHcCCcchHHhhcCCeEEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCC---CHHHHHHH
Confidence 99999999532 222233456667778886544 899999999999999999999 89998875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=326.19 Aligned_cols=260 Identities=28% Similarity=0.511 Sum_probs=217.1
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~l 664 (1003)
..+++.+.+..||.|+-|.||+++.+.+|...|||.+.+.. ..+..++++..++++...+ .|+||+.|++|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34577889999999999999999999999999999998764 4556678888888877665 89999999999999999
Q ss_pred EEEEEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
++.||.|.. -+..++++ .++++|..+-.+..-++.||.||.+ +||||||+||+|||+|..|+|||||||++-.. .+
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl-vd 244 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VD 244 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee-ec
Confidence 999999843 34444443 3789999999999999999999995 68999999999999999999999999998631 10
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHHHHhCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
........|-+.|||||.+.- ..|+-.+||||||++++||.||..|
T Consensus 245 -------------------------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yP 293 (391)
T KOG0983|consen 245 -------------------------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYP 293 (391)
T ss_pred -------------------------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCC
Confidence 011223468899999999964 4589999999999999999999999
Q ss_pred CCCC-ChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 820 FNAE-HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 820 F~~~-~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
|.+. ...+++.++++...+.......+|+.+.+|+..||++|+.+|| .-.++|+|||+...
T Consensus 294 y~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 294 YKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLEHPFIKRY 355 (391)
T ss_pred CCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhcCcceeec
Confidence 9874 4567788888866543333345899999999999999999999 88999999999854
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=320.33 Aligned_cols=256 Identities=14% Similarity=0.236 Sum_probs=191.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHH--------HHHHHHHHHHHHhcCCCcEEEEEee
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNA--------VESILAERDILISVRNPFVVRFFYS 657 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~--------ie~~lrEi~IL~~L~HPnIVkL~~~ 657 (1003)
++|++.+.||+|+||+||+|++..+ +..+|+|+........... ......+...+..++|++|+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999999877 6778888654322110000 0112233344566789999999987
Q ss_pred eeccc----eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeec
Q 001856 658 FTCRE----NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (1003)
Q Consensus 658 f~d~~----~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDF 733 (1003)
+.... ..|++||++.. ++.+.+......++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65543 45788888744 77777776666789999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHH
Q 001856 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 734 GLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYEL 813 (1003)
|+|+........ . ...........||+.|+|||++.+..++.++|||||||++|||
T Consensus 171 Gla~~~~~~~~~-------------------~-----~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 171 GIASHFIIHGKH-------------------I-----EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW 226 (294)
T ss_pred CCceeeccCCcc-------------------c-----ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 999742111000 0 0000112335799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCh-hh--------HHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 814 IVGIPPFNAEHP-QQ--------IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 814 LTGk~PF~~~~~-~e--------i~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
++|.+||.+... .. ...++...... ...+++.+.+++..|+..+|.+|| +.++|++
T Consensus 227 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp---~~~~l~~ 291 (294)
T PHA02882 227 AGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKP---DYDALIK 291 (294)
T ss_pred HhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCC---CHHHHHH
Confidence 999999987632 21 22333333222 235688999999999999999999 7877764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=369.95 Aligned_cols=273 Identities=30% Similarity=0.480 Sum_probs=211.4
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-------
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------- 660 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d------- 660 (1003)
+.+|+.++.||+||||.||+|+++-+|+.||||.|.... .......+.+|+.+|++|+|||||++|.++..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 578999999999999999999999999999999987654 44556789999999999999999999843300
Q ss_pred --------------------------------------------------------------------------------
Q 001856 661 -------------------------------------------------------------------------------- 660 (1003)
Q Consensus 661 -------------------------------------------------------------------------------- 660 (1003)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------c--------ceEEEEEEeccCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhh
Q 001856 661 ------------------------R--------ENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHS 707 (1003)
Q Consensus 661 ------------------------~--------~~lyLVmEy~~GGSL~d~L~~~g~L-sEe~ar~Ia~QIL~ALeYLHs 707 (1003)
+ ..+||-||||+.-.|.++++++... ....++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1269999999998888888776554 578899999999999999999
Q ss_pred cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCC
Q 001856 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL 787 (1003)
Q Consensus 708 ~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~Ym 787 (1003)
+|||||||||.||+++.+++|||+|||+|+.............. ..+...+. .....++.+||..|+
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~-~~~~~~g~------------~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLS-FSTNRAGS------------NDGDLTSQVGTALYV 782 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccC-ccccccCC------------CCcccccccceeeee
Confidence 99999999999999999999999999999842110000000000 00111111 112345689999999
Q ss_pred CchhhccCC---CCccceeechhHHHHHHHhCCCCCC-CCChhhHHHhhhhcCCCCC-CCCCCCCHHHHHHHHhhccCCc
Q 001856 788 APEILLGTG---HGTTADWWSVGIILFELIVGIPPFN-AEHPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDP 862 (1003)
Q Consensus 788 APEVL~g~~---ys~kSDIWSLGVILYELLTGk~PF~-~~~~~ei~qkIl~~~~~~P-~lp~~iS~elkDLIrrcL~kDP 862 (1003)
|||++.+.. |+.++|+||||+|++||+. ||. ......++.++.++..+.+ .+...--+....+|++||++||
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 999998754 9999999999999999984 574 3344555666655555444 1233344567899999999999
Q ss_pred CCcCCCCCHHHHHcCCCCC
Q 001856 863 HQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 863 ~kRpg~~SAeELLqHPFFk 881 (1003)
.+|| ||.|+|++.||-
T Consensus 860 ~kRP---tA~eLL~s~llp 875 (1351)
T KOG1035|consen 860 SKRP---TATELLNSELLP 875 (1351)
T ss_pred ccCC---CHHHHhhccCCC
Confidence 9999 999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=359.18 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=217.5
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~-----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d 660 (1003)
....+.+..+.||+|+||+||+|+... ....||||.++... ......+|.+|+++|..++|||||+|++++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 345678899999999999999998642 34579999998653 34466899999999999999999999999999
Q ss_pred cceEEEEEEeccCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLG--------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~~g--------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG 726 (1003)
++.+|||+|||..|||.++|+... +|+..+...++.||+.|++||-++.+|||||-.+|+||+++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 999999999999999999996432 278889999999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeech
Q 001856 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (1003)
Q Consensus 727 ~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSL 806 (1003)
.|||+|||+++-. .+.+.. +......-..+|||||.|+...|+.++||||+
T Consensus 641 ~VKIsDfGLsRdi--YssDYY---------------------------k~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 641 VVKISDFGLSRDI--YSSDYY---------------------------KVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred EEEecccccchhh--hhhhhh---------------------------cccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 9999999999841 111110 00112234568999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 807 GIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 807 GVILYELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
||+|||+++ |+.||++...+++++.|..+.. ...|+.++.++.+|+..||+.+|.+|| ++.||
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RP---sF~eI 755 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL--LSCPENCPTEVYSLMLECWNENPKRRP---SFKEI 755 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcccCC---CHHHH
Confidence 999999997 9999999999999999998876 457899999999999999999999999 55544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=349.47 Aligned_cols=258 Identities=20% Similarity=0.331 Sum_probs=213.7
Q ss_pred CCCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001856 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 582 sk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~ 661 (1003)
..|.+..++..+...||.|.||+||+|++-. .||||+++....... +.+.|.+|+.++++-+|.||+-+.+++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4566777889999999999999999999843 499999987765444 889999999999999999999999999887
Q ss_pred ceEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.. .||+-+|+|.+|+.+++-. ..|.....+.|+.||++|+.|||.++|||||||..||+|.+++.|||+||||+.+..
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 9999999999999999754 468899999999999999999999999999999999999999999999999997411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHHHHhCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYELLTGk 817 (1003)
. + .+ ........|...|||||+++. .+|++.+|||||||++|||++|.
T Consensus 540 ~-----w----------~g--------------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 540 R-----W----------SG--------------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred e-----e----------cc--------------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 0 0 00 011223467889999999974 56899999999999999999999
Q ss_pred CCCCCCChhhHHHhhhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 818 PPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 818 ~PF~~~~~~ei~qkIl~~~--~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.||...+.++++-++-.+. .........+++++++|+..||.+++++|| ...+||.
T Consensus 591 lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP---~F~~il~ 648 (678)
T KOG0193|consen 591 LPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP---LFPQLLS 648 (678)
T ss_pred CCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCc---cHHHHHH
Confidence 9999666666554443331 122233456888999999999999999999 6666664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=335.93 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=208.5
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--C----cEEEEEeeeecc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--P----FVVRFFYSFTCR 661 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H--P----nIVkL~~~f~d~ 661 (1003)
..+|+++.+||+|.||.|-.|.+..++..|||||++.- ....+..+-|+++|.++.+ | -+|++.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 36799999999999999999999999999999998743 2344566779999999843 3 388899999999
Q ss_pred ceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC---------------
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--------------- 724 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~--------------- 724 (1003)
++.|||+|.+ |.++++++.++ .+++...++.+++||+.+++|||+.+++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 66999999876 46899999999999999999999999999999999999842
Q ss_pred -----CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCc
Q 001856 725 -----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (1003)
Q Consensus 725 -----dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~ 799 (1003)
+-.|+|+|||.|++.. ....+.+.|..|+|||++++.+++.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~----------------------------------e~hs~iVsTRHYRAPEViLgLGwS~ 288 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH----------------------------------EHHSTIVSTRHYRAPEVILGLGWSQ 288 (415)
T ss_pred eccCCCcceEEEecCCcceec----------------------------------cCcceeeeccccCCchheeccCcCC
Confidence 2358999999998511 1124578899999999999999999
Q ss_pred cceeechhHHHHHHHhCCCCCCCCChhh---HHHhhhh------------------cCCCCCCCC---------------
Q 001856 800 TADWWSVGIILFELIVGIPPFNAEHPQQ---IFDNILN------------------RKIPWPRVP--------------- 843 (1003)
Q Consensus 800 kSDIWSLGVILYELLTGk~PF~~~~~~e---i~qkIl~------------------~~~~~P~lp--------------- 843 (1003)
++||||+||||+|+.+|...|...+..+ +.++|+. +...|++..
T Consensus 289 pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl 368 (415)
T KOG0671|consen 289 PCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPL 368 (415)
T ss_pred ccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccH
Confidence 9999999999999999999998766544 3444432 111122100
Q ss_pred -------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 844 -------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 844 -------~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
...-.++.|||++||..||.+|+ |+.|+|+||||+..
T Consensus 369 ~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 369 KKYMLQDDLEHVQLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred HHHhccCcHHHhHHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 00123588999999999999999 99999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=293.72 Aligned_cols=243 Identities=48% Similarity=0.850 Sum_probs=208.3
Q ss_pred CceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHH
Q 001856 601 AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 680 (1003)
Q Consensus 601 ~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L 680 (1003)
+||.||+|.+..+++.+|+|++........ ...+.+|+..++.++|+||+++++.+......+++|||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998899999999876543221 578889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCC
Q 001856 681 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760 (1003)
Q Consensus 681 ~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd 760 (1003)
.....++...+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||.+......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~------------------ 140 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG------------------ 140 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc------------------
Confidence 87766999999999999999999999999999999999999999999999999998741100
Q ss_pred CCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC-CChhhHHHhhhhcCCCC
Q 001856 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPW 839 (1003)
Q Consensus 761 ~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~-~~~~ei~qkIl~~~~~~ 839 (1003)
.......|+..|++||.+.+..++.++||||||+++|+|++|..||.. .+...+.+.+.......
T Consensus 141 --------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 206 (244)
T smart00220 141 --------------GLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 206 (244)
T ss_pred --------------cccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC
Confidence 012345788899999999988899999999999999999999999987 55655665555444433
Q ss_pred CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 840 PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 840 P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
......++.++.+++.+||..+|.+|| ++.++++||||
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~~~~~~~ 244 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 244 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhcc---CHHHHhhCCCC
Confidence 222222889999999999999999999 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.03 Aligned_cols=263 Identities=30% Similarity=0.531 Sum_probs=208.0
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-cc
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RE 662 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d-~~ 662 (1003)
+..|++++.||+|+||.||+|..+.++. .||||.++...- .........+|+.+++.++||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4569999999999999999997655433 799999875421 12233567799999999999999999999887 77
Q ss_pred eEEEEEEeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC----CcEEEeec
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDF 733 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~-----g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d----G~VKLiDF 733 (1003)
.++|++||.+. +|+.+|+-. ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999987 999999532 469999999999999999999999999999999999999877 89999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHH
Q 001856 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 734 GLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYE 812 (1003)
|+|+... + |.. .-......+-|.+|+|||.+.| ..|+.+.|+||+|||+.|
T Consensus 181 GlaR~~~-~-------plk--------------------pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaE 232 (438)
T KOG0666|consen 181 GLARLFN-N-------PLK--------------------PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAE 232 (438)
T ss_pred cHHHHhh-c-------ccc--------------------ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHH
Confidence 9999521 0 000 0011234678999999999998 458999999999999999
Q ss_pred HHhCCCCCCCCC---------hhhHHHhhhhcC-----CCCCC---CC--------------------------CCCCHH
Q 001856 813 LIVGIPPFNAEH---------PQQIFDNILNRK-----IPWPR---VP--------------------------EEMSPE 849 (1003)
Q Consensus 813 LLTGk~PF~~~~---------~~ei~qkIl~~~-----~~~P~---lp--------------------------~~iS~e 849 (1003)
|||-.+.|.+.. ..+...+|++-. ..||. +| ..-++.
T Consensus 233 lLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~ 312 (438)
T KOG0666|consen 233 LLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPS 312 (438)
T ss_pred HHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCch
Confidence 999999996532 123344454411 11221 11 113556
Q ss_pred HHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 850 lkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
+.+|+.+||++||.+|+ |+++.++|+||...
T Consensus 313 a~~LL~klL~yDP~kRI---ta~qAleh~yF~~d 343 (438)
T KOG0666|consen 313 ALDLLQKLLTYDPIKRI---TAEQALEHPYFTED 343 (438)
T ss_pred HHHHHHHHhccCchhhc---cHHHHhcccccccC
Confidence 99999999999999999 99999999999853
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.04 Aligned_cols=259 Identities=32% Similarity=0.546 Sum_probs=217.9
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|..+++||+|.||+||+|+++.+++.||+|.+...+ ..+......++|+-+|+.++|.|||++++....+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35777889999999999999999999999999987654 22334467789999999999999999999999999999999
Q ss_pred EeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
|||.. +|..+... ++.++.+.++.++.|++.||.|+|++++.|||+||.|+||+.+|.+||+|||+|+..-..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip----- 154 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP----- 154 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-----
Confidence 99965 88888765 478999999999999999999999999999999999999999999999999999831100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHH-hCCCCCCCCCh
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELI-VGIPPFNAEHP 825 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELL-TGk~PF~~~~~ 825 (1003)
.+-....+-|.+|.+|.++.|. -|+...|+||.|||+.|+. .|++.|.+.+.
T Consensus 155 --------------------------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 155 --------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred --------------------------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 0111235679999999999985 4899999999999999999 48999999998
Q ss_pred hhHHHhhhhcC-----CCCC------------CCC---------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 826 QQIFDNILNRK-----IPWP------------RVP---------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 826 ~ei~qkIl~~~-----~~~P------------~lp---------~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
.+.+.+|.... -.|| .+| +.++..-+||++++|.-+|.+|+ +|++.++|||
T Consensus 209 ddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri---saeaalqhpy 285 (292)
T KOG0662|consen 209 DDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI---SAEAALQHPY 285 (292)
T ss_pred HHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc---CHHHHhcCcc
Confidence 88888886521 1122 111 23456789999999999999999 9999999999
Q ss_pred CCCC
Q 001856 880 FKDI 883 (1003)
Q Consensus 880 Fk~I 883 (1003)
|.+.
T Consensus 286 f~d~ 289 (292)
T KOG0662|consen 286 FSDF 289 (292)
T ss_pred cccc
Confidence 9853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=342.72 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=182.2
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCC----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEee--
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTT----GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYS-- 657 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~t----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~-- 657 (1003)
.....++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+...+|. +....+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e~--l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNER--VRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHHH--HHhhchhhHHHHHHhhh
Confidence 345678999999999999999999999988 89999998764321 11111111 111122222222211
Q ss_pred ----eeccceEEEEEEeccCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCceec
Q 001856 658 ----FTCRENLYLVMEYLNGGDLYSLLRNLGC--------------------LDEDVARVYIAEVVLALEYLHSLRVVHR 713 (1003)
Q Consensus 658 ----f~d~~~lyLVmEy~~GGSL~d~L~~~g~--------------------LsEe~ar~Ia~QIL~ALeYLHs~GIIHR 713 (1003)
......+||||||+.+++|.+++..... ..+..++.++.||+.||+|||++|||||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2345679999999999999999875421 1234567899999999999999999999
Q ss_pred cCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhh
Q 001856 714 DLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (1003)
Q Consensus 714 DIKPeNILLd~-dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL 792 (1003)
||||+|||++. ++.+||+|||+|+..... ........+||+.|||||++
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~------------------------------~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG------------------------------INYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc------------------------------cccCCcccccCCCccChHHh
Confidence 99999999986 689999999999731000 00112356899999999976
Q ss_pred ccCC----------------------CCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhh-cCCCC----------
Q 001856 793 LGTG----------------------HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-RKIPW---------- 839 (1003)
Q Consensus 793 ~g~~----------------------ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~-~~~~~---------- 839 (1003)
.... ++.++|||||||+||||+++..|+... ...+..++. ....+
T Consensus 330 ~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~ 407 (566)
T PLN03225 330 IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPR 407 (566)
T ss_pred hccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccc
Confidence 5332 334569999999999999977665322 111222111 11100
Q ss_pred --CC------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 001856 840 --PR------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888 (1003)
Q Consensus 840 --P~------lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L 888 (1003)
+. ........+.+||.+||++||.+|| |+.++|+||||.+..+..+
T Consensus 408 ~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 408 ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred cchhhhhhhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 00 0111234566999999999999999 9999999999998776533
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=352.42 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=216.4
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCC-----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk-----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~ 661 (1003)
.-+..++.+.||+|+||.||.|....... .||+|.+++. .+...+..|++|..+|+.++|||||++++++.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 34568899999999999999999864322 4888887754 4566778999999999999999999999999999
Q ss_pred ceEEEEEEeccCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~-------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
...+|++|||.||+|..+|++. ..++...+..++.+|+.|++||+++++|||||..+|+||+....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999999876 348899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELL 814 (1003)
+|+-. ...+. + +......-...|||||.+....++.++|||||||+|||++
T Consensus 848 lArDi--y~~~y-----------------y----------r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 848 LARDI--YDKDY-----------------Y----------RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred hhHhh--hhchh-----------------e----------eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 99821 11100 0 0000112345799999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 815 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 815 T-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
+ |..||.+.+..+++...+.+. . ...|..++..+.++|.+||+.+|++|| +...|++
T Consensus 899 slG~~PY~~~~n~~v~~~~~~gg-R-L~~P~~CP~~ly~lM~~CW~~~pe~RP---~F~~i~~ 956 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLLDVLEGG-R-LDPPSYCPEKLYQLMLQCWKHDPEDRP---SFRTIVE 956 (1025)
T ss_pred hCCCCCCCCcchHHHHHHHHhCC-c-cCCCCCCChHHHHHHHHHccCChhhCc---cHHHHHh
Confidence 8 999999999999988777766 3 345789999999999999999999999 7777766
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=343.78 Aligned_cols=256 Identities=32% Similarity=0.554 Sum_probs=220.9
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec-----cc
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC-----RE 662 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d-----~~ 662 (1003)
+-|+++.+||.|.+|.||+++++.+++..|+||+.... ...+.+..|.+||+.. +|||++.+|++|.- .+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45999999999999999999999999999999987543 2335567788898876 69999999999865 35
Q ss_pred eEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.++||||||.||+..+++++. ..+.|..+..|+++++.||.+||...+||||||-.|||++.+|.|||+|||.+...
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl- 173 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL- 173 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee-
Confidence 799999999999999999765 57999999999999999999999999999999999999999999999999998631
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-----CCCCccceeechhHHHHHHHh
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~kSDIWSLGVILYELLT 815 (1003)
.....+.++.+|||.|||||++.. ..|+..+|+||||++..||--
T Consensus 174 ------------------------------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 174 ------------------------------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred ------------------------------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 112345678999999999999964 347889999999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
|.+|+.+..+...+-.|-....+-..-|..+++++.+||..||.+|-.+|| +..++|+|||.++
T Consensus 224 G~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP---~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 224 GAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP---STEELLKHPFITE 287 (953)
T ss_pred CCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc---chhhhccCCcccc
Confidence 999999988876665555444333334678999999999999999999999 9999999999984
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=324.22 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=196.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-eEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NLY 665 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~-~ly 665 (1003)
..++|.--..||+|+||.||+|... +|..||||.+....... ...|.+|+.+|.+++|||+|+|+++|.+.+ ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 3467888889999999999999975 45899999776543221 345999999999999999999999999988 599
Q ss_pred EEEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---ceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 666 LVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLR---VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~G---IIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
||+|||++|+|.+++.... .+++.....|+.+++.||+|||... ||||||||+|||||.+.+.||+|||+|+.+.
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999998764 8999999999999999999999853 9999999999999999999999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccc-cCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA-VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~-vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~P 819 (1003)
.. . ....+. .||.+|+|||++.....+.++||||||++|.||+||+.|
T Consensus 229 ~~--~-----------------------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 229 EG--D-----------------------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred cc--c-----------------------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence 10 0 001112 799999999999988899999999999999999999988
Q ss_pred CCCCC---h---hhHHHhhhhcC-C---CCCCCC-CCCC--HH---HHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 820 FNAEH---P---QQIFDNILNRK-I---PWPRVP-EEMS--PE---AHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 820 F~~~~---~---~ei~qkIl~~~-~---~~P~lp-~~iS--~e---lkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
..... . .+.....+... . --|.+. ...+ .. +..+..+|++.+|.+|| +..++.+
T Consensus 278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP---~m~~Vv~ 347 (361)
T KOG1187|consen 278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERP---TMSQVVK 347 (361)
T ss_pred cCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCc---CHHHHHH
Confidence 76432 1 11111111111 1 001121 2223 22 45666799999999999 7777543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.13 Aligned_cols=265 Identities=29% Similarity=0.481 Sum_probs=216.5
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccc----cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-ce
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD----MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-EN 663 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~----~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-~~ 663 (1003)
++|-++.+||+|||+.||+|.+....++||+|+-.... ....+..++..+|.+|.+.|+||.||++|++|.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 56999999999999999999999999999999864322 22345678899999999999999999999999765 56
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CceeccCCCcceeecC---CCcEEEeecCCccc
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKV 738 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~--GIIHRDIKPeNILLd~---dG~VKLiDFGLAk~ 738 (1003)
+|-|+|||+|.+|..+++....+++.+++.|+.||+.||.||.+. -|||-||||.|||+-. .|.|||+||||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999999999999999999999999999976 5999999999999954 48899999999996
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC----CCCccceeechhHHHHHHH
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----GHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 739 ~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~----~ys~kSDIWSLGVILYELL 814 (1003)
...++. ..+. ....+.-..||.+|++||.+.-. ..+.++||||+|||+|.++
T Consensus 623 MdddSy-----~~vd-------------------GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl 678 (775)
T KOG1151|consen 623 MDDDSY-----NSVD-------------------GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL 678 (775)
T ss_pred ccCCcc-----Cccc-------------------ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence 322111 1110 11223457899999999988632 3588999999999999999
Q ss_pred hCCCCCCCCCh-hhHHH--hhhh-cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 815 VGIPPFNAEHP-QQIFD--NILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 815 TGk~PF~~~~~-~ei~q--kIl~-~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
.|+-||..... .++++ .|++ ....||.- +-++.++++||++||++.-++|. .+.++..||||.
T Consensus 679 YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~---DV~qLA~dpyll 745 (775)
T KOG1151|consen 679 YGRKPFGHNQSQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRI---DVQQLACDPYLL 745 (775)
T ss_pred ccCCCCCCchhHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhh---hHHHHccCcccc
Confidence 99999976432 33322 2222 33455543 45899999999999999999999 899999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=322.55 Aligned_cols=152 Identities=28% Similarity=0.477 Sum_probs=133.2
Q ss_pred chhhhcccCCCCCCCCCCCcccC--CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHH
Q 001856 567 EDDVVRSLRTSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644 (1003)
Q Consensus 567 Eee~l~sl~tsp~~Psk~~~~ld--dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~ 644 (1003)
+++....|..+.|||..++..+. +|.+.++||+|-|++||+|.+..+.++|||||.+... ...+..+.|+.+|+
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~ 129 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQ 129 (590)
T ss_pred cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHH
Confidence 45566788999999999998876 6999999999999999999999999999999998653 34566778999998
Q ss_pred hcC-----C---CcEEEEEeeeec----cceEEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cC
Q 001856 645 SVR-----N---PFVVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHS-LR 709 (1003)
Q Consensus 645 ~L~-----H---PnIVkL~~~f~d----~~~lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs-~G 709 (1003)
+++ | .+||+|++.|.. ..++|||+|++ |-+|..+|.+. +.++...++.|++||+.||.|||+ +|
T Consensus 130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 873 3 379999999976 45899999999 67999999765 579999999999999999999995 69
Q ss_pred ceeccCCCcceeec
Q 001856 710 VVHRDLKPDNLLIA 723 (1003)
Q Consensus 710 IIHRDIKPeNILLd 723 (1003)
|||.||||+|||+-
T Consensus 209 IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 209 IIHTDLKPENVLLC 222 (590)
T ss_pred ccccCCCcceeeee
Confidence 99999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=332.48 Aligned_cols=264 Identities=29% Similarity=0.496 Sum_probs=219.6
Q ss_pred CCCCCCCCcccCC-eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC------Cc
Q 001856 578 PIHPSKDRTSIDD-FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN------PF 650 (1003)
Q Consensus 578 p~~Psk~~~~ldd-YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H------Pn 650 (1003)
.|+....+..++. |.+....|+|-||+|..|.+..-|..||||||...... ...=+.|+.||++|+. -|
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhH
Confidence 4566667777765 99999999999999999999999999999999876442 2344679999999963 48
Q ss_pred EEEEEeeeeccceEEEEEEeccCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-C
Q 001856 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-G 726 (1003)
Q Consensus 651 IVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~---LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-G 726 (1003)
+++|+-.|...+++|||+|.+. .+|.+++++.|. |....++.|+.|+..||..|-.+||+|.||||+|||++.. .
T Consensus 496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc
Confidence 9999999999999999999985 499999998764 8889999999999999999999999999999999999976 5
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeech
Q 001856 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (1003)
Q Consensus 727 ~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSL 806 (1003)
.+||||||.|.....+ .+ ..+.-+..|.|||++.|.+|++..|+||+
T Consensus 575 iLKLCDfGSA~~~~en---------------------ei------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSv 621 (752)
T KOG0670|consen 575 ILKLCDFGSASFASEN---------------------EI------------TPYLVSRFYRAPEIILGLPYDYPIDTWSV 621 (752)
T ss_pred eeeeccCccccccccc---------------------cc------------cHHHHHHhccCcceeecCcccCCccceee
Confidence 6899999998741100 01 11334557999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCC---------------------------------------------
Q 001856 807 GIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR--------------------------------------------- 841 (1003)
Q Consensus 807 GVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~--------------------------------------------- 841 (1003)
||+||||.||+..|.+....+++.-.+..+.+||.
T Consensus 622 gctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl 701 (752)
T KOG0670|consen 622 GCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDL 701 (752)
T ss_pred ceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhH
Confidence 99999999999999999888887766664444442
Q ss_pred ---------CCC---CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 842 ---------VPE---EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 842 ---------lp~---~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
++. .+-..+++||.+||..||++|+ ++.++|+||||.+
T Consensus 702 ~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 702 GSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred HHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 000 0114689999999999999999 9999999999974
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=335.09 Aligned_cols=242 Identities=32% Similarity=0.480 Sum_probs=193.9
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc------e
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------N 663 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~------~ 663 (1003)
-|..-+.||+||||.||+++++.+|+.||||.+++.. .....+...+|+++|++++|||||++++.-++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4777889999999999999999999999999998754 3344577889999999999999999998766654 4
Q ss_pred EEEEEEeccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC--CC--cEEEeecCCc
Q 001856 664 LYLVMEYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DG--HIKLTDFGLS 736 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~---g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~--dG--~VKLiDFGLA 736 (1003)
..+|||||.||+|+..+.+. ..|++.+...++..++.||.|||++|||||||||.||++-. +| .-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999753 46999999999999999999999999999999999999854 34 3699999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHh
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIV 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLT 815 (1003)
+... .+....+.+||+.|.+||++.. ..|+..+|.|||||++|++.|
T Consensus 172 rel~--------------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT 219 (732)
T KOG4250|consen 172 RELD--------------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT 219 (732)
T ss_pred ccCC--------------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc
Confidence 8311 1123567899999999999985 778999999999999999999
Q ss_pred CCCCCCCC----ChhhHHHhhhhcC---------------C----CCCCCCCCCCHH----HHHHHHhhccCCcCCcC
Q 001856 816 GIPPFNAE----HPQQIFDNILNRK---------------I----PWPRVPEEMSPE----AHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 816 Gk~PF~~~----~~~ei~qkIl~~~---------------~----~~P~lp~~iS~e----lkDLIrrcL~kDP~kRp 866 (1003)
|..||... +..++...+...+ . .+| +|..+++. +...+..+|..+|.+|.
T Consensus 220 G~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 220 GELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 99999532 1222322222211 1 122 23444443 44567789999999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.22 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=211.7
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-------
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------- 661 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~------- 661 (1003)
+.|+-+.+||+|.||.||+|+.+.+|+.||+|++-... .....-...++|+++|..++|+|++.+++.+...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 55888999999999999999999999999998754322 1222335678899999999999999998776542
Q ss_pred -ceEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccc
Q 001856 662 -ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 662 -~~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~ 739 (1003)
..+||||.+|+. +|+-++.+. .+++...++.++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++..
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 349999999987 999999765 67999999999999999999999999999999999999999999999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
..... .........+-|.+|++||.+.| ..|+++.|||+.||||.||.++.+
T Consensus 175 s~~~n---------------------------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 175 STSKN---------------------------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred ecccc---------------------------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 11000 00112345678999999999997 558999999999999999999999
Q ss_pred CCCCCChhhHHHhhhhcC-----CCCCC--------------CC-------------CCCCHHHHHHHHhhccCCcCCcC
Q 001856 819 PFNAEHPQQIFDNILNRK-----IPWPR--------------VP-------------EEMSPEAHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~~~-----~~~P~--------------lp-------------~~iS~elkDLIrrcL~kDP~kRp 866 (1003)
-|.+......+..|-... -.||. ++ -.-.+++.||+.+||..||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 999888777665553311 11221 11 11246899999999999999999
Q ss_pred CCCCHHHHHcCCCCCC
Q 001856 867 GSGGASEVKQHVFFKD 882 (1003)
Q Consensus 867 g~~SAeELLqHPFFk~ 882 (1003)
+++++++|.||..
T Consensus 308 ---~ad~alnh~~F~k 320 (376)
T KOG0669|consen 308 ---DADQALNHDFFWK 320 (376)
T ss_pred ---chHhhhchhhhhc
Confidence 9999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=320.32 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=190.4
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEEC----------------CCCCEEEEEEeeccccccH-----------HHHHHHH
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKR----------------TTGDLFAIKVLKKADMIRK-----------NAVESIL 637 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk----------------~tgk~VALKVIkKs~~~~~-----------~~ie~~l 637 (1003)
+...++|++.++||+|+||+||+|... ..++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 446789999999999999999999752 2456799999864321100 0112334
Q ss_pred HHHHHHHhcCCCcE-----EEEEeeeec--------cceEEEEEEeccCCChHHHHHhcC--------------------
Q 001856 638 AERDILISVRNPFV-----VRFFYSFTC--------RENLYLVMEYLNGGDLYSLLRNLG-------------------- 684 (1003)
Q Consensus 638 rEi~IL~~L~HPnI-----VkL~~~f~d--------~~~lyLVmEy~~GGSL~d~L~~~g-------------------- 684 (1003)
.|+.++.+++|.++ ++++++|.. ....||||||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 56777777776554 556655542 356899999999999999886421
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCC
Q 001856 685 ----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760 (1003)
Q Consensus 685 ----~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd 760 (1003)
.++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~------------~----- 363 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG------------I----- 363 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC------------C-----
Confidence 2356678889999999999999999999999999999999999999999998631000 0
Q ss_pred CCccchhhhhhhhhhccccccCCCCCCCchhhccCC--------------------CC--ccceeechhHHHHHHHhCCC
Q 001856 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--------------------HG--TTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 761 ~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~--------------------ys--~kSDIWSLGVILYELLTGk~ 818 (1003)
........+|+.|+|||++.... |+ ...||||+||++|+|++|..
T Consensus 364 -------------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l 430 (507)
T PLN03224 364 -------------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL 430 (507)
T ss_pred -------------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCC
Confidence 00011234589999999986432 22 24799999999999999875
Q ss_pred -CCCCCC-----------hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCc---CCcCCCCCHHHHHcCCCCCC
Q 001856 819 -PFNAEH-----------PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP---HQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 819 -PF~~~~-----------~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP---~kRpg~~SAeELLqHPFFk~ 882 (1003)
||.... ....+..+....+.++ .....++.++|||.+||.++| .+|+ |+.|+|+||||..
T Consensus 431 ~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~Rl---Sa~eaL~Hp~f~~ 505 (507)
T PLN03224 431 RPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRL---SVGQALSHRFFLP 505 (507)
T ss_pred CCccchhhhhhHHhhccchHHHHHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCC---CHHHHhCCCCcCC
Confidence 775321 1111222223334443 235678999999999999876 6899 9999999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.32 Aligned_cols=279 Identities=25% Similarity=0.443 Sum_probs=220.5
Q ss_pred chhhhcccCCCCCC-CC---CCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHH
Q 001856 567 EDDVVRSLRTSPIH-PS---KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642 (1003)
Q Consensus 567 Eee~l~sl~tsp~~-Ps---k~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~I 642 (1003)
+++.++++.++... |. -..+.-++.+-+..||.|+||+|++-.++.+|+..|||.+..... .....+++.|.+.
T Consensus 38 ~~~~lr~~s~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~ 115 (361)
T KOG1006|consen 38 EEERLRSYSTGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDT 115 (361)
T ss_pred hHHHHHHhccCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHH
Confidence 45566666554321 21 123344567778899999999999999999999999999987543 4455678888876
Q ss_pred H-HhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccC
Q 001856 643 L-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDL 715 (1003)
Q Consensus 643 L-~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~-----~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDI 715 (1003)
. +.-+.||||++|++.-.++..+|.||+|.- +|..+.+ ....++|+.+-.+..-.+.||+||-+ ..||||||
T Consensus 116 ~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv 194 (361)
T KOG1006|consen 116 VMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDV 194 (361)
T ss_pred HHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence 5 455789999999999999999999999964 6654432 23579999999999999999999995 58999999
Q ss_pred CCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-
Q 001856 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG- 794 (1003)
Q Consensus 716 KPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g- 794 (1003)
||+|||++..|.|||||||++-.. ..........|-..|||||.+..
T Consensus 195 KPSNILldr~G~vKLCDFGIcGqL--------------------------------v~SiAkT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 195 KPSNILLDRHGDVKLCDFGICGQL--------------------------------VDSIAKTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred ChhheEEecCCCEeeecccchHhH--------------------------------HHHHHhhhccCCccccChhccCCc
Confidence 999999999999999999997520 11122334578889999999964
Q ss_pred -CCCCccceeechhHHHHHHHhCCCCCCCCC-hhhHHHhhhhcCCCCCCCCC---CCCHHHHHHHHhhccCCcCCcCCCC
Q 001856 795 -TGHGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNILNRKIPWPRVPE---EMSPEAHDLIDRFLTEDPHQRLGSG 869 (1003)
Q Consensus 795 -~~ys~kSDIWSLGVILYELLTGk~PF~~~~-~~ei~qkIl~~~~~~P~lp~---~iS~elkDLIrrcL~kDP~kRpg~~ 869 (1003)
.+|+-++|+||||++|||+.||..||..-+ ..+.+..+..+..+....+. +++..+..||..||.+|-..||
T Consensus 243 ~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp--- 319 (361)
T KOG1006|consen 243 DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP--- 319 (361)
T ss_pred cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---
Confidence 568999999999999999999999997643 44555566666655443333 3899999999999999999999
Q ss_pred CHHHHHcCCCCCCC
Q 001856 870 GASEVKQHVFFKDI 883 (1003)
Q Consensus 870 SAeELLqHPFFk~I 883 (1003)
...+++++||++..
T Consensus 320 ky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 320 KYDDLKKFPFYRMY 333 (361)
T ss_pred chhhhhcCchhhhh
Confidence 89999999999743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=332.77 Aligned_cols=276 Identities=40% Similarity=0.751 Sum_probs=244.4
Q ss_pred EeeccCceEEEEEEE---CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEEEEec
Q 001856 596 PISRGAFGRVFLAKK---RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 596 ~LG~G~FGtVyLArd---k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
++|.|+||.|++++. ...|..||+|++++......... +...|..++..++ ||++|++++.|+.+..+|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999999875 34678899999988766554443 6778999999987 999999999999999999999999
Q ss_pred cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 001856 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (1003)
Q Consensus 672 ~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~ 751 (1003)
.||+|+..+.....+.+...++|.++++.|++++|+.||+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~---------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK---------- 149 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh----------
Confidence 9999999999999999999999999999999999999999999999999999999999999999984110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHh
Q 001856 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 831 (1003)
Q Consensus 752 ~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qk 831 (1003)
....|||..|||||++. ++..++||||+|+++|||++|..||.. ++..+
T Consensus 150 -------------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~ 198 (612)
T KOG0603|consen 150 -------------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR 198 (612)
T ss_pred -------------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH
Confidence 01129999999999998 788999999999999999999999988 77888
Q ss_pred hhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhh--cCCccCCCCCCCCCCC
Q 001856 832 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSY 907 (1003)
Q Consensus 832 Il~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~--~SAeELLqHPFFk~Idw~~L~~~--k~pfiP~~~s~lDts~ 907 (1003)
|+..+..+ |..++..++++++.++.++|..|+|. ..+.|+++|+||..++|+.+..+ +++|.|......|+.+
T Consensus 199 Il~~~~~~---p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~ 275 (612)
T KOG0603|consen 199 ILKAELEM---PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQ 275 (612)
T ss_pred HhhhccCC---chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhh
Confidence 88876554 56899999999999999999999998 48999999999999999988765 6899999999999999
Q ss_pred ccccccCCC
Q 001856 908 FTSRYSWNT 916 (1003)
Q Consensus 908 F~s~~s~~~ 916 (1003)
|+..|+..+
T Consensus 276 fd~eft~~~ 284 (612)
T KOG0603|consen 276 FDPEFTSQV 284 (612)
T ss_pred cCchhccCC
Confidence 998776444
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=312.69 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=218.1
Q ss_pred CCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 583 k~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~ 662 (1003)
+|...-.+..+.++||-|.||.||.+.++.....||||.++... -.++.|+.|..+|+.++|||+|+|+++|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 45555567888999999999999999999999999999987653 36788999999999999999999999999999
Q ss_pred eEEEEEEeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.+|||+|||..|+|.++|++.. .++.-.+..++.||..|++||..+++|||||...|.|+..+..||++||||+++..
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999999998753 46777777788899999999999999999999999999999999999999999621
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~P 819 (1003)
.+.. . ......-...|.|||-+....++.++|||+|||+|||+.| |..|
T Consensus 417 gDTY------------------T------------AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 417 GDTY------------------T------------AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred CCce------------------e------------cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC
Confidence 1100 0 0111223457999999999999999999999999999997 8999
Q ss_pred CCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 001856 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 820 F~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPF 879 (1003)
|.+.+..++|.-+-++ +.+ +-|++|++....|++.||++.|.+||.+..+.+.++..|
T Consensus 467 YPGidlSqVY~LLEkg-yRM-~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 467 YPGIDLSQVYGLLEKG-YRM-DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCccHHHHHHHHhcc-ccc-cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 9999998888765544 333 457899999999999999999999994433333333333
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=316.09 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=205.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCC----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTT----GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~t----gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
-+...+.+.||.|-||.||.|....- .--||||+.+.... .+..+.|+.|.-+|+.++||||++|++.+.+ ..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34456678999999999999987432 23589999876543 2336889999999999999999999999876 46
Q ss_pred EEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.+||||+++-|.|..+++.+ ..++...+..|+.||+.||.|||+..+|||||...|||+.....|||+|||+++.....
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 89999999999999999865 46999999999999999999999999999999999999999999999999999842100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
. ........-...|||||.+.-..++.++|||.|||+|||+|. |.-||.
T Consensus 545 -----~-------------------------yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 545 -----A-------------------------YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred -----c-------------------------hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 0 011111223457999999999999999999999999999996 999999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 868 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~ 868 (1003)
+-...+++-.|-++.. +..|+.|++.+..|+.+||+++|.+||.+
T Consensus 595 gvkNsDVI~~iEnGeR--lP~P~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 595 GVKNSDVIGHIENGER--LPCPPNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred cccccceEEEecCCCC--CCCCCCCChHHHHHHHHHhccCcccCCcH
Confidence 9888888777766653 45688999999999999999999999954
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=301.25 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=212.4
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~---- 662 (1003)
...+|.-++.+|.|+- .|..|-+.-+++.||+|.+.... .......+..+|..++..++|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457899999999998 88889898899999999887663 23334467889999999999999999999997654
Q ss_pred --eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 663 --~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
.+|+|||||.+ +|.+.+. -.++-..++.++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 58999999965 9999887 357888999999999999999999999999999999999999999999999998410
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
. ......++.|..|.|||++.+.+|...+||||+||++.||++|+..|
T Consensus 170 ~--------------------------------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 170 T--------------------------------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred c--------------------------------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 0 01234578999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHhhhhcC---------------------------CC----CCC--C------CCCCCHHHHHHHHhhccCC
Q 001856 821 NAEHPQQIFDNILNRK---------------------------IP----WPR--V------PEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~---------------------------~~----~P~--l------p~~iS~elkDLIrrcL~kD 861 (1003)
.+.+.-+.+.++.... .. +|+ + +..-+..++|++.+||..|
T Consensus 218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~ 297 (369)
T KOG0665|consen 218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID 297 (369)
T ss_pred cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence 9877665555554310 00 111 0 0112356999999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCCCCh
Q 001856 862 PHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~Idw 885 (1003)
|++|. +++++|+||||+ -|
T Consensus 298 pe~Ri---sv~daL~HPY~~--vw 316 (369)
T KOG0665|consen 298 PEKRI---SVDDALRHPYIK--VW 316 (369)
T ss_pred hhhcc---cHHHHhcCCeee--ee
Confidence 99999 999999999998 46
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=316.20 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=211.7
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC-CCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT-TGD--LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~-tgk--~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
.++.++.++||+|.||.|++|.+.. +|+ .||||+++...... ....|++|+.+|.+|+|||+++||++..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3567888999999999999999864 333 68999998654432 67899999999999999999999999887 778
Q ss_pred EEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 665 YLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
.||||++++|+|.+.|++. ..|....+..|+.||+.|+.||.++++|||||...|||+.....|||+||||.+....+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999999873 56888999999999999999999999999999999999999999999999998841110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
. ..+.+ ....--...|+|||.|....++.++|+|++||+||||++ |.-||.
T Consensus 266 -e----------------d~Yvm-----------~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 266 -E----------------DMYVM-----------APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred -C----------------cceEe-----------cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 0 00000 111223457999999999999999999999999999997 899999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
+....+++++|-.+. . ..-|..+++++.+++..||+.+|.+|| ++..|.
T Consensus 318 G~~g~qIL~~iD~~e-r-LpRPk~csedIY~imk~cWah~paDRp---tFsair 366 (1039)
T KOG0199|consen 318 GCRGIQILKNIDAGE-R-LPRPKYCSEDIYQIMKNCWAHNPADRP---TFSAIR 366 (1039)
T ss_pred CCCHHHHHHhccccc-c-CCCCCCChHHHHHHHHHhccCCccccc---cHHHHH
Confidence 999999999987433 2 335788999999999999999999999 555554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=335.76 Aligned_cols=240 Identities=25% Similarity=0.341 Sum_probs=188.0
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
..|.....||+|+||.||+|+++.++..||+|.+...... ...|+.++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4567778899999999999999999999999998654321 124578899999999999999999999999999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH---SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLH---s~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
||++||+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 99999999999964 788999999999999999999 6799999999999999998888775 66543200
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~ 825 (1003)
......||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus 834 ------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 834 ------------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred ------------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 01123689999999999999999999999999999999999999953211
Q ss_pred --hhHH---HhhhhcC----CCCCCC------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 826 --QQIF---DNILNRK----IPWPRV------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 --~ei~---qkIl~~~----~~~P~l------p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..+. ....... ..-+.+ +.....++.+++.+||+.||.+|| ++.|+++.
T Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~~ 947 (968)
T PLN00113 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CANDVLKT 947 (968)
T ss_pred CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHHHHHHH
Confidence 0111 1000000 000111 111223577899999999999999 89998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=289.51 Aligned_cols=253 Identities=31% Similarity=0.548 Sum_probs=205.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc--e
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE--N 663 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~--~ 663 (1003)
..++|++++++|+|.|+.||.|.+..+++.++||+++.- ..+.+.+|+.||..|. ||||++|++...+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 568899999999999999999999999999999999753 2367889999999997 999999999988754 5
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-CcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-G~VKLiDFGLAk~~~~~ 742 (1003)
..||+||+++.+...+. +.++.-.++.|+.||+.||.|||++||+|||+||.|++|+.. ..++|+|+|+|.+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 78999999987766655 458888999999999999999999999999999999999975 5799999999985210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc-CCCCccceeechhHHHHHHHhCCCCC-
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF- 820 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g-~~ys~kSDIWSLGVILYELLTGk~PF- 820 (1003)
....+..+.+..|--||.+.. +.|+++-|+|||||++..|+..+-||
T Consensus 186 -------------------------------~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 186 -------------------------------GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred -------------------------------CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 112234567788999999976 55899999999999999999988887
Q ss_pred CCCChhhHHHhhhh-----------------------------cCCCCCCC-----CCCCCHHHHHHHHhhccCCcCCcC
Q 001856 821 NAEHPQQIFDNILN-----------------------------RKIPWPRV-----PEEMSPEAHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~-----------------------------~~~~~P~l-----p~~iS~elkDLIrrcL~kDP~kRp 866 (1003)
.+.+..+.+-+|.+ ...+|..+ ..-.++++.|||.++|.+|..+|+
T Consensus 235 hG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl 314 (338)
T KOG0668|consen 235 HGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL 314 (338)
T ss_pred CCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc
Confidence 34444333333322 01111111 112579999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCC
Q 001856 867 GSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 867 g~~SAeELLqHPFFk~I 883 (1003)
||.|.+.||||..+
T Consensus 315 ---TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 315 ---TAKEAMAHPYFAPV 328 (338)
T ss_pred ---chHHHhcCchHHHH
Confidence 99999999999754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=310.36 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=209.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+...+.++||+|-||.|.+|+- ..+..||+|+++... ..+....|..|+++|.+|+||||++|++++..++.+||||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4578899999999999999997 447999999998654 3445678999999999999999999999999999999999
Q ss_pred EeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 669 EYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|||+.|+|.+++.++ ..+.......++.||+.|++||.+.+||||||.+.|+|++.++++||+|||+++....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys----- 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS----- 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc-----
Confidence 999999999999887 3334555667999999999999999999999999999999999999999999983111
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh--CCCCCCCCC
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV--GIPPFNAEH 824 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT--Gk~PF~~~~ 824 (1003)
++. .+.....+-..+|||||.+....++.++|+|++|+++||+++ ...||....
T Consensus 690 --g~y----------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 690 --GDY----------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred --CCc----------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 000 011123456779999999999999999999999999999874 789998887
Q ss_pred hhhHHHhhhhc-----CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 825 PQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 825 ~~ei~qkIl~~-----~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
.+++.++...- ....+..|.-++..+.++|.+||..|-.+|| +.+++-.
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh~ 799 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLHL 799 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHHH
Confidence 77776655331 1112345677999999999999999999999 7777644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=329.63 Aligned_cols=269 Identities=51% Similarity=0.901 Sum_probs=225.9
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.-.+|..++.|-.|+||.||+++|+.+.+.+|+|+ .+..+..++ |+....+|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn----------ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN----------ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc----------cccccCCccee--------------
Confidence 44789999999999999999999999999999965 433221111 55555667766
Q ss_pred EEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~dd 746 (1003)
|+-.+.++..+.++.+. +.+++|||+-||+|||+||+|.||+.-|++|++|||+++.+....+.
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at- 199 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT- 199 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-
Confidence 56677777777777654 78999999999999999999999999999999999999965332111
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCChh
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ 826 (1003)
.++ +..+.. ..........||||.|+|||++..++|+..+|||++|+|+||.+.|..||.++.++
T Consensus 200 ---------nl~---eg~I~k---~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 200 ---------NLK---EGHIEK---DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred ---------hhh---hcchHH---HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 110 011111 11123345679999999999999999999999999999999999999999999999
Q ss_pred hHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhhcCCccCCCCCCCCCC
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTS 906 (1003)
Q Consensus 827 ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L~~~k~pfiP~~~s~lDts 906 (1003)
+++..++...+.||+-...++++++++|.++|..+|..|.|.+++-++++|+||+.+||.-|.++++.|+|......|++
T Consensus 265 elfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddts 344 (1205)
T KOG0606|consen 265 ELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTS 344 (1205)
T ss_pred HHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccch
Confidence 99999999999999877889999999999999999999999889999999999999999999999999999999999999
Q ss_pred Ccccc
Q 001856 907 YFTSR 911 (1003)
Q Consensus 907 ~F~s~ 911 (1003)
||+++
T Consensus 345 yfdTR 349 (1205)
T KOG0606|consen 345 YFDTR 349 (1205)
T ss_pred hhccc
Confidence 99873
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=311.29 Aligned_cols=203 Identities=29% Similarity=0.520 Sum_probs=182.2
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHH-----HHHHHHHHHHHhcC---CCcEEEEEeee
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV-----ESILAERDILISVR---NPFVVRFFYSF 658 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~i-----e~~lrEi~IL~~L~---HPnIVkL~~~f 658 (1003)
.+.+|..++.||.|+||.|++|.++.+...|+||.|.|.++.....+ -.+-.|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45789999999999999999999999999999999999876544333 35667999999998 99999999999
Q ss_pred eccceEEEEEEec-cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 659 TCRENLYLVMEYL-NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 659 ~d~~~lyLVmEy~-~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
++++++||+||.- +|.+|+++|...+.++|.+++.|++|++.|+++||++||||||||-+||+++.+|.+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999976 467999999999999999999999999999999999999999999999999999999999999886
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC-CccceeechhHHHHHHHhC
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-s~kSDIWSLGVILYELLTG 816 (1003)
.. .......++||..|.|||++.|..| +..-|||+||++||.++..
T Consensus 719 ~~---------------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyk 765 (772)
T KOG1152|consen 719 YT---------------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYK 765 (772)
T ss_pred hh---------------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEec
Confidence 31 0112346899999999999999988 8889999999999999999
Q ss_pred CCCCCC
Q 001856 817 IPPFNA 822 (1003)
Q Consensus 817 k~PF~~ 822 (1003)
..||+.
T Consensus 766 enpyyn 771 (772)
T KOG1152|consen 766 ENPYYN 771 (772)
T ss_pred cCCCcC
Confidence 999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=318.22 Aligned_cols=258 Identities=31% Similarity=0.532 Sum_probs=226.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
-++|+++.++|.|+||.||+|+++.+++..|+|+++... .....-+..|+-+++.++|||||-+++.|...+.+++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 378999999999999999999999999999999998642 23445677899999999999999999999999999999
Q ss_pred EEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||||.||+|.+...--+++++.++.+..++.+.||+|||++|-+|||||-.|||+++.|.+||+|||.+-..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi-------- 162 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI-------- 162 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987520
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhh---ccCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL---~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
.....+..++.|||.|||||+. +..+|+..+|||++|++..|+-.-++|-....
T Consensus 163 -----------------------tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 163 -----------------------TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred -----------------------hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 0112345689999999999986 35779999999999999999999999987777
Q ss_pred hhhHHHhhhhcCCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 825 PQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~l--p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
+......+-+..+..|.+ +..+++.+-+|++.+|.++|++|| +++.+|+|||...
T Consensus 220 pmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~ 276 (829)
T KOG0576|consen 220 PMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQ 276 (829)
T ss_pred hHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeecc
Confidence 776666666666555544 356899999999999999999999 9999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=314.13 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=219.6
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccce
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk---~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~ 663 (1003)
......|.++||.|.||.|+.|+.+..|+ .||||.++... .+++...|+.|..||-+.+||||++|.++......
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 34567889999999999999999986664 79999998653 45667899999999999999999999999999999
Q ss_pred EEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~ 742 (1003)
++||+|||++|+|..+|+.+ +.|+..++..+++.|+.|++||-.+|+|||||...|||++.+-..|++||||+++.. +
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle-d 783 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-D 783 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc-c
Confidence 99999999999999999865 679999999999999999999999999999999999999999999999999999521 1
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~ 821 (1003)
..+ . .. .+..-.-..+|.|||.|....++.++||||+|++|||.++ |..||.
T Consensus 784 d~~-----~--~y--------------------tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 784 DPE-----A--AY--------------------TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred CCC-----c--cc--------------------cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 110 0 00 0011112468999999999999999999999999999775 999999
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
..+.++++..|..+. .+| .|.+++..+-.|+..||++|-.+|| ...+|..+
T Consensus 837 dmSNQdVIkaIe~gy-RLP-pPmDCP~aL~qLMldCWqkdR~~RP---~F~qiV~~ 887 (996)
T KOG0196|consen 837 DMSNQDVIKAIEQGY-RLP-PPMDCPAALYQLMLDCWQKDRNRRP---KFAQIVST 887 (996)
T ss_pred ccchHHHHHHHHhcc-CCC-CCCCCcHHHHHHHHHHHHHHhhcCC---CHHHHHHH
Confidence 999999999987654 444 3678999999999999999999999 78888764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-33 Score=293.48 Aligned_cols=261 Identities=29% Similarity=0.498 Sum_probs=211.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----eE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~-----~l 664 (1003)
+.+.-+.||.|+||.||.+.+..+|+.||+|.+..- ...-...+++.+|..+|...+|.|++..++..+... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 344557899999999999999999999999987532 122334578899999999999999999887776542 47
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ 744 (1003)
|+++|+|.. +|..+|-.-+.++.+.++.+++||+.||+|||+.||.||||||.|+|++.|..+||||||+|+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~--- 208 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ--- 208 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch---
Confidence 899999965 8999888888999999999999999999999999999999999999999999999999999995211
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 745 ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~ 823 (1003)
.........+-|-.|+|||+++|. .|+.++||||+|||+.|+|..+..|...
T Consensus 209 ---------------------------d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 209 ---------------------------RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred ---------------------------hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 111222335678899999999985 5899999999999999999999999888
Q ss_pred ChhhHHHhhhh-----------------------cCCCCCCC--------CCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 001856 824 HPQQIFDNILN-----------------------RKIPWPRV--------PEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 824 ~~~ei~qkIl~-----------------------~~~~~P~l--------p~~iS~elkDLIrrcL~kDP~kRpg~~SAe 872 (1003)
++.+.++.|.. +...-|.+ +..-..++.+++.++|..||.+|. +.+
T Consensus 262 ~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri---s~~ 338 (449)
T KOG0664|consen 262 GPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI---SVE 338 (449)
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc---cHh
Confidence 87776666543 11111211 123346788999999999999999 899
Q ss_pred HHHcCCCCCCCCh
Q 001856 873 EVKQHVFFKDINW 885 (1003)
Q Consensus 873 ELLqHPFFk~Idw 885 (1003)
+.+.|++..+...
T Consensus 339 ~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 339 EALQHRYLEEGRL 351 (449)
T ss_pred hhcccccccccce
Confidence 9999999976543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=317.78 Aligned_cols=246 Identities=30% Similarity=0.426 Sum_probs=198.4
Q ss_pred EEEeeccCce-EEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceEEEEEEec
Q 001856 594 IKPISRGAFG-RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 594 lk~LG~G~FG-tVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
-+.+|.|+.| .||+|.. .|+.||||.+-. .......+|+..|+.. +|||||++|+.-++...+||..|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3568999987 5889987 578999997653 2346778999999887 5999999999999999999999999
Q ss_pred cCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC---C--CcEEEeecCCccccccC
Q 001856 672 NGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---D--GHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 672 ~GGSL~d~L~~~g~----LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~---d--G~VKLiDFGLAk~~~~~ 742 (1003)
.. +|.+++...+. ......+..+.|++.||++||+.+||||||||.||||.. + ..++|+|||+|+.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 76 99999987411 112445788999999999999999999999999999976 3 46899999999842110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhC-CCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTG-k~PF~ 821 (1003)
. .......+..||-+|+|||++.....+.++||+||||++|..++| ..||.
T Consensus 665 ~----------------------------sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 665 K----------------------------SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred c----------------------------chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 0 111224567899999999999998888999999999999999985 99997
Q ss_pred CCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 822 ~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
.....+ .+|+++....-.+......++.|||.+||.++|..|| +|.++|.||||-
T Consensus 717 d~~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPlFW 771 (903)
T KOG1027|consen 717 DSLERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRP---SATDVLNHPLFW 771 (903)
T ss_pred chHHhh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCC---CHHHHhCCCccC
Confidence 654433 4677776655444332223999999999999999999 999999999995
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=305.51 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=210.6
Q ss_pred CCCcccCCeEEEEEeeccCceEEEEEEECC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEE
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRF 654 (1003)
Q Consensus 583 k~~~~lddYeIlk~LG~G~FGtVyLArdk~-------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL 654 (1003)
.+...-++..+.+.||+|.||.|++|.-.. ....||+|.++.... ....+.+..|+.+|..+ +||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455555666777899999999999997531 145799999876543 35678899999999987 59999999
Q ss_pred EeeeeccceEEEEEEeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCc
Q 001856 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718 (1003)
Q Consensus 655 ~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g----------------~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPe 718 (1003)
++++...+.+++|+||+..|+|..+++..+ .++...+..++.||+.|++||++..+|||||-.+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 3888899999999999999999999999999999
Q ss_pred ceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccC--CCCCCCchhhccCC
Q 001856 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG--TPDYLAPEILLGTG 796 (1003)
Q Consensus 719 NILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vG--Tp~YmAPEVL~g~~ 796 (1003)
|||+..+..+||+|||+|+.... .+ ......-.| ...|||||.+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~--~~----------------------------~y~~~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYN--KD----------------------------YYRTKSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred hEEecCCCEEEEccccceeccCC--CC----------------------------ceEecCCCCccceeecCHHHhccCc
Confidence 99999999999999999983110 00 000011122 33599999999999
Q ss_pred CCccceeechhHHHHHHHh-CCCCCCCCC-hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 001856 797 HGTTADWWSVGIILFELIV-GIPPFNAEH-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 797 ys~kSDIWSLGVILYELLT-Gk~PF~~~~-~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeEL 874 (1003)
|+.++||||+|++||||++ |..||.+.. ..++++.+..+.. ...|..+++++.++++.||..+|.+|| +..++
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r--~~~P~~c~~eiY~iM~~CW~~~p~~RP---~F~~~ 572 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNR--MEQPEHCSDEIYDLMKSCWNADPEDRP---TFSEC 572 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhCCCcccCC---CHHHH
Confidence 9999999999999999998 899998865 6666665555443 346788999999999999999999999 66655
Q ss_pred Hc
Q 001856 875 KQ 876 (1003)
Q Consensus 875 Lq 876 (1003)
.+
T Consensus 573 ~~ 574 (609)
T KOG0200|consen 573 VE 574 (609)
T ss_pred HH
Confidence 54
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=292.39 Aligned_cols=285 Identities=24% Similarity=0.419 Sum_probs=208.9
Q ss_pred cCCeEEEEEeeccCceEEEEEEECC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccce
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~---tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~ 663 (1003)
.+.|.++.+||.|+|++||++.+.. .+++||+|.+.... ...++.+|+++|..+ .+.||+++.+++...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3569999999999999999999877 78899999886543 346788999999988 48899999999999999
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccC
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~ 742 (1003)
+++||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|.....+
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999888888765 668899999999999999999999999999999999986 477899999999731111
Q ss_pred CCC----CC--------CCCCccCcccCCCCCcc-chhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhH
Q 001856 743 STD----DL--------SGPAVSGTTLLGDEEPQ-LTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGI 808 (1003)
Q Consensus 743 s~d----dl--------s~p~~sgttl~gd~~p~-lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGV 808 (1003)
... .. .+.....+...+...+. .................||++|+|||++... ..+.++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 100 00 01111111111100000 0000011223345578999999999999864 4689999999999
Q ss_pred HHHHHHhCCCCCCCC-ChhhHHHhhhh--------------cC------CC----------CCCC---------------
Q 001856 809 ILFELIVGIPPFNAE-HPQQIFDNILN--------------RK------IP----------WPRV--------------- 842 (1003)
Q Consensus 809 ILYELLTGk~PF~~~-~~~ei~qkIl~--------------~~------~~----------~P~l--------------- 842 (1003)
|+.-++++..||... +.......|.. +. .. |..+
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 999999999998432 11111111100 00 00 0000
Q ss_pred ---CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 843 ---PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 843 ---p~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
.+.++..+.||+.+||+.||.+|. +|+++|+||||.+.
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRi---tAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRI---TAEDALKHPFFDEA 387 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcc---cHHHHhcCcCCcch
Confidence 123456899999999999999999 99999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=246.08 Aligned_cols=212 Identities=43% Similarity=0.769 Sum_probs=186.2
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCCh
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL 676 (1003)
||.|++|.||++....+++.+++|++....... ....+.+|+.+++.+.|++|+++++.+......+++||++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653221 346788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCccC
Q 001856 677 YSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (1003)
Q Consensus 677 ~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~~~~~s~ddls~p~~sg 754 (1003)
.+++... ..++...+..++.+++.+|+|||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK----------- 147 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc-----------
Confidence 9999876 57899999999999999999999999999999999999999 8999999999987411000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhh
Q 001856 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 833 (1003)
Q Consensus 755 ttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl 833 (1003)
.......+...|++||.+... .++.+.|+|+||+++|+|
T Consensus 148 --------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------- 187 (215)
T cd00180 148 --------------------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------- 187 (215)
T ss_pred --------------------chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------
Confidence 012235678889999999887 788999999999999999
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 001856 834 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878 (1003)
Q Consensus 834 ~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHP 878 (1003)
..+.+++.+||+.||.+|| ++.++++|+
T Consensus 188 --------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 --------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred --------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 6789999999999999999 999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=251.64 Aligned_cols=214 Identities=45% Similarity=0.752 Sum_probs=183.4
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
|.+.+.||.|++|.||+|.+..+++.+|+|++...... ...+.+.+|+..+..++|+|++++++.+......|+++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999865432 2457888999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 001856 671 LNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~-LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~ 749 (1003)
+++++|.+++..... +++..+..++.+++.+|.|||++|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999988766 8999999999999999999999999999999999999999999999999987411000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhh-ccCCCCccceeechhHHHHHHHhCCCCCCC--CChh
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIVGIPPFNA--EHPQ 826 (1003)
Q Consensus 750 p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL-~g~~ys~kSDIWSLGVILYELLTGk~PF~~--~~~~ 826 (1003)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+..
T Consensus 153 ------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~ 208 (225)
T smart00221 153 ------------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTS 208 (225)
T ss_pred ------------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHH
Confidence 0012345788899999999 667788899999999999999999999987 4444
Q ss_pred hHHHhhhhcC
Q 001856 827 QIFDNILNRK 836 (1003)
Q Consensus 827 ei~qkIl~~~ 836 (1003)
.+.+.+..+.
T Consensus 209 ~~~~~~~~~~ 218 (225)
T smart00221 209 LLSDVWSFGV 218 (225)
T ss_pred HHHHHHhcCC
Confidence 6666666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=283.65 Aligned_cols=244 Identities=24% Similarity=0.425 Sum_probs=190.2
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCcEEEEEeeeeccc--
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE-- 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~--L~HPnIVkL~~~f~d~~-- 662 (1003)
.+...++++.||+|.||.||+|+. +++.||||++.. ...+.+.+|.+|... ++|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 356688889999999999999987 469999999864 345788899998765 58999999997765544
Q ss_pred --eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------cCceeccCCCcceeecCCCcEEEe
Q 001856 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS---------LRVVHRDLKPDNLLIAHDGHIKLT 731 (1003)
Q Consensus 663 --~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs---------~GIIHRDIKPeNILLd~dG~VKLi 731 (1003)
.++||+||.+.|+|.++|.. ..++.....+++.-+++||+|||+ ..|+|||||..|||+..++...|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 68999999999999999987 468999999999999999999995 369999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC-C-----ccceeec
Q 001856 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-G-----TTADWWS 805 (1003)
Q Consensus 732 DFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-s-----~kSDIWS 805 (1003)
|||||...... .........+||.+|||||++.+.-. . .+.||||
T Consensus 359 DFGLAl~~~p~-----------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYa 409 (534)
T KOG3653|consen 359 DFGLALRLEPG-----------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYA 409 (534)
T ss_pred ccceeEEecCC-----------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHH
Confidence 99999852210 00111234799999999999986421 1 3689999
Q ss_pred hhHHHHHHHhCC------------CCCC-----CCChhhHHHhhhhcCCCCCCCCCC-----CCHHHHHHHHhhccCCcC
Q 001856 806 VGIILFELIVGI------------PPFN-----AEHPQQIFDNILNRKIPWPRVPEE-----MSPEAHDLIDRFLTEDPH 863 (1003)
Q Consensus 806 LGVILYELLTGk------------~PF~-----~~~~~ei~qkIl~~~~~~P~lp~~-----iS~elkDLIrrcL~kDP~ 863 (1003)
+|.+||||++.. .||. ....+++...++..+ ..|.++.. --.-+++.|..||..||+
T Consensus 410 mgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK-~RP~~p~~W~~h~~~~~l~et~EeCWDhDae 488 (534)
T KOG3653|consen 410 MGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK-QRPKIPDAWRKHAGMAVLCETIEECWDHDAE 488 (534)
T ss_pred HHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc-cCCCChhhhhcCccHHHHHHHHHHHcCCchh
Confidence 999999999743 2342 233445544444433 23444432 235688999999999999
Q ss_pred CcCCCC
Q 001856 864 QRLGSG 869 (1003)
Q Consensus 864 kRpg~~ 869 (1003)
.|++++
T Consensus 489 ARLTA~ 494 (534)
T KOG3653|consen 489 ARLTAG 494 (534)
T ss_pred hhhhhH
Confidence 999543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=294.84 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=206.9
Q ss_pred eEEEEEeeccCceEEEEEEECCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyL 666 (1003)
.+..++||.|+||+||+|.+...|+ +||+|++..... .+....++.|+-+|.+++|||+++|++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 6667899999999999999876554 789998865432 334567899999999999999999999998776 889
Q ss_pred EEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCC
Q 001856 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~d 745 (1003)
|++|+++|+|.++++.+ +.+.......|..||+.|+.|||.+++|||||-.+|||+..-.++||+|||+|+.... +
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~---d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP---D 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc---c
Confidence 99999999999999865 5799999999999999999999999999999999999999999999999999985211 1
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLT-Gk~PF~~~~ 824 (1003)
... .......-.+.|||=|.+....|+.++||||+||++||++| |..||.+..
T Consensus 852 ~~e--------------------------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 852 EKE--------------------------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccc--------------------------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 111 01111223457999999999999999999999999999997 999999998
Q ss_pred hhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 825 ~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELL 875 (1003)
..++-.-+..+.. ...|+.++.++.-++.+||-.|+..|| +++++.
T Consensus 906 ~~eI~dlle~geR--LsqPpiCtiDVy~~mvkCwmid~~~rp---~fkel~ 951 (1177)
T KOG1025|consen 906 AEEIPDLLEKGER--LSQPPICTIDVYMVMVKCWMIDADSRP---TFKELA 951 (1177)
T ss_pred HHHhhHHHhcccc--CCCCCCccHHHHHHHHHHhccCcccCc---cHHHHH
Confidence 8887666555443 345778999999999999999999999 555443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=258.31 Aligned_cols=216 Identities=31% Similarity=0.552 Sum_probs=178.3
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeeccceEE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVkL~~~f~d~~~ly 665 (1003)
.-++...+..||+|+||.|-+.++..+|...|+|.+...- .....++.++|+++..+ ...|++|.+|+.+.....++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3456777889999999999999999999999999987543 23445778889988655 57999999999999999999
Q ss_pred EEEEeccCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCcceeecCCCcEEEeecCCccccc
Q 001856 666 LVMEYLNGGDLYSLL----RNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L----~~~g~LsEe~ar~Ia~QIL~ALeYLHs~-GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~ 740 (1003)
+.||.|.. +|..+. .+.+.++|..+-.++..++.||+|||++ .|||||+||+||||+.+|+||+||||++-. .
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~-L 199 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY-L 199 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee-e
Confidence 99999965 775544 4557899999999999999999999975 899999999999999999999999999863 1
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc----CCCCccceeechhHHHHHHHhC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g----~~ys~kSDIWSLGVILYELLTG 816 (1003)
.++ -......|--.|||||.+.. .+|+-++||||||++++||.++
T Consensus 200 ~dS-------------------------------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 200 VDS-------------------------------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred hhh-------------------------------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence 110 01112457778999999863 4789999999999999999999
Q ss_pred CCCCC-CCChhhHHHhhhhcCC
Q 001856 817 IPPFN-AEHPQQIFDNILNRKI 837 (1003)
Q Consensus 817 k~PF~-~~~~~ei~qkIl~~~~ 837 (1003)
+.||. ..++.+.+.+++....
T Consensus 249 r~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 249 RFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cccccccCCHHHHHHHHhcCCC
Confidence 99996 4677778888877654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=273.93 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=192.2
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCcEEEEEeeeeccc--
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE-- 662 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~--L~HPnIVkL~~~f~d~~-- 662 (1003)
.-.+.++++.||+|.||.||+|+++ |..||||++...+ .....+|.+|.+. |+|+||+.++++-..++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3456999999999999999999995 7889999987542 3567788888876 59999999997755433
Q ss_pred --eEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-----c---CceeccCCCcceeecCCCcEEEee
Q 001856 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-----L---RVVHRDLKPDNLLIAHDGHIKLTD 732 (1003)
Q Consensus 663 --~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-----~---GIIHRDIKPeNILLd~dG~VKLiD 732 (1003)
.+|||++|.+.|+|+++|.+ ..++.+....++.-++.||++||. + .|.|||||..|||+..+|...|+|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 59999999999999999988 678999999999999999999994 2 499999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC----C-C-ccceeech
Q 001856 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----H-G-TTADWWSV 806 (1003)
Q Consensus 733 FGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~----y-s-~kSDIWSL 806 (1003)
||||....... +. -.-..+..+||-+|||||++...- + + ..+|||||
T Consensus 360 LGLAv~h~~~t-~~--------------------------idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf 412 (513)
T KOG2052|consen 360 LGLAVRHDSDT-DT--------------------------IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF 412 (513)
T ss_pred ceeeEEecccC-Cc--------------------------ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence 99997421110 00 012345679999999999997532 1 1 35899999
Q ss_pred hHHHHHHHh-----C-----CCCCCC-----CChhhHHHhhhhcCCCCCCCCCCCC-----HHHHHHHHhhccCCcCCcC
Q 001856 807 GIILFELIV-----G-----IPPFNA-----EHPQQIFDNILNRKIPWPRVPEEMS-----PEAHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 807 GVILYELLT-----G-----k~PF~~-----~~~~ei~qkIl~~~~~~P~lp~~iS-----~elkDLIrrcL~kDP~kRp 866 (1003)
|.++||+.. | ++||++ .+.+++.+-+.-.+. .|.+|..++ ..+..+++.||..||.-|+
T Consensus 413 gLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~-RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 413 GLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKL-RPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred HHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeeccc-CCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 999999985 2 578864 334444443333332 233443322 2456789999999999999
Q ss_pred CCCCHHHHHc
Q 001856 867 GSGGASEVKQ 876 (1003)
Q Consensus 867 g~~SAeELLq 876 (1003)
||-.|++
T Consensus 492 ---tALriKK 498 (513)
T KOG2052|consen 492 ---TALRIKK 498 (513)
T ss_pred ---HHHHHHH
Confidence 7766654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-26 Score=233.17 Aligned_cols=260 Identities=40% Similarity=0.697 Sum_probs=209.5
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC-cEEEEEeeeeccceEEEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HP-nIVkL~~~f~d~~~lyLVmE 669 (1003)
|.+.+.||.|+||.||++.+. ..+++|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999987 78999999876554444578899999999999988 79999999988888999999
Q ss_pred eccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC-cEEEeecCCccccccCCCC
Q 001856 670 YLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g---~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG-~VKLiDFGLAk~~~~~s~d 745 (1003)
++.+++|.+++.... .+++..+..++.|++.+|.|+|+.|++||||||+|||++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887765 799999999999999999999999999999999999999988 7999999998731100000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhcc---CCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 746 dls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g---~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.. ........+||+.|+|||.+.+ ..+....|+||+|++++++++|..||..
T Consensus 159 -------------------~~------~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 159 -------------------SS------IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred -------------------cc------ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 00 0012356789999999999988 5788999999999999999999999877
Q ss_pred CCh----hhHHHhhhhcCCC-CC-CCCCCC----CHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 823 EHP----QQIFDNILNRKIP-WP-RVPEEM----SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 823 ~~~----~ei~qkIl~~~~~-~P-~lp~~i----S~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
... ......+.....+ .. ...... ...+.+++.+++..+|..|. +..+...++|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~---~~~~~~~~~~~~ 279 (384)
T COG0515 214 EKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL---SSSSDLSHDLLA 279 (384)
T ss_pred CCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC---CHHHHhhchHhh
Confidence 663 4555555444432 11 111111 25799999999999999999 777777775554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=298.34 Aligned_cols=223 Identities=17% Similarity=0.193 Sum_probs=153.1
Q ss_pred CcEEEEEeee-------eccceEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcce
Q 001856 649 PFVVRFFYSF-------TCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (1003)
Q Consensus 649 PnIVkL~~~f-------~d~~~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNI 720 (1003)
+||++++++| .....++++|||+ +++|.+++... ..+++..++.|++||+.||+|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4677777766 2234678889987 55999999753 5699999999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCC--Ccc--chhhhhhh---hhhccccccCCCCCCCchhhc
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE--EPQ--LTASEHQQ---ERRKKRSAVGTPDYLAPEILL 793 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~--~p~--lt~~~~~~---~~~~~~s~vGTp~YmAPEVL~ 793 (1003)
||+..|.+|++|||++......... ........+.... ... ........ ........+||+.|||||++.
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~---~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDA---TTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred EEcccCcEEEeeccccCcccccccC---cccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9998888888888887632110000 0000000000000 000 00000000 000112357999999999999
Q ss_pred cCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 001856 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 794 g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeE 873 (1003)
+..|+.++|||||||+||||++|.+||.... ..+..+..... +.......+...+++.+||+++|.+|| ++.|
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rp---s~~e 261 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRP---SMSE 261 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCc---ChHH
Confidence 9999999999999999999999999876432 12222222211 111112345678999999999999999 9999
Q ss_pred HHcCCCCCC
Q 001856 874 VKQHVFFKD 882 (1003)
Q Consensus 874 LLqHPFFk~ 882 (1003)
+++||||..
T Consensus 262 il~h~~~~~ 270 (793)
T PLN00181 262 LLQSEFINE 270 (793)
T ss_pred Hhhchhhhh
Confidence 999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=253.61 Aligned_cols=240 Identities=27% Similarity=0.424 Sum_probs=186.8
Q ss_pred cCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEE-eeeeccceEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFF-YSFTCRENLY 665 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~-~~f~d~~~ly 665 (1003)
.+.|.+.+.||+|-||.+.+|+++.++..+++|.+.+... ....|.+|...--.| .|.||+.-| ..|++.+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3569999999999999999999999999999999987643 345677777664444 488999877 4578888999
Q ss_pred EEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC--CCcEEEeecCCccccccCC
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~--dG~VKLiDFGLAk~~~~~s 743 (1003)
++|||++-|+|..-+.. ..+.|...+.++.|++.||.|||++++||||||.+||||-. .-.|||||||+.+..
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~---- 173 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV---- 173 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc----
Confidence 99999999999988876 45889999999999999999999999999999999999954 358999999998730
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC---C--CCccceeechhHHHHHHHhCCC
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---G--HGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~---~--ys~kSDIWSLGVILYELLTGk~ 818 (1003)
|++. ...--+..|.+||+.... . ..+.+|+|.||+++|.+|||++
T Consensus 174 ----------g~tV--------------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 174 ----------GTTV--------------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred ----------Ccee--------------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 0000 011234569999987532 2 3678999999999999999999
Q ss_pred CCCCCCh----hhHHHhhhhcC-CCCCCCCCCCCHHHHHHHHhhccCCcCCcC
Q 001856 819 PFNAEHP----QQIFDNILNRK-IPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 819 PF~~~~~----~ei~qkIl~~~-~~~P~lp~~iS~elkDLIrrcL~kDP~kRp 866 (1003)
||..... ---+.+-..+. ...|.....+|+.+..+.++.|+.++++|-
T Consensus 224 PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 224 PWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred cchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 9973221 11122222222 233444456899999999999999999994
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=231.10 Aligned_cols=161 Identities=26% Similarity=0.319 Sum_probs=130.0
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 001856 674 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (1003)
Q Consensus 674 GSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~ 752 (1003)
|+|.+++... +.+++..++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~------------ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT------------ 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec------------
Confidence 6899999874 56999999999999999999999998 999999999999999 99987410
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCCCCh-hhHHHh
Q 001856 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP-QQIFDN 831 (1003)
Q Consensus 753 sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~-~ei~qk 831 (1003)
.....||+.|||||++.+..|+.++|||||||++|||++|..||..... ...+..
T Consensus 61 ------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 116 (176)
T smart00750 61 ------------------------PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI 116 (176)
T ss_pred ------------------------cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH
Confidence 0112689999999999999999999999999999999999999976543 233344
Q ss_pred hhhcCCCC-C---CCCCCCCH--HHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 832 ILNRKIPW-P---RVPEEMSP--EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 832 Il~~~~~~-P---~lp~~iS~--elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
+....... + ..+..++. ++.+||.+||..+|.+|| ++.++++|+|+.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 117 LLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred HHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 43322211 0 01123334 699999999999999999 999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=242.56 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=205.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCC-----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-c
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-E 662 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk-----~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-~ 662 (1003)
.++++...+-+|.||.||.|.+++... .|-+|.++.. ...-++..++.|.-++..+.|||+..+.++.... .
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 458888889999999999998765332 3445655432 3455678889999999999999999998887654 4
Q ss_pred eEEEEEEeccCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL--------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~d~L~~~--------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
..+.++.++.-|+|..++... +.++..+...++.|++.|++|||++||||.||..+|.+|++.-+|||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 678888999999999999721 347788888899999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHH
Q 001856 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 735 LAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELL 814 (1003)
+++-...... .-+|++ .-....||+||.+.+..|+.++|+|||||+||||+
T Consensus 442 LSRDLFP~DY-----------hcLGDn------------------EnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 442 LSRDLFPGDY-----------HCLGDN------------------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred hccccCcccc-----------cccCCC------------------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 9984221111 111221 12345799999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 001856 815 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 815 T-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLq 876 (1003)
| |+.||...++.++...+..+.. ...|.++++++-.++..||+.+|++|| +.+++..
T Consensus 493 tlg~~PyaeIDPfEm~~ylkdGyR--laQP~NCPDeLf~vMacCWallpeeRP---sf~Qlv~ 550 (563)
T KOG1024|consen 493 TLGKLPYAEIDPFEMEHYLKDGYR--LAQPFNCPDELFTVMACCWALLPEERP---SFSQLVI 550 (563)
T ss_pred hcCCCCccccCHHHHHHHHhccce--ecCCCCCcHHHHHHHHHHHhcCcccCC---CHHHHHH
Confidence 8 9999999999999888877653 345779999999999999999999999 6766643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=242.51 Aligned_cols=177 Identities=22% Similarity=0.165 Sum_probs=133.0
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECC-CCCEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCcEEE-EEeeeec
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVR-FFYSFTC 660 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~-tgk~VALKVIkKs~~--~~~~~ie~~lrEi~IL~~L~HPnIVk-L~~~f~d 660 (1003)
....++|++.+.||+|+||+||+|+++. ++..||||++..... ......+.+.+|+.+|..++|+||+. ++..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3445779999999999999999999876 678889998753211 12334567899999999999999985 5432
Q ss_pred cceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccC-CCcceeecCCCcEEEeecCCcccc
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL-KPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDI-KPeNILLd~dG~VKLiDFGLAk~~ 739 (1003)
+..|||||||+|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 45799999999999973 211 11 1467899999999999999999999 999999999999999999999852
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 795 (1003)
Q Consensus 740 ~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~ 795 (1003)
..... . ........-.+.+|++.|+|||.+...
T Consensus 163 ~~~~~----------------~-------~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGA----------------L-------YRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcc----------------h-------hhhhhhhhhhhhhccCccCCcccCChh
Confidence 11000 0 000001122367899999999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=265.89 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=203.3
Q ss_pred EEEEEeeccCceEEEEEEECCCCCEEEEEEeec---cccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 592 eIlk~LG~G~FGtVyLArdk~tgk~VALKVIkK---s~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
.....+|.|++|.|+.+......+.++.|.+.. ...........+..|.-+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999998877777777776542 22223333334667777778899999988777666666555569
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
|||++ +|+.++...+.+....+.-++.||+.||+|||.+||.||||||+|+|+..+|.+||+|||.+.+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e---- 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE---- 475 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc----
Confidence 99999 9999999888899999999999999999999999999999999999999999999999999875321111
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCc-cceeechhHHHHHHHhCCCCCCCCChhh
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVGIPPFNAEHPQQ 827 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~-kSDIWSLGVILYELLTGk~PF~~~~~~e 827 (1003)
.........+|+..|+|||++.+..|.+ .+||||.|++++.|.+|+.||......+
T Consensus 476 -----------------------~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 476 -----------------------KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred -----------------------hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 0012334689999999999999999964 6899999999999999999996543332
Q ss_pred HH--HhhhhcCCC----CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 001856 828 IF--DNILNRKIP----WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 828 i~--qkIl~~~~~----~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~Id 884 (1003)
.. ...-..... ...+...++...+.+|.+||+.||.+|. ++++|++.+||+.+.
T Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~---ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 533 NSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI---TIEQILNDEWIRSIE 592 (601)
T ss_pred cchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee---cHHHHhhChHhhhcc
Confidence 21 111111110 0112345788899999999999999999 999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-23 Score=228.98 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=190.3
Q ss_pred CeEEEEEeeccCceEEEEEEECCCC-CEEEEEEeeccccccHHHHHHHHHHHHHHHhcC----CCcEEEEEeee-eccce
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKVLKKADMIRKNAVESILAERDILISVR----NPFVVRFFYSF-TCREN 663 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tg-k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~----HPnIVkL~~~f-~d~~~ 663 (1003)
.|++.++||+|+||.||+|.+..++ ..+|+|+......... ..+..|..++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997764 6899998765432111 14667888888776 26899999999 57778
Q ss_pred EEEEEEeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-----CcEEEeecCCc
Q 001856 664 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-----GHIKLTDFGLS 736 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-----G~VKLiDFGLA 736 (1003)
-||||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|+|||||||.|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 77999988655 579999999999999999999999999999999999999865 36999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhC
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTG 816 (1003)
+....-.... .. ..........+.||..|+++.+..+...+...|+||++.++.+|+.|
T Consensus 175 r~~~~~~~~~--------~~-------------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 175 RRFKYVGDSG--------GN-------------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred ccccccCCCC--------cc-------------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 8311000000 00 00001112356799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHhhhhcCCCC--CCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 001856 817 IPPFNAEHPQQIFDNILNRKIPW--PRVPEEMSPEAHDLIDRFLTEDPHQRLGS 868 (1003)
Q Consensus 817 k~PF~~~~~~ei~qkIl~~~~~~--P~lp~~iS~elkDLIrrcL~kDP~kRpg~ 868 (1003)
..||.+.........+....... .......+.++..+...+-..+...+|.+
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCH
Confidence 99997654322222222211111 11223456778888887777888889843
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=211.63 Aligned_cols=276 Identities=22% Similarity=0.301 Sum_probs=209.4
Q ss_pred cccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeeccceE
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENL 664 (1003)
Q Consensus 586 ~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H-PnIVkL~~~f~d~~~l 664 (1003)
.....|+++++||.|+||.+|+|....+|..||||+-.... ....+..|..+...+++ ..|..+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34578999999999999999999999999999999865432 12345678888888865 6788888888899999
Q ss_pred EEEEEeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC---CcEEEeecCCccccc
Q 001856 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGL 740 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~-~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d---G~VKLiDFGLAk~~~ 740 (1003)
.|||+++ |.+|.++..- ...++...+..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 6688887753 3568999999999999999999999999999999999999754 468999999998521
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCC
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF 820 (1003)
...+ ......+..+...||.+|.+-....+...+...|+=|+|.+|..+..|..||
T Consensus 166 d~~t------------------------~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW 221 (341)
T KOG1163|consen 166 DIRT------------------------RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW 221 (341)
T ss_pred cccc------------------------cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence 1100 0011123345678999999988888888899999999999999999999999
Q ss_pred CCC---ChhhHHHhhhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC-------CCCChhHH
Q 001856 821 NAE---HPQQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF-------KDINWDTL 888 (1003)
Q Consensus 821 ~~~---~~~ei~qkIl~~~~~~P--~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF-------k~Idw~~L 888 (1003)
.+. +..+-+++|...+...| .+-.+++.++.-.|.-|-..--++-|.+.=..++..--|+ --.||+.+
T Consensus 222 Qglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~l 301 (341)
T KOG1163|consen 222 QGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTML 301 (341)
T ss_pred cccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHH
Confidence 864 44556777776665433 2346788888888887777666666643222333222222 12588887
Q ss_pred hhh
Q 001856 889 ARQ 891 (1003)
Q Consensus 889 ~~~ 891 (1003)
.++
T Consensus 302 kqk 304 (341)
T KOG1163|consen 302 KQK 304 (341)
T ss_pred HHH
Confidence 654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=205.43 Aligned_cols=141 Identities=25% Similarity=0.214 Sum_probs=111.2
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHH-----------------------HHHHHHHHHHHHHhcCCCc
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN-----------------------AVESILAERDILISVRNPF 650 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~-----------------------~ie~~lrEi~IL~~L~HPn 650 (1003)
...||+|+||.||+|.+. +|+.||||+++........ ......+|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 8999999999765321111 0123345999999998776
Q ss_pred EEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCcceeecCCCcEE
Q 001856 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIK 729 (1003)
Q Consensus 651 IVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYL-Hs~GIIHRDIKPeNILLd~dG~VK 729 (1003)
+...+... ... .+|||||++|++|...+.+.+.+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPIL-LKS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEE-ecC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 64332221 222 389999999988876655557899999999999999999999 799999999999999998 58899
Q ss_pred EeecCCccc
Q 001856 730 LTDFGLSKV 738 (1003)
Q Consensus 730 LiDFGLAk~ 738 (1003)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999973
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=213.78 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=191.8
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLVm 668 (1003)
.|++.++||+|+||..++|.+.-++++||||.-.... ..-.+..|....+.|. .++|...|++.++..+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 5999999999999999999999999999999854322 2245566777777764 689999999999999999999
Q ss_pred EeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-----CcEEEeecCCccccccC
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-----GHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-----G~VKLiDFGLAk~~~~~ 742 (1003)
|++ |-+|.++..-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||..- ..|.|+|||+|+...-.
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 998 66888888654 469999999999999999999999999999999999999753 35899999999952211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCCCCC
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 743 s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~PF~~ 822 (1003)
.+ ......+...+..||.+||+-...+|...+..-|+=|||-+++.+|.|..||.+
T Consensus 183 ~T------------------------kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 183 KT------------------------KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred cc------------------------cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 11 111123445678899999999999999999999999999999999999999975
Q ss_pred ---CChhhHHHhhhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcC
Q 001856 823 ---EHPQQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 823 ---~~~~ei~qkIl~~~~~~P--~lp~~iS~elkDLIrrcL~kDP~kRp 866 (1003)
.+..+-|++|=..+..-| .+..+++.++..-++-.-..+-.+-|
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 455666777754443222 23345666665555433333333444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=196.39 Aligned_cols=141 Identities=23% Similarity=0.148 Sum_probs=112.5
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH-----------------------HHHHHHHHHHHHHHhcCCCc
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-----------------------NAVESILAERDILISVRNPF 650 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~-----------------------~~ie~~lrEi~IL~~L~HPn 650 (1003)
.+.||+|+||.||+|++. +|+.||||++........ .......+|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999986521100 01223457899999999988
Q ss_pred EEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcEE
Q 001856 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIK 729 (1003)
Q Consensus 651 IVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VK 729 (1003)
|......... ..||||||++|+++.........++...+..++.|++.+|.+||. +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7544333222 248999999998665543344678889999999999999999999 9999999999999998 89999
Q ss_pred EeecCCccc
Q 001856 730 LTDFGLSKV 738 (1003)
Q Consensus 730 LiDFGLAk~ 738 (1003)
|+|||+|+.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=203.74 Aligned_cols=138 Identities=17% Similarity=0.201 Sum_probs=115.1
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHH------HHHHHHHHHhcCCCcEEEEEeeeecc-
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES------ILAERDILISVRNPFVVRFFYSFTCR- 661 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~------~lrEi~IL~~L~HPnIVkL~~~f~d~- 661 (1003)
.+|++++.||.|+||.||++.. ++..+|+|++............. +.+|+..+.++.||+|..+...+...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5799999999999999999765 46689999997654444444444 57899999999999999998886643
Q ss_pred -------ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 662 -------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 662 -------~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
...+|+|||++|.+|.++.. +++ ....+|+.+|..||..||+||||||+||+++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 35899999999999988732 333 2456999999999999999999999999999988 9999999
Q ss_pred Ccc
Q 001856 735 LSK 737 (1003)
Q Consensus 735 LAk 737 (1003)
..+
T Consensus 180 ~~~ 182 (232)
T PRK10359 180 GKR 182 (232)
T ss_pred Ccc
Confidence 876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=206.65 Aligned_cols=234 Identities=26% Similarity=0.375 Sum_probs=151.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-----------CcEEEEE---
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-----------PFVVRFF--- 655 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H-----------PnIVkL~--- 655 (1003)
.+...+.||.|+|+.||.+++..||+.+|+|++...........+.+.+|.-....+.+ ..++.+-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36778899999999999999999999999999876554444556666666544433222 1122111
Q ss_pred -----eeeecc---c-----eEEEEEEeccCCChHHHHHh---cCCC---CHHHHHH-HHHHHHHHHHHHhhcCceeccC
Q 001856 656 -----YSFTCR---E-----NLYLVMEYLNGGDLYSLLRN---LGCL---DEDVARV-YIAEVVLALEYLHSLRVVHRDL 715 (1003)
Q Consensus 656 -----~~f~d~---~-----~lyLVmEy~~GGSL~d~L~~---~g~L---sEe~ar~-Ia~QIL~ALeYLHs~GIIHRDI 715 (1003)
.++... . +.+++|+-+. ++|.+++.. .... ....++. +..|++..+++||+.||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 011111 1 3477888774 488877642 2222 1223333 3479999999999999999999
Q ss_pred CCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC
Q 001856 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 795 (1003)
Q Consensus 716 KPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~ 795 (1003)
||+|++++.+|.++|+||+..... + ........+..|.+||.....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~--------------g--------------------~~~~~~~~~~~~~PPe~~~~~ 217 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA--------------G--------------------TRYRCSEFPVAFTPPELESCA 217 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET--------------T--------------------EEEEGGGS-TTTS-HHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec--------------C--------------------ceeeccCCCcccCChhhhhhh
Confidence 999999999999999999876520 0 000112345779999987542
Q ss_pred --------CCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCc
Q 001856 796 --------GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 796 --------~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kR 865 (1003)
.++.+.|.|+||+++|.|.+|..||........... .|.... ++++.+++||++||++||.+|
T Consensus 218 ~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 218 GQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 368899999999999999999999987654433221 233333 788999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-22 Score=238.97 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=185.1
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccc-cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~-~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+|...+.||.+.|=+|.+|++.+ |. |++||+-+.. ...-....+.+.|+. ...++|||++.+.-+-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68899999999999999999853 44 9999987654 223333334444555 56678999999988878888899999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls 748 (1003)
+|+.. +|++.+...+.+..-+.+.|+.||+.||..+|+.||+|+|||.+||||+.-+.+.|+||..-|...
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY-------- 171 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY-------- 171 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc--------
Confidence 99976 999999998889999999999999999999999999999999999999999999999998655211
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC-----------CCccceeechhHHHHHHHh-C
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIV-G 816 (1003)
Q Consensus 749 ~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~-----------ys~kSDIWSLGVILYELLT-G 816 (1003)
+.-|+-..++.+. .+-.--..|+|||.+.... .+++.||||+||++.||++ |
T Consensus 172 --------LPeDNPadf~fFF--------DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg 235 (1431)
T KOG1240|consen 172 --------LPEDNPADFTFFF--------DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG 235 (1431)
T ss_pred --------CCCCCcccceEEE--------ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC
Confidence 1111111111100 0111223699999986522 4678899999999999997 8
Q ss_pred CCCCCC-----------CChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 817 IPPFNA-----------EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 817 k~PF~~-----------~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
++||.- .+++..+++| -+..++.||..|++.||.+|+ +|++.|+.
T Consensus 236 ~PlF~LSQL~aYr~~~~~~~e~~Le~I-------------ed~~~Rnlil~Mi~rdPs~Rl---SAedyL~~ 291 (1431)
T KOG1240|consen 236 RPLFTLSQLLAYRSGNADDPEQLLEKI-------------EDVSLRNLILSMIQRDPSKRL---SAEDYLQK 291 (1431)
T ss_pred CCcccHHHHHhHhccCccCHHHHHHhC-------------cCccHHHHHHHHHccCchhcc---CHHHHHHh
Confidence 999942 1222222222 123689999999999999999 99999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=208.84 Aligned_cols=271 Identities=27% Similarity=0.389 Sum_probs=187.9
Q ss_pred CCcccCCeEEEEEeeccCceEEEEEEECCCCC-----------------------------------EEEEEEeeccccc
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----------------------------------LFAIKVLKKADMI 628 (1003)
Q Consensus 584 ~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk-----------------------------------~VALKVIkKs~~~ 628 (1003)
.++.+++|++...||+|....||.|+....|. +.|||++-.-+..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 35678999999999999999999987543110 2455654322111
Q ss_pred --cHHHHHHHHHHHH------HH--------Hh--------cCCCcEEEEEeeeecc-----------------------
Q 001856 629 --RKNAVESILAERD------IL--------IS--------VRNPFVVRFFYSFTCR----------------------- 661 (1003)
Q Consensus 629 --~~~~ie~~lrEi~------IL--------~~--------L~HPnIVkL~~~f~d~----------------------- 661 (1003)
.....+.+.+|.- .+ +. -+|||||+++.+|.+.
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 1112222223321 11 11 2599999999888653
Q ss_pred ----ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeec--CCC--cEEEeec
Q 001856 662 ----ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDG--HIKLTDF 733 (1003)
Q Consensus 662 ----~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd--~dG--~VKLiDF 733 (1003)
..+|+||...+. +|..++... ..+....+.+++|+++|+.|||++||.|||+|.+|||+. +++ .+.|+||
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 237999998865 999999763 467777888999999999999999999999999999994 343 5889999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC------Cccceeechh
Q 001856 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSVG 807 (1003)
Q Consensus 734 GLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y------s~kSDIWSLG 807 (1003)
|.+-- +..+.++-|..+. .-..-|....||||+....+- -.++|.|+.|
T Consensus 390 GCcLA---d~~hGlqlpy~S~----------------------~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~G 444 (598)
T KOG4158|consen 390 GCCLA---DDNHGLQLPYESD----------------------EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAG 444 (598)
T ss_pred ceeee---ccccccccccccc----------------------cccCCCcceecchhhhhcCCCCceeeccchhhhhhhh
Confidence 98762 1122222222110 112457778999999875431 2478999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 808 IILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 808 VILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
.+.||+++...||++.....+-.+- -..-.+|.+|..+++.+++|+..+|+.||.+|++..-|..+++--.|..
T Consensus 445 alaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 445 ALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred hhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcC
Confidence 9999999999999874332211111 1223457788999999999999999999999997666667766544443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=191.00 Aligned_cols=203 Identities=20% Similarity=0.231 Sum_probs=143.1
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH-HHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-NAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~-~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLVm 668 (1003)
+.+...|++|+||+|+++.. .+..++.+.+.-...... -....+.+|+++|++++ |++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999998875 567777776654332111 12235789999999995 5789999875 4569999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccC-CCcceeecCCCcEEEeecCCccccccCCCCCC
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL-KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDI-KPeNILLd~dG~VKLiDFGLAk~~~~~s~ddl 747 (1003)
||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~--- 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR--- 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch---
Confidence 99999999765422 1 1357889999999999999999999 79999999999999999999984110000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccC-CCC-ccceeechhHHHHHHHhCCCCCCCCC
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHG-TTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 748 s~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~-~ys-~kSDIWSLGVILYELLTGk~PF~~~~ 824 (1003)
....+.......-... -...++.|+.|+...-. ..+ ...+|++.|+-+|.++|+..|+.+++
T Consensus 148 -------------~~r~L~~rDl~~llk~--~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 -------------WMRLLAREDLRHLLKH--KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred -------------HHHHHHHHHHHHHHHH--HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0000000000000011 12378899999875432 223 57799999999999999999886544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.7e-19 Score=185.31 Aligned_cols=135 Identities=16% Similarity=0.214 Sum_probs=108.4
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-----CCCcEEEEEeeeeccc---eEE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-----RNPFVVRFFYSFTCRE---NLY 665 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-----~HPnIVkL~~~f~d~~---~ly 665 (1003)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999995 7777666 6898865422 2346789999999999 6799999999999874 444
Q ss_pred -EEEEe--ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhcCceeccCCCcceeecCC----CcEEEeecCCcc
Q 001856 666 -LVMEY--LNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL-EYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSK 737 (1003)
Q Consensus 666 -LVmEy--~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~AL-eYLHs~GIIHRDIKPeNILLd~d----G~VKLiDFGLAk 737 (1003)
+|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 558999999976 456666 36688888888 99999999999999999999743 479999954443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=185.11 Aligned_cols=144 Identities=22% Similarity=0.134 Sum_probs=115.4
Q ss_pred CeEEEEEeeccCceEEEEEE-ECCCCCEEEEEEeecccccc---------------------HHHHHHHHHHHHHHHhcC
Q 001856 590 DFEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIR---------------------KNAVESILAERDILISVR 647 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLAr-dk~tgk~VALKVIkKs~~~~---------------------~~~ie~~lrEi~IL~~L~ 647 (1003)
-|++.+.||+|+||.||+|. +..+|+.||||++....... ......+.+|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38889999999999999999 66789999999987543110 001134568999999997
Q ss_pred CC--cEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC-ceeccCCCcceeecC
Q 001856 648 NP--FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAH 724 (1003)
Q Consensus 648 HP--nIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~G-IIHRDIKPeNILLd~ 724 (1003)
+. .+++++.. ...||||||++|++|...+.....+....+..++.||+.+|.+||.+| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455542 235899999999888776644456777778899999999999999999 99999999999999
Q ss_pred CCcEEEeecCCccc
Q 001856 725 DGHIKLTDFGLSKV 738 (1003)
Q Consensus 725 dG~VKLiDFGLAk~ 738 (1003)
++.++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999873
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-19 Score=214.75 Aligned_cols=196 Identities=23% Similarity=0.354 Sum_probs=155.7
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCcEEEEEeeeeccce
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCREN 663 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~---HPnIVkL~~~f~d~~~ 663 (1003)
..+.|.|-+.||+|+||+||+|.+.. |+.||||+-+....-.- .--.+++.+|+ -+.|..+..++.-.+.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34579999999999999999999976 99999999776542211 11122333333 2345555555566677
Q ss_pred EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-------CCcEEEeecCCc
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------DGHIKLTDFGLS 736 (1003)
Q Consensus 664 lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-------dG~VKLiDFGLA 736 (1003)
-+||+||.+.|+|.+++...+.+++..+.+++.|++..++.||.++|||+||||+|+||.. +--++|+|||-|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 7899999999999999998889999999999999999999999999999999999999953 235999999987
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhC
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTG 816 (1003)
.-. +++- ........++|-.+-.+|+..|.++++.+|.|.|+.++|.||.|
T Consensus 849 iDm----------------~lfp-------------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 849 IDM----------------KLFP-------------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred eee----------------eEcC-------------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 520 0000 01234457889999999999999999999999999999999998
Q ss_pred CC
Q 001856 817 IP 818 (1003)
Q Consensus 817 k~ 818 (1003)
+.
T Consensus 900 ~y 901 (974)
T KOG1166|consen 900 KY 901 (974)
T ss_pred HH
Confidence 74
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-18 Score=173.13 Aligned_cols=137 Identities=29% Similarity=0.348 Sum_probs=114.4
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~-----~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
+.||+|++|.||+|.+ .|..+++|+....... .......+.+|..++..+.|++|+....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 6778999986543211 11223567889999999999988776666667778899999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|++|++|.+++..... ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||+++.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875432 7778999999999999999999999999999999 78999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-19 Score=214.16 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=210.0
Q ss_pred cCCeEEEEEeeccCceEEEEEEEC-CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEE
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKR-TTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 588 lddYeIlk~LG~G~FGtVyLArdk-~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~ly 665 (1003)
...|.+.+.||+|+|+.|-++... .....+|+|.+.... .......++..|..+-..+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 456999999999999999998874 344567777765543 33445566777888877777 999999999999999999
Q ss_pred EEEEeccCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-hcCceeccCCCcceeecCCC-cEEEeecCCcccccc
Q 001856 666 LVMEYLNGGDLYSLL-RNLG-CLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLI 741 (1003)
Q Consensus 666 LVmEy~~GGSL~d~L-~~~g-~LsEe~ar~Ia~QIL~ALeYLH-s~GIIHRDIKPeNILLd~dG-~VKLiDFGLAk~~~~ 741 (1003)
++++|..|++++..+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 5554 6788889999999999999999 99999999999999999999 999999999984211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccC-CCCCCCchhhccCC-CCccceeechhHHHHHHHhCCCC
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG-TPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vG-Tp~YmAPEVL~g~~-ys~kSDIWSLGVILYELLTGk~P 819 (1003)
. ..........+| ++.|+|||...+.. .+...|+||.|+++.-|++|..|
T Consensus 178 ~----------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 178 K----------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred c----------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 0 001122345678 99999999999854 47889999999999999999999
Q ss_pred CCCCChhhH-HHhhhhcCCC-CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 820 FNAEHPQQI-FDNILNRKIP-WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 820 F~~~~~~ei-~qkIl~~~~~-~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
+........ +......... -......++..+.+++.++|..+|..|. +.+++..++|+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 230 WDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDNWLSS 291 (601)
T ss_pred ccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc---ccccccccccccc
Confidence 975443322 2222222111 1223567899999999999999999999 9999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-18 Score=184.60 Aligned_cols=242 Identities=20% Similarity=0.337 Sum_probs=194.5
Q ss_pred CcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
+..+.+..++.+|.+...|..|++++.. .-++.|++.......+ ....|..|.-.|+...||||+.+++.+....++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 5667788889999999999999999954 3466788765543322 335677888889999999999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcC-ce-eccCCCcceeecCCCcEEEe--ecCCccc
Q 001856 665 YLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLR-VV-HRDLKPDNLLIAHDGHIKLT--DFGLSKV 738 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~--LsEe~ar~Ia~QIL~ALeYLHs~G-II-HRDIKPeNILLd~dG~VKLi--DFGLAk~ 738 (1003)
.++..||+-|+|+.+++.... ++..++..++..|+.|++|||+.. +| ---|....++|+++-+.+|. |--++..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 999999999999999987643 678899999999999999999874 33 33577888999988766653 2222210
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCC---CccceeechhHHHHHHHh
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIV 815 (1003)
Q Consensus 739 ~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~y---s~kSDIWSLGVILYELLT 815 (1003)
.....-.|.||+||.+...+- -.++|+|||++++||+.|
T Consensus 343 --------------------------------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t 384 (448)
T KOG0195|consen 343 --------------------------------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT 384 (448)
T ss_pred --------------------------------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence 112345788999999987664 357899999999999999
Q ss_pred CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 868 (1003)
Q Consensus 816 Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~ 868 (1003)
...||..-.+.+.-.+|.-.... +.+|++++.....|+.-|+..||.+||.+
T Consensus 385 revpfadlspmecgmkialeglr-v~ippgis~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 385 REVPFADLSPMECGMKIALEGLR-VHIPPGISRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred cccccccCCchhhhhhhhhcccc-ccCCCCccHHHHHHHHHHhcCCCCcCCCc
Confidence 99999999888877777655543 56789999999999999999999999944
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=168.04 Aligned_cols=133 Identities=26% Similarity=0.287 Sum_probs=107.2
Q ss_pred EeeccCceEEEEEEECCCCCEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEe
Q 001856 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~-----~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 670 (1003)
.||+|+||.||+|.. +|..+++|+....... .......+.+|..++..+.|+++......+......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 5788999986542211 122346778899999999887655444444556677999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
++|++|.+++..... .++.||+.+|.+||+.||+|+|++|.|||++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7889999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=168.54 Aligned_cols=136 Identities=20% Similarity=0.208 Sum_probs=107.7
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH-------------------HHHHHHHHHHHHHHhcCCC--
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-------------------NAVESILAERDILISVRNP-- 649 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~-------------------~~ie~~lrEi~IL~~L~HP-- 649 (1003)
|.+.+.||.|+||.||+|... +|+.||||++........ ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999874 799999999765321000 0112356788888888777
Q ss_pred cEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEE
Q 001856 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (1003)
Q Consensus 650 nIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VK 729 (1003)
.++..+. ....|+||||++|++|...... .....++.+|+.++.++|..||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2345899999999998765431 34567889999999999999999999999999999999999
Q ss_pred EeecCCcc
Q 001856 730 LTDFGLSK 737 (1003)
Q Consensus 730 LiDFGLAk 737 (1003)
|+|||++.
T Consensus 166 liDfg~~~ 173 (198)
T cd05144 166 IIDWPQMV 173 (198)
T ss_pred EEECCccc
Confidence 99999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=188.76 Aligned_cols=138 Identities=25% Similarity=0.225 Sum_probs=111.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCCCCEEEEEEeecccc-----ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-----IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~-----~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~l 664 (1003)
.|...+.||+|+||+||++.+... .+++|+...... ......+.+.+|+.++..++|++|+..+.++.+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 356678999999999999987543 344444322111 1122346788999999999999998877777777778
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
++||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999886 346789999999999999999999999999999 678999999999984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=160.94 Aligned_cols=137 Identities=22% Similarity=0.262 Sum_probs=99.1
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHH---------------------HHHHHHHHHHhcCCC--c
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE---------------------SILAERDILISVRNP--F 650 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie---------------------~~lrEi~IL~~L~HP--n 650 (1003)
.+.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 8999999998764322111111 113566666666443 2
Q ss_pred EEEEEeeeeccceEEEEEEeccCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcE
Q 001856 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHI 728 (1003)
Q Consensus 651 IVkL~~~f~d~~~lyLVmEy~~GGSL~d~-L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~V 728 (1003)
+.+.+.. ...++||||++|+.+... +.... . ...++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4445443 235899999999544321 21111 1 16678899999999999999 9999999999999999 8999
Q ss_pred EEeecCCccc
Q 001856 729 KLTDFGLSKV 738 (1003)
Q Consensus 729 KLiDFGLAk~ 738 (1003)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-17 Score=191.17 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=165.5
Q ss_pred CeEEEEEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEe-------eee
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY-------SFT 659 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~-------~f~ 659 (1003)
.+.+.+..+.++++.++..+-..+ ...++-|.... ..........+++-.+....|-+..-+.+ .+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~---d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV---DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhc---cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 455666677777777776554332 22232222111 11122233344444444443333222221 111
Q ss_pred -----ccceEEEEEEeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEe
Q 001856 660 -----CRENLYLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731 (1003)
Q Consensus 660 -----d~~~lyLVmEy~~GGSL~d~L~~~g---~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLi 731 (1003)
...++||.|++|.-.+|.++|.+.. ..+......++.|++.|++| +|.+|||+||.||++..+..+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 1336899999999999999997543 35677788899999999999 999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHH
Q 001856 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811 (1003)
Q Consensus 732 DFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILY 811 (1003)
|||+........ .+. .........+||..||+||.+.+..|+.++||||||+|||
T Consensus 399 DFgl~ts~~~~~-----~~~--------------------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~ 453 (516)
T KOG1033|consen 399 DFGLVTSQDKDE-----TVA--------------------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILA 453 (516)
T ss_pred hhhheeecccCC-----ccc--------------------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHH
Confidence 999976311000 000 0011234568999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 812 ELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 812 ELLT-Gk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
|++. -..+|. ...++..+.++.++ |.+..+ -++-.+|+.+||...|.+|| ++.+.--|+|.
T Consensus 454 EL~~~f~T~~e---r~~t~~d~r~g~ip-~~~~~d-~p~e~~ll~~lls~~p~~RP---~~~~~~~~~~~ 515 (516)
T KOG1033|consen 454 ELLIQFSTQFE---RIATLTDIRDGIIP-PEFLQD-YPEEYTLLQQLLSPSPEERP---SAIEVALHEFL 515 (516)
T ss_pred HHHHHhccHHH---HHHhhhhhhcCCCC-hHHhhc-CcHHHHHHHHhcCCCcccCc---hHHHHhhhhhc
Confidence 9997 333332 22233344444332 122222 24566999999999999999 77777777664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=142.53 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=112.3
Q ss_pred EEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeeccceEEEEEEe
Q 001856 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEY 670 (1003)
Q Consensus 593 Ilk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H--PnIVkL~~~f~d~~~lyLVmEy 670 (1003)
+++.||.|.++.||++.... ..+++|+...... ...+.+|..++..+.| .++++++..+...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999743 7899999865432 3567889999999976 5899999888888889999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---CceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL---RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 671 ~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~---GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||++..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 4556677889999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=158.23 Aligned_cols=137 Identities=20% Similarity=0.327 Sum_probs=106.0
Q ss_pred EEee-ccCceEEEEEEECCCCCEEEEEEeeccccc----------cHHHHHHHHHHHHHHHhcCCCcE--EEEEeeeecc
Q 001856 595 KPIS-RGAFGRVFLAKKRTTGDLFAIKVLKKADMI----------RKNAVESILAERDILISVRNPFV--VRFFYSFTCR 661 (1003)
Q Consensus 595 k~LG-~G~FGtVyLArdk~tgk~VALKVIkKs~~~----------~~~~ie~~lrEi~IL~~L~HPnI--VkL~~~f~d~ 661 (1003)
..|| .||.|+||.+... +..++||.+...... .......+.+|..++..+.|++| +..+......
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888889988763 778999988643221 11233567889999999998774 6666554332
Q ss_pred c----eEEEEEEeccC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 662 E----NLYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 662 ~----~lyLVmEy~~G-GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
. ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 689988865 4566543 568999999999999999999999999999999999999998
Q ss_pred cc
Q 001856 737 KV 738 (1003)
Q Consensus 737 k~ 738 (1003)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=168.51 Aligned_cols=197 Identities=27% Similarity=0.377 Sum_probs=151.0
Q ss_pred HHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCc-eeccCCCcce
Q 001856 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRV-VHRDLKPDNL 720 (1003)
Q Consensus 643 L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~ALeYLHs~GI-IHRDIKPeNI 720 (1003)
|+.+.|.|+.++++.+.+...+++|.+||.-|+|.+.+... ..++.-....++++|+.||+|||.-.| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999873 457777778889999999999998766 9999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCC----
Q 001856 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---- 796 (1003)
Q Consensus 721 LLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~---- 796 (1003)
+++..+.+||+|||+...... ... ..... ...-..-|.|||.+.+..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--~~~--------------~~~~~-------------~~~~~~lw~aPellr~~~~~~~ 131 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--TAE--------------PEAHH-------------PIRKALLWTAPELLRGALSQSL 131 (484)
T ss_pred eeeeeEEEEechhhhcccccc--ccc--------------ccccc-------------hhHHHHhccCHHHhcccccccc
Confidence 999999999999999764210 000 00000 001223589999998642
Q ss_pred ---CCccceeechhHHHHHHHhCCCCCCCC----ChhhHHHhhhhcCC--CCCCCC--CCCCHHHHHHHHhhccCCcCCc
Q 001856 797 ---HGTTADWWSVGIILFELIVGIPPFNAE----HPQQIFDNILNRKI--PWPRVP--EEMSPEAHDLIDRFLTEDPHQR 865 (1003)
Q Consensus 797 ---ys~kSDIWSLGVILYELLTGk~PF~~~----~~~ei~qkIl~~~~--~~P~lp--~~iS~elkDLIrrcL~kDP~kR 865 (1003)
.+.+.|+||+|+++||+++...||... .+.++...+.+... ..|.+. ....+++..+++.||..+|.+|
T Consensus 132 ~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~r 211 (484)
T KOG1023|consen 132 ESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKR 211 (484)
T ss_pred cccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhC
Confidence 356799999999999999999999652 33456656555121 223322 1456689999999999999999
Q ss_pred CCC
Q 001856 866 LGS 868 (1003)
Q Consensus 866 pg~ 868 (1003)
|..
T Consensus 212 Ps~ 214 (484)
T KOG1023|consen 212 PSI 214 (484)
T ss_pred ccH
Confidence 943
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.6e-14 Score=162.34 Aligned_cols=260 Identities=24% Similarity=0.242 Sum_probs=194.6
Q ss_pred CeEEEEEeec--cCceEEEEEEE--CCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceE
Q 001856 590 DFEIIKPISR--GAFGRVFLAKK--RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 590 dYeIlk~LG~--G~FGtVyLArd--k~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~l 664 (1003)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... .....-.+=++|....+.+ .|++.++.+..+...+.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 3777888999 99999999998 8889999999743221 1111112334566666666 489999999999999999
Q ss_pred EEEEEeccCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHhhcCceeccCCCcceeecCC-CcEEEeecCCccc
Q 001856 665 YLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL----ALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKV 738 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~-LsEe~ar~Ia~QIL~----ALeYLHs~GIIHRDIKPeNILLd~d-G~VKLiDFGLAk~ 738 (1003)
|+-+|+|. .+|..+...... +++..++.++.+... ||.++|..+|+|-|+||.||++..+ ...+++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999995 688888877654 899999999999999 9999999999999999999999999 8899999999763
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCC
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (1003)
Q Consensus 739 ~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~ 818 (1003)
... .... ..........|...|++||.+.+. ++...||++||.++.+-.+|..
T Consensus 273 i~~--------~~~~------------------~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 273 ISD--------GNFS------------------SVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred ccC--------Cccc------------------cceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcc
Confidence 100 0000 000111233577889999998765 8899999999999999998876
Q ss_pred CCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 819 PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk~I 883 (1003)
++...... .+..+-+...+ .++....+.++...+..|+..+|..|+ +++.+++|++....
T Consensus 326 ~~~~g~~~-~W~~~r~~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 326 LPSVGKNS-SWSQLRQGYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRL---TAQILTALNVIHSK 385 (524)
T ss_pred cccCCCCC-CccccccccCc-hhhhcCcchhhhhHHHHhcCcchhhhh---HHHHHhccccccch
Confidence 65433111 11122122211 233445677788899999999999999 99999999999854
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-13 Score=161.40 Aligned_cols=144 Identities=24% Similarity=0.375 Sum_probs=97.4
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc--------------------------c-----HHHHHH
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--------------------------R-----KNAVES 635 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~--------------------------~-----~~~ie~ 635 (1003)
.+.+|+. +.||.|++|.||+|+.+.+|+.||||++.+.-.. + .+..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3566887 8999999999999999888999999999753100 0 011223
Q ss_pred HHHHHHH------HHhcC----CCcEEEEEeeeec-cceEEEEEEeccCCChHHH--HHhcC----CCCHHHHHHHHHHH
Q 001856 636 ILAERDI------LISVR----NPFVVRFFYSFTC-RENLYLVMEYLNGGDLYSL--LRNLG----CLDEDVARVYIAEV 698 (1003)
Q Consensus 636 ~lrEi~I------L~~L~----HPnIVkL~~~f~d-~~~lyLVmEy~~GGSL~d~--L~~~g----~LsEe~ar~Ia~QI 698 (1003)
+.+|+++ +.++. +...+.+-.+|.+ ...-+|||||+.|+.|.++ +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3334443 33331 2222222222222 3346799999999999874 33333 24555555666665
Q ss_pred HHHHHHHhhcCceeccCCCcceeecCCC----cEEEeecCCccc
Q 001856 699 VLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKV 738 (1003)
Q Consensus 699 L~ALeYLHs~GIIHRDIKPeNILLd~dG----~VKLiDFGLAk~ 738 (1003)
+ ..|++|+|+||.||+++.+| .++++|||++..
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 4 58999999999999999888 999999999763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4e-12 Score=147.40 Aligned_cols=138 Identities=22% Similarity=0.298 Sum_probs=95.7
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccH-------------------------------HHH------HHHH
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-------------------------------NAV------ESIL 637 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~-------------------------------~~i------e~~l 637 (1003)
+.||.|++|.||+|+.+ +|+.||||+.+......- ... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999974 789999999865310000 000 1234
Q ss_pred HHHHHHHhcC-----CCcE--EEEEeeeeccceEEEEEEeccCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhhc
Q 001856 638 AERDILISVR-----NPFV--VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVL-ALEYLHSL 708 (1003)
Q Consensus 638 rEi~IL~~L~-----HPnI--VkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~-g~LsEe~ar~Ia~QIL~-ALeYLHs~ 708 (1003)
+|...+..+. +++| .++|..+ ....+|||||++|++|.++.... ..++ ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555554442 3433 3333322 33468999999999998876532 1222 2345555555 47889999
Q ss_pred CceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 709 GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|++|+|+||.||+++.+|.++|+|||++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999874
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.5e-12 Score=125.92 Aligned_cols=128 Identities=19% Similarity=0.306 Sum_probs=96.0
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeeccceEEEEEEecc
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn-IVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|..++..+.+.+ +++++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 567899999999999874 77899999754321 1123467888888775544 345554433 23579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCc-----eeccCCCcceeecCCCcEEEeecCCccc
Q 001856 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV-----VHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 673 GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GI-----IHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 01123467899999999999985 9999999999999 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.2e-12 Score=149.40 Aligned_cols=249 Identities=26% Similarity=0.280 Sum_probs=187.0
Q ss_pred ccCCeEEEEEeeccCceEEEEEEEC-CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccceE
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKR-TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk-~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L-~HPnIVkL~~~f~d~~~l 664 (1003)
...+|..+..||.|.|+.|+.+..+ .++..|++|-+.+........ ..-+.|+.+...+ .|.+++.++..|....+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4568999999999999999998866 688899999887643322222 2233455555554 588999999888888899
Q ss_pred EEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC-CcEEEeecCCccccccCC
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d-G~VKLiDFGLAk~~~~~s 743 (1003)
|+-.|||.|+++...+.-...+.+...+....|++.++.++|++.++|+|+||+||++..+ +.-++.|||..+....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-- 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-- 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence 9999999999998888666778999999999999999999999999999999999999886 7788999998752000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCC--CchhhccCCCCccceeechhHHHHHHHhCCCCC-
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL--APEILLGTGHGTTADWWSVGIILFELIVGIPPF- 820 (1003)
Q Consensus 744 ~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~Ym--APEVL~g~~ys~kSDIWSLGVILYELLTGk~PF- 820 (1003)
......++-+++ +|+......+..+.|++|||..+++.++|.+.-
T Consensus 420 --------------------------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 420 --------------------------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred --------------------------------ecccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 001122333344 555555677899999999999999999987532
Q ss_pred CCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 821 ~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFF 880 (1003)
.+.. ...|..+.. |..+ ..+..+..+.+.++..++..|+ .+.++..|.=|
T Consensus 468 ~~~~----~~~i~~~~~--p~~~-~~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~~ 517 (524)
T KOG0601|consen 468 SGVQ----SLTIRSGDT--PNLP-GLKLQLQVLLKVMINPDRKRRP---SAVELSLHSEF 517 (524)
T ss_pred cccc----ceeeecccc--cCCC-chHHhhhhhhhhhcCCccccch---hhhhhcccchh
Confidence 2222 223333333 2233 3348899999999999999999 78888777644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.7e-11 Score=126.05 Aligned_cols=139 Identities=22% Similarity=0.175 Sum_probs=102.0
Q ss_pred EEeeccCceEEEEEEECC------CCCEEEEEEeeccccc-------------------cHHHHHHHH----HHHHHHHh
Q 001856 595 KPISRGAFGRVFLAKKRT------TGDLFAIKVLKKADMI-------------------RKNAVESIL----AERDILIS 645 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~------tgk~VALKVIkKs~~~-------------------~~~~ie~~l----rEi~IL~~ 645 (1003)
..||.|--+.||.|.... .+..+|||+.+..... ..+....+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 3579999998632100 011122333 78999988
Q ss_pred cCC--CcEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCcceee
Q 001856 646 VRN--PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKPDNLLI 722 (1003)
Q Consensus 646 L~H--PnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYL-Hs~GIIHRDIKPeNILL 722 (1003)
+.. -++++++.. ..-+|||||+.+..+..-..+...+++..+..+..+++.+|..| |+.||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 456666654 45689999998755533222334566667778889999999998 89999999999999999
Q ss_pred cCCCcEEEeecCCccc
Q 001856 723 AHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 723 d~dG~VKLiDFGLAk~ 738 (1003)
. ++.+.|+|||.|..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 6 57899999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.4e-11 Score=139.65 Aligned_cols=169 Identities=22% Similarity=0.357 Sum_probs=129.8
Q ss_pred EEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCC
Q 001856 607 LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 686 (1003)
Q Consensus 607 LArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~L 686 (1003)
.|..+.++.+|.+.+++...- ...+.+.+-+..|+.++||||++++..++....+|||+|.+. .|..++++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 456678899999998876532 445567777888999999999999999999999999999985 5777777644
Q ss_pred CHHHHHHHHHHHHHHHHHHh-hcCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccc
Q 001856 687 DEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765 (1003)
Q Consensus 687 sEe~ar~Ia~QIL~ALeYLH-s~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~l 765 (1003)
...+...+.||+.||.||| .++++|++|.-.-|+++..|+.||.+|-++.... +..
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~-------------~~~--------- 159 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS-------------GFN--------- 159 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc-------------cCC---------
Confidence 6777788999999999997 6889999999999999999999999998865210 000
Q ss_pred hhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhC
Q 001856 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 766 t~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTG 816 (1003)
. ......---.|..|+.+.... ...|.|.|||++||++.|
T Consensus 160 -~--------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 -A--------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -c--------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 0 000011112366777654332 567999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.3e-10 Score=116.89 Aligned_cols=141 Identities=18% Similarity=0.246 Sum_probs=106.5
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeecc---ceEEEEE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCR---ENLYLVM 668 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H--PnIVkL~~~f~d~---~~lyLVm 668 (1003)
++.||.|.++.||++... +|+.|++|+....... .....+.+|..++..+.+ .++++++...... +..|+||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 367899999999999874 3688999997654321 123467889999998865 3456677666553 3678999
Q ss_pred EeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-----------------------------------------
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS----------------------------------------- 707 (1003)
Q Consensus 669 Ey~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs----------------------------------------- 707 (1003)
||++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888765532 356677777777777777777773
Q ss_pred ---------------cCceeccCCCcceeecC--CCcEEEeecCCccc
Q 001856 708 ---------------LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ---------------~GIIHRDIKPeNILLd~--dG~VKLiDFGLAk~ 738 (1003)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34699999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.4e-11 Score=129.35 Aligned_cols=214 Identities=23% Similarity=0.354 Sum_probs=152.3
Q ss_pred HHHHHhcCCCcEEEEEeeeeccc-----eEEEEEEeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-
Q 001856 640 RDILISVRNPFVVRFFYSFTCRE-----NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLR- 709 (1003)
Q Consensus 640 i~IL~~L~HPnIVkL~~~f~d~~-----~lyLVmEy~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~G- 709 (1003)
.+-|..+.|-|||+++.++.+.. ...++.|||..|+|.++|++. ..+.....++|.-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455667999999998887654 488999999999999999754 45888889999999999999999985
Q ss_pred -ceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCC
Q 001856 710 -VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788 (1003)
Q Consensus 710 -IIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmA 788 (1003)
|+|+++..+-|++..+|-||+.---... ++ +.+. ......+....|-++|.|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s------~h----~s~~-----------------~~~~~Ek~~~~~~~g~~a 250 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS------TH----PSVN-----------------STREAEKSVNTSLPGFSA 250 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc------cc----hhhh-----------------hhhHhhhhccccCCcccc
Confidence 9999999999999999988873211110 00 0000 001112223457789999
Q ss_pred chhhccCCCCccceeechhHHHHHHHhCCCC-CCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 001856 789 PEILLGTGHGTTADWWSVGIILFELIVGIPP-FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 867 (1003)
Q Consensus 789 PEVL~g~~ys~kSDIWSLGVILYELLTGk~P-F~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg 867 (1003)
||.=.....+-++|||++|....||..+..- -.+.+....-..|.+.-... -..--+++|++||+..|..||
T Consensus 251 ~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l------en~lqr~~i~kcl~~eP~~rp- 323 (458)
T KOG1266|consen 251 PESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL------ENGLQRGSITKCLEGEPNGRP- 323 (458)
T ss_pred CCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec------cCccccCcCcccccCCCCCCc-
Confidence 9976666667899999999999999987643 33333322222222211110 112235789999999999999
Q ss_pred CCCHHHHHcCCCCCCCChhHHh
Q 001856 868 SGGASEVKQHVFFKDINWDTLA 889 (1003)
Q Consensus 868 ~~SAeELLqHPFFk~Idw~~L~ 889 (1003)
++.+++.||.+-++.-.++.
T Consensus 324 --~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 324 --DARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred --chhhhhcCceeeecchHHHH
Confidence 99999999998777655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=113.94 Aligned_cols=134 Identities=27% Similarity=0.278 Sum_probs=100.3
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEee-c----cccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEE
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK-K----ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIk-K----s~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 669 (1003)
..+++|+-+.++++... |..+.+|.=. | ..+..+-..++..+|..++..+.--.|...+-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999763 4456666522 2 222233344677889999988865444444444556667789999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|++|-.|.+.+... .-.++..+-.-+.-||..||||+||.++||++...+ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888764 135677777888889999999999999999997765 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=106.61 Aligned_cols=144 Identities=22% Similarity=0.250 Sum_probs=106.8
Q ss_pred EEEEeeccCceEEEEEEECCCCCEEEEEEe-----eccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEE
Q 001856 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVL-----KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 593 Ilk~LG~G~FGtVyLArdk~tgk~VALKVI-----kKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.+..|-+|+-+.|+++.. .|+.+.||.= ....+..+-...+..+|..+|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999986 5788777752 222233333456788899999887643433333335666667899
Q ss_pred EEeccC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCC---cEEEeecCCccc
Q 001856 668 MEYLNG-GDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 738 (1003)
Q Consensus 668 mEy~~G-GSL~d~L~~~g--~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG---~VKLiDFGLAk~ 738 (1003)
|||++| .++.+++.... .........++.+|-..|.-||..+|||+||..+||++..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 57888886542 233333468899999999999999999999999999997755 358999999873
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.8e-08 Score=102.80 Aligned_cols=126 Identities=24% Similarity=0.280 Sum_probs=83.0
Q ss_pred EEEEEEECCCCCEEEEEEeecccc-----------------------ccHHHHHHHHHHHHHHHhcCCC--cEEEEEeee
Q 001856 604 RVFLAKKRTTGDLFAIKVLKKADM-----------------------IRKNAVESILAERDILISVRNP--FVVRFFYSF 658 (1003)
Q Consensus 604 tVyLArdk~tgk~VALKVIkKs~~-----------------------~~~~~ie~~lrEi~IL~~L~HP--nIVkL~~~f 658 (1003)
.||.|.. ..|..+|||+.+.... ..........+|...|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899987 4678999999764210 0111235677899999999765 566776442
Q ss_pred eccceEEEEEEecc--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhcCceeccCCCcceeecCCCcEEEeecCC
Q 001856 659 TCRENLYLVMEYLN--GGDLYSLLRNLGCLDEDVARVYIAEVVLALEY-LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 659 ~d~~~lyLVmEy~~--GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeY-LHs~GIIHRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
.-+|||||++ |..+..+.... ++.+....++.+++..+.. +|+.||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3379999998 65554433321 2244556677788885555 579999999999999999887 899999999
Q ss_pred cc
Q 001856 736 SK 737 (1003)
Q Consensus 736 Ak 737 (1003)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 87
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.8e-07 Score=102.56 Aligned_cols=131 Identities=15% Similarity=0.099 Sum_probs=91.1
Q ss_pred EEEEEECCCCCEEEEEEeecccccc--H------HHHHHHHHHHHHHHhcCCCc--EEEEEeeeec-----cceEEEEEE
Q 001856 605 VFLAKKRTTGDLFAIKVLKKADMIR--K------NAVESILAERDILISVRNPF--VVRFFYSFTC-----RENLYLVME 669 (1003)
Q Consensus 605 VyLArdk~tgk~VALKVIkKs~~~~--~------~~ie~~lrEi~IL~~L~HPn--IVkL~~~f~d-----~~~lyLVmE 669 (1003)
|+.+.. .|+.|.||......... + .-...+.+|...+..+..-+ ++.+..++.. ....+||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 445443 45678888654322110 0 01113678888887764322 2233333332 235789999
Q ss_pred eccCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecC-------CCcEEEeecCCcc
Q 001856 670 YLNGG-DLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 737 (1003)
Q Consensus 670 y~~GG-SL~d~L~~--~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~-------dG~VKLiDFGLAk 737 (1003)
+++|- +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99885 89999864 245667778899999999999999999999999999999975 4679999999876
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-08 Score=121.58 Aligned_cols=167 Identities=22% Similarity=0.334 Sum_probs=120.2
Q ss_pred HHHHHHHHHhh-cCceeccCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhh
Q 001856 697 EVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775 (1003)
Q Consensus 697 QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~ 775 (1003)
+.+.||.|+|. .++||+.|.|++|.++.+|..||+.|+++...... ++ ..+..+ .+.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~-~~-------~p~~~y---d~~l---------- 165 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGP-TE-------YPFSEY---DPPL---------- 165 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCC-Cc-------cccccC---CCCC----------
Confidence 45599999996 58999999999999999999999999987631110 00 000000 1111
Q ss_pred ccccccCCCCCCCchhhccCCCCccceeechhHHHHHHH-hCCCCCCCCChhhHHHhhhh-cCCCCCCCCCCCCHHHHHH
Q 001856 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILN-RKIPWPRVPEEMSPEAHDL 853 (1003)
Q Consensus 776 ~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELL-TGk~PF~~~~~~ei~qkIl~-~~~~~P~lp~~iS~elkDL 853 (1003)
.....-...|.|||++.+...+.++|++||||++|.+. .|+.-|.+.+....+..-.. ...........+++++++-
T Consensus 166 -p~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 166 -PLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred -ChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHH
Confidence 11123456799999999988899999999999999999 67777765544333322221 1111123346789999999
Q ss_pred HHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 001856 854 IDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888 (1003)
Q Consensus 854 IrrcL~kDP~kRpg~~SAeELLqHPFFk~Idw~~L 888 (1003)
|.++|..++..|| ++.+++.-|||.+..-..|
T Consensus 245 l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aL 276 (700)
T KOG2137|consen 245 LKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKAL 276 (700)
T ss_pred HHHHhcCCcccCc---chhhhhcccccCCchhhhh
Confidence 9999999999999 9999999999997654444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.1e-07 Score=105.97 Aligned_cols=211 Identities=18% Similarity=0.226 Sum_probs=153.1
Q ss_pred ceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc----ceEEEEEEeccC-CCh
Q 001856 602 FGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----ENLYLVMEYLNG-GDL 676 (1003)
Q Consensus 602 FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~----~~lyLVmEy~~G-GSL 676 (1003)
-.+.|+|....+|..|++|.+...+.... .....-+++++++.|+|||++.++|.+. ..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45889999999999999999844332222 1233457789999999999999999853 468999999986 688
Q ss_pred HHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcccccc
Q 001856 677 YSLLRNL---------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 677 ~d~L~~~---------------g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~~~ 741 (1003)
.++.-.. ...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+|+|..-|..-+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 8766321 2367899999999999999999999999999999999999988888876665432110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHHHHhCCCC-C
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP-F 820 (1003)
Q Consensus 742 ~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYELLTGk~P-F 820 (1003)
+. . |-+.+. .+-|.=.||.++..|.||.-- +
T Consensus 446 d~-------------------------------------------~--~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~ 477 (655)
T KOG3741|consen 446 DP-------------------------------------------T--EPLESQ---QQNDLRDLGLLLLALATGTENSN 477 (655)
T ss_pred CC-------------------------------------------C--cchhHH---hhhhHHHHHHHHHHHhhcccccc
Confidence 00 0 112111 356888899999999998532 2
Q ss_pred CCCChhhH-HHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 001856 821 NAEHPQQI-FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 821 ~~~~~~ei-~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqH 877 (1003)
.....+.. ... +....|.+++++|.-+...++.++ ++.+++.|
T Consensus 478 ~~d~~~~s~~~~----------I~~~yS~D~rn~v~yl~s~~~~~k----sI~~llp~ 521 (655)
T KOG3741|consen 478 RTDSTQSSHLTR----------ITTTYSTDLRNVVEYLESLNFREK----SIQDLLPM 521 (655)
T ss_pred cccchHHHHHHH----------hhhhhhHHHHHHHHHHHhcCcccc----cHHHHHHH
Confidence 22222222 111 224578899999999999888763 67888877
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.2e-09 Score=122.43 Aligned_cols=256 Identities=23% Similarity=0.249 Sum_probs=176.1
Q ss_pred CCCCCCCCCCCcccCCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEE
Q 001856 575 RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVR 653 (1003)
Q Consensus 575 ~tsp~~Psk~~~~lddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn-IVk 653 (1003)
..+.|.|.........|...+-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+.
T Consensus 228 TkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~ 298 (829)
T KOG0576|consen 228 TKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVR 298 (829)
T ss_pred hccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCccc
Confidence 4455666666666677888888999999999999876554444 5655432 34456888999999999 777
Q ss_pred EEeeeeccceEEEEEEeccCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEe
Q 001856 654 FFYSFTCRENLYLVMEYLNGG-DLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731 (1003)
Q Consensus 654 L~~~f~d~~~lyLVmEy~~GG-SL~d~L-~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLi 731 (1003)
.++.++.+.+.+++|+++.++ +-...+ ...-.+.+-+...+.+.-+.+|+|+|+.-=+||| |||... +..++.
T Consensus 299 ~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~ 373 (829)
T KOG0576|consen 299 YLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLL 373 (829)
T ss_pred ccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccc
Confidence 778888888999999999887 222111 1111233334445566777899999998778999 777655 678999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHH
Q 001856 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811 (1003)
Q Consensus 732 DFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILY 811 (1003)
||+..... + .....++..+|+.++|||+.....+....|.|++|+--.
T Consensus 374 ~~~v~~~L--------------------------~------~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~ 421 (829)
T KOG0576|consen 374 DFAVPPQL--------------------------T------RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAI 421 (829)
T ss_pred cccCCccc--------------------------C------cccccccCCCCCCCCCchhhcccccccCCCccCCCcchh
Confidence 99876520 0 001356789999999999999999999999999999877
Q ss_pred HHHhCCCCCCCCChhhHHHhhhhcCCCCCCCC--CCCCHHHH-HHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 001856 812 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP--EEMSPEAH-DLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 812 ELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp--~~iS~elk-DLIrrcL~kDP~kRpg~~SAeELLqHPFFk~ 882 (1003)
+|--|-+|-... ....-.+-++. ..+.+. ...++... ++...|+...|..|+ .+..++.|.+|.+
T Consensus 422 ~~ap~~pPr~~P--~~~~~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk---v~mgacfsKvfng 489 (829)
T KOG0576|consen 422 QMAPGLPPRSSP--PAVLPMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK---VHMGACFSKVFNG 489 (829)
T ss_pred hcCCCCCCCCCC--ccccCCCCCCC-CccccchhhhcCcccccCCcccccCCCCCCCc---chhhHHHHHHhcc
Confidence 888888776441 11111111111 011110 11122222 477889999999998 8889999998875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.7e-07 Score=95.69 Aligned_cols=105 Identities=26% Similarity=0.300 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHhcCCC--cEEEEEeeeecc----ceEEEEEEeccCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 001856 634 ESILAERDILISVRNP--FVVRFFYSFTCR----ENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706 (1003)
Q Consensus 634 e~~lrEi~IL~~L~HP--nIVkL~~~f~d~----~~lyLVmEy~~GG-SL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLH 706 (1003)
....+|...+..+..- .+++.+.+.... ...|||+|+++|- +|.+++.....++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4567788777766432 233344444332 2468999999984 89999987656788888899999999999999
Q ss_pred hcCceeccCCCcceeecCCC---cEEEeecCCccc
Q 001856 707 SLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 738 (1003)
Q Consensus 707 s~GIIHRDIKPeNILLd~dG---~VKLiDFGLAk~ 738 (1003)
..||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.5e-07 Score=97.69 Aligned_cols=137 Identities=23% Similarity=0.242 Sum_probs=101.5
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc-----------------c--HHHHHHHHHHHHHHHhcCCC--
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----------------R--KNAVESILAERDILISVRNP-- 649 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~-----------------~--~~~ie~~lrEi~IL~~L~HP-- 649 (1003)
+.+...||-|.-|.||.|.+. .|.++|||.-+..... . .-......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456678999999999999985 7899999974321100 0 01123566788899888654
Q ss_pred cEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEE
Q 001856 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (1003)
Q Consensus 650 nIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VK 729 (1003)
.|++.+++ +.-.+||||+.|-.|...- ++.+....++..|+.-+.-+-..||||+|+.+-|||++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 56666543 5568999999997665432 23455556677777777777799999999999999999999999
Q ss_pred EeecCCcc
Q 001856 730 LTDFGLSK 737 (1003)
Q Consensus 730 LiDFGLAk 737 (1003)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.4e-06 Score=83.43 Aligned_cols=138 Identities=27% Similarity=0.377 Sum_probs=82.7
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEeeeec---cceEEEEE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYSFTC---RENLYLVM 668 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HP--nIVkL~~~f~d---~~~lyLVm 668 (1003)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..++..+... .+.+++..... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999854 58999986543 3445667888888777432 35566653322 33579999
Q ss_pred EeccCCChHH----------------HHH---hc--C--CCCHHH------HHHH---------------HHHHHH-HHH
Q 001856 669 EYLNGGDLYS----------------LLR---NL--G--CLDEDV------ARVY---------------IAEVVL-ALE 703 (1003)
Q Consensus 669 Ey~~GGSL~d----------------~L~---~~--g--~LsEe~------ar~I---------------a~QIL~-ALe 703 (1003)
++++|..+.. .+. .. . .+.... .... ...+.. .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0 011000 0000 111222 233
Q ss_pred HHh-------hcCceeccCCCcceeec-CCCcEEEeecCCccc
Q 001856 704 YLH-------SLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKV 738 (1003)
Q Consensus 704 YLH-------s~GIIHRDIKPeNILLd-~dG~VKLiDFGLAk~ 738 (1003)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 35699999999999999 667778999998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.1e-06 Score=88.12 Aligned_cols=138 Identities=22% Similarity=0.324 Sum_probs=90.8
Q ss_pred CCeEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHH------HHHHHHHHhcCC---CcEEEEEeee-
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI------LAERDILISVRN---PFVVRFFYSF- 658 (1003)
Q Consensus 589 ddYeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~------lrEi~IL~~L~H---PnIVkL~~~f- 658 (1003)
.+|.+++++-......|.+-.- .|+.|.+|...............+ .+++..+..+.. -....++.+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 5699999999888888888764 578899998765332222222211 223333333321 1222222222
Q ss_pred ----eccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecC
Q 001856 659 ----TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (1003)
Q Consensus 659 ----~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFG 734 (1003)
.-....+|+|||++|..|.++.. +++ .+...|..++.-||+.|++|+|++|.|+++..++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 12234578999999988766532 333 2445677889999999999999999999998655 9999998
Q ss_pred Ccc
Q 001856 735 LSK 737 (1003)
Q Consensus 735 LAk 737 (1003)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.8e-06 Score=95.39 Aligned_cols=230 Identities=16% Similarity=0.268 Sum_probs=146.9
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEE--------EEeeeeccceE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVR--------FFYSFTCRENL 664 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~-L~HPnIVk--------L~~~f~d~~~l 664 (1003)
.+.||+|+-+.+|-.-.- .-.+.|++.+.-..... ..+..|.. -.||-+-. |++. .....+
T Consensus 16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh---hchhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 356999999999955332 12355887765322111 12222322 34553322 1211 112237
Q ss_pred EEEEEeccCCC-hHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 665 YLVMEYLNGGD-LYSLLR------NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 665 yLVmEy~~GGS-L~d~L~------~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
-++|..+.|.. +..++. .........+...++.|+.+.+.||..|.+-+|+.++|+|+++++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78899888753 222221 12346788889999999999999999999999999999999999999998754322
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc-----cCCCCccceeechhHHHHH
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~kSDIWSLGVILYE 812 (1003)
+. .........+|.+.|.+||.-. +..-+...|-|.||+++|+
T Consensus 166 i~--------------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~ 213 (637)
T COG4248 166 IN--------------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFH 213 (637)
T ss_pred ec--------------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHH
Confidence 10 0112234578999999999754 3445678999999999999
Q ss_pred HHhC-CCCCCCCC-------hhhHHHhhhhcC-----------CCCCCC--CCCCCHHHHHHHHhhccCC--cCCcCC
Q 001856 813 LIVG-IPPFNAEH-------PQQIFDNILNRK-----------IPWPRV--PEEMSPEAHDLIDRFLTED--PHQRLG 867 (1003)
Q Consensus 813 LLTG-k~PF~~~~-------~~ei~qkIl~~~-----------~~~P~l--p~~iS~elkDLIrrcL~kD--P~kRpg 867 (1003)
+|.| +.||.+.. +-+. .|..+. .+-|.. ..-+++.+..|..+|++.- +.-||+
T Consensus 214 lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~ 289 (637)
T COG4248 214 LLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPT 289 (637)
T ss_pred HHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCC
Confidence 9986 99997632 2111 222211 111111 1246788999999999843 457994
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=8.3e-06 Score=87.11 Aligned_cols=139 Identities=15% Similarity=0.223 Sum_probs=100.8
Q ss_pred eccCceEEEEEEECCCCCEEEEEEeecc---ccccHHHHHHHHHHHHHHHhcCCC--cEEEEEeeeec----cceEEEEE
Q 001856 598 SRGAFGRVFLAKKRTTGDLFAIKVLKKA---DMIRKNAVESILAERDILISVRNP--FVVRFFYSFTC----RENLYLVM 668 (1003)
Q Consensus 598 G~G~FGtVyLArdk~tgk~VALKVIkKs---~~~~~~~ie~~lrEi~IL~~L~HP--nIVkL~~~f~d----~~~lyLVm 668 (1003)
|+||-|.|+..... |+.|=+|.-... ..........+.+|...|..+..- .+++....-.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 66888889987753 446777764311 011122456788999998887532 24444422111 12478999
Q ss_pred EeccC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCc--EEEeecCCccc
Q 001856 669 EYLNG-GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKV 738 (1003)
Q Consensus 669 Ey~~G-GSL~d~L~~~--g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~--VKLiDFGLAk~ 738 (1003)
|-+.| .+|.+++... .+.++.....++.+|+.+|.-||..|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98865 5899888663 45677778899999999999999999999999999999987777 99999987763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.4e-06 Score=96.61 Aligned_cols=137 Identities=22% Similarity=0.342 Sum_probs=88.0
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeecccc---------------------------ccH----HHHH------HHH
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---------------------------IRK----NAVE------SIL 637 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~---------------------------~~~----~~ie------~~l 637 (1003)
..|+.++-|.||.|+.+ +|+.|||||....-. .-. +..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999985 599999999765210 000 0111 223
Q ss_pred HHHHHHHhc-----CCCc--EEEEEeeeeccceEEEEEEeccCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 001856 638 AERDILISV-----RNPF--VVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALEYLHSL 708 (1003)
Q Consensus 638 rEi~IL~~L-----~HPn--IVkL~~~f~d~~~lyLVmEy~~GGSL~d~L--~~~g~LsEe~ar~Ia~QIL~ALeYLHs~ 708 (1003)
+|...+..+ +.|+ |.++|.-+ ...-.|+|||++|-.+.+.. +. ..++...+.....++. +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 344444433 2343 33333222 33457999999999988874 44 4455333222222211 2233348
Q ss_pred CceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 709 GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
|++|.|.+|.||+++.+|.+.+.|||+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCccee
Confidence 99999999999999999999999999865
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.2e-05 Score=83.95 Aligned_cols=134 Identities=16% Similarity=0.132 Sum_probs=83.4
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc--EEEEEeeeeccceEEEEEEecc
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF--VVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn--IVkL~~~f~d~~~lyLVmEy~~ 672 (1003)
..||.|..+.||+. .+..+++|+..... ....+.+|.+++..+..-. +.+.+....+.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999974 24567889876432 1234678999998875432 4667777777777899999999
Q ss_pred CCC-hH--------------HHH----HhcCCC-----CHHH-HHHHHHH----------HHH-HHHHHh----hcCcee
Q 001856 673 GGD-LY--------------SLL----RNLGCL-----DEDV-ARVYIAE----------VVL-ALEYLH----SLRVVH 712 (1003)
Q Consensus 673 GGS-L~--------------d~L----~~~g~L-----sEe~-ar~Ia~Q----------IL~-ALeYLH----s~GIIH 712 (1003)
|.+ +. ..+ .+...+ +... ...+..+ +.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 964 11 111 111111 1000 0111101 111 122222 124789
Q ss_pred ccCCCcceeecCCCcEEEeecCCccc
Q 001856 713 RDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 713 RDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.08 E-value=3e-05 Score=84.60 Aligned_cols=138 Identities=24% Similarity=0.215 Sum_probs=93.6
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHH---------------------HHHHHHHHHHHHHhcC--CCc
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN---------------------AVESILAERDILISVR--NPF 650 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~---------------------~ie~~lrEi~IL~~L~--HPn 650 (1003)
...|..|--+.||+|.. .++..+|+|+++.....-+. ...-...|...|.++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788888899999986 56899999998753221111 1122345666666653 233
Q ss_pred EEEEEeeeeccceEEEEEEeccCCC-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCcceeecCCCcE
Q 001856 651 VVRFFYSFTCRENLYLVMEYLNGGD-LYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHI 728 (1003)
Q Consensus 651 IVkL~~~f~d~~~lyLVmEy~~GGS-L~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILLd~dG~V 728 (1003)
+++-+.++ +-.|||||+.... -.-.|+. -.+....+..+..+++..+.-|-. .|+||+||..-|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 44444433 2379999996531 1111221 123344688888899999998877 8999999999999999 8899
Q ss_pred EEeecCCccc
Q 001856 729 KLTDFGLSKV 738 (1003)
Q Consensus 729 KLiDFGLAk~ 738 (1003)
.|+|||.|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999999873
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.1e-05 Score=79.62 Aligned_cols=128 Identities=24% Similarity=0.358 Sum_probs=92.0
Q ss_pred CCeEEEEEeeccCc-eEEEEEEECCCCCEEEEEEeecc----------cccc--------HHHHHHHHHHHHHHHhcC--
Q 001856 589 DDFEIIKPISRGAF-GRVFLAKKRTTGDLFAIKVLKKA----------DMIR--------KNAVESILAERDILISVR-- 647 (1003)
Q Consensus 589 ddYeIlk~LG~G~F-GtVyLArdk~tgk~VALKVIkKs----------~~~~--------~~~ie~~lrEi~IL~~L~-- 647 (1003)
.+++.++.||.|.- |.||+++. .|+.||||+.+.- .... ......|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999986 5789999993320 0000 023456777877766654
Q ss_pred -CCcE--EEEEeeeecc------------------ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 001856 648 -NPFV--VRFFYSFTCR------------------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706 (1003)
Q Consensus 648 -HPnI--VkL~~~f~d~------------------~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLH 706 (1003)
+.++ |+++++..-. ...-||.||++... .+. ..-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 4555 8898887332 12457888877633 122 234567888899999
Q ss_pred hcCceeccCCCcceeecCCCcEEEeecCCc
Q 001856 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 707 s~GIIHRDIKPeNILLd~dG~VKLiDFGLA 736 (1003)
..||+-+|+++.|.. +| ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---CC--EEEecccC
Confidence 999999999999976 23 89999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.7e-05 Score=78.83 Aligned_cols=134 Identities=17% Similarity=0.124 Sum_probs=82.2
Q ss_pred eeccCc-eEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccceEEEEEEeccCC
Q 001856 597 ISRGAF-GRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGG 674 (1003)
Q Consensus 597 LG~G~F-GtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GG 674 (1003)
|-.|.+ +.||++... +..+.+|+..... ...+.+|+.++..+. +--+.+++......+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 789998753 3678888865432 234567888877763 344667777777666789999999997
Q ss_pred ChHHHH----------------HhcCCCCH------HHHHHHHHH-----------------------HHHHHHHH----
Q 001856 675 DLYSLL----------------RNLGCLDE------DVARVYIAE-----------------------VVLALEYL---- 705 (1003)
Q Consensus 675 SL~d~L----------------~~~g~LsE------e~ar~Ia~Q-----------------------IL~ALeYL---- 705 (1003)
+|.... .+...++. ........+ +...+..|
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 765331 11111110 000000000 11111222
Q ss_pred ---hhcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 706 ---HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 706 ---Hs~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=91.20 Aligned_cols=145 Identities=19% Similarity=0.370 Sum_probs=90.9
Q ss_pred EEEEeeccCceEEEEEEECCCC--CEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcE--EEEEeeeecc---ceE
Q 001856 593 IIKPISRGAFGRVFLAKKRTTG--DLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFV--VRFFYSFTCR---ENL 664 (1003)
Q Consensus 593 Ilk~LG~G~FGtVyLArdk~tg--k~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~-HPnI--VkL~~~f~d~---~~l 664 (1003)
.++.|+.|.+..+|+......+ ..+++|+........ ....+.+|..+|+.+. |++| ++++..+.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998875432 467788754432111 1245778999999885 6654 7777776654 467
Q ss_pred EEEEEeccCCChHH--------------------HHHhcCCCC----------------HHHHHHHHHH-----------
Q 001856 665 YLVMEYLNGGDLYS--------------------LLRNLGCLD----------------EDVARVYIAE----------- 697 (1003)
Q Consensus 665 yLVmEy~~GGSL~d--------------------~L~~~g~Ls----------------Ee~ar~Ia~Q----------- 697 (1003)
|+||||++|..+.+ .+.....++ ..++..+..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999864321 111111110 1223222111
Q ss_pred ----HHHHHHHHhh-----------cCceeccCCCcceeecCC-Cc-EEEeecCCcccc
Q 001856 698 ----VVLALEYLHS-----------LRVVHRDLKPDNLLIAHD-GH-IKLTDFGLSKVG 739 (1003)
Q Consensus 698 ----IL~ALeYLHs-----------~GIIHRDIKPeNILLd~d-G~-VKLiDFGLAk~~ 739 (1003)
+...+.+|.. ..+||+|++|.|||++.+ +. +-|.||+++..+
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233455632 359999999999999853 33 579999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.81 E-value=5.7e-05 Score=95.14 Aligned_cols=203 Identities=23% Similarity=0.273 Sum_probs=140.4
Q ss_pred HHHHHHHHHHHHhcCCCcEEEEEeeeeccce----EEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 001856 633 VESILAERDILISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708 (1003)
Q Consensus 633 ie~~lrEi~IL~~L~HPnIVkL~~~f~d~~~----lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~ 708 (1003)
+....-|...+..+.|+|++.++.+.-.... +.+..|+|.+-++...+...+.++...++.+..+++.||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3444557777888899999999877654432 345678999999999999999999999999999999999999998
Q ss_pred CceeccCCCc---ceeecCCCcEEEe--ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCC
Q 001856 709 RVVHRDLKPD---NLLIAHDGHIKLT--DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783 (1003)
Q Consensus 709 GIIHRDIKPe---NILLd~dG~VKLi--DFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGT 783 (1003)
...|.=+.-. +...+..+.+.++ ||+.++.... ........-+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d--------------------------------~~~~~~~~~~ 353 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD--------------------------------NEKSFSDLLA 353 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCC--------------------------------cccchhhcCc
Confidence 5444443333 3333444556665 7776653100 0011123345
Q ss_pred CCCCCchhhccCCCCcc--ceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCC
Q 001856 784 PDYLAPEILLGTGHGTT--ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 784 p~YmAPEVL~g~~ys~k--SDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kD 861 (1003)
..|.|||......+..+ .|+|.+|.....+..|..+-.- ......+ ++........+++.+|+..+
T Consensus 354 ~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~---~~~~~~~---------l~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 354 EIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK---SAVPVSL---------LDVLSTSELLDALPKCLDED 421 (1351)
T ss_pred cccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc---ccchhhh---------hccccchhhhhhhhhhcchh
Confidence 56788888877766554 6999999999999887644211 0011111 11122226788999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCC
Q 001856 862 PHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 862 P~kRpg~~SAeELLqHPFFk~ 882 (1003)
+++|+ ++.+++.|+|.+.
T Consensus 422 ~~~Rl---~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 422 SEERL---SALELLTHPFLRF 439 (1351)
T ss_pred hhhcc---chhhhhhchhccc
Confidence 99999 9999999999863
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00011 Score=87.86 Aligned_cols=138 Identities=24% Similarity=0.357 Sum_probs=86.2
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeeccccc----------------------------cHHHHHHH------HHHH
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI----------------------------RKNAVESI------LAER 640 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~----------------------------~~~~ie~~------lrEi 640 (1003)
+.||.-+.|.|++|+.+. |+.|||||-+..-.. -.+..+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999865 999999996542100 00111122 2232
Q ss_pred HHHH----hcCCCc------EEEEEeeeeccceEEEEEEeccCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 001856 641 DILI----SVRNPF------VVRFFYSFTCRENLYLVMEYLNGGDLYSL--LRNLGCLDEDVARVYIAEVVLALEYLHSL 708 (1003)
Q Consensus 641 ~IL~----~L~HPn------IVkL~~~f~d~~~lyLVmEy~~GGSL~d~--L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~ 708 (1003)
+... .+.|-+ |+++|..+.. .-.|+||||+|..+.+. |.+.+ ++...+...+.++.. +-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHhc
Confidence 2222 223433 5555544433 35799999999877544 44433 554433333222211 223357
Q ss_pred CceeccCCCcceeecC----CCcEEEeecCCccc
Q 001856 709 RVVHRDLKPDNLLIAH----DGHIKLTDFGLSKV 738 (1003)
Q Consensus 709 GIIHRDIKPeNILLd~----dG~VKLiDFGLAk~ 738 (1003)
|++|.|-+|.||++.. ++.+.+-|||+...
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 8999999999999984 56899999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00021 Score=75.93 Aligned_cols=73 Identities=16% Similarity=0.144 Sum_probs=45.5
Q ss_pred EEEeeccCce-EEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC---cEEEEEeeeecc---ceEEE
Q 001856 594 IKPISRGAFG-RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP---FVVRFFYSFTCR---ENLYL 666 (1003)
Q Consensus 594 lk~LG~G~FG-tVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HP---nIVkL~~~f~d~---~~lyL 666 (1003)
++.|+.|+.. .||+.. ..+++|+..... ....+.+|..+|..+... -+.+++...... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 588762 347788754321 234678899998877531 344455443332 23588
Q ss_pred EEEeccCCCh
Q 001856 667 VMEYLNGGDL 676 (1003)
Q Consensus 667 VmEy~~GGSL 676 (1003)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0019 Score=68.53 Aligned_cols=131 Identities=22% Similarity=0.257 Sum_probs=91.8
Q ss_pred EEeeccCceEEEEEEECCCCCEEEEEEeecccc-------------ccHHHHHHHHHHHHHHHhcC------CCcEEEEE
Q 001856 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-------------IRKNAVESILAERDILISVR------NPFVVRFF 655 (1003)
Q Consensus 595 k~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~-------------~~~~~ie~~lrEi~IL~~L~------HPnIVkL~ 655 (1003)
..||.|+.=.||.- . ......|||+..... ..........+|+.....+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999954 2 334467899876540 00112345566666655554 78999999
Q ss_pred eeeeccceEEEEEEeccC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCC--C-
Q 001856 656 YSFTCRENLYLVMEYLNG------GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--G- 726 (1003)
Q Consensus 656 ~~f~d~~~lyLVmEy~~G------GSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~d--G- 726 (1003)
+..+++..+-+|+|.+.. -+|.+++.. +.+++ . +...+-.-.+||-..+|+.+||+|.||++... |
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998742 368888855 44665 2 23334455668889999999999999999753 2
Q ss_pred -cEEEeec
Q 001856 727 -HIKLTDF 733 (1003)
Q Consensus 727 -~VKLiDF 733 (1003)
.+.|+|-
T Consensus 159 ~~lvlIDG 166 (199)
T PF10707_consen 159 FRLVLIDG 166 (199)
T ss_pred eEEEEEeC
Confidence 4777773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00053 Score=71.89 Aligned_cols=130 Identities=22% Similarity=0.319 Sum_probs=91.0
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEE-EEeeeeccceEEEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR-FFYSFTCRENLYLVME 669 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnIVk-L~~~f~d~~~lyLVmE 669 (1003)
.++.+.||+|.+|.||++.+. |..+|+|+-.... ....+..|.++|..+...++-. +|.+.. .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 455678999999999999984 5689999865432 3356778999998887665543 443322 245599
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCC-CcceeecCCCcEEEeecCCccc
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK-PDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 670 y~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIK-PeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|+.|-.|...-... +. .-+..++.+---|-..||-|..|. |..++|..++.+.|+||..|++
T Consensus 93 ~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99998877655421 22 233445555555778899999986 5555555566999999998874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=1.1e-05 Score=102.76 Aligned_cols=256 Identities=19% Similarity=0.121 Sum_probs=161.3
Q ss_pred ccCCeEEEEEeeccCceEEEEEEECCCC-CEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCR-- 661 (1003)
Q Consensus 587 ~lddYeIlk~LG~G~FGtVyLArdk~tg-k~VALKVIkKs~~~--~~~~ie~~lrEi~IL~~L~HPnIVkL~~~f~d~-- 661 (1003)
.++.|++.--+|-|.++ ++++.... ..+-+|+.+-.+.. .+-..+....|++-++...|+++...+.-....
T Consensus 1227 ~~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred Hhhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 34567776666655544 34332211 12456665433221 122235556677777778899988776555443
Q ss_pred ceEEEEEEeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhc-----CceeccCCCcceeecCCCcEEEee
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL-----RVVHRDLKPDNLLIAHDGHIKLTD 732 (1003)
Q Consensus 662 ~~lyLVmEy~~GGSL~d~L~~~----g~LsEe~ar~Ia~QIL~ALeYLHs~-----GIIHRDIKPeNILLd~dG~VKLiD 732 (1003)
...|.+++|+.+|.+++.|-+. +.+.+..+.....+.+.+..-+|+. -.+|+++|+-|.+|..+-.+|+.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 3468999999999999999653 3444544544444557888887754 269999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhccCCCCccceeechhHHHHH
Q 001856 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (1003)
Q Consensus 733 FGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~g~~ys~kSDIWSLGVILYE 812 (1003)
+|+.+.. ++. .......++++.|++|++...-.++.++|+|.+|+.+|+
T Consensus 1384 ~gLdKIk--np~-----------------------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1384 GGLDKIK--NPV-----------------------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccccccc--Cch-----------------------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 9999831 000 112335678899999999988888888999999999999
Q ss_pred HHhCCCCCCCCChhhHHHhhhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 001856 813 LIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 813 LLTGk~PF~~~~~~ei~qkIl~~~~~~P~lp~~iS~elkDLIrrcL~kDP~kRpg~~SAeELLqHPFFk 881 (1003)
...|..+|..-....+ +.+..... +-.++.-.|.++......+|-+.-..|| .-...+.-+.|.
T Consensus 1433 rs~~n~~fi~flq~~L-kgiidn~t-f~sIe~l~pgdaNve~~~~Ll~K~~~rp---~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPAL-KGIIDNHT-FFSIEKLKPGDANVEALHRLLWKYMERP---GQYISLSRDHFA 1496 (2724)
T ss_pred HhcccHHHHHHHHHHH-cCcccccc-cccccccCCCcccHHHHHHHHHHhhhcc---hhhhhccccccc
Confidence 9999888743222111 11111111 1122222233344444444444456788 566666666554
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0015 Score=68.87 Aligned_cols=137 Identities=17% Similarity=0.226 Sum_probs=80.3
Q ss_pred EEEeeccCceEEEEEEECC-CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeeccceEEEEEEec
Q 001856 594 IKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYL 671 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~-tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H-PnIVkL~~~f~d~~~lyLVmEy~ 671 (1003)
++.|..|-...||++.... .++.|++|+...... ..-...+|..++..+.. ...++++..+.. .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888888999997543 357899998754321 11122367777777743 234455544332 3799999
Q ss_pred cCCChHH--------------HHHhc---C-CC----------C-HHHHHHHHHH----------------------HH-
Q 001856 672 NGGDLYS--------------LLRNL---G-CL----------D-EDVARVYIAE----------------------VV- 699 (1003)
Q Consensus 672 ~GGSL~d--------------~L~~~---g-~L----------s-Ee~ar~Ia~Q----------------------IL- 699 (1003)
+|.++.. .+.+. . .. . .+.+..+... +.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 9976521 11111 0 11 0 1122222111 11
Q ss_pred --HHHH-HHh----hcCceeccCCCcceeecC-CCcEEEeecCCccc
Q 001856 700 --LALE-YLH----SLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 738 (1003)
Q Consensus 700 --~ALe-YLH----s~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~ 738 (1003)
..|. .+- ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 111 246999999999999998 57899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0066 Score=70.80 Aligned_cols=80 Identities=18% Similarity=0.145 Sum_probs=54.3
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeecccc-c-c--HHHHHHHHHHHHHHHhcC---CCcEEEEEeeeeccceEEE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-I-R--KNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~-~-~--~~~ie~~lrEi~IL~~L~---HPnIVkL~~~f~d~~~lyL 666 (1003)
.+.||.|.+..||++.....++.+.||.-..... . . ....++...|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864435899997431100 0 0 123456677888887752 3467778766 4456789
Q ss_pred EEEeccCCC
Q 001856 667 VMEYLNGGD 675 (1003)
Q Consensus 667 VmEy~~GGS 675 (1003)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0043 Score=69.15 Aligned_cols=78 Identities=13% Similarity=0.043 Sum_probs=54.6
Q ss_pred EEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC---CcEEEEEeeeec---cceEE
Q 001856 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTC---RENLY 665 (1003)
Q Consensus 592 eIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H---PnIVkL~~~f~d---~~~ly 665 (1003)
.-++.||.|..+.||..... ++ .+.+|+.+... ....+.+|...|+.+.. -.|+++++.+.+ .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 33567999999999998652 33 46778743210 12467789888887743 357778876654 35689
Q ss_pred EEEEeccCCCh
Q 001856 666 LVMEYLNGGDL 676 (1003)
Q Consensus 666 LVmEy~~GGSL 676 (1003)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0013 Score=69.01 Aligned_cols=96 Identities=23% Similarity=0.263 Sum_probs=77.5
Q ss_pred HHHHHHHhcCC-CcEEEEEeeeeccceEEEEEEeccCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhh---cCc
Q 001856 638 AERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL---LRNLGCLDEDVARVYIAEVVLALEYLHS---LRV 710 (1003)
Q Consensus 638 rEi~IL~~L~H-PnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~---L~~~g~LsEe~ar~Ia~QIL~ALeYLHs---~GI 710 (1003)
+|.-+|+.+.+ ++++++++++.. ++|.||...+++... +...-..++.....++.+++..+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57778888876 699999998853 678999987766432 2222345788889999999999999997 457
Q ss_pred eeccCCCcceeecCCCcEEEeecCCcc
Q 001856 711 VHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 711 IHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
.-.|++|+|+-++.+|++|++|.....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcc
Confidence 889999999999999999999998765
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0013 Score=70.72 Aligned_cols=132 Identities=20% Similarity=0.239 Sum_probs=75.5
Q ss_pred eeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeeccceEEEEEEeccCCC
Q 001856 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLVMEYLNGGD 675 (1003)
Q Consensus 597 LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn-IVkL~~~f~d~~~lyLVmEy~~GGS 675 (1003)
+..|-.+.+|+.. .+++.|++|+....... -. -...+|..+++.+.... ..+++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--cc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4567778899887 35667888976543110 00 12356777887775322 233444332 268999999866
Q ss_pred hHH--------------HHHhcC-------CCC-HHHHHHHHHHH---------HHHHHHHhh--------cCceeccCC
Q 001856 676 LYS--------------LLRNLG-------CLD-EDVARVYIAEV---------VLALEYLHS--------LRVVHRDLK 716 (1003)
Q Consensus 676 L~d--------------~L~~~g-------~Ls-Ee~ar~Ia~QI---------L~ALeYLHs--------~GIIHRDIK 716 (1003)
+.. .+.+.. .++ ...+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 531 111111 111 11222322222 111222211 258999999
Q ss_pred CcceeecCCCcEEEeecCCccc
Q 001856 717 PDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 717 PeNILLd~dG~VKLiDFGLAk~ 738 (1003)
|.|||++.++ +.|+||..|..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0054 Score=67.93 Aligned_cols=141 Identities=21% Similarity=0.239 Sum_probs=82.0
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEeee------eccc
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYSF------TCRE 662 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HP--nIVkL~~~f------~d~~ 662 (1003)
...++.++.|....||++.. .+| .|++|+..... . .+.+..|..++..|... .+++++... ...+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 44567778888889999875 334 57889875421 1 12344566666665321 234443221 1245
Q ss_pred eEEEEEEeccCCChH-----------HHH---Hhc-CCCC--------HHH-----HH----------HHHHHHHHHHHH
Q 001856 663 NLYLVMEYLNGGDLY-----------SLL---RNL-GCLD--------EDV-----AR----------VYIAEVVLALEY 704 (1003)
Q Consensus 663 ~lyLVmEy~~GGSL~-----------d~L---~~~-g~Ls--------Ee~-----ar----------~Ia~QIL~ALeY 704 (1003)
..+++|||++|..+. ..+ +.. ..++ ... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999985431 111 110 1110 000 00 011123345555
Q ss_pred Hh-------hcCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 705 LH-------SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 705 LH-------s~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
+. ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 54 26899999999999999888778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0036 Score=68.81 Aligned_cols=76 Identities=12% Similarity=0.088 Sum_probs=46.9
Q ss_pred EEEeeccCceEEEEEEECC------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeeccceEEE
Q 001856 594 IKPISRGAFGRVFLAKKRT------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYL 666 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~------tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn-IVkL~~~f~d~~~lyL 666 (1003)
++.|..|-...||++.... .++.|++|+...... ......+|..++..+.... ..++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4556667777899887543 257899999765321 1234456777777764322 3455555542 35
Q ss_pred EEEeccCCChH
Q 001856 667 VMEYLNGGDLY 677 (1003)
Q Consensus 667 VmEy~~GGSL~ 677 (1003)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.013 Score=64.84 Aligned_cols=31 Identities=32% Similarity=0.358 Sum_probs=26.8
Q ss_pred cCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
.|+||+|++|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999998665568999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0088 Score=65.35 Aligned_cols=137 Identities=19% Similarity=0.158 Sum_probs=82.0
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEee------eeccceEE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYS------FTCRENLY 665 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HP--nIVkL~~~------f~d~~~ly 665 (1003)
++.|..|....+|++.. .+..+++|+.... . ...+..|..++..+.+. .+++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56778888889999865 3346899987641 1 23455677777666432 24444431 12345678
Q ss_pred EEEEeccCCChHH-----------HH---Hhc-CCCC--------HHHHH------------HHHHHHHHHHHHHhh---
Q 001856 666 LVMEYLNGGDLYS-----------LL---RNL-GCLD--------EDVAR------------VYIAEVVLALEYLHS--- 707 (1003)
Q Consensus 666 LVmEy~~GGSL~d-----------~L---~~~-g~Ls--------Ee~ar------------~Ia~QIL~ALeYLHs--- 707 (1003)
+|+++++|..+.. .+ +.. ..+. ..... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 11 110 0010 00000 011123334445443
Q ss_pred ----cCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 708 ----LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ----~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887778999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0016 Score=73.72 Aligned_cols=136 Identities=15% Similarity=0.186 Sum_probs=94.6
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccc------cH-----------HH--HHHHHHHHHHHHhcC-CCc
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI------RK-----------NA--VESILAERDILISVR-NPF 650 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~------~~-----------~~--ie~~lrEi~IL~~L~-HPn 650 (1003)
+.+...||-|.-+-||.+-+ ..|.++++|+-...+.. .+ .. .-...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66778899999999999987 56889999964321110 00 00 113456777777774 222
Q ss_pred -EEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCcceeecCCCcEE
Q 001856 651 -VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (1003)
Q Consensus 651 -IVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHRDIKPeNILLd~dG~VK 729 (1003)
|++.++ .+..|+|||++.|..|.+.-+-. .+..+...++.-+--|..+|+||+|..-=||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 333332 35578999999998877554211 1234455666667778899999999999999999999999
Q ss_pred EeecCCcc
Q 001856 730 LTDFGLSK 737 (1003)
Q Consensus 730 LiDFGLAk 737 (1003)
++||-...
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.041 Score=60.87 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=25.8
Q ss_pred CceeccCCCcceeecCCCc-EEEeecCCccc
Q 001856 709 RVVHRDLKPDNLLIAHDGH-IKLTDFGLSKV 738 (1003)
Q Consensus 709 GIIHRDIKPeNILLd~dG~-VKLiDFGLAk~ 738 (1003)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.052 Score=61.78 Aligned_cols=145 Identities=20% Similarity=0.264 Sum_probs=79.7
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeeccc--eEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCRE--NLYL 666 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~H--PnIVkL~~~f~d~~--~lyL 666 (1003)
..++..+-.|.--.+|.... +++.++|. .. .............+|..+|+.+.- --+...++.+.+.. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34444443333334444443 26777777 22 112223344566778888877643 12334455555544 6799
Q ss_pred EEEeccCCChH------------------HHHHhcCC--------------CCHHHHHHHHHHH--------------HH
Q 001856 667 VMEYLNGGDLY------------------SLLRNLGC--------------LDEDVARVYIAEV--------------VL 700 (1003)
Q Consensus 667 VmEy~~GGSL~------------------d~L~~~g~--------------LsEe~ar~Ia~QI--------------L~ 700 (1003)
||+|+.|..+. ++|..... ....++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999984322 11111000 0111111121111 12
Q ss_pred HHHHHhh--------cCceeccCCCcceeecCCCcEEEeecCCcccc
Q 001856 701 ALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 701 ALeYLHs--------~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~~ 739 (1003)
-..+|+. -.++|+|+.+.||+++..+-+=++||+++.++
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2333432 35899999999999999988999999999863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.11 Score=57.16 Aligned_cols=30 Identities=20% Similarity=0.418 Sum_probs=26.5
Q ss_pred cCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57999999999999987 6789999998763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.048 Score=63.07 Aligned_cols=83 Identities=20% Similarity=0.121 Sum_probs=50.8
Q ss_pred EeeccCceEEEEEEECCCCCEEEEEEeecc-cc---ccHHHHHHHHHHHHHHHhcC--CC-cEEEEEeeeeccceEEEEE
Q 001856 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKA-DM---IRKNAVESILAERDILISVR--NP-FVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 596 ~LG~G~FGtVyLArdk~tgk~VALKVIkKs-~~---~~~~~ie~~lrEi~IL~~L~--HP-nIVkL~~~f~d~~~lyLVm 668 (1003)
.||-|....||++.....++.++||--..- +. .-.-..++..-|...|+... -| +++++|. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999998544467888864321 10 01223355567777776653 24 5666653 3445567999
Q ss_pred EeccCC-ChHHHH
Q 001856 669 EYLNGG-DLYSLL 680 (1003)
Q Consensus 669 Ey~~GG-SL~d~L 680 (1003)
|+++.. .|.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999543 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.048 Score=63.11 Aligned_cols=141 Identities=28% Similarity=0.271 Sum_probs=91.3
Q ss_pred EEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccH---------------------HHH--HHHHHHHHHHHhcCCC
Q 001856 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---------------------NAV--ESILAERDILISVRNP 649 (1003)
Q Consensus 593 Ilk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~---------------------~~i--e~~lrEi~IL~~L~HP 649 (1003)
+-..|..|--+-||.|.. .+|..+|||+++-+-+.-+ ..+ --...|.+-|.+++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678889999999986 5788899999875322111 001 1223456667776544
Q ss_pred cEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCcceeecCCCcE
Q 001856 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHI 728 (1003)
Q Consensus 650 nIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYL-Hs~GIIHRDIKPeNILLd~dG~V 728 (1003)
.|.-.-- ..- ..-.|||+|+.+.....=..+.-.++...++.+-.|++.-+.-| |.+++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PeP-IlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEP-ILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCc-eee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 3321100 000 12479999996422222222334577778888888888777765 46899999999999988 56889
Q ss_pred EEeecCCcc
Q 001856 729 KLTDFGLSK 737 (1003)
Q Consensus 729 KLiDFGLAk 737 (1003)
.|+|-+.+.
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999999876
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.055 Score=61.69 Aligned_cols=138 Identities=19% Similarity=0.227 Sum_probs=78.7
Q ss_pred EEEEeeccCceEEEEEEECC----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeeccceEEEE
Q 001856 593 IIKPISRGAFGRVFLAKKRT----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 593 Ilk~LG~G~FGtVyLArdk~----tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPn-IVkL~~~f~d~~~lyLV 667 (1003)
-+..|-.|-.-.+|++.... .++.|.+|+..... ...+. ..+|..++..+..-+ -.++++.+... .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34455557788899987532 34689999876532 11112 245777777764322 23455555432 58
Q ss_pred EEeccCCChHHH--------------HHhc---C-C-----CCHHHHHHHHHHH-----------------HHHHHHH--
Q 001856 668 MEYLNGGDLYSL--------------LRNL---G-C-----LDEDVARVYIAEV-----------------VLALEYL-- 705 (1003)
Q Consensus 668 mEy~~GGSL~d~--------------L~~~---g-~-----LsEe~ar~Ia~QI-----------------L~ALeYL-- 705 (1003)
++|++|.+|... +.+. . + .....+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999988766311 1111 1 0 0112222332221 1111111
Q ss_pred ------hhcCceeccCCCcceeecC-CCcEEEeecCCccc
Q 001856 706 ------HSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 738 (1003)
Q Consensus 706 ------Hs~GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~ 738 (1003)
+...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236899999999999986 47899999998873
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.19 Score=59.07 Aligned_cols=77 Identities=19% Similarity=0.142 Sum_probs=50.5
Q ss_pred EEEEeeccCceEEEEEEECCCCCEEEEEEeecccc-ccH---HHHHHHHHHHHHHHhcC---CCcEEEEEeeeeccceEE
Q 001856 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-IRK---NAVESILAERDILISVR---NPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 593 Ilk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~-~~~---~~ie~~lrEi~IL~~L~---HPnIVkL~~~f~d~~~ly 665 (1003)
..+.||-|....||++... +..|+||.-...-. ... ....+...|...|..+. ..+++++|.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678899999999999873 45688987541111 011 12344555666666553 247888887766 4467
Q ss_pred EEEEeccC
Q 001856 666 LVMEYLNG 673 (1003)
Q Consensus 666 LVmEy~~G 673 (1003)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.096 Score=59.33 Aligned_cols=140 Identities=16% Similarity=0.178 Sum_probs=76.9
Q ss_pred CeEEEEEeeccCceEEEEEEECCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE-EEEEeeeeccceEE
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLY 665 (1003)
Q Consensus 590 dYeIlk~LG~G~FGtVyLArdk~t---gk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L~HPnI-VkL~~~f~d~~~ly 665 (1003)
+.++. .|..|=...+|++..... +..|.+|+...... ..-.-.+|..+++.+..-++ +++++.+.. +
T Consensus 16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G--- 86 (330)
T PLN02421 16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G--- 86 (330)
T ss_pred ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---
Confidence 44444 444477778898875432 34788998754321 11122457777777654333 345555532 2
Q ss_pred EEEEeccCCChHH--------------HHHhcC--C------C-CHHHHHHHHHHH----------------------HH
Q 001856 666 LVMEYLNGGDLYS--------------LLRNLG--C------L-DEDVARVYIAEV----------------------VL 700 (1003)
Q Consensus 666 LVmEy~~GGSL~d--------------~L~~~g--~------L-sEe~ar~Ia~QI----------------------L~ 700 (1003)
+|.+|++|.+|.. .+++.. . . ....+..|..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5889998766521 111111 0 1 112222332222 11
Q ss_pred HHHH----Hhhc----CceeccCCCcceeecC-CCcEEEeecCCccc
Q 001856 701 ALEY----LHSL----RVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 738 (1003)
Q Consensus 701 ALeY----LHs~----GIIHRDIKPeNILLd~-dG~VKLiDFGLAk~ 738 (1003)
-+.. +... -++|.|+.+.|||++. ++.++++||..|-.
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111 1122 2799999999999975 57899999998863
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.22 Score=58.43 Aligned_cols=85 Identities=22% Similarity=0.173 Sum_probs=53.9
Q ss_pred EEEeeccCceEEEEEEECCCCCEEEEEEeecc-cc--ccHHHHHHHHHHHHHHHhcC--CC-cEEEEEeeeeccceEEEE
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-DM--IRKNAVESILAERDILISVR--NP-FVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 594 lk~LG~G~FGtVyLArdk~tgk~VALKVIkKs-~~--~~~~~ie~~lrEi~IL~~L~--HP-nIVkL~~~f~d~~~lyLV 667 (1003)
++.||-|.-..||++.+...++.++||--..- +. .-.-..++..-|..+|+... -| +++++|. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 67899999999999998444567888853211 00 11223466677888887653 24 5666764 345566789
Q ss_pred EEeccCC-ChHHHH
Q 001856 668 MEYLNGG-DLYSLL 680 (1003)
Q Consensus 668 mEy~~GG-SL~d~L 680 (1003)
||+++.. .|++.+
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998542 344443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.43 Score=53.20 Aligned_cols=30 Identities=17% Similarity=0.197 Sum_probs=28.0
Q ss_pred CceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 709 GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.073 Score=63.68 Aligned_cols=163 Identities=21% Similarity=0.301 Sum_probs=104.1
Q ss_pred HHHHHHHHHHhcCCCcEEEEEeeeecc-ceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceec
Q 001856 635 SILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713 (1003)
Q Consensus 635 ~~lrEi~IL~~L~HPnIVkL~~~f~d~-~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~GIIHR 713 (1003)
.++-...+++.+.|+|....+++-... ....+|||++. -+|.+.+.... +-... +. .+|+.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s-------~~-------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDES-------LL-------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhh-------hc-------cccccee
Confidence 455667788999999999988776653 45889999994 59999887643 21111 11 2223222
Q ss_pred cCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCchhhc
Q 001856 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (1003)
Q Consensus 714 DIKPeNILLd~dG~VKLiDFGLAk~~~~~s~ddls~p~~sgttl~gd~~p~lt~~~~~~~~~~~~s~vGTp~YmAPEVL~ 793 (1003)
|| ++++| -++.. ..+..|
T Consensus 92 -----~~-------~~~td-~~~t~--------------------------------------~~~~~~----------- 109 (725)
T KOG1093|consen 92 -----NI-------IYITD-HFLTK--------------------------------------YPSPIG----------- 109 (725)
T ss_pred -----hh-------hhccc-ccccc--------------------------------------CCCCCC-----------
Confidence 11 22333 11100 001111
Q ss_pred cCCCCccceeechhHHHHHHHhCCCCCCCCChhhHHHhhhhcCCCCC---------CCCCCCCHHHHHHHHhhccCCcCC
Q 001856 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP---------RVPEEMSPEAHDLIDRFLTEDPHQ 864 (1003)
Q Consensus 794 g~~ys~kSDIWSLGVILYELLTGk~PF~~~~~~ei~qkIl~~~~~~P---------~lp~~iS~elkDLIrrcL~kDP~k 864 (1003)
+++|||++|.++.++.-|...|......+....+.+-...-. .+.-.++....+++.+|+-..|..
T Consensus 110 -----pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 110 -----PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred -----cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccc
Confidence 499999999999999999887766555555544443211100 011235677888999999999999
Q ss_pred cCCCCCHHHHHcCCCCCCC
Q 001856 865 RLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 865 Rpg~~SAeELLqHPFFk~I 883 (1003)
|| ...++.+|+-|.++
T Consensus 185 r~---l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 185 RP---LPMELSKRCSFTEV 200 (725)
T ss_pred cc---chhHHhcCccHHHH
Confidence 99 88999999988765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.32 Score=56.64 Aligned_cols=29 Identities=28% Similarity=0.323 Sum_probs=24.8
Q ss_pred cCceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 708 ~GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
..++|.|+-+.|||.+. +.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 46899999999998754 569999999876
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.46 E-value=1.5 Score=57.18 Aligned_cols=30 Identities=37% Similarity=0.591 Sum_probs=26.2
Q ss_pred cCceeccCCCcceeecCCC--cEE-EeecCCcc
Q 001856 708 LRVVHRDLKPDNLLIAHDG--HIK-LTDFGLSK 737 (1003)
Q Consensus 708 ~GIIHRDIKPeNILLd~dG--~VK-LiDFGLAk 737 (1003)
.++||.|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 565 99999876
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.10 E-value=1.3 Score=50.15 Aligned_cols=29 Identities=28% Similarity=0.436 Sum_probs=24.8
Q ss_pred cCceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ~GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4789999999999995 3 578999998874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.04 E-value=1.1 Score=50.52 Aligned_cols=76 Identities=20% Similarity=0.315 Sum_probs=47.0
Q ss_pred eEEEEEeeccCceEEEEEEECCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeeccceEEEE
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 591 YeIlk~LG~G~FGtVyLArdk~tgk~VALKVIkKs~~~~~~~ie~~lrEi~IL~~L---~HPnIVkL~~~f~d~~~lyLV 667 (1003)
.+-.+.|+-|....+|+.. .+++.|-+|+-... ....+..|..-|+.| .--.+++.+.+....+.-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446778999999999987 67788999986532 224566777777766 344678888888877778999
Q ss_pred EEeccCC
Q 001856 668 MEYLNGG 674 (1003)
Q Consensus 668 mEy~~GG 674 (1003)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.42 E-value=0.4 Score=50.25 Aligned_cols=31 Identities=45% Similarity=0.771 Sum_probs=22.3
Q ss_pred cCceeccCCCcceee-cCCCcEEEeecCCccc
Q 001856 708 LRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ~GIIHRDIKPeNILL-d~dG~VKLiDFGLAk~ 738 (1003)
..++|.|+.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458999999999999 8889999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.29 Score=56.84 Aligned_cols=73 Identities=26% Similarity=0.409 Sum_probs=54.2
Q ss_pred ccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCcceeecCCCcEEEeecCCccc
Q 001856 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 660 d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs~-GIIHRDIKPeNILLd~dG~VKLiDFGLAk~ 738 (1003)
...+.|++|++- |+.|. .+ .....+++..++.+.+..|.-+..+ .+=|||+.-.||||+ +|+|.|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 345678888875 44443 22 2234566677777777777766654 689999999999999 99999999999984
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=90.51 E-value=1.5 Score=48.15 Aligned_cols=29 Identities=34% Similarity=0.635 Sum_probs=25.5
Q ss_pred ceeccCCCcceeecCC--C---cEEEeecCCccc
Q 001856 710 VVHRDLKPDNLLIAHD--G---HIKLTDFGLSKV 738 (1003)
Q Consensus 710 IIHRDIKPeNILLd~d--G---~VKLiDFGLAk~ 738 (1003)
++|+|++..|||+..+ | .++++||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 8999999999999764 3 699999999885
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.16 E-value=2.3 Score=50.67 Aligned_cols=28 Identities=29% Similarity=0.534 Sum_probs=24.2
Q ss_pred CceeccCCCcceeecCCCcEEEeecCCcc
Q 001856 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 709 GIIHRDIKPeNILLd~dG~VKLiDFGLAk 737 (1003)
.++|.|+-+.|||.+.+ .++|+||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccc
Confidence 58999999999987654 49999999876
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.79 E-value=1.3 Score=48.68 Aligned_cols=85 Identities=18% Similarity=0.205 Sum_probs=59.2
Q ss_pred HHHHHHHHHHHhcCCCcEEEEEeeeeccceEEEEEEeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--cCce
Q 001856 634 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--LRVV 711 (1003)
Q Consensus 634 e~~lrEi~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGSL~d~L~~~g~LsEe~ar~Ia~QIL~ALeYLHs--~GII 711 (1003)
.-+.++.+++++++ .|+++..- +.-.+-+++|+|..... ...-++.+ =+.+|.-.|+ .+.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N~i~a-gi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSNFITA-GIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhHHHHH-hHHHHHHhhccCCCee
Confidence 34577888888874 58888732 33457799999954111 11111221 1456778884 4799
Q ss_pred eccCCCcceeecCCCcEEEeecCC
Q 001856 712 HRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 712 HRDIKPeNILLd~dG~VKLiDFGL 735 (1003)
|+|-.|+||+-|..|.+||.|-+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999874
|
The function of this family is unknown. |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=88.54 E-value=0.56 Score=39.91 Aligned_cols=31 Identities=39% Similarity=0.755 Sum_probs=25.6
Q ss_pred CCCChhHHhhh--cCCccCCCCCCCCCCCcccc
Q 001856 881 KDINWDTLARQ--KAAFVPTSESALDTSYFTSR 911 (1003)
Q Consensus 881 k~Idw~~L~~~--k~pfiP~~~s~lDts~F~s~ 911 (1003)
++++|+.+..+ .+||+|...+..|+++|+..
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~ 33 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDE 33 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCc
Confidence 46899999764 58999999888899888653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1003 | ||||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-62 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-62 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-62 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-62 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-62 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-62 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-62 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-61 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-61 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-61 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-61 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-61 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-61 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-61 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-61 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-61 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-61 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-61 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-61 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-61 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-61 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-61 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-61 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-61 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-61 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-61 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-61 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-61 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-61 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-61 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-61 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-61 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-61 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-61 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-61 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-61 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-61 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-61 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-61 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-61 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-61 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-61 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-61 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-61 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-61 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-61 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-61 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-61 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-61 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-61 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-61 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-60 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-60 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-60 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-60 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-60 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-60 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-60 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-60 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-60 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-60 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-60 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-59 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-59 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-59 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-59 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-59 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-59 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-59 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-59 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-58 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-58 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-58 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-58 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-58 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-58 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-58 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-56 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-55 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-55 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-55 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-55 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-54 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-53 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-52 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-52 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-51 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-51 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-50 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-50 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-50 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-50 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-50 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-50 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-50 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-50 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-50 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-50 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-50 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-50 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-50 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-50 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-50 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-50 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-50 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-49 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-49 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-49 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-49 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-48 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-48 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-42 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-41 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-41 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-41 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-41 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-40 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-40 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-40 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-40 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-40 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-40 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-40 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-40 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-40 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-40 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-40 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-40 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-40 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-40 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-39 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-39 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-39 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-39 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-39 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-39 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-39 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-39 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-39 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-39 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-38 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-37 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-37 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-37 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-37 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-36 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-36 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-35 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-35 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-35 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-35 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-35 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-34 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-34 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-33 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-33 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-33 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-32 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-32 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-32 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-32 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-32 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-32 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-32 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-32 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-32 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-32 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-32 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-32 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-32 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-32 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-32 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-32 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-32 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-32 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-32 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-32 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-32 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-32 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-31 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-31 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-31 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-31 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-31 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-31 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-30 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-30 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-30 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-30 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-30 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-29 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-29 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-29 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-29 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-29 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-29 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-29 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-29 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-29 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-28 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-28 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-28 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-28 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-27 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-27 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-27 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-26 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-26 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-26 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-25 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-25 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-25 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-25 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-25 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-25 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-25 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-25 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-25 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-25 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-25 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-25 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-25 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-25 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-24 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-24 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-24 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-22 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-22 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-22 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-22 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-22 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-22 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-22 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-22 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-22 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-22 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-22 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-22 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-22 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-22 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-22 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-22 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-22 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-22 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-22 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-22 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-22 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-22 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-21 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-21 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-21 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-21 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-21 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-21 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-21 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-21 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-21 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-20 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-20 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-20 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-20 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-16 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-11 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-07 |
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1003 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-143 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-136 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-133 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-133 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-132 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-130 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-129 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-129 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-127 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-127 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-125 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-125 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-124 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-122 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-122 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-122 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-121 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-120 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-116 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-114 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-111 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-109 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-103 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-102 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-86 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-85 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 9e-85 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-84 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-83 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-82 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-79 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-75 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-74 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-73 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-72 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-71 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-71 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-71 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-70 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-70 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-69 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-69 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-68 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-68 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-68 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-68 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-68 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-68 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-68 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-68 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-67 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-67 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-67 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-67 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-67 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-67 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-66 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-66 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-66 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-66 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-66 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-66 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-65 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-65 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-65 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-65 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-65 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-65 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-65 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 7e-65 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-64 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-64 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-64 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-63 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-63 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-63 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-62 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-62 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-62 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-62 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-62 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-61 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-61 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-61 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-61 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-60 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-60 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-60 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-60 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-60 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-59 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-59 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-59 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-59 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-58 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-58 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-57 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-57 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-56 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-56 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-55 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 8e-55 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-54 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 7e-54 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 8e-54 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-53 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-53 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-53 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-52 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-52 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-52 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-52 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-52 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-50 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-47 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 9e-47 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-46 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-46 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-45 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-44 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-43 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-43 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-42 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-42 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-42 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-42 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-42 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-42 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-41 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-41 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-41 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-41 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-40 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-40 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-40 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-40 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-39 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-39 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-39 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-38 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-38 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-35 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-35 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-34 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-34 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-34 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-34 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 6e-34 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-33 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-33 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-33 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-33 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-32 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-32 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-32 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-32 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-32 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-32 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-31 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-31 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-31 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-30 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-30 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 7e-30 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-30 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-29 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-28 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-26 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-25 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-25 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-24 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-24 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-23 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-23 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-23 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-23 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-22 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-22 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-22 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-22 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-21 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-21 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-21 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-21 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-21 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-20 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-20 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-20 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-20 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-20 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-20 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-20 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-20 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-19 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-19 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-19 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-19 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-19 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-19 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-19 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-19 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-19 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 6e-19 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-18 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-18 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-18 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-18 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-17 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-17 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-17 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-17 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-17 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-17 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-17 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-17 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-17 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-17 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-17 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-16 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-16 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-16 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-15 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-15 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 5e-04 | |
| 3k1f_M | 197 | Transcription initiation factor IIB; RNA polymeras | 6e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 432 bits (1114), Expect = e-143
Identities = 133/440 (30%), Positives = 207/440 (47%), Gaps = 71/440 (16%)
Query: 554 DITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTT 613
++ ++ + +D + D + + + + R DDFEI+K I RGAF V + K + T
Sbjct: 27 ELGASELAQDKYVADFLQWA-EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT 85
Query: 614 GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673
G ++A+K++ K DM+++ V ERD+L++ ++ + ++F LYLVMEY G
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145
Query: 674 GDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732
GDL +LL G + ++AR Y+AE+V+A++ +H L VHRD+KPDN+L+ GHI+L D
Sbjct: 146 GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792
FG + T + AVGTPDYL+PEIL
Sbjct: 206 FGSCLKLRADGTV------------------------------RSLVAVGTPDYLSPEIL 235
Query: 793 LGTG-------HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVP 843
G +G DWW++G+ +E+ G PF A+ + + I++ K + P V
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295
Query: 844 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESAL 903
E + EA D I R L P RLG GGA + + H FF ++WD L F P E A
Sbjct: 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGAT 354
Query: 904 DTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESG 963
DT F D + +SG LS+ +E +
Sbjct: 355 DTCNF-----------------DLVEDGLTAMVSGGGETLSDIRE------------GAP 385
Query: 964 SSVNYSFSNFSFKNLSQLAS 983
V+ F +S+ ++ S
Sbjct: 386 LGVHLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 415 bits (1068), Expect = e-136
Identities = 125/424 (29%), Positives = 200/424 (47%), Gaps = 73/424 (17%)
Query: 568 DDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM 627
+ + + + R +DFEI+K I RGAFG V + K + +FA+K+L K +M
Sbjct: 53 LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112
Query: 628 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCL 686
+++ ERD+L++ + ++ Y+F NLYLVM+Y GGDL +LL L
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
E++AR Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV- 231
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTA 801
+ AVGTPDY++PEIL +G
Sbjct: 232 -----------------------------QSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 802 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLT 859
DWWS+G+ ++E++ G PF AE + + I+N K +P ++S A DLI R +
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC 322
Query: 860 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 919
H RLG G + K+H FF I+WD + +A ++P S DTS F D
Sbjct: 323 SREH-RLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF---------DV 372
Query: 920 NIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFKNLS 979
D + +++++ + S + F F++ +
Sbjct: 373 ------DDDCLKNSETMPPPTHTAF-------------------SGHHLPFVGFTYTSSC 407
Query: 980 QLAS 983
L+
Sbjct: 408 VLSD 411
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-133
Identities = 106/337 (31%), Positives = 173/337 (51%), Gaps = 35/337 (10%)
Query: 560 IEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAI 619
++ A SL+ + P + +DF+ K + G+F V LA++ T +AI
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 620 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679
K+L+K +I++N V + ERD++ + +PF V+ +++F E LY + Y G+L
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+R +G DE R Y AE+V ALEYLH ++HRDLKP+N+L+ D HI++TDFG +KV
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
S + S VGT Y++PE+L
Sbjct: 181 SPESKQA-----------------------------RANSFVGTAQYVSPELLTEKSACK 211
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 859
++D W++G I+++L+ G+PPF A + IF I+ + +P + P+A DL+++ L
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KFFPKARDLVEKLLV 268
Query: 860 EDPHQRLGSG---GASEVKQHVFFKDINWDTLARQKA 893
D +RLG G +K H FF+ + W+ L +Q
Sbjct: 269 LDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-133
Identities = 114/329 (34%), Positives = 183/329 (55%), Gaps = 42/329 (12%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ S+ DF+I++ + G+FGRV L + R G +A+KVLKK ++R VE ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
V +PF++R + +F + ++++M+Y+ GG+L+SLLR VA+ Y AEV LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +++RDLKP+N+L+ +GHIK+TDFG +K P
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----------------------YVPD 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+T + GTPDY+APE++ + + DWWS GI+++E++ G PF +
Sbjct: 159 VT-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKD 882
+ ++ ILN ++ +P + + DL+ R +T D QRLG+ G +VK H +FK+
Sbjct: 208 TMKTYEKILNAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
Query: 883 INWDTLARQK--AAFVPTSESA-LDTSYF 908
+ W+ L + + P + DTS F
Sbjct: 265 VVWEKLLSRNIETPYEPPIQQGQGDTSQF 293
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-132
Identities = 129/388 (33%), Positives = 206/388 (53%), Gaps = 56/388 (14%)
Query: 549 TDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLA 608
K +V E A ++D ++ T PS++ +D F+ IK + G+FGRV L
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWET----PSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 609 KKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668
K + +G+ +A+K+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VM
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728
EY+ GG+++S LR +G E AR Y A++VL EYLHSL +++RDLKP+NLLI G+I
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788
++TDFG +K V G T + GTP+ LA
Sbjct: 181 QVTDFGFAKR-------------VKGRT---------------------WTLCGTPEALA 206
Query: 789 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSP 848
PEI+L G+ DWW++G++++E+ G PPF A+ P QI++ I++ K+ +P S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS---HFSS 263
Query: 849 EAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALD 904
+ DL+ L D +R G+ G +++K H +F +W + ++K A F+P + D
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323
Query: 905 TSYFTSRYSWNTTDENIYPASDFEDSSD 932
TS F D+ Y + S +
Sbjct: 324 TSNF---------DD--YEEEEIRVSIN 340
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-130
Identities = 142/471 (30%), Positives = 222/471 (47%), Gaps = 84/471 (17%)
Query: 528 TFGARIEKLIREKYLQLCELVTDDKVDITSTVIEE--DAPLE-----DDVVRSLRTSPIH 580
+F R EK+ E+ +D +D ++ + L D+ + + +
Sbjct: 1 SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINK 60
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
R +D+E++K I RGAFG V L + ++T ++A+K+L K +MI+++ ER
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
DI+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ N + E AR Y AEVVL
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVL 179
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL+ +HS+ +HRD+KPDN+L+ GH+KL DFG
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--------------- 224
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVG 816
+ +AVGTPDY++PE+L G +G DWWSVG+ L+E++VG
Sbjct: 225 ---------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 817 IPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
PF A+ + I+N K + +P ++S EA +LI FLT D RLG G E+
Sbjct: 270 DTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFLT-DREVRLGRNGVEEI 327
Query: 875 KQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSD 932
K+H+FFK+ W + A VP S +DTS F D+ ED +
Sbjct: 328 KRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF---------DD------LEEDKGE 372
Query: 933 ADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFKNLSQLAS 983
++ + + N+ F F++ + + S
Sbjct: 373 EETFPIPKAFVGNQLP---------------------FVGFTYYSNRRYLS 402
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-129
Identities = 121/341 (35%), Positives = 190/341 (55%), Gaps = 42/341 (12%)
Query: 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-N 631
+ ++ ++ + FE+++ + +G +G+VF +K T TG +FA+KVLKKA ++R
Sbjct: 4 ETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK 63
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
AER+IL V++PF+V Y+F LYL++EYL+GG+L+ L G ED A
Sbjct: 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA 123
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
Y+AE+ +AL +LH +++RDLKP+N+++ H GH+KLTDFGL K + + T
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT------- 176
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
T + GT +Y+APEIL+ +GH DWWS+G +++
Sbjct: 177 ---VT---------------------HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 812 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG-- 869
+++ G PPF E+ ++ D IL K+ P ++ EA DL+ + L + RLG+G
Sbjct: 213 DMLTGAPPFTGENRKKTIDKILKCKLNLPP---YLTQEARDLLKKLLKRNAASRLGAGPG 269
Query: 870 GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
A EV+ H FF+ INW+ L +K F P +S D S F
Sbjct: 270 DAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-129
Identities = 122/350 (34%), Positives = 191/350 (54%), Gaps = 42/350 (12%)
Query: 566 LEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVL 622
+E + T + ++ FE++K + +G+FG+VFL KK + L+A+KVL
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
KKA + ++ V ERDIL+ V +PF+V+ Y+F LYL++++L GGDL++ L
Sbjct: 61 KKATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
E+ + Y+AE+ LAL++LHSL +++RDLKP+N+L+ +GHIKLTDFGLSK + +
Sbjct: 120 EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
S GT +Y+APE++ GH +AD
Sbjct: 180 ----------EKKA---------------------YSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WWS G+++FE++ G PF + ++ IL K+ P+ +SPEA L+ +P
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ---FLSPEAQSLLRMLFKRNP 265
Query: 863 HQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
RLG+G G E+K+H FF I+W+ L R++ F P + DT YF
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYF 315
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-127
Identities = 122/357 (34%), Positives = 192/357 (53%), Gaps = 47/357 (13%)
Query: 565 PLEDDVVRSLRTSPIHPS---------KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD 615
P E +++ + P PS DF +K I +G+FG+V LA+ +
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV 64
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674
+A+KVL+K +++K + I++ER++L+ +V++PF+V +SF + LY V++Y+NGG
Sbjct: 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124
Query: 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
+L+ L+ C E AR Y AE+ AL YLHSL +V+RDLKP+N+L+ GHI LTDFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L K + + + TT + GTP+YLAPE+L
Sbjct: 185 LCKENIEH----------NSTT---------------------STFCGTPEYLAPEVLHK 213
Query: 795 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLI 854
+ T DWW +G +L+E++ G+PPF + + +++DNILN+ + ++ A L+
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP---NITNSARHLL 270
Query: 855 DRFLTEDPHQRLGSG-GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
+ L +D +RLG+ E+K HVFF INWD L +K F P D +F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-127
Identities = 122/328 (37%), Positives = 186/328 (56%), Gaps = 38/328 (11%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ +++DF+ +K + +G FG+V L +++ TG +A+K+L+K +I K+ V + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+ R+PF+ Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS VV+RD+K +NL++ DGHIK+TDFGL K G+ + T
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----------GATM-------- 162
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
++ GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 163 -------------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKD 882
+++F+ IL +I +PR +SPEA L+ L +DP QRLG G A EV +H FF
Sbjct: 210 HERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
Query: 883 INWDTLARQK--AAFVPTSESALDTSYF 908
INW + ++K F P S +DT YF
Sbjct: 267 INWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-125
Identities = 130/357 (36%), Positives = 200/357 (56%), Gaps = 48/357 (13%)
Query: 567 EDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLK 623
V LRT+ + ++ I++FE++K + GA+G+VFL +K + TG L+A+KVLK
Sbjct: 32 LLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK 91
Query: 624 KADMIRK-NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 681
KA +++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L
Sbjct: 92 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 151
Query: 682 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741
E ++Y+ E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK +
Sbjct: 152 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211
Query: 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGT 799
+ T+ GT +Y+AP+I+ G +GH
Sbjct: 212 DETE---------RA---------------------YDFCGTIEYMAPDIVRGGDSGHDK 241
Query: 800 TADWWSVGIILFELIVGIPPFNAEH----PQQIFDNILNRKIPWPRVPEEMSPEAHDLID 855
DWWS+G++++EL+ G PF + +I IL + P+P+ EMS A DLI
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ---EMSALAKDLIQ 298
Query: 856 RFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
R L +DP +RLG G A E+K+H+FF+ INWD LA +K A F P LD S F
Sbjct: 299 RLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-125
Identities = 123/334 (36%), Positives = 189/334 (56%), Gaps = 40/334 (11%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
S +R ID+FE I+ + +G+FG+V LA+ + TGDL+A+KVLKK +++ + VE + E+
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 641 DILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
IL RN PF+ + F F + L+ VME++NGGDL ++ DE AR Y AE++
Sbjct: 75 RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
AL +LH +++RDLK DN+L+ H+GH KL DFG+ K G+ N TT
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV----------TT--- 181
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
+ GTPDY+APEIL +G DWW++G++L+E++ G P
Sbjct: 182 ------------------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG---GASEVKQ 876
F AE+ +F+ ILN ++ +P + +A ++ F+T++P RLGS G + +
Sbjct: 224 FEAENEDDLFEAILNDEVVYPT---WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280
Query: 877 HVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
H FFK+I+W L ++ F P +S D S F
Sbjct: 281 HPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF 314
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-124
Identities = 117/331 (35%), Positives = 186/331 (56%), Gaps = 39/331 (11%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
+ + I+DF + K + +G+FG+VFLA+ + T FAIK LKK ++ + VE + E+
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 641 DIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+L ++ +PF+ F +F +ENL+ VMEYLNGGDL +++ D A Y AE++
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L L++LHS +V+RDLK DN+L+ DGHIK+ DFG+ K ++ T
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----------DAKT--- 175
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
+ GTPDY+APEILLG + + DWWS G++L+E+++G P
Sbjct: 176 ------------------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
Query: 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
F+ + +++F +I +PR + EA DL+ + +P +RLG G +++QH
Sbjct: 218 FHGQDEEELFHSIRMDNPFYPR---WLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPL 272
Query: 880 FKDINWDTLARQK--AAFVPTSESALDTSYF 908
F++INW+ L R++ F P +S D S F
Sbjct: 273 FREINWEELERKEIDPPFRPKVKSPFDCSNF 303
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-122
Identities = 131/377 (34%), Positives = 197/377 (52%), Gaps = 40/377 (10%)
Query: 538 REKYLQLCELVTDD-KVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKP 596
RE++ + V D K + + D+ + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKL 155
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG+V L K++ TG +A+K+LKK ++ K+ V L E +L + R+PF+ Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDL 715
SF + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS + VV+RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K +NL++ DGHIK+TDFGL K E ++
Sbjct: 276 KLENLMLDKDGHIKITDFGLCK-------------------------------EGIKDGA 304
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 835
++ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ IL
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
Query: 836 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQKA 893
+I +PR + PEA L+ L +DP QRLG G A E+ QH FF I W + +K
Sbjct: 365 EIRFPR---TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421
Query: 894 A--FVPTSESALDTSYF 908
+ F P S DT YF
Sbjct: 422 SPPFKPQVTSETDTRYF 438
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-122
Identities = 104/341 (30%), Positives = 184/341 (53%), Gaps = 40/341 (11%)
Query: 573 SLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
++ + ++DR + DF + + +G+FG+V L++++ T +L+A+K+LKK +I+ +
Sbjct: 4 TVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 63
Query: 633 VESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
VE + E+ +L PF+ + F + LY VMEY+NGGDL ++ +G E A
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA 123
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
Y AE+ + L +L S +++RDLK DN+++ +GHIK+ DFG+ K + +
Sbjct: 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------- 176
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
TT ++ GTPDY+APEI+ +G + DWW+ G++L+
Sbjct: 177 ---TT---------------------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 812 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG-- 869
E++ G PF E ++F +I+ + +P+ MS EA + +T+ P +RLG G
Sbjct: 213 EMLAGQAPFEGEDEDELFQSIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPE 269
Query: 870 GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
G ++K+H FF+ I+W+ L R++ + P + + F
Sbjct: 270 GERDIKEHAFFRYIDWEKLERKEIQPPYKPKA-CGRNAENF 309
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-122
Identities = 104/342 (30%), Positives = 176/342 (51%), Gaps = 49/342 (14%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+ D + DF++++ I RG++ +V L + + T ++A+KV+KK + ++ + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 642 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ N PF+V F L+ V+EY+NGGDL ++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL YLH +++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ + GTP+Y+APEIL G +G + DWW++G+++FE++ G PF
Sbjct: 162 -----------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 821 NAEHP---------QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG-- 869
+ +F IL ++I PR +S +A ++ FL +DP +RLG
Sbjct: 211 DIVGSSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQ 267
Query: 870 -GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
G ++++ H FF++++WD + +++ F P F
Sbjct: 268 TGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 309
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-121
Identities = 91/342 (26%), Positives = 165/342 (48%), Gaps = 45/342 (13%)
Query: 577 SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI 636
P+ + + D FEI++ I +G+FG+V + +K T ++A+K + K + +N V ++
Sbjct: 3 PPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E I+ + +PF+V +YSF E++++V++ L GGDL L+ E+ +++I
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
E+V+AL+YL + R++HRD+KPDN+L+ GH+ +TDF ++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------- 163
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFEL 813
+ + GT Y+APE+ G G+ DWWS+G+ +EL
Sbjct: 164 -------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
Query: 814 IVGIPPF---NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 870
+ G P+ ++ ++I + +P S E L+ + L +P QR
Sbjct: 211 LRGRRPYHIRSSTSSKEIVHTFETTVVTYPS---AWSQEMVSLLKKLLEPNPDQRF--SQ 265
Query: 871 ASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTS 910
S+V+ + DINWD + +++ F+P F
Sbjct: 266 LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFEL 307
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-120
Identities = 103/356 (28%), Positives = 180/356 (50%), Gaps = 49/356 (13%)
Query: 568 DDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM 627
++ ++ T + + DF++++ I RG++ +V L + + T ++A++V+KK +
Sbjct: 31 EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV 90
Query: 628 IRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 686
++ + E+ + N PF+V F L+ V+EY+NGGDL ++ L
Sbjct: 91 NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL 150
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
E+ AR Y AE+ LAL YLH +++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 151 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL------ 204
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
+ + GTP+Y+APEIL G +G + DWW++
Sbjct: 205 -------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 807 GIILFELIVGIPPFNAEHP---------QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 857
G+++FE++ G PF+ +F IL ++I PR +S +A ++ F
Sbjct: 240 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSF 296
Query: 858 LTEDPHQRLGSG---GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
L +DP +RLG G ++++ H FF++++WD + +++ F P F
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 352
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 372 bits (955), Expect = e-116
Identities = 106/353 (30%), Positives = 188/353 (53%), Gaps = 40/353 (11%)
Query: 561 EEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
+ E+ ++ + ++DR + DF + + +G+FG+V L++++ T +L+A+K
Sbjct: 313 QGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 621 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679
+LKK +I+ + VE + E+ +L PF+ + F + LY VMEY+NGGDL
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
++ +G E A Y AE+ + L +L S +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 433 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
+ + TT ++ GTPDY+APEI+ +G
Sbjct: 493 IWD----------GVTT---------------------KTFCGTPDYIAPEIIAYQPYGK 521
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 859
+ DWW+ G++L+E++ G PF E ++F +I+ + +P+ MS EA + +T
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---SMSKEAVAICKGLMT 578
Query: 860 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYF 908
+ P +RLG G G ++K+H FF+ I+W+ L R++ + P + S + F
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA-SGRNAENF 630
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 361 bits (927), Expect = e-114
Identities = 103/440 (23%), Positives = 183/440 (41%), Gaps = 63/440 (14%)
Query: 510 EDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITSTVIEEDAPLEDD 569
+ LR + A L E + D + L
Sbjct: 100 DALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAH--LGQA 157
Query: 570 VVRSLRTSPI--------HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV 621
+ S D F + + RG FG VF + + TG L+A K
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK 217
Query: 622 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL----Y 677
L K + ++ + + E+ IL V + F+V Y+F + +L LVM +NGGD+ Y
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
++ + E A Y A++V LE+LH +++RDLKP+N+L+ DG+++++D GL+
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
E + + K + GTP ++APE+LLG +
Sbjct: 338 -------------------------------ELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 798 GTTADWWSVGIILFELIVGIPPFNAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHDL 853
+ D++++G+ L+E+I PF A +++ +L + + +P + SP + D
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD---KFSPASKDF 423
Query: 854 IDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVP-----TSESALD 904
+ L +DP +RLG ++ H F+DI+W L FVP +++ D
Sbjct: 424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQD 483
Query: 905 TSYFTSR--YSWNTTDENIY 922
F++ ++ D +
Sbjct: 484 VGAFSTVKGVAFEKADTEFF 503
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-111
Identities = 110/390 (28%), Positives = 174/390 (44%), Gaps = 63/390 (16%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+++DF + + I RG FG V+ +K TG ++A+K L K + K L ER
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 642 ILISVRN---PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+L V PF+V Y+F + L +++ +NGGDL+ L G E R Y AE+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L LE++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-------------- 347
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGI 817
++VGT Y+APE+L G + ++ADW+S+G +LF+L+ G
Sbjct: 348 -------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 818 PPFNAEHP---QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GAS 872
PF +I L + P+ SPE L++ L D ++RLG GA
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 445
Query: 873 EVKQHVFFKDINWDTLARQK--AAFVPT-----SESALDTSYFTSRYSWNTTDENIYPAS 925
EVK+ FF+ ++W + QK +P + A D F +
Sbjct: 446 EVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKL------- 498
Query: 926 DFEDSSDADSLSGSSSCLSNR-QEEVGDEC 954
SD + +S R Q+EV +
Sbjct: 499 ---LDSDQELYRNFPLTISERWQQEVAETV 525
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-109
Identities = 94/336 (27%), Positives = 154/336 (45%), Gaps = 45/336 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642
+ + + F + + +G FG V + R TG ++A K L+K + ++ L E+ I
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVL 700
L V + FVV Y++ ++ L LV+ +NGGDL + ++G E A Y AE+
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
LE LH R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV----------------------- 334
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
H E + + VGT Y+APE++ + + DWW++G +L+E+I G PF
Sbjct: 335 ---------HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385
Query: 821 NAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEV 874
+++ + + SP+A L + L +DP +RLG A EV
Sbjct: 386 QQRKKKIKREEVERLVKEVPEEYSE---RFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442
Query: 875 KQHVFFKDINWDTLARQKAA--FVPTSESALDTSYF 908
K+H FK +N+ L F P ++
Sbjct: 443 KEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVL 478
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-103
Identities = 91/306 (29%), Positives = 154/306 (50%), Gaps = 39/306 (12%)
Query: 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES 635
T+ K + +IDDF+I +P+ +G FG V+LA+++ + A+KVL K+ + ++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
+ E +I +R+P ++R + F R+ +YL++E+ G+LY L+ G DE + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
E+ AL Y H +V+HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
RR+ + GT DYL PE++ G H D W G++ +E +V
Sbjct: 163 -------------HAPSLRRR--TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
G+PPF++ + I+N + + P +S + DLI + L P QRL V
Sbjct: 208 GMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDLISKLLRYHPPQRL---PLKGVM 261
Query: 876 QHVFFK 881
+H + K
Sbjct: 262 EHPWVK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = e-102
Identities = 93/299 (31%), Positives = 146/299 (48%), Gaps = 39/299 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642
K + +++DFEI +P+ +G FG V+LA+++ + + A+KVL KA + + + E +I
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+R+P ++R + F +YL++EY G +Y L+ L DE YI E+ AL
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y HS RV+HRD+KP+NLL+ G +K+ DFG S
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------------------- 157
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
++ GT DYL PE++ G H D WS+G++ +E +VG PPF A
Sbjct: 158 --------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
Q+ + I + P+ ++ A DLI R L +P QR EV +H +
Sbjct: 210 NTYQETYKRISRVEF---TFPDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWIT 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-86
Identities = 70/351 (19%), Positives = 143/351 (40%), Gaps = 80/351 (22%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK--------- 630
+ + I+D+ II+ +++G F ++ L +K +A+K +K+ + +K
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 631 -----NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 685
+ + E I+ ++N + + T + +Y++ EY+ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 686 LD--------EDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDGHIKLTDFGLS 736
LD V + I V+ + Y+H+ + + HRD+KP N+L+ +G +KL+DFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
+ ++ K + GT +++ PE
Sbjct: 200 E-------------------------------YMVDKKIK--GSRGTYEFMPPEFFSNES 226
Query: 797 --HGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNILNRKIPWPRVPEE-------- 845
+G D WS+GI L+ + + PF+ + ++F+NI + I +P
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNK 286
Query: 846 --------MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888
+S E D + FL ++P +R+ + + +H + D N + L
Sbjct: 287 KSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIEDL 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-85
Identities = 85/320 (26%), Positives = 140/320 (43%), Gaps = 42/320 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DFE I + +GAFG+V A+ +AIK ++ + + +IL+E +L S+ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 649 PFVVRFFYSFTCREN-------------LYLVMEYLNGGDLYSLLRNLGC-LDEDVARVY 694
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+++ AL Y+HS ++HRDLKP N+ I ++K+ DFGL+K
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV-----HRSLDILKLD 176
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFEL 813
+ L LT SA+GT Y+A E+L GTGH D +S+GII FE+
Sbjct: 177 SQNLPGSSDNLT------------SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872
I P I + + I +P + +I + DP++R GA
Sbjct: 225 I--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GAR 279
Query: 873 EVKQHVFFKDINWDTLARQK 892
+ + + D + ++
Sbjct: 280 TLLNSGWLPVKHQDEVIKEA 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 9e-85
Identities = 81/302 (26%), Positives = 145/302 (48%), Gaps = 38/302 (12%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
+ I+DF++ + +G+F V+ A+ TG AIK++ K M + V+ + E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVV 699
I +++P ++ + F +YLV+E + G++ L+N + E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ YLHS ++HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
T + E+ + GTP+Y++PEI + HG +D WS+G + + L++G PP
Sbjct: 160 ------TQLKMPHEKHY--TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
F+ + + + ++ +P +S EA DLI + L +P RL S V H F
Sbjct: 212 FDTDTVKNTLNKVVLADY---EMPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPF 265
Query: 880 FK 881
Sbjct: 266 MS 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 1e-84
Identities = 79/341 (23%), Positives = 125/341 (36%), Gaps = 48/341 (14%)
Query: 546 ELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTS--IDDFEIIKPISRGAFG 603
+L T++ + ++ SP + S F+ + + G++G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 604 RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662
VF + + G L+A+K K+ LAE V ++P VR ++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721
LYL E G L G L E Y+ + +LAL +LHS +VH D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 781
+ G KL DFGL + +
Sbjct: 190 LGPRGRCKLGDFGLLVE--LGTAG------------------------------AGEVQE 217
Query: 782 GTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP-PFNAEHPQQIFDNILNRKIPWP 840
G P Y+APE+L G +GT AD +S+G+ + E+ + P E QQ+ L P
Sbjct: 218 GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----P 271
Query: 841 RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+S E ++ L DP R A + +
Sbjct: 272 EFTAGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLR 309
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 7e-83
Identities = 86/299 (28%), Positives = 137/299 (45%), Gaps = 37/299 (12%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642
D S + + + +G F + F T ++FA K++ K+ +++ + E + E I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
S+ + VV F F + +++V+E L L + L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+YLH RV+HRDLK NL + D +K+ DFGL+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------------------------- 162
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
T E+ ER+K GTP+Y+APE+L GH D WS+G I++ L+VG PPF
Sbjct: 163 ---TKVEYDGERKK--VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
++ + I + P+ ++P A LI + L DP R +E+ FF
Sbjct: 218 SCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 5e-82
Identities = 86/302 (28%), Positives = 137/302 (45%), Gaps = 37/302 (12%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
D S + + + +G F + F T ++FA K++ K+ +++ + E + E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
I S+ + VV F F + +++V+E L L + L E AR Y+ ++V
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L +YLH RV+HRDLK NL + D +K+ DFGL+
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA----------------------- 188
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
T E+ ER+K GTP+Y+APE+L GH D WS+G I++ L+VG PP
Sbjct: 189 ------TKVEYDGERKK--VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
F ++ + I + P+ ++P A LI + L DP R +E+ F
Sbjct: 241 FETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEF 294
Query: 880 FK 881
F
Sbjct: 295 FT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 1e-79
Identities = 75/303 (24%), Positives = 139/303 (45%), Gaps = 39/303 (12%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+ S++ + ++ I G+FG+ L K G + IK + + M K E E
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVA 75
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVV 699
+L ++++P +V++ SF +LY+VM+Y GGDL+ + + ED + ++
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
LAL+++H +++HRD+K N+ + DG ++L DFG+++V +NST +L
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL------------ 181
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
R+ +GTP YL+PEI + +D W++G +L+EL
Sbjct: 182 -----------------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
Query: 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
F A + + I++ P V S + L+ + +P R + + + F
Sbjct: 225 FEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGF 279
Query: 880 FKD 882
Sbjct: 280 IAK 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-75
Identities = 79/308 (25%), Positives = 144/308 (46%), Gaps = 48/308 (15%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
+ +D+E++ I G++GR ++++ G + K L M + +++E ++L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 646 VRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVV 699
+++P +VR++ R N LY+VMEY GGDL S++ LDE+ + ++
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 700 LALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
LAL+ H V+HRDLKP N+ + ++KL DFGL+++ +N +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
++ VGTP Y++PE + + +D WS+G +L+EL
Sbjct: 174 -----------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 210
Query: 815 VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
+PPF A +++ I K R+P S E +++I R L + R E+
Sbjct: 211 ALMPPFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEI 265
Query: 875 KQHVFFKD 882
++ +
Sbjct: 266 LENPLILE 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 3e-74
Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 38/300 (12%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
+ + P ++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLD 687
A + E D+L + +P V++++ SF L +V+E + GDL ++++ +
Sbjct: 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
E Y ++ ALE++HS RV+HRD+KP N+ I G +KL D GL + +S
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTA 192
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807
S VGTP Y++PE + G+ +D WS+G
Sbjct: 193 -----------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 808 IILFELIVGIPPFNAE--HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+L+E+ PF + + + I P P + S E L++ + DP +R
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-73
Identities = 73/312 (23%), Positives = 136/312 (43%), Gaps = 43/312 (13%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ DFE I+ + RG FG VF AK + +AIK ++ + + A E ++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 648 NPFVVRFFYSFTCREN------------LYLVMEYLNGGDLYSLL---RNLGCLDEDVAR 692
+P +VR+F ++ + LY+ M+ +L + + + V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
++ A+E+LHS ++HRDLKP N+ D +K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA-------------- 167
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
+ +E + T + VGT Y++PE + G + D +S+G+ILFE
Sbjct: 168 -----MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 813 LIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872
L+ P + ++ R + +P + + P + ++ L+ P +R A
Sbjct: 223 LLY--PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAI 275
Query: 873 EVKQHVFFKDIN 884
+ ++ F+D++
Sbjct: 276 NIIENAVFEDLD 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 4e-72
Identities = 71/323 (21%), Positives = 123/323 (38%), Gaps = 51/323 (15%)
Query: 573 SLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
L T ++ + I+K I G +VF ++AIK + +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQT 69
Query: 633 VESILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV 690
++S E L ++ + ++R + + +Y+VME DL S L+ +D
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++T +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV--- 184
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGT 799
K S VGT +Y+ PE +
Sbjct: 185 --------------------------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 800 TADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 858
+D WS+G IL+ + G PF + I++ P+ + D++ L
Sbjct: 219 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCL 277
Query: 859 TEDPHQRLGSGGASEVKQHVFFK 881
DP QR+ E+ H + +
Sbjct: 278 KRDPKQRI---SIPELLAHPYVQ 297
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-71
Identities = 66/318 (20%), Positives = 126/318 (39%), Gaps = 69/318 (21%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D+ DF+ I+ I G FG+VF AK R G + IK +K + E E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58
Query: 644 ISVRNPFVVRFFYSF----------------TCRENLYLVMEYLNGGDLYSLL--RNLGC 685
+ + +V + + + + L++ ME+ + G L + R
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 686 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
LD+ +A ++ ++Y+HS ++++RDLKP N+ + +K+ DFGL + +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
+ + GT Y++PE + +G D ++
Sbjct: 177 KRT------------------------------RSKGTLRYMSPEQISSQDYGKEVDLYA 206
Query: 806 VGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 864
+G+IL EL+ V F + F ++ + I + + L+ + L++ P
Sbjct: 207 LGLILAELLHVCDTAFET---SKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPED 258
Query: 865 RLGSGGASEVKQHVFFKD 882
R SE+ + +
Sbjct: 259 RP---NTSEILRTLTVWK 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-71
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 51/306 (16%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-- 647
+ I+K I G +VF ++AIK + + ++S E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ ++R + + +Y+VME DL S L+ +D + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+VH DLKP N LI DG +KL DFG++ ++T +
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV-------------------- 165
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIVG 816
K S VGT +Y+ PE + +D WS+G IL+ + G
Sbjct: 166 ---------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
Query: 817 IPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
PF + I++ P+ + D++ L DP QR+ E+
Sbjct: 217 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELL 272
Query: 876 QHVFFK 881
H + +
Sbjct: 273 AHPYVQ 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 8e-71
Identities = 88/297 (29%), Positives = 142/297 (47%), Gaps = 51/297 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F ++ + GAF VFL K+R TG LFA+K +KK+ R +++E+ E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V + + YLVM+ ++GG+L+ + G E A + I +V+ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+NLL + I +TDFGLSK+ ++ +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---------------------EQNGIM 164
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ +A GTP Y+APE+L + D WS+G+I + L+ G PPF E
Sbjct: 165 S------------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
++F+ I W + S A D I L +DP++R + H
Sbjct: 213 SKLFEKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY---TCEKALSH 262
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 4e-70
Identities = 81/302 (26%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D++++ + + +GAF V +TTG FA K++ + ++ + + E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQH 64
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHR+LKP+NLL+A +KL DFGL+ + D E
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-------------------VNDSEAWH 165
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
GTP YL+PE+L + D W+ G+IL+ L+VG PPF E
Sbjct: 166 G-------------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+++ I W V +PEA LID LT +P +R+ A + + +
Sbjct: 213 HRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWI 265
Query: 881 KD 882
+
Sbjct: 266 CN 267
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 8e-70
Identities = 87/309 (28%), Positives = 143/309 (46%), Gaps = 48/309 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D ++ + + +G+FG V L K + TG A+KV+ K + +K ES+L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + F + YLV E GG+L+ + + E A I +V+ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
++VHRDLKP+NLL+ D +I++ DFGLS ++ +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKD---------------- 187
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+GT Y+APE+L GT + D WS G+IL+ L+ G PPFN +
Sbjct: 188 --------------KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANE 232
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
I + K W +V S A DLI + LT P R+ A + H +
Sbjct: 233 YDILKKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRI---SARDALDHEWI 285
Query: 881 KDINWDTLA 889
+ + ++
Sbjct: 286 QTYTKEQIS 294
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-69
Identities = 83/302 (27%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I+ + +G+FG V K R T +A+KV+ KA K+ +IL E ++L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ F + Y+V E GG+L+ + E A I +V + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+N+L+ D IK+ DFGLS +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK----------------- 181
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+GT Y+APE+L GT + D WS G+IL+ L+ G PPF ++
Sbjct: 182 -------------DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
I + K W + S +A DLI + LT P R+ A++ +H +
Sbjct: 228 YDILKRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWI 280
Query: 881 KD 882
+
Sbjct: 281 QK 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-69
Identities = 86/317 (27%), Positives = 144/317 (45%), Gaps = 52/317 (16%)
Query: 580 HPSKDRTSI-------DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
H S R ++ D F + + GAFG V L ++R++G IK + K +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVP 63
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY----SLLRNLGCLDE 688
+E I AE ++L S+ +P +++ F F N+Y+VME GG+L S L E
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 689 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTD 745
+ +++ AL Y HS VVH+DLKP+N+L IK+ DFGL+++ S +
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDE 181
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
+ +A GT Y+APE+ D WS
Sbjct: 182 HST------------------------------NAAGTALYMAPEVFKR-DVTFKCDIWS 210
Query: 806 VGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G++++ L+ G PF +++ ++ + ++P+A DL+ + LT+DP +R
Sbjct: 211 AGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR 270
Query: 866 LGSGGASEVKQHVFFKD 882
A++V H +FK
Sbjct: 271 P---SAAQVLHHEWFKQ 284
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-68
Identities = 69/321 (21%), Positives = 120/321 (37%), Gaps = 51/321 (15%)
Query: 575 RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
+ S + I+K I G +VF ++AIK + + ++
Sbjct: 42 KASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLD 99
Query: 635 SILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
S E L ++ + ++R + + +Y+VME DL S L+ +D +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 158
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++T +
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV----- 212
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTA 801
K S VG +Y+ PE + +
Sbjct: 213 ------------------------KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 802 DWWSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 860
D WS+G IL+ + G PF + I++ P+ + D++ L
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKR 307
Query: 861 DPHQRLGSGGASEVKQHVFFK 881
DP QR+ E+ H + +
Sbjct: 308 DPKQRI---SIPELLAHPYVQ 325
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-68
Identities = 70/349 (20%), Positives = 122/349 (34%), Gaps = 86/349 (24%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
TS + + + +GA VF + + TGDLFAIKV +R V+ + E ++L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63
Query: 646 VRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVL 700
+ + +V+ F T + L+ME+ G LY++L N L E + + +VV
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 701 ALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ +L +VHR++KP N++ KLTDFG ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR------------------- 164
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL--------LGTGHGTTADWWSVGI 808
++ + S GT +YL P++ +G T D WS+G+
Sbjct: 165 -------------ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 809 ILFELIVGIPPFNAEHP----QQIFDNILNRKIP----------------------WPRV 842
+ G PF +++ I+ K +
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 843 PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 891
+ ++ L D + G + D L R
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCW---GFDQFFAET------SDILHRG 311
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-68
Identities = 81/302 (26%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D++++ + + +GAF V +TTG FA K++ + + + E I +++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQH 87
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHR+LKP+NLL+A +KL DFGL+ +N ++ G
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHG---------------- 189
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
GTP YL+PE+L + D W+ G+IL+ L+VG PPF E
Sbjct: 190 --------------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+++ I W V +PEA LID LT +P +R+ A + + +
Sbjct: 236 HRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWI 288
Query: 881 KD 882
+
Sbjct: 289 CN 290
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-68
Identities = 79/345 (22%), Positives = 130/345 (37%), Gaps = 85/345 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA--VESILAERDILISV 646
+ + I +G++G V +A + T + AIK++ K + + N VE I E ++ +
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---------------------- 684
+P + R + + + + LVME +GG L L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 685 ------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726
E + + ++ AL YLH+ + HRD+KP+N L + +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 727 --HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 784
IKL DFGLSK + E + GTP
Sbjct: 206 SFEIKLVDFGLSKE---------------------------FYKLNNGEYYGMTTKAGTP 238
Query: 785 DYLAPEILLGTGH--GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI----- 837
++APE+L T G D WS G++L L++G PF + +LN+K+
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP 298
Query: 838 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+ + SP A DL+ L + +R A QH +
Sbjct: 299 NYNVL----SPLARDLLSNLLNRNVDERF---DAMRALQHPWISQ 336
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 85/328 (25%), Positives = 130/328 (39%), Gaps = 59/328 (17%)
Query: 581 PSKDRTS--IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV----- 633
P T +++E + + RG V + T +A+K++ +A
Sbjct: 7 PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 634 -ESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
E+ L E DIL V P +++ ++ +LV + + G+L+ L L E
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
R + ++ + LH L +VHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------------- 173
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWS 805
L E GTP YLAPEI+ G+G D WS
Sbjct: 174 ------LDPGEKLRE-------------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 806 VGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTE 860
G+I++ L+ G PPF + I++ W S DL+ RFL
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVV 270
Query: 861 DPHQRLGSGGASEVKQHVFFKDINWDTL 888
P +R A E H FF+ + +
Sbjct: 271 QPQKRY---TAEEALAHPFFQQYVVEEV 295
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 5e-68
Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 51/302 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I RG++G V +A ++ T A K + K + V+ E +I+ S+ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P ++R + +F ++YLVME GG+L+ + + E A + +V+ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
V HRDLKP+N L D +KL DFGL+ +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMM------------------ 165
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
R+ VGTP Y++P++L G +G D WS G++++ L+ G PPF+A
Sbjct: 166 ------------RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD 212
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
++ I W V SP+A LI R LT+ P QR+ + + +H +F
Sbjct: 213 SEVMLKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQALEHEWF 265
Query: 881 KD 882
+
Sbjct: 266 EK 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 5e-68
Identities = 95/367 (25%), Positives = 162/367 (44%), Gaps = 69/367 (18%)
Query: 534 EKLIREKYLQLCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSI-DDFE 592
E + + K L + ++ ++ + + V + S ++ D++
Sbjct: 90 ELVGKGKR---RPLNNNSEIALSLS--------RNKVFVFFDLTVDDQSVYPKALRDEYI 138
Query: 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK-----ADMIRKNAVESILAERDILISVR 647
+ K + GA G V LA +R T AI+++ K + ++ E +IL +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+P +++ F E+ Y+V+E + GG+L+ + L E ++Y +++LA++YLH
Sbjct: 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 708 LRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
++HRDLKP+N+L++ D IK+TDFG SK+ LG+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-------------------LGETSLM 298
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFN 821
T GTP YLAPE+L+ G+ D WS+G+ILF + G PPF+
Sbjct: 299 RT-------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 822 AEH-PQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
+ D I + K W V S +A DL+ + L DP R E
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTEEAL 398
Query: 876 QHVFFKD 882
+H + +D
Sbjct: 399 RHPWLQD 405
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 6e-68
Identities = 88/320 (27%), Positives = 143/320 (44%), Gaps = 56/320 (17%)
Query: 580 HPSKDRTSI-------DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
H S R ++ + + I+ + +G+FG V K R T +A+KV+ KA K+
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD- 64
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+IL E ++L + +P +++ F + Y+V E GG+L+ + E A
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSG 749
I +V + Y+H +VHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST------------ 172
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
Q+ K + +GT Y+APE+L GT + D WS G+I
Sbjct: 173 --------------------CFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVI 211
Query: 810 LFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQ 864
L+ L+ G PPF ++ I + K W + S +A DLI + LT P
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSL 267
Query: 865 RLGSGGASEVKQHVFFKDIN 884
R+ A++ +H + + +
Sbjct: 268 RI---TATQCLEHPWIQKYS 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-67
Identities = 70/318 (22%), Positives = 123/318 (38%), Gaps = 38/318 (11%)
Query: 565 PLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++ V + R + + RG+FG V K + TG A+K ++
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+ E + +P +V + + + + ME L GG L L++ +G
Sbjct: 94 EVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINS 743
CL ED A Y+ + + LEYLH+ R++H D+K DN+L++ DG L DFG +
Sbjct: 146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL------ 199
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
L + GT ++APE+++G D
Sbjct: 200 --------------------CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 804 WSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPH 863
WS ++ ++ G P+ + I + P +P +P I L ++P
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 864 QRLGSGGASEVKQHVFFK 881
R A E+++ V
Sbjct: 300 HR---ASAMELRRKVGKA 314
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-67
Identities = 91/311 (29%), Positives = 145/311 (46%), Gaps = 57/311 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDIL 643
D++ + K + GA G V LA +R T AIK++ K + ++ E +IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
+ +P +++ F E+ Y+V+E + GG+L+ + L E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 704 YLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
YLH ++HRDLKP+N+L++ D IK+TDFG SK+ LG+
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-------------------LGE 169
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGI 817
T GTP YLAPE+L+ G+ D WS+G+ILF + G
Sbjct: 170 TSLMRT-------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 818 PPFNAEH-PQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
PPF+ + D I + K W V S +A DL+ + L DP R
Sbjct: 217 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TT 269
Query: 872 SEVKQHVFFKD 882
E +H + +D
Sbjct: 270 EEALRHPWLQD 280
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-67
Identities = 79/305 (25%), Positives = 140/305 (45%), Gaps = 52/305 (17%)
Query: 586 TSIDDF-EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA---VESILAERD 641
+ ++D E+ + + G F V +++ TG +A K +KK + E I E +
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
IL +R+P ++ F + ++ L++E ++GG+L+ L L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ YLHS R+ H DLKP+N+++ + IKL DFG++ I + ++
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF---------- 168
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
++ GTP+++APEI+ G AD WS+G+I + L+ G
Sbjct: 169 --------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208
Query: 818 PPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872
PF E Q+ NI + S A D I R L +DP +R+ +
Sbjct: 209 SPFLGETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRM---TIA 261
Query: 873 EVKQH 877
+ +H
Sbjct: 262 QSLEH 266
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-67
Identities = 81/316 (25%), Positives = 131/316 (41%), Gaps = 53/316 (16%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA--VESILA 638
D D +E+ + I +G F V R TG FA+K++ A E +
Sbjct: 16 ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY----SLLRNLGCLDEDVARVY 694
E I +++P +V +++ LY+V E+++G DL E VA Y
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ +++ AL Y H ++HRD+KP +L+A +KL FG++
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ------------- 182
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
LG+ VGTP ++APE++ +G D W G+ILF
Sbjct: 183 ------LGESGLVAG------------GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 812 ELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866
L+ G PF +++F+ I+ K W + S A DL+ R L DP +R+
Sbjct: 225 ILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERI 279
Query: 867 GSGGASEVKQHVFFKD 882
E H + K+
Sbjct: 280 ---TVYEALNHPWLKE 292
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-67
Identities = 76/380 (20%), Positives = 131/380 (34%), Gaps = 86/380 (22%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
TS + + + +GA VF + + TGDLFAIKV +R V+ + E ++L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63
Query: 646 VRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVL 700
+ + +V+ F T + L+ME+ G LY++L N L E + + +VV
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 701 ALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ +L +VHR++KP N++ KLTDFG ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR------------------- 164
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL--------LGTGHGTTADWWSVGI 808
++ + S GT +YL P++ +G T D WS+G+
Sbjct: 165 -------------ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 809 ILFELIVGIPPFNAEHPQQIFDNILNRKI--------------------------PWPRV 842
+ G PF + ++ + I +
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 843 PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESA 902
+ ++ L D + G Q FF + D L R +
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWG------FDQ--FFAET-SDILHRMVIHVFSLQQMT 322
Query: 903 LDTSYFTSRYSWNTTDENIY 922
Y S + E +Y
Sbjct: 323 AHKIYIHSYNTATIFHELVY 342
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 7e-67
Identities = 89/324 (27%), Positives = 151/324 (46%), Gaps = 52/324 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ +K + GA+G V L + + T AIK+++K + + +L E +L + +
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDH 95
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + F + N YLVME GG+L+ + + +E A V I +V+ + YLH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 709 RVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+NLL+ D IK+ DFGLS
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA---------------------------- 187
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ ++K + +GT Y+APE+L + D WS+G+ILF L+ G PPF +
Sbjct: 188 ----VFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
Q+I + K W V S A DLI + L D +R+ A + +H +
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQFDSQRRI---SAQQALEHPWI 295
Query: 881 KDINWDTLARQKAAFVPTSESALD 904
K+ ++ +P+ +A++
Sbjct: 296 KE---MCSKKESGIELPSLANAIE 316
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-66
Identities = 78/316 (24%), Positives = 138/316 (43%), Gaps = 51/316 (16%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA---VES 635
+ P K + D ++I + + G F V ++++TG +A K +KK E
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
I E IL V + V+ + R ++ L++E ++GG+L+ L L E+ A +I
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+++ + YLH+ ++ H DLKP+N+++ HIKL DFGL+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-------------- 167
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
++ + ++ GTP+++APEI+ G AD WS+G+I +
Sbjct: 168 ------------------EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 812 ELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866
L+ G PF + Q+ NI + + S A D I + L ++ +RL
Sbjct: 210 ILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRL 265
Query: 867 GSGGASEVKQHVFFKD 882
E +H +
Sbjct: 266 ---TIQEALRHPWITP 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-66
Identities = 79/302 (26%), Positives = 138/302 (45%), Gaps = 47/302 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+++++ + + +GAF V K G +A ++ + + + E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKH 69
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
VVHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------- 161
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
E + E++ GTP YL+PE+L +G D W+ G+IL+ L+VG PPF E
Sbjct: 162 ---EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+++ I W V +PEA DLI++ LT +P +R+ A+E +H +
Sbjct: 219 HRLYQQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI---TAAEALKHPWI 271
Query: 881 KD 882
Sbjct: 272 SH 273
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-66
Identities = 83/322 (25%), Positives = 139/322 (43%), Gaps = 58/322 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR----------KNAVESILA 638
+ + ++ + GA+G V L K++ AIKV+KK+ + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E +L S+ +P +++ F F ++ YLV E+ GG+L+ + N DE A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+ + YLH +VHRD+KP+N+L+ + +IK+ DFGLS + L
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRD------ 207
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
+GT Y+APE+L + D WS G+I++ L+
Sbjct: 208 ------------------------RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
Query: 816 GIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 870
G PPF ++ Q I + K W + S EA +LI LT D ++R
Sbjct: 243 GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRC---T 295
Query: 871 ASEVKQHVFFKDINWDTLARQK 892
A E + K + +
Sbjct: 296 AEEALNSRWIKKYANNINKSDQ 317
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-66
Identities = 93/315 (29%), Positives = 140/315 (44%), Gaps = 53/315 (16%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
+ I S D FE+ + RGA V+ K++ T +A+KVLKK
Sbjct: 36 SLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TV 90
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
+ + E +L+ + +P +++ F + LV+E + GG+L+ + G E A
Sbjct: 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLS 748
+ +++ A+ YLH +VHRDLKP+NLL A D +K+ DFGLSK+
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---------- 200
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
+ + + + GTP Y APEIL G +G D WSVGI
Sbjct: 201 ----------VEHQVLMK------------TVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 809 ILFELIVGIPPFNAEHPQQ-IFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDP 862
I + L+ G PF E Q +F ILN + W V S A DL+ + + DP
Sbjct: 239 ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDP 294
Query: 863 HQRLGSGGASEVKQH 877
+RL + QH
Sbjct: 295 KKRL---TTFQALQH 306
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-66
Identities = 78/324 (24%), Positives = 140/324 (43%), Gaps = 51/324 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA---VESILAERDILIS 645
D ++ + + G F V ++++TG +A K +KK E I E IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+++P V+ + + ++ L++E + GG+L+ L L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 706 HSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
HSL++ H DLKP+N+++ IK+ DFGL+
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 166
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
+ ++ GTP+++APEI+ G AD WS+G+I + L+ G PF
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 822 AEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
+ Q+ N+ + S A D I R L +DP +R+ + Q
Sbjct: 219 GDTKQETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRM---TIQDSLQ 271
Query: 877 HVFFKDINWDTLARQKAAFVPTSE 900
H + K + +KA+ V +
Sbjct: 272 HPWIKPKDTQQALSRKASAVNMEK 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 9e-66
Identities = 89/350 (25%), Positives = 134/350 (38%), Gaps = 64/350 (18%)
Query: 549 TDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLA 608
D + T + + ED++ + ++ I RG V
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFY--------QKYDPKDVIGRGVSSVVRRC 113
Query: 609 KKRTTGDLFAIKVLKKADMIRK-----NAVESILAERDILISVRN-PFVVRFFYSFTCRE 662
R TG FA+K+++ E+ E IL V P ++ S+
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722
++LV + + G+L+ L L E R + ++ A+ +LH+ +VHRDLKP+N+L+
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL 233
Query: 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 782
+ I+L+DFG S L E G
Sbjct: 234 DDNMQIRLSDFGFSCH-------------------LEPGEKLRE-------------LCG 261
Query: 783 TPDYLAPEILLGT------GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 836
TP YLAPEIL + G+G D W+ G+ILF L+ G PPF + I+ +
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321
Query: 837 I-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
W S DLI R L DP RL A + QH FF+
Sbjct: 322 YQFSSPEWDDR----SSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-65
Identities = 87/306 (28%), Positives = 149/306 (48%), Gaps = 40/306 (13%)
Query: 577 SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI 636
S + ++ I ++ ++K I +G F +V LA+ TG AIK++ K + +++ +
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKL 61
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E I+ + +P +V+ F + LYL+MEY +GG+++ L G + E AR
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
++V A++Y H R+VHRDLK +NLL+ D +IK+ DFG S N G
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS-----NEFTV-------GGK 169
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIV 815
L + G P Y APE+ G G D WS+G+IL+ L+
Sbjct: 170 L--------------------DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
G PF+ ++ +++ + +L K R+P MS + +L+ RFL +P +R ++
Sbjct: 210 GSLPFDGQNLKELRERVLRGKY---RIPFYMSTDCENLLKRFLVLNPIKRG---TLEQIM 263
Query: 876 QHVFFK 881
+ +
Sbjct: 264 KDRWIN 269
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-65
Identities = 76/319 (23%), Positives = 138/319 (43%), Gaps = 59/319 (18%)
Query: 571 VRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK 630
+ + + + D ++I + + G F V ++++TG +A K +KK
Sbjct: 2 METFKQQKVE--------DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS 53
Query: 631 NA---VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 687
E I E IL V +P ++ + R ++ L++E ++GG+L+ L L
Sbjct: 54 RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLINS 743
E+ A +I +++ + YLH+ ++ H DLKP+N+++ HIKL DFGL+
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------ 167
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
++ + ++ GTP+++APEI+ G AD
Sbjct: 168 --------------------------EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 804 WSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFL 858
WS+G+I + L+ G PF + Q+ NI + + S A D I + L
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLL 257
Query: 859 TEDPHQRLGSGGASEVKQH 877
++ +RL E +H
Sbjct: 258 VKETRKRL---TIQEALRH 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-65
Identities = 82/338 (24%), Positives = 136/338 (40%), Gaps = 52/338 (15%)
Query: 573 SLRTSPIHPSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
L T ++ + + + K + RG F V ++TG +A K LKK +
Sbjct: 12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC 71
Query: 632 AVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDE 688
IL E +L + P V+ + + L++EY GG+++SL + E
Sbjct: 72 -RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130
Query: 689 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTD 745
+ I +++ + YLH +VH DLKP N+L++ G IK+ DFG+S+
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-------- 182
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
+ R +GTP+YLAPEIL T D W+
Sbjct: 183 ------------------------KIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 806 VGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTE 860
+GII + L+ PF E Q+ + NI + + V S A D I L +
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLVK 274
Query: 861 DPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPT 898
+P +R A H + + +++ L + +
Sbjct: 275 NPEKRP---TAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-65
Identities = 80/301 (26%), Positives = 141/301 (46%), Gaps = 39/301 (12%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
R I + + + G FG+V + + + TG A+K+L + + + V I E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L R+P +++ + + + ++VMEY++GG+L+ + G ++E AR +++ A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
++Y H VVHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM----------------------- 160
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF 820
+ R++ G+P+Y APE++ G G D WS G+IL+ L+ G PF
Sbjct: 161 ---------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ EH +F I +PE ++ L+ L DP +R ++++H +F
Sbjct: 212 DDEHVPTLFKKIRGGVF---YIPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWF 265
Query: 881 K 881
K
Sbjct: 266 K 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-65
Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 51/297 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I + + RG FG V + ++ + K +K + + E IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHS 707
++ SF E L ++ E+++G D++ + L+E Y+ +V AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 708 LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+ H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ R P+Y APE+ T D WS+G +++ L+ GI PF AE
Sbjct: 153 ----QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 826 QQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
QQI +NI+N + + + S EA D +DR L ++ R+ ASE QH
Sbjct: 209 QQIIENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRM---TASEALQH 258
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-65
Identities = 87/331 (26%), Positives = 143/331 (43%), Gaps = 64/331 (19%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-------- 630
S D ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 631 ---------------NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNG 673
+E + E IL + +P VV+ ++LY+V E +N
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733
G + + L ED AR Y +++ +EYLH +++HRD+KP NLL+ DGHIK+ DF
Sbjct: 123 GPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793
G+S + L + VGTP ++APE L
Sbjct: 182 GVS-------------------NEFKGSDALL------------SNTVGTPAFMAPESLS 210
Query: 794 GTG---HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEA 850
T G D W++G+ L+ + G PF E + I ++ + +P P +++ +
Sbjct: 211 ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDL 269
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
DLI R L ++P R+ E+K H +
Sbjct: 270 KDLITRMLDKNPESRI---VVPEIKLHPWVT 297
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-65
Identities = 67/326 (20%), Positives = 133/326 (40%), Gaps = 51/326 (15%)
Query: 560 IEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAI 619
I + +D+ + P+ + D ++I++ + GAFG V ++ TG +F
Sbjct: 23 INDYDKFYEDIWKKYVPQPVEVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 620 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY-S 678
K + + K ++ E I+ + +P ++ +F + + L++E+L+GG+L+
Sbjct: 82 KFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 138
Query: 679 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLS 736
+ + E Y+ + L+++H +VH D+KP+N++ +K+ DFGL+
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
+ T ++ APEI+
Sbjct: 199 T--------------------------------KLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAH 851
G D W++G++ + L+ G+ PF E + N+ + V SPEA
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----SPEAK 282
Query: 852 DLIDRFLTEDPHQRLGSGGASEVKQH 877
D I L ++P +RL + +H
Sbjct: 283 DFIKNLLQKEPRKRL---TVHDALEH 305
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 7e-65
Identities = 71/299 (23%), Positives = 136/299 (45%), Gaps = 43/299 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++D+++++ + GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ VV+F+ YL +EY +GG+L+ + + E A+ + +++ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV----------------------------- 154
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN-AEHP 825
+ R GT Y+APE+L H D WS GI+L ++ G P++
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 826 QQIFDNILNRK---IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
Q + + +K PW +++ L+ + L E+P R+ ++K+ ++
Sbjct: 215 CQEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-64
Identities = 82/328 (25%), Positives = 135/328 (41%), Gaps = 71/328 (21%)
Query: 574 LRTSPIHPSKDRTSIDDFEI---IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK 630
++ SP + +++ KP+ G+F + + FA+K+ I K
Sbjct: 1 MKDSPFY--------QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI------ISK 46
Query: 631 NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 689
+ E L P +V+ F + + +LVME LNGG+L+ ++ E
Sbjct: 47 RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDD 746
A + ++V A+ ++H + VVHRDLKP+NLL + IK+ DFG ++
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR--------- 157
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
L + L + T Y APE+L G+ + D WS+
Sbjct: 158 ----------LKPPDNQPLK------------TPCFTLHYAAPELLNQNGYDESCDLWSL 195
Query: 807 GIILFELIVGIPPFNAEH-------PQQIFDNILNRKI-----PWPRVPEEMSPEAHDLI 854
G+IL+ ++ G PF + +I I W V S EA DLI
Sbjct: 196 GVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV----SQEAKDLI 251
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFFKD 882
LT DP++RL S ++ + + +D
Sbjct: 252 QGLLTVDPNKRL---KMSGLRYNEWLQD 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-64
Identities = 60/303 (19%), Positives = 108/303 (35%), Gaps = 41/303 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ I+ + G F V L + G +A+K + + E E D+ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 650 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLA 701
++R +L++ + G L++ + L L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
LE +H+ HRDLKP N+L+ +G L D G L +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ--------ACIHVEGSRQALTLQ 198
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVGIP 818
+ A++ T Y APE+ H D WS+G +L+ ++ G
Sbjct: 199 D---WAAQR-----------CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 819 PFNAEHPQ-QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
P++ + + ++ P+ P S L++ +T DPHQR +
Sbjct: 245 PYDMVFQKGDSVALAVQNQLSIPQSP-RHSSALWQLLNSMMTVDPHQRP---HIPLLLSQ 300
Query: 878 VFF 880
+
Sbjct: 301 LEA 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-63
Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 31/299 (10%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
+F ++ I G FG VF KR G ++AIK KK + ++ L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQ 69
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL----RNLGCLDEDVARVYIAEVVLALE 703
+ VVR+F ++ +++ + EY NGG L + R + E + + +V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
Y+HS+ +VH D+KP N+ I+ + ++ +GD
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK---------IGD--- 177
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNA 822
H + G +LA E+L H AD +++ + + P
Sbjct: 178 ----LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
R+ PR+P+ +S E +L+ + DP +R A + +H
Sbjct: 234 GDQWHEI-----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVLL 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-63
Identities = 85/400 (21%), Positives = 139/400 (34%), Gaps = 72/400 (18%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
PS + +E+ + + G FG V + TG+ AIK ++ ++ KN E E
Sbjct: 6 PSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCLEI 63
Query: 641 DILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVA 691
I+ + +P VV + L MEY GGDL L N L E
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLS 748
R ++++ AL YLH R++HRDLKP+N+++ K+ D G +K
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---------- 173
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
L E VGT YLAPE+L + T D+WS G
Sbjct: 174 ---------LDQGE-------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 809 ILFELIVGIPPFNAEHPQQIFDNILNRKI---------------------PWPRVPEEMS 847
+ FE I G PF + + K + ++
Sbjct: 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA 271
Query: 848 PEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSY 907
+ + L QR G + F+ ++ L+ + + + + T
Sbjct: 272 GKLERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD-SILSLKLLSVMNMVSGRVHTYP 327
Query: 908 FTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQ 947
T + + + + + L S L++ Q
Sbjct: 328 VTENENLQNLKSWLQQDTGIP-EEEQELLQASGLALNSAQ 366
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 5e-63
Identities = 71/299 (23%), Positives = 136/299 (45%), Gaps = 43/299 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++D+++++ + GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ VV+F+ YL +EY +GG+L+ + + E A+ + +++ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV----------------------------- 154
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEH-P 825
+ R GT Y+APE+L H D WS GI+L ++ G P++
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 826 QQIFDNILNRK---IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
Q + + +K PW +++ L+ + L E+P R+ ++K+ ++
Sbjct: 215 CQEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 77/307 (25%), Positives = 130/307 (42%), Gaps = 58/307 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVR 647
D +E+ + I G++ + T FA+K++ K K E +IL+ +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SK---RDPTEEIEILLRYGQ 74
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+P ++ + + +Y+V E + GG+L + E A + + +EYLH+
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 708 LRVVHRDLKPDNLLIAHDGH----IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
VVHRDLKP N+L + I++ DFG +K L +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ------------------LRAENGL 176
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA- 822
+T T +++APE+L G+ D WS+G++L+ ++ G PF
Sbjct: 177 LMT-------------PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223
Query: 823 --EHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
+ P++I I + K W V S A DL+ + L DPHQRL A+ V
Sbjct: 224 PDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLHVDPHQRL---TAALVL 276
Query: 876 QHVFFKD 882
+H +
Sbjct: 277 RHPWIVH 283
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-62
Identities = 71/303 (23%), Positives = 138/303 (45%), Gaps = 50/303 (16%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ + G FG+V ++ TG A K++K M K E + E ++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSL 708
+++ + +F + ++ LVMEY++GG+L+ + + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 709 RVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
++H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLAR----------------------------- 237
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ R K + GTP++LAPE++ D WSVG+I + L+ G+ PF ++
Sbjct: 238 ---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294
Query: 827 QIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ +NIL + + + S EA + I + L ++ R+ ASE +H +
Sbjct: 295 ETLNNILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRI---SASEALKHPWLS 347
Query: 882 DIN 884
D
Sbjct: 348 DHK 350
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-62
Identities = 78/301 (25%), Positives = 145/301 (48%), Gaps = 40/301 (13%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+ + I + I + + G+FG+V LA T A+K + + + + + + E
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L +R+P +++ + T ++ +V+EY GG+L+ + + ED R + +++ A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+EY H ++VHRDLKP+NLL+ + ++K+ DFGLS +
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI----------------------- 157
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF 820
+ +++ G+P+Y APE++ G G D WS GI+L+ ++VG PF
Sbjct: 158 ---------MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ E +F + + +P+ +SP A LI R + DP QR+ E+++ +F
Sbjct: 209 DDEFIPNLFKKVNSCVY---VMPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWF 262
Query: 881 K 881
Sbjct: 263 N 263
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-62
Identities = 78/380 (20%), Positives = 139/380 (36%), Gaps = 74/380 (19%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
+ + + + P+ GAFG V+ A + +K +KK ++ +E +
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 641 -----DILISVRNPFVVRFFYSFTCRENLYLVME-YLNGGDLYSLLRNLGCLDEDVARVY 694
IL V + +++ F + LVME + +G DL++ + LDE +A
Sbjct: 76 VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
++V A+ YL ++HRD+K +N++IA D IKL DFG +
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---------------- 179
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFEL 813
+ + + GT +Y APE+L+G G + WS+G+ L+ L
Sbjct: 180 ----------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873
+ PF + + I P +S E L+ L P +R +
Sbjct: 224 VFEENPFCE------LEETVEAAI---HPPYLVSKELMSLVSGLLQPVPERRT---TLEK 271
Query: 874 VKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDA 933
+ + + Y+W P S ++
Sbjct: 272 LVTDPWVT-----------------------QPVNLADYTWEEVFRVNKPESGVLSAASL 308
Query: 934 DSLSGSSSCLSNRQEEVGDE 953
+ + S S ++ QE G E
Sbjct: 309 EMGNRSLSDVAQAQELCGGE 328
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-62
Identities = 76/334 (22%), Positives = 137/334 (41%), Gaps = 51/334 (15%)
Query: 552 KVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
V TV D+ + P+ D D ++I + + GAFG V +R
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTER 179
Query: 612 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671
TG+ FA K + ++ E++ E + +R+P +V +F + ++ E++
Sbjct: 180 ATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 672 NGGDLYS-LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHI 728
+GG+L+ + + ED A Y+ +V L ++H VH DLKP+N++ +
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788
KL DFGL+ H ++ + GT ++ A
Sbjct: 297 KLIDFGLTA--------------------------------HLDPKQSVKVTTGTAEFAA 324
Query: 789 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVP 843
PE+ G G D WSVG++ + L+ G+ PF E+ + N+ + + +
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI- 383
Query: 844 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
S + D I + L DP+ R+ + +H
Sbjct: 384 ---SEDGKDFIRKLLLADPNTRM---TIHQALEH 411
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-61
Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 39/306 (12%)
Query: 577 SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI 636
+ R I + + + G FG+V + K TG A+K+L + + + V I
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E L R+P +++ + + ++++VMEY++GG+L+ + G LDE +R
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ ++Y H VVHRDLKP+N+L+ + K+ DFGLS N D G
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-----NMMSD-------GEF 171
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIV 815
L R++ G+P+Y APE++ G G D WS G+IL+ L+
Sbjct: 172 L--------------------RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
G PF+ +H +F I + P+ ++P L+ L DP +R +++
Sbjct: 212 GTLPFDDDHVPTLFKKICDGIF---YTPQYLNPSVISLLKHMLQVDPMKRA---TIKDIR 265
Query: 876 QHVFFK 881
+H +FK
Sbjct: 266 EHEWFK 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-61
Identities = 84/328 (25%), Positives = 129/328 (39%), Gaps = 56/328 (17%)
Query: 565 PLEDDVVRSLRTSPIHPSKDRTS-IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK 623
PL+ +P KDR + ++ + + +G FG VF + T AIKV+
Sbjct: 6 PLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP 65
Query: 624 KADMIRKNAVES---ILAERDILISVRN----PFVVRFFYSFTCRENLYLVMEY-LNGGD 675
+ ++ + + E +L V P V+R F +E LV+E L D
Sbjct: 66 RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD 125
Query: 676 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFG 734
L+ + G L E +R + +VV A+++ HS VVHRD+K +N+LI G KL DFG
Sbjct: 126 LFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
A+ GT Y PE +
Sbjct: 186 SG--------------ALLHDEPY-------------------TDFDGTRVYSPPEWISR 212
Query: 795 TG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 853
H A WS+GI+L++++ G PF E Q+I + L P +SP+ L
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEAEL-------HFPAHVSPDCCAL 263
Query: 854 IDRFLTEDPHQRLGSGGASEVKQHVFFK 881
I R L P R E+ + +
Sbjct: 264 IRRCLAPKPSSRP---SLEEILLDPWMQ 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-61
Identities = 92/321 (28%), Positives = 147/321 (45%), Gaps = 55/321 (17%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
R+ T+ D ++ +K I G FG L + + T +L A+K +++ I +N
Sbjct: 3 RAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN 62
Query: 632 AVESILAERDILI--SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 689
+R+I+ S+R+P +VRF +L ++MEY +GG+LY + N G ED
Sbjct: 63 V------QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED 116
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSKVGLINSTDDL 747
AR + +++ + Y HS+++ HRDLK +N L+ + +K+ DFG SK +++S
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 172
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSV 806
+S VGTP Y+APE+LL G AD WS
Sbjct: 173 ---------QP-------------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204
Query: 807 GIILFELIVGIPPFNAEHPQQIFDNILNR------KIPWPRVPEEMSPEAHDLIDRFLTE 860
G+ L+ ++VG PF + + + R IP +SPE LI R
Sbjct: 205 GVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVA 261
Query: 861 DPHQRLGSGGASEVKQHVFFK 881
DP R+ E+K H +F
Sbjct: 262 DPATRI---SIPEIKTHSWFL 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-61
Identities = 45/395 (11%), Positives = 106/395 (26%), Gaps = 102/395 (25%)
Query: 555 ITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSID--------DFEIIKPISRGAFGRVF 606
I + + SL ++ + + ++ + +
Sbjct: 31 IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL 90
Query: 607 LAKKRTTGDLFAIKVLKKADMIRKNAVE-------------------------SILAERD 641
A + TG+ F + V + NA++ + D
Sbjct: 91 EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150
Query: 642 ILISVRNPFVVRFFYSFTCRE--NLYLVMEYLN------GGDLYSLLRNLGCLDEDVARV 693
++ + ++R + + + + G L S L
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+V+ L LH +VH L+P ++++ G + LT F
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---------------- 254
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----------GTGHGTTAD 802
+ + + + PE+ T + D
Sbjct: 255 -------------------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
W++G++++ + P + + I R + + L++ FL
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIF-------RSCKNIPQPVRALLEGFLRYPK 348
Query: 863 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 897
RL + + ++ L + +A +P
Sbjct: 349 EDRL---LPLQAMETPEYEQ-----LRTELSAALP 375
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-60
Identities = 82/319 (25%), Positives = 131/319 (41%), Gaps = 71/319 (22%)
Query: 581 PSKDRTSI-DDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
P + ++ DD+++ K + G G+V R TG A+K+L + R+
Sbjct: 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------- 70
Query: 639 ERDILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--LLRNLGCLDEDVA 691
E D P +V + + L ++ME + GG+L+S R E A
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLS 748
+ ++ A+++LHS + HRD+KP+NLL D +KLTDFG +K
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---------- 180
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
+ L + TP Y+APE+L + + D WS+G+
Sbjct: 181 -----------TTQNALQ------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 809 ILFELIVGIPPFNAEHPQQIFDNILNRKI----------PWPRVPEEMSPEAHDLIDRFL 858
I++ L+ G PPF + Q I + R+I W V S +A LI L
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQLIRLLL 272
Query: 859 TEDPHQRLGSGGASEVKQH 877
DP +RL ++ H
Sbjct: 273 KTDPTERL---TITQFMNH 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-60
Identities = 75/322 (23%), Positives = 132/322 (40%), Gaps = 54/322 (16%)
Query: 572 RSLRTSPIHPSKDRTS-IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA---DM 627
L + + P K++ +++ + G FG V+ + + AIK ++K D
Sbjct: 25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84
Query: 628 IRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEYLNG-GDLYSLLRNLG 684
+ E +L V + V+R F ++ L++E DL+ + G
Sbjct: 85 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG 144
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINS 743
L E++AR + +V+ A+ + H+ V+HRD+K +N+LI + G +KL DFG
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG------- 197
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTAD 802
A+ T+ GT Y PE + HG +A
Sbjct: 198 -------ALLKDTVY-------------------TDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
WS+GI+L++++ G PF EH ++I + + +S E LI L P
Sbjct: 232 VWSLGILLYDMVCGDIPF--EHDEEIIRGQV-------FFRQRVSSECQHLIRWCLALRP 282
Query: 863 HQRLGSGGASEVKQHVFFKDIN 884
R E++ H + +D+
Sbjct: 283 SDRP---TFEEIQNHPWMQDVL 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-60
Identities = 81/293 (27%), Positives = 145/293 (49%), Gaps = 38/293 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ I G+ G V LA+++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
VV + S+ E L+++ME+L GG L ++ L+E+ V+ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+HRD+K D++L+ DG +KL+DFG Q++
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA--------------------------QIS-- 192
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
++ K++S VGTP ++APE++ + + T D WS+GI++ E++ G PP+ ++ P Q
Sbjct: 193 ---KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ + P + ++SP D ++R L DP +R A E+ H F
Sbjct: 250 MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER---ATAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-60
Identities = 99/321 (30%), Positives = 158/321 (49%), Gaps = 54/321 (16%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LR+ S P + + I +GA G V+ A TG AI+ +
Sbjct: 2 DEEILEKLRSIVSVGDPK------KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-- 53
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 54 -NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-T 111
Query: 685 CLDEDVARVYIA----EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740
C+DE IA E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 112 CMDEG----QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--- 164
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 165 -----------------------QIT-----PEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 801 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 860
D WS+GI+ E+I G PP+ E+P + I P + PE++S D ++R L
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256
Query: 861 DPHQRLGSGGASEVKQHVFFK 881
D +R G A E+ QH F K
Sbjct: 257 DVEKR---GSAKELLQHQFLK 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-60
Identities = 82/323 (25%), Positives = 139/323 (43%), Gaps = 50/323 (15%)
Query: 573 SLRTSPIHPSKDRTSIDDFEII-----KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM 627
S+R++ + D+E + +G +G V+ + + AIK + + D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD- 59
Query: 628 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--- 684
+ + E + +++ +V++ SF+ + + ME + GG L +LLR+
Sbjct: 60 --SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINS 743
+E Y +++ L+YLH ++VHRD+K DN+LI + G +K++DFG SK
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK------ 171
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTA 801
+L + GT Y+APEI+ G+G A
Sbjct: 172 --------------------RLAGI-----NPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 802 DWWSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 860
D WS+G + E+ G PPF PQ + K+ P +PE MS EA I +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPESMSAEAKAFILKCFEP 265
Query: 861 DPHQRLGSGGASEVKQHVFFKDI 883
DP +R A+++ F K
Sbjct: 266 DPDKRA---CANDLLVDEFLKVS 285
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-59
Identities = 86/336 (25%), Positives = 136/336 (40%), Gaps = 67/336 (19%)
Query: 562 EDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIK 620
+ P K IDD+++ + + G G+V + T + FA+K
Sbjct: 34 QPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK 93
Query: 621 VLKKADMIRKNAVESILAERDILISVRN-PFVVRF--FY--SFTCRENLYLVMEYLNGGD 675
+L+ R+ E ++ P +VR Y + R+ L +VME L+GG+
Sbjct: 94 MLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145
Query: 676 LYS--LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKL 730
L+S R E A + + A++YLHS+ + HRD+KP+NLL + +KL
Sbjct: 146 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
TDFG +K S + L+ P TP Y+APE
Sbjct: 206 TDFGFAK--ETTSHNSLTTP------------------------------CYTPYYVAPE 233
Query: 791 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFDNILNRKI-----PWPR 841
+L + + D WS+G+I++ L+ G PPF + H + I + W
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 842 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
V S E LI L +P QR+ +E H
Sbjct: 294 V----SEEVKMLIRNLLKTEPTQRM---TITEFMNH 322
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 82/319 (25%), Positives = 139/319 (43%), Gaps = 51/319 (15%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILA 638
+ DD+E+ + I GA V A + AIK L+K +++ +L
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLK 62
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--------GCLDEDV 690
E + +P +V ++ SF ++ L+LVM+ L+GG + +++++ G LDE
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ EV+ LEYLH +HRD+K N+L+ DG +++ DFG
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG---------------- 166
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGTTADWWSVGII 809
VS L + +++ VGTP ++APE + G+ AD WS GI
Sbjct: 167 -VSA---------FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
Query: 810 LFELIVGIPPFNAEHPQQIFDNILNRKIP-------WPRVPEEMSPEAHDLIDRFLTEDP 862
EL G P++ P ++ L P + ++ +I L +DP
Sbjct: 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276
Query: 863 HQRLGSGGASEVKQHVFFK 881
+R A+E+ +H FF+
Sbjct: 277 EKRP---TAAELLRHKFFQ 292
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-59
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 43/301 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES-ILAERDILISV 646
I + + + G++G+V T A+K+LKK + R E+ + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 647 RNPFVVRFF--YSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDVARVYIAEVVLAL 702
R+ V++ ++ +Y+VMEY G ++ + A Y +++ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGL 122
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
EYLHS +VH+D+KP NLL+ G +K++ G++ + P + T
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA---------EALHPFAADDTC----- 168
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPF 820
R++ G+P + PEI G G D WS G+ L+ + G+ PF
Sbjct: 169 ---------------RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
++ ++F+NI +P + P DL+ L +P +R +++QH +F
Sbjct: 214 EGDNIYKLFENIGKGSY---AIPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWF 267
Query: 881 K 881
+
Sbjct: 268 R 268
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-59
Identities = 78/319 (24%), Positives = 128/319 (40%), Gaps = 64/319 (20%)
Query: 589 DDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
D +++ + + GA RV T +A+K+++K ++ V E ++L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 648 N-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
V+ F + YLV E + GG + S + +E A V + +V AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 707 SLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ + HRDLKP+N+L H +K+ DF L +N T
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT-------- 180
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIP 818
G+ +Y+APE++ + + D WS+G+IL+ L+ G P
Sbjct: 181 ----------------PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 819 PFNAEH---------------PQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFL 858
PF +F++I K W + S A DLI + L
Sbjct: 225 PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLL 280
Query: 859 TEDPHQRLGSGGASEVKQH 877
D QRL A++V QH
Sbjct: 281 VRDAKQRL---SAAQVLQH 296
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-58
Identities = 87/295 (29%), Positives = 144/295 (48%), Gaps = 43/295 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILAERDILISV 646
+ F ++ I +G+FG VF T + AIK+ L++A+ + +E I E +L
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQC 77
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+P+V +++ S+ L+++MEYL GG LL G LDE + E++ L+YLH
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH 136
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S + +HRD+K N+L++ G +KL DFG V+G QLT
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFG-----------------VAG---------QLT 170
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ + K+ + VGTP ++APE++ + + + AD WS+GI EL G PP + HP
Sbjct: 171 DT-----QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM 225
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
++ I P + S + ++ L ++P R A E+ +H F
Sbjct: 226 KVLFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIL 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-58
Identities = 45/342 (13%), Positives = 101/342 (29%), Gaps = 80/342 (23%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ + GAF +V+ A + F +KV K A+ + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEV 698
++F+ + + LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKVGLINSTDDL 747
+ +E +H ++H D+KPDN ++ + + L D G S D+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI--------DM 233
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807
+ + T + E+L D++ V
Sbjct: 234 K---------------------LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 808 IILFELIVGIPPFNAEHPQQ------------------IFDNILNRKIPWPRVPEEMSPE 849
++ ++ G + F +LN +P+
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLP 325
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 891
+ DL+ + L + Q + ++ + +R+
Sbjct: 326 SLDLLRQKLKKVFQQHYTNKI--RALRNRLIVLLLECKRSRK 365
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-57
Identities = 82/300 (27%), Positives = 147/300 (49%), Gaps = 43/300 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +EI+ + GAFG+V+ AK + TG L A KV+ + + +E + E +IL + +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
P++V+ ++ L++++E+ GG + +++ L L E +V +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
R++HRDLK N+L+ +G I+L DFG VS +
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFG-----------------VSA---------KNLK 169
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822
+ +K+ S +GTP ++APE+++ T + AD WS+GI L E+ PP +
Sbjct: 170 T-----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+P ++ I P P + S E D + L ++P R A+++ +H F
Sbjct: 225 LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR---PSAAQLLEHPFVSS 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-57
Identities = 86/295 (29%), Positives = 141/295 (47%), Gaps = 40/295 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ F++++ + G++G V+ A + TG + AIK + ++ I+ E I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+R +HRD+K N+L+ +GH KL DFG V+G QLT
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFG-----------------VAG---------QLT- 176
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
K+ + +GTP ++APE++ G+ AD WS+GI E+ G PP+ HP +
Sbjct: 177 ----DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232
Query: 828 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
I P R PE S D + + L + P QR A+++ QH F +
Sbjct: 233 AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR---ATATQLLQHPFVRS 284
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 2e-56
Identities = 63/329 (19%), Positives = 134/329 (40%), Gaps = 48/329 (14%)
Query: 561 EEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
+E+ + D + L T + S D + I RG+F V+ T A
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEI---GRGSFKTVYKGLDTETTVEVAWC 57
Query: 621 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDL 676
L+ + K+ + E ++L +++P +VRF+ S+ ++ + LV E + G L
Sbjct: 58 ELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHS--LRVVHRDLKPDNLLI-AHDGHIKLTDF 733
+ L+ + V R + +++ L++LH+ ++HRDLK DN+ I G +K+ D
Sbjct: 117 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793
GL+ + ++ +GTP+++APE +
Sbjct: 177 GLAT---------------------------------LKRASFAKAVIGTPEFMAPE-MY 202
Query: 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 853
+ + D ++ G+ + E+ P++ + + + PE ++
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 854 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
I+ + ++ +R ++ H FF++
Sbjct: 263 IEGCIRQNKDERY---SIKDLLNHAFFQE 288
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 9e-56
Identities = 41/353 (11%), Positives = 91/353 (25%), Gaps = 78/353 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE---------------- 634
+ + A + TG+ F + V + NA++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 635 ---------SILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG------GDLY 677
+ D++ + ++R + + + + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
S L +V+ L LH +VH L+P ++++ G + LT F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
D ++ P+ A +L H
Sbjct: 260 R---------------------DGASAVSPI---------GRGFAPPETTAERMLPFGQH 289
Query: 798 GTT-----ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 852
T D W++G+ ++ + P + + I + +
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-------CKNIPQPVRA 342
Query: 853 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDT 905
L++ FL RL + + ++ + + A +
Sbjct: 343 LLEGFLRYPKEDRL---LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGG 392
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-55
Identities = 56/389 (14%), Positives = 103/389 (26%), Gaps = 87/389 (22%)
Query: 556 TSTVIEEDAPLEDDVVRSL---RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT 612
++E A + + V ++ S ++++P+ G VFL +
Sbjct: 26 REEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVE 85
Query: 613 TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF----------------- 655
+ FA+KV ++ +E + +
Sbjct: 86 RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145
Query: 656 ---------YSFTCRENLYLVMEYLNGGDLYSLLRNL-------GCLDEDVARVYIAEVV 699
N L+M DL L L G + A+++
Sbjct: 146 PPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L S +VH PDNL I DG + L D
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------------------- 242
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGI 817
+ + ++ Y E L + W +G+ ++ +
Sbjct: 243 ------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
Query: 818 PPF--NAEHPQQIFDNILNRKIPWPRVP----EEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
PF + + R + + LI RFL D +RL
Sbjct: 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL---LP 347
Query: 872 SEVKQHVFFKDINWDTLARQKAAFVPTSE 900
E + F L + ++ + T +
Sbjct: 348 LEAMETPEFLQ-----LQNEISSSLSTGQ 371
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-55
Identities = 77/325 (23%), Positives = 132/325 (40%), Gaps = 57/325 (17%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
+ I + + I+D E + + G G+V+ + R TG + A+K +R++
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ------MRRS 61
Query: 632 AVES----ILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 686
+ IL + D+++ S P++V+ F +F ++++ ME + R G +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 687 DEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
E + +V AL YL V+HRD+KP N+L+ G IKL DFG
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG----------- 170
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTT 800
+SG +L + K + G Y+APE + +
Sbjct: 171 ------ISG---------RLVDD------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209
Query: 801 ADWWSVGIILFELIVGIPPFNAEHPQQIFD---NILNRKIPWPRVPEEMSPEAHDLIDRF 857
AD WS+GI L EL G P+ F+ +L + P S + +
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 858 LTEDPHQRLGSGGASEVKQHVFFKD 882
LT+D +R +++ +H F K
Sbjct: 268 LTKDHRKRP---KYNKLLEHSFIKR 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-54
Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 46/305 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+ + ++ G F V+ A+ +G +A+K L + + +I+ E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHP 86
Query: 650 FVVRFFYSF--------TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVV 699
+V+F + T + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 700 LALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
A++++H + ++HRDLK +NLL+++ G IKL DFG + T
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA-------------------TT 187
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELI 814
+ +++ + ++ + TP Y PEI+ + G D W++G IL+ L
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 815 VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
PF + I+N K P H LI L +P +RL +EV
Sbjct: 248 FRQHPFEDGAKLR----IVNGKYSIPPHD-TQYTVFHSLIRAMLQVNPEERL---SIAEV 299
Query: 875 KQHVF 879
+
Sbjct: 300 VHQLQ 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-54
Identities = 68/296 (22%), Positives = 113/296 (38%), Gaps = 42/296 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F ++ I G+FG V+ A+ ++ AIK + + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + +LVMEY G L + L E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+K N+L++ G +KL DFG + +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFG-----------------SAS---------IMA-- 205
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
S VGTP ++APE++L + D WS+GI EL PP +
Sbjct: 206 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
Query: 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+I + P + S + +D L + P R + + +H F
Sbjct: 259 MSALYHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDR---PTSEVLLKHRFVL 310
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-54
Identities = 63/304 (20%), Positives = 106/304 (34%), Gaps = 50/304 (16%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRN 648
F + GA G + A+K + E +L S +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHS 707
P V+R+F + R+ Y+ +E L + + + + L +LHS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 708 LRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
L +VHRDLKP N+LI+ ++DFGL K
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK------------------------ 172
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIV-GIP 818
+ + ++ GT ++APE+L T D +S G + + +I G
Sbjct: 173 ----LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
Query: 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
PF +Q + + + A +LI++ + DP +R A V +H
Sbjct: 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHP 285
Query: 879 FFKD 882
FF
Sbjct: 286 FFWS 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-53
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 58/311 (18%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES----ILAERDI 642
DD E I + RGA+G V + +G + A+K IR +L + DI
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDI 58
Query: 643 LI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLY-SLLRNLGCLDEDVARVYIAEV 698
+ +V PF V F+ + ++++ ME ++ Y ++ + ED+ +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 699 VLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V ALE+LHS L V+HRD+KP N+LI G +K+ DFG +SG
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG-----------------ISG--- 158
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT----ADWWSVGIILFEL 813
L K G Y+APE + + +D WS+GI + EL
Sbjct: 159 ------YLVDD------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
Query: 814 IVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRLGSGGA 871
+ P+++ P Q ++ P P++P + S E D + L ++ +R
Sbjct: 207 AILRFPYDSWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKERP---TY 261
Query: 872 SEVKQHVFFKD 882
E+ QH FF
Sbjct: 262 PELMQHPFFTL 272
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-53
Identities = 73/313 (23%), Positives = 132/313 (42%), Gaps = 54/313 (17%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV-ESILAERDIL 643
+ +D + + I RGA+G V + +G + A+K + + +L + D++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKEQKQLLMDLDVV 74
Query: 644 I-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNL--GCLDEDVARVYIAEV 698
+ S P++V+F+ + + ++ ME ++ Y + ++ + E++
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 699 VLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V AL +L L+++HRD+KP N+L+ G+IKL DFG +SG
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG-----------------ISG--- 174
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT----ADWWSVGIILFEL 813
QL S K G Y+APE + + +D WS+GI L+EL
Sbjct: 175 ------QLVDS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
Query: 814 IVGIPPFNAEHP--QQIFDNILNRKIPWPRVPEEM--SPEAHDLIDRFLTEDPHQRLGSG 869
G P+ + Q+ ++ P EE SP + ++ LT+D +R
Sbjct: 223 ATGRFPYPKWNSVFDQLT-QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP--- 278
Query: 870 GASEVKQHVFFKD 882
E+ +H F
Sbjct: 279 KYKELLKHPFILM 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-53
Identities = 54/301 (17%), Positives = 113/301 (37%), Gaps = 32/301 (10%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
++ I++ + ++ + + +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS-VKIRRMDPF 118
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN---LGCLDEDVARVYIAEVVLALE 703
V + + LY+ M+ +L + L + V ++ A+E
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+LHS ++HRDLKP N+ D +K+ DFGL + +E
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA-------------------MDQDEE 219
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ T VGT Y++PE + G + D +S+G+ILFEL+ F+ +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQ 276
Query: 824 H-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+I ++ R + +P + + P+ H ++ L+ P +R A+++ ++ F++
Sbjct: 277 MERVRIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFEN 331
Query: 883 I 883
+
Sbjct: 332 L 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 2/70 (2%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DFE I+ + RG FG VF AK + +AIK ++ + E ++ E L + +
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEH 63
Query: 649 PFVVRFFYSF 658
P +VR+F ++
Sbjct: 64 PGIVRYFNAW 73
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-52
Identities = 76/324 (23%), Positives = 120/324 (37%), Gaps = 88/324 (27%)
Query: 574 LRTSPIHPSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
K IDD+++ + + G G+V + T + FA+K+L+ R+
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-- 59
Query: 633 VESILAERDILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--LLRNLGC 685
E ++ P +VR + R+ L +VME L+GG+L+S R
Sbjct: 60 ------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 113
Query: 686 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLIN 742
E A + + A++YLHS+ + HRD+KP+NLL + +KLTDFG
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
A E G + + D
Sbjct: 166 --------------------------------------------FAKET-TGEKYDKSCD 180
Query: 803 WWSVGIILFELIVGIPPFNAEHP----QQIFDNILNRKI-----PWPRVPEEMSPEAHDL 853
WS+G+I++ L+ G PPF + H + I + W V S E L
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKML 236
Query: 854 IDRFLTEDPHQRLGSGGASEVKQH 877
I L +P QR+ +E H
Sbjct: 237 IRNLLKTEPTQRM---TITEFMNH 257
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-52
Identities = 73/309 (23%), Positives = 134/309 (43%), Gaps = 53/309 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
FE+++ + G +G+V+ + TG L AIKV+ + + E I E ++L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 648 NPFVVRFFYSF------TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVV 699
+ + ++ +F + L+LVME+ G + L++N L E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L +LH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 177
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELI 814
QL + ++ + +GTP ++APE++ + +D WS+GI E+
Sbjct: 178 ----QLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 815 VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
G PP HP + I P + ++ S + I+ L ++ QR ++
Sbjct: 229 EGAPPLCDMHPMRALFLIPRNPAPRLK-SKKWSKKFQSFIESCLVKNHSQRP---ATEQL 284
Query: 875 KQHVFFKDI 883
+H F +D
Sbjct: 285 MKHPFIRDQ 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-52
Identities = 69/333 (20%), Positives = 131/333 (39%), Gaps = 69/333 (20%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
P+ +++ + K + G+ G V G A+K + + L E
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEI 59
Query: 641 DILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-------AR 692
+L S +P V+R++ S T LY+ +E +L L+ + DE++
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKVG 739
+ ++ + +LHSL+++HRDLKP N+L++ + I ++DFGL K
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK- 177
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-- 797
L + + + + GT + APE+L + +
Sbjct: 178 ------------------LDSGQSSFRTNLN--------NPSGTSGWRAPELLEESNNLQ 211
Query: 798 -----GTTADWWSVGIILFELIV-GIPPFNAEHPQQ--IFDNILNRKIPWPRVPEEMSPE 849
+ D +S+G + + ++ G PF ++ ++ I I + + E
Sbjct: 212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE 271
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
A DLI + + DP +R A +V +H F
Sbjct: 272 ATDLISQMIDHDPLKRP---TAMKVLRHPLFWP 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-52
Identities = 92/366 (25%), Positives = 142/366 (38%), Gaps = 87/366 (23%)
Query: 562 EDAPLEDDVVRSLRTSPIHPSKD-RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
E+ L++ + L K DDFE I + G G VF + +G + A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 621 V--LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 678
+ L+ IR I+ E +L +P++V F+ +F + + ME+++GG L
Sbjct: 65 LIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 679 LLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+L+ G + E + V+ L YL +++HRD+KP N+L+ G IKL DFG
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG--- 177
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VSG QL S S VGT Y++PE L GT +
Sbjct: 178 --------------VSG---------QLIDS-------MANSFVGTRSYMSPERLQGTHY 207
Query: 798 GTTADWWSVGIILFELIVGIPPFNAE---------------------------------- 823
+D WS+G+ L E+ VG P
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 824 -----HPQQIFD---NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
P IF+ I+N P S E D +++ L ++P +R ++
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERA---DLKQLM 323
Query: 876 QHVFFK 881
H F K
Sbjct: 324 VHAFIK 329
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 2e-50
Identities = 65/344 (18%), Positives = 119/344 (34%), Gaps = 81/344 (23%)
Query: 589 DDFEIIKPISRGA--FGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+E++ I +G V LA+ + TG+ ++ + + V + E +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEY 704
+P +V + +F L++V ++ G L+ ++E + V+ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+H + VHR +K ++LI+ DG + L+ +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLR-----------------SNL---------S 177
Query: 765 LTASEHQQERRK--KRSAVGTPDYLAPEIL--LGTGHGTTADWWSVGIILFELIVGIPPF 820
+ + +Q + +V +L+PE+L G+ +D +SVGI EL G PF
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 821 NAEHPQQIFDNILNRKIP------------------------------------------ 838
Q+ LN +P
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 839 -WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
SP H +++ L +P R AS + H FFK
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDAR---PSASTLLNHSFFK 338
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 46/315 (14%)
Query: 561 EEDAPLEDDVVRSLRTSPIHPSKDRT--SID--DFEIIKPISRGAFGRVFLAKKRTTGDL 616
P+ D + + + D I D I + I G+FG V A+ G
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSD 62
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
A+K+L + D V L E I+ +R+P +V F + T NL +V EYL+ G L
Sbjct: 63 VAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 677 YSLLRNLGC---LDEDVARVYIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKL 730
Y LL G LDE R+ +A +V + YLH+ +VHR+LK NLL+ +K+
Sbjct: 122 YRLLHKSGAREQLDERR-RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
DFGLS++ +SA GTP+++APE
Sbjct: 181 CDFGLSRL-------------------------------KASTFLSSKSAAGTPEWMAPE 209
Query: 791 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEA 850
+L +D +S G+IL+EL P+ +P Q+ + + +P ++P+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQV 268
Query: 851 HDLIDRFLTEDPHQR 865
+I+ T +P +R
Sbjct: 269 AAIIEGCWTNEPWKR 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-47
Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 51/320 (15%)
Query: 564 APLEDDVVRSLRTSPIHPSKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDL 616
P + + S R+ P S+ + +++I + I +G FG+V+ + G++
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV 58
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
AI+++ ++ +++ E R+ VV F + +L ++ G L
Sbjct: 59 -AIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 677 YSLLRNLGC-LDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
YS++R+ LD + IA E+V + YLH+ ++H+DLK N+ +G + +TDFG
Sbjct: 117 YSVVRDAKIVLDVNK-TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFG 174
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L +SG G E +L G +LAPEI+
Sbjct: 175 LFS--------------ISGVLQAGRREDKLRI------------QNGWLCHLAPEIIRQ 208
Query: 795 TGHGTT---------ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEE 845
T +D +++G I +EL PF + + I + P
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIG 267
Query: 846 MSPEAHDLIDRFLTEDPHQR 865
M E D++ + +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-46
Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 60/289 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ E+ + + RGAFG V AK R AIK ++ ++ + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIA-EVVLALEY 704
P +V+ + + C + LVMEY GG LY++L L + + + Y
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH-AMSWCLQCSQGVAY 117
Query: 705 LHSLR---VVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
LHS++ ++HRDLKP NLL+ G +K+ DFG + D
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----------------------D 155
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ +T + G+ ++APE+ G+ + D +S GIIL+E+I PF
Sbjct: 156 IQTHMT------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
Query: 821 N--AEHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ +I + N R P + + + L+ R ++DP QR
Sbjct: 204 DEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-46
Identities = 65/279 (23%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D + + +G FG+ R TG++ +K L + D + + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAE-VVLALEYLH 706
P V++F + L + EY+ GG L +++++ RV A+ + + YLH
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSFAKDIASGMAYLH 125
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S+ ++HRDL N L+ + ++ + DFGL+++ + T P+
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ-----------------PEGL 168
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
S + +R+K+ + VG P ++APE++ G + D +S GI+L E+I + P+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ + R P P + R DP +R
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 65/303 (21%), Positives = 120/303 (39%), Gaps = 55/303 (18%)
Query: 581 PSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
P ++ + E K I +G FG V + + AIK L D + +
Sbjct: 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 639 ----ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARV 693
E I+ ++ +P +V+ + +VME++ GDLY L + + V ++
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KL 125
Query: 694 YIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDG-----HIKLTDFGLSKVGLINSTD 745
+ ++ L +EY+ + +VHRDL+ N+ + K+ DFGLS+
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------- 178
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT--ADW 803
+G ++APE + T AD
Sbjct: 179 ---------------------------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADT 211
Query: 804 WSVGIILFELIVGIPPFNAEHPQQI-FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 862
+S +IL+ ++ G PF+ +I F N++ + P +PE+ P ++I+ + DP
Sbjct: 212 YSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDP 271
Query: 863 HQR 865
+R
Sbjct: 272 KKR 274
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 64/300 (21%), Positives = 118/300 (39%), Gaps = 48/300 (16%)
Query: 580 HPSKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
H R + DD+EI + I G+FG V+ K GD+ A+K+L
Sbjct: 8 HHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQQ 63
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 64 LQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKL 122
Query: 693 VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ IA + ++YLH+ ++HRDLK +N+ + D +K+ DFGL+
Sbjct: 123 IDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------- 169
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGI 808
+ G+ ++APE++ +D ++ GI
Sbjct: 170 ----------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213
Query: 809 ILFELIVGIPPF-NAEHPQQIFDNIL--NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+L+EL+ G P+ N + QI + + + +V L+ L + +R
Sbjct: 214 VLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 51/290 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK-ADMIRKNAVESILAERDILISVR 647
+ + + I G FG+V+ A GD A+K + D +E++ E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLH 706
+P ++ NL LVME+ GG L +L + D+ V A ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDI-LVNWAVQIARGMNYLH 122
Query: 707 S---LRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+ ++HRDLK N+LI +K+TDFGL++
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----------------- 165
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
R K SA G ++APE++ + +D WS G++L+EL+
Sbjct: 166 ----------------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G PF + + K+ +P L++ DPH R
Sbjct: 210 GEVPFRGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 77/371 (20%), Positives = 140/371 (37%), Gaps = 85/371 (22%)
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
+ + + + + + TSID + I + G +G V+ A T +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 617 FAIKVLK--KAD------MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668
AIK ++ + IR E +L +++ ++ L+L+
Sbjct: 62 VAIKRIRLEHEEEGVPGTAIR---------EVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-----A 723
EY DL + + V + ++ +++ + + HS R +HRDLKP NLL+ +
Sbjct: 113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171
Query: 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783
+K+ DFGL++ G Q T H+ + T
Sbjct: 172 ETPVLKIGDFGLARA-------------------FGIPIRQFT---HE---------IIT 200
Query: 784 PDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--NAEHPQ--QIFD-------- 830
Y PEILLG+ H +T+ D WS+ I E+++ P F ++E Q +IF+
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 831 ---------NILNRKIPWPR------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
+ + + + E DL+ L DP +R+ A
Sbjct: 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI---SAKNAL 317
Query: 876 QHVFFKDINWD 886
+H +F ++D
Sbjct: 318 EHPYFSHNDFD 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 1e-42
Identities = 78/329 (23%), Positives = 132/329 (40%), Gaps = 72/329 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA---DMIRKNAVESILAERDILIS 645
+ +E I I G++G VF + R TG + AIK ++ +I+K A L E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LREIRMLKQ 58
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEY 704
+++P +V F + L+LV EY + + L + E + + + + A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H +HRD+KP+N+LI IKL DFG +++ L
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARL-------------------LTGPSDY 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823
+ V T Y +PE+L+G G D W++G + EL+ G+P + +
Sbjct: 159 YD---DE---------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
Query: 824 -HPQQIF--------------------DNILNRKIPWPRVPE-------EMSPEAHDLID 855
Q++ KIP P E +S A L+
Sbjct: 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK 266
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
L DP +RL ++ H +F++I
Sbjct: 267 GCLHMDPTERL---TCEQLLHHPYFENIR 292
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 79/335 (23%), Positives = 133/335 (39%), Gaps = 80/335 (23%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAER 640
++ +E + + G F V+ A+ + T + AIK +K R A + I L E
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH--RSEAKDGINRTALREI 63
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVV 699
+L + +P ++ +F + N+ LV +++ DL ++++ L + Y+ +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
LEYLH ++HRDLKP+NLL+ +G +KL DFGL+K G
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS-------------------FG 163
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIP 818
T HQ V T Y APE+L G D W+VG IL EL++ +P
Sbjct: 164 SPNRAYT---HQ---------VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
Query: 819 PFNAE-HPQQIFDNILNRKI-------------------------PWPRVP-----EEMS 847
+ Q+ +I +P +P
Sbjct: 212 FLPGDSDLDQLT------RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 265
Query: 848 PEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+ DLI +P R+ A++ + +F +
Sbjct: 266 DDLLDLIQGLFLFNPCARI---TATQALKMKYFSN 297
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 85/330 (25%), Positives = 145/330 (43%), Gaps = 75/330 (22%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE-----SILAERDI 642
++ + ++ I G +G V+ A+ G+ FA LKK IR + + + E I
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFA---LKK---IRLEKEDEGIPSTTIREISI 53
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLA 701
L +++ +V+ + ++ L LV E+L+ DL LL L+ A+ ++ +++
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ Y H RV+HRDLKP NLLI +G +K+ DFGL++ G
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA-------------------FGIP 153
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
+ T H+ + T Y AP++L+G+ +T D WSVG I E++ G P F
Sbjct: 154 VRKYT---HE---------IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 821 --NAEHPQ--QIFD-----------------NILNRKIPWPRVP-----EEMSPEAHDLI 854
+E Q +IF + +P + + DL+
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
+ L DP+QR+ A + +H +FK+ N
Sbjct: 262 SKMLKLDPNQRI---TAKQALEHAYFKENN 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-42
Identities = 68/287 (23%), Positives = 108/287 (37%), Gaps = 56/287 (19%)
Query: 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+E+ I+ G G ++LA + G +K L + A +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139
Query: 650 FVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS+ +V+ DLKP+N+++ + +KL D G ++
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-------------RINSFG-------- 235
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
GTP + APEI+ G D ++VG L L + +P N +
Sbjct: 236 --------------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRY 280
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
L P + + L+ R + DP QR +
Sbjct: 281 VDG-----LPEDDPVLKTYDSY----GRLLRRAIDPDPRQRFTTAEE 318
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 81/339 (23%), Positives = 141/339 (41%), Gaps = 66/339 (19%)
Query: 575 RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
+S + ++ ++ ++ + G +G V+ AK G + A+K ++ D +
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LDAEDEGIPS 64
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARV 693
+ + E +L + +P +V L LV E++ DL +L L + ++
Sbjct: 65 TAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI 123
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y+ +++ + + H R++HRDLKP NLLI DG +KL DFGL++
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA--------------- 168
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFE 812
G T H+ V T Y AP++L+G+ +T+ D WS+G I E
Sbjct: 169 ----FGIPVRSYT---HE---------VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
Query: 813 LIVGIPPF--NAEHPQ--QIFD-----------------NILNRKIP-WPRVP-----EE 845
+I G P F + Q +IF R + + P
Sbjct: 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPG 272
Query: 846 MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
E DL+ L DP++R+ A + H +FKD++
Sbjct: 273 FCQEGIDLLSNMLCFDPNKRI---SARDAMNHPYFKDLD 308
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-42
Identities = 75/330 (22%), Positives = 127/330 (38%), Gaps = 74/330 (22%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDIL 643
++ + + + G + V+ K + T +L A LK+ IR E + E +L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVA---LKE---IRLEHEEGAPCTAIREVSLL 54
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLAL 702
+++ +V ++L LV EYL+ DL L + G ++ ++++ +++ L
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y H +V+HRDLKP NLLI G +KL DFGL++
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA-------------------KSIPT 154
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF- 820
++ V T Y P+ILLG+ +T D W VG I +E+ G P F
Sbjct: 155 KTYD---NE---------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 821 -NAEHPQ--QIFD-----------------NILNRKIP-WPRVP-----EEMSPEAHDLI 854
+ Q IF P + + + DL+
Sbjct: 203 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLL 262
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
+ L + R+ A + +H FF +
Sbjct: 263 TKLLQFEGRNRI---SAEDAMKHPFFLSLG 289
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 82/334 (24%), Positives = 134/334 (40%), Gaps = 74/334 (22%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI---- 642
+ +E + I GA+G V+ A+ +G A+K ++ + I R++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 643 -LISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVY 694
L + +P VVR + LV E+++ DL + L L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ + + L++LH+ +VHRDLKP+N+L+ G +KL DFGL+++
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---------------- 169
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ LT V T Y APE+LL + + T D WSVG I E+
Sbjct: 170 ---YSYQMA-LT---PV---------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
Query: 815 VGIPPF--NAEHPQ--QIFDNIL----------NRKIPWPRVPE-----------EMSPE 849
P F N+E Q +IFD ++ + +P P EM
Sbjct: 214 RRKPLFCGNSEADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
L+ LT +PH+R+ A QH +
Sbjct: 273 GAQLLLEMLTFNPHKRI---SAFRALQHSYLHKD 303
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 73/342 (21%), Positives = 134/342 (39%), Gaps = 87/342 (25%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERD 641
+S F+ ++ + G + V+ +TTG A LK+ ++ ++ E + E
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVA---LKE---VKLDSEEGTPSTAIREIS 55
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC------LDEDVARVYI 695
++ +++ +VR + L LV E+++ DL + + L+ ++ + +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+++ L + H +++HRDLKP NLLI G +KL DFGL++
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------------- 157
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
G + + V T Y AP++L+G+ +T+ D WS G IL E+I
Sbjct: 158 --FGIPVNTFS---SE---------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 815 VGIPPF---------------------------------NAEHPQQIFDNILNRKIPWPR 841
G P F N Q+ ++ R++ P
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL--RQVLQPH 261
Query: 842 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
E + D + L +P RL A + H +F +
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRL---SAKQALHHPWFAEY 300
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 83/332 (25%), Positives = 137/332 (41%), Gaps = 77/332 (23%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDIL 643
+ +E ++ I G +G VF AK R T ++ A+K ++ + E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLL 55
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLAL 702
+++ +VR + L LV E+ + DL + LD ++ + ++ +++ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+ HS V+HRDLKP NLLI +G +KL +FGL++ G
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA-------------------FGIPV 155
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF 820
+ + V T Y P++L G +T+ D WS G I EL G P F
Sbjct: 156 RCYS---AE---------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 821 --NAEHPQ--QIFDNIL---NRKIPWPRVPE---------------------EMSPEAHD 852
N Q +IF +L + WP + + +++ D
Sbjct: 204 PGNDVDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261
Query: 853 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
L+ L +P QR+ A E QH +F D
Sbjct: 262 LLQNLLKCNPVQRI---SAEEALQHPYFSDFC 290
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 50/287 (17%), Positives = 98/287 (34%), Gaps = 49/287 (17%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ ++ G ++ + + G+ +KVLK D E L
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS 65
Query: 648 NPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDVA-RVYIA-EVVLALE 703
+P V+ + + L+ ++ G LY++L D + V A ++ +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 704 YLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+LH+L + L +++I D +++ +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS----------------------- 162
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT---ADWWSVGIILFELIVGIP 818
+ + P ++APE L T AD WS ++L+EL+
Sbjct: 163 -------------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209
Query: 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
PF +I + + P +P +SP L+ + EDP +R
Sbjct: 210 PFADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-40
Identities = 89/365 (24%), Positives = 143/365 (39%), Gaps = 92/365 (25%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADM-----------IRKNAVE 634
+ +E + I GA+G+VF A+ + G A LK+ + IR E
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIR----E 61
Query: 635 -SILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--L 686
++L L + +P VVR F L LV E+++ DL + L + +
Sbjct: 62 VAVLRH---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
+ + + +++ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------- 169
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
+ LT V T Y APE+LL + + T D WSV
Sbjct: 170 ------------YSFQMALT---SV---------VVTLWYRAPEVLLQSSYATPVDLWSV 205
Query: 807 GIILFELIVGIPPFNAE-HPQQ---IFDNIL----------NRKIPWPRVPE-------- 844
G I E+ P F Q I D ++ + +P
Sbjct: 206 GCIFAEMFRRKPLFRGSSDVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 264
Query: 845 ---EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSES 901
++ DL+ + LT +P +R+ A H +F+D+ + S
Sbjct: 265 FVTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCKENLDSHLPPSQNTS 321
Query: 902 ALDTS 906
L+T+
Sbjct: 322 ELNTA 326
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-40
Identities = 73/335 (21%), Positives = 134/335 (40%), Gaps = 84/335 (25%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA---DMIRKNAVESILAERDIL 643
S++ +E + + G++G V + + TG + AIK ++ M++K A + E +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MREIKLL 78
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLAL 702
+R+ +V ++ YLV E+++ + L LD V + Y+ +++ +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+ HS ++HRD+KP+N+L++ G +KL DFG ++ L
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART-------------------LAAPG 178
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFN 821
+ V T Y APE+L+G G D W++G ++ E+ +G P F
Sbjct: 179 EVYD---DE---------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226
Query: 822 AE-HPQQIFDNILNRKI------P----WPRV-----------PE------------EMS 847
+ Q++ I PE ++S
Sbjct: 227 GDSDIDQLY------HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 848 PEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
DL + L DP +R +E+ H FF+
Sbjct: 281 EVVIDLAKKCLHIDPDKRP---FCAELLHHDFFQM 312
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 34/288 (11%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILI 644
T + + + + RG G V+ A+ + A+K++ + + E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
++ P VV LY+ M +NG DL ++LR G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H+ HRD+KP+N+L++ D L DFG++ A +
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-------------ATTDEK-------- 188
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
LT + VGT Y+APE + AD +++ +L+E + G PP+ +
Sbjct: 189 LTQL---------GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
Query: 825 PQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
+ + +N+ IP P V + +I R + ++P R + G
Sbjct: 240 LSVMGAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGD 286
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-40
Identities = 93/341 (27%), Positives = 139/341 (40%), Gaps = 87/341 (25%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDI 642
DR + K I G+FG V+ AK +G+L AIK VL+ D KN E I
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNR------ELQI 100
Query: 643 LISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGC----LDEDVAR 692
+ + + +VR FFYS +++ L LV++Y+ +Y + R+ L +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+Y+ ++ +L Y+HS + HRD+KP NLL+ +KL DFG +K
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ------------- 206
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIIL 810
L EP S + + Y APE++ G T++ D WS G +L
Sbjct: 207 ------LVRGEP-------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 811 FELIVGIPPF---------------------------NAEHPQQIFDNILNRKIPWPRV- 842
EL++G P F N + + F I + PW +V
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVF 305
Query: 843 PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
PEA L R L P RL E H FF ++
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDEL 343
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
++I+ + G V+LA+ AIK + ++ ++ E + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+V + YLVMEY+ G L + + G L D A + +++ +++ H +R+
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+KP N+LI + +K+ DFG++K A+S T+ LT +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAK-------------ALSETS--------LTQTN- 170
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
+GT Y +PE G D +S+GI+L+E++VG PPFN E I
Sbjct: 171 --------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222
Query: 831 NILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
+ +P V +++ ++I R +D R +
Sbjct: 223 KHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQE 265
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 82/335 (24%), Positives = 138/335 (41%), Gaps = 84/335 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DD+++++ + RG + VF A T + +K+LK + I E IL ++R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRG 89
Query: 649 -PFVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
P ++ LV E++N D L + L D D+ R Y+ E++ AL+Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT--DYDI-RFYMYEILKALDYC 146
Query: 706 HSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
HS+ ++HRD+KP N++I H+ ++L D+GL++ +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------------------YHPGQE 186
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--N 821
R V + + PE+L+ + D WS+G +L +I PF
Sbjct: 187 YN------VR------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 822 AEHPQQI--------------------------FDNILNR--KIPWPR-VPEE----MSP 848
++ Q+ F++IL R + W R V E +SP
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
EA D +D+ L D RL A E +H +F +
Sbjct: 295 EALDFLDKLLRYDHQSRL---TAREAMEHPYFYTV 326
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 92/334 (27%), Positives = 139/334 (41%), Gaps = 88/334 (26%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDILISVRNP 649
+ K I G+FG VF AK + + AIK VL+ D KN E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ--DKRFKNR------ELQIMRIVKHP 92
Query: 650 FVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVV 699
VV FFYS +++ L LV+EY+ +Y R+ + + ++Y+ +++
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 700 LALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L Y+HS+ + HRD+KP NLL+ G +KL DFG +K+
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI-------------------- 191
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
S + + Y APE++ G + TT D WS G ++ EL+ G
Sbjct: 192 ------------LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
Query: 818 PPF---------------------------NAEHPQQIFDNILNRKIPWPRV-PEEMSPE 849
P F N + + F I R P+ +V P+
Sbjct: 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPD 297
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
A DLI R L P RL A E H FF ++
Sbjct: 298 AIDLISRLLEYTPSARL---TAIEALCHPFFDEL 328
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 89/351 (25%), Positives = 143/351 (40%), Gaps = 92/351 (26%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK--VLKKADMIRKNAVESILA 638
+ R +D F++ + +G FG V L K+++TG AIK + R L
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR------ELQ 68
Query: 639 ERDILISVRNPFVVR---FFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC----LD 687
L + +P +V+ +FY+ R+ L +VMEY+ L+ RN
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127
Query: 688 EDVARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINST 744
+ +V++ +++ ++ LH S+ V HRD+KP N+L+ DG +KL DFG +K
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK------ 181
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DW 803
L EP + + + + Y APE++ G H TTA D
Sbjct: 182 -------------LSPSEPNV-------------AYICSRYYRAPELIFGNQHYTTAVDI 215
Query: 804 WSVGIILFELIVGIPPF---------------------------NAEHPQQIFDNILNRK 836
WSVG I E+++G P F N H N +
Sbjct: 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNS--KG 273
Query: 837 IPWPRV----PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
IPW V + + EA+DL+ L P +R+ E H +F ++
Sbjct: 274 IPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFDEL 321
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 35/287 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILISVRNP 649
+E+ + + G V LA+ A+KVL+ AD+ R + E ++ +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 650 FVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H ++HRD+KP N++I+ +K+ DFG+++ A++ + +
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-------------AIADSG------NSV 173
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
T + + +GT YL+PE G +D +S+G +L+E++ G PPF + P
Sbjct: 174 TQTA---------AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
Query: 826 QQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
+ + P E +S + ++ + L ++P R +
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-38
Identities = 88/342 (25%), Positives = 131/342 (38%), Gaps = 85/342 (24%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVES--ILAERDIL 643
+ +E + I +G FG VF A+ R TG A LKK + +N E I A R+I
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKK---VLMENEKEGFPITALREIK 68
Query: 644 I--SVRNPFVVR--------FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVAR 692
I +++ VV C+ ++YLV ++ DL LL N+ +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
+ ++ L Y+H +++HRD+K N+LI DG +KL DFGL A
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL---------------AR 172
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 811
+ + + + T + V T Y PE+LLG D W G I+
Sbjct: 173 AFSLAKNSQPNRYT------------NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 220
Query: 812 ELIVGIPPF--NAEHPQ--QIFDNIL---NRKIPWPRVPE-------------------- 844
E+ P N E Q I + ++ WP V
Sbjct: 221 EMWTRSPIMQGNTEQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDR 278
Query: 845 ----EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
P A DLID+ L DP QR+ + + H FF
Sbjct: 279 LKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFWS 317
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 66/334 (19%), Positives = 116/334 (34%), Gaps = 78/334 (23%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
S RT D +++ + +G +G V+ + G+ A+K+ D +S E +
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE------KSWFRETE 52
Query: 642 I--LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
+ + +R+ ++ F S L+L+ Y G LY L+ LD +
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIV 111
Query: 696 AEVVLALEYLHSLR--------VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
+ L +LH + HRDLK N+L+ +G + D GL+ +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--------- 162
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT------A 801
+ Q VGT Y+APE+L T
Sbjct: 163 ------------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204
Query: 802 DWWSVGIILFELIVGI----------PPFNAEHPQQ-----IFDNILNRK----IPWPRV 842
D W+ G++L+E+ + PPF P + + + IP
Sbjct: 205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWF 264
Query: 843 PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
+ L+ ++P RL A +K+
Sbjct: 265 SDPTLTSLAKLMKECWYQNPSARL---TALRIKK 295
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-35
Identities = 75/358 (20%), Positives = 128/358 (35%), Gaps = 103/358 (28%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKA----------------------DM 627
+ + K + G+FG V +G FA+K VL+ D
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 628 IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--------LYLVMEYLNGGDLYSL 679
E + + + L ++MEY+ L+ +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKV 127
Query: 680 LRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFG 734
L++ + ++ +YI ++ A+ ++HSL + HRD+KP NLL+ + D +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
+K L EP + + + Y APE++LG
Sbjct: 188 SAKK-------------------LIPSEP-SV------------AYICSRFYRAPELMLG 215
Query: 795 TGHGTTA-DWWSVGIILFELIVGIPPF---------------------------NAEHPQ 826
T + D WS+G + ELI+G P F N + +
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE 275
Query: 827 QIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883
F + + W ++ PE A DL+++ L +P R+ E H FF +
Sbjct: 276 VRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHL 328
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 70/331 (21%), Positives = 122/331 (36%), Gaps = 78/331 (23%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-- 642
RT +++K I +G +G V++ K R G+ A+KV + S E +I
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQ 84
Query: 643 LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+ +R+ ++ F LYL+ +Y G LY L++ LD
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 699 VLALEYLHSLR--------VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
V L +LH+ + HRDLK N+L+ +G + D GL+ + ++ + P
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT------ADWW 804
+ VGT Y+ PE+L + + AD +
Sbjct: 204 ---------------------------NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236
Query: 805 SVGIILFELIVGI----------PPFNAEHPQQ-----IFDNILNRK----IPWPRVPEE 845
S G+IL+E+ P++ P + + + +K P +E
Sbjct: 237 SFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE 296
Query: 846 MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
+ L+ +P RL A VK+
Sbjct: 297 CLRQMGKLMTECWAHNPASRL---TALRVKK 324
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 77/334 (23%), Positives = 137/334 (41%), Gaps = 73/334 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
DF++ + GA+G V A + TG++ AIK K + + ++ R+I
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHF 66
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I++ N F +F +Y++ E + DL+ ++ L +D + +I +
Sbjct: 67 KHENIITIFNIQRPDSFENF---NEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQT 121
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ A++ LH V+HRDLKP NLLI + +K+ DFGL+++ + + +
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI---------IDESAADNSEP 172
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
++ + E V T Y APE++L + + A D WS G IL EL +
Sbjct: 173 TGQQSGMV--EF----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
Query: 818 PPFNAEH----------------PQQIFDNILN-------------RKIPWPRVPEEMSP 848
P F I + P ++ ++P
Sbjct: 221 PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNP 280
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+ DL+ R L DP +R+ A E +H + +
Sbjct: 281 KGIDLLQRMLVFDPAKRI---TAKEALEHPYLQT 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 66/341 (19%), Positives = 115/341 (33%), Gaps = 87/341 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV---ESILAERDI--- 642
+ + + IS G++G V + G AIK + + +S L +R +
Sbjct: 22 SPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 643 ----------LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVA 691
++ +R+ FV + LYLV E + DL ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAM---HKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ ++ ++L L LH VVHRDL P N+L+A + I + DF L++
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE------------- 183
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIIL 810
+ T + V Y APE+++ T D WS G ++
Sbjct: 184 -------DTADANKT--HY----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 811 FELIVGIPPFNAEHPQQIFDNILN-----------------------------RKIPWPR 841
E+ F + I+ W
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284
Query: 842 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
V P A DLI + L +P +R+ + +H +F+
Sbjct: 285 VVPTADPVALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 76/334 (22%), Positives = 128/334 (38%), Gaps = 86/334 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-----DMIRKNAVESILAERDIL 643
+ + GA+G V A + +G+ AIK L + R E +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR------AYRELLLL 77
Query: 644 ISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
+++ V+ F + N YLVM ++ DL ++ E+ + + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQ 134
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ L+Y+HS VVHRDLKP NL + D +K+ DFGL++
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH------------------- 175
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVG 816
+ ++T + V T Y APE++L H D WSVG I+ E++ G
Sbjct: 176 ---ADAEMT--GY----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 817 IPPFNAEHPQQIFDNILN----------------------------RKIPWPRVPEEMSP 848
F + IL + + ++ SP
Sbjct: 221 KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP 280
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+A DL+++ L D +RL A++ H FF+
Sbjct: 281 QAADLLEKMLELDVDKRL---TAAQALTHPFFEP 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 79/317 (24%), Positives = 127/317 (40%), Gaps = 72/317 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK------------VLKKADMIRKNAVESILA 638
+ +KP+ G G VF A AIK L++ +IR+ ++I+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+IL + S T ++Y+V EY+ DL ++L G L E+ AR+++ ++
Sbjct: 73 VFEILGP-SGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMYQL 129
Query: 699 VLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ L+Y+HS V+HRDLKP NL I D +K+ DFGL++
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR----------------IMDP 173
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVG 816
+ L+ E + T Y +P +LL + T A D W+ G I E++ G
Sbjct: 174 HYSHKGHLS--EG----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
Query: 817 IPPFNAEHPQQIFDNILN---------------------------RKIPWPRVPEEMSPE 849
F H + IL P ++ +S E
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281
Query: 850 AHDLIDRFLTEDPHQRL 866
A D +++ LT P RL
Sbjct: 282 AVDFLEQILTFSPMDRL 298
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 77/333 (23%), Positives = 129/333 (38%), Gaps = 83/333 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
+ ++P+ GA+G V A TG AIK K ++ + + A R++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + + V + + YLVM ++ G DL L+++ L ED + + ++
Sbjct: 82 RHENVIGLLD--VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQM 137
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L Y+H+ ++HRDLKP NL + D +K+ DFGL++
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-------------------- 177
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
+ ++T V T Y APE++L T D WSVG I+ E+I G
Sbjct: 178 --ADSEMT------------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 818 PPFNAEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPE 849
F I+ K + + SP
Sbjct: 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 283
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
A +L+++ L D QR+ A E H +F+
Sbjct: 284 AVNLLEKMLVLDAEQRV---TAGEALAHPYFES 313
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 84/332 (25%), Positives = 131/332 (39%), Gaps = 77/332 (23%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL----KKADMIRKNAVESILAERDILI 644
+ + I GA+G V A AIK + + R L E IL+
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR------TLREIKILL 80
Query: 645 SVRNPFVVRFFYSFT--CREN---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
R+ ++ E +Y+V + + DLY LL+ L D ++ +++
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L+Y+HS V+HRDLKP NLL+ +K+ DFGL++
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR----------------VADPDH 182
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIP 818
D LT E+ V T Y APEI+L + T + D WSVG IL E++ P
Sbjct: 183 DHTGFLT--EY----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 819 PFNAEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEA 850
F +H ++IL K+PW R+ +A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 851 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
DL+D+ LT +PH+R+ + H + +
Sbjct: 291 LDLLDKMLTFNPHKRI---EVEQALAHPYLEQ 319
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-33
Identities = 76/333 (22%), Positives = 129/333 (38%), Gaps = 83/333 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
+ ++ + P+ GA+G V A TG A+K K ++ + + R++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + + V S ++YLV + G DL ++++ L +D + I ++
Sbjct: 86 KHENVIGLLD--VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQI 141
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L+Y+HS ++HRDLKP NL + D +K+ DFGL++
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-------------------- 181
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
++T V T Y APEI+L H D WSVG I+ EL+ G
Sbjct: 182 --TADEMT------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
Query: 818 PPFNAEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPE 849
F IL K+ + V +P
Sbjct: 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 287
Query: 850 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
A DL+++ L D +R+ A++ H +F
Sbjct: 288 AVDLLEKMLVLDSDKRI---TAAQALAHAYFAQ 317
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 69/365 (18%), Positives = 125/365 (34%), Gaps = 80/365 (21%)
Query: 551 DKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKK 610
D+ I+ +D L D+ S S + RT + + I +G FG V+ K
Sbjct: 6 DRPFISEGTTLKD--LIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 611 RTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVVRFFYSFTCREN----L 664
R G+ A+K+ + S E +I + +R+ ++ F + L
Sbjct: 64 R--GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLK 716
+LV +Y G L+ L + + L +LH + HRDLK
Sbjct: 116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
N+L+ +G + D GL+ + A H+
Sbjct: 175 SKNILVKKNGTCCIADLGLAVR------------------HDSATDTIDIAPNHR----- 211
Query: 777 KRSAVGTPDYLAPEILLGTGHGTT------ADWWSVGIILFELIVGI----------PPF 820
VGT Y+APE+L + + AD +++G++ +E+ P+
Sbjct: 212 ----VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 821 NAEHP-----QQIFDNILNRK----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
P +++ + +K IP E ++ + RL A
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL---TA 324
Query: 872 SEVKQ 876
+K+
Sbjct: 325 LRIKK 329
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-32
Identities = 79/361 (21%), Positives = 135/361 (37%), Gaps = 104/361 (28%)
Query: 587 SIDDFEIIKP-ISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D FE + RG +G V+ AK++ +A+K ++ + S E +L
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALL 72
Query: 644 ISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL- 700
+++P V+ F + ++L+ +Y DL+ +++ + V + ++
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 701 --------ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDLS 748
+ YLH+ V+HRDLKP N+L+ + G +K+ D G ++
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----------- 180
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVG 807
L L + V T Y APE+LLG H T A D W++G
Sbjct: 181 --------LFNSPLKPLADLDPV---------VVTFWYRAPELLLGARHYTKAIDIWAIG 223
Query: 808 IILFELIVGIPPF----------NAEHPQQ---IFDNIL---NRKIPWPRV---PE---- 844
I EL+ P F N H Q IF N++ K W + PE
Sbjct: 224 CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF-NVMGFPADKD-WEDIKKMPEHSTL 281
Query: 845 -----------------------EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ +A L+ + LT DP +R+ + + Q +F
Sbjct: 282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFL 338
Query: 882 D 882
+
Sbjct: 339 E 339
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 80/373 (21%), Positives = 134/373 (35%), Gaps = 100/373 (26%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
D +EI I G++G V A + + AIK K + ++ ++ R+I
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
++ V + + + F + LY+V+E D L R L E + + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKF---DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS--------KVGLINSTDDLSGP 750
++ ++Y+HS ++HRDLKP N L+ D +K+ DFGL+ + +
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGII 809
+ + + QLT H V T Y APE++L + T A D WS+G I
Sbjct: 226 NLVTFPHTKNLKRQLT--GH----------VVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 810 LFELIVGIPPFNAEHP-----------------------------------QQIFD---- 830
EL+ I A H IF+
Sbjct: 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333
Query: 831 ---------------NILNRKIPWPRVP-EEM----SPEAHDLIDRFLTEDPHQRLGSGG 870
+ E S +A L+ R L +P++R+
Sbjct: 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI---T 390
Query: 871 ASEVKQHVFFKDI 883
+E H FFK++
Sbjct: 391 INECLAHPFFKEV 403
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 68/358 (18%), Positives = 120/358 (33%), Gaps = 108/358 (30%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVRN 648
+E++K I +G+FG+V A A+K+++ + A E IL + ++
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQD 154
Query: 649 P----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLAL 702
V+ +FT R ++ + E L +LY L++ + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
+ LH R++H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------------------CYEHQ 254
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
S Y APE++LG +G D WS+G IL EL+ G P
Sbjct: 255 RVYTYIQSRF---------------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
Query: 821 ----NAEH-----------PQQI----------FDNILNRKIPWPRVPEEMSPEAH---- 851
+ Q++ + + + S +
Sbjct: 300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRS 359
Query: 852 ---------------------------DLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
D + + L DP R+ + +H + +
Sbjct: 360 RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRR 414
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 74/398 (18%), Positives = 135/398 (33%), Gaps = 122/398 (30%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
++ +KPI GA G V A AIK K +N + A R++
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + N V S +++Y+VME + +L +++ LD + + ++
Sbjct: 82 NHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQM 136
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ +++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------------------- 176
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
+T V T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 177 AGTSFMMTPY------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
Query: 819 PFNAEHPQQIFDNILN---------------------------RKIPWPRV--------- 842
F ++ ++ + ++
Sbjct: 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD 284
Query: 843 ---PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTS 899
+ + +A DL+ + L D +R +
Sbjct: 285 SEHNKLKASQARDLLSKMLVIDASKR-------------------------------ISV 313
Query: 900 ESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLS 937
+ AL Y Y + ++ P + D +
Sbjct: 314 DEALQHPYINVWY--DPSEAEAPPPKIPDKQLDEREHT 349
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 88/349 (25%), Positives = 154/349 (44%), Gaps = 78/349 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER-----DIL 643
+E++K + +GA+G V+ + R TG++ A+K K D + S A+R IL
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQN----STDAQRTFREIMIL 62
Query: 644 ISVRN-PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ +V + +YLV +Y+ DL++++R L+ + + +++
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIK 120
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL--SKVGLINSTDDLSGPAVSGTTLL 758
++YLHS ++HRD+KP N+L+ + H+K+ DFGL S V + T+++ T
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
D++P LT ++ V T Y APEILLG+ T D WS+G IL E++ G
Sbjct: 181 DDDQPILT--DY----------VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 818 PPF------------------------------NA--------EHPQQIFDNILNRKIPW 839
P F A E + N + W
Sbjct: 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW 288
Query: 840 PRVPEEM------SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+ ++ + EA DL+D+ L +P++R+ A++ +H F
Sbjct: 289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 72/365 (19%), Positives = 134/365 (36%), Gaps = 92/365 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
D++ I I RG++G V+LA + T AIK K + + ++ ++ R+I
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + + + F + LY+V+E DL L + L E+ + + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKF---DELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV---GLINSTDDLSGPAVSGT 755
+L ++H ++HRDLKP N L+ D +K+ DFGL++ + +
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
+ + QLT H V T Y APE++L + T + D WS G I EL+
Sbjct: 199 PHNKNLKKQLT--SH----------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 815 VGIPPFNAEHP--------------------------------QQIFD------------ 830
+ + IF+
Sbjct: 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN 306
Query: 831 -------NILNRKIPWPRVP-EEM----SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
+ + ++ S + +L++ L +P++R+ + H
Sbjct: 307 INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHP 363
Query: 879 FFKDI 883
+ KD+
Sbjct: 364 YLKDV 368
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 73/399 (18%), Positives = 135/399 (33%), Gaps = 124/399 (31%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER-----DIL 643
++ +KPI GA G V A AIK K + + A+R ++
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN----QTHAKRAYRELVLM 115
Query: 644 ISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ F E +YLVME + +L +++ LD + + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQ 172
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------------------- 213
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
+T V T Y APE++LG G+ D WSVG I+ E++
Sbjct: 214 -AGTSFMMTPY------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 818 PPFNAEHPQQIFDNILN---------------------------RKIPWPRV-------- 842
F ++ ++ + +P++
Sbjct: 261 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA 320
Query: 843 ----PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPT 898
+ + +A DL+ + L DP +R +
Sbjct: 321 DSEHNKLKASQARDLLSKMLVIDPAKR-------------------------------IS 349
Query: 899 SESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLS 937
+ AL Y Y + + P ++ D +
Sbjct: 350 VDDALQHPYINVWY--DPAEVEAPPPQIYDKQLDEREHT 386
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 56/250 (22%), Positives = 94/250 (37%), Gaps = 55/250 (22%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LIS 645
+D+ ++++ I RG +G V+ A+KV A+ ++ + E++I +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 646 VRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ + + RF + R LVMEY G L L D + V
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTR 122
Query: 701 ALEYLHS---------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
L YLH+ + HRDL N+L+ +DG ++DFGLS N
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-------GHGTTADWW 804
+ + VGT Y+APE+L G D +
Sbjct: 183 NAAISE-----------------------VGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 805 SVGIILFELI 814
++G+I +E+
Sbjct: 220 ALGLIYWEIF 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 72/348 (20%), Positives = 123/348 (35%), Gaps = 81/348 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--- 647
F +I+ + G FGRV L + +A+KV++ ++A E DIL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDD 92
Query: 648 --NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALE 703
N +V++ F +++ L+ E L G LY ++ + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV-------SGTT 756
YL + + H DLKP+N+L+ K + T
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT- 210
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ S + T Y APE++L G ++D WS G +L EL G
Sbjct: 211 ---------------FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 817 IPPF----NAEH-----------PQQI-----------FDNILNRKIPWPRV-------- 842
F + EH P+ + + N K+ WP
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315
Query: 843 PEEMSPEAH---------DLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ + D + L DP R +E+ +H F +
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 56/345 (16%), Positives = 119/345 (34%), Gaps = 86/345 (24%)
Query: 576 TSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV 633
+S + + ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK------ 60
Query: 634 ESILAERDI--LISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLD 687
+S E ++ L +++ +++F + + L+L+ + G L L+ +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVS 119
Query: 688 EDVARVYIAEVVLALEYLHS----------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+ + L YLH + HRD+K N+L+ ++ + DFGL+
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
+ + VGT Y+APE+L G +
Sbjct: 180 KFEAGKSAGDT-----------------------------HGQVGTRRYMAPEVLEGAIN 210
Query: 798 GTT-----ADWWSVGIILFELIVGIPPFNAEHP----------------QQIFDNILNRK 836
D +++G++L+EL + + + + ++++K
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 270
Query: 837 IPWPRVPEEMSPEAH-----DLIDRFLTEDPHQRLGSGGASEVKQ 876
P + + A + I+ D RL A V +
Sbjct: 271 KR-PVLRDYWQKHAGMAMLCETIEECWDHDAEARL---SAGCVGE 311
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-30
Identities = 79/360 (21%), Positives = 127/360 (35%), Gaps = 111/360 (30%)
Query: 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVR 647
+EI+ + GAFG+V + G A+K++K D + A +E +L ++
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTT 71
Query: 648 NPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLA 701
+P V+ F ++ +V E L G Y ++ G D R ++ +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH-------------------IKLTDFGLSKVGLIN 742
+ +LHS ++ H DLKP+N+L + IK+ DFG +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-------S 183
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
+T D + L ++ H Y APE++L G D
Sbjct: 184 ATYD------------DEHHSTLVSTRH---------------YRAPEVILALGWSQPCD 216
Query: 803 WWSVGIILFELIVGIPPF----NAEH-----------PQQIFDNILNRK------IPWP- 840
WS+G IL E +G F + EH P+ + RK + W
Sbjct: 217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE 276
Query: 841 ------RVPEEMSP-------------EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
V P DLI + L DP +R+ E +H FF
Sbjct: 277 HSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFD 333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 87/364 (23%), Positives = 127/364 (34%), Gaps = 115/364 (31%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVRN 648
+EI I +G+FG+V A R + AIK++K A E +L ++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHD 111
Query: 649 P----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLAL 702
++V F R +L LV E L +LY LLRN + ++ R + ++ AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 703 EYLHS--LRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L + L ++H DLKP+N+L+ + IK+ DFG S L
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-------------------CQL 211
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
G Q S Y +PE+LLG + D WS+G IL E+ G P
Sbjct: 212 GQRIYQYIQSRF---------------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
Query: 819 PF----NAEH-----------PQQI----------FDNILN------------------- 834
F + P I F+ + +
Sbjct: 257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPG 316
Query: 835 -----------RKIPWPRVPEEMSPEA------HDLIDRFLTEDPHQRLGSGGASEVKQH 877
P R E DLI R L DP R+ QH
Sbjct: 317 TRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQH 373
Query: 878 VFFK 881
FFK
Sbjct: 374 SFFK 377
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 66/361 (18%), Positives = 125/361 (34%), Gaps = 111/361 (30%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP- 649
+ +++ + G F V+LAK A+K+++ + + A E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76
Query: 650 ----------FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC--LDEDVARV 693
+++ F + + +V E L G +L +L++ + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 694 YIAEVVLALEYLHS-LRVVHRDLKPDNLLIAH------DGHIKLTDFGLSKVGLINSTDD 746
+++L L+Y+H ++H D+KP+N+L+ IK+ D G + + T+
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
+ T +Y +PE+LLG G AD WS
Sbjct: 196 IQ----------------------------------TREYRSPEVLLGAPWGCGADIWST 221
Query: 807 GIILFELIVGIPPF----------NAEH---------------------PQQIFDNILNR 835
++FELI G F + +H + F++
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 281
Query: 836 KI-----PWPRVPE-----EMSPEAH----DLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ WP + S + D + L DP +R A + H + K
Sbjct: 282 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLK 338
Query: 882 D 882
D
Sbjct: 339 D 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 71/362 (19%), Positives = 115/362 (31%), Gaps = 111/362 (30%)
Query: 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVR 647
+EI+ + G FG+V A+K+++ R+ A E ++L I +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEK 76
Query: 648 NPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLA 701
+ V F ++ + E L G + + L+ R ++ A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH-------------------IKLTDFGLSKVGLIN 742
L +LH ++ H DLKP+N+L + I++ DFG
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-------- 187
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T + + A+ H Y PE++L G D
Sbjct: 188 -----------SATFDHEHHTTIVATRH---------------YRPPEVILELGWAQPCD 221
Query: 803 WWSVGIILFELIVGIPPF----NAEH-----------PQQIFDNILNRK------IPWPR 841
WS+G ILFE G F N EH P + +K + W
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE 281
Query: 842 VPEE--------------------MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ + DL+ R L DP QR+ +E H FF
Sbjct: 282 NSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFA 338
Query: 882 DI 883
+
Sbjct: 339 GL 340
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 34/290 (11%), Positives = 72/290 (24%), Gaps = 64/290 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V R R +V E++ GG L + R + + A + H V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 830
+ D +G L+ L+V P +
Sbjct: 175 ---------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
Query: 831 NILNRKIPWPRVPEEMSPEAH----DLIDRFLTEDPHQRLGSGGASEVKQ 876
P P ++ + + R + D R S + ++Q
Sbjct: 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAK----KRTTGDL 616
D P +++ +D T + + ++ + +G FG V + + + TG++
Sbjct: 13 DIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEV 72
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGG 674
A+K L+ + + E +IL S+++ +V++ R NL L+MEYL G
Sbjct: 73 VAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 675 DLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733
L L+ + +D Y +++ +EYL + R +HRDL N+L+ ++ +K+ DF
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189
Query: 734 GLSKV 738
GL+KV
Sbjct: 190 GLTKV 194
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 70/282 (24%), Positives = 113/282 (40%), Gaps = 41/282 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D + + I RG FG VF + R L A+K ++ + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHS 707
P +VR T ++ +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+HRDL N L+ +K++DFG+S+
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSRE--------------------------EAD 265
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPFNAEHP 825
+ ++ V + APE L G ++ D WS GI+L+E +G P+
Sbjct: 266 GVYAASGGLRQVPV---KWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
Query: 826 QQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
QQ + + R P PE L+++ +P QR
Sbjct: 322 QQTREFVEKGGR---LPC-PELCPDAVFRLMEQCWAYEPGQR 359
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-25
Identities = 59/276 (21%), Positives = 106/276 (38%), Gaps = 45/276 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVRN 648
+ +I+ + G F V+L+ A+KV+K A+ + A++ E +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVRNSD 94
Query: 649 P------FVVRFFYSFT---------CRENLYLVMEYLNGGDLYSLLR--NLGCLDEDVA 691
P VV+ F C +V E L G L + N L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 692 RVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ I +V+ L+YLH+ R++H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 751 AVSGTTL--------------LGDEEPQLTASEHQQERRKKRSAVGTPD-YLAPEILLGT 795
AVS + ++ + K + Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 796 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 831
G+ T AD WS + FEL G F ++ +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 75/313 (23%), Positives = 121/313 (38%), Gaps = 57/313 (18%)
Query: 577 SPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRK 630
+ ++ +D T + + I + +G FG V L + GD L A+K L+ +
Sbjct: 9 AQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--- 65
Query: 631 NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLD 687
+ E IL ++ + F+V++ R++L LVMEYL G L L+ + LD
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
+Y +++ +EYL S R VHRDL N+L+ + H+K+ DFGL+K
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK---------- 175
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWS 805
LL ++ E Q +P + APE L + D WS
Sbjct: 176 ---------LLPLDKDYYVVREPGQ----------SPIFWYAPESLS-DNIFSRQSDVWS 215
Query: 806 VGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRV------------PEEMSPEAHD 852
G++L+EL + R+ P E H+
Sbjct: 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHE 275
Query: 853 LIDRFLTEDPHQR 865
L+ P R
Sbjct: 276 LMKLCWAPSPQDR 288
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 583 KDRTSID--DFEIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESI 636
D T + + ++ + +G FG V + + + TG++ A+K L+ + +
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDF 58
Query: 637 LAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARV 693
E +IL S+++ +V++ R NL L+MEYL G L L+ + +D
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
Y +++ +EYL + R +HRDL N+L+ ++ +K+ DFGL+KV
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 39/284 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGDLF--AIKVLKKADMIRKNAVESILAERDILIS 645
D +++ + G+FG V + +G A+K LK + + A++ + E + + S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEY 704
+ + ++R Y + +V E G L LR + G Y +V + Y
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R +HRDL NLL+A +K+ DFGL + L +
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMR-------------------ALPQNDDH 177
Query: 765 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPFN 821
EH++ P + APE L T + A D W G+ L+E+ G P+
Sbjct: 178 YVMQEHRK----------VPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWI 226
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ QI I PR PE+ + ++++ + P R
Sbjct: 227 GLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 269
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 11/168 (6%)
Query: 580 HPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAV 633
D T + + I+ + G FG+V L + GD A+K LK N +
Sbjct: 10 ATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHI 67
Query: 634 ESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDV 690
+ E +IL ++ + +V++ + + L+ME+L G L L N ++
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
Y ++ ++YL S + VHRDL N+L+ + +K+ DFGL+K
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 68/252 (26%), Positives = 107/252 (42%), Gaps = 42/252 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILI 644
+F+ IK + GAFG V+ G+ AIK L++A A + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALE 703
SV NP V R + L+ + + G L +R + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YL R+VHRDL N+L+ H+K+TDFGL+K LLG EE
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLGAEE- 171
Query: 764 QLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF 820
E+ E K P ++A E +L T D WS G+ ++EL+ G P+
Sbjct: 172 ----KEYHAEGGK------VPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 821 NAEHPQQIFDNI 832
+ +I +
Sbjct: 221 DGIPASEISSIL 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 15/179 (8%)
Query: 568 DDVVRSLRTSPIHPSKDRTSI--DDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKV 621
+ L P D T + I+ + G FG+V L T D + A+K
Sbjct: 12 HGALEVLFQGP----GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 622 LKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSL 679
LK E DIL ++ + ++++ +L LVMEY+ G L
Sbjct: 68 LKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125
Query: 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
L + ++ ++ + YLH+ +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 126 LPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 66/281 (23%), Positives = 123/281 (43%), Gaps = 43/281 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + + +G FG V++ T + AIK LK M + E+ L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLH 706
+V+ + + E +Y+V EY++ G L L+ + + V +A ++ + Y+
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+ VHRDL+ N+L+ + K+ DFGL+++ E+ + T
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLI---------------------EDNEYT 336
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHP 825
A + + K + APE L +D WS GI+L EL G P+
Sbjct: 337 ARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387
Query: 826 QQIFDNILNR-KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+++ D + ++P P E HDL+ + ++P +R
Sbjct: 388 REVLDQVERGYRMP---CPPECPESLHDLMCQCWRKEPEER 425
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 46/297 (15%)
Query: 578 PIHPSK---DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNA 632
I P + DR + + K + G FG V + + A+K+LK
Sbjct: 5 EIRPKEVYLDRKLLTLED--KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPAL 61
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+ +LAE +++ + NP++VR E+ LVME G L L+ + +
Sbjct: 62 KDELLAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
+ +V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-------------- 166
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG--TTA-DWWSVGII 809
L +E A H + K + APE + + ++ D WS G++
Sbjct: 167 -----LRADENYYKAQTHGKWPVK---------WYAPECIN---YYKFSSKSDVWSFGVL 209
Query: 810 LFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
++E G P+ ++ + + P E +DL++ T D R
Sbjct: 210 MWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGC-PAGCPREMYDLMNLCWTYDVENR 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 60/295 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF-------AIKVLKKADMIRKNAVESILAERD 641
+D + + +G F ++F +R GD +KVL KA N ES
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVL 700
++ + + +V + C + LV E++ G L + L+ N C++ ++
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKVGLINSTDDLSGPAV 752
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------------- 170
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 811
+ + QER ++ PE + + A D WS G L+
Sbjct: 171 ------------VLPKDILQERIP---------WVPPECIENPKNLNLATDKWSFGTTLW 209
Query: 812 ELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
E+ G P +A Q+ +R ++P + E +LI+ + +P R
Sbjct: 210 EICSGGDKPLSALDSQRKLQFYEDRH----QLPAPKAAELANLINNCMDYEPDHR 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 7e-22
Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 45/294 (15%)
Query: 578 PIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES 635
+KD I + + +G FG V++ T + AIK LK M + E+
Sbjct: 254 TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 308
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VY 694
L E ++ +R+ +V+ + + E +Y+V EY++ G L L+ + + V
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+A ++ + Y+ + VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-------------- 413
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
E+ + TA + + K + APE L +D WS GI+L EL
Sbjct: 414 -------EDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 814 I-VGIPPFNAEHPQQIFDNILNR-KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
G P+ +++ D + ++P P E HDL+ + ++P +R
Sbjct: 458 TTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPESLHDLMCQCWRKEPEER 508
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-21
Identities = 63/282 (22%), Positives = 115/282 (40%), Gaps = 43/282 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D + + G +G V+ + A+K LK+ M VE L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLH 706
P +V+ T Y++ E++ G+L LR + +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HR+L N L+ + +K+ DFGLS++ + GD T
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL------------------MTGDT---YT 374
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHP 825
A + K APE L +D W+ G++L+E+ G+ P+
Sbjct: 375 AHAGAKFPIKW---------TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
Query: 826 QQIFDNILN--RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
Q+++ + R R PE + ++L+ +P R
Sbjct: 426 SQVYELLEKDYR---MER-PEGCPEKVYELMRACWQWNPSDR 463
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 6/151 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ I G FG V L + AIK +++ M + E + E ++++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHS 707
P +V+ + + + LV E++ G L LR G + +V + YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
V+HRDL N L+ + IK++DFG+++
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 581 PSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
P+ D+ ++ D + + G +G V+ + A+K LK+ M VE L
Sbjct: 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLK 58
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA- 696
E ++ +++P +V+ T Y++ E++ G+L LR + +Y+A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
++ A+EYL +HRDL N L+ + +K+ DFGLS++
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 42/252 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILI 644
+F+ IK + GAFG V+ G+ AIK L++A A + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALE 703
SV NP V R + L+ + + G L +R + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YL R+VHRDL N+L+ H+K+TDFGL+K LLG EE
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLGAEEK 172
Query: 764 QLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF 820
+ A + P ++A E +L T D WS G+ ++EL+ G P+
Sbjct: 173 EYHAEGGK-----------VPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 821 NAEHPQQIFDNI 832
+ +I +
Sbjct: 221 DGIPASEISSIL 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 9e-21
Identities = 89/415 (21%), Positives = 147/415 (35%), Gaps = 53/415 (12%)
Query: 461 QIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLDDDSSIPYLLSFLEDLRVVIDRRK 520
I AGK + E F + +L + + + Y L +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQLVEYLKL-------KADGLIYCLKEACPNSSASNASG 264
Query: 521 FDALTVETFGARIEKLIREKYLQLCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIH 580
A T+ + + R + T + ITS P++ V S + P
Sbjct: 265 AAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEE 324
Query: 581 PSKDRTSIDDFEII---KPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVES 635
+ + ++ + G FG V R AIKVLK+ K E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEE 382
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVY 694
++ E I+ + NP++VR E L LVME GG L+ L +
Sbjct: 383 MMREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ +V + ++YL VHR+L N+L+ + + K++DFGLSK
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA---------------- 485
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
LG ++ TA + K + APE + ++ D WS G+ ++E
Sbjct: 486 ---LGADDSYYTARSAGKWPLK---------WYAPECIN-FRKFSSRSDVWSYGVTMWEA 532
Query: 814 I-VGIPPFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQR 865
+ G P+ ++ I K R+ P E PE + L+ R
Sbjct: 533 LSYGQKPYKKMKGPEVMAFIEQGK----RMECPPECPPELYALMSDCWIYKWEDR 583
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
++ ++K + G FG V L K + D+ A+K++K+ M + + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHS 707
P +V+F+ + +Y+V EY++ G L + LR+ G E + + +V + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ +HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 8/160 (5%)
Query: 582 SKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
ID D +K + G FG V K R D+ AIK++K+ M + + + E
Sbjct: 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEE 69
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EV 698
+++++ + +V+ + T + ++++ EY+ G L + LR + + + + +V
Sbjct: 70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
A+EYL S + +HRDL N L+ G +K++DFGLS+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 34/152 (22%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ + G FG V++ + A+K LK+ M + ++ LAE +++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLH 706
+VR + T +E +Y++ EY+ G L L+ + + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
R + + + + G FG V+ A+K KK + E ++E
Sbjct: 10 AREDV---VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEA 64
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
I+ ++ +P +V+ E +++ME G+L L N L +Y ++
Sbjct: 65 VIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 9/159 (5%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
+ + I I K I G G V + R G AIK LK + L+E
Sbjct: 47 EASRI---HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEA 101
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
I+ +P ++R T +V EY+ G L + LR + G + V
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ YL L VHRDL N+L+ + K++DFGLS+V
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 65/250 (26%), Positives = 99/250 (39%), Gaps = 42/250 (16%)
Query: 589 DDFEIIK-PISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILIS 645
D+ I + G FG V R AIKVLK+ K E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEY 704
+ NP++VR E L LVME GG L+ L + + +V + ++Y
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L VHRDL N+L+ + + K++DFGLSK LG ++
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-------------------LGADDSY 166
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF-- 820
TA + K + APE + ++ D WS G+ ++E + G P+
Sbjct: 167 YTARSAGKWPLK---------WYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
Query: 821 --NAEHPQQI 828
E I
Sbjct: 217 MKGPEVMAFI 226
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 38/165 (23%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 578 PIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES 635
KD I ++ K + G FG V++A + A+K +K M +VE+
Sbjct: 175 QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEA 229
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VY 694
LAE +++ ++++ +V+ T +E +Y++ E++ G L L++ + + + +
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ ++ + ++ +HRDL+ N+L++ K+ DFGL++V
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 25/186 (13%)
Query: 582 SKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKN 631
+ + ++D I + + +G FG V A+ + F A+K+LK D+I +
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIASS 67
Query: 632 AVESILAERDILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLYSLLRNLGC 685
+E L E + +P V + + +++ ++ GDL++ L
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 686 LDEDVA-----RVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+ V ++ +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK- 186
Query: 740 LINSTD 745
I S D
Sbjct: 187 -IYSGD 191
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 55/267 (20%), Positives = 93/267 (34%), Gaps = 54/267 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+++ + I G+FG +F AIK R++ + E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ +Y + LV++ L G L LL G R + + V
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-------RKFSVKTVAMAAKQMLAR 118
Query: 702 LEYLHSLRVVHRDLKPDNLLI-----AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
++ +H +V+RD+KPDN LI + I + DFG+ K T
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK----------- 167
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+H R KK + GT Y++ LG D ++G + + G
Sbjct: 168 ------------QHIPYREKK-NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
Query: 817 IPP---FNAEHPQQIFDNILNRKIPWP 840
P A +Q ++ I +K P
Sbjct: 215 SLPWQGLKAATNKQKYERIGEKKQSTP 241
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 10/160 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAE 639
+ + K I G FG V+ +T+ AIK LK + L E
Sbjct: 42 HPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGE 96
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEV 698
I+ + ++R + + + ++ EY+ G L LR G + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
++YL ++ VHRDL N+L+ + K++DFGLS+V
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 58/264 (21%), Positives = 99/264 (37%), Gaps = 54/264 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
F + K I G FG + L K T + AIK+ K+ + E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ + +Y C + +V+E L G L L R + + VL
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-------RTFSLKTVLMIAIQLISR 117
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+EY+HS +++RD+KP+N LI G+ I + DF L+K + T
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK----------- 166
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+H R+ +S GT Y++ LG D ++G + + G
Sbjct: 167 ------------KH-IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
Query: 817 IPP---FNAEHPQQIFDNILNRKI 837
P A+ ++ + I + K
Sbjct: 214 SLPWQGLKADTLKERYQKIGDTKR 237
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 61/299 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGD----LFAIKVLKKADMIRKNAVESILAERDIL 643
+ + + + +G+FG V+ K D AIK + +A +R L E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR---------VY 694
VVR + + ++ME + GDL S LR+L + +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+A E+ + YL++ + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETD-------- 192
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL-----APEILLGTGHGTTA-DWWSVG 807
RK + L +PE L G TT D WS G
Sbjct: 193 -------------------YYRKGGKGL-----LPVRWMSPESLK-DGVFTTYSDVWSFG 227
Query: 808 IILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
++L+E+ + P+ +Q+ ++ + + P+ +L+ +P R
Sbjct: 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDK-PDNCPDMLFELMRMCWQYNPKMR 284
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 49/256 (19%), Positives = 99/256 (38%), Gaps = 43/256 (16%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAE 639
T + +K + G FG V G+ IKV++ + + +++
Sbjct: 11 KETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDH 65
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEV 698
+ S+ + +VR +L LV +YL G L +R + G L + + ++
Sbjct: 66 MLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ YL +VHR+L N+L+ +++ DFG++ +
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL-------------------- 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VG 816
L + Q + ++ + ++A E + G T D WS G+ ++EL+ G
Sbjct: 165 ------LPPDDKQLLYSEAKTPI---KWMALESIH-FGKYTHQSDVWSYGVTVWELMTFG 214
Query: 817 IPPFNAEHPQQIFDNI 832
P+ ++ D +
Sbjct: 215 AEPYAGLRLAEVPDLL 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAERDILIS 645
+ E+ + I G FG V + + AIK K E L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 447
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEY 704
+P +V+ ++++ME G+L S L+ LD +Y ++ AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R VHRD+ N+L++ + +KL DFGLS+ + D
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------------------MEDST-- 545
Query: 765 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPFN 821
++ + K P ++APE + T+A D W G+ ++E++ G+ PF
Sbjct: 546 ----YYKASKGK------LPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQ 594
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ I N + P P P + L+ + DP +R
Sbjct: 595 GVKNNDVIGRIENGERL-PM-PPNCPPTLYSLMTKCWAYDPSRR 636
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
R I E+ + I G FG V + + AIK K E L E
Sbjct: 13 QRERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEA 67
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
+ +P +V+ ++++ME G+L S L+ LD +Y ++
Sbjct: 68 LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
AL YL S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 56/262 (21%), Positives = 96/262 (36%), Gaps = 52/262 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+ + + I G+FG ++L G+ AIK+ K + E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ + + +VME L G L L R + + VL
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-------RKFSLKTVLLLADQMISR 117
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+EY+HS +HRD+KPDN L+ + + DFGL+K ++
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-KYRDARTH------------ 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
+H R+ ++ GT Y + LG D S+G +L +G
Sbjct: 165 ----------QH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213
Query: 819 P---FNAEHPQQIFDNILNRKI 837
P A +Q ++ I +K+
Sbjct: 214 PWQGLKAATKRQKYERISEKKM 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 580 HPSKDRTSI--DDFEIIKPISRGAFGRVFLAK-KRTTGD----LFAIKVLKKADMIRKNA 632
H I D + + + GAFG+VFLA+ + L A+K LK + A
Sbjct: 4 HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AA 60
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+ E ++L ++++ +V+F+ + L +V EY+ GDL LR G +
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 693 ---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
++IA ++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 737 KVGLINSTD 745
+ + STD
Sbjct: 181 RD--VYSTD 187
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 9/159 (5%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
D T+I I K + G FG V + + AIK LK + L E
Sbjct: 43 DATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEA 97
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
I+ +P ++R T + + +V EY+ G L S LR + + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
++YL + VHRDL N+LI + K++DFGL +V
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ I +G FG V L R A+K +K ++ LAE ++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQLRH 73
Query: 649 PFVVRFFYSFTCRE-NLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYL 705
+V+ + LY+V EY+ G L LR+ G + + +V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 44/281 (15%)
Query: 562 EDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---A 618
+ + L ++V++++ I P + + I RG FG V+ A
Sbjct: 3 DLSALNPELVQAVQHVVIGP--SSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 57
Query: 619 IKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLY 677
+K L + I V L E I+ +P V+ + +V+ Y+ GDL
Sbjct: 58 VKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 678 SLLRNLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+ +RN + +V ++YL S + VHRDL N ++ +K+ DFGL+
Sbjct: 116 NFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGT 795
+ + + ++ P ++A E L T
Sbjct: 176 RD--MYDKEY--------------------------YSVHNKTGAKLPVKWMALESLQ-T 206
Query: 796 GHGTTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILN 834
TT D WS G++L+EL+ G PP+ + I +L
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 24/189 (12%)
Query: 578 PIHPSKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADM 627
P + + ++D I K + G FG V + A+K +K +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 628 IRKNAVESILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRN 682
++ +E L+E + +P V+R S +++ ++ GDL++ L
Sbjct: 76 SQR-EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY 134
Query: 683 LGCLDEDVA-----RVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+ ++ L +EYL + +HRDL N ++ D + + DFGLS
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
Query: 737 KVGLINSTD 745
K I S D
Sbjct: 195 KK--IYSGD 201
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAK-KRTTGD----LFAIKVLKKADMIRKNAVESILA 638
R I + + GAFG+VFLA+ + L A+K LK+A +A +
Sbjct: 39 KRRDI---VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQR 92
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------ 692
E ++L +++ +VRFF T L +V EY+ GDL LR+ G + +A
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 693 --------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+ +A +V + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 42/180 (23%), Positives = 70/180 (38%), Gaps = 25/180 (13%)
Query: 581 PSKDRTSIDD-----FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK-----KADMIRK 630
P + +DD + + K I G FG ++LA + A V+K + +
Sbjct: 24 PFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSE 83
Query: 631 NAVESILAERDILISVRNPFV--------VRFFYSFTCRENLY--LVMEYLNGGDLYSLL 680
+A++D + + Y +VME L G DL +
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142
Query: 681 RNLGCLDED-VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSK 737
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 143 GQNGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ I +G FG V L R G+ A+K +K ++ LAE ++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 649 PFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYL 705
+V+ + LY+V EY+ G L LR+ G + + +V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 42/259 (16%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
+ + I RG FG V+ A+K L + I V L E
Sbjct: 87 SSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEG 141
Query: 641 DILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EV 698
I+ +P V+ + +V+ Y+ GDL + +RN + +V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+++L S + VHRDL N ++ +K+ DFGL++ + +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEF------------ 247
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-V 815
+ ++ P ++A E L T TT D WS G++L+EL+
Sbjct: 248 --------------DSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTR 292
Query: 816 GIPPFNAEHPQQIFDNILN 834
G PP+ + I +L
Sbjct: 293 GAPPYPDVNTFDITVYLLQ 311
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/261 (22%), Positives = 98/261 (37%), Gaps = 42/261 (16%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILA 638
+R + I +G FG V+ + AIK L + ++ VE+ L
Sbjct: 17 PHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLR 71
Query: 639 ERDILISVRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA- 696
E ++ + +P V+ E ++++ Y+ GDL +R+ +
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V +EYL + VHRDL N ++ +K+ DFGL++ I + S
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHAR 189
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
L P + A E L T TT D WS G++L+EL+
Sbjct: 190 L--------------------------PVKWTALESLQ-TYRFTTKSDVWSFGVLLWELL 222
Query: 815 -VGIPPFNAEHPQQIFDNILN 834
G PP+ P + +
Sbjct: 223 TRGAPPYRHIDPFDLTHFLAQ 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 39/183 (21%), Positives = 68/183 (37%), Gaps = 28/183 (15%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILA 638
+++ ++ + FG+V+ AIK LK E
Sbjct: 7 SLSAV---RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRH 61
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E + +++P VV T + L ++ Y + GDL+ L + + V
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 699 VLAL----------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
AL EYL S VVH+DL N+L+ ++K++D GL + +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VY 179
Query: 743 STD 745
+ D
Sbjct: 180 AAD 182
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF-------AIKVLKKADMIRKNAVESILAERD 641
D + KP+ GAFG+V +A+ A+K+LK + + +++E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 642 ILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-------- 692
++ + ++ ++ + T LY+++EY + G+L LR + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 693 -------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
V ++ +EYL S + +HRDL N+L+ + +K+ DFGL++ IN+
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNI 210
Query: 745 D 745
D
Sbjct: 211 D 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ + K + G FG+V A R A+K+LK+ + +L+E ++L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR----------- 692
V +P V++ + + + L L++EY G L LR +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 693 ------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+ A ++ ++YL +++VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 740 LINSTD 745
+ D
Sbjct: 199 DVYEED 204
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 35/192 (18%), Positives = 68/192 (35%), Gaps = 28/192 (14%)
Query: 572 RSLRTSPIHPSKDRTSIDD-----FEIIKPISRGAFGRVFLAKKRTTGDL--------FA 618
T+ + T + D +++ +R G ++ A +T F+
Sbjct: 20 FQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFS 79
Query: 619 IKVLKK-------ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY--LVME 669
+K+ K + ++ A + + L S + F ++ Y LV+
Sbjct: 80 LKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMG-FGVHQDKYRFLVLP 138
Query: 670 YLNGGDLYSLLRNLGCLDEDVARVY-IAEVVL-ALEYLHSLRVVHRDLKPDNLLI--AHD 725
L G L S L V +A +L ALE+LH VH ++ +N+ +
Sbjct: 139 SL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197
Query: 726 GHIKLTDFGLSK 737
+ L +G +
Sbjct: 198 SQVTLAGYGFAF 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 56/245 (22%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILISVRNPFVVRFF 655
+ G FG V+ K A+K L I + + E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 656 -YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLD--------EDVARVYIAEVVLALE 703
+S + LV Y+ G L L L + A +
Sbjct: 97 GFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GIN 147
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+LH +HRD+K N+L+ K++DFGL++ ++
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--------------------ASEKF- 186
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIPPFNA 822
A R VGT Y+APE L G T +D +S G++L E+I G+P +
Sbjct: 187 ---AQTVMTSR-----IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 823 EHPQQ 827
Q
Sbjct: 237 HREPQ 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-------KRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
D + KP+ G FG+V +A+ K A+K+LK + + +++E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 642 ILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-------- 692
++ + ++ ++ + T LY+++EY + G+L LR + +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 693 -------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
V ++ +EYL S + +HRDL N+L+ + +K+ DFGL++ IN+
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNI 256
Query: 745 D 745
D
Sbjct: 257 D 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-------KRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
D + KP+ GAFG+V LA+ K A+K+LK + + +++E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 642 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-------- 692
++ + ++ + T LY+++EY + G+L L+ + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 693 -------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
V A +V +EYL S + +HRDL N+L+ D +K+ DFGL++ I+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHI 244
Query: 745 D 745
D
Sbjct: 245 D 245
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 60/249 (24%), Positives = 99/249 (39%), Gaps = 49/249 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
++F+ I G FG+V+ R G A+K +E E + L R+
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPES---SQGIEEFETEIETLSFCRH 94
Query: 649 PFVVRFF-YSFTCREN--LYLVMEYLNGGDLYSLL----RNLGCLDEDVARVYIA-EVVL 700
P +V + C E + L+ +Y+ G+L L + + R+ I
Sbjct: 95 PHLVSLIGF---CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE-QRLEICIGAAR 150
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
L YLH+ ++HRD+K N+L+ + K+TDFG+SK G LS
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS------------ 198
Query: 761 EEPQLTASEHQQERRKKRSAV-GTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIP 818
+ V GT Y+ PE + G T +D +S G++LFE++
Sbjct: 199 ------------------TVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 819 PFNAEHPQQ 827
P++
Sbjct: 240 AIVQSLPRE 248
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 52/265 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
F + + I G+FG ++L T + AIK+ K +L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ + + LVM+ L G L L R + VL
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINR 115
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+E++HS +HRD+KPDN L+ + + DFGL+K ST
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH------------- 162
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
+H R+ ++ GT Y + LG D S+G +L + G
Sbjct: 163 ----------QH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211
Query: 819 P---FNAEHPQQIFDNILNRKIPWP 840
P A +Q ++ I +K+
Sbjct: 212 PWQGLKAGTKKQKYEKISEKKVATS 236
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 33/186 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ E ++ I GAFGRVF A+ + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN------LGCLDEDVAR----- 692
NP +V+ + + L+ EY+ GDL LR+ D++
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 693 ------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+ IA +V + YL + VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 223
Query: 740 LINSTD 745
I S D
Sbjct: 224 -IYSAD 228
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 41/181 (22%), Positives = 69/181 (38%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ K + GAFG+V A K A+K+LK + + E++++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI------- 695
+ N +V + T ++ EY GDL + LR
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 696 -----------AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
+V + +L S +HRDL N+L+ H K+ DFGL++ I +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKND 198
Query: 745 D 745
Sbjct: 199 S 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 24/177 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ + K + GAFG+V A K A+K+LK E++++E I+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+ +V + T + ++ EY GDL + LR + E IA +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 703 --------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+L S +HRD+ N+L+ + K+ DFGL++ I +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDS 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISV 646
+D + I G FG+V A+ + G AIK +K+ K+ E ++L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 647 -RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL--- 702
+P ++ + R LYL +EY G+L LR L+ D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 703 -------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+YL + +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D ++ KP+ RGAFG+V A K T A+K+LK+ ++++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 644 ISV-RNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLGCLDEDVAR--------- 692
I + + VV + T L +++E+ G+L + LR+
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 693 ------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+ + +V +E+L S + +HRDL N+L++ +K+ DFGL++ I
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDP 202
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 19/172 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGDLF----AIKVLKKADMIRKNAVESILAERDIL 643
+ +I+ + GAFG V+ + D A+K L + + L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------VYIA- 696
+ +VR +++ME + GGDL S LR + +++A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTD 745
++ +YL +HRD+ N L+ G K+ DFG+++ I
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAS 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 19/172 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGDLF----AIKVLKKADMIRKNAVESILAERDIL 643
+ +I+ + GAFG V+ + D A+K L + + L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------VYIA- 696
+ +VR ++++E + GGDL S LR + +++A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTD 745
++ +YL +HRD+ N L+ G K+ DFG+++ I
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAG 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 33/186 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ E K + GAFG+V A K A+K+LK+ E++++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 644 ISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+ + +V + T +YL+ EY GDL + LR+ + Y + L
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 703 -----------------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-- 220
Query: 740 LINSTD 745
I S
Sbjct: 221 DIMSDS 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 37/198 (18%), Positives = 71/198 (35%), Gaps = 40/198 (20%)
Query: 572 RSLRTSPIHPSKDRTSIDD-----FEIIKPISRGAFGRVFLAKKRTTGDL-----FAIKV 621
S + I D +++ PI +G FG ++LA ++ + +KV
Sbjct: 13 SSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV 72
Query: 622 LKK--------ADMIRKNAVESILAERDILISVRNPFVVRFFYS--FTCRENLY--LVME 669
++ A + + ++ V +++ S Y ++M+
Sbjct: 73 EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD 132
Query: 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------ALEYLHSLRVVHRDLKPDNLL 721
G DL + + + + VL LEY+H VH D+K NLL
Sbjct: 133 RF-GSDLQKIYEANA-------KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 722 I--AHDGHIKLTDFGLSK 737
+ + + L D+GL+
Sbjct: 185 LNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 72/290 (24%), Positives = 114/290 (39%), Gaps = 56/290 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES-ILAERDILISVR 647
D+F + RG FG+V+ + G L A+K LK+ R E E +++
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEE---RTQGGELQFQTEVEMISMAV 85
Query: 648 NPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLA- 701
+ ++R + T E L LV Y+ G + S LR LD R IA + A
Sbjct: 86 HRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWP-KRQRIA-LGSAR 142
Query: 702 -LEYLH---SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
L YLH +++HRD+K N+L+ + + DFGL+K+ T V+ T +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH------VT-TAV 195
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVG 816
GT ++APE L TG + D + G++L ELI G
Sbjct: 196 -----------------------RGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231
Query: 817 IPPFNAEHPQ-QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
F+ +L+ + E+ L+D L +
Sbjct: 232 QRAFDLARLANDDDVMLLDW--VKGLLKEKKLEA---LVDVDLQGNYKDE 276
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 9e-14
Identities = 102/703 (14%), Positives = 194/703 (27%), Gaps = 190/703 (27%)
Query: 285 HQHKVSWGYWGDQQNISDDSSSIICRICEEEVPTSHVEDHSKICAIADRCDQ--KGLSVN 342
H H + + G+ Q D S+ + V+D K + D
Sbjct: 3 HHHHMDFET-GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 343 ERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSE 402
LR+ TL E VQK + V+ + L R+ S
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVL--RINY------------KFLMSPIKTEQRQPSM 107
Query: 403 DMLDYVPEA-----DNSVFMDD-------LKGLPSMACKTRFGPKSD---QGMT----TS 443
Y+ + DN VF L + R P + G+ T
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR--PAKNVLIDGVLGSGKTW 165
Query: 444 SAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLDDDSSIP 503
A + + +I L S + +L T+ D S+I
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKN-CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 504 YLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITSTVIEED 563
+ ++ + +L++ K + C LV + + +
Sbjct: 225 LRIHSIQA--------------------ELRRLLKSKPYENCLLVLLNVQN--AKAWN-- 260
Query: 564 APLEDDV-VRSLRTSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
++ + L T+ + + D IS L K
Sbjct: 261 -AF--NLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLT--PDEVKSLLL-K 309
Query: 621 VLK-KADMIRKNAVE------SILAERDILISVRNPFVVRF-FYSFTCRENLYLVME--- 669
L + + + + SI+AE S+R+ + + + + L ++E
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAE-----SIRD-GLATWDNWKHVNCDKLTTIIESSL 363
Query: 670 -YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA--------------LEYLHSLRVVHRD 714
L + + L +I ++L+ + LH +V +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ-- 772
K + I +++L + + E L H+
Sbjct: 421 PKESTISI-PSIYLELK-------------------------VKLENEYAL----HRSIV 450
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTAD---WWSVGIILFELIVGIPPFNAEHPQQI- 828
+ + D + P + D + +G L N EHP+++
Sbjct: 451 DHYNIPKTFDSDDLIPPYL----------DQYFYSHIG---HHL------KNIEHPERMT 491
Query: 829 -FDNI------LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
F + L +KI S + + + K ++
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL--------------KFYKPYICDN 537
Query: 882 DINWDTLARQKAAFVPTSESALDTSYFTS--RYSWNTTDENIY 922
D ++ L F+P E L S +T R + DE I+
Sbjct: 538 DPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 104/716 (14%), Positives = 202/716 (28%), Gaps = 208/716 (29%)
Query: 136 HMFQFRQSRVLHSADKRIP---QGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDH 192
H F + + + + + K+ S++ DH
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI-----------DH 53
Query: 193 AVKQGN-----------ILSPPGDDNAKSLESSAARDR---MSSWK---KLPSPVGKIMK 235
+ + +LS + K +E + MS K + PS + + M
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR-MY 112
Query: 236 ESPTSKEQNDGKVEPLKSSNIRRGLSEIDLTAKPSEFPP-----------------AAET 278
+ ND + N+ R + L E P A +
Sbjct: 113 IEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 279 LEHSSKHQHKVSWG-YWGDQQNISDDSSSIICRICEEEVPTSHVEDHSKICAIADRCDQK 337
S K Q K+ + +W N+ + +S P + +E K+ + D
Sbjct: 171 CL-SYKVQCKMDFKIFW---LNLKNCNS-----------PETVLEMLQKLLY---QIDPN 212
Query: 338 GLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWS 397
S ++ I + L
Sbjct: 213 WTSRSDHSSNIKLRIH------------------------------SIQAELRRLLKSKP 242
Query: 398 RRGSEDMLDYVPEADNSV---FMDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPL 454
+L V + F +L CK +TT S
Sbjct: 243 YENCLLVLLNV--QNAKAWNAF--NLS------CKIL--------LTTRFKQVTDFLSAA 284
Query: 455 LTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATT----PLDDDSSIPYLLSFL- 509
T S L+ ++ L + + + P + ++ P LS +
Sbjct: 285 TTTHISLDHH----SMTLTP----DEVKSL--LLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 510 EDLRVVIDRRKF------DALTVETFGARIEKL----IREKYLQLCELVTDDKVDITSTV 559
E +R + D LT + + L R+ + +L V I + +
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLT-TIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTIL 391
Query: 560 IE---EDAPLED--DVVRSLRTSPI---HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
+ D D VV L + P + SI ++L K
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS--------------IYLELKV 437
Query: 612 TTGDLFAI--KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV-- 667
+ +A+ ++ ++ + + ++ P++ ++FYS ++
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDSDDLIP----------PYLDQYFYS-------HIGHH 480
Query: 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP-DNLLIAHDG 726
++ + + +L R + LD I A S+ + LK + +D
Sbjct: 481 LKNIEHPERMTLFRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539
Query: 727 HIK-----LTDFGLSKVG--LINSTD-DLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+ + DF L K+ LI S DL A L+ ++E + Q +R
Sbjct: 540 KYERLVNAILDF-LPKIEENLICSKYTDLLRIA-----LMAEDEAIFEEAHKQVQR 589
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 2e-13
Identities = 40/197 (20%), Positives = 63/197 (31%), Gaps = 50/197 (25%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL-----KKADMIRKNAVESILAERD 641
+ + + I G FG VF AIK++ + + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 642 IL-----------------ISVRNPFVVRFFY----------------------SFTCRE 662
I I + + V+ Y F +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 663 NLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNL 720
L++V+E+ GG DL + L A+ + ++ +L SLR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 721 LIAHDGHIKLTDFGLSK 737
L+ KL K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 9/101 (8%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D ++ KP+ RGAFG+V A K T A+K+LK + + ++++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 644 ISVRN-PFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRN 682
I + + VV L +++E+ G+L + LR+
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 29/118 (24%)
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V +E+L S + +HRDL N+L++ +K+ DFGL++ I
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP----------- 247
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ +K A ++APE + + +D WS G++L+E+
Sbjct: 248 ----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720
+N ++M Y+NG ++ + + + + + LH V+H DL N
Sbjct: 411 LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE-IVGK-------LHKNDVIHNDLTTSNF 462
Query: 721 LIAHDGHIKLTDFGLSKV 738
+ D + + DFGL K+
Sbjct: 463 IF--DKDLYIIDFGLGKI 478
|
| >3k1f_M Transcription initiation factor IIB; RNA polymerase II, TFIIB, transcription factor, DNA-binding, DNA-directed RNA polymerase; 4.30A {Saccharomyces cerevisiae} Length = 197 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 16/63 (25%)
Query: 292 GYWGDQQNISDDSSSIICRICEEEVPTSHVEDHSK---ICAIADRCDQKGLSVNERLL-R 347
G G NI + C C+ P VE S+ +CA C GL ++++L+
Sbjct: 12 GRRGPNLNIV-----LTCPECKVY-PPKIVERFSEGDVVCA---LC---GLVLSDKLVDT 59
Query: 348 ISE 350
SE
Sbjct: 60 RSE 62
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1003 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-90 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-86 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-84 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-83 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-82 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-81 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-78 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-76 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-73 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-72 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-72 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-69 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-68 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-63 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-62 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-60 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-58 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-55 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-55 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-49 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-36 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 286 bits (733), Expect = 8e-90
Identities = 105/321 (32%), Positives = 171/321 (53%), Gaps = 37/321 (11%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
P K R +DF+ K + G+F V LA++ T +AIK+L+K +I++N V + E
Sbjct: 1 QPRKKRP--EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 58
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
RD++ + +PF V+ +++F E LY + Y G+L +R +G DE R Y AE+V
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
ALEYLH ++HRDLKP+N+L+ D HI++TDFG +KV
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV--------------------- 157
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
+ ++ + S VGT Y++PE+L ++D W++G I+++L+ G+PP
Sbjct: 158 --------LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQ 876
F A + IF I+ + + PE+ P+A DL+++ L D +RLG G +K
Sbjct: 210 FRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
Query: 877 HVFFKDINWDTLARQKAAFVP 897
H FF+ + W+ L +Q +
Sbjct: 267 HPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (712), Expect = 2e-86
Identities = 120/354 (33%), Positives = 190/354 (53%), Gaps = 40/354 (11%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISV 646
I+DF + K + +G+FG+VFLA+ + T FAIK LKK ++ + VE + E+ +L ++
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+PF+ F +F +ENL+ VMEYLNGGDL +++ D A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +V+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------------- 151
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
E+ K + GTPDY+APEILLG + + DWWS G++L+E+++G PF+ + +
Sbjct: 152 --ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886
++F +I +PR + EA DL+ + +P +RLG +++QH F++INW+
Sbjct: 210 ELFHSIRMDNPFYPR---WLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWE 264
Query: 887 TLARQK--AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSG 938
L R++ F P +S D S F + N + +S D +
Sbjct: 265 ELERKEIDPPFRPKVKSPFDCSNFDKEFL-NEKPRLSFADRALINSMDQNMFRN 317
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (700), Expect = 2e-84
Identities = 123/355 (34%), Positives = 190/355 (53%), Gaps = 38/355 (10%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ +++DF+ +K + +G FG+V L +++ TG +A+K+L+K +I K+ V + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+ R+PF+ Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS VV+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ ++ GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 156 ------ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKD 882
+++F+ IL +I +PR +SPEA L+ L +DP QRLG G A EV +H FF
Sbjct: 210 HERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
Query: 883 INWDTLARQKAA--FVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADS 935
INW + ++K F P S +DT YF ++ + D + D
Sbjct: 267 INWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQ 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (684), Expect = 5e-83
Identities = 92/295 (31%), Positives = 146/295 (49%), Gaps = 39/295 (13%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+++DFEI +P+ +G FG V+LA+++ + + A+KVL KA + + + E +I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
R+P ++R + F +YL++EY G +Y L+ L DE YI E+ AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S RV+HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
++ + GT DYL PE++ G H D WS+G++ +E +VG PPF A Q
Sbjct: 155 ----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ + I + + P+ ++ A DLI R L +P QR EV +H +
Sbjct: 211 ETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWIT 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 267 bits (683), Expect = 3e-82
Identities = 112/327 (34%), Positives = 179/327 (54%), Gaps = 42/327 (12%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
S+ DF+I++ + G+FGRV L + R G +A+KVLKK ++R VE ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+PF++R + +F + ++++M+Y+ GG+L+SLLR VA+ Y AEV LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAK----------------------------- 152
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ GTPDY+APE++ + + DWWS GI+++E++ G PF +
Sbjct: 153 -----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDIN 884
+ ++ ILN ++ + P + + DL+ R +T D QRLG+ G +VK H +FK++
Sbjct: 208 KTYEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264
Query: 885 WDTLARQK--AAFVPT-SESALDTSYF 908
W+ L + + P + DTS F
Sbjct: 265 WEKLLSRNIETPYEPPIQQGQGDTSQF 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 265 bits (677), Expect = 8e-81
Identities = 106/377 (28%), Positives = 174/377 (46%), Gaps = 47/377 (12%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER---DIL 643
+++DF + + I RG FG V+ +K TG ++A+K L K + K L ER ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
+ PF+V Y+F + L +++ +NGGDL+ L G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 822
++K ++VGT Y+APE+L G + ++ADW+S+G +LF+L+ G PF
Sbjct: 156 -------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFF 880
+ + +P+ SPE L++ L D ++RLG GA EVK+ FF
Sbjct: 209 HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 881 KDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSG 938
+ ++W + QK +P F + I SD +
Sbjct: 269 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKL-----LDSDQELYRN 323
Query: 939 SSSCLSNR-QEEVGDEC 954
+S R Q+EV +
Sbjct: 324 FPLTISERWQQEVAETV 340
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 258 bits (661), Expect = 9e-79
Identities = 122/356 (34%), Positives = 199/356 (55%), Gaps = 45/356 (12%)
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
+V E A ++D ++ T PS++ +D F+ IK + G+FGRV L K + +G+
Sbjct: 13 ESVKEFLAKAKEDFLKKWET----PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
+A+K+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VMEY+ GG++
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+S LR +G E AR Y A++VL EYLHSL +++RDLKP+NLLI G+I++TDFG +
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
K + + + + GTP+ LAPEI+L G
Sbjct: 189 K----------------------------------RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 856
+ DWW++G++++E+ G PPF A+ P QI++ I++ K+ + P S + DL+
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---PSHFSSDLKDLLRN 271
Query: 857 FLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 908
L D +R G+ G +++K H +F +W + ++K A F+P + DTS F
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 1e-78
Identities = 69/295 (23%), Positives = 134/295 (45%), Gaps = 35/295 (11%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++D+++++ + GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ VV+F+ YL +EY +GG+L+ + + E A+ + +++ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ + HRD+KP+NLL+ ++K++DFGL+ V N+ + L
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------------ 163
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
GT Y+APE+L H D WS GI+L ++ G P++
Sbjct: 164 -----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+ K + +++ L+ + L E+P R+ ++K+ ++
Sbjct: 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (649), Expect = 7e-78
Identities = 86/318 (27%), Positives = 147/318 (46%), Gaps = 44/318 (13%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
H ++D D +EII + GAFG+V+ A+ + T L A KV+ + +E + E
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVE 59
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEV 698
DIL S +P +V+ +F NL++++E+ GG + +++ L L E +V +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL YLH +++HRDLK N+L DG IKL DFG+S
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN------------------- 160
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGIILFEL 813
+ +++ S +GTP ++APE+++ + AD WS+GI L E+
Sbjct: 161 ------------TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208
Query: 814 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873
PP + +P ++ I + P P S D + + L ++ R S+
Sbjct: 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQ 265
Query: 874 VKQHVFFKDINWDTLARQ 891
+ QH F ++ + R+
Sbjct: 266 LLQHPFVT-VDSNKPIRE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 251 bits (643), Expect = 3e-76
Identities = 77/347 (22%), Positives = 141/347 (40%), Gaps = 43/347 (12%)
Query: 569 DVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI 628
D+ + P+ D +D ++I + + GAFG V +R TG+ FA K +
Sbjct: 7 DIWKQYYPQPVEIKHDHV-LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES 65
Query: 629 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLD 687
K E++ E + +R+P +V +F + ++ E+++GG+L+ + +
Sbjct: 66 DK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 122
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTD 745
ED A Y+ +V L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------- 174
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
H ++ + GT ++ APE+ G G D WS
Sbjct: 175 ------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 210
Query: 806 VGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQ 864
VG++ + L+ G+ PF E+ + N+ + +S + D I + L DP+
Sbjct: 211 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270
Query: 865 RLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 911
R+ + +H + N Q + T + + +
Sbjct: 271 RM---TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (638), Expect = 7e-76
Identities = 127/347 (36%), Positives = 195/347 (56%), Gaps = 42/347 (12%)
Query: 570 VVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKK---RTTGDLFAIKVLKKAD 626
V LRT+ + ++ I++FE++K + GA+G+VFL +K TG L+A+KVLKKA
Sbjct: 5 VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64
Query: 627 MIRK-NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
E ++Y+ E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK + + T
Sbjct: 125 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTAD 802
+ GT +Y+AP+I+ G +GH D
Sbjct: 185 ERAYDF------------------------------CGTIEYMAPDIVRGGDSGHDKAVD 214
Query: 803 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW-PRVPEEMSPEAHDLIDRFLTED 861
WWS+G++++EL+ G PF + + I R + P P+EMS A DLI R L +D
Sbjct: 215 WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274
Query: 862 PHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALD 904
P +RLG G A E+K+H+FF+ INWD LA +K A F P LD
Sbjct: 275 PKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 251 bits (641), Expect = 8e-76
Identities = 70/355 (19%), Positives = 144/355 (40%), Gaps = 43/355 (12%)
Query: 560 IEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAI 619
I + +D+ + P+ K + D ++I++ + GAFG V ++ TG +F
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEV-KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 59
Query: 620 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679
K + + K ++ E I+ + +P ++ +F + + L++E+L+GG+L+
Sbjct: 60 KFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 680 LRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLS 736
+ + E Y+ + L+++H +VH D+KP+N++ +K+ DFGL+
Sbjct: 117 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
+ T ++ APEI+
Sbjct: 177 T--------------------------------KLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLID 855
G D W++G++ + L+ G+ PF E + N+ + +SPEA D I
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 856 RFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS 910
L ++P +RL + +H + K + + +R ++ + Y
Sbjct: 265 NLLQKEPRKRL---TVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 1e-75
Identities = 91/294 (30%), Positives = 141/294 (47%), Gaps = 38/294 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I +GA G V+ A TG AI+ + +K E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +V + S+ + L++VMEYL GG L ++ C+DE E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA------------------------------- 164
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
+ E+ K+ + VGTP ++APE++ +G D WS+GI+ E+I G PP+ E+P +
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
I P + PE++S D ++R L D +R A E+ QH F K
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (625), Expect = 1e-74
Identities = 81/307 (26%), Positives = 127/307 (41%), Gaps = 49/307 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR------KNAVESILAERDI 642
+++E + + RG V + T +A+K++ + E+ L E DI
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 643 LISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L V P +++ ++ +LV + + G+L+ L L E R + ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ LH L +VHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELIV 815
K R GTP YLAPEI+ G+G D WS G+I++ L+
Sbjct: 159 --------QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874
G PPF + I++ + ++ S DL+ RFL P +R A E
Sbjct: 211 GSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEA 267
Query: 875 KQHVFFK 881
H FF+
Sbjct: 268 LAHPFFQ 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 1e-74
Identities = 78/302 (25%), Positives = 139/302 (46%), Gaps = 48/302 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D+E++ I G++GR ++++ G + K L M + +++E ++L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKH 62
Query: 649 PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLAL 702
P +VR++ R N LY+VMEY GGDL S++ LDE+ + ++ LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 703 EYLHSL-----RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ H V+HRDLKP N+ + ++KL DFGL++ +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-------------------I 163
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
L + A TP Y++PE + + +D WS+G +L+EL +
Sbjct: 164 LNHDTSFAKAFVG------------TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211
Query: 818 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
PPF A +++ I K + R+P S E +++I R L + R E+ ++
Sbjct: 212 PPFTAFSQKELAGKIREGK--FRRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILEN 266
Query: 878 VF 879
Sbjct: 267 PL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 5e-73
Identities = 81/340 (23%), Positives = 136/340 (40%), Gaps = 80/340 (23%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE I + G G VF + +G + A K++ I+ I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS- 707
P++V F+ +F + + ME+++GG L +L+ G + E + V+ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+++HRD+KP N+L+ G IKL DFG+S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------------------ 153
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF---NAEH 824
Q S VGT Y++PE L GT + +D WS+G+ L E+ VG P +A+
Sbjct: 154 ---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 825 PQQIFDNILN-------------------------------------RKIPWPRVPEE-M 846
+ +F + P P++P
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
Query: 847 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886
S E D +++ L ++P +R ++ H F K + +
Sbjct: 271 SLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAE 307
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 240 bits (613), Expect = 1e-72
Identities = 85/301 (28%), Positives = 140/301 (46%), Gaps = 41/301 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D ++ + GAF V LA+ + T L AIK + K + + S+ E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +V + +LYL+M+ ++GG+L+ + G E A I +V+ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ +A GTP Y+APE+L + D WS+G+I + L+ G PPF E+
Sbjct: 160 -----EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
Query: 826 QQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
++F+ IL + + +++S A D I + +DP +R + QH +
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDT 271
Query: 885 W 885
Sbjct: 272 A 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (610), Expect = 5e-72
Identities = 69/296 (23%), Positives = 113/296 (38%), Gaps = 42/296 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F ++ I G+FG V+ A+ ++ AIK + + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + +LVMEY G L + L E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+K N+L++ G +KL DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGIILFELIVGIPPFNAEHP 825
S VGTP ++APE++L G D WS+GI EL PP +
Sbjct: 165 -----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881
+I + P + S + +D L + P R + + +H F
Sbjct: 220 MSALYHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 4e-69
Identities = 75/312 (24%), Positives = 135/312 (43%), Gaps = 43/312 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN---AVESILAERDILIS 645
D ++ + + G F V ++++TG +A K +KK + E I E IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+++P V+ + + ++ L++E + GG+L+ L L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 706 HSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
HSL++ H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
+ ++ GTP+++APEI+ G AD WS+G+I + L+ G PF
Sbjct: 166 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 822 AEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ Q+ N+ + S A D I R L +DP +R+ + QH +
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 274
Query: 881 KDINWDTLARQK 892
K +
Sbjct: 275 KPKDTQQALSSA 286
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 8e-69
Identities = 78/335 (23%), Positives = 143/335 (42%), Gaps = 49/335 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I + + RG FG V + ++ + K +K + + E IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHS 707
++ SF E L ++ E+++G D++ + L+E Y+ +V AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 708 LRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+ H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ R P+Y APE+ T D WS+G +++ L+ GI PF AE
Sbjct: 153 ----QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 826 QQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD-- 882
QQI +NI+N + + +E+S EA D +DR L ++ R+ ASE QH + K
Sbjct: 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQKI 265
Query: 883 --INWDTL--ARQKAAFVPTSESALDTSYFTSRYS 913
++ + + + + + L+ +R S
Sbjct: 266 ERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARIS 300
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 3e-68
Identities = 59/305 (19%), Positives = 125/305 (40%), Gaps = 47/305 (15%)
Query: 586 TSIDD--FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
S D + I RG+F V+ T A L+ + K+ + E ++L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEML 62
Query: 644 ISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+++P +VRF+ S+ ++ + LV E + G L + L+ + V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 700 LALEYLHSL--RVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
L++LH+ ++HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ ++ +GTP+++APE+ + + D ++ G+ + E+
Sbjct: 165 ---------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS 208
Query: 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
P++ + + + PE ++I+ + ++ +R ++
Sbjct: 209 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLN 265
Query: 877 HVFFK 881
H FF+
Sbjct: 266 HAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 221 bits (565), Expect = 3e-66
Identities = 63/293 (21%), Positives = 123/293 (41%), Gaps = 35/293 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +E+ + + G V LA+ A+KVL+ + E ++ +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 649 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H ++HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR--------------------------- 159
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
++ + + +GT YL+PE G +D +S+G +L+E++ G PPF +
Sbjct: 160 -AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218
Query: 825 PQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
P + + P E +S + ++ + L ++P R + A+E++
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 8e-64
Identities = 83/317 (26%), Positives = 137/317 (43%), Gaps = 61/317 (19%)
Query: 583 KDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
K IDD+++ + + G G+V + T + FA+K+L+ R+ E +
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 642 ILISV-RNPFVVRFFYSF----TCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVY 694
+ + P +VR + R+ L +VME L+GG+L+S +++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ + A++YLHS+ + HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
+ TP Y+APE+L + + D WS+G+I++
Sbjct: 163 ------------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204
Query: 812 ELIVGIPPFNAEHPQQIFDNILNR------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
L+ G PPF + H I + R + P P E+S E LI L +P QR
Sbjct: 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS-EVSEEVKMLIRNLLKTEPTQR 263
Query: 866 LGSGGASEVKQHVFFKD 882
+ +E H +
Sbjct: 264 M---TITEFMNHPWIMQ 277
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-63
Identities = 53/296 (17%), Positives = 109/296 (36%), Gaps = 44/296 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I G+FG V+ K A+K+L +++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
++ F ++ L +V ++ G LY L + + + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRDLK +N+ + D +K+ DFGL+ V
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV----------------------------- 153
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGIILFELIVGIPPFNAEH 824
+ G+ ++APE++ +D ++ GI+L+EL+ G P++ +
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 825 PQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
+ ++ R P +V L+ L + +R ++
Sbjct: 214 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-62
Identities = 72/319 (22%), Positives = 118/319 (36%), Gaps = 62/319 (19%)
Query: 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN--AVESILAERDILISVRNP 649
E + + G F V+ A+ + T + AIK +K + L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
++ +F + N+ LV +++ + N L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK-------------------------------S 149
Query: 770 HQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828
R V T Y APE+L G +G D W+VG IL EL++ +P +
Sbjct: 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209
Query: 829 FDNILN-------------------------RKIPWPRVPEEMSPEAHDLIDRFLTEDPH 863
I IP + + DLI +P
Sbjct: 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 269
Query: 864 QRLGSGGASEVKQHVFFKD 882
R+ A++ + +F +
Sbjct: 270 ARI---TATQALKMKYFSN 285
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 6e-62
Identities = 67/303 (22%), Positives = 126/303 (41%), Gaps = 53/303 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES---ILAERDIL-- 643
+++ + G FG V+ + + AIK ++K + + + + E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+S V+R F ++ L++E DL+ + G L E++AR + +V+ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 703 EYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ H+ V+HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ GT Y PE + HG +A WS+GI+L++++ G PF
Sbjct: 161 ----------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880
+ + I+ ++ + + +S E LI L P R E++ H +
Sbjct: 211 EHD------EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWM 258
Query: 881 KDI 883
+D+
Sbjct: 259 QDV 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 7e-62
Identities = 61/311 (19%), Positives = 119/311 (38%), Gaps = 39/311 (12%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLA--KKRTTGDLFAIKVLKKADMIRKNAVESI 636
++ + +++D K + G FG V + + A+K+LK + + +
Sbjct: 1 VYLDRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDEL 55
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
LAE +++ + NP++VR E+ LVME G L L+ + + +
Sbjct: 56 LAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA------------------ 156
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-V 815
+ + + + APE + + +D WS G++++E
Sbjct: 157 ----------LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875
G P+ ++ + + P E +DL++ T D R G
Sbjct: 207 GQKPYRGMKGSEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
Query: 876 QHVFFKDINWD 886
++ ++ +N
Sbjct: 265 RNYYYDVVNEG 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 207 bits (528), Expect = 5e-61
Identities = 76/321 (23%), Positives = 134/321 (41%), Gaps = 63/321 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + + E IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V+ + ++ L LV E+L+ L G L+ A+ ++ +++ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
RV+HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA------------------------------ 149
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQ 827
RK + T Y AP++L+G+ + TT D WSVG I E++ G P F
Sbjct: 150 -FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 828 IFDNILN--------------------------RKIPWPRVPEEMSPEAHDLIDRFLTED 861
I +PW + + DL+ + L D
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 862 PHQRLGSGGASEVKQHVFFKD 882
P+QR+ A + +H +FK+
Sbjct: 269 PNQRI---TAKQALEHAYFKE 286
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-60
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 50/295 (16%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
++ + ++++ I +G FG V L R G+ A+K +K ++ LAE ++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 647 RNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALE 703
R+ +V+ + LY+V EY+ G L LR+ G L D + +V A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YL VHRDL N+L++ D K++DFGL+K +ST D
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD----------------- 158
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNA 822
+ + APE L T +D WS GI+L+E+ G P+
Sbjct: 159 ---------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
Query: 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
+ + + P+ P ++++ D R ++++
Sbjct: 204 IPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-60
Identities = 67/303 (22%), Positives = 108/303 (35%), Gaps = 41/303 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAER 640
+D I D E+ G FG V R AIKVLK+ K E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREA 60
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVV 699
I+ + NP++VR L LVME GG L+ L + + +V
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIP 818
+ + + APE + + +D WS G+ ++E + G
Sbjct: 159 -------LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
Query: 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
P+ ++ I K P E PE + L+ R + +
Sbjct: 212 PYKKMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 879 FFK 881
++
Sbjct: 270 YYS 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-59
Identities = 78/325 (24%), Positives = 134/325 (41%), Gaps = 63/325 (19%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+++F+ ++ I G +G V+ A+ + TG++ A+K ++ D + + + E +L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDVARVYIAEVVLALEYLH 706
+P +V+ LYLV E+L+ + L + + + Y+ +++ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S RV+HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------- 151
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNAEHP 825
R V T Y APEILLG + +TA D WS+G I E++ F +
Sbjct: 152 ---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 826 QQIFDNILN--------------------------RKIPWPRVPEEMSPEAHDLIDRFLT 859
I + + +V + + L+ + L
Sbjct: 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268
Query: 860 EDPHQRLGSGGASEVKQHVFFKDIN 884
DP++R+ A H FF+D+
Sbjct: 269 YDPNKRI---SAKAALAHPFFQDVT 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 58/284 (20%), Positives = 105/284 (36%), Gaps = 35/284 (12%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDIL 643
D +++ + G+FG V + A+K LK + + A++ + E + +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLAL 702
S+ + ++R + + +V E G L L ++ G Y +V +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YL S R +HRDL NLL+A +K+ DFGL +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA------------------------ 160
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821
++ + + APE L +D W G+ L+E+ G P+
Sbjct: 161 ----LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+ QI I PR PE+ + ++++ + P R
Sbjct: 217 GLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-58
Identities = 80/333 (24%), Positives = 129/333 (38%), Gaps = 70/333 (21%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDI--- 642
+ +E + I GA+G+VF A+ + G A+K ++ + S + E +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRH 63
Query: 643 LISVRNPFVVRFFYSFTCREN-----LYLVMEYLNGGDL-YSLLRNLGCLDEDVARVYIA 696
L + +P VVR F T L LV E+++ Y + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------ 165
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ S V T Y APE+LL + + T D WSVG I E+
Sbjct: 166 --------------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211
Query: 817 IPPFNAEHPQQIFDNILN------------------------RKIPWPRVPEEMSPEAHD 852
P F IL+ P + ++ D
Sbjct: 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 271
Query: 853 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885
L+ + LT +P +R+ A H +F+D+
Sbjct: 272 LLLKCLTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-58
Identities = 76/334 (22%), Positives = 120/334 (35%), Gaps = 69/334 (20%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+ +E + I +G FG VF A+ R TG A+K + + ++ + L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66
Query: 647 RNPFVVRFFYSFT--------CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
++ VV C+ ++YLV ++ L L + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L Y+H +++HRD+K N+LI DG +KL DFGL++ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------------ 174
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGI 817
+ + V T Y PE+LLG +G D W G I+ E+
Sbjct: 175 ---------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
Query: 818 PPFNAEHPQQIFDNILN-----------------------------RKIPWPRVPEEMSP 848
P Q I RK+ P
Sbjct: 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDP 279
Query: 849 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
A DLID+ L DP QR+ + + H FF
Sbjct: 280 YALDLIDKLLVLDPAQRI---DSDDALNHDFFWS 310
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-58
Identities = 82/328 (25%), Positives = 131/328 (39%), Gaps = 69/328 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I GA+G V A AIK + + + + L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 649 PFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
++ + +++YLV + G DLY LL+ L D ++ +++ L+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-QHLSNDHICYFLYQILRGLK 123
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
Y+HS V+HRDLKP NLL+ +K+ DFGL++V
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV------------------------- 158
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 822
A V T Y APEI+L G+ + D WSVG IL E++ P F
Sbjct: 159 ---ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215
Query: 823 EHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEAHDLI 854
+H ++IL K+PW R+ +A DL+
Sbjct: 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 275
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFFKD 882
D+ LT +PH+R+ + H + +
Sbjct: 276 DKMLTFNPHKRI---EVEQALAHPYLEQ 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-57
Identities = 56/292 (19%), Positives = 115/292 (39%), Gaps = 42/292 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +K + G FG V K R AIK++K+ M + E +++++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
+V+ + T + ++++ EY+ G L + LR + +V A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ +HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR------------------------------ 148
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQ 826
E + + PE+L+ + + +D W+ G++++E+ +G P+
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
+ ++I + P S + + ++ E +R + ++
Sbjct: 209 ETAEHIAQGLRLYR--PHLASEKVYTIMYSCWHEKADERP---TFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-56
Identities = 53/291 (18%), Positives = 111/291 (38%), Gaps = 42/291 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ I G FG V L D AIK +++ M ++ + E ++++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHS 707
P +V+ + + + LV E++ G L LR L + +V + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
V+HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV---------------------------- 151
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826
+ + +PE+ + + + +D WS G++++E+ G P+
Sbjct: 152 --LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
++ ++I + P S + +++ E P R S + +
Sbjct: 210 EVVEDISTGFRLYK--PRLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 3e-56
Identities = 62/284 (21%), Positives = 102/284 (35%), Gaps = 35/284 (12%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDIL 643
I +I + I G FG V + G AIK LK + L+E I+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIM 81
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLAL 702
+P V+ T + ++ E++ G L S LR N G + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+YL + VHRDL N+L+ + K++DFGLS+
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR------------------------- 176
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFN 821
L + APE + + +D WS GI+++E++ G P+
Sbjct: 177 -FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 822 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
Q + + I P P + H L+ +D + R
Sbjct: 236 DMTNQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-56
Identities = 81/355 (22%), Positives = 128/355 (36%), Gaps = 80/355 (22%)
Query: 571 VRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK 630
V ++ +P DR + K I G+FG V+ AK +G+L AIK + + +
Sbjct: 3 VTTVVATPGQG-PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN 61
Query: 631 NAVESILAERDILISVRNPFVVRFFYSFTC------RENLYLVMEYLNGGDLYSLLRNL- 683
E I+ + + +VR Y F L LV++Y+
Sbjct: 62 R-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 684 --GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGL 740
L ++Y+ ++ +L Y+HS + HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGT 799
S + + Y APE++ G + +
Sbjct: 172 -----------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN------------------------- 834
+ D WS G +L EL++G P F + I+
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262
Query: 835 RKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 888
+ PW +V PEA L R L P RL E H FF ++ +
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV 314
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-56
Identities = 62/319 (19%), Positives = 116/319 (36%), Gaps = 65/319 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDL-----FAIKVLKKADMIRKNAVESILAERDIL 643
++ E K + GAFG+V A A+K+LK+ + E++++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 94
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------------------- 682
+ + +V + T +YL+ EY GDL + LR+
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 683 ---LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
L L + + +V +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
+ +A ++APE L +
Sbjct: 214 ----------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 800 TADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 858
+D WS GI+L+E+ +G+ P+ F ++ + P + E + ++
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCW 304
Query: 859 TEDPHQRLGSGGASEVKQH 877
D +R +
Sbjct: 305 AFDSRKRP---SFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-56
Identities = 61/309 (19%), Positives = 115/309 (37%), Gaps = 55/309 (17%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+D + I G FG+V A+ + G + + + K+ E ++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 647 RN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------------LGCLDED 689
+ P ++ + R LYL +EY G+L LR L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ A+V ++YL + +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 175
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
Q+ KK ++A E L + + T +D WS G++
Sbjct: 176 --------------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215
Query: 810 LFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 868
L+E++ G P+ ++++ + P E +DL+ + E P++R
Sbjct: 216 LWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP-- 271
Query: 869 GGASEVKQH 877
+++
Sbjct: 272 -SFAQILVS 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-55
Identities = 82/352 (23%), Positives = 135/352 (38%), Gaps = 75/352 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++P+ GA+G V A TG AIK L + + + E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 649 PFVVRFFYSFTCRE------NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
V+ FT E + YLVM ++ G DL L+++ L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 134
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y+H+ ++HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------------------- 169
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN 821
Q + V T Y APE++L + T D WSVG I+ E+I G F
Sbjct: 170 ---------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 822 AEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEAHDL 853
I+ K + + SP A +L
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
Query: 854 IDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDT 905
+++ L D QR+ A E H +F+ ++ Q + + + T
Sbjct: 281 LEKMLVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (490), Expect = 1e-55
Identities = 61/307 (19%), Positives = 112/307 (36%), Gaps = 63/307 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ E ++ I GAFGRVF A+ + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG------------------- 684
NP +V+ + + L+ EY+ GDL LR++
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 685 -----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
L +V + YL + VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
G + ++ PE + + T
Sbjct: 191 YSADYYKADG-----------------------------NDAIPIRWMPPESIFYNRYTT 221
Query: 800 TADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 858
+D W+ G++L+E+ G+ P+ +++ + + I PE E ++L+
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCW 279
Query: 859 TEDPHQR 865
++ P R
Sbjct: 280 SKLPADR 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 56/280 (20%), Positives = 112/280 (40%), Gaps = 41/280 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ + G FG V++ A+K LK+ M ++ LAE +++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLH 706
+VR Y+ +E +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--------------------------- 159
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825
E + A + APE + +D WS GI+L E++ G P+
Sbjct: 160 ---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
++ N+ + P+ E + L+ E P R
Sbjct: 217 PEVIQNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 2e-55
Identities = 51/316 (16%), Positives = 101/316 (31%), Gaps = 45/316 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + + + I G+FG ++L G+ AIK+ K + E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 649 P-FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ + + +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 708 LRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
R+ ++ GT Y + LG D S+G +L +G P+
Sbjct: 162 ----HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
Query: 825 PQQIFDNILNRK-----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879
P + + E ++ + + ++ +++F
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
Query: 880 FKD-------INWDTL 888
+ +W+ L
Sbjct: 278 HRQGFSYDYVFDWNML 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-55
Identities = 67/349 (19%), Positives = 120/349 (34%), Gaps = 47/349 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISV 646
+F+ IK + GAFG V+ G+ I V K + A + IL E ++ SV
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
NP V R + G L + + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
R+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHP 825
++A E +L + +D WS G+ ++EL+ G P++
Sbjct: 167 -------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219
Query: 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885
+I + + P + + + ++ + D R E+ +
Sbjct: 220 SEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIEFSKMARDP 274
Query: 886 DTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDAD 934
+ S D++++ + DE D +D DAD
Sbjct: 275 QRYLVIQGDERMHLPSPTDSNFYRA-----LMDE-----EDMDDVVDAD 313
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 191 bits (486), Expect = 9e-55
Identities = 77/340 (22%), Positives = 136/340 (40%), Gaps = 84/340 (24%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+ DD+++++ + RG + VF A T + +K+LK + I E IL ++
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENL 86
Query: 647 R-NPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
R P ++ + LV E++N D L + L + R Y+ E++ AL+
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALD 143
Query: 704 YLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y HS+ ++HRD+KP N++I H+ ++L D+GL++
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY----------------------- 180
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF- 820
++ V + + PE+L+ + + D WS+G +L +I PF
Sbjct: 181 ---------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 821 ----NAEHPQQI-----------------------FDNILNR-------KIPWPRVPEEM 846
N + +I F++IL R + +
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291
Query: 847 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886
SPEA D +D+ L D RL A E +H +F + D
Sbjct: 292 SPEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-54
Identities = 77/322 (23%), Positives = 122/322 (37%), Gaps = 63/322 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+E ++ I G +G VF AK R T ++ A+K ++ D + S L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+VR + L LV E+ + G LD ++ + ++ +++ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA------------------------------ 150
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVG-IPPFNAEHPQ 826
R + V T Y P++L G + T+ D WS G I EL P F
Sbjct: 151 -FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 827 QIFDNILN--------------------------RKIPWPRVPEEMSPEAHDLIDRFLTE 860
I V +++ DL+ L
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 861 DPHQRLGSGGASEVKQHVFFKD 882
+P QR+ A E QH +F D
Sbjct: 270 NPVQRI---SAEEALQHPYFSD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-54
Identities = 68/307 (22%), Positives = 119/307 (38%), Gaps = 48/307 (15%)
Query: 582 SKDRTSI--DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
+KD I + + + +G FG V++ T AIK LK M E+ L E
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQE 62
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAE 697
++ +R+ +V+ Y+ E +Y+V EY++ G L L+ L A+
Sbjct: 63 AQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ + Y+ + VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI------------------ 163
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816
E ++ A + APE L +D WS GI+L EL G
Sbjct: 164 ------------EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 211
Query: 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876
P+ +++ D + P E HDL+ + ++P +R ++
Sbjct: 212 RVPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 266
Query: 877 --HVFFK 881
+F
Sbjct: 267 FLEDYFT 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-54
Identities = 65/294 (22%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILIS 645
+ E+ + I G FG V + + AIK K + E L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+P +V+ T ++++ME G+L S L LD +Y ++ AL Y
Sbjct: 65 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--------------------------- 156
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823
K ++APE + + +D W G+ ++E+++ G+ PF
Sbjct: 157 ---YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 824 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877
+ I N + +P P + L+ + DP +R +E+K
Sbjct: 214 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 2e-53
Identities = 64/316 (20%), Positives = 122/316 (38%), Gaps = 46/316 (14%)
Query: 577 SPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
P P+ D+ ++ D + + G +G V+ + A+K LK+ M VE
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVE 58
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVAR 692
L E ++ +++P +V+ T Y++ E++ G+L L N + V
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
++ A+EYL +HRDL N L+ + +K+ DFGLS++
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-------------- 164
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
A + APE L +D W+ G++L+E
Sbjct: 165 ----------------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 208
Query: 813 LIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871
+ G+ P+ Q+++ + K PE + ++L+ +P R
Sbjct: 209 IATYGMSPYPGIDLSQVYELL--EKDYRMERPEGCPEKVYELMRACWQWNPSDRP---SF 263
Query: 872 SEVKQHVFFKDINWDT 887
+E+ Q F+ + ++
Sbjct: 264 AEIHQ--AFETMFQES 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 182 bits (463), Expect = 4e-52
Identities = 46/286 (16%), Positives = 92/286 (32%), Gaps = 40/286 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+++ + I G+FG +F AIK + ++ + E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 710 VVHRDLKPDNLLIA-----HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ R+K++ GT Y++ LG D ++G + + G P+
Sbjct: 162 ----KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
Query: 825 PQ---QIFDNILNRKIPWPR--VPEEMSPEAHDLIDRFLTEDPHQR 865
Q ++ I +K P + E + +
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 67/316 (21%), Positives = 115/316 (36%), Gaps = 60/316 (18%)
Query: 578 PIHPSKDRT---SIDDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIR 629
P D + K + GAFG+V A K A+K+LK + +
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 630 KNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR------- 681
+ E++++E +L + N +V + T ++ EY GDL + LR
Sbjct: 69 E--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 682 -----------NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730
+ LD + + +V + +L S +HRDL N+L+ H K+
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
DFGL++ ++ K +A ++APE
Sbjct: 187 CDFGLARD-----------------------------IKNDSNYVVKGNARLPVKWMAPE 217
Query: 791 ILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPE 849
+ + +D WS GI L+EL +G P+ F ++ PE E
Sbjct: 218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAE 276
Query: 850 AHDLIDRFLTEDPHQR 865
+D++ DP +R
Sbjct: 277 MYDIMKTCWDADPLKR 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 59/318 (18%), Positives = 114/318 (35%), Gaps = 58/318 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ + + + +G+FG V+ K AIK + +A +R+ L E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 77
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------LGCLDEDVARV 693
VVR + + ++ME + GDL S LR+ L
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
E+ + YL++ + VHRDL N ++A D +K+ DFG+++
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------------- 182
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
RK + +++PE L T +D WS G++L+E+
Sbjct: 183 --------------IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
Query: 814 IVGI-PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872
P+ +Q+ ++ + P+ +L+ +P R
Sbjct: 229 ATLAEQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRP---SFL 283
Query: 873 EVKQ------HVFFKDIN 884
E+ F++++
Sbjct: 284 EIISSIKEEMEPGFREVS 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-49
Identities = 67/342 (19%), Positives = 126/342 (36%), Gaps = 84/342 (24%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
T + ++ +KPI GA G V A AIK L + + + E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 646 VRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
V + ++ FT + +++YLVME ++ + LD + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQML 129
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------------- 167
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
V T Y APE++LG G+ D WSVG I+ E++
Sbjct: 168 ----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
Query: 820 FNAEHPQQIFDNILN---------------------------RKIPWPRV---------- 842
F ++ ++ + +P++
Sbjct: 218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS 277
Query: 843 --PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882
+ + +A DL+ + L DP +R+ + QH +
Sbjct: 278 EHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-49
Identities = 77/330 (23%), Positives = 129/330 (39%), Gaps = 73/330 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ + P+ GA+G V A TG A+K L + +A + E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKH 76
Query: 649 PFVVRFFYSFT-----CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
Y+HS ++HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNA 822
+ + V T Y APEI+L H T D WSVG I+ EL+ G F
Sbjct: 169 -------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 823 EHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEAHDLI 854
IL K+ + V +P A DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 855 DRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884
++ L D +R+ A++ H +F +
Sbjct: 282 EKMLVLDSDKRI---TAAQALAHAYFAQYH 308
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 2e-49
Identities = 65/312 (20%), Positives = 122/312 (39%), Gaps = 60/312 (19%)
Query: 581 PSKDRTSI--DDFEIIKPISRGAFGRVFLAKKRTTGD-------LFAIKVLKKADMIRKN 631
P R + D + KP+ GAFG+V LA+ A+K+LK D K+
Sbjct: 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKD 61
Query: 632 AVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----- 685
+ +++E +++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 62 -LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 686 -----------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
L +V +EYL S + +HRDL N+L+ D +K+ DFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L++ H +K + ++APE L
Sbjct: 181 LARD-----------------------------IHHIDYYKKTTNGRLPVKWMAPEALFD 211
Query: 795 TGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 853
+ +D WS G++L+E+ +G P+ +++F + P + E + +
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMM 269
Query: 854 IDRFLTEDPHQR 865
+ P QR
Sbjct: 270 MRDCWHAVPSQR 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-49
Identities = 71/324 (21%), Positives = 126/324 (38%), Gaps = 59/324 (18%)
Query: 578 PIHPSKDRTSIDDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNA 632
P SK D ++ KP+ RGAFG+V A K T A+K+LK+ +
Sbjct: 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSE 59
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN-------- 682
++++E ILI + + V + L +++E+ G+L + LR+
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 683 --------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
L + Y +V +E+L S + +HRDL N+L++ +K+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L++ + +K A ++APE +
Sbjct: 180 LARD-----------------------------IYKDPDYVRKGDARLPLKWMAPETIFD 210
Query: 795 TGHGTTADWWSVGIILFELIVGI-PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 853
+ +D WS G++L+E+ P+ + F L R P+ +PE +
Sbjct: 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQT 269
Query: 854 IDRFLTEDPHQRLGSGGASEVKQH 877
+ +P QR SE+ +H
Sbjct: 270 MLDCWHGEPSQRP---TFSELVEH 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 7e-48
Identities = 57/295 (19%), Positives = 103/295 (34%), Gaps = 43/295 (14%)
Query: 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKN 631
T+ IHPS K I G FG V+ +T+ AIK LK +
Sbjct: 1 TTEIHPS-------CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EK 51
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDV 690
L E I+ + ++R + + + ++ EY+ G L G
Sbjct: 52 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 111
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ + ++YL ++ VHRDL N+L+ + K++DFGLS+V
Sbjct: 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV------------ 159
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810
+ + + APE + + +D WS GI++
Sbjct: 160 ----------------LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 203
Query: 811 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 865
+E++ E +N P P + + L+ + ++ +R
Sbjct: 204 WEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 7e-47
Identities = 65/318 (20%), Positives = 116/318 (36%), Gaps = 45/318 (14%)
Query: 566 LEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAK---KRTTGDLFAIKVL 622
L ++V++++ I PS ++ I RG FG V+ A+K L
Sbjct: 9 LNPELVQAVQHVVIGPSSLIVHFNEV-----IGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLR 681
+ I + V L E I+ +P V+ + +V+ Y+ GDL + +R
Sbjct: 64 NRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 682 NLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740
N + +V +++L S + VHRDL N ++ +K+ DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--- 178
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800
+ K A ++A E L T
Sbjct: 179 ------------------------DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 801 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 859
+D WS G++L+EL+ G PP+ + I +L + PE ++++ +
Sbjct: 215 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ--PEYCPDPLYEVMLKCWH 272
Query: 860 EDPHQRLGSGGASEVKQH 877
R SE+
Sbjct: 273 PKAEMRP---SFSELVSR 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 58/325 (17%), Positives = 104/325 (32%), Gaps = 74/325 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I +G FG V+ K G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 649 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
++ F + L+LV +Y G L+ L E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 705 LHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
LH + HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSVGIIL 810
S VGT Y+APE+L + + AD +++G++
Sbjct: 157 --------RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208
Query: 811 FELIVGIPPFNAEHPQQ-------------------IFDNILNRKIPWPRVPEEMSPEAH 851
+E+ Q + + L IP E
Sbjct: 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268
Query: 852 DLIDRFLTEDPHQRLGSGGASEVKQ 876
++ + RL A +K+
Sbjct: 269 KIMRECWYANGAARL---TALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 1e-36
Identities = 59/364 (16%), Positives = 121/364 (33%), Gaps = 93/364 (25%)
Query: 580 HPSK--DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESIL 637
HP+ + + +++ + G F V+LAK A+K+++ + + A + I
Sbjct: 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 61
Query: 638 AERDI-------LISVRNPFVVRFFYSFT--CRENLYLVMEYLNGG---DLYSLLRNLGC 685
+ + S+ +++ F +++VM + G
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 686 LDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINS 743
+ + +++L L+Y+H ++H D+KP+N+L+ L ++ +G
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---- 177
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
+++ T +Y +PE+LLG G AD
Sbjct: 178 -------------------------NACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADI 212
Query: 804 WSVGIILFELIVGIPPFNAEHPQQIFDNI------------------------------- 832
WS ++FELI G F + +
Sbjct: 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272
Query: 833 -----LNRKIPWP---------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878
+++ WP + ++ + E D + L DP +R A + H
Sbjct: 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHP 329
Query: 879 FFKD 882
+ KD
Sbjct: 330 WLKD 333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 2e-19
Identities = 26/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---------------IRKNAVESI 636
I K + G VF +K K A+ S
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
++ + + +VH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1003 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.05 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=491.36 Aligned_cols=293 Identities=40% Similarity=0.791 Sum_probs=266.4
Q ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 55689089987500596699999998999789999930410001789999999999998559996778985653163289
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~Ly 665 (1003)
+.+++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+|+.++||||++++++|++.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 84474289889831768499999998999899999981565449799999999999998679998877876403564211
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99986268784999984299999999999999999999876258230457986256357993999516875335557888
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
+|||||+||+|.+++.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC---
T ss_conf 10003579860555532567759999999999965211343159622464777847658998888205652003567---
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 99999766854479997410033566643102565688887881001259999632163216799999829999999993
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~ 825 (1003)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus 159 ----------------------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 159 ----------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp ----------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf ----------------------------8620551008899666650489888333102230678899878999999699
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC--CCHHHHHCCCCCCCCCHHHHHHH--CCCCCCCCCC
Q ss_conf 5678756304789999999899889999875265993776999--99889870978899993378620--1986578899
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 901 (1003)
Q Consensus 826 ~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~--~TAeEILqHPFFk~Idw~~L~~~--k~pfiP~~~s 901 (1003)
.++++.+......+ |..+|+++++||.+||++||.+|+++ .++.++++||||++++|+.+..+ .+|++|...+
T Consensus 211 ~~~~~~i~~~~~~~---p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~ 287 (337)
T d1o6la_ 211 ERLFELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 287 (337)
T ss_dssp HHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSS
T ss_pred HHHHHHHHCCCCCC---CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCCCCCCC
T ss_conf 99999985289989---866899999999866638934422565234999972915036999999847899897888898
Q ss_pred CCCCCCCCCCC
Q ss_conf 87888855654
Q 001856 902 ALDTSYFTSRY 912 (1003)
Q Consensus 902 ~lD~s~Fss~~ 912 (1003)
..|+.+|+..+
T Consensus 288 ~~~~~~f~~~~ 298 (337)
T d1o6la_ 288 EVDTRYFDDEF 298 (337)
T ss_dssp TTCCTTSCHHH
T ss_pred HHHHHHCCCHH
T ss_conf 01433238333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=469.52 Aligned_cols=288 Identities=40% Similarity=0.797 Sum_probs=261.4
Q ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 55689089987500596699999998999789999930410001789999999999998559996778985653163289
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~Ly 665 (1003)
..+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC
T ss_conf 87237089889611768089999998999899999982677458899999999999999748772740344443222223
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99986268784999984299999999999999999999876258230457986256357993999516875335557888
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~----- 192 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred CCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECC-----
T ss_conf 222233466226667515898999999999999998999985998617679999360778978861010333225-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 99999766854479997410033566643102565688887881001259999632163216799999829999999993
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~ 825 (1003)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 193 -----------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 193 -----------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp -----------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf -----------------------------666433676356788997179988533114500789999758899899599
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC--CCHHHHHCCCCCCCCCHHHHHHH--CCCCCCCCCC
Q ss_conf 5678756304789999999899889999875265993776999--99889870978899993378620--1986578899
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 901 (1003)
Q Consensus 826 ~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~--~TAeEILqHPFFk~Idw~~L~~~--k~pfiP~~~s 901 (1003)
..++.+|...... .|..+++++.+||++||.+||.+|++. .++.++++||||++++|..+..+ .+||+|....
T Consensus 244 ~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 244 IQIYEKIVSGKVR---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp HHHHHHHHHCCCC---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHHCCCCC---CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCCCCCCC
T ss_conf 9999998617988---9766899999999998340998606553454999971905158998999836789693688899
Q ss_pred CCCCCCCCC
Q ss_conf 878888556
Q 001856 902 ALDTSYFTS 910 (1003)
Q Consensus 902 ~lD~s~Fss 910 (1003)
..|+++|+.
T Consensus 321 ~~d~s~~~~ 329 (350)
T d1rdqe_ 321 PGDTSNFDD 329 (350)
T ss_dssp TTCCTTSCC
T ss_pred CCHHHHCCC
T ss_conf 211332599
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=470.97 Aligned_cols=288 Identities=40% Similarity=0.788 Sum_probs=256.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCEEEEEEEEECCCEEEE
Q ss_conf 689089987500596699999998999789999930410001789999999999998-5599967789856531632899
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~-~L~HPnIVkLl~sf~d~~~LyL 666 (1003)
+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..++. .++||||+++++++.+.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99862687849999842999999999999999999998762582304579862563579939995168753355578889
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~dd 746 (1003)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~---- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG---- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT----
T ss_pred EEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC----
T ss_conf 7750379808998640478999999999999999999998689340347654044448996301555302323566----
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 99997668544799974100335666431025656888878810012599996321632167999998299999999935
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~ 826 (1003)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 157 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 157 ---------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp ---------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf ---------------------------53345457877768999982799883232011227898987388999998999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHH-HHHCCCCCCCCCHHHHHHH--CCCCCCCCCCCC
Q ss_conf 6787563047899999998998899998752659937769999988-9870978899993378620--198657889987
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTLARQ--KAAFVPTSESAL 903 (1003)
Q Consensus 827 el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAe-EILqHPFFk~Idw~~L~~~--k~pfiP~~~s~l 903 (1003)
+++.++...... +|..+|+++.+||.+||++||.+|| ++. ++++||||++++|+.+..+ .||++|...+..
T Consensus 210 ~~~~~i~~~~~~---~p~~~s~~~~dli~~~L~~dP~~R~---s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~ 283 (320)
T d1xjda_ 210 ELFHSIRMDNPF---YPRWLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPF 283 (320)
T ss_dssp HHHHHHHHCCCC---CCTTSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHHHHHTTCSCC----------
T ss_pred HHHHHHHCCCCC---CCCCCCHHHHHHHHHHCCCCCCCCC---CHHHHHHHCCHHCCCCHHHHHHCCCCCCCCCCCCCCC
T ss_conf 999999718998---9756799999999996544898783---8899998090131589999983689989779789964
Q ss_pred CCCCCCCCC
Q ss_conf 888855654
Q 001856 904 DTSYFTSRY 912 (1003)
Q Consensus 904 D~s~Fss~~ 912 (1003)
|+++|+..+
T Consensus 284 d~~~f~~~~ 292 (320)
T d1xjda_ 284 DCSNFDKEF 292 (320)
T ss_dssp ---------
T ss_pred CHHHCCHHH
T ss_conf 124429576
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=465.12 Aligned_cols=286 Identities=39% Similarity=0.775 Sum_probs=256.7
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 56890899875005966999999989997899999304100017899999999999985599967789856531632899
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyL 666 (1003)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf 65470888897207680899999989997999999845775488999999999999986369675330356852880056
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99862687849999842999999999999999999998762582304579862563579939995168753355578889
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~dd 746 (1003)
|||||.||+|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEEC------
T ss_conf 76503786322343222211100799999999876554124767705568105038689988983175216712------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 99997668544799974100335666431025656888878810012599996321632167999998299999999935
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~ 826 (1003)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 156 ----------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 207 (316)
T d1fota_ 156 ----------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207 (316)
T ss_dssp ----------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf ----------------------------4564345763435999983899980430465333689997598999996999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC--CCHHHHHCCCCCCCCCHHHHHHH--CCCCCCCCCC-
Q ss_conf 678756304789999999899889999875265993776999--99889870978899993378620--1986578899-
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES- 901 (1003)
Q Consensus 827 el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~--~TAeEILqHPFFk~Idw~~L~~~--k~pfiP~~~s- 901 (1003)
+++.++......+ |..+++++.++|.+||.+||.+|++. .+++++++||||++++|+.+..+ .+|++|....
T Consensus 208 ~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~ 284 (316)
T d1fota_ 208 KTYEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQG 284 (316)
T ss_dssp HHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC---
T ss_pred HHHHHHHCCCCCC---CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHCCCCCCCCCCCCCC
T ss_conf 9999997089889---9778999999999995449976664310219999819351467989998378996988986788
Q ss_pred CCCCCCCC
Q ss_conf 87888855
Q 001856 902 ALDTSYFT 909 (1003)
Q Consensus 902 ~lD~s~Fs 909 (1003)
..|+++|+
T Consensus 285 ~~d~~~f~ 292 (316)
T d1fota_ 285 QGDTSQFD 292 (316)
T ss_dssp --------
T ss_pred CCHHHHCC
T ss_conf 64133258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=468.04 Aligned_cols=276 Identities=37% Similarity=0.736 Sum_probs=248.7
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 56890899875005966999999989997899999304100017899999999999985599967789856531632899
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyL 666 (1003)
..++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 99877898898508790999999989997999999865775577789999999999987688886179999998998899
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99862687849999842999999999999999999998762582304579862563579939995168753355578889
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~dd 746 (1003)
|||||+||+|.+++...+.+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~---- 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---- 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC----
T ss_conf 9970489877776531599999999999999999997621650884767741236688853886032102422567----
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 99997668544799974100335666431025656888878810012599996321632167999998299999999935
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 747 ls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~ 826 (1003)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 162 -------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 216 (288)
T d1uu3a_ 162 -------------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216 (288)
T ss_dssp ---------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH
T ss_conf -------------------------7643335556775525844002689896662304569999980388998995999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHH------HHCCCCCCCCCHHHHHHHCCCCCC
Q ss_conf 67875630478999999989988999987526599377699999889------870978899993378620198657
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE------VKQHVFFKDINWDTLARQKAAFVP 897 (1003)
Q Consensus 827 el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeE------ILqHPFFk~Idw~~L~~~k~pfiP 897 (1003)
+++.+|.+....+ |..+++++++||.+||++||.+|+ +++| +++||||++++|+.+.++.||-+|
T Consensus 217 ~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~R~---t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 217 LIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRL---GCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHHHHTTCCCC---CTTCCHHHHHHHHTTSCSSGGGST---TSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHHHHCCCCCC---CCCCCHHHHHHHHHHCCCCHHHCC---CHHHHCCCHHHHCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 9999997189999---854799999999998557976891---9789737789876976478998896157999999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=461.31 Aligned_cols=290 Identities=33% Similarity=0.600 Sum_probs=241.9
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHH---HHHHHHCCCCCEEEEEEEEECCCE
Q ss_conf 56890899875005966999999989997899999304100017899999999---999985599967789856531632
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE---RDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrE---i~IL~~L~HPnIVkLl~sf~d~~~ 663 (1003)
.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+| ..++..++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998998
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 89999862687849999842999999999999999999998762582304579862563579939995168753355578
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s 743 (1003)
+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCC--
T ss_conf 899999148983899987325532789999999999999999977962204442216785889679822010233378--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCCC
Q ss_conf 889999976685447999741003356664310256568888788100125-9999632163216799999829999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g-~~yt~kSDIWSLGVILYELLTGkpPF~~ 822 (1003)
......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+
T Consensus 160 -------------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 160 -------------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp -------------------------------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred -------------------------------CCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf -------------------------------8643311345542168760389998441046778999999859998888
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC--CCHHHHHCCCCCCCCCHHHHHHH--CCCCCCC
Q ss_conf 9935678756304789999999899889999875265993776999--99889870978899993378620--1986578
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPT 898 (1003)
Q Consensus 823 ~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~--~TAeEILqHPFFk~Idw~~L~~~--k~pfiP~ 898 (1003)
.+...............+..+..+|+++.+||.+||++||.+||++ ..|+++++||||++++|..+..+ .+|++|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 209 HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp SCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHHHCCCCCCCCCCC
T ss_conf 99899999998604688878877899999999998566988808874357999974910237898799628899593799
Q ss_pred CCCCCCCCCCC
Q ss_conf 89987888855
Q 001856 899 SESALDTSYFT 909 (1003)
Q Consensus 899 ~~s~lD~s~Fs 909 (1003)
.......+.|+
T Consensus 289 ~~~~~~~~~~d 299 (364)
T d1omwa3 289 RGEVNAADAFD 299 (364)
T ss_dssp CC---------
T ss_pred CCCCCCCCCCC
T ss_conf 88888687454
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=446.52 Aligned_cols=258 Identities=36% Similarity=0.657 Sum_probs=235.9
Q ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 55689089987500596699999998999789999930410001789999999999998559996778985653163289
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 586 ~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~Ly 665 (1003)
..+++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 61537699889851778589999998999499999981688567689999999999998568888885999999899989
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99986268784999984299999999999999999999876258230457986256357993999516875335557888
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 666 LVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCC----
T ss_conf 9985047985898875048999999999999999999999988946522023441466899871155563354488----
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 99999766854479997410033566643102565688887881001259999632163216799999829999999993
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~ 825 (1003)
......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus 159 -----------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 159 -----------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp -----------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf -----------------------------852355788763499997589989314404675999998329999888999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 567875630478999999989988999987526599377699999889870978899
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 826 ~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~ 882 (1003)
.+++.++......+ |..+|+++.+||.+||++||.+|| ++.|+|+||||..
T Consensus 210 ~~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~~ 260 (263)
T d2j4za1 210 QETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHTTCCCC---CTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCCCC---CCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCCCC
T ss_conf 99999997189999---866899999999997647976890---9999971907078
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=439.91 Aligned_cols=264 Identities=27% Similarity=0.493 Sum_probs=235.0
Q ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 85568908998750059669999999899978999993041000178999999999999855999677898565316328
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 585 ~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~L 664 (1003)
+..+++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|..++|||||+++++|.+.+.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 878657589889840768199999988999899999984524---31699999999999867997999299999989999
Q ss_pred EEEEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC--CCCEEEEECCCCCCCCC
Q ss_conf 999986268784999984-299999999999999999999876258230457986256357--99399951687533555
Q 001856 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 665 yLVmEyl~GGSL~dlLkk-~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~--~G~IKLsDFGLAk~~~~ 741 (1003)
|||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 99998579988999997623789999999999999999999975697600015467364168898699954521044256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 78889999976685447999741003356664310256568888788100125999963216321679999982999999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~ 821 (1003)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 179 --------------------------------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 179 --------------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp --------------------------------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf --------------------------------543200068624218899758998726765546599999985989989
Q ss_pred CCCHHHHHHHHHHCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCCCHH
Q ss_conf 99935678756304789999-999899889999875265993776999998898709788999933
Q 001856 822 AEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 822 ~~s~~el~qkIl~~~~~~P~-ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~Idw~ 886 (1003)
+.+..+++..|......++. ....+|+++++||.+||++||.+|| ++.|+|+||||+..++.
T Consensus 227 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAP 289 (350)
T ss_dssp CSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTCC
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCCCCCCCC
T ss_conf 9799999999984788989422358999999999997568966790---89998629132889888
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=435.96 Aligned_cols=263 Identities=24% Similarity=0.471 Sum_probs=234.6
Q ss_pred CCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 89855689089987500596699999998999789999930410001789999999999998559996778985653163
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 583 k~~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~ 662 (1003)
+.+...++|++++.||+|+||+||+|+++.+++.||+|++.+... .....+.+|+.+|+.++|||||+++++|.+.+
T Consensus 23 ~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred CCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 899854035998999317782999999989997999999887264---67999999999998679979891999999899
Q ss_pred EEEEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC--CCCCEEEEECCCCCCC
Q ss_conf 2899998626878499998429-999999999999999999987625823045798625635--7993999516875335
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlLkk~g-~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId--~~G~IKLsDFGLAk~~ 739 (1003)
.+|||||||+||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf 99999982899808888986389989999999999999999999977926513144553113467884899525630343
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCC
Q ss_conf 55788899999766854479997410033566643102565688887881001259999632163216799999829999
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 740 ~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpP 819 (1003)
.. .......+||+.|||||++.+..|+.++|||||||++|+|++|.+|
T Consensus 180 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 227 (352)
T d1koba_ 180 NP--------------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227 (352)
T ss_dssp CT--------------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred CC--------------------------------CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCC
T ss_conf 78--------------------------------8720100476453489997479989763338989999999968899
Q ss_pred CCCCCHHHHHHHHHHCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9999935678756304789999-999899889999875265993776999998898709788999
Q 001856 820 FNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 820 F~~~s~~el~qkIl~~~~~~P~-ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~I 883 (1003)
|.+.+..+++..|......++. .+..+|+++.+||.+||++||.+|| ++.|+|+||||++.
T Consensus 228 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 228 FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCCC
T ss_conf 899799999999984788989300247999999999997569966891---89999609734888
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=437.64 Aligned_cols=258 Identities=33% Similarity=0.578 Sum_probs=232.4
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996778985653163289999
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLVm 668 (1003)
+.|++.+.||+|+||+||+|+++.+++.||+|++.+.... .....+.+|+.+|..++||||++++++|.+.+.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 6669988994065839999999999989999998157731--28999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCCCCC
Q ss_conf 8626878499998429999999999999999999987625823045798625635---7993999516875335557888
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 669 Eyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId---~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~----- 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED----- 161 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC-----
T ss_conf 526898488865303678878999999999999875241305568704630011046888249983154358725-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 99999766854479997410033566643102565688887881001259999632163216799999829999999993
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~ 825 (1003)
......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 162 ---------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 162 ---------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp --------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ---------------------------89704400328422591887379998078734515999999859799999899
Q ss_pred HHHHHHHHHCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 567875630478999-9999899889999875265993776999998898709788999
Q 001856 826 QQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 826 ~el~qkIl~~~~~~P-~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~I 883 (1003)
.+++..+......++ ..+..+|+++.+||.+||.+||.+|| ++.|+++||||++.
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTSS
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCCC
T ss_conf 999999861687778766667899999999997608975791---89998629844799
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=437.50 Aligned_cols=256 Identities=35% Similarity=0.586 Sum_probs=229.4
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996778985653163289999
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLVm 668 (1003)
++|++++.||+|+||+||+|+++.+|+.||+|++.+..... .+.+.+|+.+++.++||||++++++|.+.+++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 05388789812858299999998999899999984301727---999999999998679998805857798899989999
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 86268784999984299999999999999999999876258230457986256357993999516875335557888999
Q 001856 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (1003)
Q Consensus 669 Eyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddls 748 (1003)
|||+||+|.+++.+ +.+++..++.|+.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------- 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------- 168 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred EECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECC-------
T ss_conf 70379808988641-5999999999999999999999987972267768886887899686425156413213-------
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 99766854479997410033566643102565688887881001259999632163216799999829999999993567
Q 001856 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 749 ~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~el 828 (1003)
........+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.
T Consensus 169 ------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 224 (293)
T d1yhwa1 169 ------------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (293)
T ss_dssp ------------------------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------66644444447773682664479988012031372999998048899899799999
Q ss_pred HHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 875630478999999989988999987526599377699999889870978899
Q 001856 829 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 829 ~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~ 882 (1003)
...+.....+....+..+|+++++||.+||.+||.+|| ++.|+|+||||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred HHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCC
T ss_conf 99998579998888553799999999998669966890---9999964996577
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=440.42 Aligned_cols=261 Identities=26% Similarity=0.469 Sum_probs=225.0
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316328999
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLV 667 (1003)
+++|++++.||+|+||+||+|+++.+++.||+|++.+... ....+.+.+|+.+++.++||||+++++++.+.+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 7460899897217480999999999997999999845664--12799999999999857998884696540467436798
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 98626878499998429999999999999999999987625823045798625635799399951687533555788899
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddl 747 (1003)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~---- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 157 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC----
T ss_conf 8645898089997537999999999999999999999997598357546899788789987983231422404688----
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC-CCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 99976685447999741003356664310256568888788100125999-96321632167999998299999999935
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-t~kSDIWSLGVILYELLTGkpPF~~~s~~ 826 (1003)
........+||+.|||||++.+..+ +.++|||||||++|||++|++||...+..
T Consensus 158 -------------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 158 -------------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp -------------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred -------------------------CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHH
T ss_conf -------------------------6531113255747428728618999997101617379999998299788889859
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 67875630478999999989988999987526599377699999889870978899
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 827 el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~ 882 (1003)
................+..+|+++.+||.+||+.||.+|| ++.|+++||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCC
T ss_conf 9999998638887886446999999999997679966890---9999961984585
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=434.05 Aligned_cols=260 Identities=32% Similarity=0.538 Sum_probs=231.3
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996778985653163289999
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLVm 668 (1003)
+.|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37598479930778199999999999399999987289---999999999999998679999884988980099589999
Q ss_pred EECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 862687849999842-9999999999999999999987625823045798625635799399951687533555788899
Q 001856 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 669 Eyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddl 747 (1003)
|||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~------- 161 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT------- 161 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH-------
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCC-------
T ss_conf 6279981889998628999999999999999999999998898871407003148789998997161230357-------
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHC-----CCCCCCCCEEECHHHHHHHHHHCCCCCCC
Q ss_conf 9997668544799974100335666431025656888878810012-----59999632163216799999829999999
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 748 s~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~-----g~~yt~kSDIWSLGVILYELLTGkpPF~~ 822 (1003)
.......+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+
T Consensus 162 ------------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 162 ------------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp ------------------------HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ------------------------CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf ------------------------78641001025626479999832025788888066578789999998208899999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCCCH
Q ss_conf 993567875630478999999989988999987526599377699999889870978899993
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 823 ~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~Idw 885 (1003)
.+..+++.++.....+....+..+|+++.+||.+||++||.+|| ++.|+++||||+.-..
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTVDSN 277 (288)
T ss_dssp SCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCCCCC
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCCCCCCC
T ss_conf 89999999997079987776566999999999997669966891---9999962923188989
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=441.13 Aligned_cols=263 Identities=29% Similarity=0.492 Sum_probs=224.1
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 56890899875005966999999989997899999304100017899999999999985599967789856531632899
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyL 666 (1003)
..++|++++.||+|+||+||+|+++.+++.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+..++|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 7568889789712778099999998999699999987540--97899999999999986799999949999998999999
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99862687849999842999999999999999999998762-58230457986256357993999516875335557888
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs-~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+..
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~------ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------ 155 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH------
T ss_pred EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCC------
T ss_conf 99767998689987424999999999999999999999998599971445779946878998999548776256------
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 99999766854479997410033566643102565688887881001259999632163216799999829999999993
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~ 825 (1003)
......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 156 ---------------------------~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 156 ---------------------------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ---------------------------HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ---------------------------CCCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ---------------------------78862111377141194687589989488899899999999988899899887
Q ss_pred HHHHHHHHH----------------------------------------CCCCCCCCC-CCCCHHHHHHHHHHCCCCCCC
Q ss_conf 567875630----------------------------------------478999999-989988999987526599377
Q 001856 826 QQIFDNILN----------------------------------------RKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQ 864 (1003)
Q Consensus 826 ~el~qkIl~----------------------------------------~~~~~P~ip-~~iS~elkDLIkkLLskDPsk 864 (1003)
.+....... .....+..+ ..+|.++.+||.+||+.||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 89999998875177545774212333221111222354134778876650268766764448999999999986899467
Q ss_pred CCCCCCHHHHHCCCCCCCCCHHH
Q ss_conf 69999988987097889999337
Q 001856 865 RLGSGGASEVKQHVFFKDINWDT 887 (1003)
Q Consensus 865 Rpg~~TAeEILqHPFFk~Idw~~ 887 (1003)
|| +|.|+|+||||++.+|+.
T Consensus 289 R~---ta~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 289 RA---DLKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp SC---CHHHHHTSHHHHHHHHSC
T ss_pred CC---CHHHHHHCHHHCCCCCCC
T ss_conf 90---899996098647698231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=432.44 Aligned_cols=267 Identities=28% Similarity=0.500 Sum_probs=238.4
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCH---HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 890899875005966999999989997899999304100017---89999999999998559996778985653163289
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---NAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~---~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~Ly 665 (1003)
+.|++++.||+|+||+||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC----CEEEEECCCCCCCCC
Q ss_conf 9998626878499998429999999999999999999987625823045798625635799----399951687533555
Q 001856 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLI 741 (1003)
Q Consensus 666 LVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G----~IKLsDFGLAk~~~~ 741 (1003)
||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCCC
T ss_conf 99986778643100103564215578999999999987666254221133301279825898666469643344210577
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 78889999976685447999741003356664310256568888788100125999963216321679999982999999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~ 821 (1003)
.....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 170 --------------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 170 --------------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp --------------------------------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
T ss_conf --------------------------------763122477774309999818999976652214099999970889988
Q ss_pred CCCHHHHHHHHHHCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHH
Q ss_conf 9993567875630478999-99998998899998752659937769999988987097889999337862
Q 001856 822 AEHPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR 890 (1003)
Q Consensus 822 ~~s~~el~qkIl~~~~~~P-~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~Idw~~L~~ 890 (1003)
+.+..+++..+......++ ..+..+|.++.+||.+||++||.+|| ++.++++||||+..+|.....
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~~~~~~l~ 284 (293)
T d1jksa_ 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQALS 284 (293)
T ss_dssp CSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTCC--------
T ss_pred CCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCCCCCCHHHHHC
T ss_conf 9999999999981688887010478899999999998638966891---999996190418887057645
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=429.44 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=230.0
Q ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 90899875005966999999989997899999304100017899999999999985599967789856531632899998
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 590 dYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLVmE 669 (1003)
.|+.++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 62687849999842999999999999999999998762582304579862563579939995168753355578889999
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 yl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddls~ 749 (1003)
||.||+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC---------
T ss_conf 06999457899737999999999999999999999986897666788421798799978984436533467---------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCC---CCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 976685447999741003356664310256568888788100125---99996321632167999998299999999935
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 750 p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g---~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~ 826 (1003)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..
T Consensus 167 --------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~ 220 (309)
T d1u5ra_ 167 --------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (309)
T ss_dssp --------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred --------------------------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf --------------------------787313476636889983467888672145455899999998788999997999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 67875630478999999989988999987526599377699999889870978899
Q 001856 827 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 827 el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~ 882 (1003)
+.+.++.....+.+ .+..+|+++.+||.+||++||.+|| ++.++++||||..
T Consensus 221 ~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 221 SALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred HHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHCHHHCC
T ss_conf 99999982899988-8788899999999997737965791---8999971997537
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=426.32 Aligned_cols=256 Identities=30% Similarity=0.552 Sum_probs=228.8
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCEEE
Q ss_conf 6890899875005966999999989997899999304100017899999999999985599967789856531--63289
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLY 665 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d--~~~Ly 665 (1003)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+.... ....+.+.+|+.+++.++|||||++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 33379967983088919999999999979999998746579-79999999999999977899982489999917899899
Q ss_pred EEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99986268784999984----299999999999999999999876258-----230457986256357993999516875
Q 001856 666 LVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 666 LVmEyl~GGSL~dlLkk----~g~LsEe~ir~Ia~QIL~ALeYLHs~G-----IIHRDIKPeNILId~~G~IKLsDFGLA 736 (1003)
+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHC
Q ss_conf 33555788899999766854479997410033566643102565688887881001259999632163216799999829
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTG 816 (1003)
+.... ........+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 162 ~~~~~-------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg 210 (269)
T d2java1 162 RILNH-------------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210 (269)
T ss_dssp HHC------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred EECCC-------------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHC
T ss_conf 32245-------------------------------77755667788232799998399999389887527899998018
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 9999999935678756304789999999899889999875265993776999998898709788
Q 001856 817 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 817 kpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFF 880 (1003)
.+||.+.+..++..++..... +.+|..+|+++.+||.+||+.||.+|| ++.|+++|||+
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~hp~i 269 (269)
T d2java1 211 MPPFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENPLI 269 (269)
T ss_dssp SCSCCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTC
T ss_pred CCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHCCCC
T ss_conf 899899899999999971899--889743599999999997679955791---89999729819
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=420.63 Aligned_cols=252 Identities=23% Similarity=0.465 Sum_probs=218.8
Q ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC----CCEEEE
Q ss_conf 0899875005966999999989997899999304100017899999999999985599967789856531----632899
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYL 666 (1003)
Q Consensus 591 YeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d----~~~LyL 666 (1003)
|++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf 8851697008284999999999995999999851227-989999999999999857999850699998403345888999
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEEC-CCCCEEEEECCCCCCCCCCC
Q ss_conf 9986268784999984299999999999999999999876258--23045798625635-79939995168753355578
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~G--IIHRDIKPeNILId-~~G~IKLsDFGLAk~~~~~s 743 (1003)
|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC---
T ss_conf 99578989489997513554699999999999999999997899799687674351166799988980057654236---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCC
Q ss_conf 88999997668544799974100335666431025656888878810012599996321632167999998299999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~ 823 (1003)
.......+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.
T Consensus 167 ------------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 ------------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp ------------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ------------------------------CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf ------------------------------876677553813008988478-9998671100799999998788999876
Q ss_pred C-HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 9-356787563047899999998998899998752659937769999988987097889
Q 001856 824 H-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 881 (1003)
Q Consensus 824 s-~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk 881 (1003)
. ...+++.+..... .+.++..+++++.+||.+||.+||.+|| ++.|+++||||+
T Consensus 216 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 216 QNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp SSHHHHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred CCHHHHHHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCCC
T ss_conf 559999999973899-8656755789999999997637975892---999996775409
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=423.38 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=230.2
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 56890899875005966999999989997899999304100017899999999999985599967789856531632899
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyL 666 (1003)
.+++|++++.||+|+||+||+|+++.+++.||+|++++.. .....+.+|+.+|..++||||++++++|.+.+++||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 7010588789831778399999998999699999975786----659999999999985799798909899988998899
Q ss_pred EEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCC--CCEEEEECCCCCCCCCCC
Q ss_conf 998626878499998429-99999999999999999998762582304579862563579--939995168753355578
Q 001856 667 VMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g-~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~--G~IKLsDFGLAk~~~~~s 743 (1003)
|||||+||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC--
T ss_conf 995389980889987538999999999999999999999987699751355444344378851899764411100346--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCC
Q ss_conf 88999997668544799974100335666431025656888878810012599996321632167999998299999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~ 823 (1003)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 157 ------------------------------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 157 ------------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp ------------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ------------------------------CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCC
T ss_conf ------------------------------77532122332223402104877784011302799999998289999998
Q ss_pred CHHHHHHHHHHCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 935678756304789999-99989988999987526599377699999889870978899
Q 001856 824 HPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 824 s~~el~qkIl~~~~~~P~-ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~ 882 (1003)
+..+++.+|++....++. .+..+|+++++||.+||.+||.+|| ++.|+++||||+.
T Consensus 207 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 207 TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred CHHHHHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCC
T ss_conf 99999999983899988022367899999999998669966890---9999963996566
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=413.68 Aligned_cols=261 Identities=31% Similarity=0.520 Sum_probs=231.9
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCC------HHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 689089987500596699999998999789999930410001------789999999999998559-9967789856531
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR------KNAVESILAERDILISVR-NPFVVRFFYSFTC 660 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~------~~~ie~ilrEi~IL~~L~-HPnIVkLl~sf~d 660 (1003)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+..... +...+.+.+|+.++..++ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 63289999862687849999842999999999999999999998762582304579862563579939995168753355
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 661 ~~~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~ 740 (1003)
++++|||||||+||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECC
T ss_conf 76059999768986689999865999999999999999999999987599432346254898689983871240316726
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCC------CCCCCCCEEECHHHHHHHHH
Q ss_conf 578889999976685447999741003356664310256568888788100125------99996321632167999998
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELI 814 (1003)
Q Consensus 741 ~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g------~~yt~kSDIWSLGVILYELL 814 (1003)
. .......+||+.|+|||++.+ ..++.++||||+||++|+|+
T Consensus 162 ~--------------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 162 P--------------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp T--------------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred C--------------------------------CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHC
T ss_conf 8--------------------------------87213452467888988860534456788992331856560231032
Q ss_pred HCCCCCCCCCHHHHHHHHHHCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 299999999935678756304789999-999899889999875265993776999998898709788999
Q 001856 815 VGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 815 TGkpPF~~~s~~el~qkIl~~~~~~P~-ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~I 883 (1003)
+|.+||.+.+.......+......++. ....+|+++++||.+||++||.+|| ++.|+|+||||+..
T Consensus 210 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil~h~~~~~~ 276 (277)
T d1phka_ 210 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQY 276 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCTT
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHHHH
T ss_conf 28889889999999999981898889854346899999999997658966891---99999739787975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.20 Aligned_cols=290 Identities=41% Similarity=0.801 Sum_probs=246.4
Q ss_pred CCCCCCEEEEEEEECCCCEEEEEEEEC---CCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEE
Q ss_conf 855689089987500596699999998---99978999993041000-17899999999999985599-96778985653
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISVRN-PFVVRFFYSFT 659 (1003)
Q Consensus 585 ~~~ledYeIlk~LGkGsFGtVylArdk---~tgk~VAIKVIkKs~l~-~~~~ie~ilrEi~IL~~L~H-PnIVkLl~sf~ 659 (1003)
+..+++|++++.||+|+||+||+|++. .+|+.||+|++++.... .....+.+.+|+.++.+++| |||+++++.+.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred CCCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 34510259998983287839999998765887948999998367721016899999999999986467983999620002
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 16328999986268784999984299999999999999999999876258230457986256357993999516875335
Q 001856 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 660 d~~~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~ 739 (1003)
+...+|++|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 48730012312341179999873045437888888999999998851499896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC--CCCCCCEEECHHHHHHHHHHCC
Q ss_conf 55788899999766854479997410033566643102565688887881001259--9996321632167999998299
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 740 ~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~--~yt~kSDIWSLGVILYELLTGk 817 (1003)
.. .......+..|++.|+|||++.+. .++.++|||||||+||+|++|.
T Consensus 180 ~~------------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~ 229 (322)
T d1vzoa_ 180 VA------------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229 (322)
T ss_dssp CG------------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred CC------------------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCC
T ss_conf 34------------------------------444322122233333106876057768871325177779999997689
Q ss_pred CCCCCCCHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC--CCHHHHHCCCCCCCCCHHHHHHH--C
Q ss_conf 99999993567875630478-9999999899889999875265993776999--99889870978899993378620--1
Q 001856 818 PPFNAEHPQQIFDNILNRKI-PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--K 892 (1003)
Q Consensus 818 pPF~~~s~~el~qkIl~~~~-~~P~ip~~iS~elkDLIkkLLskDPskRpg~--~TAeEILqHPFFk~Idw~~L~~~--k 892 (1003)
.||.+.+.......+..... ..+.++..+++++.+||.+||.+||.+|+++ .+++|+++||||++++|+.+..+ .
T Consensus 230 ~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 230 SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309 (322)
T ss_dssp CTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHHHHHHCCCC
T ss_conf 99888877779999998335689988654799999999997445898819997450999974972348998899737898
Q ss_pred CCCCCCCCCCCC
Q ss_conf 986578899878
Q 001856 893 AAFVPTSESALD 904 (1003)
Q Consensus 893 ~pfiP~~~s~lD 904 (1003)
+|++|...+..|
T Consensus 310 ~p~~p~~~~~~~ 321 (322)
T d1vzoa_ 310 APFKPVIRDELD 321 (322)
T ss_dssp CSCCCCCCC-CC
T ss_pred CCCCCCCCCCCC
T ss_conf 598999999777
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=415.37 Aligned_cols=255 Identities=31% Similarity=0.535 Sum_probs=215.0
Q ss_pred CCCCCCEEEEE-EEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCEEEEEEEEEC--
Q ss_conf 85568908998-75005966999999989997899999304100017899999999999985-599967789856531--
Q 001856 585 RTSIDDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTC-- 660 (1003)
Q Consensus 585 ~~~ledYeIlk-~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~-L~HPnIVkLl~sf~d-- 660 (1003)
...+++|+++. .||+|+||+||+|+++.+++.||+|++++. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 970148798107965454869999998899989999998974--------779999999998669999782989995034
Q ss_pred --CCEEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC---CCCEEEEEC
Q ss_conf --63289999862687849999842--99999999999999999999876258230457986256357---993999516
Q 001856 661 --RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDF 733 (1003)
Q Consensus 661 --~~~LyLVmEyl~GGSL~dlLkk~--g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~---~G~IKLsDF 733 (1003)
..++|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++. .+.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 68978999997789984999998627877579999999999999999999769864441002201135555663113545
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHH
Q ss_conf 87533555788899999766854479997410033566643102565688887881001259999632163216799999
Q 001856 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (1003)
Q Consensus 734 GLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYEL 813 (1003)
|+|+..... ......+||+.|||||++.+..|+.++|||||||++|+|
T Consensus 159 G~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~l 206 (335)
T d2ozaa1 159 GFAKETTSH--------------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 206 (335)
T ss_dssp TTCEECCCC--------------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHH
T ss_pred CEEEECCCC--------------------------------CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHH
T ss_conf 512333688--------------------------------864322677563792777489888888887645167788
Q ss_pred HHCCCCCCCCCHHHHHH----HHHHCCCCCCCC-CCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 82999999999356787----563047899999-9989988999987526599377699999889870978899
Q 001856 814 IVGIPPFNAEHPQQIFD----NILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 882 (1003)
Q Consensus 814 LTGkpPF~~~s~~el~q----kIl~~~~~~P~i-p~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~ 882 (1003)
++|.+||.+.+...... .+......+|.. ...+|+++.+||++||++||.+|| ++.|+++||||.+
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 277 (335)
T d2ozaa1 207 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 277 (335)
T ss_dssp TTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSHHHHT
T ss_pred HHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHHC
T ss_conf 6588998898877889999999853888889854346999999999997569965790---9999970987617
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=413.96 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=219.8
Q ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 899875005966999999989997899999304100017--899999999999985599967789856531632899998
Q 001856 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK--NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (1003)
Q Consensus 592 eIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~--~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLVmE 669 (1003)
+.++.||+|+||+||+|+++.+++.||+|++++...... .....+.+|+.+++.++|||||+++++|.+.+++|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225874022045
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 62687849999842999999999999999999998762582304579862563579939995168753355578889999
Q 001856 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (1003)
Q Consensus 670 yl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddls~ 749 (1003)
|+.|+++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------- 153 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------- 153 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-------
T ss_pred HHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC-------
T ss_conf 5345077655412667789999999999999998863163550357762588537784114657610005787-------
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 976685447999741003356664310256568888788100125-9999632163216799999829999999993567
Q 001856 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 828 (1003)
Q Consensus 750 p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g-~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~el 828 (1003)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus 154 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 154 ------------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp ------------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------55433020473336399972677888056436304289999859699999999999
Q ss_pred HHHHHHCCCCC--------------------CC-----CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 87563047899--------------------99-----999899889999875265993776999998898709788999
Q 001856 829 FDNILNRKIPW--------------------PR-----VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 883 (1003)
Q Consensus 829 ~qkIl~~~~~~--------------------P~-----ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~I 883 (1003)
+.+|....... +. ....+++++.+||.+||++||.+|| +|.|+|+||||++.
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~---sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---CHHHHHTSGGGTSS
T ss_pred HHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCCC
T ss_conf 999998518997254521000213443034789886785656899999999997638945690---89999679965789
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.43 Aligned_cols=261 Identities=30% Similarity=0.526 Sum_probs=219.8
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316328999
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLV 667 (1003)
+++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|+.+++.++|||||+++++|.+..++|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 9997765177237680999999999997999999802225-758999999999999867998388744533224320378
Q ss_pred EEECCCCCHHHHH-HH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 9862687849999-84-299999999999999999999876258230457986256357993999516875335557888
Q 001856 668 MEYLNGGDLYSLL-RN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 668 mEyl~GGSL~dlL-kk-~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
|||+.+ .+.+++ .. .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~---- 154 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---- 154 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC----
T ss_pred EEECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCC----
T ss_conf 862377-445554420256888899999999999999986528899213571140113467621035786134368----
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC-CCCCEEECHHHHHHHHHHCCCCCCCCC
Q ss_conf 9999976685447999741003356664310256568888788100125999-963216321679999982999999999
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-t~kSDIWSLGVILYELLTGkpPF~~~s 824 (1003)
........+||+.|+|||++....+ +.++|||||||++|+|++|++||.+.+
T Consensus 155 ---------------------------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 155 ---------------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp ---------------------------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------CCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC
T ss_conf ---------------------------86410010365215411221366577742210333313427966879989889
Q ss_pred HHHHHHHHHHCCCCCC------------------C--------CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCC
Q ss_conf 3567875630478999------------------9--------9998998899998752659937769999988987097
Q 001856 825 PQQIFDNILNRKIPWP------------------R--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878 (1003)
Q Consensus 825 ~~el~qkIl~~~~~~P------------------~--------ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHP 878 (1003)
..+...++........ . ....++.++.+||++||+.||.+|| ++.|+++||
T Consensus 208 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---t~~ell~H~ 284 (298)
T d1gz8a_ 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI---SAKAALAHP 284 (298)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSG
T ss_pred HHHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCH
T ss_conf 99999999983289833314442224212434543222204441667899999999997639955791---899996787
Q ss_pred CCCCCC
Q ss_conf 889999
Q 001856 879 FFKDIN 884 (1003)
Q Consensus 879 FFk~Id 884 (1003)
||++++
T Consensus 285 ff~~~~ 290 (298)
T d1gz8a_ 285 FFQDVT 290 (298)
T ss_dssp GGTTCC
T ss_pred HHCCCC
T ss_conf 014699
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.52 Aligned_cols=262 Identities=31% Similarity=0.456 Sum_probs=216.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCC-CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEC---
Q ss_conf 68908998750059669999999899-978999993041000178999999999999855---99967789856531---
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTT-GDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTC--- 660 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~t-gk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L---~HPnIVkLl~sf~d--- 660 (1003)
.++|++++.||+|+||+||+|++..+ ++.||+|++.+.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 589798889921558699999998889989999998023245-1679999999999998742589880236632214666
Q ss_pred --CCEEEEEEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf --6328999986268784999984-2999999999999999999998762582304579862563579939995168753
Q 001856 661 --RENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (1003)
Q Consensus 661 --~~~LyLVmEyl~GGSL~dlLkk-~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk 737 (1003)
..++|++||++.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++..+.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHHH
T ss_conf 66746999997405871444443037899989999999999999999975889835798627898589975421000101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCC
Q ss_conf 35557888999997668544799974100335666431025656888878810012599996321632167999998299
Q 001856 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 738 ~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGk 817 (1003)
... ........+||+.|||||++.+..|+.++|||||||++|||++|.
T Consensus 165 ~~~--------------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~ 212 (305)
T d1blxa_ 165 IYS--------------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212 (305)
T ss_dssp CCC--------------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred HHC--------------------------------CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCC
T ss_conf 100--------------------------------234577765485114831001798881110003289999998787
Q ss_pred CCCCCCCHHHHHHHHHHCCC------------------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 99999993567875630478------------------------999999989988999987526599377699999889
Q 001856 818 PPFNAEHPQQIFDNILNRKI------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 818 pPF~~~s~~el~qkIl~~~~------------------------~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeE 873 (1003)
+||.+.+..+.+.+++.... +.+..+..+++.+.+||.+||++||.+|| +|.|
T Consensus 213 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---sa~e 289 (305)
T d1blxa_ 213 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYS 289 (305)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC---CHHH
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCC---CHHH
T ss_conf 9989989899999999840799611053211110333022345645440445899999999998748966791---8999
Q ss_pred HHCCCCCCCCCH
Q ss_conf 870978899993
Q 001856 874 VKQHVFFKDINW 885 (1003)
Q Consensus 874 ILqHPFFk~Idw 885 (1003)
+|+||||+++++
T Consensus 290 ~L~Hpff~~i~~ 301 (305)
T d1blxa_ 290 ALSHPYFQDLER 301 (305)
T ss_dssp HHTSGGGTTCCC
T ss_pred HHCCHHHCCCHH
T ss_conf 966963407521
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=400.27 Aligned_cols=259 Identities=30% Similarity=0.469 Sum_probs=221.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-----
Q ss_conf 689089987500596699999998999789999930410001789999999999998559996778985653163-----
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~----- 662 (1003)
.+.|++++.||+|+||+||+|+++.+++.||+|++++.. ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 771899889801778199999999999899999985222-5969999999999999866898754799986357655554
Q ss_pred -EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf -2899998626878499998429999999999999999999987625823045798625635799399951687533555
Q 001856 663 -NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 -~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~ 741 (1003)
++|+||||| |.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred CEEEEEEECC-CCCHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECCC-
T ss_conf 1599998405-5218999874-022699999999999999999873787645668511112100122113431022068-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCC
Q ss_conf 788899999766854479997410033566643102565688887881001259-9996321632167999998299999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~-~yt~kSDIWSLGVILYELLTGkpPF 820 (1003)
......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 173 ---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf 219 (346)
T d1cm8a_ 173 ---------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219 (346)
T ss_dssp ---------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ---------------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCC
T ss_conf ---------------------------------76310245533358899817878996501030038999999786998
Q ss_pred CCCCHHHHHHHHHHCCC----------------------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 99993567875630478----------------------------99999998998899998752659937769999988
Q 001856 821 NAEHPQQIFDNILNRKI----------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 872 (1003)
Q Consensus 821 ~~~s~~el~qkIl~~~~----------------------------~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAe 872 (1003)
.+.+....+..+..... .+......+++.+.+||.+||+.||.+|| ++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---ta~ 296 (346)
T d1cm8a_ 220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV---TAG 296 (346)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC---CHH
T ss_pred CCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHH
T ss_conf 88976899999985037884888865300034433115786665566775568999999999997729955792---999
Q ss_pred HHHCCCCCCCCCHH
Q ss_conf 98709788999933
Q 001856 873 EVKQHVFFKDINWD 886 (1003)
Q Consensus 873 EILqHPFFk~Idw~ 886 (1003)
|+|+||||+++.+.
T Consensus 297 eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 297 EALAHPYFESLHDT 310 (346)
T ss_dssp HHHHSGGGTTTC--
T ss_pred HHHCCHHHCCCCCC
T ss_conf 99639623758776
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=400.88 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=223.1
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCC-----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 9898556890899875005966999999989997-----8999993041000178999999999999855-999677898
Q 001856 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFF 655 (1003)
Q Consensus 582 ~k~~~~ledYeIlk~LGkGsFGtVylArdk~tgk-----~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L-~HPnIVkLl 655 (1003)
.+|.+..++|++.+.||+|+||+||+|+++.+++ .||+|++.... .......+.+|+.++..+ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 44657789939701983078819999998578855420499999966335--8789999999999999715899686877
Q ss_pred EEEECCCEEEEEEEECCCCCHHHHHHHC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEE
Q ss_conf 5653163289999862687849999842-----------------------99999999999999999999876258230
Q 001856 656 YSFTCRENLYLVMEYLNGGDLYSLLRNL-----------------------GCLDEDVARVYIAEVVLALEYLHSLRVVH 712 (1003)
Q Consensus 656 ~sf~d~~~LyLVmEyl~GGSL~dlLkk~-----------------------g~LsEe~ir~Ia~QIL~ALeYLHs~GIIH 712 (1003)
+++.+.+.+|+|||||+||+|.++++.. +.+++..++.|+.||+.||.|||++||||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHH
Q ss_conf 45798625635799399951687533555788899999766854479997410033566643102565688887881001
Q 001856 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (1003)
Q Consensus 713 RDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL 792 (1003)
|||||+|||++.++++||+|||+|+...... ......+.+||+.|||||++
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-----------------------------NYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-----------------------------TSEEETTEEECGGGCCHHHH
T ss_pred CCCCHHCCCCCCCCEEEEEECCCCCCCCCCC-----------------------------CEEEECCCCCCCCCCCHHHH
T ss_conf 5270321443459828985142222045778-----------------------------61562343578765783887
Q ss_pred CCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 25999963216321679999982-99999999935678756304789999999899889999875265993776999998
Q 001856 793 LGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871 (1003)
Q Consensus 793 ~g~~yt~kSDIWSLGVILYELLT-GkpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TA 871 (1003)
.+..|+.++|||||||++|||++ |.+||.+.+....+.+++..... +..|..+|+++.+||.+||+.||.+|| ++
T Consensus 239 ~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RP---t~ 314 (325)
T d1rjba_ 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRP---SF 314 (325)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCC---CH
T ss_conf 27999963303000399999983899999998989999999856998-998876789999999997588966893---99
Q ss_pred HHHHCC
Q ss_conf 898709
Q 001856 872 SEVKQH 877 (1003)
Q Consensus 872 eEILqH 877 (1003)
.||++|
T Consensus 315 ~ei~~~ 320 (325)
T d1rjba_ 315 PNLTSF 320 (325)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=398.35 Aligned_cols=261 Identities=24% Similarity=0.404 Sum_probs=227.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EE
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996778985653163----28
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NL 664 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~----~L 664 (1003)
++|++.+.||+|+||+||+|+++.+++.||+|++++...........+.+|+.+++.++||||+++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99998626878499998429999999999999999999987625823045798625635799399951687533555788
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (1003)
Q Consensus 665 yLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ 744 (1003)
|||||||+|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~- 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG- 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCC-
T ss_conf 9999778898710112035899999999999999999999985795276346755665754320100344432212354-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCC
Q ss_conf 89999976685447999741003356664310256568888788100125999963216321679999982999999999
Q 001856 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (1003)
Q Consensus 745 ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~s 824 (1003)
.........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 166 ---------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 166 ---------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ----------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC
T ss_conf ---------------------------43333464257624369999839999966320265289999976979989969
Q ss_pred HHHHHHHHHHCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 3567875630478999-9999899889999875265993776999998898709788
Q 001856 825 PQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 825 ~~el~qkIl~~~~~~P-~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFF 880 (1003)
..+...+++......+ .....+|+++.+||.+||++||.+||. ++++++ |+|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~-~~l~ 272 (277)
T d1o6ya_ 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR-ADLV 272 (277)
T ss_dssp HHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH-HHHH
T ss_pred HHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHH--HHHHHH-HHHH
T ss_conf 99999999846999971003478999999999986679767773--999999-9999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.82 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=216.9
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCH---HHHHHHHHHHHHHHHCC--CCCEEEEEEEEECCCE
Q ss_conf 890899875005966999999989997899999304100017---89999999999998559--9967789856531632
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---NAVESILAERDILISVR--NPFVVRFFYSFTCREN 663 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~---~~ie~ilrEi~IL~~L~--HPnIVkLl~sf~d~~~ 663 (1003)
++|++.+.||+|+||+||+|+++.+++.||+|++.+...... .....+.+|+.+++.++ ||||++++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC-CCCEEEEECCCCCCCCC
Q ss_conf 8999986268-784999984299999999999999999999876258230457986256357-99399951687533555
Q 001856 664 LYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 664 LyLVmEyl~G-GSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~-~G~IKLsDFGLAk~~~~ 741 (1003)
+|+|||++.+ +++.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECCC
T ss_conf 89999833686228999861589999999999999999999998779755667611147744788489775465353244
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC-CCCCEEECHHHHHHHHHHCCCCC
Q ss_conf 78889999976685447999741003356664310256568888788100125999-96321632167999998299999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~y-t~kSDIWSLGVILYELLTGkpPF 820 (1003)
....+.+||+.|+|||++.+..+ +.++|||||||++|||++|.+||
T Consensus 164 ---------------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 164 ---------------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp ---------------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCC
T ss_conf ---------------------------------45566565877479999848997886533255403453675688998
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCCCHH
Q ss_conf 999935678756304789999999899889999875265993776999998898709788999933
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 821 ~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~Idw~ 886 (1003)
.+.+ .+...... ++..+|+++.+||.+||++||.+|| ++.|+++||||+++...
T Consensus 211 ~~~~------~i~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~~~~p 264 (273)
T d1xwsa_ 211 EHDE------EIIRGQVF---FRQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVLLP 264 (273)
T ss_dssp CSHH------HHHHCCCC---CSSCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCCCH
T ss_pred CCCH------HHHHCCCC---CCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHHHCCCCCC
T ss_conf 8736------77615447---7877999999999997608975893---99998539866788788
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=396.42 Aligned_cols=259 Identities=29% Similarity=0.509 Sum_probs=222.1
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316328999
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLV 667 (1003)
+++|+++++||+|+||+||+|+++ +++.||+|++..... .......+.+|+.+|+.++||||++++++|.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 999634318722778189999968-999999999812326-858999999999999867998687660120467731589
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 98626878499998429999999999999999999987625823045798625635799399951687533555788899
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddl 747 (1003)
||++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.|.....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~------ 152 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI------ 152 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCC------
T ss_conf 97400456789986047751445689999999999986057488267877505686899787323664301146------
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 999766854479997410033566643102565688887881001259-9996321632167999998299999999935
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (1003)
Q Consensus 748 s~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~-~yt~kSDIWSLGVILYELLTGkpPF~~~s~~ 826 (1003)
........+|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..
T Consensus 153 -------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 153 -------------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp ----------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -------------------------CCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHH
T ss_conf -------------------------7654101024311013788717888884100211175899997797998988989
Q ss_pred HHHHHHHHCCCC--------------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 678756304789--------------------------999999899889999875265993776999998898709788
Q 001856 827 QIFDNILNRKIP--------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 827 el~qkIl~~~~~--------------------------~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFF 880 (1003)
+.+.++...... +...+..+++.+.|||++||++||.+|| ++.|+|+||||
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---s~~ell~Hp~f 284 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQALEHAYF 284 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSGGG
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCC
T ss_conf 999999986389971104212333221433333567646665125899999999998668966890---99998569220
Q ss_pred CC
Q ss_conf 99
Q 001856 881 KD 882 (1003)
Q Consensus 881 k~ 882 (1003)
++
T Consensus 285 ~~ 286 (286)
T d1ob3a_ 285 KE 286 (286)
T ss_dssp GC
T ss_pred CC
T ss_conf 74
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.26 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=209.8
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC------CC
Q ss_conf 890899875005966999999989997899999304100017899999999999985599967789856531------63
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------RE 662 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d------~~ 662 (1003)
-+|+.+++||+|+||+||+|+++.+++.||+|++.+... ...+|+.+|+.++||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 776751698217683999999999997999999881606-------8999999998668989873878997447657731
Q ss_pred EEEEEEEECCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf 289999862687849999---8429999999999999999999987625823045798625635799-399951687533
Q 001856 663 NLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKV 738 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlL---kk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G-~IKLsDFGLAk~ 738 (1003)
++|||||||+++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 89999841688607888863103689999999999999999999998668764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCC-CCCCCCCEEECHHHHHHHHHHCC
Q ss_conf 55578889999976685447999741003356664310256568888788100125-99996321632167999998299
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 739 ~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g-~~yt~kSDIWSLGVILYELLTGk 817 (1003)
... .....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 173 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~ 220 (350)
T d1q5ka_ 173 LVR--------------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220 (350)
T ss_dssp CCT--------------------------------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCC--------------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCC
T ss_conf 047--------------------------------765320025555568277640468882100024652778550287
Q ss_pred CCCCCCCHHHHHHHHHHCC-----------------CCCCC---------CCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 9999999356787563047-----------------89999---------999899889999875265993776999998
Q 001856 818 PPFNAEHPQQIFDNILNRK-----------------IPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 871 (1003)
Q Consensus 818 pPF~~~s~~el~qkIl~~~-----------------~~~P~---------ip~~iS~elkDLIkkLLskDPskRpg~~TA 871 (1003)
+||...+..+.+..+.... ..++. ....+++++.+||.+||.+||.+|| +|
T Consensus 221 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta 297 (350)
T d1q5ka_ 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TP 297 (350)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred CCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCC---CH
T ss_conf 998987999999999997489817765430621011035544567444431568999999999997658955792---99
Q ss_pred HHHHCCCCCCCC
Q ss_conf 898709788999
Q 001856 872 SEVKQHVFFKDI 883 (1003)
Q Consensus 872 eEILqHPFFk~I 883 (1003)
.|+|+||||+++
T Consensus 298 ~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 298 LEACAHSFFDEL 309 (350)
T ss_dssp HHHHTSGGGGGG
T ss_pred HHHHCCHHHCCC
T ss_conf 999669845246
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=390.76 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=221.2
Q ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCC---EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 556890899875005966999999989997---89999930410001789999999999998559996778985653163
Q 001856 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 586 ~~ledYeIlk~LGkGsFGtVylArdk~tgk---~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~ 662 (1003)
...++|++.+.||+|+||+||+|+++.+++ .+|+|.+.... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 08004278569802788299999995799788999999978445--9899999999999998579988861899996288
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 289999862687849999842-9999999999999999999987625823045798625635799399951687533555
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~ 741 (1003)
.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 77999972279853002104567999999999999999988988527983576150448988999199888443157567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCC
Q ss_conf 78889999976685447999741003356664310256568888788100125999963216321679999982-99999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF 820 (1003)
... ...........||+.|||||++.+..|+.++|||||||++|||+| |.+||
T Consensus 181 ~~~--------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf 234 (299)
T d1jpaa_ 181 DTS--------------------------DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234 (299)
T ss_dssp -----------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCC--------------------------CCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 777--------------------------653650256668830038788836997861214453578999986799999
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 999935678756304789999999899889999875265993776999998898709
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 821 ~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
.+.+..++...+..... +..+..++..+.+||.+||+.||.+|| ++.+++++
T Consensus 235 ~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~~ 286 (299)
T d1jpaa_ 235 WDMTNQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred CCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 99999999999973788--999742269999999997587976892---99999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=391.46 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=221.7
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 98985568908998750059669999999899978999993041000178999999999999855999677898565316
Q 001856 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 582 ~k~~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~ 661 (1003)
.+|.+..++|++.+.||+|+||+||+|+++.+++.||+|++++... ..+.+.+|+.+|..++|||||++++++.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC----HHHHHHHHHHHHHHCCCCCEECCCCCEEEC
T ss_conf 6517457993986598208880899999999996999999777610----399999999999867999882677527457
Q ss_pred CEEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 3289999862687849999842--99999999999999999999876258230457986256357993999516875335
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 662 ~~LyLVmEyl~GGSL~dlLkk~--g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~ 739 (1003)
+.+|+|||||++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 85478763146760677753035541579999999999999788898789305760457689989992898324454653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCC-
Q ss_conf 5578889999976685447999741003356664310256568888788100125999963216321679999982999-
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP- 818 (1003)
Q Consensus 740 ~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkp- 818 (1003)
.... ........||+.|||||++.+..|+.++|||||||++|||++|..
T Consensus 166 ~~~~------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p 215 (287)
T d1opja_ 166 TGDT------------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215 (287)
T ss_dssp CSSS------------------------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCC------------------------------CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCC
T ss_conf 7887------------------------------2210355665466692787279998104302178999999867998
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC--CCCCC
Q ss_conf 99999935678756304789999999899889999875265993776999998898709--78899
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH--VFFKD 882 (1003)
Q Consensus 819 PF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH--PFFk~ 882 (1003)
||.+.+...+++.+... .. +..+..+++.+.+||.+||+.||.+|| ++.++++. .++++
T Consensus 216 ~~~~~~~~~~~~~i~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 216 PYPGIDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQAFETMFQE 276 (287)
T ss_dssp SSTTCCHHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHTTSS
T ss_pred CCCCCHHHHHHHHHHCC-CC-CCCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHHHHHHHHHHHH
T ss_conf 87742599999998558-88-888743309999999997577976893---999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.36 Aligned_cols=265 Identities=28% Similarity=0.402 Sum_probs=220.3
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC------
Q ss_conf 56890899875005966999999989997899999304100017899999999999985599967789856531------
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------ 660 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d------ 660 (1003)
.+++|+++++||+|+||+||+|+++.+++.||+|++.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 62798899997227482999999989997999999842224-63789999999999998359996606765402465444
Q ss_pred --CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --632899998626878499998429999999999999999999987625823045798625635799399951687533
Q 001856 661 --RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 661 --~~~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~ 738 (1003)
..++|+|||++.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEE
T ss_conf 45763899985357874101222034433089999999999999885229988567672220366899687631350022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC-CCCCCCEEECHHHHHHHHHHCC
Q ss_conf 555788899999766854479997410033566643102565688887881001259-9996321632167999998299
Q 001856 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGI 817 (1003)
Q Consensus 739 ~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~-~yt~kSDIWSLGVILYELLTGk 817 (1003)
...... .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|+
T Consensus 167 ~~~~~~---------------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~ 219 (318)
T d3blha1 167 FSLAKN---------------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219 (318)
T ss_dssp CCC--------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCCC---------------------------CCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCC
T ss_conf 355444---------------------------32113566024978742899707999891787006786466174487
Q ss_pred CCCCCCCHHHHHHHHHHCCCCCCCC-C----------------------------CCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 9999999356787563047899999-9----------------------------9899889999875265993776999
Q 001856 818 PPFNAEHPQQIFDNILNRKIPWPRV-P----------------------------EEMSPEAHDLIDRFLTEDPHQRLGS 868 (1003)
Q Consensus 818 pPF~~~s~~el~qkIl~~~~~~P~i-p----------------------------~~iS~elkDLIkkLLskDPskRpg~ 868 (1003)
+||.+.+.......+......++.. . ...++.+.|||.+||++||.+|+
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-- 297 (318)
T d3blha1 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-- 297 (318)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC--
T ss_pred CCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCC--
T ss_conf 998998999999999984189982553443203444332013344555033404445998999999998738965890--
Q ss_pred CCHHHHHCCCCCCC
Q ss_conf 99889870978899
Q 001856 869 GGASEVKQHVFFKD 882 (1003)
Q Consensus 869 ~TAeEILqHPFFk~ 882 (1003)
+|.|+|+||||++
T Consensus 298 -sa~elL~Hpff~~ 310 (318)
T d3blha1 298 -DSDDALNHDFFWS 310 (318)
T ss_dssp -CHHHHHHSGGGSS
T ss_pred -CHHHHHCCHHHCC
T ss_conf -9999974950156
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=389.04 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=211.1
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC--CCE
Q ss_conf 5689089987500596699999998999789999930410001789999999999998559-9967789856531--632
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTC--REN 663 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~-HPnIVkLl~sf~d--~~~ 663 (1003)
..++|+++++||+|+||+||+|+++.+++.||+|++++.. .+.+.+|+.+|..++ ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCC
T ss_conf 9867189789831748199999988999799999988899------9999999999985157998767999998168771
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CEEEEECCCCCCCCCC
Q ss_conf 899998626878499998429999999999999999999987625823045798625635799-3999516875335557
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G-~IKLsDFGLAk~~~~~ 742 (1003)
+|+|||||.+++|..+. +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred EEEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC-
T ss_conf 26888631798589974---68999999999999999998876433443456441237748998366415654266468-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 88899999766854479997410033566643102565688887881001259-99963216321679999982999999
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~-~yt~kSDIWSLGVILYELLTGkpPF~ 821 (1003)
.......+||+.|+|||++.+. .|+.++||||+||++|+|++|..||.
T Consensus 183 -------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 183 -------------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp -------------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred -------------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
T ss_conf -------------------------------8744432248642476102688888845232335455587604889998
Q ss_pred CCCH-HHHHHHHHHC-------------C---------------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 9993-5678756304-------------7---------------------899999998998899998752659937769
Q 001856 822 AEHP-QQIFDNILNR-------------K---------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 866 (1003)
Q Consensus 822 ~~s~-~el~qkIl~~-------------~---------------------~~~P~ip~~iS~elkDLIkkLLskDPskRp 866 (1003)
.... ......+... . .........+++++.|||++||++||.+||
T Consensus 232 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 87601899999999878841555554225444743000003334331121155211244899999999998669956890
Q ss_pred CCCCHHHHHCCCCCCCCCHH
Q ss_conf 99998898709788999933
Q 001856 867 GSGGASEVKQHVFFKDINWD 886 (1003)
Q Consensus 867 g~~TAeEILqHPFFk~Idw~ 886 (1003)
||+|+|+||||+++.|+
T Consensus 312 ---ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 312 ---TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp ---CHHHHHTSGGGTTSCCC
T ss_pred ---CHHHHHCCCCCCCCCCC
T ss_conf ---89999649355887979
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=389.16 Aligned_cols=260 Identities=31% Similarity=0.502 Sum_probs=215.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-----E
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996778985653163-----2
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----N 663 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~-----~ 663 (1003)
++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+++|+.+|+.++||||+++++++.... +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 98599789940648099999999999499999980310--9589999999999999768989885888995056455414
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 89999862687849999842999999999999999999998762582304579862563579939995168753355578
Q 001856 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 664 LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s 743 (1003)
+|++ +++.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 9999-96259865664405-899999999999999999999997898677787643788799977875457056504777
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCCC
Q ss_conf 889999976685447999741003356664310256568888788100125-9999632163216799999829999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g-~~yt~kSDIWSLGVILYELLTGkpPF~~ 822 (1003)
. ........+||+.|+|||++.. ..++.++||||+||++|+|++|.+||.+
T Consensus 164 ~----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 164 D----------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp C----------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred C----------------------------CCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCC
T ss_conf 6----------------------------410101102652000387860478887410100467013377669799788
Q ss_pred CCHHHHHHHHHHCCC----------------------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 993567875630478----------------------------9999999899889999875265993776999998898
Q 001856 823 EHPQQIFDNILNRKI----------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 823 ~s~~el~qkIl~~~~----------------------------~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEI 874 (1003)
.+..+....+..... ++......+++++.+||.+||++||.+|| +|.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---ta~e~ 292 (345)
T d1pmea_ 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI---EVEQA 292 (345)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC---CHHHH
T ss_pred CCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHHH
T ss_conf 888999998765206997566423433222202446775577877783789999999999997648956790---89998
Q ss_pred HCCCCCCCC
Q ss_conf 709788999
Q 001856 875 KQHVFFKDI 883 (1003)
Q Consensus 875 LqHPFFk~I 883 (1003)
|+||||+..
T Consensus 293 L~hpf~~~~ 301 (345)
T d1pmea_ 293 LAHPYLEQY 301 (345)
T ss_dssp HTSGGGTTT
T ss_pred HCCHHHCCC
T ss_conf 619865558
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=392.68 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=218.3
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC------
Q ss_conf 56890899875005966999999989997899999304100017899999999999985599967789856531------
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------ 660 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d------ 660 (1003)
.+++|+++++||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 33775998896217585999999999998999999882336-97999999999999986489876489989702564345
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 63289999862687849999842999999999999999999998762582304579862563579939995168753355
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 661 ~~~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~ 740 (1003)
..++|+|||||.| ++.+.+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCEEEEEEECCCH-HHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCC
T ss_conf 7626999841446-7787650--389999999999999999988652211245677632113654431320102321146
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCC
Q ss_conf 57888999997668544799974100335666431025656888878810012599996321632167999998299999
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (1003)
Q Consensus 741 ~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF 820 (1003)
........+||+.|+|||++.+..++.++||||+||++|+|++|++||
T Consensus 171 --------------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 171 --------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp ------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred --------------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCC
T ss_conf --------------------------------665533221465555813314777787743335662578986598998
Q ss_pred CCCCHHHHHHHHHHCCCC----------------------CCCC-----------------CCCCCHHHHHHHHHHCCCC
Q ss_conf 999935678756304789----------------------9999-----------------9989988999987526599
Q 001856 821 NAEHPQQIFDNILNRKIP----------------------WPRV-----------------PEEMSPEAHDLIDRFLTED 861 (1003)
Q Consensus 821 ~~~s~~el~qkIl~~~~~----------------------~P~i-----------------p~~iS~elkDLIkkLLskD 861 (1003)
.+.+......+++..... .... ....++++.+||++||..|
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d 298 (355)
T d2b1pa1 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred CCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 88977889999997205898799987656677776417543566642126433354321013337999999999987699
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCH
Q ss_conf 377699999889870978899993
Q 001856 862 PHQRLGSGGASEVKQHVFFKDINW 885 (1003)
Q Consensus 862 PskRpg~~TAeEILqHPFFk~Idw 885 (1003)
|.+|| +|+|+|+||||+...+
T Consensus 299 P~~R~---ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 299 PAKRI---SVDDALQHPYINVWYD 319 (355)
T ss_dssp TTTSC---CHHHHHTSTTTGGGCC
T ss_pred HHHCC---CHHHHHCCCCCCCCCC
T ss_conf 45790---8999966942087888
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.22 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=215.2
Q ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCE
Q ss_conf 98556890899875005966999999989997899999304100017899999999999985599967789856531632
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (1003)
Q Consensus 584 ~~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~ 663 (1003)
|.+..++|++.+.||+|+||+||+|+.+ ..||+|+++.... .....+.+.+|+.++..++|||||++++++. ...
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCE
T ss_conf 1315451899889830788589999999---9899999973469-9899999999999998479987864567971-558
Q ss_pred EEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 89999862687849999842-99999999999999999999876258230457986256357993999516875335557
Q 001856 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 664 LyLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~ 742 (1003)
+|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 99999658998889998523578999999999999999988875099951614789979818997887500221333556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC---CCCCCCEEECHHHHHHHHHHCCCC
Q ss_conf 88899999766854479997410033566643102565688887881001259---999632163216799999829999
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPP 819 (1003)
Q Consensus 743 s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~---~yt~kSDIWSLGVILYELLTGkpP 819 (1003)
.......+.+||+.|||||++.+. .|+.++|||||||++|||+||+.|
T Consensus 158 -----------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P 208 (276)
T d1uwha_ 158 -----------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208 (276)
T ss_dssp -------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred -----------------------------CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCC
T ss_conf -----------------------------776312566557431799999505689999531516359999999978899
Q ss_pred CCCCCHHHHHHHHHHCCCCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 999993567875630478999---9999899889999875265993776999998898709
Q 001856 820 FNAEHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 820 F~~~s~~el~qkIl~~~~~~P---~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
|.+.+.......+.......| ..+..+++++.+||.+||..||.+|| ++.+++++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 209 YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp TTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 89989699999999658889860003655549999999997588976892---99999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.14 Aligned_cols=261 Identities=30% Similarity=0.464 Sum_probs=223.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316328999
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLV 667 (1003)
+++|++++.||+|+||+||+|+++.+++.||+|++++.. ........+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999786269712868199999999999699999980321-7868999999999999856757888213544444311588
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 98626878499998429999999999999999999987625823045798625635799399951687533555788899
Q 001856 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddl 747 (1003)
++++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~---- 155 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---- 155 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----
T ss_pred EEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC----
T ss_conf 6302332221121235654036789999999999877433998600146761211337826652046011046887----
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC-CCCCCEEECHHHHHHHHHHCCCCC-CCCCH
Q ss_conf 9997668544799974100335666431025656888878810012599-996321632167999998299999-99993
Q 001856 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF-NAEHP 825 (1003)
Q Consensus 748 s~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~-yt~kSDIWSLGVILYELLTGkpPF-~~~s~ 825 (1003)
.......+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+.
T Consensus 156 ---------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 156 ---------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ---------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ---------------------------CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCH
T ss_conf ---------------------------51001034431014667506988880444026541889985189999889999
Q ss_pred HHHHHHHHHCCCC--------------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCC
Q ss_conf 5678756304789--------------------------99999989988999987526599377699999889870978
Q 001856 826 QQIFDNILNRKIP--------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 879 (1003)
Q Consensus 826 ~el~qkIl~~~~~--------------------------~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPF 879 (1003)
.+.+.++...... ....+..+++.+.+||++||++||.+|| +|+|+|+|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---sa~e~L~Hp~ 285 (292)
T d1unla_ 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQHPY 285 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHTTSGG
T ss_pred HHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCHH
T ss_conf 9999999861189973551344322211334445443104330656899999999998649966890---9999964953
Q ss_pred CCCC
Q ss_conf 8999
Q 001856 880 FKDI 883 (1003)
Q Consensus 880 Fk~I 883 (1003)
|+++
T Consensus 286 f~~~ 289 (292)
T d1unla_ 286 FSDF 289 (292)
T ss_dssp GSSC
T ss_pred HCCC
T ss_conf 4079
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.69 Aligned_cols=259 Identities=26% Similarity=0.368 Sum_probs=218.9
Q ss_pred CCCCCEEEEEE-EECCCCEEEEEEEECCC--CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 55689089987-50059669999999899--9789999930410001789999999999998559996778985653163
Q 001856 586 TSIDDFEIIKP-ISRGAFGRVFLAKKRTT--GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 586 ~~ledYeIlk~-LGkGsFGtVylArdk~t--gk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~ 662 (1003)
+..++|.+... ||+|+||+||+|.++.+ +..||+|++++.. .....+.+.+|+.+|..++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 54447188784873060809999999608976899999988203--97899999999999986799888068656036-8
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 289999862687849999842-9999999999999999999987625823045798625635799399951687533555
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~ 741 (1003)
.+|||||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 07999980789968997521256999999999999999987899868810576764660454688542033134211554
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCC
Q ss_conf 78889999976685447999741003356664310256568888788100125999963216321679999982-99999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF 820 (1003)
... ........+||+.|||||++.+..++.++|||||||++|||+| |.+||
T Consensus 162 ~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf 213 (285)
T d1u59a_ 162 DDS----------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213 (285)
T ss_dssp CSC----------------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCC----------------------------CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCC
T ss_conf 343----------------------------2113562113743358688727999954123220178999993899999
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHH---HCCCCC
Q ss_conf 999935678756304789999999899889999875265993776999998898---709788
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV---KQHVFF 880 (1003)
Q Consensus 821 ~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEI---LqHPFF 880 (1003)
.+.+..++...+..+.. +..|..+++++.+||.+||..||.+|| ++.++ |+|+|+
T Consensus 214 ~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RP---s~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 214 KKMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRP---DFLTVEQRMRACYY 271 (285)
T ss_dssp TTCCTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHHHHHHHH
T ss_conf 99799999999981899--999976789999999997577976890---99999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.62 Aligned_cols=257 Identities=29% Similarity=0.410 Sum_probs=219.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-----C
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316-----3
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----E 662 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~-----~ 662 (1003)
.++|+++++||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 9871888898317883999999999997999999882002-868999999999999866898742599999634645668
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 28999986268784999984299999999999999999999876258230457986256357993999516875335557
Q 001856 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~ 742 (1003)
..+++++++.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred CEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC--
T ss_conf 64999996258862320022-453099999999999999999973887651667763345543220013210001257--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC-CCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 888999997668544799974100335666431025656888878810012599-9963216321679999982999999
Q 001856 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 743 s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~-yt~kSDIWSLGVILYELLTGkpPF~ 821 (1003)
....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.
T Consensus 173 --------------------------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 173 --------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp --------------------------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------------------------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
T ss_conf --------------------------------544443454355583553377567855124320589999976889978
Q ss_pred CCCHHHHHHHHHHCCCCCC--------------------C--------CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9993567875630478999--------------------9--------99989988999987526599377699999889
Q 001856 822 AEHPQQIFDNILNRKIPWP--------------------R--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 873 (1003)
Q Consensus 822 ~~s~~el~qkIl~~~~~~P--------------------~--------ip~~iS~elkDLIkkLLskDPskRpg~~TAeE 873 (1003)
+.+.......+.......+ . ....+++++.+||.+||+.||.+|+ +|.|
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---ta~e 297 (348)
T d2gfsa1 221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQ 297 (348)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC---CHHH
T ss_pred CCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC---CHHH
T ss_conf 8988999999997307997577320010244544430355787555662678999999999997758834593---8999
Q ss_pred HHCCCCCCCC
Q ss_conf 8709788999
Q 001856 874 VKQHVFFKDI 883 (1003)
Q Consensus 874 ILqHPFFk~I 883 (1003)
+|+||||++.
T Consensus 298 lL~Hp~f~~~ 307 (348)
T d2gfsa1 298 ALAHAYFAQY 307 (348)
T ss_dssp HHTSGGGTTT
T ss_pred HHCCHHHCCC
T ss_conf 8559954879
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.98 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=215.9
Q ss_pred EEEECCCCEEEEEEEECC--CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf 875005966999999989--997899999304100017899999999999985599967789856531632899998626
Q 001856 595 KPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (1003)
Q Consensus 595 k~LGkGsFGtVylArdk~--tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLVmEyl~ 672 (1003)
++||+|+||+||+|.++. +++.||+|+++... ......+.+.+|+.+|..++|||||++++++.+ +..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 87849999842999999999999999999998762582304579862563579939995168753355578889999976
Q 001856 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (1003)
Q Consensus 673 GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~ddls~p~~ 752 (1003)
||+|.+++.+...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-------- 162 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-------- 162 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--------
T ss_pred CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCC--------
T ss_conf 896899975225789999999999999997668747955677761131023567512341345331343234--------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCHHHHHHH
Q ss_conf 685447999741003356664310256568888788100125999963216321679999982-9999999993567875
Q 001856 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 831 (1003)
Q Consensus 753 ~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF~~~s~~el~qk 831 (1003)
.........||+.|||||++.+..++.++|||||||++|||++ |.+||.+.+..++...
T Consensus 163 --------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~ 222 (277)
T d1xbba_ 163 --------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222 (277)
T ss_dssp --------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred --------------------CCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf --------------------432244567784203916653799984344303403132896589999999899999999
Q ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHH---HCCCCCCC
Q ss_conf 6304789999999899889999875265993776999998898---70978899
Q 001856 832 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV---KQHVFFKD 882 (1003)
Q Consensus 832 Il~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEI---LqHPFFk~ 882 (1003)
+..+.. +..|..+|+++.+||.+||+.||.+|| ++.++ |+|+|+.-
T Consensus 223 i~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~RP---s~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 223 LEKGER--MGCPAGCPREMYDLMNLCWTYDVENRP---GFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHHHHHHHHHH
T ss_pred HHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHHHHCHHHHC
T ss_conf 982899--999865679999999997588976890---9899999852887504
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.14 Aligned_cols=259 Identities=23% Similarity=0.388 Sum_probs=220.0
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 98985568908998750059669999999899978999993041000178999999999999855999677898565316
Q 001856 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (1003)
Q Consensus 582 ~k~~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~ 661 (1003)
..|.+..++|++.+.||+|+||+||+|+++ ++..||+|++..... ..+.+.+|+.++..++|||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEECC-
T ss_conf 770038899388679810798289999999-999999999864768----88999999999986799988578731045-
Q ss_pred CEEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 3289999862687849999842--99999999999999999999876258230457986256357993999516875335
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 662 ~~LyLVmEyl~GGSL~dlLkk~--g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~ 739 (1003)
+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEEC
T ss_conf 97699999578982888875147898878899999999999999997489546756422515620244042341014773
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCC
Q ss_conf 5578889999976685447999741003356664310256568888788100125999963216321679999982-999
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (1003)
Q Consensus 740 ~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-Gkp 818 (1003)
... .........||+.|||||++.+..|+.++|||||||++|||+| |.+
T Consensus 160 ~~~------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 160 EDN------------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp SSS------------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCC------------------------------CCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCC
T ss_conf 588------------------------------64420356774444582898379998245645257999999968988
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC--CCCCC
Q ss_conf 9999993567875630478999999989988999987526599377699999889870--97889
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ--HVFFK 881 (1003)
Q Consensus 819 PF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq--HPFFk 881 (1003)
||...+..++.+.+..... +..|..+++++.+||.+||+.||.+|| ++.++++ |+||.
T Consensus 210 ~~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 210 PYPGMTNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFFT 269 (272)
T ss_dssp SSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHHHHHHHHHHH
T ss_conf 8888899999999970688--889655719999999997588976893---99999998611321
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.32 Aligned_cols=250 Identities=22% Similarity=0.400 Sum_probs=218.5
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316328999
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLV 667 (1003)
.++|++++.||+|+||+||+|+++ ++..||+|++.+.... .+.+.+|+.++..++||||+++++++...+.+|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEE
T ss_conf 699588889820888299999988-9999999998788676----89999999999966899756535243159933799
Q ss_pred EEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 9862687849999842-999999999999999999998762582304579862563579939995168753355578889
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~dd 746 (1003)
||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~---- 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---- 154 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCC----
T ss_conf 9836999189975201347889999999999999877653164310443153266668877686553210023688----
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 999976685447999741003356664310256568888788100125999963216321679999982-9999999993
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF~~~s~ 825 (1003)
.........||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+.
T Consensus 155 --------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 155 --------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp ------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred --------------------------CCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf --------------------------733504300176667857860799984033210599999998789888778999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 5678756304789999999899889999875265993776999998898709
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
.++...+..+.. +..|..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 209 ~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 209 SEVVEDISTGFR--LYKPRLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 999999980688--899543679999999997657976891---99999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.50 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=216.3
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCC----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 890899875005966999999989997----8999993041000178999999999999855999677898565316328
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk----~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~L 664 (1003)
++|++++.||+|+||+||+|+++.+++ .||+|.+.... .....+.+.+|+.++..++|||||++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CE
T ss_conf 999783198208992999999958998898999999965134--979999999999999867998881589999619-83
Q ss_pred EEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 9999862687849999842-999999999999999999998762582304579862563579939995168753355578
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s 743 (1003)
++++|++.+|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCC
T ss_conf 69998426874010111334579999999999999999999987695047621203116799875860255222335444
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCC
Q ss_conf 889999976685447999741003356664310256568888788100125999963216321679999982-9999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF~~ 822 (1003)
.........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+
T Consensus 166 -----------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 166 -----------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp -----------------------------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred -----------------------------CCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf -----------------------------532236510586446708874699983565440799999999779999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCC
Q ss_conf 99356787563047899999998998899998752659937769999988987097
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 878 (1003)
Q Consensus 823 ~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHP 878 (1003)
.+..++...+..+.. +..|..+++.+.+||.+||..||.+|| ++.++++|.
T Consensus 217 ~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~l 267 (317)
T d1xkka_ 217 IPASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIEF 267 (317)
T ss_dssp SCGGGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHHH
T ss_pred CCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHHH
T ss_conf 998999999975998--999855689999999984789934691---999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.03 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=220.8
Q ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 9855689089987500596699999998999---7899999304100017899999999999985599967789856531
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (1003)
Q Consensus 584 ~~~~ledYeIlk~LGkGsFGtVylArdk~tg---k~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d 660 (1003)
|.+..++|++.+.||+|+||.||+|++..++ ..||+|+++.. ......+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf 976889969877993078829999999369964499999993656--68799999999999998689999856988995-
Q ss_pred CCEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 63289999862687849999842-99999999999999999999876258230457986256357993999516875335
Q 001856 661 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (1003)
Q Consensus 661 ~~~LyLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~ 739 (1003)
.+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 37479999840698077654224789999999999999987752302267441410265532067896787650342133
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCC
Q ss_conf 5578889999976685447999741003356664310256568888788100125999963216321679999982-999
Q 001856 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (1003)
Q Consensus 740 ~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-Gkp 818 (1003)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+
T Consensus 159 ~~~------------------------------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~ 208 (273)
T d1mp8a_ 159 EDS------------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208 (273)
T ss_dssp ------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCC------------------------------CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 677------------------------------62330540058310326675169988745244424789999826999
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 99999935678756304789999999899889999875265993776999998898709
Q 001856 819 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 819 PF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
||.+.+..+++..+..+.. +..+..+|+++.+||.+||+.||.+|| ++.+|++|
T Consensus 209 P~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 209 PFQGVKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp TTTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 9888999999999981899--989877799999999997687976892---99999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.05 Aligned_cols=264 Identities=24% Similarity=0.393 Sum_probs=223.2
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
Q ss_conf 88998985568908998750059669999999899978999993041000178999999999999855999677898565
Q 001856 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF 658 (1003)
Q Consensus 579 i~p~k~~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf 658 (1003)
.....|.+..++|++.+.||+|+||+||+|+++.+ ..||+|+++.... ..+.+.+|+.++..++|||||++++++
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~ 81 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV 81 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCEECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 88756074779979846993079809999999999-9999999880448----889999999999866667886899998
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 316328999986268784999984--299999999999999999999876258230457986256357993999516875
Q 001856 659 TCRENLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 659 ~d~~~LyLVmEyl~GGSL~dlLkk--~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLA 736 (1003)
.+ +.+|+|||||++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 82 ~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 82 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EC-CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHH
T ss_conf 23-97599999447994354200003553059999999999999999875411433531230799989992998442555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-
Q ss_conf 3355578889999976685447999741003356664310256568888788100125999963216321679999982-
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT- 815 (1003)
+.... ..........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~~~~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 161 RLIED------------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp C--------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred HHCCC------------------------------CCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHC
T ss_conf 42568------------------------------873352454556654580898379989177413235899999868
Q ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC--CCCCCCC
Q ss_conf 9999999993567875630478999999989988999987526599377699999889870--9788999
Q 001856 816 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ--HVFFKDI 883 (1003)
Q Consensus 816 GkpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq--HPFFk~I 883 (1003)
|.+||.+....+++..+..... +..+..+++++.+||.+||+.||.+|| ++.++++ |+||...
T Consensus 211 ~~p~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 211 GRVPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFTST 275 (285)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHHHHHHHCCC
T ss_conf 9999988889999999982689--999832379999999997566975891---9999999876662389
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.28 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=215.7
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 99898556890899875005966999999989-----9978999993041000178999999999999855-99967789
Q 001856 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRF 654 (1003)
Q Consensus 581 p~k~~~~ledYeIlk~LGkGsFGtVylArdk~-----tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L-~HPnIVkL 654 (1003)
+.+|.+..++|++.+.||+|+||.||+|++.. +++.||+|+++... .......+.+|..++..+ +|+||+.+
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEE
T ss_conf 825261679979844984167839999998677755578399999986001--717899999999998861499849974
Q ss_pred EEEEECC-CEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCC
Q ss_conf 8565316-3289999862687849999842----------------9999999999999999999987625823045798
Q 001856 655 FYSFTCR-ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 717 (1003)
Q Consensus 655 l~sf~d~-~~LyLVmEyl~GGSL~dlLkk~----------------g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKP 717 (1003)
++++... ..+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 11540479757999984589929999985366666532220233214689999999999999999988737971786773
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
Q ss_conf 62563579939995168753355578889999976685447999741003356664310256568888788100125999
Q 001856 718 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797 (1003)
Q Consensus 718 eNILId~~G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~y 797 (1003)
+|||++.++++||+|||+|+...... ........+||+.|||||++.+..+
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~-----------------------------~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDP-----------------------------DYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCT-----------------------------TSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred CCEEECCCCCEEECCCCCHHHCCCCC-----------------------------CCCCCCCEEECCCCCCHHHHHCCCC
T ss_conf 10657799828984575200113566-----------------------------5222475166721020368646889
Q ss_pred CCCCEEECHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC
Q ss_conf 9632163216799999829-999999993567875630478999999989988999987526599377699999889870
Q 001856 798 GTTADWWSVGIILFELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 798 t~kSDIWSLGVILYELLTG-kpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq 876 (1003)
+.++|||||||++|||++| .+||.+....+.+..++..... +..|..+++++.+||.+||+.||.+|| ++.++++
T Consensus 214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~eil~ 289 (299)
T d1ywna1 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVE 289 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHH
T ss_conf 966322136789999986889999899989999999963898-888865789999999997677966791---9999999
Q ss_pred C
Q ss_conf 9
Q 001856 877 H 877 (1003)
Q Consensus 877 H 877 (1003)
|
T Consensus 290 ~ 290 (299)
T d1ywna1 290 H 290 (299)
T ss_dssp H
T ss_pred H
T ss_conf 9
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.57 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=216.5
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 5689089987500596699999998999----789999930410001789999999999998559996778985653163
Q 001856 587 SIDDFEIIKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (1003)
Q Consensus 587 ~ledYeIlk~LGkGsFGtVylArdk~tg----k~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~ 662 (1003)
..+.|++.+.||+|+||+||+|.++.++ ..||+|++.... .......+.+|+.++..++|||||++++++.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 88996861598117790999999968998787999999988445--9689999999999998568987832367783388
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 289999862687849999842-9999999999999999999987625823045798625635799399951687533555
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~ 741 (1003)
.+|+|||||.+++|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 03899972135740222102345420899999999999854121212342576564427888998499845510300357
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHC-CCCC
Q ss_conf 788899999766854479997410033566643102565688887881001259999632163216799999829-9999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPF 820 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTG-kpPF 820 (1003)
.. ..........||+.|||||++.+..++.++|||||||++|||+++ .+||
T Consensus 163 ~~----------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 163 DP----------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp ---------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CC----------------------------CCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 87----------------------------65267426777734348888704999973556344898999996798865
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC
Q ss_conf 99993567875630478999999989988999987526599377699999889870
Q 001856 821 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 821 ~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq 876 (1003)
...+..+++..+..+.. +..+..++..+.+||.+||..||.+|| ++.++++
T Consensus 215 ~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 215 WELSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp TTCCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred CCCCHHHHHHHHHCCCC--CCCCHHHHHHHHHHHHHHCCCCHHHCC---CHHHHHH
T ss_conf 56899999999863578--998504579999999997767976893---9999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.30 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=220.6
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 68908998750059669999999899978999993041000178999999999999855999677898565316328999
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~LyLV 667 (1003)
.++|+++++||+|+||+||+|+++ +++.||+|++++.... .+.+.+|+.++..++||||+++++++.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEE
T ss_conf 699799689820788399999988-9989999998747577----89999999999966898601588998507816999
Q ss_pred EEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 986268784999984-2999999999999999999998762582304579862563579939995168753355578889
Q 001856 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk-~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~dd 746 (1003)
|||+.+|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--- 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--- 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS---
T ss_pred EECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC---
T ss_conf 97048993888641024677689999999999999998754684346654135887699847988614420235787---
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 999976685447999741003356664310256568888788100125999963216321679999982-9999999993
Q 001856 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (1003)
Q Consensus 747 ls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF~~~s~ 825 (1003)
........||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+.
T Consensus 155 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 155 ---------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp ---------------------------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ---------------------------CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH
T ss_conf ---------------------------22524657887757807863799885210336432467397559999889999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 5678756304789999999899889999875265993776999998898709
Q 001856 826 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 826 ~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
.++..++..... +..|..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 208 ~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 208 SETAEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 999999980797--899654659999999997668976893---99999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=371.31 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=221.7
Q ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
Q ss_conf 8556890899875005966999999989-----99789999930410001789999999999998559996778985653
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659 (1003)
Q Consensus 585 ~~~ledYeIlk~LGkGsFGtVylArdk~-----tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~ 659 (1003)
....++|++++.||+|+||+||+|+.+. +++.||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 38988938867982078839999998887657788299999988210--8579999999999999668997655246660
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEECCC
Q ss_conf 1632899998626878499998429------------------------9999999999999999999876258230457
Q 001856 660 CRENLYLVMEYLNGGDLYSLLRNLG------------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715 (1003)
Q Consensus 660 d~~~LyLVmEyl~GGSL~dlLkk~g------------------------~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDI 715 (1003)
....++++|||+.+|+|.+++.... .++...+..++.||+.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578685488
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
Q ss_conf 98625635799399951687533555788899999766854479997410033566643102565688887881001259
Q 001856 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 795 (1003)
Q Consensus 716 KPeNILId~~G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~ 795 (1003)
||+|||++.++.+||+|||+|+..... .......+.+||+.|+|||++.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~ 217 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSA-----------------------------DYYKADGNDAIPIRWMPPESIFYN 217 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG-----------------------------GCBC----CCBCGGGCCHHHHHHC
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCC-----------------------------CCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 401168989992898331442113677-----------------------------641115777767676798997268
Q ss_pred CCCCCCEEECHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 999632163216799999829-9999999935678756304789999999899889999875265993776999998898
Q 001856 796 GHGTTADWWSVGIILFELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 874 (1003)
Q Consensus 796 ~yt~kSDIWSLGVILYELLTG-kpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEI 874 (1003)
.|+.++|||||||++|||++| .+||.+.+..++...+..+.. +..|..+++++.+||.+||+.||.+|| ++.++
T Consensus 218 ~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RP---t~~ev 292 (301)
T d1lufa_ 218 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRP---SFCSI 292 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHH
T ss_conf 8980563025236299998068999999899999999973997--888732529999999997488965793---99999
Q ss_pred HC
Q ss_conf 70
Q 001856 875 KQ 876 (1003)
Q Consensus 875 Lq 876 (1003)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
T ss_conf 99
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.61 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=220.6
Q ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCE--EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEECC
Q ss_conf 85568908998750059669999999899978--999993041000178999999999999855-999677898565316
Q 001856 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR 661 (1003)
Q Consensus 585 ~~~ledYeIlk~LGkGsFGtVylArdk~tgk~--VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L-~HPnIVkLl~sf~d~ 661 (1003)
.+..++|++.+.||+|+||+||+|+++.++.. ||+|.+... ......+.+.+|+.+|..+ +|||||++++++.+.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC
T ss_conf 6687996887798207882899999989996999999997823--38579999999999998622899883678888418
Q ss_pred CEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCC
Q ss_conf 3289999862687849999842----------------999999999999999999998762582304579862563579
Q 001856 662 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (1003)
Q Consensus 662 ~~LyLVmEyl~GGSL~dlLkk~----------------g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~ 725 (1003)
+.+|+||||++||+|.++++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
T ss_conf 73699998028986999986403555551231012345789999999999999999876630895455505204898688
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEEC
Q ss_conf 93999516875335557888999997668544799974100335666431025656888878810012599996321632
Q 001856 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (1003)
Q Consensus 726 G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWS 805 (1003)
+.+||+|||+|+.... ........||+.|+|||.+.+..|+.++||||
T Consensus 164 ~~~kl~DfG~a~~~~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwS 211 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211 (309)
T ss_dssp GCEEECCTTCEESSCE--------------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred CCEEECCCCCCCCCCC--------------------------------CCCCCCEECCCCCCCHHHHCCCCCCCCCEEEH
T ss_conf 7638743443224442--------------------------------23455301377555538752699996221531
Q ss_pred HHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 16799999829-9999999935678756304789999999899889999875265993776999998898709
Q 001856 806 VGIILFELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 806 LGVILYELLTG-kpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
|||++|||++| .+||.+.+..+++..+..+.. +..+..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 212 fGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~ 279 (309)
T d1fvra_ 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 279 (309)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 388999998368999999999999999982688--888766789999999997678966894---99999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.33 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=226.2
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 8899898556890899875005966999999989-----99789999930410001789999999999998559996778
Q 001856 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653 (1003)
Q Consensus 579 i~p~k~~~~ledYeIlk~LGkGsFGtVylArdk~-----tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVk 653 (1003)
+.|.+|.+..++|++.+.||+|+||+||+|.++. ++..||+|++++.. .......+.+|+.+++.++||||++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred CCCCCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 68610042689918835982078818999998786447789689999987012--8689999999999999769998841
Q ss_pred EEEEEECCCEEEEEEEECCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC
Q ss_conf 985653163289999862687849999842----------9999999999999999999987625823045798625635
Q 001856 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723 (1003)
Q Consensus 654 Ll~sf~d~~~LyLVmEyl~GGSL~dlLkk~----------g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId 723 (1003)
+++.+.....+++|||||++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167 (308)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred EEEEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEEC
T ss_conf 25478428810677760489988999875033211344468879999999999999999987647965432867754035
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEE
Q ss_conf 79939995168753355578889999976685447999741003356664310256568888788100125999963216
Q 001856 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (1003)
Q Consensus 724 ~~G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDI 803 (1003)
.++++||+|||+|+..... .........+||+.|+|||.+.+..++.++||
T Consensus 168 ~~~~~Kl~DFGla~~~~~~-----------------------------~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv 218 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYET-----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 218 (308)
T ss_dssp TTCCEEECCTTCCCGGGGG-----------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred CCCEEEEEECCCCEECCCC-----------------------------CCEEECCCEECCCCCCCHHHHCCCCCCCCCCC
T ss_conf 9964999424542023577-----------------------------63031340231632378888736998833344
Q ss_pred ECHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 3216799999829-9999999935678756304789999999899889999875265993776999998898709
Q 001856 804 WSVGIILFELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 804 WSLGVILYELLTG-kpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
|||||++|||++| .+||.+.+..+++..+..+.. +..|..+++.+.+||.+||+.||.+|| ++.+++++
T Consensus 219 ~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RP---s~~~il~~ 288 (308)
T d1p4oa_ 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 288 (308)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 43789999999689999999899999999980888--888633539999999997577965893---99999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.05 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=222.6
Q ss_pred CCCCCCCCEEEEEEEECCCCEEEEEEEECCCC-------CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 89855689089987500596699999998999-------78999993041000178999999999999855-99967789
Q 001856 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTG-------DLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRF 654 (1003)
Q Consensus 583 k~~~~ledYeIlk~LGkGsFGtVylArdk~tg-------k~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L-~HPnIVkL 654 (1003)
+|.+..++|++.+.||+|+||.||+|+...++ ..||+|++++.. .......+.+|..++..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEC
T ss_conf 672258996970098516782899999857875556675499999988112--868899999999999981399969734
Q ss_pred EEEEECCCEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCC
Q ss_conf 85653163289999862687849999842----------------99999999999999999999876258230457986
Q 001856 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718 (1003)
Q Consensus 655 l~sf~d~~~LyLVmEyl~GGSL~dlLkk~----------------g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPe 718 (1003)
++++.++..+|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCC
T ss_conf 65220188689999736999099999860677643222334574346799999999999999998766379786302210
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
Q ss_conf 25635799399951687533555788899999766854479997410033566643102565688887881001259999
Q 001856 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 798 (1003)
Q Consensus 719 NILId~~G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt 798 (1003)
|||++.++.+||+|||+++...... ........+||+.|+|||++.+..|+
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHID-----------------------------YYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCC-----------------------------TTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred CEEECCCCCEEECCCHHHCCCCCCC-----------------------------CCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 2245478976762211101135555-----------------------------54314667888466326675179888
Q ss_pred CCCEEECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC
Q ss_conf 63216321679999982-9999999993567875630478999999989988999987526599377699999889870
Q 001856 799 TTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 799 ~kSDIWSLGVILYELLT-GkpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq 876 (1003)
.++|||||||++|||++ |.+||.+.+..+++..+..+.. +..|..+++.+.+||.+||++||.+|| ++.|+++
T Consensus 216 ~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rp---s~~eil~ 289 (299)
T d1fgka_ 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRP---TFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCC---CHHHHHH
T ss_conf 2555477588888740179898999999999999972888--898743529999999997667976793---9999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.34 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=222.2
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 989855689089987500596699999998-----99978999993041000178999999999999855-999677898
Q 001856 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFF 655 (1003)
Q Consensus 582 ~k~~~~ledYeIlk~LGkGsFGtVylArdk-----~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L-~HPnIVkLl 655 (1003)
.+|.+..++|++.++||+|+||.||+|+++ .+++.||+|++++.. .......+.+|+.++..+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 02637789969854982068829999998066447788699999987424--8779999999999987626999887899
Q ss_pred EEEECCCEEEEEEEECCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCC
Q ss_conf 56531632899998626878499998429------------------999999999999999999987625823045798
Q 001856 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLG------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 717 (1003)
Q Consensus 656 ~sf~d~~~LyLVmEyl~GGSL~dlLkk~g------------------~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKP 717 (1003)
+++.+...+|+|||||+||+|.+++++.. .+++..+..++.||+.||+|||+++||||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
Q ss_conf 62563579939995168753355578889999976685447999741003356664310256568888788100125999
Q 001856 718 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797 (1003)
Q Consensus 718 eNILId~~G~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~y 797 (1003)
+|||++..+.+||+|||+++...... ........+||+.|+|||++.+..+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDS-----------------------------NYVVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT-----------------------------TSEECSSSEECGGGCCHHHHHHCCC
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCCC-----------------------------CCEEEEECCCCHHHCCHHHHCCCCC
T ss_conf 21000025752102340102336788-----------------------------6158620135968767788617999
Q ss_pred CCCCEEECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC
Q ss_conf 963216321679999982-9999999993567875630478999999989988999987526599377699999889870
Q 001856 798 GTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 798 t~kSDIWSLGVILYELLT-GkpPF~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq 876 (1003)
+.++|||||||++|||++ |.+||...+..+.+.+++..... +..+..++..+.+||.+||+.||.+|| ++.++++
T Consensus 225 ~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RP---s~~~il~ 300 (311)
T d1t46a_ 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRP---TFKQIVQ 300 (311)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHH
T ss_conf 974001025899999985899887789989999999866898-898543659999999997577965792---9999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.65 Aligned_cols=248 Identities=26% Similarity=0.459 Sum_probs=218.8
Q ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CC
Q ss_conf 98556890899875005966999999989997899999304100017899999999999985599967789856531-63
Q 001856 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RE 662 (1003)
Q Consensus 584 ~~~~ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d-~~ 662 (1003)
|.+..++|++++.||+|+||.||+|+.+ +..||+|++++.. ..+.+.+|+.+++.++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCHH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf 9557899488579820798089999999--9099999988577-----79999999999986789898549878872389
Q ss_pred EEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 289999862687849999842--999999999999999999998762582304579862563579939995168753355
Q 001856 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (1003)
Q Consensus 663 ~LyLVmEyl~GGSL~dlLkk~--g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~ 740 (1003)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECC
T ss_conf 28999963699989999874578888999999999999852321133765536665676014689977632456003447
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCC
Q ss_conf 578889999976685447999741003356664310256568888788100125999963216321679999982-9999
Q 001856 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (1003)
Q Consensus 741 ~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpP 819 (1003)
.......+|+.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 155 ----------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 155 ----------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp -----------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ----------------------------------CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf ----------------------------------8776556664677817872798885887775799999999789999
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 9999935678756304789999999899889999875265993776999998898709
Q 001856 820 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 820 F~~~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
|...+..++...+.++.. +.++..+++++.+||.+||..||.+|| ++.+++++
T Consensus 201 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~ 253 (262)
T d1byga_ 201 YPRIPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253 (262)
T ss_dssp CTTSCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 999999999999980899--999765799999999997566976893---99999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.52 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=220.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECC-CC--CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 6890899875005966999999989-99--78999993041000178999999999999855999677898565316328
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRT-TG--DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~-tg--k~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~~L 664 (1003)
.++|++++.||+|+||.||+|+... ++ ..||+|++++.........+.+.+|+.+|..++||||+++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 9999862687849999842-999999999999999999998762582304579862563579939995168753355578
Q 001856 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 665 yLVmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s 743 (1003)
|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred HEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCCC
T ss_conf 11465423861254442126899999999999999999987521787520566888156556543325611555303588
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCC
Q ss_conf 889999976685447999741003356664310256568888788100125999963216321679999982-9999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLT-GkpPF~~ 822 (1003)
. .........|++.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 166 ~----------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 166 D----------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp C----------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred C----------------------------CCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 7----------------------------526547632573107999983799994215661489999999689999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHC
Q ss_conf 993567875630478999999989988999987526599377699999889870
Q 001856 823 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 876 (1003)
Q Consensus 823 ~s~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILq 876 (1003)
.+..++..++......+ ..+..+|+.+.+||.+||..||.+|| ++.+|++
T Consensus 218 ~~~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RP---t~~ei~~ 267 (273)
T d1u46a_ 218 LNGSQILHKIDKEGERL-PRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHH
T ss_conf 69999999998479999-98544539999999997688966792---9999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.93 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=209.9
Q ss_pred EEEEEEEECCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEE
Q ss_conf 089987500596699999998999---7899999304100017899999999999985599967789856531-632899
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYL 666 (1003)
Q Consensus 591 YeIlk~LGkGsFGtVylArdk~tg---k~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d-~~~LyL 666 (1003)
+...++||+|+||+||+|++..++ ..||+|++++. ......+.+.+|+.+|..++||||+++++++.. +..+|+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 52666981368809999999779987999999998843--6978999999999999867899986786789806994389
Q ss_pred EEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99862687849999842-99999999999999999999876258230457986256357993999516875335557888
Q 001856 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGLAk~~~~~s~d 745 (1003)
|||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~- 185 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF- 185 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC-
T ss_pred EEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC-
T ss_conf 9987406741442101345404899999999988765200336762577668757677999889910652322556655-
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCC-CCC
Q ss_conf 9999976685447999741003356664310256568888788100125999963216321679999982999999-999
Q 001856 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN-AEH 824 (1003)
Q Consensus 746 dls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~-~~s 824 (1003)
..........||+.|+|||++.+..++.++||||||+++|||++|..||. ..+
T Consensus 186 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 186 --------------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp --------------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred --------------------------CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf --------------------------531002565556455676887437999745746619999999978999988899
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCC
Q ss_conf 35678756304789999999899889999875265993776999998898709
Q 001856 825 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 877 (1003)
Q Consensus 825 ~~el~qkIl~~~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqH 877 (1003)
..++...+..+.. +..|..+++++.+||.+||..||.+|| ++.|+++|
T Consensus 240 ~~~~~~~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 240 TFDITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp ---CHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHHH
T ss_conf 9999999980898--899644759999999997688976893---99999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=357.02 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=204.3
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-EEEEEEEEECCCEEEEE
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996-77898565316328999
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPn-IVkLl~sf~d~~~LyLV 667 (1003)
++|++.+.||+|+||.||+|+++.+++.||+|++...... ..+..|..+++.++|++ |+.++..+.+....|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC-----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 8899968985078809999999889989999997210058-----88999999999703899601799999519877899
Q ss_pred EEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC---CCCEEEEECCCCCCCCCCC
Q ss_conf 986268784999984-299999999999999999999876258230457986256357---9939995168753355578
Q 001856 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINS 743 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk-~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~---~G~IKLsDFGLAk~~~~~s 743 (1003)
|||+. ++|...+.. .+.+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEECC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCC
T ss_conf 98738-71333244306887689999999999999999997994426678766064335777615650467513425544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCC
Q ss_conf 88999997668544799974100335666431025656888878810012599996321632167999998299999999
Q 001856 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (1003)
Q Consensus 744 ~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~~~ 823 (1003)
... ........+.+||+.|||||++.+..++.++|||||||++|||++|.+||...
T Consensus 161 ~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 161 THQ------------------------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp TCC------------------------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCC------------------------CEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCC
T ss_conf 554------------------------10001357767873532999991899898321886177899998498766553
Q ss_pred CHHHHHHHHH---HC--CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 9356787563---04--789999999899889999875265993776999998898709788
Q 001856 824 HPQQIFDNIL---NR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 880 (1003)
Q Consensus 824 s~~el~qkIl---~~--~~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFF 880 (1003)
........+. .. ..+.+..+..+|+++.+||.+||+.+|.+||.+..+.++|+|+|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp C-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 05779999998523567898357534788999999999843995579199999999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=346.24 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=204.6
Q ss_pred CCCCCCCCCCC--CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC---------
Q ss_conf 88998985568--9089987500596699999998999789999930410001789999999999998559---------
Q 001856 579 IHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--------- 647 (1003)
Q Consensus 579 i~p~k~~~~le--dYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~--------- 647 (1003)
++|...+..+. +|+++++||+|+||+||+|+++.+|+.||+|++++.. ...+.+.+|+.+++.++
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCCCCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC----CCHHHHHHHHHHHHHHCCHHHHHHHH
T ss_conf 97888888844785799899750778189999999999799999983431----33689999999999840145555542
Q ss_pred --CCCEEEEEEEEECC--CEEEEEEEECCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCC
Q ss_conf --99677898565316--3289999862687849999---842999999999999999999998762-582304579862
Q 001856 648 --NPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDN 719 (1003)
Q Consensus 648 --HPnIVkLl~sf~d~--~~LyLVmEyl~GGSL~dlL---kk~g~LsEe~ir~Ia~QIL~ALeYLHs-~GIIHRDIKPeN 719 (1003)
|+||+++++++... ...+++++++..+...... .....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred CCCCCEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 27676478998763125652023432000354200000122346786899999999999998887640586465677057
Q ss_pred EEECCCC------CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHC
Q ss_conf 5635799------3999516875335557888999997668544799974100335666431025656888878810012
Q 001856 720 LLIAHDG------HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (1003)
Q Consensus 720 ILId~~G------~IKLsDFGLAk~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~ 793 (1003)
||++.++ .++|+|||.|.... ......+||+.|+|||++.
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~----------------------------------~~~~~~~gt~~y~aPE~~~ 202 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYD----------------------------------EHYTNSIQTREYRSPEVLL 202 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETT----------------------------------BCCCSCCSCGGGCCHHHHH
T ss_pred EEEECCCCCCCCCEEEEEECCCCCCCC----------------------------------CCCCCCCCCCCCCCHHHCC
T ss_conf 056305765644305675314421234----------------------------------4542236652105713214
Q ss_pred CCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHCCC------------------------C-----
Q ss_conf 599996321632167999998299999999935------67875630478------------------------9-----
Q 001856 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ------QIFDNILNRKI------------------------P----- 838 (1003)
Q Consensus 794 g~~yt~kSDIWSLGVILYELLTGkpPF~~~s~~------el~qkIl~~~~------------------------~----- 838 (1003)
+..|+.++||||+||++++|++|+.||...... .....++.... .
T Consensus 203 ~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
T d1q8ya_ 203 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282 (362)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCC
T ss_conf 66777643201237899999878899898755432102689999999837998788624532200013201220243235
Q ss_pred ----------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ----------9999998998899998752659937769999988987097889999
Q 001856 839 ----------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 884 (1003)
Q Consensus 839 ----------~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEILqHPFFk~Id 884 (1003)
....+...++.+.|||.+||++||.+|| ||.|+|+||||++..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 283 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTL 335 (362)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCT
T ss_pred CCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC---CHHHHHCCCCCCCCC
T ss_conf 77644421000156743589999999998779945790---899996693407898
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=341.47 Aligned_cols=254 Identities=19% Similarity=0.260 Sum_probs=205.1
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEECCCEEEEE
Q ss_conf 890899875005966999999989997899999304100017899999999999985599-9677898565316328999
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLV 667 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~H-PnIVkLl~sf~d~~~LyLV 667 (1003)
++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|..++..+.| ++|+.+++.+......|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 806997998417882999999988997999999750258-----299999999999964899987799996018811799
Q ss_pred EEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC-----CCCEEEEECCCCCCCCC
Q ss_conf 9862687849999842-99999999999999999999876258230457986256357-----99399951687533555
Q 001856 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-----DGHIKLTDFGLSKVGLI 741 (1003)
Q Consensus 668 mEyl~GGSL~dlLkk~-g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~-----~G~IKLsDFGLAk~~~~ 741 (1003)
|||+ |++|.+++... ..+++..+..++.|++.||.|||++|||||||||+|||++. .+.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCC
T ss_conf 9964-888799997520311068999999999999999997796626677131523475434479568723660577146
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 78889999976685447999741003356664310256568888788100125999963216321679999982999999
Q 001856 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (1003)
Q Consensus 742 ~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~yt~kSDIWSLGVILYELLTGkpPF~ 821 (1003)
..... ........+.+||+.|||||++.+..++.++|||||||++|||++|..||.
T Consensus 159 ~~~~~------------------------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 159 PVTKQ------------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp TTTCC------------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCCCC------------------------CEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 76654------------------------111024676277510267989648888869998983199999986987678
Q ss_pred CCCH---HHHHHHHHHCC--CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 9993---56787563047--899999998998899998752659937769999988987
Q 001856 822 AEHP---QQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 875 (1003)
Q Consensus 822 ~~s~---~el~qkIl~~~--~~~P~ip~~iS~elkDLIkkLLskDPskRpg~~TAeEIL 875 (1003)
+... ...+..+.... .+.+.++..+|+++.+++..|+..+|.+|| +...+.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP---~y~~l~ 270 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDYLQ 270 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHHHH
T ss_pred CCCCHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCC---CHHHHH
T ss_conf 85302199999999705679995896579989999999998439930085---999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.58 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=192.7
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EE
Q ss_conf 89089987500596699999998999789999930410001789999999999998559996778985653163----28
Q 001856 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NL 664 (1003)
Q Consensus 589 edYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~HPnIVkLl~sf~d~~----~L 664 (1003)
.+|.+.+.||+|+||.||+|+. +|+.||+|++.... ........|+..+..++||||+++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
T ss_conf 6899988982078819999999--99899999987200----46799999999996279986832688998379860489
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 9999862687849999842999999999999999999998762--------58230457986256357993999516875
Q 001856 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (1003)
Q Consensus 665 yLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs--------~GIIHRDIKPeNILId~~G~IKLsDFGLA 736 (1003)
|+|||||++|+|.+++++. .++......++.|++.||.|+|+ +|||||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 9999646698989998658-999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC------CCCCCEEECHHHHH
Q ss_conf 335557888999997668544799974100335666431025656888878810012599------99632163216799
Q 001856 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------HGTTADWWSVGIIL 810 (1003)
Q Consensus 737 k~~~~~s~ddls~p~~~gttL~gd~~p~ls~s~~~~~~~~~~s~vGTp~YmAPEVL~g~~------yt~kSDIWSLGVIL 810 (1003)
+....... .........+||+.|||||++.+.. ++.++|||||||+|
T Consensus 156 ~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 156 VRHDSATD---------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp EEEETTTT---------------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCC---------------------------CEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 23467776---------------------------200135525035476782210565454677767501220159999
Q ss_pred HHHHHCCCCCCCCC---------------HHHHHHHHHHCCCCCCCCCCC-----CCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99982999999999---------------356787563047899999998-----9988999987526599377699999
Q 001856 811 FELIVGIPPFNAEH---------------PQQIFDNILNRKIPWPRVPEE-----MSPEAHDLIDRFLTEDPHQRLGSGG 870 (1003)
Q Consensus 811 YELLTGkpPF~~~s---------------~~el~qkIl~~~~~~P~ip~~-----iS~elkDLIkkLLskDPskRpg~~T 870 (1003)
|||++|.+||.... .......+..... .|.++.. ....+.+|+.+||..||.+|| +
T Consensus 209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s 284 (303)
T d1vjya_ 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARL---T 284 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC---C
T ss_pred HHHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCC---C
T ss_conf 999628998876631124101225564309999998750246-888776557768999999999997606985895---9
Q ss_pred HHHHHCC
Q ss_conf 8898709
Q 001856 871 ASEVKQH 877 (1003)
Q Consensus 871 AeEILqH 877 (1003)
+.|++++
T Consensus 285 ~~ei~~~ 291 (303)
T d1vjya_ 285 ALRIKKT 291 (303)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
T ss_conf 9999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.4e-23 Score=177.60 Aligned_cols=135 Identities=19% Similarity=0.166 Sum_probs=106.8
Q ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCC---------------CHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 08998750059669999999899978999993041000---------------178999999999999855999677898
Q 001856 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI---------------RKNAVESILAERDILISVRNPFVVRFF 655 (1003)
Q Consensus 591 YeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~---------------~~~~ie~ilrEi~IL~~L~HPnIVkLl 655 (1003)
+.+.++||+|+||+||+|++. +|+.||+|+++..... .........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEECCCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 56531632899998626878499998429999999999999999999987625823045798625635799399951687
Q 001856 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (1003)
Q Consensus 656 ~sf~d~~~LyLVmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs~GIIHRDIKPeNILId~~G~IKLsDFGL 735 (1003)
+... .+++||++++..+.. ++...+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EECC----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECCC
T ss_conf 8628----889999504565420-------0157899999999999999826888983689036114289-899987788
Q ss_pred CCC
Q ss_conf 533
Q 001856 736 SKV 738 (1003)
Q Consensus 736 Ak~ 738 (1003)
|+.
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred CCC
T ss_conf 430
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=4.4e-07 Score=63.54 Aligned_cols=141 Identities=15% Similarity=0.127 Sum_probs=93.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCEEEE
Q ss_conf 689089987500596699999998999789999930410001789999999999998559-9967789856531632899
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~-HPnIVkLl~sf~d~~~LyL 666 (1003)
++.|+..+..+-++.+.||++. ..+..+.+|+....... ....+.+|..++..+. +--+.+++....+.+..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCC---CHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEE
T ss_conf 1352799767899877189999--08986999984887653---255699999999987606998728999750896499
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q ss_conf 99862687849999842999999999999999999998762---------------------------------------
Q 001856 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------------------------------------- 707 (1003)
Q Consensus 667 VmEyl~GGSL~dlLkk~g~LsEe~ir~Ia~QIL~ALeYLHs--------------------------------------- 707 (1003)
||++++|.++........ . ...++.++...|..||+
T Consensus 88 v~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEECCCCCCCCCCCCCC--C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 998604334354334402--6---99999989999999855684214357644656555778998776555543033232
Q ss_pred --------------------CCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --------------------5823045798625635799399951687533
Q 001856 708 --------------------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 --------------------~GIIHRDIKPeNILId~~G~IKLsDFGLAk~ 738 (1003)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=5.4e-06 Score=56.01 Aligned_cols=147 Identities=17% Similarity=0.133 Sum_probs=83.8
Q ss_pred CCCCCCCEEEEEEEECCC-CEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEC
Q ss_conf 985568908998750059-6699999998999789999930410001789999999999998559--9967789856531
Q 001856 584 DRTSIDDFEIIKPISRGA-FGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--NPFVVRFFYSFTC 660 (1003)
Q Consensus 584 ~~~~ledYeIlk~LGkGs-FGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~--HPnIVkLl~sf~d 660 (1003)
+...+..++.. .+..|. .+.||++.. ..+..+.+|....... ..+..|...++.+. .-.+.+++....+
T Consensus 6 ~~~~l~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 6 WVERLFGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp GTTTTTTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred HHHHCCCCCEE-ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCCCEEEECCC
T ss_conf 99752598358-7678654775899993-8987899995896677------68999999999998659998861322245
Q ss_pred CCEEEEEEEECCCCCHHH--------------HHHHCCCCC---------HHH-HH----HHH---------------HH
Q ss_conf 632899998626878499--------------998429999---------999-99----999---------------99
Q 001856 661 RENLYLVMEYLNGGDLYS--------------LLRNLGCLD---------EDV-AR----VYI---------------AE 697 (1003)
Q Consensus 661 ~~~LyLVmEyl~GGSL~d--------------lLkk~g~Ls---------Ee~-ir----~Ia---------------~Q 697 (1003)
.+..++||++++|.++.. .+.+...++ ... .. .+. ..
T Consensus 78 ~~~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp SSCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCCEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHH
T ss_conf 66159998744135543221268999999999999873688544887554124688999999875411011340112137
Q ss_pred HHHHHHHHHH-------CCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9999998762-------5823045798625635799399951687533
Q 001856 698 VVLALEYLHS-------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 698 IL~ALeYLHs-------~GIIHRDIKPeNILId~~G~IKLsDFGLAk~ 738 (1003)
....+..+.. ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 999999998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=1.4e-05 Score=53.10 Aligned_cols=141 Identities=19% Similarity=0.171 Sum_probs=81.1
Q ss_pred EEEEECCCCEEEEEEEECCCCCEEEEEEEECC-CCCC---HHHHHHHHHHHHHHHHCC-C--CCEEEEEEEEECCCEEEE
Q ss_conf 98750059669999999899978999993041-0001---789999999999998559-9--967789856531632899
Q 001856 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-DMIR---KNAVESILAERDILISVR-N--PFVVRFFYSFTCRENLYL 666 (1003)
Q Consensus 594 lk~LGkGsFGtVylArdk~tgk~VAIKVIkKs-~l~~---~~~ie~ilrEi~IL~~L~-H--PnIVkLl~sf~d~~~LyL 666 (1003)
.+.||.|....||++....+++.+.+|.-... +... .....+...|...|..+. + ..+++++.. +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCHH-HHHHHCCCCCHHHHHHHHHH------------------------------------------------
Q ss_conf 99862687849-99984299999999999999------------------------------------------------
Q 001856 667 VMEYLNGGDLY-SLLRNLGCLDEDVARVYIAE------------------------------------------------ 697 (1003)
Q Consensus 667 VmEyl~GGSL~-dlLkk~g~LsEe~ir~Ia~Q------------------------------------------------ 697 (1003)
|||++.+..+. ..+.... .....+..+...
T Consensus 109 vmE~L~~~~~~~~~l~~~~-~~~~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~ 187 (392)
T d2pula1 109 VMEDLSHLKIARKGLIEGE-NYPHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDT 187 (392)
T ss_dssp EECCCTTSEEHHHHHHHTC-CCTTHHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTT
T ss_pred EEECCCCCCCCHHHHCCCC-HHHHHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
T ss_conf 8713577653022201542-128999999999999998735033442111012334465788877776401047889887
Q ss_pred -------------------HHHHHHHHH------HCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------------------999999876------25823045798625635799399951687533
Q 001856 698 -------------------VVLALEYLH------SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 698 -------------------IL~ALeYLH------s~GIIHRDIKPeNILId~~G~IKLsDFGLAk~ 738 (1003)
+......+. ...++|+|+.|.|||++.+ .++++||..|..
T Consensus 188 ~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 188 NDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCC
T ss_conf 41065455778765520789999999874323688600335776784667599-308952265222
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.0012 Score=39.72 Aligned_cols=29 Identities=21% Similarity=0.303 Sum_probs=23.9
Q ss_pred CCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 5823045798625635799399951687533
Q 001856 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 708 ~GIIHRDIKPeNILId~~G~IKLsDFGLAk~ 738 (1003)
.++||+|+.|.|||++. + ..++||+-|..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 12024788804287838-9-35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.09 E-value=0.0023 Score=37.84 Aligned_cols=77 Identities=17% Similarity=0.258 Sum_probs=49.0
Q ss_pred CEEEEEEEECCCCEEEEEEEECC-------CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECC
Q ss_conf 90899875005966999999989-------99789999930410001789999999999998559-99677898565316
Q 001856 590 DFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCR 661 (1003)
Q Consensus 590 dYeIlk~LGkGsFGtVylArdk~-------tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~-HPnIVkLl~sf~d~ 661 (1003)
++++ +.|+.|-.-.+|++.... ..+.|.+++...... . ....+|..+++.+. +....++++.+.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----~-idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----E-SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----H-HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCH----H-HHHHHHHHHHHHHHHCCCCCEEEEECCC-
T ss_conf 1699-9917853343489996887754457898179996599611----6-5899999999999757999808998189-
Q ss_pred CEEEEEEEECCCCCH
Q ss_conf 328999986268784
Q 001856 662 ENLYLVMEYLNGGDL 676 (1003)
Q Consensus 662 ~~LyLVmEyl~GGSL 676 (1003)
.+|+||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---CEEEEEECCCCC
T ss_conf ---569997345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.05 E-value=0.038 Score=29.44 Aligned_cols=144 Identities=18% Similarity=0.145 Sum_probs=75.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----CCCEEEEE---EEEE
Q ss_conf 689089987500596699999998999789999930410001789999999999998559-----99677898---5653
Q 001856 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-----NPFVVRFF---YSFT 659 (1003)
Q Consensus 588 ledYeIlk~LGkGsFGtVylArdk~tgk~VAIKVIkKs~l~~~~~ie~ilrEi~IL~~L~-----HPnIVkLl---~sf~ 659 (1003)
++...-++.|..|---+.|++... .+ .|.+|++.... .. ..+..|..++..+. -|..+... ....
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCCEEEECCCCCCCCCEEEEEEC-CC-CEEEEECCCCC--CH---HHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEE
T ss_conf 998568523788852673899978-97-28999807899--98---8999999998754302555455641048976213
Q ss_pred CCCEEEEEEEECCCCCHH--------------HHHHHCC---------CCCHH------------------HHHHHHHHH
Q ss_conf 163289999862687849--------------9998429---------99999------------------999999999
Q 001856 660 CRENLYLVMEYLNGGDLY--------------SLLRNLG---------CLDED------------------VARVYIAEV 698 (1003)
Q Consensus 660 d~~~LyLVmEyl~GGSL~--------------dlLkk~g---------~LsEe------------------~ir~Ia~QI 698 (1003)
.......++.++.|.... ..++... ..... .....+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred EECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 41255024531146553332046788888998764544432024531011101200245677776531141279999999
Q ss_pred HHHHHHHH----HCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99999876----25823045798625635799399951687533
Q 001856 699 VLALEYLH----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (1003)
Q Consensus 699 L~ALeYLH----s~GIIHRDIKPeNILId~~G~IKLsDFGLAk~ 738 (1003)
...+.... ..|+||+|+.+.||+++.+...-++||+.|..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 87642048554545033378636564020454126742221236
|